Citrus Sinensis ID: 039681
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 624 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LZM4 | 657 | Wall-associated receptor | yes | no | 0.951 | 0.904 | 0.641 | 0.0 | |
| Q9M342 | 639 | Wall-associated receptor | no | no | 0.971 | 0.948 | 0.496 | 1e-168 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.605 | 0.477 | 0.390 | 5e-79 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.926 | 0.751 | 0.304 | 8e-78 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.546 | 0.454 | 0.436 | 3e-76 | |
| Q8GYF5 | 622 | Wall-associated receptor | no | no | 0.600 | 0.602 | 0.408 | 2e-75 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.556 | 0.475 | 0.429 | 2e-74 | |
| Q8RY67 | 708 | Wall-associated receptor | no | no | 0.777 | 0.685 | 0.353 | 2e-73 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.564 | 0.470 | 0.407 | 3e-73 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.945 | 0.819 | 0.303 | 6e-73 |
| >sp|Q9LZM4|WAKLQ_ARATH Wall-associated receptor kinase-like 20 OS=Arabidopsis thaliana GN=WAKL20 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 782 bits (2020), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/620 (64%), Positives = 481/620 (77%), Gaps = 26/620 (4%)
Query: 27 RCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGILWFDARNGSSYMIASINPLSQRIIIRP 86
RC NCGP VPYPLSTGP CG Q+Y+I C G L+F A +GSSY+I SIN ++QRI++RP
Sbjct: 42 RCPNCGPMVVPYPLSTGPTCGDQAYRINCVGGKLYFGALHGSSYVITSINSVTQRIVLRP 101
Query: 87 PGPAGS-TCTATDMRTQGIQLDDNLPFNITSSNTIMLLNCTDAI---------------Y 130
PG A S +C + D+ QG++LD +LPF+ITSSNTI+LLNC+ A+ Y
Sbjct: 102 PGLASSVSCISADVSKQGLELDPHLPFSITSSNTILLLNCSQAMLQAPIDCSPTSLCYSY 161
Query: 131 IKDKAPPCMTASSLCCVFKTGGSQTAYTIRVHNGGCTAYQSFVNLDANWV---PGKTWPE 187
IK+ A PC A LCC F+T GSQTAYTIR++ GGC AYQSFV L+ N PGK WP+
Sbjct: 162 IKNNASPCSKAP-LCCTFRTDGSQTAYTIRINGGGCLAYQSFVGLNPNKEVPPPGKKWPD 220
Query: 188 PGMELEWELPPEPICKTPEDCKDLL-HSNCLADPMYPGLKRCLCNPGFIWDPVNGLCQSS 246
G+EL+W LP EP+CKT DC LL S CL DP GLKRC C G WDPVN +C
Sbjct: 221 TGLELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWDPVNAIC--G 278
Query: 247 KYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGILVYNKLNEHMKKETKKLLIKQREE 306
K RHGK CK KKKKT++ AG A+ G L + + ++ ++ +KK+ K ++K+REE
Sbjct: 279 KCRHGKHCK-KKKKTVVFAGAAVAVVGVTLAIAVAVIGTKHSHQKVKKDIHKNIVKEREE 337
Query: 307 MLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN 366
ML+A + GKS+RIFTG+EI +ATNNFSKDNLIGTGGFGEVFK +L+DGT+TAIKRAKL N
Sbjct: 338 MLSANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNN 397
Query: 367 TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWP 426
TKGTD +LNEVRILCQVNHRSLVRLLGCCV+L+ L+IYE+IPNGTLF+HLH W
Sbjct: 398 TKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWK 457
Query: 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486
PL W RL IA+Q AEGL YLHSAA PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV+
Sbjct: 458 PLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDL 517
Query: 487 TET--NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544
TET N+SHIFT AQGT+GYLDPEYYRNFQLTDKSDVYSFGVVLLE++TSKKAIDF REE
Sbjct: 518 TETANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREE 577
Query: 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604
E+VNLV+Y+ K+MD+ERL E +DP+LK+ A +D++T++ LG LA++CL+ERRQNRPSMK
Sbjct: 578 EDVNLVMYINKMMDQERLTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMK 637
Query: 605 EVADEIEYIISIAKGRISES 624
EVADEIEYII+I ++E+
Sbjct: 638 EVADEIEYIINILSQEVTET 657
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9M342|WAKLP_ARATH Wall-associated receptor kinase-like 15 OS=Arabidopsis thaliana GN=WAKL15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 593 bits (1529), Expect = e-168, Method: Compositional matrix adjust.
Identities = 320/644 (49%), Positives = 418/644 (64%), Gaps = 38/644 (5%)
Query: 1 MKRSVLTVFIFTATLL---SCTTCALAVLRCGNCGPTPVPYPLSTGPNCGHQSYKIRC-A 56
M+ L++ FT +LL S TT A RC NCG T VPYPLSTG +CG Y+IRC
Sbjct: 1 MELPWLSLTTFTLSLLIYFSSTTQAFK--RCPNCGSTRVPYPLSTGLDCGDPGYRIRCDN 58
Query: 57 AGILWFDARNGSSYMIASINPLSQRIIIRPPGPAGSTCTATDMRTQGIQLDDNLPFNITS 116
G LWFD NGS+ I +I+P QR ++RPPG + C + D++ GIQLD NLPFN++
Sbjct: 59 YGSLWFDTLNGSTNPIKTIDPSGQRFVLRPPGFEQNKCVSVDIKYHGIQLDLNLPFNVSC 118
Query: 117 SNTIMLLNCT----DAIYIK------------------DKAPPCMTASSLCCVFKTGGSQ 154
SNT++++NCT DA + + C +S CC +KTG S
Sbjct: 119 SNTVIIMNCTKDGLDAYSSQGFNCSDNSLCHKFLNANLEARGNCRGVTS-CCWYKTGASV 177
Query: 155 TAYTI-RVHNGGCTAYQSFVNLDANWVPGKTWPEPGMELEWELPPEPICKTPEDCKDLLH 213
Y + R C+AYQSF+NLD +P W EP +E+ WE P EP+CK+ DC+DLL+
Sbjct: 178 NTYKVYRARPDMCSAYQSFMNLDLT-IPVSKWGEPAVEILWEAPREPVCKSQGDCRDLLN 236
Query: 214 SNCLADPMYPGLKRCLCNPGFIWDPVNGLCQSSKYRHGKGCKRKKKKTMLIAGMVAALGG 273
S C D G KRC C GF WD VN +C+ ++ K CKR +L
Sbjct: 237 SVCSNDSTNLGQKRCFCKKGFQWDSVNAVCEVNRCSKRKSCKRWSNLPLLGGLAGGVGA- 295
Query: 274 SLLVVLIGILVYNKLNEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFS 333
L+ I + +K N + +++ L + + RIFTGKEI +AT+NF+
Sbjct: 296 ILIAGFITKTIVSKQNRRIAGNQSWASVRKLHRNLLSINSTGLDRIFTGKEIVKATDNFA 355
Query: 334 KDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
K NL+G GGFGEVFKG LDDGT A+KRAKLGN K ++NEV+ILCQV+H++LV+LLG
Sbjct: 356 KSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVNEVQILCQVSHKNLVKLLG 415
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGK---WPPLPWHLRLVIAHQIAEGLTYLHSA 450
CC+EL+ +++YE++PNGTLF+H++ G + LP RL+IAHQ A+GL YLHS+
Sbjct: 416 CCIELEMPVLVYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRRLMIAHQTAQGLDYLHSS 475
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
+ PPIYHRDVKSSNILLDE L+ KV+DFGLSRL ++ SH+ T AQGT+GYLDPEYY
Sbjct: 476 SSPPIYHRDVKSSNILLDENLDVKVADFGLSRL---GVSDVSHVTTCAQGTLGYLDPEYY 532
Query: 511 RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570
NFQLTDKSDVYSFGVVL ELLT KKAIDFNREEE+VNLVV+++K + E RLM+V+DPV+
Sbjct: 533 LNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKALKEGRLMDVIDPVI 592
Query: 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614
AT ++E+MKALG+LA C+ E RQ RP+M+ A EIE I+
Sbjct: 593 GIGATEKEIESMKALGVLAELCVKETRQCRPTMQVAAKEIENIL 636
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (756), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 167/428 (39%), Positives = 250/428 (58%), Gaps = 50/428 (11%)
Query: 219 DPMYPGLKRCLCNPGFIWDPVNGLCQSSKYRHGKGCKR----KKKKTMLIAG-------- 266
D Y RC C GF +P YR G GCK K+++ M G
Sbjct: 311 DNAYLSYARCSCTRGFQGNP---------YRLG-GCKDINECKEEEGMTYCGTNKCVNLQ 360
Query: 267 ------------MVAALGGSL--LVVLIGI-LVYNKLNEHMKKETKKLLIKQ------RE 305
+ LG S L+ ++GI L+Y + + K KK K+ ++
Sbjct: 361 GHFKCVYNNHRPLAIGLGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQ 420
Query: 306 EMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLG 365
++++ + +F+ +E+ +AT NFS + ++G GG G V+KG+L DG + A+K++K+
Sbjct: 421 QLISTVGMVEKTIVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVV 480
Query: 366 NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKW 425
+ + +NEV IL Q+NHR++V+LLGCC+E +++YE+IPNG LF+HLH +F
Sbjct: 481 DEDKLEEFINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENI 540
Query: 426 PPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485
W++RL IA IA L+YLHS+A PIYHRDVKS+NI+LDEK AKVSDFG SR V
Sbjct: 541 MA-TWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTV- 598
Query: 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
+ +H+ T GT+GY+DPEY+++ Q TDKSDVYSFGVVL+EL+T +K+I F R +E
Sbjct: 599 --TVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQE 656
Query: 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKE 605
N L Y M E +L +++D +++ L + A +A CL+ + + RPSM+E
Sbjct: 657 NRTLATYFILAMKENKLFDIIDARIRDGCM---LSQVTATAKVARKCLNLKGRKRPSMRE 713
Query: 606 VADEIEYI 613
V+ E++ I
Sbjct: 714 VSMELDSI 721
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 8e-78, Method: Compositional matrix adjust.
Identities = 211/692 (30%), Positives = 330/692 (47%), Gaps = 114/692 (16%)
Query: 31 CGPTPVPYPLSTGPNCGHQS-YKIRCAAGILWFDARNGSSYMIASINPLSQRII------ 83
CG +PYP G C + Y+I C + F + + S + + +R
Sbjct: 31 CGGIDIPYPFGIGTGCYLEKWYEIICVNNSVPFLSIINREVVSISFSDMYRRFFNVGYGS 90
Query: 84 IRPPGPAGSTCTATDMRTQGIQLD-DNLPFNITSSNTIMLLNCTDAIYIKDKAPPCMTAS 142
IR P S ++ + G L+ PF + +N ++ + C + + + P +
Sbjct: 91 IRIRNPIASKGCSSGGQEFGSLLNMTGYPFYLGDNNMLIAVGCNNTASLTNVEPSIVGCE 150
Query: 143 SLC----------------CVFKTGGSQTAYTIRVHN-------GGCTA-----YQ---- 170
S C C + G S+ I + N G C A YQ
Sbjct: 151 STCSTNQDIPINDYLGVLYCNARYGDSEYCKNISIMNDTSCNGIGCCKASLPARYQQIIG 210
Query: 171 ---------------SFVNLDANWVPGKTWPE-------PGMELEWELPPEPI------- 201
+F+ + ++ + PE ++L W +
Sbjct: 211 VEIDDSNTESKGCKVAFITDEEYFLSNGSDPERLHANGYDTVDLRWFIHTANHSFIGSLG 270
Query: 202 CKTPEDCKDLLHSN------CLAD--PMYPGLKRCLCNPGFIWDPV-------------- 239
CK+ ++ L N CL D G C C GF +P
Sbjct: 271 CKSIDEYTILRRDNREYGIGCLCDYNSTTTGYATCSCASGFEGNPYIPGECKDINECVRG 330
Query: 240 ---NGLCQSSKYRH---GKGCKRKKKKTMLIAGMVAALGGSLLVVLIGIL-VYNKLNEHM 292
N +C + K + G C+ + ++I G+ + S LV + GI +Y +
Sbjct: 331 IDGNPVCTAGKCVNLLGGYTCEYTNHRPLVI-GLSTSF--STLVFIGGIYWLYKFIRRQR 387
Query: 293 KKETKKLLIKQR------EEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEV 346
+ KK K+ +++ + S R+F +E+ +AT NFS ++G GG G V
Sbjct: 388 RLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTV 447
Query: 347 FKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406
+KG+L DG + A+K++K+ + + +NEV IL Q+NHR++V+LLGCC+E D +++YE
Sbjct: 448 YKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYE 507
Query: 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466
+IPNG LF+HLH D + + W +RL IA IA L+YLHSAA PIYHRD+KS+NI+
Sbjct: 508 FIPNGNLFEHLH-DDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIM 566
Query: 467 LDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGV 526
LDEK AKVSDFG SR V + +H+ T GT+GY+DPEY+++ Q TDKSDVYSFGV
Sbjct: 567 LDEKHRAKVSDFGTSRTV---TVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGV 623
Query: 527 VLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALG 586
VL EL+T +K++ F R +E L Y M E RL +++D +++ L + A
Sbjct: 624 VLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCK---LNQVTAAA 680
Query: 587 LLAASCLDERRQNRPSMKEVADEIEYIISIAK 618
+A CL+ + + RPSM++V+ E+E I S ++
Sbjct: 681 KIARKCLNMKGRKRPSMRQVSMELEKIRSYSE 712
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 158/362 (43%), Positives = 228/362 (62%), Gaps = 21/362 (5%)
Query: 263 LIAGMVAALGGSLLVVLIGILVYNKL---------NEHMKKETKKLLIKQREEMLNAKAA 313
L G+V LG LL +++GI K K LL+KQ ++
Sbjct: 347 LFPGLV--LGFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQ--QLTTRGGN 402
Query: 314 GKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLV 373
+S++IF+ KE+ +AT+NF+ + ++G GG G V+KG+L DG + A+KR+K+ + +
Sbjct: 403 VQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEF 462
Query: 374 LNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLR 433
+NEV +L Q+NHR++V+L+GCC+E + +++YE+IPNG LF LH D + W +R
Sbjct: 463 INEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDY--TMTWDVR 520
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493
L I+ +IA L YLHSAA P+YHRDVK++NILLDEK AKVSDFG SR + +T H
Sbjct: 521 LRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQT---H 577
Query: 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553
+ T GT GYLDPEY++ Q TDKSDVYSFGVVL+EL+T +K R EEN LV +
Sbjct: 578 LTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHF 637
Query: 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
+ M + R++++VD +KE T LE + A+ LA CL + + RP+M+EV+ E+E I
Sbjct: 638 NEAMKQNRVLDIVDSRIKEGCT---LEQVLAVAKLARRCLSLKGKKRPNMREVSVELERI 694
Query: 614 IS 615
S
Sbjct: 695 RS 696
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYF5|WAKLR_ARATH Wall-associated receptor kinase-like 21 OS=Arabidopsis thaliana GN=WAKL21 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 284 bits (726), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 159/389 (40%), Positives = 227/389 (58%), Gaps = 14/389 (3%)
Query: 227 RCLCNPGFIWDP--VNGLCQSSKYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGILV 284
RC C GF V G C Y KRK +++ G L G L++V++
Sbjct: 217 RCTCREGFSGKAFTVPGGCHRLVY------KRKGLHKLVVLGTAGILVGVLVIVVLIATY 270
Query: 285 YNKLNEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFG 344
+ + + E + +L A S +T KEI +AT++FS N++GTG +G
Sbjct: 271 FFRNKQSASSERASIA----NRLLCELAGNSSVPFYTYKEIEKATDSFSDKNMLGTGAYG 326
Query: 345 EVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404
V+ G + + AIKR K +T D V+NE+++L V+H +LVRLLGCC + ++
Sbjct: 327 TVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIKLLSSVSHPNLVRLLGCCFADGEPFLV 386
Query: 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSN 464
YE++PNGTL+ HL + G+ PPL W LRL IA Q A + +LHS+ PPIYHRD+KSSN
Sbjct: 387 YEFMPNGTLYQHLQHE-RGQ-PPLSWQLRLAIACQTANAIAHLHSSVNPPIYHRDIKSSN 444
Query: 465 ILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSF 524
ILLD + N+K+SDFGLSRL T+ SHI T QGT GYLDP+Y+++FQL+DKSDVYSF
Sbjct: 445 ILLDHEFNSKISDFGLSRLGMSTDFEASHISTAPQGTPGYLDPQYHQDFQLSDKSDVYSF 504
Query: 525 GVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKA 584
GVVL+E+++ K IDF R VNL + R+++++DP L + ++
Sbjct: 505 GVVLVEIISGFKVIDFTRPYSEVNLASLAVDRIGRGRVVDIIDPCLNKEINPKMFASIHN 564
Query: 585 LGLLAASCLDERRQNRPSMKEVADEIEYI 613
L LA CL R RP+M E+ +++ I
Sbjct: 565 LAELAFRCLSFHRNMRPTMVEITEDLHRI 593
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (716), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 158/368 (42%), Positives = 231/368 (62%), Gaps = 21/368 (5%)
Query: 257 KKKKTMLIAGMVAALGGSLLVVLIGILVYNKL---------NEHMKKETKKLLIKQREEM 307
K K ++ G++ L G LV +G+ KL ++ K LL+KQ ++
Sbjct: 349 KPTKPPVLQGILIGLSG--LVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQ--QL 404
Query: 308 LNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT 367
+ ++IF+ KE+R+AT+NFS D ++G GG G V+KG+L DG++ A+KR+K+ +
Sbjct: 405 TTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDE 464
Query: 368 KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP 427
+ +NE+ +L Q+NHR++V+LLGCC+E + +++YEYIPNG LF LH D + +
Sbjct: 465 DKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLH-DESDDY-T 522
Query: 428 LPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487
+ W +RL IA +IA LTY+HSAA PI+HRD+K++NILLDEK AKVSDFG SR V
Sbjct: 523 MTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLD 582
Query: 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV 547
+T H+ T GT GY+DPEY+ + Q T KSDVYSFGVVL+EL+T +K + R EE
Sbjct: 583 QT---HLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGR 639
Query: 548 NLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607
L + + M E R V+D + LE + A+ LA CL+ + +NRP+MKEV+
Sbjct: 640 GLATHFLEAMKENR---VIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVS 696
Query: 608 DEIEYIIS 615
+E+E I S
Sbjct: 697 NELERIRS 704
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY67|WAKLO_ARATH Wall-associated receptor kinase-like 14 OS=Arabidopsis thaliana GN=WAKL14 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 277 bits (709), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 185/524 (35%), Positives = 268/524 (51%), Gaps = 39/524 (7%)
Query: 112 FNITSSNTIMLLNC---TDAIYIKDK-------APPCMTASSLCCVFKTGGSQTAYTIR- 160
F TS N+ ++ NC TD IK K C ++ C S + + +
Sbjct: 117 FAPTSENSFLMENCNRTTDGCSIKQKFLENVLKLKSCDATGNISCFSLDSNSSSKNSAKF 176
Query: 161 -----VHNGGCTAYQSFVNLDANWV-PGKTWPEPGMELEWELP---PEPICKTPEDCKDL 211
+ N C+ S + ++ V G + L W L C DC D+
Sbjct: 177 FSMKTLRNSSCSLLFSSIAFESVGVNAGIALEFERVRLGWWLKGGCESGTCAANTDCTDV 236
Query: 212 LHSNCLADPMYPGLKRCLCNPGFIWDPVNGLCQSSKYR-HGKGCKRKKKKTMLIAGMVAA 270
P RC C GF D CQ + G + ++ LI +
Sbjct: 237 ------ETPHGYAGHRCSCLDGFHGDGYTNPCQRALPECRGSKLVWRHCRSNLITIVGGT 290
Query: 271 LGGSLLVVLIGILVYNKLNEHMKKETKKLLIKQREEMLNAKAAGKSA-RIFTGKEIRRAT 329
+GG+ L+ + + K ++ + L + L ++AAG S+ F KEI +AT
Sbjct: 291 VGGAFLLAALAFFFFCK-----RRRSTPLRSHLSAKRLLSEAAGNSSVAFFPYKEIEKAT 345
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV 389
+ FS+ +G G +G V++G L + AIKR + +++ D V+NE+++L V+H +LV
Sbjct: 346 DGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNEIKLLSSVSHPNLV 405
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
RLLGCC+E +++YEY+PNGTL +HL D + LPW LRL +A Q A+ + YLHS
Sbjct: 406 RLLGCCIEQGDPVLVYEYMPNGTLSEHLQRD---RGSGLPWTLRLTVATQTAKAIAYLHS 462
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
+ PPIYHRD+KS+NILLD N+KV+DFGLSRL T SHI T QGT GYLDP+Y
Sbjct: 463 SMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRL---GMTESSHISTAPQGTPGYLDPQY 519
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569
++ F L+DKSDVYSFGVVL E++T K +DF R +NL + + E++DP+
Sbjct: 520 HQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCIDEIIDPI 579
Query: 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
L L ++ + LA CL RP+M EVADE+E I
Sbjct: 580 LDLDLDAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQI 623
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 151/371 (40%), Positives = 237/371 (63%), Gaps = 19/371 (5%)
Query: 254 CKRKKKKTM--LIAGMVAALGGSLLVVLIGILVYNKLNEHMKK--ETKKLLIKQREEMLN 309
C+ KK + + +I G++ +G +LL+ GI K + +K +K + +L
Sbjct: 331 CQPKKPEQLKRVIQGVL--IGSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLK 388
Query: 310 AKAAGKS-----ARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKL 364
+ A K +RIF+ E+ +AT+NF+K+ ++G GG G V+KG+L DG + A+KR+K
Sbjct: 389 QQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKA 448
Query: 365 GNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGK 424
+ + +NEV +L Q+NHR++V+LLGCC+E + +++YE++PNG L LH D +
Sbjct: 449 VDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLH-DESDD 507
Query: 425 WPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484
+ + W +RL IA +IA L+YLHSAA PIYHRD+K++NILLDE+ AKVSDFG SR V
Sbjct: 508 Y-TMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSV 566
Query: 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544
+T H+ T GT GY+DPEY+++ + T+KSDVYSFGVVL+ELLT +K R E
Sbjct: 567 TIDQT---HLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSE 623
Query: 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604
EN L + + + E R++++VD +K+ +++ + ++ LA CL+ + + RP+M+
Sbjct: 624 ENRGLAAHFVEAVKENRVLDIVDDRIKDEC---NMDQVMSVANLARRCLNRKGKKRPNMR 680
Query: 605 EVADEIEYIIS 615
EV+ E+E I S
Sbjct: 681 EVSIELEMIRS 691
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 275 bits (704), Expect = 6e-73, Method: Compositional matrix adjust.
Identities = 211/695 (30%), Positives = 335/695 (48%), Gaps = 105/695 (15%)
Query: 5 VLTVFIFTATLLSCTTCALAVLRCGN-CGPTPVPYPLSTGPNC-GHQSYKIRCAAG---- 58
V+ + + + +T LA+ C + CG VPYP G C ++ ++I C +
Sbjct: 10 VVMLLLRICEYAAASTFPLALRNCSDHCGNVSVPYPFGIGKGCYKNKWFEIVCKSSSDQQ 69
Query: 59 ---ILWFDARNGSSYMIA---SINPLSQRIIIRPPGPAGSTCTATDMRTQGIQLDDNLPF 112
+L R +S+ + SI+ ++ I P +G C D + PF
Sbjct: 70 PILLLPRIRRAVTSFNLGDPFSISVYNKFYIQSPLKHSG--CPNRDGYSSSSLNLKGSPF 127
Query: 113 NITSSNTIMLLNCTDAIYIKDKAPPCMTASSLCCVFKTGGSQTAYTIRVHNGGCTAY--- 169
I+ +N + C + ++ + + C G +Y + N C Y
Sbjct: 128 FISENNKFTAVGCNNKAFMNVTGLQIVGCETTC-----GNEIRSY--KGANTSCVGYKCC 180
Query: 170 ----------QSFVNLDANWVPGK------------------TWPE-------PGMELEW 194
Q F P K T PE +ELEW
Sbjct: 181 QMTIPPLLQLQVFDATVEKLEPNKQGCQVAFLTQFTLSGSLFTPPELMEYSEYTTIELEW 240
Query: 195 ELPPEPICKTPEDCKDLLHSNCLADPMYPGLKRCLCNPGFIWDP-VNGLCQ---SSKYRH 250
L + CK + + +C C+ G+ +P + G CQ + H
Sbjct: 241 RLDLSYMTSKRVLCK--------GNTFFEDSYQCSCHNGYEGNPYIPGGCQDIDECRDPH 292
Query: 251 GKGCKRKKKKTML---------IAGMVAALGGSLLVVLIGILVYNKLNEHMKKETKK--- 298
C ++K +L A + L LL+++ G+ + K N K +K
Sbjct: 293 LNKCGKRKCVNVLGSYRCEKTWPAILSGTLSSGLLLLIFGMWLLCKANRKRKVAKQKRKF 352
Query: 299 ------LLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILD 352
LL++Q+ L+ ++F+ ++ AT+ F+ ++G GG G V+KG+L+
Sbjct: 353 FQRNGGLLLQQQTSFLHGSV--NRTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLE 410
Query: 353 DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGT 412
DG + A+K++K + + +NE+ +L Q+NHR++V++LGCC+E + +++YE+IPN
Sbjct: 411 DGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRN 470
Query: 413 LFDHLHC---DFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE 469
LFDHLH DF P+ W +RL IA ++A+ L+YLHSA PIYHRDVKS+NILLDE
Sbjct: 471 LFDHLHNPSEDF-----PMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDE 525
Query: 470 KLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLL 529
K AKVSDFG+SR V +D+H+ T QGT+GY+DPEY ++ T KSDVYSFGV+L+
Sbjct: 526 KHRAKVSDFGISRSV---AIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLI 582
Query: 530 ELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLA 589
ELLT +K + R +E L Y + M +RL E++D +KE D E + A+ LA
Sbjct: 583 ELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEEC---DREEVLAVAKLA 639
Query: 590 ASCLDERRQNRPSMKEVADEIEYIISIAKGRISES 624
CL ++RP+M++V E++ + S KG S++
Sbjct: 640 RRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQA 674
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 624 | ||||||
| 255578007 | 641 | kinase, putative [Ricinus communis] gi|2 | 0.995 | 0.968 | 0.677 | 0.0 | |
| 297810305 | 657 | hypothetical protein ARALYDRAFT_486985 [ | 0.951 | 0.904 | 0.641 | 0.0 | |
| 15241674 | 657 | wall-associated receptor kinase-like 20 | 0.951 | 0.904 | 0.641 | 0.0 | |
| 147790445 | 636 | hypothetical protein VITISV_001450 [Viti | 0.969 | 0.951 | 0.642 | 0.0 | |
| 225440470 | 636 | PREDICTED: wall-associated receptor kina | 0.967 | 0.949 | 0.641 | 0.0 | |
| 356520931 | 605 | PREDICTED: wall-associated receptor kina | 0.937 | 0.966 | 0.607 | 0.0 | |
| 225449384 | 629 | PREDICTED: wall-associated receptor kina | 0.950 | 0.942 | 0.601 | 0.0 | |
| 296086176 | 690 | unnamed protein product [Vitis vinifera] | 0.950 | 0.859 | 0.601 | 0.0 | |
| 359486770 | 609 | PREDICTED: wall-associated receptor kina | 0.919 | 0.942 | 0.589 | 0.0 | |
| 449448886 | 639 | PREDICTED: wall-associated receptor kina | 0.945 | 0.923 | 0.569 | 0.0 |
| >gi|255578007|ref|XP_002529875.1| kinase, putative [Ricinus communis] gi|223530651|gb|EEF32525.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2336), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/644 (67%), Positives = 516/644 (80%), Gaps = 23/644 (3%)
Query: 1 MKRSVLTVFIFTATLLSCTTCALAVLRCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGIL 60
M+ +VL + I L+S + CA+AV CGNCG VPYPLST P+CG Q YK+RC AG L
Sbjct: 1 MENNVLMMSILMVALMSYSPCAIAVRPCGNCGRLLVPYPLSTRPDCGDQHYKLRCTAGTL 60
Query: 61 WFDARNGSSYMIASINPLSQRIIIRPPGPAGSTCTATDMRTQGIQLDDNLPFNITSSNTI 120
WFD NGSSY I +INPL +R+II+PP A ++C ++D +QGIQLD NLPFNI+SSNTI
Sbjct: 61 WFDGVNGSSYTIKTINPLIRRLIIQPPNLANNSCISSDFHSQGIQLDHNLPFNISSSNTI 120
Query: 121 MLLNCTDAI-------------------YIKDKAPPCMTASSLCCVFKTGGSQTAYTIRV 161
+LLNCTD++ YIK+ A C+ A LCC F+TGG Q ++V
Sbjct: 121 LLLNCTDSVSHLKLNPPMDCSPASICHNYIKEHAAACIIAP-LCCTFRTGGLQNVDALKV 179
Query: 162 HNGGCTAYQSFVNLDANWVPG-KTWPEPGMELEWELPPEPICKTPEDCKDLLHSNCLADP 220
+ G C+AYQSFVNLD V WPEP +E+EW LP EP+C+TP DC++LL+S CLADP
Sbjct: 180 YVGECSAYQSFVNLDLKTVLALNKWPEPEVEIEWMLPQEPVCRTPVDCRELLYSKCLADP 239
Query: 221 MYPGLKRCLCNPGFIWDPVNGLCQSSKYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLI 280
+ G KRC CN GF WDP+NGLCQ+ K R GK C+++KKKT L AG+ A G LLV +
Sbjct: 240 IIFGQKRCFCNAGFKWDPINGLCQNVKCRTGKACRKRKKKTALFAGVALAGGAILLVAVT 299
Query: 281 GILVYNKLNEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGT 340
GIL YN+ H ++ +K LIK+R+EMLNAK +GKSARIFTGKEI +ATNNFSKDNLIG+
Sbjct: 300 GILFYNQ--HHRSRQAQKNLIKERKEMLNAKHSGKSARIFTGKEIIKATNNFSKDNLIGS 357
Query: 341 GGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400
GGFGEVFKGILDDGT+TAIKRAKLGNTKGTD VLNEVRILCQVNHRSLVRLLGCCVEL+
Sbjct: 358 GGFGEVFKGILDDGTITAIKRAKLGNTKGTDQVLNEVRILCQVNHRSLVRLLGCCVELEL 417
Query: 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDV 460
+MIYEYIPNGTLF+HLHC+ + KW PLPW RL IAHQ AEGL YLHSAA+PPIYHRDV
Sbjct: 418 PIMIYEYIPNGTLFEHLHCNQSSKWTPLPWQRRLRIAHQTAEGLAYLHSAALPPIYHRDV 477
Query: 461 KSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSD 520
KSSNILLDE+LNAKVSDFGLSRLVE +E NDSHIFT AQGT+GYLDPEYYRNFQLTDKSD
Sbjct: 478 KSSNILLDERLNAKVSDFGLSRLVETSENNDSHIFTCAQGTLGYLDPEYYRNFQLTDKSD 537
Query: 521 VYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLE 580
VYSFGVVL+E+LTSKKAIDFNREEE+VNLVVYMKK+++E+R+++ +DPVLKE A+ L+LE
Sbjct: 538 VYSFGVVLMEILTSKKAIDFNREEEDVNLVVYMKKMIEEDRILDAIDPVLKESASKLELE 597
Query: 581 TMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRISES 624
TMKALG LAA+CLDE+RQNRPSMKEVADEI+YII I R+S+S
Sbjct: 598 TMKALGSLAATCLDEKRQNRPSMKEVADEIQYIIGITSERVSKS 641
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297810305|ref|XP_002873036.1| hypothetical protein ARALYDRAFT_486985 [Arabidopsis lyrata subsp. lyrata] gi|297318873|gb|EFH49295.1| hypothetical protein ARALYDRAFT_486985 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 784 bits (2024), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/620 (64%), Positives = 487/620 (78%), Gaps = 26/620 (4%)
Query: 27 RCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGILWFDARNGSSYMIASINPLSQRIIIRP 86
RC NCGP VPYPLSTGPNCG Q+Y+I C G L+F A +GSSY+I SIN ++QRI++ P
Sbjct: 42 RCPNCGPMVVPYPLSTGPNCGDQAYRINCVGGKLYFGALHGSSYVITSINSVTQRIVLSP 101
Query: 87 PGPAGS-TCTATDMRTQGIQLDDNLPFNITSSNTIMLLNCTDAI---------------Y 130
PG A S +C + D+ QG++LD +LPF+ITSSNTI+LLNC+ A+ Y
Sbjct: 102 PGLASSVSCISADVSKQGLELDPHLPFSITSSNTILLLNCSQAMLQAPIDCSPTSLCYSY 161
Query: 131 IKDKAPPCMTASSLCCVFKTGGSQTAYTIRVHNGGCTAYQSFVNLDANWV---PGKTWPE 187
IK+ A PC A LCC F+T GSQTAYTIR+++GGC AYQSFV L+ N PG WP+
Sbjct: 162 IKNNASPCSKAP-LCCTFRTDGSQTAYTIRINSGGCLAYQSFVGLNPNKEVPPPGIKWPD 220
Query: 188 PGMELEWELPPEPICKTPEDCKDLL-HSNCLADPMYPGLKRCLCNPGFIWDPVNGLCQSS 246
G+EL+W LP EP+CKT DC LL S CL DP GLKRC C G WDPVN +C
Sbjct: 221 TGLELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKRGLEWDPVNAIC--G 278
Query: 247 KYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGILVYNKLNEHMKKETKKLLIKQREE 306
K RHGK CK KKKKT++ AG+ A+ G+ L + + ++ ++ +KK+ K ++K+REE
Sbjct: 279 KCRHGKHCK-KKKKTVVFAGVAVAVVGATLAIAVAVIATKHSHQKVKKDLHKNIVKEREE 337
Query: 307 MLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN 366
ML+A + GKS+RIFTG+EI +ATNNFSKDNLIGTGGFGEVFK +L+DGT+TAIKRAKL N
Sbjct: 338 MLSANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNN 397
Query: 367 TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWP 426
TKGTD +LNEVRILCQVNHRSLVRLLGCCV+L+ L+IYE+IPNGTLF+HLH + W
Sbjct: 398 TKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGNPDHTWK 457
Query: 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486
PL W RL IA+Q AEGL YLHSAA PPIYHRDVKSSNILLD+KLNAKVSDFGLSRLV+
Sbjct: 458 PLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDDKLNAKVSDFGLSRLVDL 517
Query: 487 TET--NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544
TET N+SHIFT AQGT+GYLDPEYYRNFQLTDKSDVYSFGVVLLE++TSKKAIDF+REE
Sbjct: 518 TETANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFSREE 577
Query: 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604
E+VNLV+Y+ K+MD+ERL+E +DP+LK+ A+ LD++TM+ LG LA++CL+ERRQNRPSMK
Sbjct: 578 EDVNLVMYINKMMDQERLIECIDPLLKKTASKLDMQTMQQLGNLASACLNERRQNRPSMK 637
Query: 605 EVADEIEYIISIAKGRISES 624
EVADEIEYII+I ++E+
Sbjct: 638 EVADEIEYIINILSQEVTET 657
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15241674|ref|NP_195827.1| wall-associated receptor kinase-like 20 [Arabidopsis thaliana] gi|75335716|sp|Q9LZM4.1|WAKLQ_ARATH RecName: Full=Wall-associated receptor kinase-like 20; Flags: Precursor gi|7340681|emb|CAB82980.1| putative protein kinase [Arabidopsis thaliana] gi|332003045|gb|AED90428.1| wall-associated receptor kinase-like 20 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2020), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/620 (64%), Positives = 481/620 (77%), Gaps = 26/620 (4%)
Query: 27 RCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGILWFDARNGSSYMIASINPLSQRIIIRP 86
RC NCGP VPYPLSTGP CG Q+Y+I C G L+F A +GSSY+I SIN ++QRI++RP
Sbjct: 42 RCPNCGPMVVPYPLSTGPTCGDQAYRINCVGGKLYFGALHGSSYVITSINSVTQRIVLRP 101
Query: 87 PGPAGS-TCTATDMRTQGIQLDDNLPFNITSSNTIMLLNCTDAI---------------Y 130
PG A S +C + D+ QG++LD +LPF+ITSSNTI+LLNC+ A+ Y
Sbjct: 102 PGLASSVSCISADVSKQGLELDPHLPFSITSSNTILLLNCSQAMLQAPIDCSPTSLCYSY 161
Query: 131 IKDKAPPCMTASSLCCVFKTGGSQTAYTIRVHNGGCTAYQSFVNLDANWV---PGKTWPE 187
IK+ A PC A LCC F+T GSQTAYTIR++ GGC AYQSFV L+ N PGK WP+
Sbjct: 162 IKNNASPCSKAP-LCCTFRTDGSQTAYTIRINGGGCLAYQSFVGLNPNKEVPPPGKKWPD 220
Query: 188 PGMELEWELPPEPICKTPEDCKDLL-HSNCLADPMYPGLKRCLCNPGFIWDPVNGLCQSS 246
G+EL+W LP EP+CKT DC LL S CL DP GLKRC C G WDPVN +C
Sbjct: 221 TGLELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWDPVNAIC--G 278
Query: 247 KYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGILVYNKLNEHMKKETKKLLIKQREE 306
K RHGK CK KKKKT++ AG A+ G L + + ++ ++ +KK+ K ++K+REE
Sbjct: 279 KCRHGKHCK-KKKKTVVFAGAAVAVVGVTLAIAVAVIGTKHSHQKVKKDIHKNIVKEREE 337
Query: 307 MLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN 366
ML+A + GKS+RIFTG+EI +ATNNFSKDNLIGTGGFGEVFK +L+DGT+TAIKRAKL N
Sbjct: 338 MLSANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNN 397
Query: 367 TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWP 426
TKGTD +LNEVRILCQVNHRSLVRLLGCCV+L+ L+IYE+IPNGTLF+HLH W
Sbjct: 398 TKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWK 457
Query: 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486
PL W RL IA+Q AEGL YLHSAA PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV+
Sbjct: 458 PLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDL 517
Query: 487 TET--NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544
TET N+SHIFT AQGT+GYLDPEYYRNFQLTDKSDVYSFGVVLLE++TSKKAIDF REE
Sbjct: 518 TETANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREE 577
Query: 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604
E+VNLV+Y+ K+MD+ERL E +DP+LK+ A +D++T++ LG LA++CL+ERRQNRPSMK
Sbjct: 578 EDVNLVMYINKMMDQERLTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMK 637
Query: 605 EVADEIEYIISIAKGRISES 624
EVADEIEYII+I ++E+
Sbjct: 638 EVADEIEYIINILSQEVTET 657
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147790445|emb|CAN69970.1| hypothetical protein VITISV_001450 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/623 (64%), Positives = 477/623 (76%), Gaps = 18/623 (2%)
Query: 1 MKRSVLTVFIFTATLLSCTTCALAVLRCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGIL 60
M+++VL + + LL CT A+ RCG+CG PVPYPLSTGP CG QSYK+RC AG L
Sbjct: 1 MEKNVLPLLLHALALLLCTRAAMCAPRCGDCGRXPVPYPLSTGPGCGDQSYKVRCNAGTL 60
Query: 61 WFDARNGSSYMIASINPLSQRIIIRPPGPAGSTCTATDMRTQGIQLDDNLPFNITSSNTI 120
WFDA + SSY+I SINP ++R+I++P +TC TD++ G+QLD P+NI SSNTI
Sbjct: 61 WFDALSQSSYVITSINPGTRRMIVKPASLLANTCITTDIQVGGLQLDRISPYNIPSSNTI 120
Query: 121 MLLNCTDAI---------------YIKDK-APPCMTASSLCCVFKTGGSQTAYTIRVHNG 164
ML+NC++A+ YI++ A ++ CC FKTGG AY I V +
Sbjct: 121 MLMNCSNAVLNSSVNCSPNSICHAYIRENVAAAACRSTXKCCWFKTGGPVNAYKIGVRDE 180
Query: 165 GCTAYQSFVNLDANWVPGKTWPEPGMELEWELPPEPICKTPEDCKDLLHSNCLADPMYPG 224
GC AYQSFVNL A +P K WPEPG+E+EW LP EPICK P+DC LL+S CL D G
Sbjct: 181 GCMAYQSFVNL-ATSLPVKRWPEPGLEIEWALPQEPICKIPKDCSTLLNSMCLPDGAILG 239
Query: 225 LKRCLCNPGFIWDPVNGLCQSSKYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGILV 284
+RC C GF W P+NGLCQ+ K K CK KKK + G VA + L++V +GILV
Sbjct: 240 QRRCFCKAGFHWGPINGLCQNLKCEKAKSCKHKKKSRTPLLGGVAVVAAILILVPVGILV 299
Query: 285 YNKLNEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFG 344
+ +++K+E + LIK+RE+MLNA +GK A+IF+GKEI+RATNNFSKDN IG+GGF
Sbjct: 300 C-RHRQNLKREAQGSLIKKREDMLNANNSGKMAKIFSGKEIKRATNNFSKDNFIGSGGFS 358
Query: 345 EVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404
EVFKGILDDGTVTA+KRAKLGNTKGTD VLNEVRILCQVNHR LVRLLGCCVEL+Q +MI
Sbjct: 359 EVFKGILDDGTVTAVKRAKLGNTKGTDQVLNEVRILCQVNHRCLVRLLGCCVELEQPIMI 418
Query: 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSN 464
YEYIPNGTLFDHLH + KWP L W RL IA Q AEGL YLHS+AVPPIYHRDVKSSN
Sbjct: 419 YEYIPNGTLFDHLHGHHSRKWPALTWRRRLSIALQTAEGLAYLHSSAVPPIYHRDVKSSN 478
Query: 465 ILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSF 524
ILLDEKL+AKVSDFGLSRL +E N SHI T AQGT+GYLDPEYYRNFQLTDKSDVYSF
Sbjct: 479 ILLDEKLDAKVSDFGLSRLAVVSEANASHITTCAQGTLGYLDPEYYRNFQLTDKSDVYSF 538
Query: 525 GVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKA 584
GVVLLELLTSKKAIDFNREEE+VNLV+Y+KKIM EE+LM+V+DPVLK+ A+ +D+E++KA
Sbjct: 539 GVVLLELLTSKKAIDFNREEEDVNLVLYIKKIMKEEKLMDVIDPVLKDGASKVDMESVKA 598
Query: 585 LGLLAASCLDERRQNRPSMKEVA 607
LGLLAA+CLDERRQ+RPSMKE A
Sbjct: 599 LGLLAAACLDERRQSRPSMKEAA 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440470|ref|XP_002271602.1| PREDICTED: wall-associated receptor kinase-like 20 [Vitis vinifera] gi|297740320|emb|CBI30502.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1972), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/624 (64%), Positives = 477/624 (76%), Gaps = 20/624 (3%)
Query: 1 MKRSVLTVFIFTATLLSCTTCALAVLRCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGIL 60
M+++VL + + LL CT A+ RCG+CG PVPYPLSTGP CG QSYK+RC AG L
Sbjct: 1 MEKNVLPLLLHALALLLCTRAAMCAPRCGDCGRIPVPYPLSTGPGCGDQSYKVRCNAGTL 60
Query: 61 WFDARNGSSYMIASINPLSQRIIIRPPGPAGSTCTATDMRTQGIQLDDNLPFNITSSNTI 120
WFDA + SSY+I SINP ++R+I++P +TC TD++ G+QLD P+NI SSNTI
Sbjct: 61 WFDALSQSSYVITSINPGTRRMIVKPASLLANTCITTDIQVGGLQLDRISPYNIPSSNTI 120
Query: 121 MLLNCTDAI---------------YIKDK--APPCMTASSLCCVFKTGGSQTAYTIRVHN 163
ML+NC++A+ YI++ A C + + CC FK GG AY I V +
Sbjct: 121 MLMNCSNAVLNSSVNCSPNSICHAYIRENVVAAACRSTAK-CCWFKAGGPVNAYKIGVRD 179
Query: 164 GGCTAYQSFVNLDANWVPGKTWPEPGMELEWELPPEPICKTPEDCKDLLHSNCLADPMYP 223
GC AYQSFVNL A +P K WPEPG+E+EW LP EPICK P+DC LL+S CL D
Sbjct: 180 EGCMAYQSFVNL-ATSLPVKRWPEPGLEIEWALPQEPICKIPKDCSTLLNSMCLPDGAIL 238
Query: 224 GLKRCLCNPGFIWDPVNGLCQSSKYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGIL 283
G +RC C GF W P+NGLCQ+ K K CK KKK + G VA + L++V +GIL
Sbjct: 239 GQRRCFCKAGFHWGPINGLCQNLKCEKAKSCKHKKKSRTPLLGGVAVVAAILILVPVGIL 298
Query: 284 VYNKLNEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGF 343
V + +++K+E + LIK+RE+MLNA +GK A+IF+GKEI+RATNNFSKDN IG+GGF
Sbjct: 299 VC-RHRQNLKREAQGSLIKKREDMLNANNSGKMAKIFSGKEIKRATNNFSKDNFIGSGGF 357
Query: 344 GEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403
EVFKGILDDGTVTA+KRAKLGNTKGTD VLNEVRILCQVNHR LVRLLGCCVEL+Q +M
Sbjct: 358 SEVFKGILDDGTVTAVKRAKLGNTKGTDQVLNEVRILCQVNHRCLVRLLGCCVELEQPIM 417
Query: 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSS 463
IYEYIPNGTLFDHLH + KWP L W RL IA Q AEGL YLHS+AVPPIYHRDVKSS
Sbjct: 418 IYEYIPNGTLFDHLHGHHSRKWPALTWRRRLSIALQTAEGLAYLHSSAVPPIYHRDVKSS 477
Query: 464 NILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYS 523
NILLDEKL+AKVSDFGLSRL +E N SHI T AQGT+GYLDPEYYRNFQLTDKSDVYS
Sbjct: 478 NILLDEKLDAKVSDFGLSRLAVVSEANASHITTCAQGTLGYLDPEYYRNFQLTDKSDVYS 537
Query: 524 FGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMK 583
FGVVLLELLTSKKAIDFNREEE+VNLV+Y+KKIM EE+LM+V+DPVLK+ A+ +D+E++K
Sbjct: 538 FGVVLLELLTSKKAIDFNREEEDVNLVLYIKKIMKEEKLMDVIDPVLKDGASKVDMESVK 597
Query: 584 ALGLLAASCLDERRQNRPSMKEVA 607
ALGLLAA+CLDERRQ+RPSMKE A
Sbjct: 598 ALGLLAAACLDERRQSRPSMKEAA 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520931|ref|XP_003529113.1| PREDICTED: wall-associated receptor kinase-like 20-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/616 (60%), Positives = 459/616 (74%), Gaps = 31/616 (5%)
Query: 27 RCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGILWFDARNGSSYMIASINPLSQRIIIRP 86
+CGNCG PVPYPLSTGP+CG YKIRC AG LW DA GS+Y+I+SI+PL++ II RP
Sbjct: 3 KCGNCGLNPVPYPLSTGPDCGDPWYKIRCTAGTLWLDALAGSAYLISSIDPLTRSIITRP 62
Query: 87 PGPAGSTCTATDMRTQGIQLDDNLPFNITSSNTIMLLNCTDAI-------------YIKD 133
TC +TD ++G+ L++ LPF++ S NT+ L NCT Y+K+
Sbjct: 63 ASITPKTCVSTDFHSEGMHLNETLPFSVASGNTVFLFNCTTHAPSMNCAASGTCHRYVKE 122
Query: 134 KAPPCMTAS-SLCCVFKTGGSQTAYTIRVHNGGCTAYQSFVNLDANWVPGKTWPEPGMEL 192
A +CC +K+ GS Y +RVH GGC AYQSFV+ + GK WPEPG+ +
Sbjct: 123 HADFGACGRVGVCCEYKSAGSLKEYVVRVHGGGCAAYQSFVDFNGT-AAGKRWPEPGVGI 181
Query: 193 EWELPPEPICKTPEDCKDLLHSNCLADPMYPGLKRCLCNPGFIWDPVNGLCQSSKYRHGK 252
+W P EP+CK P DCK+LL+S C P ++RCLCN GF W S RHGK
Sbjct: 182 KWVAPQEPVCKAPIDCKELLNSKCGVGPAGGVVQRCLCNVGFKW-------TRSMVRHGK 234
Query: 253 GC--KRKKKKTMLIAGM-VAALGGSL-LVVLIGILVYNKLNEHMKKETKKLLIKQREEML 308
K +KKK ML+AGM VA+LGG +V +IG++ Y K N+ K+ IK+R+E+
Sbjct: 235 DSNGKVRKKKKMLLAGMLVASLGGIFSIVTVIGVIFYKKHNQ-----AKQAKIKKRKEIS 289
Query: 309 NAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK 368
+AKA S+RIFTG+EIR+ATNNFS++NL+GTGGFGEVFKG DDGTV AIKRAKLG TK
Sbjct: 290 SAKANALSSRIFTGREIRKATNNFSQENLVGTGGFGEVFKGTFDDGTVFAIKRAKLGCTK 349
Query: 369 GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPL 428
G D + NEVRILCQVNHRSLVRLLGCC+EL+ L+IYEY+ NGTLFD+LH +G PL
Sbjct: 350 GIDQMQNEVRILCQVNHRSLVRLLGCCLELENPLLIYEYVSNGTLFDYLHRYSSGSREPL 409
Query: 429 PWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488
WH RL IAHQ AEGL YLHSAAVPPIYHRDVKSSNILLD+KL+AKVSDFGLSRLVE E
Sbjct: 410 KWHQRLKIAHQTAEGLCYLHSAAVPPIYHRDVKSSNILLDDKLDAKVSDFGLSRLVELAE 469
Query: 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548
N SHIFT+AQGT+GYLDPEYYRNFQLTDKSDVYSFGVVL+ELLT++KAIDFNREEE+VN
Sbjct: 470 ENKSHIFTSAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLMELLTAQKAIDFNREEESVN 529
Query: 549 LVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608
L +Y K+ M E++LM+VVDP+LKE A+ L+LETMK+LG LA +C+D++RQ RPSMKEVAD
Sbjct: 530 LAMYGKRKMVEDKLMDVVDPLLKEGASALELETMKSLGYLATACVDDQRQKRPSMKEVAD 589
Query: 609 EIEYIISIAKGRISES 624
+IEY+I I KG++S+S
Sbjct: 590 DIEYMIKIVKGQVSKS 605
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225449384|ref|XP_002282445.1| PREDICTED: wall-associated receptor kinase-like 20 isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 727 bits (1877), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/622 (60%), Positives = 453/622 (72%), Gaps = 29/622 (4%)
Query: 21 CALAVLRCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGILWFDARNGSSYMIASINPLSQ 80
CA+A RC +CG T VPYPLSTG +CG Q YKIRC AG L FD N SSY I+SI P Q
Sbjct: 17 CAMAANRCPDCGNTSVPYPLSTGADCGDQEYKIRCDAGTLRFDTLN-SSYSISSITPQIQ 75
Query: 81 RIIIRPPGPAGSTCTATDMRTQGIQLDDNLPFNITSSNTIMLLNCTDAI----------- 129
R +IRP AG+TC TD+ QGIQL+++LPFN+TSSNTI+ LNCTD +
Sbjct: 76 RFVIRPASFAGNTCVTTDLPNQGIQLNESLPFNVTSSNTILYLNCTDTLLRSPLNCSSIS 135
Query: 130 ----YIKD--KAPPCMTASSLCCVFKTGGSQTAYTIRVHNGGCTAYQSFVNLDANWVPGK 183
YI A C A +CC FK GGS T+++IRV + GC AY+SFVNLDA+ P
Sbjct: 136 LCHTYINGTRDAAACEDAP-ICCTFKAGGSTTSHSIRVRDAGCRAYRSFVNLDAS-TPVN 193
Query: 184 TWPEPGMELEWELPPEPICKTPEDCKDLLHSNCLADPMYPGLKRCLCNPGFIWDPVNGLC 243
WPEPG+E++W P EP+C + DC D ++S C DP G+ RC C G WDPV GLC
Sbjct: 194 RWPEPGVEIQWVSPREPVCTSQSDCTDGMNSTCGPDPATAGVSRCFCKSGLWWDPVGGLC 253
Query: 244 -QSSKYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGILVYNKLNEHMK-KETKKLLI 301
Q+ + GC KT LIAG+ +G +L+ +I ILVY + H + KE + L
Sbjct: 254 AQNVTCQDPDGCG-STNKTPLIAGLTVGIGAALIAAVIAILVYRR---HRRIKEAQDRLA 309
Query: 302 KQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKR 361
++REE+LNA GK A+ FTGKEI+RATN+FS D L+G GG+GEV+KGILDDGT+ AIK
Sbjct: 310 REREEILNANGGGKFAKNFTGKEIKRATNSFSHDRLLGAGGYGEVYKGILDDGTIVAIKC 369
Query: 362 AKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDF 421
AKLGN KGTD VLNEV ILCQVNHRSLVRLLGCCVEL+Q +M+YE+IPNGTL +HL
Sbjct: 370 AKLGNAKGTDQVLNEVGILCQVNHRSLVRLLGCCVELEQPIMVYEFIPNGTLLEHLQGQR 429
Query: 422 TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481
G L W RL IAH AEGL YLHS+AVPPIYHRDVKSSNILLDEK+NAKV+DFGLS
Sbjct: 430 PGGRGSLTWSHRLRIAHDTAEGLAYLHSSAVPPIYHRDVKSSNILLDEKMNAKVADFGLS 489
Query: 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541
RL T+ SH+ T AQGT+GYLDPEYYRN+QLTDKSDVYSFGVVLLELLTS+KAIDFN
Sbjct: 490 RLA---HTDMSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSFGVVLLELLTSQKAIDFN 546
Query: 542 REEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP 601
R ++VNL VY+++ ++EERLM+ +DP+LKE+A+ L+LETMKA+G LA CL+ERRQNRP
Sbjct: 547 RPADDVNLAVYVQRTVEEERLMDAIDPLLKEQASSLELETMKAMGFLAVGCLEERRQNRP 606
Query: 602 SMKEVADEIEYIISIAKGRISE 623
SMKEV +EI YIISIA ++ E
Sbjct: 607 SMKEVTEEIGYIISIATAKVVE 628
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296086176|emb|CBI31617.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 727 bits (1876), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/622 (60%), Positives = 453/622 (72%), Gaps = 29/622 (4%)
Query: 21 CALAVLRCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGILWFDARNGSSYMIASINPLSQ 80
CA+A RC +CG T VPYPLSTG +CG Q YKIRC AG L FD N SSY I+SI P Q
Sbjct: 17 CAMAANRCPDCGNTSVPYPLSTGADCGDQEYKIRCDAGTLRFDTLN-SSYSISSITPQIQ 75
Query: 81 RIIIRPPGPAGSTCTATDMRTQGIQLDDNLPFNITSSNTIMLLNCTDAI----------- 129
R +IRP AG+TC TD+ QGIQL+++LPFN+TSSNTI+ LNCTD +
Sbjct: 76 RFVIRPASFAGNTCVTTDLPNQGIQLNESLPFNVTSSNTILYLNCTDTLLRSPLNCSSIS 135
Query: 130 ----YIKD--KAPPCMTASSLCCVFKTGGSQTAYTIRVHNGGCTAYQSFVNLDANWVPGK 183
YI A C A +CC FK GGS T+++IRV + GC AY+SFVNLDA+ P
Sbjct: 136 LCHTYINGTRDAAACEDAP-ICCTFKAGGSTTSHSIRVRDAGCRAYRSFVNLDAS-TPVN 193
Query: 184 TWPEPGMELEWELPPEPICKTPEDCKDLLHSNCLADPMYPGLKRCLCNPGFIWDPVNGLC 243
WPEPG+E++W P EP+C + DC D ++S C DP G+ RC C G WDPV GLC
Sbjct: 194 RWPEPGVEIQWVSPREPVCTSQSDCTDGMNSTCGPDPATAGVSRCFCKSGLWWDPVGGLC 253
Query: 244 -QSSKYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGILVYNKLNEHMK-KETKKLLI 301
Q+ + GC KT LIAG+ +G +L+ +I ILVY + H + KE + L
Sbjct: 254 AQNVTCQDPDGCG-STNKTPLIAGLTVGIGAALIAAVIAILVYRR---HRRIKEAQDRLA 309
Query: 302 KQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKR 361
++REE+LNA GK A+ FTGKEI+RATN+FS D L+G GG+GEV+KGILDDGT+ AIK
Sbjct: 310 REREEILNANGGGKFAKNFTGKEIKRATNSFSHDRLLGAGGYGEVYKGILDDGTIVAIKC 369
Query: 362 AKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDF 421
AKLGN KGTD VLNEV ILCQVNHRSLVRLLGCCVEL+Q +M+YE+IPNGTL +HL
Sbjct: 370 AKLGNAKGTDQVLNEVGILCQVNHRSLVRLLGCCVELEQPIMVYEFIPNGTLLEHLQGQR 429
Query: 422 TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481
G L W RL IAH AEGL YLHS+AVPPIYHRDVKSSNILLDEK+NAKV+DFGLS
Sbjct: 430 PGGRGSLTWSHRLRIAHDTAEGLAYLHSSAVPPIYHRDVKSSNILLDEKMNAKVADFGLS 489
Query: 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541
RL T+ SH+ T AQGT+GYLDPEYYRN+QLTDKSDVYSFGVVLLELLTS+KAIDFN
Sbjct: 490 RLA---HTDMSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSFGVVLLELLTSQKAIDFN 546
Query: 542 REEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP 601
R ++VNL VY+++ ++EERLM+ +DP+LKE+A+ L+LETMKA+G LA CL+ERRQNRP
Sbjct: 547 RPADDVNLAVYVQRTVEEERLMDAIDPLLKEQASSLELETMKAMGFLAVGCLEERRQNRP 606
Query: 602 SMKEVADEIEYIISIAKGRISE 623
SMKEV +EI YIISIA ++ E
Sbjct: 607 SMKEVTEEIGYIISIATAKVVE 628
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486770|ref|XP_003633474.1| PREDICTED: wall-associated receptor kinase-like 20 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/621 (58%), Positives = 443/621 (71%), Gaps = 47/621 (7%)
Query: 21 CALAVLRCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGILWFDARNGSSYMIASINPLSQ 80
CA+A RC +CG T VPYPLSTG +CG Q YKIRC AG L FD N SSY I+SI P Q
Sbjct: 17 CAMAANRCPDCGNTSVPYPLSTGADCGDQEYKIRCDAGTLRFDTLN-SSYSISSITPQIQ 75
Query: 81 RIIIRPPGPAGSTCTATDMRTQGIQLDDNLPFNITSSNTIMLLNCTDAI----------- 129
R +IRP AG+TC TD+ QGIQL+++LPFN+TSSNTI+ LNCTD +
Sbjct: 76 RFVIRPASFAGNTCVTTDLPNQGIQLNESLPFNVTSSNTILYLNCTDTLLRSPLNCSSIS 135
Query: 130 ----YIKD--KAPPCMTASSLCCVFKTGGSQTAYTIRVHNGGCTAYQSFVNLDANWVPGK 183
YI A C A +CC FK GGS T+++IRV + GC AY+SFVNLDA+ P
Sbjct: 136 LCHTYINGTRDAAACEDAP-ICCTFKAGGSTTSHSIRVRDAGCRAYRSFVNLDAS-TPVN 193
Query: 184 TWPEPGMELEWELPPEPICKTPEDCKDLLHSNCLADPMYPGLKRCLCNPGFIWDPVNGLC 243
WPEPG+E++W P EP+C + DC D ++S C DP G+ RC C G WDPV GLC
Sbjct: 194 RWPEPGVEIQWVSPREPVCTSQSDCTDGMNSTCGPDPATAGVSRCFCKSGLWWDPVGGLC 253
Query: 244 QSSKYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGILVYNKLNEHMK-KETKKLLIK 302
S + +G +L+ +I ILVY + H + KE + L +
Sbjct: 254 AQS--------------------LTVGIGAALIAAVIAILVYRR---HRRIKEAQDRLAR 290
Query: 303 QREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRA 362
+REE+LNA GK A+ FTGKEI+RATN+FS D L+G GG+GEV+KGILDDGT+ AIK A
Sbjct: 291 EREEILNANGGGKFAKNFTGKEIKRATNSFSHDRLLGAGGYGEVYKGILDDGTIVAIKCA 350
Query: 363 KLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFT 422
KLGN KGTD VLNEV ILCQVNHRSLVRLLGCCVEL+Q +M+YE+IPNGTL +HL
Sbjct: 351 KLGNAKGTDQVLNEVGILCQVNHRSLVRLLGCCVELEQPIMVYEFIPNGTLLEHLQGQRP 410
Query: 423 GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
G L W RL IAH AEGL YLHS+AVPPIYHRDVKSSNILLDEK+NAKV+DFGLSR
Sbjct: 411 GGRGSLTWSHRLRIAHDTAEGLAYLHSSAVPPIYHRDVKSSNILLDEKMNAKVADFGLSR 470
Query: 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNR 542
L T+ SH+ T AQGT+GYLDPEYYRN+QLTDKSDVYSFGVVLLELLTS+KAIDFNR
Sbjct: 471 LA---HTDMSHVSTCAQGTLGYLDPEYYRNYQLTDKSDVYSFGVVLLELLTSQKAIDFNR 527
Query: 543 EEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS 602
++VNL VY+++ ++EERLM+ +DP+LKE+A+ L+LETMKA+G LA CL+ERRQNRPS
Sbjct: 528 PADDVNLAVYVQRTVEEERLMDAIDPLLKEQASSLELETMKAMGFLAVGCLEERRQNRPS 587
Query: 603 MKEVADEIEYIISIAKGRISE 623
MKEV +EI YIISIA ++ E
Sbjct: 588 MKEVTEEIGYIISIATAKVVE 608
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448886|ref|XP_004142196.1| PREDICTED: wall-associated receptor kinase-like 20-like [Cucumis sativus] gi|449519080|ref|XP_004166563.1| PREDICTED: wall-associated receptor kinase-like 20-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/616 (56%), Positives = 441/616 (71%), Gaps = 26/616 (4%)
Query: 27 RCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGILWFDARNGSSYMIASINPLSQRIIIRP 86
RC +CG TPVPYPLST P+CG Y++RCAA LWF++ NGSSY+I S+N +++++IIRP
Sbjct: 25 RCPDCGRTPVPYPLSTRPDCGDPLYRVRCAAAELWFESANGSSYLITSVNSVARKLIIRP 84
Query: 87 PGPAGSTCTATDMRTQGIQLDDNLPFNITSSNTIMLLNCTDAI---------------YI 131
PG A +TC ++D RT G LD LPF I+ NT++L NC+ + +I
Sbjct: 85 PGLAKNTCVSSDFRTDGFWLDTRLPFTISDRNTVLLYNCSIEVLENNWNCSHNSVCHDFI 144
Query: 132 KDKA---PPCMTASSLCCVFKTGGSQTAYTIRVHNGGCTAYQSFVNLDANWVPGKTWPEP 188
K C TA + CC + +GGS T+Y IRV C+AY+ FVNL + P K WPEP
Sbjct: 145 KQNPVAMAACKTAPT-CCWYTSGGSLTSYRIRVRKERCSAYECFVNLGGS-APAKKWPEP 202
Query: 189 GMELEWELPPEPICKTPEDCKDLLHSNCLADPMYPGLKRCLCNPGFIWDPVNGLCQSSKY 248
G+E++W P EP C+ DC++ +S CL D P KRCLC WDPVNGLC +
Sbjct: 203 GVEIQWAPPREPPCRVAMDCRNWENSACLPDHTNPKQKRCLCKVPSKWDPVNGLCNGNNL 262
Query: 249 RHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIG--ILVYNKLNEHMKKETKKLLIKQREE 306
+ KKK + + + G L+V+ G I V +K E + K + + RE
Sbjct: 263 KIQNKTIHKKKHKKVPVILGGVMAGVFLMVIGGSIIFVISKRREQLPKRNELSSKQVREV 322
Query: 307 MLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN 366
+L A ++GKSAR+FT KEI +ATNNFSK+NL+G+GG+GEVFKG L+DGT+ A+KRAKLG+
Sbjct: 323 ILTANSSGKSARMFTTKEIAKATNNFSKENLLGSGGYGEVFKGNLEDGTLVAVKRAKLGS 382
Query: 367 TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTG-KW 425
KG D +LNEVRILCQVNHR LVRLLGCC+EL+Q L+IYEYI NG LFDHLH + + KW
Sbjct: 383 MKGIDQILNEVRILCQVNHRYLVRLLGCCLELEQPLLIYEYISNGNLFDHLHGNTSSSKW 442
Query: 426 PPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485
PPL RL IA Q A+GL YLH++A+P IYHRD+KSSNILLDEKLNAKV+DFGLSRL
Sbjct: 443 PPLTLSHRLYIARQTADGLAYLHTSAMPRIYHRDIKSSNILLDEKLNAKVADFGLSRL-- 500
Query: 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
T SHI T AQGT+GYLDPEYY NFQLTDKSDVYSFGVV+LELLTS+KAIDFNREEE
Sbjct: 501 -AITESSHITTGAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVMLELLTSEKAIDFNREEE 559
Query: 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKE 605
+VNLVVY+KKI+ E+RLMEVVDPV+K RA+ +++E +KALG LAA+CLDE+RQNRP+MKE
Sbjct: 560 DVNLVVYIKKIIQEDRLMEVVDPVIKHRASRVEVEIIKALGSLAAACLDEKRQNRPTMKE 619
Query: 606 VADEIEYIISIAKGRI 621
VADE+ IISI +
Sbjct: 620 VADELANIISILNNEV 635
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 624 | ||||||
| TAIR|locus:2185118 | 657 | AT5G02070 [Arabidopsis thalian | 0.951 | 0.904 | 0.616 | 5e-202 | |
| TAIR|locus:2084425 | 639 | AT3G53840 [Arabidopsis thalian | 0.753 | 0.735 | 0.516 | 1.7e-154 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.509 | 0.401 | 0.446 | 9.2e-80 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.517 | 0.420 | 0.446 | 7.5e-78 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.498 | 0.414 | 0.461 | 6.6e-77 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.498 | 0.426 | 0.464 | 1.3e-76 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.498 | 0.395 | 0.454 | 5.9e-74 | |
| TAIR|locus:2014902 | 735 | WAK1 "cell wall-associated kin | 0.503 | 0.427 | 0.435 | 1.6e-72 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.509 | 0.401 | 0.425 | 3.3e-72 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.501 | 0.434 | 0.428 | 4.7e-72 |
| TAIR|locus:2185118 AT5G02070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1955 (693.3 bits), Expect = 5.0e-202, P = 5.0e-202
Identities = 382/620 (61%), Positives = 460/620 (74%)
Query: 27 RCGNCGPTPVPYPLSTGPNCGHQSYKIRCAAGILWFDARNGSSYMIASINPLSQRIIIRP 86
RC NCGP VPYPLSTGP CG Q+Y+I C G L+F A +GSSY+I SIN ++QRI++RP
Sbjct: 42 RCPNCGPMVVPYPLSTGPTCGDQAYRINCVGGKLYFGALHGSSYVITSINSVTQRIVLRP 101
Query: 87 PGPAGS-TCTATDMRTQGIQLDDNLPFNITSSNTIMLLNCTDAI---------------Y 130
PG A S +C + D+ QG++LD +LPF+ITSSNTI+LLNC+ A+ Y
Sbjct: 102 PGLASSVSCISADVSKQGLELDPHLPFSITSSNTILLLNCSQAMLQAPIDCSPTSLCYSY 161
Query: 131 IKDKAPPCMTASSLCCVFKTGGSQTAYTIRVHNGGCTAYQSFVNLDANWV---PGKTWPE 187
IK+ A PC A LCC F+T GSQTAYTIR++ GGC AYQSFV L+ N PGK WP+
Sbjct: 162 IKNNASPCSKAP-LCCTFRTDGSQTAYTIRINGGGCLAYQSFVGLNPNKEVPPPGKKWPD 220
Query: 188 PGMELEWELPPEPICKTPEDCKDLL-HSNCLADPMYPGLKRCLCNPGFIWDPVNGLCQSS 246
G+EL+W LP EP+CKT DC LL S CL DP GLKRC C G WDPVN +C
Sbjct: 221 TGLELQWALPKEPVCKTDVDCNLLLGKSKCLPDPTSLGLKRCSCKKGLEWDPVNAICGKC 280
Query: 247 XXXXXXXXXXXXXXTMLIXXXXXXXXXXXXXXXXXXXXYNKLNEHMKKETKKLLIKQREE 306
T++ ++ +KK+ K ++K+REE
Sbjct: 281 RHGKHCKKKKK---TVVFAGAAVAVVGVTLAIAVAVIGTKHSHQKVKKDIHKNIVKEREE 337
Query: 307 MLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN 366
ML+A + GKS+RIFTG+EI +ATNNFSKDNLIGTGGFGEVFK +L+DGT+TAIKRAKL N
Sbjct: 338 MLSANSTGKSSRIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNN 397
Query: 367 TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWP 426
TKGTD +LNEVRILCQVNHRSLVRLLGCCV+L+ L+IYE+IPNGTLF+HLH W
Sbjct: 398 TKGTDQILNEVRILCQVNHRSLVRLLGCCVDLELPLLIYEFIPNGTLFEHLHGSSDRTWK 457
Query: 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486
PL W RL IA+Q AEGL YLHSAA PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV+
Sbjct: 458 PLTWRRRLQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDL 517
Query: 487 TET--NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544
TET N+SHIFT AQGT+GYLDPEYYRNFQLTDKSDVYSFGVVLLE++TSKKAIDF REE
Sbjct: 518 TETANNESHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREE 577
Query: 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604
E+VNLV+Y+ K+MD+ERL E +DP+LK+ A +D++T++ LG LA++CL+ERRQNRPSMK
Sbjct: 578 EDVNLVMYINKMMDQERLTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMK 637
Query: 605 EVADEIEYIISIAKGRISES 624
EVADEIEYII+I ++E+
Sbjct: 638 EVADEIEYIINILSQEVTET 657
|
|
| TAIR|locus:2084425 AT3G53840 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1222 (435.2 bits), Expect = 1.7e-154, Sum P(2) = 1.7e-154
Identities = 249/482 (51%), Positives = 322/482 (66%)
Query: 138 CMTASSLCCVFKTGGSQTAYTI-RVHNGGCTAYQSFVNLDANWVPGKTWPEPGMELEWEL 196
C +S CC +KTG S Y + R C+AYQSF+NLD +P W EP +E+ WE
Sbjct: 162 CRGVTS-CCWYKTGASVNTYKVYRARPDMCSAYQSFMNLDLT-IPVSKWGEPAVEILWEA 219
Query: 197 PPEPICKTPEDCKDLLHSNCLADPMYPGLKRCLCNPGFIWDPVNGLCQSSXXXXXXXXXX 256
P EP+CK+ DC+DLL+S C D G KRC C GF WD VN +C+ +
Sbjct: 220 PREPVCKSQGDCRDLLNSVCSNDSTNLGQKRCFCKKGFQWDSVNAVCEVNRCSKRKSCKR 279
Query: 257 XXXXTMLIXXXXXXXXXXXXXXXXXXXXYNKLNEHMK-KETKKLLIKQREEMLNAKAAGK 315
+L +K N + ++ + K +L+ + G
Sbjct: 280 WSNLPLL-GGLAGGVGAILIAGFITKTIVSKQNRRIAGNQSWASVRKLHRNLLSINSTGL 338
Query: 316 SARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLN 375
RIFTGKEI +AT+NF+K NL+G GGFGEVFKG LDDGT A+KRAKLGN K ++N
Sbjct: 339 D-RIFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVN 397
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGK---WPPLPWHL 432
EV+ILCQV+H++LV+LLGCC+EL+ +++YE++PNGTLF+H++ G + LP
Sbjct: 398 EVQILCQVSHKNLVKLLGCCIELEMPVLVYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRR 457
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492
RL+IAHQ A+GL YLHS++ PPIYHRDVKSSNILLDE L+ KV+DFGLSRL ++ S
Sbjct: 458 RLMIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRL---GVSDVS 514
Query: 493 HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552
H+ T AQGT+GYLDPEYY NFQLTDKSDVYSFGVVL ELLT KKAIDFNREEE+VNLVV+
Sbjct: 515 HVTTCAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVF 574
Query: 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612
++K + E RLM+V+DPV+ AT ++E+MKALG+LA C+ E RQ RP+M+ A EIE
Sbjct: 575 VRKALKEGRLMDVIDPVIGIGATEKEIESMKALGVLAELCVKETRQCRPTMQVAAKEIEN 634
Query: 613 II 614
I+
Sbjct: 635 IL 636
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 9.2e-80, Sum P(3) = 9.2e-80
Identities = 147/329 (44%), Positives = 217/329 (65%)
Query: 287 KLNEHMK--KETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFG 344
KLN+ K K LL++Q ++++ + +F+ +E+ +AT NFS + ++G GG G
Sbjct: 402 KLNQKKKFFKRNGGLLLQQ--QLISTVGMVEKTIVFSSRELEKATENFSSNRILGQGGQG 459
Query: 345 EVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404
V+KG+L DG + A+K++K+ + + +NEV IL Q+NHR++V+LLGCC+E +++
Sbjct: 460 TVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETKVPVLV 519
Query: 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSN 464
YE+IPNG LF+HLH +F W++RL IA IA L+YLHS+A PIYHRDVKS+N
Sbjct: 520 YEFIPNGNLFEHLHDEFDENIMAT-WNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTN 578
Query: 465 ILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSF 524
I+LDEK AKVSDFG SR V T H+ T GT+GY+DPEY+++ Q TDKSDVYSF
Sbjct: 579 IMLDEKYRAKVSDFGTSRTVTVDHT---HLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSF 635
Query: 525 GVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKA 584
GVVL+EL+T +K+I F R +EN L Y M E +L +++D +++ L + A
Sbjct: 636 GVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDGCM---LSQVTA 692
Query: 585 LGLLAASCLDERRQNRPSMKEVADEIEYI 613
+A CL+ + + RPSM+EV+ E++ I
Sbjct: 693 TAKVARKCLNLKGRKRPSMREVSMELDSI 721
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 7.5e-78, Sum P(2) = 7.5e-78
Identities = 149/334 (44%), Positives = 217/334 (64%)
Query: 287 KLNEHMK--KETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFG 344
+LN+ K K LL++Q ++ + S R+F +E+ +AT NFS ++G GG G
Sbjct: 388 RLNQKKKFFKRNGGLLLQQ--QLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQG 445
Query: 345 EVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404
V+KG+L DG + A+K++K+ + + +NEV IL Q+NHR++V+LLGCC+E D +++
Sbjct: 446 TVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILV 505
Query: 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSN 464
YE+IPNG LF+HLH D + + W +RL IA IA L+YLHSAA PIYHRD+KS+N
Sbjct: 506 YEFIPNGNLFEHLHDD-SDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTN 564
Query: 465 ILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSF 524
I+LDEK AKVSDFG SR V T H+ T GT+GY+DPEY+++ Q TDKSDVYSF
Sbjct: 565 IMLDEKHRAKVSDFGTSRTVTVDHT---HLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSF 621
Query: 525 GVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKA 584
GVVL EL+T +K++ F R +E L Y M E RL +++D +++ L + A
Sbjct: 622 GVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCK---LNQVTA 678
Query: 585 LGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618
+A CL+ + + RPSM++V+ E+E I S ++
Sbjct: 679 AAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSE 712
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 6.6e-77, Sum P(2) = 6.6e-77
Identities = 149/323 (46%), Positives = 215/323 (66%)
Query: 294 KETKKLLIKQREEMLNAKAAG-KSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILD 352
K LL+KQ+ L + +S++IF+ KE+ +AT+NF+ + ++G GG G V+KG+L
Sbjct: 385 KRNGGLLLKQQ---LTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLV 441
Query: 353 DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGT 412
DG + A+KR+K+ + + +NEV +L Q+NHR++V+L+GCC+E + +++YE+IPNG
Sbjct: 442 DGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGD 501
Query: 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472
LF LH D + W +RL I+ +IA L YLHSAA P+YHRDVK++NILLDEK
Sbjct: 502 LFKRLHHDSDDY--TMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYR 559
Query: 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
AKVSDFG SR + +T H+ T GT GYLDPEY++ Q TDKSDVYSFGVVL+EL+
Sbjct: 560 AKVSDFGTSRSINVDQT---HLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELI 616
Query: 533 TSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASC 592
T +K R EEN LV + + M + R++++VD +KE T LE + A+ LA C
Sbjct: 617 TGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCT---LEQVLAVAKLARRC 673
Query: 593 LDERRQNRPSMKEVADEIEYIIS 615
L + + RP+M+EV+ E+E I S
Sbjct: 674 LSLKGKKRPNMREVSVELERIRS 696
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 1.3e-76, Sum P(3) = 1.3e-76
Identities = 150/323 (46%), Positives = 220/323 (68%)
Query: 294 KETKKLLIKQREEMLNAKAAG-KSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILD 352
K LL+KQ+ L K + ++IF+ KE+R+AT+NFS D ++G GG G V+KG+L
Sbjct: 393 KRNGGLLLKQQ---LTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLV 449
Query: 353 DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGT 412
DG++ A+KR+K+ + + +NE+ +L Q+NHR++V+LLGCC+E + +++YEYIPNG
Sbjct: 450 DGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGD 509
Query: 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472
LF LH D + + + W +RL IA +IA LTY+HSAA PI+HRD+K++NILLDEK
Sbjct: 510 LFKRLH-DESDDYT-MTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYR 567
Query: 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
AKVSDFG SR V +T H+ T GT GY+DPEY+ + Q T KSDVYSFGVVL+EL+
Sbjct: 568 AKVSDFGTSRSVTLDQT---HLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELI 624
Query: 533 TSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASC 592
T +K + R EE L + + M E R+++++D +K+ + LE + A+ LA C
Sbjct: 625 TGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESK---LEQVMAVAKLARKC 681
Query: 593 LDERRQNRPSMKEVADEIEYIIS 615
L+ + +NRP+MKEV++E+E I S
Sbjct: 682 LNRKGKNRPNMKEVSNELERIRS 704
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
Identities = 146/321 (45%), Positives = 207/321 (64%)
Query: 294 KETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDD 353
K LL++Q E+ + + ARIFT KE+ +AT NFS++ ++G GG G V+KG+L D
Sbjct: 408 KRNGGLLLQQ--ELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQGTVYKGMLVD 465
Query: 354 GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413
G A+K++K+ + +NEV IL Q+NHR +V+LLGCC+E + +++YE+I NG L
Sbjct: 466 GRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNL 525
Query: 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473
F H+H + + + W +RL IA IA L+YLHSAA PIYHRD+KS+NILLDEK A
Sbjct: 526 FKHIHEEEADDYTMI-WGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRA 584
Query: 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
KV+DFG SR V +T H T GT+GY+DPEYYR+ Q T+KSDVYSFGV+L EL+T
Sbjct: 585 KVADFGTSRSVTIDQT---HWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELIT 641
Query: 534 SKK-AIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASC 592
K I +E + L + + M E RL +++D +++ + E + A+ LA C
Sbjct: 642 GDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKP---EQVMAVANLAMKC 698
Query: 593 LDERRQNRPSMKEVADEIEYI 613
L R +NRP+M+EV E+E I
Sbjct: 699 LSSRGRNRPNMREVFTELERI 719
|
|
| TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 670 (240.9 bits), Expect = 1.6e-72, Sum P(3) = 1.6e-72
Identities = 142/326 (43%), Positives = 206/326 (63%)
Query: 287 KLNEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEV 346
KL E ++ ++ QR + A + +IFT +++ATN +++ ++G GG G V
Sbjct: 366 KLREQFFEQNGGGMLTQR--LSGAGPSNVDVKIFTEDGMKKATNGYAESRILGQGGQGTV 423
Query: 347 FKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406
+KGIL D ++ AIK+A+LG++ + +NEV +L Q+NHR++V+LLGCC+E + L++YE
Sbjct: 424 YKGILPDNSIVAIKKARLGDSSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYE 483
Query: 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466
+I NGTLFDHLH L W RL IA ++A L YLHS+A PI HRD+K++NIL
Sbjct: 484 FITNGTLFDHLHGSMIDS--SLTWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTANIL 541
Query: 467 LDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGV 526
LD L AKV+DFG SRL+ + + T QGT+GYLDPEYY L +KSDVYSFGV
Sbjct: 542 LDVNLTAKVADFGASRLIPMDK---EELETMVQGTLGYLDPEYYNTGLLNEKSDVYSFGV 598
Query: 527 VLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD-PVLKERATHLDLETMKAL 585
VL+ELL+ +KA+ F R + + +LV Y E RL E++ V+ E +L+ ++
Sbjct: 599 VLMELLSGQKALCFKRPQSSKHLVSYFATATKENRLDEIIGGEVMNED----NLKEIQEA 654
Query: 586 GLLAASCLDERRQNRPSMKEVADEIE 611
+AA C + RP MKEVA ++E
Sbjct: 655 ARIAAECTRLMGEERPRMKEVAAKLE 680
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 656 (236.0 bits), Expect = 3.3e-72, Sum P(3) = 3.3e-72
Identities = 141/331 (42%), Positives = 209/331 (63%)
Query: 287 KLNEHMKKETKK---LLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGF 343
++ + KK K+ LL+ Q E+ + + R+F +E+ +AT NFS++ ++G GG
Sbjct: 407 RITKRKKKFFKRNGGLLLLQ--ELNTREGYVEKTRVFNSRELEKATENFSENRVLGHGGQ 464
Query: 344 GEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403
G V+KG+L DG A+K++K+ + +NEV IL Q+NHR +V+LLGCC+E + ++
Sbjct: 465 GTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPML 524
Query: 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSS 463
+YE+I NG LF H+H + + + L W +RL IA IA L+YLHS+A PIYHRD+KS+
Sbjct: 525 VYEFIINGNLFKHIHEEESDDYTML-WGMRLRIAVDIAGALSYLHSSASSPIYHRDIKST 583
Query: 464 NILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYS 523
NILLDEK AKV+DFG SR V +T H T GT+GY+DPEYY++ Q T+KSDVYS
Sbjct: 584 NILLDEKYRAKVADFGTSRSVTIDQT---HWTTVISGTVGYVDPEYYQSSQYTEKSDVYS 640
Query: 524 FGVVLLELLTSKK-AIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETM 582
FGV+L EL+T K I +E V L + + M E+RL +++D ++ E +
Sbjct: 641 FGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIIDARIRNDCKP---EQV 697
Query: 583 KALGLLAASCLDERRQNRPSMKEVADEIEYI 613
A+ +A CL + + RP+M+EV E+E I
Sbjct: 698 MAVAKVAMKCLSSKGKKRPNMREVFTELERI 728
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 694 (249.4 bits), Expect = 4.7e-72, Sum P(2) = 4.7e-72
Identities = 141/329 (42%), Positives = 214/329 (65%)
Query: 299 LLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTA 358
LL++Q+ L+ ++F+ ++ AT+ F+ ++G GG G V+KG+L+DG + A
Sbjct: 359 LLLQQQTSFLHGSV--NRTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVA 416
Query: 359 IKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLH 418
+K++K + + +NE+ +L Q+NHR++V++LGCC+E + +++YE+IPN LFDHLH
Sbjct: 417 VKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLH 476
Query: 419 C---DFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475
DF P+ W +RL IA ++A+ L+YLHSA PIYHRDVKS+NILLDEK AKV
Sbjct: 477 NPSEDF-----PMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKV 531
Query: 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
SDFG+SR V +D+H+ T QGT+GY+DPEY ++ T KSDVYSFGV+L+ELLT +
Sbjct: 532 SDFGISRSVA---IDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGE 588
Query: 536 KAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDE 595
K + R +E L Y + M +RL E++D +KE D E + A+ LA CL
Sbjct: 589 KPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEEC---DREEVLAVAKLARRCLSL 645
Query: 596 RRQNRPSMKEVADEIEYIISIAKGRISES 624
++RP+M++V E++ + S KG S++
Sbjct: 646 NSEHRPTMRDVFIELDRMQSKRKGTQSQA 674
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LZM4 | WAKLQ_ARATH | 2, ., 7, ., 1, 1, ., - | 0.6419 | 0.9519 | 0.9041 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.6__119__AT5G02070.1 | annotation not avaliable (657 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 624 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-41 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-09 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 7e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-49
Identities = 72/198 (36%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGT-DLVLNEVRILCQVNHRSLVRLLGCC 395
+G GGFG V+ G AIK K ++ + +L E+ IL ++NH ++V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPI 455
+ + ++ EY G+L D L + L L I QI EGL YLHS I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 456 YHRDVKSSNILLDEK-LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-F 513
HRD+K NILLD K++DFGLS+L+ T+D + T GT Y+ PE
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLL----TSDKSLLKTIVGTPAYMAPEVLLGKG 169
Query: 514 QLTDKSDVYSFGVVLLEL 531
++KSD++S GV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 333 SKDNLIGTGGFGEVFKGILDDGTVT-----AIKRAKLG-NTKGTDLVLNEVRILCQVNHR 386
+ +G G FGEV+KG L A+K K + + + L E RI+ +++H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
++V+LLG C E + ++ EY+ G L +L P L L A QIA G+ Y
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR----KNRPKLSLSDLLSFALQIARGMEY 117
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG--- 503
L S HRD+ + N L+ E L K+SDFGLSR + + +G
Sbjct: 118 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK------RGGKLPIR 168
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
++ PE + + T KSDV+SFGV+L E+ T
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-44
Identities = 71/206 (34%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGT-DLVLNEVRILCQVNHRSLV 389
+ +G G FG+V+ G + AIK K K + +L E++IL ++ H ++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
RL + D+ ++ EY G LFD L K L QI L YLHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK-----KRGRLSEDEARFYLRQILSALEYLHS 115
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
I HRD+K NILLDE + K++DFGL+R ++ E TT GT Y+ PE
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK-----LTTFVGTPEYMAPEV 167
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSK 535
D++S GV+L ELLT K
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 71/212 (33%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 333 SKDNLIGTGGFGEVFKGILDDGTVT-----AIKRAKLG-NTKGTDLVLNEVRILCQVNHR 386
+ +G G FGEV+KG L A+K K + + + L E RI+ +++H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
++V+LLG C E + +++ EY+P G L D+L + L L A QIA G+ Y
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR---KNRPKELSLSDLLSFALQIARGMEY 118
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH-----IFTTAQGT 501
L S HRD+ + N L+ E L K+SDFGLSR + + I A
Sbjct: 119 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA--- 172
Query: 502 MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
PE + + T KSDV+SFGV+L E+ T
Sbjct: 173 -----PESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 82/299 (27%), Positives = 127/299 (42%), Gaps = 61/299 (20%)
Query: 332 FSKDNLIGTGGFGEVFKGILDD-----GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNH 385
+G G FGEV+KG L T A+K K G + + + L E I+ +++H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
++VRLLG C + + ++ EY+P G L D L L L +A QIA+G+
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR----KHGEKLTLKDLLQMALQIAKGME 116
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH------IFTTAQ 499
YL S HRD+ + N L+ E L K+SDFGLSR + + I A
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA- 172
Query: 500 GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-------SKKAIDFNREEENVNLVVY 552
PE ++ + T KSDV+SFGV+L E+ T +
Sbjct: 173 -------PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV------------ 213
Query: 553 MKKIMDEERLMEVVDPVLKERATHLDL-ETMKALGLLAASCLDERRQNRPSMKEVADEI 610
++ + D RL + +L E M C ++RP+ E+ +++
Sbjct: 214 LELLEDGYRLP-------RPENCPDELYELML-------QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 72/209 (34%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 336 NLIGTGGFGEVFKGILDDG----TVTAIKRAKLGNTKGT-DLVLNEVRILCQVNHRSLVR 390
+G G FGEV+KG L T A+K K ++ L E R++ ++ H ++VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHL----HCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
LLG C E + ++ EY+ G L D+L + + L L A QIA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM--GY 504
L S HRD+ + N L+ E L K+SDFGLSR V +D + G + +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY----DDDYYRKKTGGKLPIRW 173
Query: 505 LDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ PE ++ T KSDV+SFGV+L E+ T
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 87/273 (31%), Positives = 125/273 (45%), Gaps = 29/273 (10%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLV--LNEVRILCQVNHRSLVRLLGC 394
+G+G FG V+K G + A+K K + K E+RIL +++H ++VRL+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPP 454
+ D ++ EY G LFD+L + PL IA QI GL YLHS
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEYLHSNG--- 118
Query: 455 IYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ 514
I HRD+K NILLDE K++DFGL++ + ++ S TT GT Y+ PE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKS----SSSLTTFVGTPWYMAPEVLLGGN 174
Query: 515 L-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573
K DV+S GV+L ELLT K F+ E L + + + E E
Sbjct: 175 GYGPKVDVWSLGVILYELLT-GKPP-FSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 574 ATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
A L CL++ RP+ +E+
Sbjct: 233 AKD-----------LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 6e-41
Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRS 387
+++ L+G G FG V+ + D G + A+K +L +L + E+RIL + H +
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 388 LVRLLGCCV-ELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+VR G E TL I+ EY+ G+L L K+ LP + QI EGL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-----KFGKLPEPVIRKYTRQILEGLA 115
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
YLHS I HRD+K +NIL+D K++DFG ++ + ET + + +GT ++
Sbjct: 116 YLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG--TGSVRGTPYWM 170
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
PE R + +D++S G ++E+ T K
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 76/202 (37%), Positives = 109/202 (53%), Gaps = 22/202 (10%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
+G G FGEV+ G + T A+K K G L E +I+ ++ H LV+L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAF-LQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAEGLTYLHSAAVPPIY 456
+ ++ EY+ G+L D L GK LP +LV +A QIAEG+ YL S
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLP---QLVDMAAQIAEGMAYLESRNY---I 125
Query: 457 HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT---MGYLDPE--YYR 511
HRD+ + NIL+ E L K++DFGL+RL+E E +T +G + + PE Y
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDE------YTAREGAKFPIKWTAPEAANYG 179
Query: 512 NFQLTDKSDVYSFGVVLLELLT 533
F T KSDV+SFG++L E++T
Sbjct: 180 RF--TIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 17/209 (8%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRS 387
N+ +LIG G FG V+KG+ L+ G AIK+ L K L ++ E+ +L + H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V+ +G D +I EY NG+L + K+ P P L V +Q+ +GL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYL 115
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI-FTTAQGTMGYLD 506
H V HRD+K++NIL + K++DFG++ T+ ND + GT ++
Sbjct: 116 HEQGV---IHRDIKAANILTTKDGVVKLADFGVA-----TKLNDVSKDDASVVGTPYWMA 167
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
PE + SD++S G ++ELLT
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR 390
F IG GGFGEV+K G AIK KL + + + ++NE++IL + H ++V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
G ++ D+ ++ E+ G+L D L L + ++ +GL YLHS
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLK----STNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
I HRD+K++NILL K+ DFGLS + T+ ++ + GT ++ PE
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-----GTPYWMAPEVI 169
Query: 511 RNFQLTDKSDVYSFGVVLLELLTSK 535
K+D++S G+ +EL K
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 11/210 (5%)
Query: 331 NFSKDNLIGTGGFGEVFKG-ILDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRS 387
+ IG G FG+V+ DG + +K L N + LNEV+IL ++NH +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+++ E + ++ EY G L + + P P L Q+ L YL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
HS I HRD+K NI L K+ DFG+S+++ + + T GT YL P
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS----STVDLAKTVVGTPYYLSP 172
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKA 537
E +N KSD++S G VL EL T K
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (305), Expect = 4e-30
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 24/285 (8%)
Query: 331 NFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNHRS 387
++ +G G FGEV+ D + A+K + V L E++IL +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 388 -LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+V+L + ++ EY+ G+L D L G+ PL L I QI L Y
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEY 116
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLN-AKVSDFGLSRLV--ERTETNDSHIFTTAQGTMG 503
LHS I HRD+K NILLD K+ DFGL++L+ + ++ + +T+ GT G
Sbjct: 117 LHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 504 YLDPEYYRNFQL---TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
Y+ PE L + SD++S G+ L ELLT + + + + + +
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKE 605
L + P E + KA L L + +NR S
Sbjct: 234 SLASPLSPSNPELIS-------KAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 73/217 (33%), Positives = 108/217 (49%), Gaps = 15/217 (6%)
Query: 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRS 387
+F N IG G FG VFK + D V A+K+ L N + + ++E R+L +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
++R ++ + ++ EY NG L L G+ PLP QI GL +L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLK-MQRGR--PLPEDQVWRFFIQILLGLAHL 117
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT-TAQGTMGYLD 506
HS I HRD+KS N+ LD N K+ D G+++L+ +D+ F T GT YL
Sbjct: 118 HSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-----SDNTNFANTIVGTPYYLS 169
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNRE 543
PE + +KSDV++ GVVL E T K D N +
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 21/198 (10%)
Query: 337 LIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCV 396
IG G FG+V G V A+K K ++ L E ++ + H +LV+LLG +
Sbjct: 13 TIGKGEFGDVMLGDYRGQKV-AVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 397 ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIY 456
+ + ++ EY+ G+L D+L + + +L A + EG+ YL
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLR---SRGRAVITLAQQLGFALDVCEGMEYLEEKN---FV 124
Query: 457 HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT---TAQGTMGYLDPEYYRNF 513
HRD+ + N+L+ E L AKVSDFGL++ E ++ DS TA PE R
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWTA--------PEALREK 174
Query: 514 QLTDKSDVYSFGVVLLEL 531
+ + KSDV+SFG++L E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 338 IGTGGFGEVFKGILD-DGTVTAIKRAKL-GNTKGTDLVLNEVRILCQVNHRSLVRLLGCC 395
+G G G V+K G + A+K+ + G+ + +L E++ L +V+ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL-VIAHQIAEGLTYLHSAAVPP 454
+ + ++ EY+ G+L D L GK P L IA QI +GL YLH+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL--KKVGKIPEPV----LAYIARQILKGLDYLHTKR--H 120
Query: 455 IYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ 514
I HRD+K SN+L++ K K++DFG+S+++E T + T GT+ Y+ PE +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN----TFVGTVTYMSPERIQGES 176
Query: 515 LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
+ +D++S G+ LLE K + M+ I D
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPP---GQPSFFELMQAICDGP 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 336 NLIGTGGFGEVFKGI-LDDGTVTAIKRAKL--GNTKGTDLVLNEVRILCQVNHRSLVRLL 392
N IG G FG+V+ + LD G + A+K ++ + K + +E+++L + H +LV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
G V ++ + EY GTL + L G+ L H+ V Q+ EGL YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLE---HGR--ILDEHVIRVYTLQLLEGLAYLHSHG- 119
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
I HRD+K +NI LD K+ DFG + ++ T + GT Y+ PE
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 513 FQLTDK---SDVYSFGVVLLELLTSKK 536
+ +D++S G V+LE+ T K+
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 91/295 (30%), Positives = 142/295 (48%), Gaps = 41/295 (13%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVN 384
++ +K +IG G FGEVF+GIL AIK K G T K L+E I+ Q +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAEG 443
H +++RL G + ++I EY+ NG L +L D G++ +LV + IA G
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR-DHDGEFSSY----QLVGMLRGIAAG 119
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
+ YL HRD+ + NIL++ L KVSDFGLSR++ E + +TT+ G +
Sbjct: 120 MKYLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIP 173
Query: 504 --YLDPE--YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559
+ PE YR F T SDV+SFG+V+ E+++ + ++ V MK I D
Sbjct: 174 IRWTAPEAIAYRKF--TSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-----MKAINDG 226
Query: 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614
RL +D A+ L C + R RP ++ + ++ ++
Sbjct: 227 FRLPAPMD-------------CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 74/213 (34%), Positives = 111/213 (52%), Gaps = 19/213 (8%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
E+ R T K +G G FGEV+ G + T AIK K G + + L E ++ Q+
Sbjct: 2 EVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQL 58
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
H LVRL V + +I EY+ NG+L D L K L + + +A QIAEG
Sbjct: 59 QHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIK---LTINKLIDMAAQIAEG 114
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT-- 501
+ ++ HRD++++NIL+ E L K++DFGL+RL+E E +T +G
Sbjct: 115 MAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNE------YTAREGAKF 165
Query: 502 -MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + PE T KSDV+SFG++L E++T
Sbjct: 166 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 86/298 (28%), Positives = 131/298 (43%), Gaps = 43/298 (14%)
Query: 332 FSKDNL-----IGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLN---EVRI 379
F + NL +G G FGEVF KGI ++G T + L TK +L E+ +
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 380 LCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC----DFTGKWPPLPWHLRLV 435
+++H+++VRLLG C E + MI EY G L L D K PPL ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
+ QIA G+ +L +A HRD+ + N L+ + KVS LS+ V +E +
Sbjct: 122 LCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY---YKL 175
Query: 496 TTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK 555
A + +L PE + + KSDV+SFGV++ E+ F + E +
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV--------FTQGE------LPFYG 221
Query: 556 IMDEERLMEVVDPVLKERATHLDL--ETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
+ DEE L L+ L + L L C ++RPS E+ +
Sbjct: 222 LSDEEVLNR-----LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 338 IGTGGFGEVFKGI--LDDGTV--TAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLL 392
+G G FG V KG+ + G A+K K G L E ++ Q++H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
G C + +++ E P G L +L K +P +AHQ+A G+ YL S
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLK-----KRREIPVSDLKELAHQVAMGMAYLESKH- 115
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA-QGTMGYLDPE--Y 509
HRD+ + N+LL + AK+SDFG+SR + +D + TTA + + + PE
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALG--AGSDYYRATTAGRWPLKWYAPECIN 171
Query: 510 YRNFQLTDKSDVYSFGVVLLELLT 533
Y F + KSDV+S+GV L E +
Sbjct: 172 YGKF--SSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 338 IGTGGFGEVFKGIL------DDGTVTAIKRAKLGNTKGTDL-VLNEVRILCQVNHRSLVR 390
+G G FG+VF G +D + A+K K + E +L H ++V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHL-----HCDFTGKWPPLPWHLRLV----IAHQIA 441
G C E D +M++EY+ +G L L F L L IA QIA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH-IFTTAQG 500
G+ YL A HRD+ + N L+ L K+ DFG+SR V T D + +
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV---YTTDYYRVGGHTML 186
Query: 501 TMGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLTSKK 536
+ ++ PE YR F T +SDV+SFGVVL E+ T K
Sbjct: 187 PIRWMPPESIMYRKF--TTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 20/214 (9%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
EI R + + +G G FGEV++G+ ++ T A+K K G D L E +I+ ++
Sbjct: 2 EIDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDF-LAEAQIMKKL 58
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAE 442
H L++L C + ++ E + G+L ++L G+ LP +L+ +A Q+A
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG-AGRALKLP---QLIDMAAQVAS 114
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT- 501
G+ YL + HRD+ + N+L+ E KV+DFGL+R++ I+ +G
Sbjct: 115 GMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVI------KEDIYEAREGAK 165
Query: 502 --MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + PE + + KSDV+SFG++L E++T
Sbjct: 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 70/203 (34%), Positives = 108/203 (53%), Gaps = 18/203 (8%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
+G G FGEV+ G ++ T A+K K G T L E ++ + H LVRL +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAEGLTYLHSAAVPPIY 456
+ +I EY+ G+L D L D GK LP +L+ + QIAEG+ Y+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVL-LP---KLIDFSAQIAEGMAYIERKNY---I 125
Query: 457 HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT---MGYLDPEYYRNF 513
HRD++++N+L+ E L K++DFGL+R++E E +T +G + + PE
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE------YTAREGAKFPIKWTAPEAINFG 179
Query: 514 QLTDKSDVYSFGVVLLELLTSKK 536
T KSDV+SFG++L E++T K
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDL-VLNEVRILCQVNHRSL 388
+ K IG G +G+V+K G + A+K+ ++ N K G + + E+++L ++ H ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 389 VRLLGCCVELDQ--TLMIYEYIP---NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
VRL + M++EY+ G L D FT ++ Q+ EG
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTG-LLDSPEVKFT------ESQIK-CYMKQLLEG 112
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
L YLHS I HRD+K SNIL++ K++DFGL+R + + D +T T+
Sbjct: 113 LQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD---YTNRVITLW 166
Query: 504 YLDPE-------YYRNFQLTDKSDVYSFGVVLLELLTSK 535
Y PE Y + D++S G +L EL K
Sbjct: 167 YRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 83/304 (27%), Positives = 139/304 (45%), Gaps = 51/304 (16%)
Query: 317 ARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKG--ILDDGTV---TAIK--RAKLGNTKG 369
RI E+ K ++G+G FG V+KG I + V AIK R +
Sbjct: 1 LRILKETELE-------KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN 53
Query: 370 TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM-IYEYIPNGTLFDHL--HCDFTGKWP 426
++ L+E ++ V+H +VRLLG C L + I + +P G L D++ H D G
Sbjct: 54 KEI-LDEAYVMASVDHPHVVRLLGIC--LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY 110
Query: 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486
L W QIA+G++YL + HRD+ + N+L+ + K++DFGL++L++
Sbjct: 111 LLNW------CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161
Query: 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN 546
E + + + ++ E + T KSDV+S+GV + EL+T + E
Sbjct: 162 DE--KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGA-----KPYEG 214
Query: 547 VNLVVYMKKIMDEERLMEVVDPVLK-ERATHLDLETMKALGLLAASCLDERRQNRPSMKE 605
+ V E+ D + K ER + T+ +L C ++RP+ KE
Sbjct: 215 IPAV-------------EIPDLLEKGERLPQPPICTIDVYMVL-VKCWMIDAESRPTFKE 260
Query: 606 VADE 609
+ +E
Sbjct: 261 LINE 264
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 74/203 (36%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
+G G FGEV+ G + T AIK K G T + L E +++ ++ H LV+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAEGLTYLHSAAVPPIY 456
+ ++ EY+ G+L D L + GK+ LP +LV +A QIA G+ Y+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLP---QLVDMAAQIASGMAYVERMNY---V 124
Query: 457 HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT---MGYLDPEYYRNF 513
HRD++++NIL+ E L KV+DFGL+RL+E E +T QG + + PE
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAALYG 178
Query: 514 QLTDKSDVYSFGVVLLELLTSKK 536
+ T KSDV+SFG++L EL T +
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 37/223 (16%)
Query: 332 FSKDNL-----IGTGGFGEVFKG---ILDDGT--VTAIK--RAKLGNTKGTDLVLNEVRI 379
F K +L +G G FG+V L D T A+K +D E+ I
Sbjct: 1 FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE-REIEI 59
Query: 380 LCQVNHRSLVRLLGCCVELDQT--LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIA 437
L ++H ++V+ G C + +I EY+P+G+L D+L + L+ +
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ----RHRDQINLKRLLLFS 115
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT-------ETN 490
QI +G+ YL S HRD+ + NIL++ + K+SDFGL++++ E
Sbjct: 116 SQICKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+S IF A PE R + + SDV+SFGV L EL T
Sbjct: 173 ESPIFWYA--------PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 67/202 (33%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 338 IGTGGFGEVFK-GILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
+G G FG+V D G + A+K + K+ K + L E IL ++NH +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 394 CCVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLP-WHLRLVIAHQIAEGLTYLHSAA 451
+ ++ L ++ EY P G LF HL K R A +I L YLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLS-----KEGRFSEERARFYAA-EIVLALEYLHSLG 113
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR 511
I +RD+K NILLD + K++DFGL++ + S T GT YL PE
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE---GSRTNTFC-GTPEYLAPEVLL 166
Query: 512 NFQLTDKSDVYSFGVVLLELLT 533
D +S GV+L E+LT
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 72/203 (35%), Positives = 110/203 (54%), Gaps = 19/203 (9%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
+G G FGEV+ G + T A+K K G T + L E +I+ ++ H LV+L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAEGLTYLHSAAVPPIY 456
+ ++ EY+ G+L D L D G+ LP LV +A Q+A G+ Y+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLK-DGEGRALKLP---NLVDMAAQVAAGMAYIERMNY---I 124
Query: 457 HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT---MGYLDPEYYRNF 513
HRD++S+NIL+ + L K++DFGL+RL+E E +T QG + + PE
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNE------YTARQGAKFPIKWTAPEAALYG 178
Query: 514 QLTDKSDVYSFGVVLLELLTSKK 536
+ T KSDV+SFG++L EL+T +
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 65/207 (31%), Positives = 86/207 (41%), Gaps = 23/207 (11%)
Query: 337 LIGTGGFGEVFKGILDDGT-------VTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV 389
+G G FG V +G V +K KL + D L E I+ ++H +L+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLI 59
Query: 390 RLLGCCVELDQTLM-IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
RL G V L LM + E P G+L D L D A QIA G+ YL
Sbjct: 60 RLYG--VVLTHPLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLE 114
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM--GYLD 506
S HRD+ + NILL K+ DFGL R N+ H + +
Sbjct: 115 SKR---FIHRDLAARNILLASDDKVKIGDFGLMR---ALPQNEDHYVMEEHLKVPFAWCA 168
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLT 533
PE R + SDV+ FGV L E+ T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 38/284 (13%)
Query: 331 NFSKDNLIGTGGFGE-VFKGILDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRS 387
++ ++G G FGE +D ++ K L + K LNE+ IL + H +
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 388 LVRLLGCCVELDQTLMI-YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH--QIAEGL 444
++ ++ D TL+I EY GTL+D + + +V+ + QI +
Sbjct: 61 IIAYYNHFMD-DNTLLIEMEYANGGTLYDKIVRQKGQLFEE-----EMVLWYLFQIVSAV 114
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
+Y+H A I HRD+K+ NI L + K+ DFG+S+++ +E + + T GT Y
Sbjct: 115 SYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAE---TVVGTPYY 167
Query: 505 LDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564
+ PE + + KSD+++ G VL ELLT K+ D +NLVV KI+
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV---KIVQGNYTP- 220
Query: 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608
VV E L L S L + + RP+ EV D
Sbjct: 221 VVSVYSSE------------LISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 65/214 (30%), Positives = 112/214 (52%), Gaps = 20/214 (9%)
Query: 334 KDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKL--GNTKGT-------DLVLNEVRILCQV 383
K LIG+G FG V+ G+ G + A+K+ +L + D + E+ +L ++
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
H ++V+ LG ++ D + EY+P G++ L+ + L QI +G
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVRQILKG 118
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER--TETNDSHIFTTAQGT 501
L YLH+ I HRD+K +NIL+D K K+SDFG+S+ +E T + + QG+
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 502 MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
+ ++ PE + T K+D++S G +++E+LT K
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 332 FSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL 391
F+ + +G+G FGEV++G+ + AIK K + EV+ L ++ H+ L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
C + +I E + G+L L G+ P+ L + +A Q+AEG+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLR-SPEGQVLPVA-SL-IDMACQVAEGMAYLEEQN 124
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY--LDPEY 509
HRD+ + NIL+ E L KV+DFGL+RL++ ++ ++ + Y PE
Sbjct: 125 ---SIHRDLAARNILVGEDLVCKVADFGLARLIKED------VYLSSDKKIPYKWTAPEA 175
Query: 510 --YRNFQLTDKSDVYSFGVVLLELLT 533
+ F KSDV+SFG++L E+ T
Sbjct: 176 ASHGTFST--KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 337 LIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL---VLNEVRILCQVNHRSLVRLLG 393
IG G FG+V+KG+L T A+K + T DL L E IL Q +H ++V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRS--TLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
CV+ ++ E +P G+L L K L L ++ A G+ YL S
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLR----KKKNRLTVKKLLQMSLDAAAGMEYLESKNC- 114
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT----MGYLDPEY 509
HRD+ + N L+ E K+SDFG+SR + I+T + G + + PE
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSR------EEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 510 YRNFQLTDKSDVYSFGVVLLELLT 533
+ T +SDV+S+G++L E +
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 29/227 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVN- 384
++F +IG G F V + AIK + +L K V E +L ++N
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
H +++L + + + EY PNG L ++ K+ L A +I L
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-----KYGSLDEKCTRFYAAEILLAL 115
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS------HIFTTA 498
YLHS I HRD+K NILLD+ ++ K++DFG +++++ + +S +I +
Sbjct: 116 EYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 499 Q----------GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
+ GT Y+ PE SD+++ G ++ ++LT K
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 4e-23
Identities = 72/203 (35%), Positives = 112/203 (55%), Gaps = 19/203 (9%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
+G G FGEV+ G + T AIK K G T + L E +I+ ++ H LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAEGLTYLHSAAVPPIY 456
+ ++ E++ G+L D L + GK+ LP +LV +A QIA+G+ Y+
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLK-EGDGKYLKLP---QLVDMAAQIADGMAYIERMNY---I 124
Query: 457 HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT---MGYLDPEYYRNF 513
HRD++++NIL+ + L K++DFGL+RL+E E +T QG + + PE
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNE------YTARQGAKFPIKWTAPEAALYG 178
Query: 514 QLTDKSDVYSFGVVLLELLTSKK 536
+ T KSDV+SFG++L EL+T +
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN-----TKGTDLVLNEVRILCQV 383
N+ + L+G G FG V+ +D G A+K+ K + + E+++L +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 384 NHRSLVRLLGCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
H +V+ GC + D+TL I+ EY+P G++ D L + L + QI E
Sbjct: 62 QHERIVQYYGC-LRDDETLSIFMEYMPGGSVKDQLK-----AYGALTETVTRKYTRQILE 115
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI--FTTAQG 500
G+ YLHS I HRD+K +NIL D N K+ DFG S+ R +T S + G
Sbjct: 116 GVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICSSGTGMKSVTG 169
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
T ++ PE K+DV+S G ++E+LT K
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 92/291 (31%), Positives = 140/291 (48%), Gaps = 50/291 (17%)
Query: 330 NNFSKDNLIGTGGFGEVFKGIL-----DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV 383
+ + + +IG G FGEV +G L + V AIK K G++ K L E I+ Q
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDV-AIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 384 NHRSLVRLLGCCVELDQTLMIY-EYIPNGTLFDHL-HCDFTGKWPPLPWHLRLV-IAHQI 440
+H +++RL G V + +MI EY+ NG+L L D GK+ +LV + I
Sbjct: 63 DHPNIIRLEGV-VTKSRPVMIITEYMENGSLDKFLREND--GKFTVG----QLVGMLRGI 115
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
A G+ YL HRD+ + NIL++ L KVSDFGLSR +E +E +TT G
Sbjct: 116 ASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA----TYTTKGG 168
Query: 501 TMG--YLDPEY--YRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556
+ + PE YR F T SDV+SFG+V+ E+++ + ++ ++V +K +
Sbjct: 169 KIPIRWTAPEAIAYRKF--TSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-----IKAV 221
Query: 557 MDEERLMEVVD-PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
D RL +D P AL L C + R RP+ ++
Sbjct: 222 EDGYRLPPPMDCP--------------SALYQLMLDCWQKDRNERPTFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 72/231 (31%), Positives = 105/231 (45%), Gaps = 35/231 (15%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAK-LGNTKGTDLVLNE 376
EI + F ++ +G G FG+V+KG L T AIK K K E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-----HCDF------TGKW 425
++ + H ++V LLG C + T M++EY+ +G L + L H D
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 426 PPLPWHLRLV-IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484
L + IA QIA G+ YL S HRD+ + N L+ E L K+SDFGLSR +
Sbjct: 119 SSL-DCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 485 ERTETNDSHIFTTAQGT----MGYLDPEYYRNFQLTDKSDVYSFGVVLLEL 531
S + Q + ++ PE + T +SD++SFGVVL E+
Sbjct: 175 Y------SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNT---------KGTDLVLN-EVRI 379
+ K LIG G +G V+ + + G + A+K+ +L T K L E+
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 380 LCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIA 437
L ++H ++V+ LG + + EY+P G++ L + F L
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE---EQLVRFF----T 114
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
Q+ EGL YLHS I HRD+K+ N+L+D K+SDFG+S+ + ND + +
Sbjct: 115 EQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN--MS 169
Query: 498 AQGTMGYLDPEYYRNFQ--LTDKSDVYSFGVVLLELLTSKK 536
QG++ ++ PE ++ + K D++S G V+LE+ ++
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
EI R + + +G G FGEV+ + T A+K K G + + L E ++ +
Sbjct: 2 EIPRES--LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTL 58
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAE 442
H LV+L V + +I E++ G+L D L D G PLP +L+ + QIAE
Sbjct: 59 QHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLP---KLIDFSAQIAE 113
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT- 501
G+ ++ HRD++++NIL+ L K++DFGL+R++E E +T +G
Sbjct: 114 GMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNE------YTAREGAK 164
Query: 502 --MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + PE T KSDV+SFG++L+E++T
Sbjct: 165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-22
Identities = 80/268 (29%), Positives = 131/268 (48%), Gaps = 35/268 (13%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
IG+G FG V+ G + AIK + G D + E +++ +++H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCTE 70
Query: 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYH 457
+++E++ +G L D+L GK L + + EG+ YL S+ V H
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGK---FSQETLLGMCLDVCEGMAYLESSNV---IH 123
Query: 458 RDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT---MGYLDPEYYRNFQ 514
RD+ + N L+ E KVSDFG++R V +D +T++ GT + + PE + +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFV----LDDQ--YTSSTGTKFPVKWSSPEVFSFSK 177
Query: 515 LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERA 574
+ KSDV+SFGV++ E+ + K NR V ++ I RL + P L ++
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-----VETINAGFRLYK---PRLASQS 229
Query: 575 THLDLETMKALGLLAASCLDERRQNRPS 602
+ E M+ C ER ++RPS
Sbjct: 230 VY---ELMQ-------HCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 13/211 (6%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
E+ R + + + +G G +GEV++G+ ++T + +T + L E ++ ++
Sbjct: 2 EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 59
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLH-CDFTGKWPPLPWHLRLVIAHQIAE 442
H +LV+LLG C +I E++ G L D+L C+ + + L +A QI+
Sbjct: 60 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ----EVNAVVLLYMATQISS 115
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
+ YL HRD+ + N L+ E KV+DFGLSRL+ +T +H A+ +
Sbjct: 116 AMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAH--AGAKFPI 169
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ PE + + KSDV++FGV+L E+ T
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 81/282 (28%), Positives = 129/282 (45%), Gaps = 45/282 (15%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
+GTG FG V G AIK K G+ D + E +++ +++H LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYH 457
++ EY+ NG L ++L P L L + + EG+ YL S H
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQL-LEMCKDVCEGMAYLESKQ---FIH 123
Query: 458 RDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT---MGYLDPEYYRNFQ 514
RD+ + N L+D++ KVSDFGLSR V E +T++ G+ + + PE +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPEVLLYSK 177
Query: 515 LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL--MEVVDPVLKE 572
+ KSDV++FGV++ E+ + K M ER E V+ V +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGK--------------------MPYERFNNSETVEKVSQG 217
Query: 573 R---ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
HL E + A + SC E+ + RP+ +++ IE
Sbjct: 218 LRLYRPHLASEKVYA---IMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 334 KDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL-----VLNEVRILCQVNHRS 387
K L+G+G FG V++G+ LDDG A+K L + T + E+ +L ++ H +
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 388 LVRLLGCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+V+ LG + L I+ E +P G+L L K+ P + + QI GL Y
Sbjct: 64 IVQYLGT-EREEDNLYIFLELVPGGSLAKLL-----KKYGSFPEPVIRLYTRQILLGLEY 117
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
LH HRD+K +NIL+D K++DFG+++ V S +G+ ++
Sbjct: 118 LHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-----FKGSPYWMA 169
Query: 507 PEYYR-----NFQLTDKSDVYSFGVVLLELLTSK 535
PE +D++S G +LE+ T K
Sbjct: 170 PEVIAQQGGYGLA----ADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL 388
N K IG G GEV+K G AIK+ +L + +L++NE+ I+ H ++
Sbjct: 22 KNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNI 77
Query: 389 VRLLGCCVELDQTL-MIYEYIPNGTLFDHL-HCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
V + L ++ EY+ G+L D + P + + + ++ +GL Y
Sbjct: 78 VDYYDS-YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLEY 131
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG----LSRLVERTETNDSHIFTTAQGTM 502
LHS + HRD+KS NILL + + K++DFG L++ + + GT
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--------NSVVGTP 180
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
++ PE + K D++S G++ +E+
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 331 NFSKDNLIGTGGFGEVFK-GILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHR 386
+F +IG G FG+V D + A+K + K VLNE RIL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWH-LRLVIAHQIAEGLT 445
LV L + + ++ + + G L HL + ++ I +I L
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-----SQKVKFSEEQVKFWIC-EIVLALE 114
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
YLHS I HRD+K NILLDE+ + ++DF ++ V D+ +T+ GT GY+
Sbjct: 115 YLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP----DTLTTSTS-GTPGYM 166
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544
PE + D +S GV E L K+ +
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
+G+G FG V G AIK + G D + E +++ +++H +LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFI-EEAKVMMKLSHPNLVQLYGVCTK 70
Query: 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYH 457
++ EY+ NG L ++L + GK L L + + E + YL S H
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR-ERKGK---LGTEWLLDMCSDVCEAMEYLESNGF---IH 123
Query: 458 RDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT---MGYLDPEYYRNFQ 514
RD+ + N L+ E KVSDFGL+R V + +T++QGT + + PE + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ------YTSSQGTKFPVKWAPPEVFDYSR 177
Query: 515 LTDKSDVYSFGVVLLELLTSKK 536
+ KSDV+SFGV++ E+ + K
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 74/288 (25%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 332 FSKDNLIGTGGFGEVFKGILDDGTVTAIKRA------KLGNTKGTDLVLNEVRILCQVNH 385
++K ++G G +G V+ G+ + G + A+K+ L K + + EV +L + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 386 RSLVRLLGCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
++V+ LG C++ D T+ I+ E++P G++ L+ ++ PLP + QI +G+
Sbjct: 62 VNIVQYLGTCLD-DNTISIFMEFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGV 115
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH--IFTTAQGTM 502
YLH+ V HRD+K +N++L K+ DFG +R + + +H + + GT
Sbjct: 116 AYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562
++ PE KSD++S G + E+ T K + +++ + M I L
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL------ASMDRLAAMFYIGAHRGL 226
Query: 563 MEVVDPVLKER--ATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608
M P L + A +D T CL + RPS ++
Sbjct: 227 M----PRLPDSFSAAAIDFVTS---------CLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 331 NFSKDNLIGTGGFGEVFK-GILDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRS 387
+F +G G +G V+K L D A+K LG + K + +NE+RIL VNH +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
++ ++ ++ ++ EY P G L + K +P I Q+ GL L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
H I HRD+KS+NILL K+ D G+S+++++ T GT Y+ P
Sbjct: 120 HEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK------TQIGTPHYMAP 170
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLT 533
E ++ + KSD++S G +L E+ T
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 74/216 (34%), Positives = 102/216 (47%), Gaps = 42/216 (19%)
Query: 338 IGTGGFGEVFKGILD---DGT--VTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLVRL 391
+G G FG+V D DGT + A+K K + T E+ IL + H ++V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 392 LGCCVEL-DQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWH-----LRLVIAHQIAEGL 444
GCC E + L +I EY+P G+L D+L P H L+ A QI EG+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----------PKHKLNLAQLLLFAQQICEGM 120
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER-------TETNDSHIFTT 497
YLHS HRD+ + N+LLD K+ DFGL++ V E DS +F
Sbjct: 121 AYLHSQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177
Query: 498 AQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
A E + + + SDV+SFGV L ELLT
Sbjct: 178 A--------VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 338 IGTGGFGEVF---KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRL 391
I G +G VF K D + AIK +A + D VL E IL Q +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 392 LGCCVELDQTL-MIYEYIPNG---TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+ + L ++ EY+P G +L +++ L + + +I L YL
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGS--------LDEDVARIYIAEIVLALEYL 109
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR--LVERTETNDSHIFTTAQ--GTMG 503
HS I HRD+K NIL+D + K++DFGLS+ LV R + + GT
Sbjct: 110 HSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
Y+ PE + D +S G +L E L
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGC 394
IG G FG V K DG + K GN K +++EV IL ++ H ++VR
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD- 66
Query: 395 CVELD---QTLMIY-EYIPNGTLFDHL-HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
+D QTL I EY G L + C K + I Q+ L H+
Sbjct: 67 -RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK--YIEEEFIWRILTQLLLALYECHN 123
Query: 450 AAVPP--IYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
+ P + HRD+K +NI LD N K+ DFGL++++ +DS T GT Y+ P
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG----HDSSFAKTYVGTPYYMSP 179
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLT 533
E + +KSD++S G ++ EL
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 338 IGTGGFGEVFKGILDD------GTVTAIKRAKLGNTKGTDL-VLNEVRILCQVNHRSLVR 390
+G G FG V++G+ T AIK + + LNE ++ + N +VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHC-----DFTGKWPPLPWHLRLVIAHQIAEGLT 445
LLG TL++ E + G L +L + P + +A +IA+G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG-- 503
YL + HRD+ + N ++ E L K+ DFG++R + T+ + +G +
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD----YYRKGGKGLLPVR 186
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
++ PE ++ T KSDV+SFGVVL E+ T
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 23/210 (10%)
Query: 335 DNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLV 389
+ +IG G FGEV +G L AIK K G T K L+E I+ Q +H +++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAEGLTYLH 448
L G + ++I E++ NG L L + G++ + +LV + IA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVI----QLVGMLRGIAAGMKYLS 123
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG---TMGYL 505
HRD+ + NIL++ L KVSDFGLSR +E ++ + +T++ G + +
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWT 178
Query: 506 DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
PE YR F T SDV+S+G+V+ E+++
Sbjct: 179 APEAIAYRKF--TSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 337 LIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL-VLNEVRILCQVNHRSLVRLLGCC 395
L+G G FGEVFKG L D T A+K K + + L+E RIL Q +H ++V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPI 455
+ ++ E +P G L K L + A A G+ YL S
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR----KKKDELKTKQLVKFALDAAAGMAYLESKNC--- 114
Query: 456 YHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA---QGTMGYLDPEYYRN 512
HRD+ + N L+ E K+SDFG+SR D I++++ Q + + PE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR------QEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 513 FQLTDKSDVYSFGVVLLELLT 533
+ + +SDV+S+G++L E +
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 21/202 (10%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
IG G FG V +G G A+K K T L E ++ +++H++LVRLLG V
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLG--VI 68
Query: 398 LDQTLMI-YEYIPNGTLFDHLHCDFTGKWP-PLPWHLRLVIAHQIAEGLTYLHSAAVPPI 455
L L I E + G L + L G+ + L+ + +AEG+ YL S +
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSL--DVAEGMEYLESKK---L 121
Query: 456 YHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL 515
HRD+ + NIL+ E AKVSDFGL+R V ++S + + + PE ++ +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKL------PVKWTAPEALKHKKF 174
Query: 516 TDKSDVYSFGVVLLELLTSKKA 537
+ KSDV+S+GV+L E+ + +A
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 76/229 (33%), Positives = 116/229 (50%), Gaps = 37/229 (16%)
Query: 318 RIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAK--LGNTKGTDL-- 372
RI E++R ++G+G FG V+KGI + +G I A L T G
Sbjct: 2 RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54
Query: 373 -VLNEVRILCQVNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFD--HLHCDFTGKWPPL 428
++E I+ ++H LVRLLG C L T+ ++ + +P+G L D H H D G L
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVC--LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLL 112
Query: 429 PWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488
W + QIA+G+ YL + HRD+ + N+L+ + K++DFGL+RL+E
Sbjct: 113 NWCV------QIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE--- 160
Query: 489 TNDSHIFTTAQGTMGY----LDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
D + G M L+ +YR F T +SDV+S+GV + EL+T
Sbjct: 161 -GDEKEYNADGGKMPIKWMALECIHYRKF--THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCC 395
++G G +G V+ L AIK +++ + E+ + + HR++V+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH--QIAEGLTYLHSAAVP 453
E + E +P G+L L KW PL + + +I + QI EGL YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLR----SKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ-- 128
Query: 454 PIYHRDVKSSNILLDEKLNA-KVSDFGLSRLVER----TETNDSHIFTTAQGTMGYLDPE 508
I HRD+K N+L++ K+SDFG S+ + TET FT GT+ Y+ PE
Sbjct: 129 -IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-----FT---GTLQYMAPE 179
Query: 509 YYRNFQLTDK--------SDVYSFGVVLLELLTSK 535
+ DK +D++S G ++E+ T K
Sbjct: 180 ------VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQVNHRSL 388
+ K +G G +G V+K G + A+K+ +L N + L E+ +L ++ H ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
V+LL + +++EY L +L + PL +L I +Q+ GL Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLD----KRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
S I HRD+K NIL++ K++DFGL+R +T T+ Y PE
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAF----GIPLRTYTHEVVTLWYRAPE 168
Query: 509 ------YYRNFQLTDKS-DVYSFGVVLLELLTSK 535
+Y + D++S G + E++T K
Sbjct: 169 ILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 86/294 (29%), Positives = 135/294 (45%), Gaps = 49/294 (16%)
Query: 335 DNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLV 389
+ +IG G FGEV G L AIK K G T K L+E I+ Q +H +++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLH---CDFTGKWPPLPWHLRLV-IAHQIAEGLT 445
L G + +++ EY+ NG+L L FT ++LV + IA G+
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT--------VIQLVGMLRGIASGMK 120
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG-- 503
YL HRD+ + NIL++ L KVSDFGLSR++ E + +TT G +
Sbjct: 121 YLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIR 174
Query: 504 YLDPE--YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561
+ PE YR F T SDV+S+G+V+ E+++ + + ++V +K I + R
Sbjct: 175 WTAPEAIAYRKF--TSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-----IKAIEEGYR 227
Query: 562 LMEVVD-PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614
L +D P AL L C + R RP +++ ++ +I
Sbjct: 228 LPAPMDCPA--------------ALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 70/220 (31%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 338 IGTGGFGEVF----KGIL--DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL 391
+G G FG+VF +L D + A+K K + E +L + H+ +VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHC--------DFTGKWPPLPWHL--RLVIAHQIA 441
G C E LM++EY+ +G L L P L L IA QIA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
G+ YL S HRD+ + N L+ + L K+ DFG+SR + T+ + T
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-----YYRVGGRT 184
Query: 502 M---GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLTSKK 536
M ++ PE YR F T +SD++SFGVVL E+ T K
Sbjct: 185 MLPIRWMPPESILYRKF--TTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 70/201 (34%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 338 IGTGGFGEVFKG-ILDDGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
+GTG FG V G A+K AK+ K + VLNE RIL + H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
+ ++ EY+P G LF HL +G+ P P R A Q+ L YLHS
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL--RKSGR-FPEP-VARFYAA-QVVLALEYLHSLD-- 121
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
I +RD+K N+LLD K++DFG + R+ RT +T GT YL PE +
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-------YTLC-GTPEYLAPEIILS 172
Query: 513 FQLTDKS-DVYSFGVVLLELL 532
+ K+ D ++ G+++ E+L
Sbjct: 173 -KGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLV 389
F+ IG G FGEV+K I V AIK L + + + E++ L Q +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 390 RLLGCCVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
+ G ++ L +I EY G+ D L K L I ++ GL YLH
Sbjct: 63 KYYGSFLK-GSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEYLH 115
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
HRD+K++NILL E+ + K++DFG+S + T + + T GT ++ PE
Sbjct: 116 EEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN----TFVGTPFWMAPE 168
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLT 533
+ +K+D++S G+ +EL
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 37/232 (15%)
Query: 331 NFSKDNLIGTGGFGEVFKGI------LDDGTVTAIKRAKLGNTKGT--DLVLNEVRILCQ 382
N +G G FG+V K T A+K K + DL L+E +L Q
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDL-LSEFNLLKQ 59
Query: 383 VNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLH------CDFTGKWP---------- 426
VNH +++L G C + L+I EY G+L L + G
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 427 ---PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483
L + A QI+ G+ YL A + HRD+ + N+L+ E K+SDFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 484 VERTETNDSHIFTTAQGTM--GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
V DS++ ++G + ++ E + T +SDV+SFGV+L E++T
Sbjct: 177 VYE---EDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 71/218 (32%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 338 IGTGGFGEVFKGIL------DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL 391
+G G FG+VF D + A+K K + E +L + H +V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCD------FTGKWPP--LPWHLRLVIAHQIAEG 443
G CVE D +M++EY+ +G L L P L L IA QIA G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM- 502
+ YL S HRD+ + N L+ E L K+ DFG+SR V T+ + TM
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-----YYRVGGHTML 184
Query: 503 --GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLTSKK 536
++ PE YR F T +SDV+S GVVL E+ T K
Sbjct: 185 PIRWMPPESIMYRKF--TTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR 390
F +G G +G V+K I + G V AIK + + ++ E+ IL Q + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
G + ++ EY G++ D + T K L I +Q +GL YLHS
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNK--TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQGTMGYLDPEY 509
HRD+K+ NILL+E+ AK++DFG+S +L + ++ I GT ++ PE
Sbjct: 119 K---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-----GTPFWMAPEV 170
Query: 510 YRNFQLTDKSDVYSFGVVLLEL 531
+ +K+D++S G+ +E+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 73/298 (24%), Positives = 130/298 (43%), Gaps = 43/298 (14%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAK---LGNTKGTDLVLNEVRILCQVN 384
NF + IG G F V+K I L DG V A+K+ + + + K L E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLP----WHLRLVIAHQI 440
H ++++ L +E ++ ++ E G L + F + +P W + Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFV----QL 115
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
L ++HS I HRD+K +N+ + K+ D GL R ++T +H + G
Sbjct: 116 CSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAH---SLVG 168
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
T Y+ PE KSD++S G +L E+ + + +NL KKI +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKKIEKCD 224
Query: 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618
P+ + + + L L + C++ + RP +I Y++ +AK
Sbjct: 225 -----YPPLPADHYS-------EELRDLVSRCINPDPEKRP-------DISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 67/195 (34%), Positives = 98/195 (50%), Gaps = 17/195 (8%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
IG G FG+V G G A+K K N L E ++ Q+ H +LV+LLG VE
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 398 LDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIY 456
L I EY+ G+L D+L G+ L L + + E + YL +
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRS--RGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 457 HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLT 516
HRD+ + N+L+ E AKVSDFGL++ E + T D T + + + PE R + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD-----TGKLPVKWTAPEALREKKFS 177
Query: 517 DKSDVYSFGVVLLEL 531
KSDV+SFG++L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 65/284 (22%), Positives = 126/284 (44%), Gaps = 31/284 (10%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKL-GNTKGT-----DLVLNEVRILCQV 383
+ K +GTG F ++ + GT+ A+K+ NT + + E+R++ ++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
NH ++R+LG E + E++ G++ L K+ + + Q+ G
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRG 115
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
L+YLH I HRDVK +N+L+D +++DFG + + T GT+
Sbjct: 116 LSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562
++ PE R Q DV+S G V++E+ T+K + + ++ L+ + +
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232
Query: 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
E + P L++ + CL+ + ++RP +E+
Sbjct: 233 PEHLSPGLRD---------------VTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 67/200 (33%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 338 IGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDL---VLNEVRILCQVNHRSLVRLLG 393
IG G FGEVF G L D T A+K + T DL L E RIL Q +H ++VRL+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
C + ++ E + G L + P L + + A G+ YL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA---QGTMGYLDPEYY 510
HRD+ + N L+ EK K+SDFG+SR E D +T Q + + PE
Sbjct: 116 --IHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 511 RNFQLTDKSDVYSFGVVLLE 530
+ + +SDV+SFG++L E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 338 IGTGGFGEVFK-GILDDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQVNHRSLVRLLGC 394
IG G G VFK + G A+K+ L +G + L E++ L H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 395 CVELDQTLMIYEYIPNGTLFDHL-HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
+++ EY+P L + L + PLP + +G+ Y+H+
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHANG-- 119
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF 513
I HRD+K +N+L+ K++DFGL+RL + +++ T Y PE
Sbjct: 120 -IMHRDLKPANLLISADGVLKIADFGLARL---FSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 514 QLTDKS-DVYSFGVVLLELL 532
+ D D+++ G + ELL
Sbjct: 176 RKYDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 17/213 (7%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG-----NTKGTDLVLNEVRILCQVN 384
N+ + L+G G FG V+ +D G A K+ + +K + E+++L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 385 HRSLVRLLGCCVE-LDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
H +V+ GC + ++TL I+ EY+P G++ D L + L + QI E
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILE 117
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
G++YLHS I HRD+K +NIL D N K+ DFG S+ ++ + + I + GT
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI-RSVTGTP 173
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
++ PE K+DV+S G ++E+LT K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLV--LNEVRILCQVNHRSLVRLLGC 394
IG G +G V+K G + AIK+ KL L E+++L ++NH ++++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCDFT-GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
+++E++ D + LP L +Q+ +GL + HS
Sbjct: 67 FRHKGDLYLVFEFM------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG-- 118
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE-YYRN 512
I HRD+K N+L++ + K++DFGL+R + +T T Y PE +
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARSF----GSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 513 FQLTDKSDVYSFGVVLLELLT 533
+ D++S G + ELL+
Sbjct: 174 KGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 34/277 (12%)
Query: 332 FSKDNLIGTGGFGEVFKGILDDGT-VTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLV 389
F+K IG G FGEV+KGI + V AIK L + + + E+ +L Q + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
R G ++ + +I EY+ G+ D L K PL I +I +GL YLHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLHS 119
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
HRD+K++N+LL E+ + K++DFG++ + T+ + T GT ++ PE
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEV 172
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569
+ K+D++S G+ +EL E N +L M V+ +
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKG--------EPPNSDL-----------HPMRVLFLI 213
Query: 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
K L+ + K +CL++ + RP+ KE+
Sbjct: 214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 65/238 (27%), Positives = 108/238 (45%), Gaps = 28/238 (11%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKG-ILDDGTVTAIKRAKLGNTKGTDLV--LNEVRILCQV 383
R+ F K N IG G +G V++ G + A+K+ ++ N + + L E+ +L +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 384 NHRSLVRLLGCCV--ELDQTLMIYEYIPN--GTLFDHLHCDFTG---KWPPLPWHLRLVI 436
H ++V L V LD ++ EY +L D++ F+ K +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK----------CL 113
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
Q+ GL YLH I HRD+K SN+LL +K K++DFGL+R + T
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG----LPAKPMT 166
Query: 497 TAQGTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553
T+ Y PE + D+++ G +L ELL K + E E ++L++ +
Sbjct: 167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 78/273 (28%), Positives = 125/273 (45%), Gaps = 29/273 (10%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
+G+G FG V G AIK G D + E +++ +++H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFI-EEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYH 457
++ E++ NG L ++L GK + L + + EG+ YL + H
Sbjct: 71 QKPLYIVTEFMENGCLLNYLR-QRQGKLSK---DMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 458 RDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTD 517
RD+ + N L+ KVSDFG++R V E S + A+ + + PE + + +
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS---SGAKFPVKWSPPEVFNFSKYSS 180
Query: 518 KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHL 577
KSDV+SFGV++ E+ T K + F E+ N V ++ I RL P L A+
Sbjct: 181 KSDVWSFGVLMWEVFTEGK-MPF---EKKSNYEV-VEMISRGFRLYR---PKL---ASMT 229
Query: 578 DLETMKALGLLAASCLDERRQNRPSMKEVADEI 610
E M SC E+ + RP+ E+ I
Sbjct: 230 VYEVM-------YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 23/202 (11%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCV 396
IG+G +G+V+K + G + AIK KL +++ E+ +L + H ++V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 397 ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH---QIAEGLTYLHSAAVP 453
D+ ++ EY G+L D PL L IA+ + +GL YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRG----PLS---ELQIAYVCRETLKGLAYLHETGK- 122
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT-ETNDSHIFTTAQGTMGYLDPEYY-- 510
HRD+K +NILL E + K++DFG+S + T S I GT ++ PE
Sbjct: 123 --IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAV 175
Query: 511 -RNFQLTDKSDVYSFGVVLLEL 531
R K D+++ G+ +EL
Sbjct: 176 ERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKRAKLGNTKG-TDLVLNEVR 378
EI+R + + IG G FG+V++G+ ++ A+K K + + L E
Sbjct: 2 EIQR--EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI-A 437
I+ Q +H +V+L+G E + ++ E P G L +L + L L++ +
Sbjct: 60 IMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS----LD-LASLILYS 113
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
+Q++ L YL S HRD+ + N+L+ K+ DFGLSR +E D +
Sbjct: 114 YQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-----DESYYKA 165
Query: 498 AQGTM--GYLDPEY--YRNFQLTDKSDVYSFGVVLLELL 532
++G + ++ PE +R F T SDV+ FGV + E+L
Sbjct: 166 SKGKLPIKWMAPESINFRRF--TSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 74/242 (30%), Positives = 115/242 (47%), Gaps = 31/242 (12%)
Query: 326 RRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDLV-LNEVRILCQ 382
+R + F IG G +G+V+K D G + A+K+ +L N K G + + E++IL Q
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 383 VNHRSLVRLLGCCVELDQTL----------MIYEYIPN---GTLFDHLHCDFTGKWPPLP 429
+NHR++V L + L +++EY+ + G L L F+
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSED----- 116
Query: 430 WHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489
H++ Q+ EGL Y H HRD+K SNILL+ K K++DFGL+RL
Sbjct: 117 -HIK-SFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNS--- 168
Query: 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSKKAIDFNREEENVN 548
+S +T T+ Y PE + + DV+S G +L EL T K N+E +
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228
Query: 549 LV 550
L+
Sbjct: 229 LI 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 8e-18
Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 37/290 (12%)
Query: 332 FSKDNLIGTGGFGEVFKGILDDGT--VTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSL 388
F+K IG G FGEVFKGI D+ T V AIK L + + + E+ +L Q + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
+ G ++ + +I EY+ G+ D L PL I +I +GL YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLH 118
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
S HRD+K++N+LL E K++DFG++ + T+ + GT ++ PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPE 171
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568
+ K+D++S G+ +EL + E M+V+
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPP-------------------HSELHPMKVLFL 212
Query: 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618
+ K L+ K L +CL++ RP+ KE+ ++I+ AK
Sbjct: 213 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH-KFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 9e-18
Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 36/278 (12%)
Query: 332 FSKDNLIGTGGFGEVFKGILDDGT--VTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSL 388
F+K IG G FGEVFKGI D+ T V AIK L + + + E+ +L Q + +
Sbjct: 6 FTKLERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
+ G ++ + +I EY+ G+ D L P + +I +GL YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLH 118
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
S HRD+K++N+LL E+ + K++DFG++ + T+ + T GT ++ PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPE 171
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568
+ K+D++S G+ +EL E N ++ M V+
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKG--------EPPNSDM-----------HPMRVLFL 212
Query: 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ K L E K +CL++ RP+ KE+
Sbjct: 213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 35/228 (15%)
Query: 318 RIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDG----TVTAIKRAKLGNT-KGTD 371
RI E++ K ++G+G FG V+KGI + DG AIK + + K
Sbjct: 2 RILKETELK-------KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK 54
Query: 372 LVLNEVRILCQVNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHL--HCDFTGKWPPL 428
+L+E ++ V + RLLG C L T+ ++ + +P G L D++ + D G L
Sbjct: 55 EILDEAYVMAGVGSPYVCRLLGIC--LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLL 112
Query: 429 PWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488
W + QIA+G++YL + HRD+ + N+L+ + K++DFGL+RL++ E
Sbjct: 113 NWCV------QIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163
Query: 489 TNDSHIFTTAQG---TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
T + H A G + ++ E + + T +SDV+S+GV + EL+T
Sbjct: 164 T-EYH----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 21/231 (9%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKL-GNTKGTDL-VLNEVRILCQVNHRS 387
+ K ++G G FG V D + IK+ + TK L NE ++L ++H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
++ +E +++ EY P GTL +++ I H + L L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD------EDTILHFFVQILLAL 114
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNA-KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
H I HRD+K+ NILLD+ K+ DFG+S+++ ++ S +T GT Y+
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVV-GTPCYIS 169
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557
PE KSD+++ G VL EL + K+A E NL + KIM
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAF------EAANLPALVLKIM 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 66/214 (30%), Positives = 113/214 (52%), Gaps = 28/214 (13%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDG----TVTAIKRAKLGNT-KGTDLVLNEVRILCQVNH 385
F K ++G+G FG V+KG+ + +G AIK + + K +L+E ++ V++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 386 RSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIAE 442
+ RLLG C L T+ +I + +P G L D++ H D G L W + QIA+
Sbjct: 69 PHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAK 120
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG-- 500
G+ YL + HRD+ + N+L+ + K++DFGL++L+ E + H A+G
Sbjct: 121 GMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE-KEYH----AEGGK 172
Query: 501 -TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ ++ E + T +SDV+S+GV + EL+T
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 17/213 (7%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG-----NTKGTDLVLNEVRILCQVN 384
N+ L+G G FG V+ D G A+K+ + +K + + E+++L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 385 HRSLVRLLGCCVE-LDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
H +V+ GC + +++TL I+ E++P G++ D L + L ++ QI E
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILE 117
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
G++YLHS I HRD+K +NIL D N K+ DFG S+ ++ + + + + GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM-KSVTGTP 173
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
++ PE K+D++S G ++E+LT K
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 338 IGTGGFGEVFKGILDDGTVTA---IKRAK-LGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
IG G FG+V G G A +K + L L EV+ ++NH ++++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLH-CDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
C+E L++ E+ P G L ++L + +A ++A GL +LH A
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLHQAD- 120
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGL--SRLVER-TETNDSHIFTTAQGTMGYLDPEY 509
H D+ N L L+ K+ D+GL + E T D H + +L PE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-----PLRWLAPEL 173
Query: 510 YRNFQ-------LTDKSDVYSFGVVLLELLT 533
T KS+++S GV + EL T
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 75/257 (29%), Positives = 110/257 (42%), Gaps = 34/257 (13%)
Query: 338 IGTGGFGEVFKG------ILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL 391
+G G FG+VF D + A+K K E +L + H +V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCD------FTGKWP-----PLPWHLRLVIAHQI 440
G C + D +M++EY+ +G L L P L L IA QI
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
A G+ YL S HRD+ + N L+ L K+ DFG+SR V T+ +
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----YYRVGGH 184
Query: 501 TM---GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK 555
TM ++ PE YR F T +SDV+SFGV+L E+ T K F V + +
Sbjct: 185 TMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242
Query: 556 IMDEERL--MEVVDPVL 570
+++ R+ EV D +L
Sbjct: 243 VLERPRVCPKEVYDIML 259
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 336 NLIGTGGFGEVFKG----ILDDGT---VTAIKRAKLGNTKGTDL-VLNEVRILCQVNHRS 387
N +G+G FGEV++G IL G+ A+K + G T L E ++ NH +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLR--LVIAHQIAEGLT 445
+V+LLG C+ + +I E + G L +L ++ P L+ L I +A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNA-----KVSDFGLSRLVERTETNDSHIFTTAQG 500
YL HRD+ + N L+ EK K+ DFGL+R + +++ + +G
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD----YYRKEGEG 173
Query: 501 TMG--YLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ ++ PE + + T +SDV+SFGV++ E+LT
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 82/310 (26%), Positives = 133/310 (42%), Gaps = 70/310 (22%)
Query: 337 LIGTGGFGEVFKGILD-----DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL 391
+G G FG V D G V A+K+ + + E+ IL + H ++V+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 392 LGCCVELDQTLM--IYEYIPNGTLFDHLH-----CDFTGKWPPLPWHLRLVI-AHQIAEG 443
G C + + + EY+P G+L D+L D H +L++ A QI +G
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD----------HRKLLLYASQICKG 120
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER-------TETNDSHIFT 496
+ YL S HRD+ + NIL++ + K+ DFGL++++ + E +S IF
Sbjct: 121 MEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 497 TAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556
A PE + + SDV+SFGVVL EL T D + +M+ +
Sbjct: 178 YA--------PESLTESKFSVASDVWSFGVVLYELFTY---SDKSCSPP----AEFMRMM 222
Query: 557 MDEERLMEVVDPVLKERATHLDLETMKALGLLAA-------------SCLDERRQNRPSM 603
++++ +V HL +E +K G L A C + RPS
Sbjct: 223 GNDKQGQMIV--------YHL-IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSF 273
Query: 604 KEVADEIEYI 613
E+A ++E I
Sbjct: 274 SELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 17/213 (7%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG-----NTKGTDLVLNEVRILCQVN 384
N+ L+G G FGEV+ D G A+K+ +K + + E+++L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 385 HRSLVRLLGCCVELDQ-TLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
H +V+ GC + ++ L I+ EY+P G++ D L + L ++ QI +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQ 117
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
G++YLHS I HRD+K +NIL D N K+ DFG S+ ++ + + I + GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI-KSVTGTP 173
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
++ PE K+DV+S ++E+LT K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLV-LNEVRILCQVN-HRSLVRLLGC 394
+G G FG V+ + G + AIK+ K + + L EV+ L ++N H ++V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPP 454
E D+ ++EY+ G L+ L D GK P + I +QI +GL ++H
Sbjct: 67 FRENDELYFVFEYM-EGNLY-QLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKHG--- 119
Query: 455 IYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE------ 508
+HRD+K N+L+ K++DFGL+R E +T T Y PE
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRAPEILLRST 174
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSK 535
Y + + D+++ G ++ EL T +
Sbjct: 175 SY-SSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 43/227 (18%)
Query: 338 IGTGGFGEVFK----GIL--DDGTVTAIKRAKLGNTKGTDL-VLNEVRILCQVNHRSLVR 390
IG G FG VF+ G+L + T+ A+K K + E ++ + +H ++V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHL-HCD----------------FTGKWPPLPWHLR 433
LLG C +++EY+ G L + L H PL +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE-----RTE 488
L IA Q+A G+ YL + HRD+ + N L+ E + K++DFGLSR + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 489 TNDSHIFTTAQGTMGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
ND+ + ++ PE +Y + T +SDV+++GVVL E+ +
Sbjct: 190 ENDAI-------PIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 28/227 (12%)
Query: 315 KSARIFTGKEIRR-ATNNFSKDNLIGTGGFGEV----FKGILDDGTVTAIKRAKLGNTKG 369
K+A +FT + ++F +GTG FG V KG + + +K+ ++ K
Sbjct: 2 KAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ 61
Query: 370 TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWP--- 426
V E IL +++H +V ++ + ++ + E++ G LF HL G++P
Sbjct: 62 VQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK--AGRFPNDV 119
Query: 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV-E 485
+H LV+A + YLHS I +RD+K N+LLD K + KV+DFG ++ V +
Sbjct: 120 AKFYHAELVLAFE------YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
Query: 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
RT FT GT YL PE ++ D ++ GV+L E +
Sbjct: 171 RT-------FTLC-GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 338 IGTGGFGEVFKG-ILDDGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCC 395
+G G G V K G + A+K +L N +L E+ IL + N +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPI 455
+ EY+ +G D + + G +P + IA + +GLTYLH I
Sbjct: 69 YNNGDISICMEYM-DGGSLDKILKEVQG---RIPERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 456 YHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ 514
HRDVK SNIL++ + K+ DFG+S +LV +S + T GT Y+ PE +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLV------NS-LAKTFVGTSSYMAPERIQGND 175
Query: 515 LTDKSDVYSFGVVLLELLTSK 535
+ KSD++S G+ L+EL T +
Sbjct: 176 YSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 336 NLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDL-VLNEV---RILCQVNHRSLV 389
IG G +G V+K L+ G A+K+ ++ ++ G L L E+ + L H ++V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 390 RLLGCC--VELDQTLMIYEYIPNGTLFDHLHCD---FTGKWPP--LPWHLRLVIAHQIAE 442
RLL C D+ L + +F+H+ D + K P LP + Q+
Sbjct: 65 RLLDVCHGPRTDRELKLT------LVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
G+ +LHS I HRD+K NIL+ K++DFGL+R+ T+ T+
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-----LTSVVVTL 170
Query: 503 GYLDPEYYRNFQLTDKS--DVYSFGVVLLELLTSKKAIDFNRE 543
Y PE Q + + D++S G + EL F R
Sbjct: 171 WYRAPEVL--LQSSYATPVDMWSVGCIFAEL--------FRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 338 IGTGGFGEVFKGIL---DDGTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLVRLLG 393
+G+G FG V KG+ AIK K N K D ++ E I+ Q+++ +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
C E + +++ E G L L +GK + + + HQ++ G+ YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFL----SGKKDEITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT--MGYLDPE--Y 509
HRD+ + N+LL + AK+SDFGLS+ + +DS+ + G + + PE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKAL---GADDSYYKARSAGKWPLKWYAPECIN 171
Query: 510 YRNFQLTDKSDVYSFGVVLLELLT 533
+R F + +SDV+S+G+ + E +
Sbjct: 172 FRKF--SSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 47/223 (21%)
Query: 336 NLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL----VLNEVRILCQVNHRSLVR 390
IG+G +G V + G AIK K+ N + +L E+++L + H +++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDH-----------LHCDFTGKWPPLPWHLRLVIAHQ 439
LL ++ + F+ LH P H++ + +Q
Sbjct: 64 LL--------DILRPPSPED---FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFL-YQ 111
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
I GL YLHSA + HRD+K SNIL++ + K+ DFGL+R V+ + ++ T
Sbjct: 112 ILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD-PDEDEKGFLT--- 164
Query: 500 GTMGYLDPEYYR------NFQLTDKS-DVYSFGVVLLELLTSK 535
Y+ +YR + K+ D++S G + ELLT K
Sbjct: 165 ---EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRSLVRLLGC 394
IG G V+ I L + AIKR L T + + EV+ + Q NH ++V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPP 454
V D+ ++ Y+ G+L D + + L + + ++ +GL YLHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNG--- 122
Query: 455 IYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ 514
HRD+K+ NILL E + K++DFG+S + + T GT ++ PE
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 515 -LTDKSDVYSFGVVLLELLT 533
K+D++SFG+ +EL T
Sbjct: 183 GYDFKADIWSFGITAIELAT 202
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 79/290 (27%), Positives = 135/290 (46%), Gaps = 39/290 (13%)
Query: 336 NLIGTGGFGEVFKGILDDGTVTAIKRA-----KLGNTKGTDLVLNEVRILCQVNHRSLVR 390
+IG G FG V+ G L D I A ++ + + + L E I+ +H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 391 LLGCCVELDQT-LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IAHQIAEGLTYLH 448
LLG C+ + + L++ Y+ +G L + F P L+ Q+A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRN-----FIRSETHNPTVKDLIGFGLQVAKGMEYL- 114
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
A HRD+ + N +LDE KV+DFGL+R + E H T A+ + ++ E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME---V 565
+ + T KSDV+SFGV+L EL+T + + ++ ++ VY ++ RL++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVY---LLQGRRLLQPEYC 227
Query: 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615
DP+ + + SC + + RP+ E+ IE I S
Sbjct: 228 PDPLYE----------------VMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKG-ILDDGTVTAIKRAKLGNTKGTDLV----LNEVRILCQVN 384
N + ++G G +G V K G + AIK+ K ++ + V L EV++L Q+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFK--ESEDDEDVKKTALREVKVLRQLR 58
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
H ++V L + +++EY+ TL + L G LP Q+ + +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG----LPPDAVRSYIWQLLQAI 113
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
Y HS I HRD+K NIL+ E K+ DFG +R + S T T Y
Sbjct: 114 AYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARAL--RARPASP-LTDYVATRWY 167
Query: 505 LDPEYYRNFQLTDKS-----DVYSFGVVLLELLT 533
PE + D + DV++ G ++ ELL
Sbjct: 168 RAPE----LLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 70/277 (25%), Positives = 127/277 (45%), Gaps = 34/277 (12%)
Query: 354 GTVTAIKRAKLGNTKGTDLV------------LNEVRILCQVNHRSLVRLLGCCVELDQT 401
G+V+ +K G +V L E++I+ + +V G + +
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78
Query: 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVK 461
M E++ G+L D ++ K P+P + IA + EGLTYL++ V I HRD+K
Sbjct: 79 CMCMEFMDCGSL-DRIY----KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIK 131
Query: 462 SSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDV 521
SNIL++ + K+ DFG+S E +S I T GT Y+ PE + + T KSDV
Sbjct: 132 PSNILVNSRGQIKLCDFGVS-----GELINS-IADTFVGTSTYMSPERIQGGKYTVKSDV 185
Query: 522 YSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLET 581
+S G+ ++EL K F+ +++ D +++++ +++E L
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQD--------DPMGILDLLQQIVQEPPPRLPSSD 237
Query: 582 M-KALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617
+ L +CL + RP+ +++ +I ++
Sbjct: 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 338 IGTGGFGEVF----KGILDDG--TVTAIKRA-KLGNTKGTDLVLNEVRILCQVNHRSLVR 390
+G G FG V+ KG++ D T AIK + + + LNE ++ + N +VR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHC------DFTGKWPPLPWHLRLVIAHQIAEGL 444
LLG + TL+I E + G L +L + + PP + +A +IA+G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP-SLKKMIQMAGEIADGM 132
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG- 503
YL++ HRD+ + N ++ E K+ DFG++R + T+ + +G +
Sbjct: 133 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLLPV 185
Query: 504 -YLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
++ PE ++ T SDV+SFGVVL E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 338 IGTGGFGEVF----KGIL-----------DDGTVTAIK--RAKLGNTKGTDLVLNEVRIL 380
+G G FGEV +G+ + A+K RA + T D L E++I+
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF-LKEIKIM 71
Query: 381 CQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-----HCDFT--GKWPPLPWHLR 433
++ + +++RLLG CV D MI EY+ NG L L FT P +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493
L +A QIA G+ YL S HRD+ + N L+ K++DFG+SR + +
Sbjct: 132 LYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY--YR 186
Query: 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
I A + ++ E + T SDV++FGV L E+ T
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 337 LIGTGGFGEVFKGIL--DDGTV--TAIKRAKLGNTKGTDL--VLNEVRILCQVNHRSLVR 390
++G G FG V +G L DDG+ A+K KL +++ L+E + +H ++++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 391 LLGCCVELDQT------LMIYEYIPNGTLFDHLHCDFTGKWPP-LPWHLRLVIAHQIAEG 443
L+G C E ++I ++ +G L L G P LP L IA G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET-NDSHIFTTAQGTM 502
+ YL + HRD+ + N +L E + V+DFGLS+ + + I A+ +
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI---AKMPV 179
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
++ E + T KSDV++FGV + E+ T
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 69/231 (29%), Positives = 116/231 (50%), Gaps = 22/231 (9%)
Query: 337 LIGTGGFGEVF--KGIL--DDGTVTAIKRAKLGNTKGTDLV--LNEVRILCQVNHRSLVR 390
++G G FG+VF + I D G + A+K K K D V E IL +VNH +V+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
L + +I +++ G LF L + FT + ++ +A ++A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLA-ELALALDHLH 115
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
S I +RD+K NILLDE+ + K++DFGLS+ + ++ ++ GT+ Y+ PE
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFC-GTVEYMAPE 168
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559
T +D +SFGV++ E+LT +E + +++ K M +
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ 219
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRL 391
++G G FG+V KG + V +K+ + + + E R+L H L +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
C D+ + EY+ G L H+ G++ P R A +I GL +LH
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFD-EP-RARFYAA-EIVLGLQFLHERG 116
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSR--LVERTETNDSHIFTTAQGTMGYLDPEY 509
+ IY RD+K N+LLD + + K++DFG+ + ++ T+ T GT Y+ PE
Sbjct: 117 I--IY-RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS------TFCGTPDYIAPEI 167
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
D ++ GV+L E+L + + + E+E
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 332 FSKDNL-----IGTGGFGEVFK----GILDDGTV--TAIKRAK-LGNTKGTDLVLNEVRI 379
F ++NL +G G FG+V + G+ V A+K K ++ + +++E++I
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 380 LCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH 438
+ + NH ++V LLG C L+I EY G L + L + L L ++
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSY 148
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT-- 496
Q+A+G+ +L S HRD+ + N+LL K+ DFGL+R + NDS+
Sbjct: 149 QVAKGMAFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDI----MNDSNYVVKG 201
Query: 497 TAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
A+ + ++ PE N T +SDV+S+G++L E+ +
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 57/184 (30%), Positives = 80/184 (43%), Gaps = 47/184 (25%)
Query: 374 LNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL--HCDFTGKW----PP 427
L EV+IL +++ ++ RLLG C MI EY+ NG L L H T
Sbjct: 67 LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 428 LPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487
L + L +A QIA G+ YL S HRD+ + N L+ + K++DFG+SR
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSR---NL 180
Query: 488 ETNDSHIFTTAQGTMGYLDPEYYR------------------NFQLTDKSDVYSFGVVLL 529
++D YYR + T KSDV++FGV L
Sbjct: 181 YSSD-----------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 530 ELLT 533
E+LT
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 26/219 (11%)
Query: 328 ATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NH 385
T F +IG G +G+V+K G + AIK + + ++ E IL + NH
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE-EYNILRKYSNH 62
Query: 386 RSLVRLLGC------CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQ 439
++ G DQ ++ E G++ D L K L I +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYILRE 121
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE--TNDSHIFTT 497
GL YLH V HRD+K NILL + K+ DFG+S ++ T N T
Sbjct: 122 TLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN------T 172
Query: 498 AQGTMGYLDPE-----YYRNFQLTDKSDVYSFGVVLLEL 531
GT ++ PE + +SDV+S G+ +EL
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 331 NFSKDNLIGTGGFGEVFKGILDDGTVT----AIKRAKLGNT---KGTDLVLNEVRILCQV 383
+ + +GTG FG V L ++ A+K + K V NE R+L +V
Sbjct: 2 DLERIKTVGTGTFGRVH---LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 384 NHRSLVRLLGCCVELDQTL--MIYEYIPNGTLFDHLHC--DFTGKWPPLPWHLRLVIAHQ 439
+H ++RL E DQ M+ EY+P G LF +L F+ L A +
Sbjct: 59 SHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-------TGLFYASE 109
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR-LVERTETNDSHIFTTA 498
I L YLHS I +RD+K NILLD++ + K++DFG ++ L +RT T
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--------WTL 158
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
GT YL PE ++ D ++ G+++ E+L
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 67/258 (25%), Positives = 118/258 (45%), Gaps = 42/258 (16%)
Query: 338 IGTGGFGEVFKGILDD-GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL----- 391
+G G G VF + D A+K+ L + + L E++I+ +++H ++V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 392 ---------LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
+G EL+ ++ EY+ + + + P H RL +Q+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM------ETDLANVLEQGPLSEEHARL-FMYQLLR 125
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
GL Y+HSA V HRD+K +N+ ++ E L K+ DFGL+R+V D H +
Sbjct: 126 GLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIV------DPHYSHKGYLS 176
Query: 502 MGYLDPEYYRNFQL-------TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554
G L ++YR+ +L T D+++ G + E+LT K E E + L++
Sbjct: 177 EG-LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235
Query: 555 KIMDEERLMEV--VDPVL 570
++ EE E+ V P
Sbjct: 236 PVVREEDRNELLNVIPSF 253
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 70/225 (31%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 330 NNFSKDNLIGTGGFGEVFKG-ILDDGTV--TAIKRAKLGNTKGTDL-VLNEVRILCQVN- 384
N+ ++IG G FG+V K I DG AIKR K +K E+ +LC++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP-----------LPWHLR 433
H +++ LLG C + EY P+G L D L + P L
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493
L A +A G+ YL HRD+ + NIL+ E AK++DFGLSR E
Sbjct: 127 LHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQE-------- 175
Query: 494 IFTTAQGTMGYLDPEYYR----NFQL-TDKSDVYSFGVVLLELLT 533
+ TMG L + N+ + T SDV+S+GV+L E+++
Sbjct: 176 --VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 15/198 (7%)
Query: 338 IGTGGFGEVFKGILD---DGTVTAIKRAKLGNTKGT--DLVLNEVRILCQVNHRSLVRLL 392
+G+G FG V KG+ A+K K N D +L E ++ Q+++ +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
G C E + +++ E G L L K + + HQ++ G+ YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ-----KNKHVTEKNITELVHQVSMGMKYLEETN- 115
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
HRD+ + N+LL + AK+SDFGLS+ + + N T + + + PE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 513 FQLTDKSDVYSFGVVLLE 530
++ + KSDV+SFGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 27/225 (12%)
Query: 317 ARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTV----TAIKRAKLGNTKGT- 370
ARI E+R+ L+G+G FG V KGI + +G AIK + + + T
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 371 DLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL--HCDFTGKWPPL 428
+ + + + ++H +VRLLG C ++ + P G+L DH+ H D L
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 429 PWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488
W + QIA+G+ YL + HR++ + NILL +++DFG++ L+
Sbjct: 113 NWCV------QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL--YP 161
Query: 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + ++ + + ++ E + T +SDV+S+GV + E+++
Sbjct: 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 338 IGTGGFGEVFKGILDD------GTVTAIKRAKLGNTKGTDL-VLNEVRILCQVNHRSLVR 390
+G G FG V++G D T A+K + + LNE ++ +VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHC------DFTGKWPPLPWHLRLVI--AHQIAE 442
LLG + TL++ E + +G L +L + G+ PP L+ +I A +IA+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP---TLQEMIQMAAEIAD 130
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
G+ YL++ HRD+ + N ++ K+ DFG++R + T+ + +G +
Sbjct: 131 GMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD----YYRKGGKGLL 183
Query: 503 --GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
++ PE ++ T SD++SFGVVL E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 338 IGTGGFGEVFKGIL-----DDGTVTAIKRAK-LGNTKGTDLVLNEVRILCQVNHRSLVRL 391
+G FG+++KG L D + AIK K + N + E ++ +++H ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHL-----HCDF--------TGKWPPLPWHLRLVIAH 438
LG + M++EY+ G L + L H D T K L L IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK-SSLDHGDFLHIAI 131
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
QIA G+ YL S H+D+ + NIL+ E+L+ K+SD GLSR E + +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR-----EIYSADYYRVQ 183
Query: 499 QGTM---GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
++ ++ PE + + SD++SFGVVL E+ +
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 335 DNLIGTGGFGEVFKGILD-DGT--VTAIKRAK-LGNTKGTDLVLNEVRILCQV-NHRSLV 389
+++IG G FG+V + ++ DG AIK K + E+ +LC++ +H +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP-----------LPWHLRLVIAH 438
LLG C + EY P G L D L + P L L A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
+A G+ YL HRD+ + N+L+ E L +K++DFGLSR E
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEE----------VYV 173
Query: 499 QGTMGYLDPEYYR----NFQL-TDKSDVYSFGVVLLELLT 533
+ TMG L + N+ + T KSDV+SFGV+L E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 71/299 (23%), Positives = 132/299 (44%), Gaps = 42/299 (14%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNH--- 385
+ + LIG G +G V++G + G V A+K L +T D+ + EV +L Q+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL-DTPDDDVSDIQREVALLSQLRQSQP 61
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
++ + G ++ + +I EY G++ + K P+ VI ++ L
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM------KAGPIAEKYISVIIREVLVALK 115
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
Y+H + HRD+K++NIL+ N K+ DFG++ L+ + + S T GT ++
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS----TFVGTPYWM 168
Query: 506 DPEYYRNFQLTD-KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564
PE + D K+D++S G+ + E+ T +
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP-------------------YSDVDAFR 209
Query: 565 VVDPVLKERATHLDLETM-KALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRIS 622
+ + K + L+ K L A+CLDE + R S +E+ + ++I + +K +S
Sbjct: 210 AMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELL-KSKWIKAHSKTPVS 267
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 25/204 (12%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNHRSLVRLLGC 394
+G G FG+V+K + A+ AK+ TK + + + E+ IL NH +V+LLG
Sbjct: 20 LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 395 CVELDQTLMIYEYIPNGTL-FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
+ ++ E+ P G + L D P + VI Q+ E L YLHS
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQYLHSMK-- 130
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
I HRD+K+ N+LL + K++DFG+S + V+ + DS I GT ++ PE
Sbjct: 131 -IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMC 184
Query: 513 FQLTD-----KSDVYSFGVVLLEL 531
+ D K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 331 NFSKDNLIGTGGFGEVF--KGILDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHR 386
+ IG G FG+++ K D IK L K + EV +L ++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHL---HCDFTGKWPPLPWHLRLVIAHQIAEG 443
++V E + ++ EY G L + + L W + QI+ G
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV------QISLG 113
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDFGLSRLVERTETNDSHIFT-TAQGT 501
L ++H I HRD+KS NI L + + AK+ DFG++R + NDS T GT
Sbjct: 114 LKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-----NDSMELAYTCVGT 165
Query: 502 MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541
YL PE +N +K+D++S G VL EL T K + N
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 70/236 (29%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 337 LIGTGGFGEVFKG-ILDDGTVTAIKR-AKLGNTKGTDLVLNEVRILCQVNHRS--LVRLL 392
IG+G G+V+K G V A+K+ + GN + +L ++ ++ + +H +V+
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIVKCY 80
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL---HS 449
G + + E + T D L G P+P + + I + L YL H
Sbjct: 81 GYFITDSDVFICMELM--STCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQGTMGYLDPE 508
+ HRDVK SNILLD N K+ DFG+S RLV DS T + G Y+ PE
Sbjct: 136 -----VIHRDVKPSNILLDASGNVKLCDFGISGRLV------DSKAKTRSAGCAAYMAPE 184
Query: 509 YYRNFQLTDK----SDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
K +DV+S G+ L+EL T + + E V + KI+ EE
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-----LTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 51/229 (22%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL----VLNEVRILCQVNHRSLVRLL 392
+G G FGEV+K + G V A+K+ + N K D L E++IL ++ H ++V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLI 73
Query: 393 GCCVELDQTLMIYEYIPNG--------TLFDHLHCDFTG--KWPPLPWHLRLVIAH---- 438
M E + ++ D +G + P ++L +
Sbjct: 74 D---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP----SVKLTESQIKCY 120
Query: 439 --QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI-- 494
Q+ EG+ YLH I HRD+K++NIL+D + K++DFGL+R + N
Sbjct: 121 MLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 495 -----FTTAQGTMGYLDPEYY---RNFQLTDKSDVYSFGVVLLELLTSK 535
+T T Y PE R + T D++ G V E+ T +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRY--TTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 68/220 (30%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 336 NLIGTGGFGEVFKGILD-DGTV--TAIKRAK--LGNTKGTDLVLNEVRILCQVNHR-SLV 389
++IG G FG+V K + DG AIKR K D E+ +LC++ H +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNII 59
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP-----------LPWHLRLVIAH 438
LLG C + EY P+G L D L + P L L A
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
+A G+ YL HRD+ + NIL+ E AK++DFGLSR E
Sbjct: 120 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQE----------VYV 166
Query: 499 QGTMGYLDPEYYR----NFQL-TDKSDVYSFGVVLLELLT 533
+ TMG L + N+ + T SDV+S+GV+L E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 75/289 (25%), Positives = 134/289 (46%), Gaps = 35/289 (12%)
Query: 338 IGTGGFGEVFKGIL--DDGTV-TAIKRAKLGNTKGTDL--VLNEVRILCQVNHRSLVRLL 392
+G G FG V +G L DD + A+K K+ +++ L+E + + +H +++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 393 GCCVELDQT------LMIYEYIPNGTLFDHLHCDFTGKWPP-LPWHLRLVIAHQIAEGLT 445
G C++ ++ ++I ++ +G L L G P LP + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
YL S + HRD+ + N +L+E +N V+DFGLS+ + + A+ + ++
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG--RIAKMPVKWI 181
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565
E + T KSDV+SFGV + E+ T + EN + Y+++
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSEIYDYLRQ---------- 229
Query: 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614
LK+ LD L L +SC ++RPS + + E+E +
Sbjct: 230 -GNRLKQPPDCLD-----GLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 60/199 (30%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 338 IGTGGFGEVFK-GILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
+G GGFGEV + G + A K + +L KG + LNE +IL +V+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
D ++ + G L H G+ P P + A QI GL +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDL--KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR-- 115
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF 513
I +RD+K N+LLD+ N ++SD GL+ E GT GY+ PE +
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLA-----VELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 514 QLTDKSDVYSFGVVLLELL 532
D ++ G L E++
Sbjct: 170 VYDFSVDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 42/222 (18%)
Query: 327 RATNNFS---KDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLN----EVR 378
A + S + N IG+G G V+K I G + A+K GN + D V E+
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHE--DTVRRQICREIE 124
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV--I 436
IL VNH ++V+ + ++ E++ G+L + H + + +
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHI----------ADEQFLADV 173
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT--ETNDSHI 494
A QI G+ YLH I HRD+K SN+L++ N K++DFG+SR++ +T N S
Sbjct: 174 ARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-- 228
Query: 495 FTTAQGTMGYLDPEYYRNFQLTD------KSDVYSFGVVLLE 530
GT+ Y+ PE N L D++S GV +LE
Sbjct: 229 ----VGTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 332 FSKDNLIGTGGFGEVFK-GILDDGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVNHRS 387
F + ++G GGFGEV + G + A K+ ++ KG + LNE +IL +VN R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHL-HCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+V L D ++ + G L H+ H G + A +I GL
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLED 117
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
LH I +RD+K NILLD+ + ++SD GL+ V +T + GT+GY+
Sbjct: 118 LHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-----GTVGYMA 169
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
PE +N + T D ++ G +L E++ +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 44/280 (15%)
Query: 338 IGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLN--EVRILCQVNHRSLVRL 391
+G G FG V+ K + + + +K +G + V E ++L +++H ++V+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLH-CDFTGKWPPLP----WHLRLVIAHQIAEGLTY 446
+E D +I EY L L TGK W ++L++ G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
+H I HRD+K+ NI L L K+ DFG+SRL+ + TT GT Y+
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL----MGSCDLATTFTGTPYYMS 173
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566
PE ++ KSD++S G +L E+ A E N + + +I++
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAF------EGQNFLSVVLRIVEGP------ 221
Query: 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
P L E + + L + S L++ RPS E+
Sbjct: 222 TPSLPETYS-------RQLNSIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 58/177 (32%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 374 LNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLH-----------CDFT 422
L EV+IL ++ +++RLLG CV+ D MI EY+ NG L L D
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 423 GKWPPLP---WHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479
LP + L +A QIA G+ YL S HRD+ + N L+ E L K++DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFG 183
Query: 480 LSRLVERTETNDSHIFTTAQG----TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
+SR + + + QG + ++ E + T SDV++FGV L E+L
Sbjct: 184 MSRNLYAGD------YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 28/237 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDLV-LNEVRILCQVNHR 386
+ + K IG G FGEVFK + A+K+ + N K G + L E++IL + H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 387 SLVRLLGCCVEL--------DQTLMIYEYIPN--GTLFDHLHCDFTGKWPPLPWHLRLVI 436
++V L+ C +++E+ + L + + FT L ++ V+
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT-----LS-EIKKVM 125
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
+ GL Y+H I HRD+K++NIL+ + K++DFGL+R ++ + + +T
Sbjct: 126 -KMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 497 TAQGTMGYLDPEYY---RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550
T+ Y PE R++ D++ G ++ E+ T + N E+ + L+
Sbjct: 182 NRVVTLWYRPPELLLGERDY--GPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 72/243 (29%), Positives = 111/243 (45%), Gaps = 28/243 (11%)
Query: 331 NFSKDNLIGTGGFGEVF----KGILDDGTVTAIKRAK----LGNTKGTDLVLNEVRILCQ 382
NF ++GTG +G+VF G D G + A+K K + K + E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 383 VNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHLHC--DFTGKWPPLPWHLRLVIAHQ 439
V + L + D L +I +Y+ G LF HL+ FT +R+ IA +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES------EVRVYIA-E 113
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
I L +LH + IY RD+K NILLD + + ++DFGLS+ E ++ F
Sbjct: 114 IVLALDHLHQLGI--IY-RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC--- 167
Query: 500 GTMGYLDPEYYRNFQL--TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557
GT+ Y+ PE R D +S GV+ ELLT A F + E + ++I+
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG--ASPFTVDGEQNSQSEISRRIL 225
Query: 558 DEE 560
+
Sbjct: 226 KSK 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 332 FSKDNLIGTGGFGEVFKGIL----DDGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVN 384
+ K IG G FG K IL +DG IK +K+ K + EV +L +
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMK 57
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP---LPWHLRLVIAHQIA 441
H ++V+ E ++ +Y G L+ ++ +P L W + QI
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV------QIC 111
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
L ++H I HRD+KS NI L + K+ DFG++R++ T + T GT
Sbjct: 112 LALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----VELARTCIGT 164
Query: 502 MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAID 539
YL PE N +KSD+++ G VL E+ T K A +
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 51/172 (29%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 376 EVRILCQVNHRSLVRLL--GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPW-HL 432
E + ++ H ++V LL G ++EY+P TL + L D G P L
Sbjct: 28 ETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAAD--GALPAGETGRL 84
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTET 489
L Q+ + L H+ I HRD+K NI++ + +AKV DFG+ L+
Sbjct: 85 ML----QVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137
Query: 490 NDSHIFTTAQ---GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538
D T GT Y PE R +T SD+Y++G++ LE LT ++ +
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLV----LNEVRILCQVN 384
+ + +G G G V K L + G + A+K T + L E+ I
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALK---TITTDPNPDLQKQILRELEINKSCK 57
Query: 385 HRSLVRLLGCCVELDQTLMIY---EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441
+V+ G ++ + + I EY G+L D ++ + + + IA +
Sbjct: 58 SPYIVKYYGAFLD-ESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQG 500
+GL+YLHS I HRD+K SNILL K K+ DFG+S LV FT G
Sbjct: 116 KGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT----FT---G 165
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLEL 531
T Y+ PE + + SDV+S G+ LLE+
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 337 LIGTGGFGEVFKGILDDG--TVTAIKRAKLGN----------TKGTDLVLNEVRILC-QV 383
+G+G FG V+K + + A+K + N K +++EV I+ Q+
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL------HCDFTGK--WPPLPWHLRLV 435
H ++VR +E D+ ++ + I L +H FT + W
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN--------- 117
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
I Q+ L YLH I HRD+ +NI+L E ++DFGL++ +
Sbjct: 118 IFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKL 170
Query: 496 TTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
T+ GT+ Y PE +N +K+DV++FG +L ++ T
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCV 396
+G G FG+V+K + G A K ++ + + + + E+ IL + H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 397 ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIY 456
++ ++ E+ G L D + + L + Q+ E L +LHS V
Sbjct: 73 YENKLWILIEFCDGGAL-DSI-MLELER--GLTEPQIRYVCRQMLEALNFLHSHKV---I 125
Query: 457 HRDVKSSNILLDEKLNAKVSDFGLSRLVERT-ETNDSHIFTTAQGTMGYLDPEY-----Y 510
HRD+K+ NILL + K++DFG+S + T + D+ I GT ++ PE +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVACETF 180
Query: 511 RNFQLTDKSDVYSFGVVLLEL 531
++ K+D++S G+ L+EL
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 81/277 (29%), Positives = 124/277 (44%), Gaps = 41/277 (14%)
Query: 338 IGTGGFGEV-FKGILDDGTVTAIKRAKLGNTKGTD--LVLNEVRILCQVNHRSLVRLLGC 394
+G G +GEV DG IK+ L N + E ++L Q+ H ++V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 395 CVELDQTLMI-YEYIPNGTLFDHLHCDFTGKWPP----LPWHLRLVIAHQIAEGLTYLHS 449
D L I + G L+ L + GK P + W + QIA L YLH
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFV------QIAMALQYLHE 120
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
I HRD+K+ N+ L KV D G++R++E N + +T GT Y+ PE
Sbjct: 121 KH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE----NQCDMASTLIGTPYYMSPEL 173
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569
+ N KSDV++ G + E+ T K A FN +++N +VY R++E P
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHA--FN--AKDMNSLVY--------RIIEGKLPP 221
Query: 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ + + LG L A+ L +R + RPS+K +
Sbjct: 222 MPKDYS-------PELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 17/233 (7%)
Query: 332 FSKDNLIGTGGFGEVFK-GILDDGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVNHRS 387
F + ++G GGFGEV + G + A KR ++ KG + LNE +IL +VN +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V L D ++ + G L H+ + P L A +I GL L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
H +RD+K NILLD+ + ++SD GL+ + E+ + GT+GY+ P
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTVGYMAP 170
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
E N + T D + G ++ E++ + F +E V +++++ E
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSP--FRGRKEKVKREEVDRRVLETE 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 336 NLIGTGGFGEVFKGILDDGTVTA-----IKRAKLGNTK-GTDLVLNEVRILCQVNHRSLV 389
+L+ G FG +F GIL D +K K ++ L+L E +L ++H++++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 390 RLLGCCVEL-DQTLMIYEYIPNGTLFDHLH-CDFTGKWPP--LPWHLRLVIAHQIAEGLT 445
+L C+E + ++Y Y+ G L L C P L + +A QIA G++
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG-TMGY 504
YLH V H+D+ + N ++DE+L K++D LSR + D H + + +
Sbjct: 132 YLHKRGV---IHKDIAARNCVIDEELQVKITDNALSRDL---FPMDYHCLGDNENRPVKW 185
Query: 505 LDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ E N + + SDV+SFGV+L EL+T
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 60/239 (25%), Positives = 94/239 (39%), Gaps = 51/239 (21%)
Query: 330 NNFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKRAK---LGNTKGTDLVLNEVRILCQ 382
++F +IG G FGEV+ L D G V A+K + + V E IL
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 383 VNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQ 439
+ +V+L + ++ L ++ EY+P G L + L F + R IA +
Sbjct: 58 ADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET------ARFYIA-E 109
Query: 440 IAEGLTYLHSAAVPPIY-HRDVKSSNILLDEKLNAKVSDFGLS----------------- 481
+ L +H + HRD+K NIL+D + K++DFGL
Sbjct: 110 LVLALDSVHKLG----FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 482 --------RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
+ R + GT Y+ PE R + D +S GV+L E+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 332 FSKDNLIGTGGFGEVFK-GILDDGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVNHRS 387
F ++G GGFGEV + G + A K+ ++ KG + LNE +IL +VN R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V L D ++ + G L H++ G P + A +I GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGN-PGFDEERAVFYAAEITCGLEDL 118
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
H I +RD+K NILLD+ + ++SD GL+ + ET + GT+GY+ P
Sbjct: 119 HRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-----GTVGYMAP 170
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV 547
E +N + T D + G ++ E++ K F + +E V
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP--FRQRKEKV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 338 IGTGGFGEVFKGILD-DGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
+G GGFGEV + G + A K+ +L KG + + E RIL +V+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 394 CCVELDQTLMIYEYIPNG-TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
+ L + I NG L H++ + + P P QI GL +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQRR- 117
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA-QGTMGYLDPEYYR 511
I +RD+K N+LLD N ++SD GL+ E D T GT G++ PE +
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLA-----VELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 512 NFQLTDKSDVYSFGVVLLELLTSK 535
+ D ++ GV L E++ ++
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 338 IGTGGFGEV-----------------FKGILDDGTVTAIK--RAKLGNTKGTDLVLNEVR 378
+G G FGEV + + A+K R D L E++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF-LKEIK 71
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV--- 435
I+ ++ +++RLL C+ D MI EY+ NG L L + + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL-SRHEPQEAAEKADVVTISYS 130
Query: 436 ----IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491
+A QIA G+ YL S HRD+ + N L+ + K++DFG+SR + +
Sbjct: 131 TLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD--- 184
Query: 492 SHIFTTAQG----TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ QG + ++ E + T SDV++FGV L E+LT
Sbjct: 185 ---YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 22/197 (11%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCC 395
+G G G V+K L + A+K L T + +++E+ IL + + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPI 455
++ + E++ G+L D K +P H+ IA + +GLTYL S I
Sbjct: 69 FVENRISICTEFMDGGSL------DVYRK---IPEHVLGRIAVAVVKGLTYLWSLK---I 116
Query: 456 YHRDVKSSNILLDEKLNAKVSDFGLSR-LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ 514
HRDVK SN+L++ + K+ DFG+S LV + I T GT Y+ PE Q
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-------NSIAKTYVGTNAYMAPERISGEQ 169
Query: 515 LTDKSDVYSFGVVLLEL 531
SDV+S G+ +EL
Sbjct: 170 YGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 68/206 (33%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 338 IGTGGFGEV-FKGILDDGTVTAIKR----AKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
IG G FG V F + V AIK+ K N K D ++ EVR L Q+ H + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQQLRHPNTIEYK 81
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
GC + ++ EY G+ D L + K PL I H +GL YLHS
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDIL--EVHKK--PLQEVEIAAICHGALQGLAYLHSHER 136
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
HRD+K+ NILL E K++DFG + LV + ++ F GT ++ PE
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSASLV-----SPANSFV---GTPYWMAPEVILA 185
Query: 513 F---QLTDKSDVYSFGVVLLELLTSK 535
Q K DV+S G+ +EL K
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 326 RRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN 384
R +F IG+G +G+V+K ++ G + AIK KL + +V E+ ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
H ++V G + D+ + E+ G+L D H TG PL ++ + +GL
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV--TG---PLSESQIAYVSRETLQGL 119
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
YLHS HRD+K +NILL + + K++DFG+S + T GT +
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI----GTPYW 172
Query: 505 LDPEYY---RNFQLTDKSDVYSFGVVLLEL 531
+ PE R D+++ G+ +EL
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 338 IGTGGFGEVFKGILDDGTVT----AIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
+G GGFG V + T +K+ + T + + +E IL + NH +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
+ M+ EY G L+ L G + + R IA + YLH+ +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDE--YTARFYIA-CVVLAFEYLHNRGI- 114
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF 513
IY RD+K N+LLD K+ DFG ++ ++ + + GT Y+ PE N
Sbjct: 115 -IY-RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYVAPEIILNK 167
Query: 514 QLTDKSDVYSFGVVLLELLTSK 535
D +S G++L ELLT +
Sbjct: 168 GYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 335 DNLIGTGGFGEVFKGIL-----DDGTVT-AIKRAKLGNTKGTDL--VLNEVRILCQV-NH 385
+G G FG+V K + T T A+K K + DL +++E+ ++ + H
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKH 75
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL--------HCDFTGKWPPLPWHLRLV-- 435
++++ LLG C + ++ EY +G L D L + PP L
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE-TLTQKDL 134
Query: 436 --IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493
A+Q+A G+ +L S HRD+ + N+L+ E K++DFGL+R + D +
Sbjct: 135 VSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDI---HHIDYY 188
Query: 494 IFTTAQGTMGY--LDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
TT G + + PE + T +SDV+SFGV+L E+ T
Sbjct: 189 RKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 55/229 (24%), Positives = 90/229 (39%), Gaps = 59/229 (25%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLN-----EVRILCQVN 384
+ K +G G + V+K + G + AIK+ KLG K +N E+++L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI-------- 436
H +++ LL +++E+ + L VI
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEF--------------------METDLEKVIKDKSIVLT 100
Query: 437 -AH------QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489
A GL YLHS I HRD+K +N+L+ K++DFGL+ R+
Sbjct: 101 PADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA----RSFG 153
Query: 490 NDSHIFTTAQGTMGYLDPE------YYRNFQLTDKSDVYSFGVVLLELL 532
+ + T T Y PE +Y D++S G + ELL
Sbjct: 154 SPNRKMTHQVVTRWYRAPELLFGARHY-----GVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 19/223 (8%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGI---LDDGTV---TAIKRAKLGNTKGTDL-VLN 375
E+ R + + +G G FGEV++G+ D V A+K ++ + L
Sbjct: 1 PEVPRD--SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM 58
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-HCDFTGKWP-PLPWHLR 433
E I+ + NH+++VRL+G E ++ E + G L L + P L
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK---LNAKVSDFGLSRLVERTETN 490
L A +A+G YL HRD+ + N LL K AK++DFG++R + R
Sbjct: 119 LFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY- 174
Query: 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
A + ++ PE + + T K+DV+SFGV+L E+ +
Sbjct: 175 -YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDLV-LNEVRILCQV 383
R+ + + K N I G +G V++ G + A+K+ K+ K G + L E+ IL ++
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL 61
Query: 384 NHRSLVRLLGCCV--ELDQTLMIYEYIPNG--TLFDHLHCDFTGKWPPLPWHLRLVIAHQ 439
H ++V + V LD+ M+ EY+ + +L + + F ++ ++ Q
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFL------QSEVKCLM-LQ 114
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
+ G+ +LH I HRD+K+SN+LL+ + K+ DFGL+R + +
Sbjct: 115 LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--- 168
Query: 500 GTMGYLDPE------YYRNFQLTDKSDVYSFGVVLLELLTSK 535
T+ Y PE Y + D++S G + ELLT K
Sbjct: 169 -TLWYRAPELLLGAKEY-----STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR 390
+++ IG G G V+ I + G AIK+ L +L++NE+ ++ + H ++V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLH--CDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
L + D+ ++ EY+ G+L D + C G+ + + + L +LH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--------AVCRECLQALEFLH 132
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
S V HRD+KS NILL + K++DFG + T + +T GT ++ PE
Sbjct: 133 SNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPE 185
Query: 509 YYRNFQLTDKSDVYSFGVVLLELL 532
K D++S G++ +E++
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 67/231 (29%), Positives = 111/231 (48%), Gaps = 37/231 (16%)
Query: 332 FSKDNLI-----GTGGFGEVFK----GI----LDDGTVTAIKRAKLGNTKGTDL--VLNE 376
F +D L+ G G FG+V + GI D A+K K N DL +++E
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISE 67
Query: 377 VRILCQVN-HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC------DFTGKWPPLP 429
+ ++ + H++++ LLG C + +I EY G L + L D+T +P
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 430 WHL----RLV-IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484
LV A+Q+A G+ YL S HRD+ + N+L+ E K++DFGL+R V
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRC---IHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 485 ERTETNDSHIFTTAQGTM--GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + T+ G + ++ PE + T +SDV+SFG+++ E+ T
Sbjct: 185 HDID----YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 64/211 (30%), Positives = 87/211 (41%), Gaps = 41/211 (19%)
Query: 338 IGTGGFGEVF---KGILDDGTVTAIKRAK---LGNTKGTDLVLNEVRILCQVNHRSLVRL 391
+G GG+G+VF K D G + A+KR K L VL E IL LV+L
Sbjct: 9 VGQGGYGQVFLAKKK--DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 392 LGCCVELDQTLMIYEYIPNG---TLFDH---LHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
L + + + EY+P G TL ++ L D H R +A E +
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED----------HARFYMAEMF-EAVD 115
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG-- 503
LH HRD+K N L+D + K++DFGLS I T A +G
Sbjct: 116 ALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS----------KGIVTYANSVVGSP 162
Query: 504 -YLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
Y+ PE R D +S G +L E L
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 332 FSKDNLIGTGGFGEVFK-GILDDGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVNHRS 387
F ++G GGFGEV + G + A K+ ++ KG + LNE RIL +VN R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V L D ++ + G L H+ + P + A ++ GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
I +RD+K NILLD++ + ++SD GL+ + ET + GT+GY+ P
Sbjct: 119 QRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-----GTVGYMAP 170
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV 547
E N + T D + G ++ E++ + F + +E V
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP--FRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-13
Identities = 84/376 (22%), Positives = 153/376 (40%), Gaps = 35/376 (9%)
Query: 240 NGLCQSSKYRHGKGCKRKKKKTMLIAGMVAALGGSLLVVLIGILVYNKLNEHMKKETKKL 299
LC CKR +K T + G+ LV+ + + + E K+
Sbjct: 605 IDLCGGDTTSGLPPCKRVRK-TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKR- 662
Query: 300 LIKQREEMLNAKA-AGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVT- 357
++ + + K ++ T +I + ++N+I G G +KG +
Sbjct: 663 -VENEDGTWELQFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQF 718
Query: 358 AIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL 417
+K N+ + +E+ + ++ H ++V+L+G C +I+EYI L + L
Sbjct: 719 VVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 418 HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477
L W R IA IA+ L +LH P + ++ I++D K +
Sbjct: 775 R--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR- 825
Query: 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKA 537
L L+ D+ F ++ Y+ PE +T+KSD+Y FG++L+ELLT K
Sbjct: 826 LSLPGLL----CTDTKCFISS----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
Query: 538 IDFNREEENVN--LVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDE 595
D E V+ +V + + + L +DP ++ + E ++ + LA C
Sbjct: 878 ADA---EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMN-LALHCTAT 933
Query: 596 RRQNRPSMKEVADEIE 611
RP +V +E
Sbjct: 934 DPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 335 DNLIGTGGFGEVFKGILD--DGTVTAIKRAK--LGNTKGTDLVLNEVRILCQVNHRSLVR 390
D IG G FG V+ + D DG A+K+ N V E+++LC H +++
Sbjct: 5 DRPIGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDH-------LHCDFTG---KWPPL-PWHLRLVIAHQ 439
L ++ Q P+ F+ + D PL H++ V +Q
Sbjct: 64 AL----DILQP-------PHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVK-VFLYQ 111
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
I GL YLHSA I HRD+K N+L++ K+ DFGL+R+ E ++S T
Sbjct: 112 ILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESKHMTQEV 165
Query: 500 GTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSK 535
T Y PE + T D++S G + ELL +
Sbjct: 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 41/222 (18%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG-NTKGT-DLVLNEVRILCQVNHRS 387
NF K IG G +G V+K G V A+K+ +L T+G + E+ +L ++NH +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCD---FTGKWPP--LPWHLRLVIAHQIAE 442
+V+LL ++ +++E+ LH D F P +P L Q+ +
Sbjct: 61 IVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR---LVERTETNDSHIFTTAQ 499
GL + HS V HRD+K N+L++ + K++DFGL+R + RT +T
Sbjct: 112 GLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-------YTHEV 161
Query: 500 GTMGYLDPE------YYRNFQLTDKSDVYSFGVVLLELLTSK 535
T+ Y PE YY + D++S G + E++T +
Sbjct: 162 VTLWYRAPEILLGCKYY-----STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 39/232 (16%)
Query: 332 FSKDNL-----IGTGGFGEVFK----GILDD----GTVTAIKRAKLGNTKG--TDLVLNE 376
FS+D L +G G FG+V GI D A+K K T+ +DLV +E
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SE 70
Query: 377 VRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC----------DFTGKW 425
+ ++ + H++++ LLG C + +I EY G L ++L D +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA-RV 129
Query: 426 PPLPWHLRLVIA--HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483
P + +++ +Q+A G+ YL S HRD+ + N+L+ E K++DFGL+R
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 484 VERTETNDSHIFTTAQGTM--GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
V N + T G + ++ PE + T +SDV+SFGV++ E+ T
Sbjct: 187 VN----NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 37/293 (12%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAK---LGNTKGTDLVLNEVRILCQVNHR 386
NF + IG G F EV++ L DG A+K+ + L + K + E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
++++ +E ++ ++ E G L + F + +P Q+ L +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
+HS + HRD+K +N+ + K+ D GL R ++T +H GT Y+
Sbjct: 122 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV---GTPYYMS 174
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566
PE KSD++S G +L E+ A+ + +NL KKI E
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKI-------EQC 223
Query: 567 D-PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618
D P L + H E + L C++ + RP +I Y+ +AK
Sbjct: 224 DYPPLP--SDHYSEELRQ----LVNMCINPDPEKRP-------DITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 37/102 (36%), Positives = 51/102 (50%), Gaps = 11/102 (10%)
Query: 435 VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI 494
+ +QI GL Y+HSA I HRD+K SNI ++E K+ DFGL+R +
Sbjct: 122 FLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTD-------DE 171
Query: 495 FTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSK 535
T T Y PE N+ D++S G ++ ELLT K
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 21/230 (9%)
Query: 308 LNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTV--TAIKR---A 362
L+ K S + ++ + +F+ +GTG FG V + AIKR +
Sbjct: 9 LHKKKDSDSTKE-PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS 67
Query: 363 KLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFT 422
K+ K D V +E +IL +NH V L G + ++ E++ G F F
Sbjct: 68 KIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT-----FL 122
Query: 423 GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
+ P + A QI YL S I +RD+K N+LLD+ K++DFG ++
Sbjct: 123 RRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAK 179
Query: 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
+V+ T T T GT Y+ PE N +D ++ G+ + E+L
Sbjct: 180 VVD-TRT------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 45/169 (26%), Positives = 71/169 (42%), Gaps = 29/169 (17%)
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
++ + ++L L ++I +YI +G LFD L + L I Q+ E
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEA 121
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLN-AKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
L LH I H D+K N+L D + + D+GL +++ D GT+
Sbjct: 122 LNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--------GTL 170
Query: 503 GYLDPE------YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
Y PE Y +F D ++ GV+ ELLT K + +EE
Sbjct: 171 DYFSPEKIKGHNYDVSF------DWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 37/222 (16%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKR-AKLGNTKGTDLVLNEVRILCQVNHRSL 388
+ + IG G +G V G AIK+ + + L E++IL + H ++
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 389 VRLLGCC----------VELDQTLM---IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV 435
+ +L V + Q LM +Y+ I L + F
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL------------- 112
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
+QI GL Y+HSA V HRD+K SN+LL+ + K+ DFGL+R+ +D F
Sbjct: 113 --YQILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGF 165
Query: 496 TTAQ-GTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSK 535
T T Y PE N + K+ D++S G +L E+L+++
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 338 IGTGGFGEVFKGIL---------DDGTVTAIKRAKLGNTKGTDLVLNE-VRILCQVNHRS 387
+G G F ++KG+L G ++ LG+ L E ++ Q++H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
LV+L G CV D+ +M+ EY+ G L LH + L W +L +A Q+A L YL
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNN--VSLHW--KLDVAKQLASALHYL 117
Query: 448 HSAAVPPIYHRDVKSSNILLDE-------KLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
+ H +V NIL+ K+SD G+ V E I
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI------ 168
Query: 501 TMGYLDPEYYRNFQ--LTDKSDVYSFGVVLLEL 531
++ PE RN Q LT +D +SFG LLE+
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 31/226 (13%)
Query: 331 NFSKDNLIGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR 386
NF ++G G FG+V KG + + +K+ + + + E R+L
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 387 SLVRLLGCCVE-LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+ L C + +D+ + EY+ G L H+ K P ++ A +IA GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY-----AAEIAIGLF 115
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF---TTAQ--G 500
+LHS + IY RD+K N++LD + + K++DFG+ + +IF TT G
Sbjct: 116 FLHSKGI--IY-RDLKLDNVMLDAEGHIKIADFGMCK---------ENIFGGKTTRTFCG 163
Query: 501 TMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSKKAIDFNREEE 545
T Y+ PE +Q KS D ++FGV+L E+L + D E+E
Sbjct: 164 TPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 73/229 (31%), Positives = 100/229 (43%), Gaps = 48/229 (20%)
Query: 338 IGTGGFGEV----FKGILDDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVN---HRS 387
+G G FG+V +K G + AIK K G+ D V + E RI N H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCD-FTGKWPPLPWHLRLVI-AHQIAEGLT 445
LV L C D + EY G L H+H D F+ R V A + GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP--------RAVFYAACVVLGLQ 115
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR----LVERTETNDSHIFTTAQGT 501
YLH + +Y RD+K N+LLD + K++DFGL + +RT T F GT
Sbjct: 116 YLHENKI--VY-RDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FC---GT 164
Query: 502 MGYLDPEYYRNFQLTDKS-----DVYSFGVVLLELLTSKKAIDFNREEE 545
+L PE LT+ S D + GV++ E+L + + EEE
Sbjct: 165 PEFLAPEV-----LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLV----LNEVRILCQVN 384
TN + +G G FG V D T + K+ T ++ E+++L +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSA-RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
H +++ L + + IY L LH T + PL +QI GL
Sbjct: 68 HENIISL--SDIFISPLEDIY--FVTELLGTDLHRLLTSR--PLEKQFIQYFLYQILRGL 121
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
Y+HSA V HRD+K SNIL++E + K+ DFGL+R+ D + GY
Sbjct: 122 KYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARI------QDPQM-------TGY 165
Query: 505 LDPEYYR--NFQLT-----DKSDVYSFGVVLLELLTSK 535
+ YYR LT + D++S G + E+L K
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 30/219 (13%)
Query: 338 IGTGGFGEVFK----GILDDGTVTAIKRA-KLGNTKGTDL----VLNEVRILCQV-NHRS 387
+G G FG+V GI D + A K+ TD +++E+ ++ + H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC------DF---TGKWP--PLPWHLRLVI 436
++ LLG C + ++ EY G L ++L D+ T K P L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
A+Q+A G+ YL S HRD+ + N+L+ E K++DFGL+R V N +
Sbjct: 140 AYQVARGMEYLASQKC---IHRDLAARNVLVTEDNVMKIADFGLARDVH----NIDYYKK 192
Query: 497 TAQGTM--GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
T G + ++ PE + T +SDV+SFGV+L E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 57/180 (31%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 363 KLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDF- 421
K+G KGT L+ E +L VNH S++R+ V T M+ +P H D
Sbjct: 97 KIGQ-KGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP------HYSSDLY 144
Query: 422 ---TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478
T + PLP L+I QI EGL YLH+ I HRDVK+ NI +++ + D
Sbjct: 145 TYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDL 201
Query: 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538
G ++ A GT+ PE + K+D++S G+VL E+L I
Sbjct: 202 GAAQF----PVVAPAFLGLA-GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 337 LIGTGGFGEVFKGILD-DGTVTAIK---RAKLGNTKGTDLVLNEVRILCQ-VNHRSLVRL 391
+IG G FG+V DG A+K + + N K ++ E +L + V H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
++ + +++ G LF HL + + P R A +IA L YLHS
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP----RARFYAA-EIASALGYLHSIN 116
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR 511
I +RD+K NILLD + + ++DFGL + E +D+ TT GT YL PE R
Sbjct: 117 ---IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTT--TTFCGTPEYLAPEVIR 169
Query: 512 NFQLTDKSDVYSFGVVLLELL 532
+ D + G VL E+L
Sbjct: 170 KQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 78/287 (27%), Positives = 117/287 (40%), Gaps = 43/287 (14%)
Query: 332 FSKDNLIGTGGFGEV-FKGILDDGTVTAIKR----AKLGNTKGTDLVLNEVRILCQVNHR 386
F+ IG G FG V F + V AIK+ K N K D++ EV+ L ++ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII-KEVKFLQRIKHP 85
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+ + GC + ++ EY G+ D L PL I H +GL Y
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAY 140
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
LHS + HRD+K+ NILL E K++DFG + + + F GT ++
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FV---GTPYWMA 189
Query: 507 PEYYRNF---QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563
PE Q K DV+S G+ +EL K + N+N + + I E
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQNE--- 240
Query: 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610
P L+ E SCL + Q+RP+ +E+ +
Sbjct: 241 ---SPTLQSN------EWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 22/227 (9%)
Query: 331 NFSKDNLIGTGGFGEVF--KGIL--DDGTVTAIKRAK----LGNTKGTDLVLNEVRILCQ 382
NF ++GTG +G+VF + + D G + A+K K + K T+ E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 383 VNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441
+ + L + D L +I +YI G LF HL + + + +I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-----SQRERFKEQEVQIYSGEIV 115
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
L +LH I +RD+K NILLD + ++DFGLS+ E ++ F GT
Sbjct: 116 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC---GT 169
Query: 502 MGYLDPEYYRNFQLT-DKS-DVYSFGVVLLELLTSKKAIDFNREEEN 546
+ Y+ P+ R DK+ D +S GV++ ELLT + E+ +
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 338 IGTGGFGEV-FKGILDDGTVTAIKR----AKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
IG G FG V F V A+K+ K N K D ++ EV+ L Q+ H + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHPNTIEYK 87
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
GC ++ ++ EY G+ D L PL I H +GL YLHS
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
+ HRD+K+ NILL E K++DFG + + F GT ++ PE
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FV---GTPYWMAPEVILA 191
Query: 513 F---QLTDKSDVYSFGVVLLELLTSKKAIDFN 541
Q K DV+S G+ +EL K + FN
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPL-FN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 5e-12
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR 390
+++ IG G G V+ I + G AIK+ L +L++NE+ ++ + + ++V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLH--CDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
L + D+ ++ EY+ G+L D + C G+ + + + L +LH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--------AVCRECLQALDFLH 132
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
S V HRD+KS NILL + K++DFG + ++ S T GT ++ PE
Sbjct: 133 SNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPE 185
Query: 509 YYRNFQLTDKSDVYSFGVVLLELL 532
K D++S G++ +E++
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 58/251 (23%), Positives = 104/251 (41%), Gaps = 53/251 (21%)
Query: 354 GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413
G A+K+ L + +L+ NEV I+ H ++V + + D+ ++ E++ G L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 414 FDHLHCDFTGKWPPLPWHLRL------VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467
D + H R+ + + + L++LH+ V HRD+KS +ILL
Sbjct: 104 TD------------IVTHTRMNEEQIATVCLAVLKALSFLHAQGV---IHRDIKSDSILL 148
Query: 468 DEKLNAKVSDFGL-SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGV 526
K+SDFG +++ + S + GT ++ PE + D++S G+
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPYGTEVDIWSLGI 203
Query: 527 VLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE------------------RLMEVVDP 568
+++E+ +D N + MK+I D M V DP
Sbjct: 204 MVIEM------VDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257
Query: 569 VLKERATHLDL 579
+RAT +L
Sbjct: 258 --AQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQVNHRS 387
+++K IG G +G V+KG G + A+K+ +L + + + E+ +L ++ H +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFD-HLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+V L ++ + +I+E++ D + D K + L +QI +G+ +
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
HS V HRD+K N+L+D K K++DFGL+R ++T T+ Y
Sbjct: 117 CHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLARAFGIP----VRVYTHEVVTLWYRA 169
Query: 507 PEYYRNFQL-TDKSDVYSFGVVLLELLTSK 535
PE + D++S G + E+ T K
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 338 IGTGGFGEVFKGILD-----DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVR 390
+G G FG+V D G A+K K + DL E+ IL + H ++V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL-KKEIEILRNLYHENIVK 70
Query: 391 LLGCCVEL--DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH----QIAEGL 444
G C E + +I E++P+G+L ++L P + L QI +G+
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--------PRNKNKINLKQQLKYAVQICKGM 122
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN-------DSHIFTT 497
YL S HRD+ + N+L++ + K+ DFGL++ +E + DS +F
Sbjct: 123 DYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 498 AQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
A PE + SDV+SFGV L ELLT
Sbjct: 180 A--------PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 59/260 (22%)
Query: 338 IGTGGFGEVFKGILDDGTVT---AIKRAKLGNTKGTDL---VLNEVRILCQVNHRSLVRL 391
IG G +G V+K +G AIK+ K + T + E+ +L ++ H ++V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-----------IAHQI 440
+ +E +Y LFD+ D W + +H + + QI
Sbjct: 68 VEVFLE-HADKSVY------LLFDYAEHDL---WQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLSRLVERTETNDSHIFT 496
G+ YLHS + HRD+K +NIL+ E+ K+ D GL+RL F
Sbjct: 118 LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL-----------FN 163
Query: 497 TAQGTMGYLDPE----YYRNFQL-------TDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
+ LDP +YR +L T D+++ G + ELLT + I RE +
Sbjct: 164 APLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL-EPIFKGREAK 222
Query: 546 NVNLVVYMKKIMDEERLMEV 565
+ + + ER+ EV
Sbjct: 223 IKKSNPFQRDQL--ERIFEV 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 326 RRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN 384
R +++ +G+G +G+V+K L G + A+K KL L+ E+ ++ +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
H ++V G + ++ + EY G+L D H TG PL + + +GL
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV--TG---PLSELQIAYVCRETLQGL 119
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
YLHS HRD+K +NILL + + K++DFG++ + T GT +
Sbjct: 120 AYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI----GTPYW 172
Query: 505 LDPEYY---RNFQLTDKSDVYSFGVVLLEL 531
+ PE +N D+++ G+ +EL
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNHRSLVRLLGC 394
+G G FG+V+K + V A AK+ +TK + + + E+ IL +H ++V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPP 454
+ ++ E+ G + D + + PL V+ Q E L YLH
Sbjct: 71 FYYENNLWILIEFCAGGAV-DAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK--- 123
Query: 455 IYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT-ETNDSHIFTTAQGTMGYLDPEYYRNF 513
I HRD+K+ NIL + K++DFG+S RT + DS I GT ++ PE
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCE 178
Query: 514 QLTD-----KSDVYSFGVVLLEL 531
D K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 337 LIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL---- 391
++G G FG+VF L AIK K D+VL + + C + + ++ L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK------KDVVLMDDDVECTMVEKRVLSLAWEH 55
Query: 392 -----LGCCVELDQTLM-IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
L C + + L + EY+ G L H+ P ++ A +I GL
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY-----AAEIICGLQ 110
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR--LVERTETNDSHIFTTAQGTMG 503
+LHS I +RD+K NILLD + K++DFG+ + ++ +T T GT
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC------TFCGTPD 161
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
Y+ PE + D +SFGV+L E+L + + EEE
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 67/201 (33%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQ-VNHRSLVRLL 392
IG G FG+V DG A+K + + K ++ E +L + V H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
D+ + +Y+ G LF HL + + P P R A +IA L YLHS
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRE---RSFPEP-RARFYAA-EIASALGYLHSLN- 116
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
I +RD+K NILLD + + ++DFGL + E E + + +T GT YL PE R
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTT--STFCGTPEYLAPEVLRK 170
Query: 513 FQLTDKS-DVYSFGVVLLELL 532
Q D++ D + G VL E+L
Sbjct: 171 -QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 24/170 (14%)
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q+ + ++HS + HRD+KS+NILL K+ DFG S++ T ++D + T
Sbjct: 151 QVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD--VGRTF 205
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558
GT Y+ PE +R + K+D++S GV+L ELLT +K+ D
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-------------------LKRPFD 246
Query: 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608
E + EV+ L R L + + + L + RPS ++ +
Sbjct: 247 GENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296
|
Length = 496 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 68/275 (24%), Positives = 113/275 (41%), Gaps = 65/275 (23%)
Query: 365 GNTKGTDLVLNEVRILCQVNHRSLVRLLG--------CCVELDQTLMIYEYIPNGTLFDH 416
G T G E+ IL ++HR+++ L+ C V ++ Y+
Sbjct: 130 GKTPGR-----EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-------- 176
Query: 417 LHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476
D +G PLP + I ++ E L YLH I HRDVK+ NI LDE NA +
Sbjct: 177 ---DRSG---PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLG 227
Query: 477 DFGLS-RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
DFG + +L +T + ++ GT+ PE K+D++S G+VL E+
Sbjct: 228 DFGAACKLDAHPDTPQCYGWS---GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
Query: 536 K------------------------AIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLK 571
++F + + NL + K+ R + PV++
Sbjct: 285 VTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ-NGSTNLCKHFKQYAIVLRPPYTIPPVIR 343
Query: 572 ERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ H+D+E L A L ++ RPS +++
Sbjct: 344 KYGMHMDVE------YLIAKMLTFDQEFRPSAQDI 372
|
Length = 392 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 14/206 (6%)
Query: 331 NFSKDNLIGTGGFGEVFKG--ILDDGTVTAIKRAK---LGNTKGTDLVLNEVRILCQVNH 385
NF + IG G F EV++ +LD V A+K+ + + + K + E+ +L Q+NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPV-ALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
++++ L +E ++ ++ E G L + F + +P Q+ +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDL-SQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
++HS V HRD+K +N+ + K+ D GL R ++T +H GT Y+
Sbjct: 121 HMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV---GTPYYM 173
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLEL 531
PE KSD++S G +L E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q+ G+ ++H V HRD+KS NI L + K+ DFG +RL+ T+ T
Sbjct: 108 QMCLGVQHIHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLL----TSPGAYACTY 160
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
GT Y+ PE + N +KSD++S G +L EL T K
Sbjct: 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR 390
+++ IG G G VF I + G AIK+ L +L++NE+ ++ ++ + ++V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
L + D+ ++ EY+ G+L D + C + + + + L +LH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA--------AVCRECLQALEFLH 132
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
+ V HRD+KS N+LL + K++DFG + ++ S T GT ++ PE
Sbjct: 133 ANQV---IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPE 185
Query: 509 YYRNFQLTDKSDVYSFGVVLLELL 532
K D++S G++ +E++
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR 390
+++ IG G G V+ + + G AI++ L +L++NE+ ++ + + ++V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLH--CDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
L + D+ ++ EY+ G+L D + C G+ + + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--------AVCRECLQALEFLH 133
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
S V HRD+KS NILL + K++DFG + ++ S + GT ++ PE
Sbjct: 134 SNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPE 186
Query: 509 YYRNFQLTDKSDVYSFGVVLLELL 532
K D++S G++ +E++
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 338 IGTGGFGEV-FKGILDDGTVTAIKR----AKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
IG G FG V F + + V AIK+ K N K D++ EVR L ++ H + ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII-KEVRFLQKLRHPNTIQYR 81
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
GC + ++ EY G+ D L PL + H +GL YLHS
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
+ HRDVK+ NILL E K+ DFG + ++ F GT ++ PE
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FV---GTPYWMAPEVILA 185
Query: 513 F---QLTDKSDVYSFGVVLLELLTSKKAIDFN 541
Q K DV+S G+ +EL K + FN
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL-FN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 36/222 (16%)
Query: 338 IGTGGFGEVF--------KGILDDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQV-NHR 386
+G G FG+V K + T A+K K T+ +DL+ +E+ ++ + H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGKHK 84
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP---------------LPWH 431
+++ LLG C + +I EY G L ++L + PP L +
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYCYNPTQVPEEQLSFK 140
Query: 432 LRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491
+ A+Q+A G+ YL S HRD+ + N+L+ E K++DFGL+R + +
Sbjct: 141 DLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
T + + ++ PE + T +SDV+SFGV+L E+ T
Sbjct: 198 KT--TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 326 RRATNNFSKDNLIGTGGFGEV-FKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN 384
R +NF K IG G G V + G + A+K+ L + +L+ NEV I+
Sbjct: 19 RTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL------VIAH 438
H ++V + + D+ ++ E++ G L D + H R+ +
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTD------------IVTHTRMNEEQIAAVCL 123
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
+ + L+ LH+ V HRD+KS +ILL K+SDFG V + +
Sbjct: 124 AVLKALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--- 177
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
GT ++ PE + D++S G++++E++
Sbjct: 178 -GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 68/212 (32%), Positives = 102/212 (48%), Gaps = 38/212 (17%)
Query: 337 LIGTGGFGEVFK-GILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
+IG GGFGEV+ D G + A+K + ++ +G L LNE RI+ SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIML-----SLVSTG 54
Query: 393 GC----CVEL-----DQTLMIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIA 441
C C+ D+ I + + G L HL H F+ K +R A +I
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK------EMRFY-ATEII 107
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
GL ++H+ V +RD+K +NILLDE + ++SD GL+ + + + S GT
Sbjct: 108 LGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGT 158
Query: 502 MGYLDPEYYRNFQLTDKS-DVYSFGVVLLELL 532
GY+ PE + D S D +S G +L +LL
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 23/223 (10%)
Query: 331 NFSKDNLIGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR 386
+F+ ++G G FG+V KG + + +K+ + + + E R+L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 387 S-LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
L +L C +D+ + EY+ G L H+ K P ++ A +I+ GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY-----AAEISVGLF 115
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR--LVERTETNDSHIFTTAQGTMG 503
+LH I +RD+K N++LD + + K++DFG+ + +V+ T T GT
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR------TFCGTPD 166
Query: 504 YLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSKKAIDFNREEE 545
Y+ PE +Q KS D +++GV+L E+L + D E+E
Sbjct: 167 YIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 41/105 (39%), Positives = 55/105 (52%), Gaps = 13/105 (12%)
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHI 494
IA I + L YLHS + HRDVK SN+L++ K+ DFG+S LV DS
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV------DSVA 159
Query: 495 FTTAQGTMGYLDPEYY---RNFQLTD-KSDVYSFGVVLLELLTSK 535
T G Y+ PE N + D KSDV+S G+ ++EL T +
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 338 IGTGGFGEVFKGILDDGT----VTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
IG G FG+V + D + I++A + + L E +L QVN +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
++ ++ +I G LF HL + G++ R A ++ L LH V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE--GRFDL--SRARFYTA-ELLCALENLHKFNV- 114
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRL-VERTETNDSHIFTTAQGTMGYLDPEYYRN 512
IY RD+K NILLD + + + DFGL +L ++ + + T GT YL PE
Sbjct: 115 -IY-RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN-----TFCGTPEYLAPELLLG 167
Query: 513 FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559
T D ++ GV+L E+LT +ENVN + +KI+ E
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPPF----YDENVNEM--YRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 23/227 (10%)
Query: 337 LIGTGGFGEVFKGIL----DDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNHRSLV 389
L+G G FG+V IL G A+K K D V L E R+L H L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
L D+ + EY+ G LF HL + ++ +I L YLHS
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFY-----GAEIVSALDYLHS 113
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
I +RD+K N++LD+ + K++DFGL + D+ T GT YL PE
Sbjct: 114 GK---IVYRDLKLENLMLDKDGHIKITDFGLC----KEGITDAATMKTFCGTPEYLAPEV 166
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556
+ D + GVV+ E++ + +N++ E + ++ M+ I
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEDI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS-LVRL 391
++G G FG+V KG + + +K+ + + + E R+L L +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
C +D+ + EY+ G L + K P ++ A +IA GL +LHS
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY-----AAEIAIGLFFLHSKG 121
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR 511
I +RD+K N++LD + + K++DFG+ + D T GT Y+ PE
Sbjct: 122 ---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 512 NFQLTDKS-DVYSFGVVLLELLTSKKAIDFNREEE 545
+Q KS D ++FGV+L E+L + + E+E
Sbjct: 175 -YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 42/214 (19%)
Query: 337 LIGTGGFGEVF---KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVR 390
+IG GGFGEV+ K D G + A+K + ++ +G L LNE RI+ SLV
Sbjct: 1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNE-RIML-----SLVS 52
Query: 391 LLGC----CVEL-----DQTLMIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQ 439
C C+ D+ I + + G L HL H F+ +R A +
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------EMRFY-AAE 105
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
I GL ++H+ V +RD+K +NILLDE + ++SD GL+ + + + S
Sbjct: 106 IILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------V 156
Query: 500 GTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELL 532
GT GY+ PE + D S D +S G +L +LL
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 337 LIGTGGFGEVFKGILD-DGTVTAIK---RAKLGNTKGTDLVLNEVRILCQ-VNHRSLVRL 391
+IG G FG+V DG+ A+K + + K + ++ E +L + + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
++ + +Y+ G LF HL + P ++ A ++A + YLHS
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY-----AAEVASAIGYLHSLN 116
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL-VERTETNDSHIFTTAQGTMGYLDPEYY 510
I +RD+K NILLD + + ++DFGL + VE ET +T GT YL PE
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT-----STFCGTPEYLAPEVL 168
Query: 511 RNFQLTDKSDVYSFGVVLLELL 532
R D + G VL E+L
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 41/236 (17%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNTKGTDLVL--- 374
EI +T F ++ +G FG+V+KG L + AIK K + L
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK----DKAEGPLREE 54
Query: 375 --NEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-----HCDF------ 421
+E + ++ H ++V LLG + MI+ Y + L + L H D
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 422 ----TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477
+ P H I QIA G+ +L S V H+D+ + N+L+ +KLN K+SD
Sbjct: 115 KTVKSTLEPADFVH----IVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISD 167
Query: 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
GL R E + + + + ++ PE + + SD++S+GVVL E+ +
Sbjct: 168 LGLFR--EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 17/214 (7%)
Query: 337 LIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQV-NHRSLVRL 391
++G G FG+V L + G + A+K K D V + E RIL NH L +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
C D+ + E++ G L H+ ++ A +I L +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY-----AAEITSALMFLHDKG 116
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR 511
+ IY RD+K N+LLD + + K++DFG+ + + +T GT Y+ PE +
Sbjct: 117 I--IY-RDLKLDNVLLDHEGHCKLADFGMC----KEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 512 NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
D ++ GV+L E+L + E++
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 338 IGTGGFGEVFK-GILDDGTVTAIKRAKLGNTKGTD------LVLNEVRILCQVNHRSLVR 390
IG G +G VFK + G + AIK+ + D + L E+R+L Q+ H +LV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
L+ + +++EY + T+ + L + G +P HL I Q + + + H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCHKH 119
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
HRDVK NIL+ ++ K+ DFG +R++ + +T T Y PE
Sbjct: 120 NC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD----YTDYVATRWYRAPELL 172
Query: 511 -RNFQLTDKSDVYSFGVVLLELLTS 534
+ Q DV++ G V ELLT
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 51/236 (21%)
Query: 334 KDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKL-----GNTKGTDLV---------LNEVR 378
K +G G +G+V K G + AIK+ K+ TK LV L E++
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN--GTLFDHLHCDFTGKWPPLPWHLRLVI 436
I+ ++ H +++ L+ VE D ++ + + + + D +RL
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDR--------------KIRLTE 118
Query: 437 AH------QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR-----LVE 485
+ QI GL LH HRD+ +NI ++ K K++DFGL+R
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 486 RTETNDSHI-----FTTAQGTMGYLDPE-YYRNFQLTDKSDVYSFGVVLLELLTSK 535
T + D + T+ T+ Y PE + D++S G + ELLT K
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 6/180 (3%)
Query: 375 NEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL 434
+E+ L +H +V+ D+ L+I EY G L + P + + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 435 VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI 494
+ +QI L +HS + HRD+KS+NI L K+ DFG S+ + +++ +
Sbjct: 174 LF-YQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLDV 227
Query: 495 FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554
++ GT YL PE + + + K+D++S GV+L ELLT + + E + V+Y K
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 38/99 (38%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
+Q+ GL Y+HSA V HRD+K SN+LL+ + K+ DFGL+ RT + T
Sbjct: 115 YQLLRGLKYIHSANV---LHRDLKPSNLLLNANCDLKICDFGLA----RTTSEKGDFMTE 167
Query: 498 AQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSK 535
T Y PE N + T DV+S G + ELL K
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 325 IRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
+R F L+G G +G+V+KG + G + AIK + + + + E+ +L +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE-IKQEINMLKKY 59
Query: 384 NH-RSLVRLLGCCVEL------DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
+H R++ G ++ DQ ++ E+ G++ D + K L I
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK---NTKGNTLKEEWIAYI 116
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
+I GL++LH V HRD+K N+LL E K+ DFG+S ++RT +
Sbjct: 117 CREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN---- 169
Query: 497 TAQGTMGYLDPEYYRNFQLTD-----KSDVYSFGVVLLEL 531
T GT ++ PE + D KSD++S G+ +E+
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 337 LIGTGGFGEVF--KGILDDG--TVTAIKRAKLGNTKGTDLVLNEVRILCQ-VNHRSLVRL 391
+IG G FG+V + ++ V +++ + K +++E +L + V H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
D+ + +YI G LF HL + P ++ A +IA L YLHS
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY-----AAEIASALGYLHSLN 116
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR 511
I +RD+K NILLD + + ++DFGL + E E N + +T GT YL PE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTT--STFCGTPEYLAPEVLH 169
Query: 512 NFQLTDKSDVYSFGVVLLELL 532
D + G VL E+L
Sbjct: 170 KQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 15/107 (14%)
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV-ERTETNDSHI 494
I +Q+ + L Y+HS V HRD+K SNILL+ K++DFGL+R + E E ++ +
Sbjct: 112 IMYQLLKALKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 495 FTTAQGTMGYLDPE------YYRNFQLTDKSDVYSFGVVLLELLTSK 535
T T Y PE Y T D++S G +L E+L K
Sbjct: 169 LTDYVATRWYRAPEILLGSTRY-----TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 40/100 (40%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR-LVERTETNDSHIFT 496
+QI GL Y+HSA V HRD+K N+L++ K+ DFGL+R E N + T
Sbjct: 112 YQILCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-T 167
Query: 497 TAQGTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSK 535
T Y PE +FQ K+ DV+S G +L ELL K
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 17/215 (7%)
Query: 337 LIGTGGFGEVFKGILDDG----TVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRL 391
+IG G + +V L + +K+ + + + D V E + Q NH LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
C + + EY+ G L H+ + LP + +I+ L YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR 511
I +RD+K N+LLD + + K++D+G+ + R S GT Y+ PE R
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC----GTPNYIAPEILR 169
Query: 512 NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN 546
D ++ GV++ E++ + D +N
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/232 (25%), Positives = 113/232 (48%), Gaps = 25/232 (10%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLV-LNEVRILCQVNHRS 387
+++ K +G G + V+KG +G + A+K +L +GT + E +L + H +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 388 LVRLLGCCVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPP--LPWHLRLVIAHQIAEGL 444
+V LL + +TL +++EY+ C + K P P +++L + Q+ GL
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYVHTDL------CQYMDKHPGGLHPENVKLFL-FQLLRGL 116
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
+Y+H I HRD+K N+L+ + K++DFGL+ R ++ SH ++ T+ Y
Sbjct: 117 SYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA----RAKSVPSHTYSNEVVTLWY 169
Query: 505 LDPE-YYRNFQLTDKSDVYSFGVVLLELLTSKKAI----DFNREEENVNLVV 551
P+ + + + D++ G + +E++ A D + E + LV+
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 338 IGTGGFGEVFKG--ILDDGTVTAIKRAKLGNTK-GTDL-VLNEVRILCQVN---HRSLVR 390
IG G +G+VFK + + G A+KR ++ + G L + EV +L + H ++VR
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 391 LLGCCV------ELDQTLMIYEYIPNGTLFDHLHCDFTGKW-----PPLPWHLRLVIAHQ 439
L C E TL +F+H+ D T P +P + Q
Sbjct: 69 LFDVCTVSRTDRETKLTL----------VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
+ GL +LHS V HRD+K NIL+ K++DFGL+R+ + T+
Sbjct: 119 LLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY-----SFQMALTSVV 170
Query: 500 GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
T+ Y PE D++S G + E+ K
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 326 RRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN 384
R ++F K IG G G V G A+K+ L + +L+ NEV I+ +
Sbjct: 21 REYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL------VIAH 438
H ++V + + D+ ++ E++ G L D + H R+ +
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTD------------IVTHTRMNEEQIATVCL 125
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
+ L+YLH+ V HRD+KS +ILL K+SDFG V + +
Sbjct: 126 SVLRALSYLHNQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV--- 179
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
GT ++ PE + D++S G++++E++
Sbjct: 180 -GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 23/227 (10%)
Query: 337 LIGTGGFGEVFKGIL----DDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNHRSLV 389
L+G G FG+V IL G A+K K D V L E R+L H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
L D+ + EY G LF HL + R A +I L YLHS
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGA-EIVSALGYLHS 113
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
V +Y RD+K N++LD+ + K++DFGL + +D T GT YL PE
Sbjct: 114 CDV--VY-RDLKLENLMLDKDGHIKITDFGLC----KEGISDGATMKTFCGTPEYLAPEV 166
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556
+ D + GVV+ E++ + +N++ E + ++ M++I
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKR-----AKLGNTKGTDLVLNEVRILCQVNHRSLVRL 391
IG+G +G V I G AIK+ K T L E++IL H +++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFKHDNIIAI 69
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDH-----------LHCDFTGKWPPLPWHLRLVIAHQI 440
L P G F LH P H+R + +Q+
Sbjct: 70 R-------DILR-----PPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFL-YQL 116
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
GL Y+HSA V HRD+K SN+L++E ++ DFG++R + + T + T
Sbjct: 117 LRGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 501 TMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELL 532
T Y PE + + T D++S G + E+L
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 17/229 (7%)
Query: 337 LIGTGGFGEVFKGILDDG----TVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
+IG G + +V L + +K+ + + + D V E + Q + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 393 GCCVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
C + L ++ EY+ G L H+ + LP A +I L +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR 511
I +RD+K N+LLD + K++D+G+ + E D+ +T GT Y+ PE R
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTT--STFCGTPNYIAPEILR 169
Query: 512 NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
+ D ++ GV++ E++ + D + ++N Y+ +++ E+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 48/216 (22%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLN--EVRILCQVN-HRSLVRLLG 393
IG G F EV K G AIK K + K + V N E++ L +++ H +++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 394 C-------CVELDQTLM---IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
+ L LM +YE I G+ PLP +Q+ +
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELI-------------KGRKRPLPEKRVKSYMYQLLKS 112
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
L ++H I+HRD+K NIL+ + + K++DFG R + +T T
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGI-----YSKPPYTEYISTRW 163
Query: 504 YLDPE------YYRNFQLTDKSDVYSFGVVLLELLT 533
Y PE YY K D+++ G V E+L+
Sbjct: 164 YRAPECLLTDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEV----FKGILDDGTVTAIKR-AKLGNTKGTDLVL--N 375
++R +F +IG G FGEV K V A+K +K K +D
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHL-HCDFTGKWPPLPWHLR 433
E I+ N +V+L + D+ L M+ EY+P G L + + + D KW R
Sbjct: 93 ERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA------R 145
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493
A ++ L +HS HRDVK N+LLD+ + K++DFG ++
Sbjct: 146 FYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC- 200
Query: 494 IFTTAQGTMGYLDPEYYRNFQLTD-----KSDVYSFGVVLLELL 532
TA GT Y+ PE ++ Q D + D +S GV L E+L
Sbjct: 201 --DTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 337 LIGTGGFGEVFKGILDDGT-------VTAIKRAKL-GNTKGTDLVLNEVRILCQVNHRSL 388
++G GG+G+VF+ G + +K+A + N K T E IL V H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
V L+ + +I EY+ G LF HL + ++L +I+ L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISLALEHLH 117
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND-SHIFTTAQGTMGYLDP 507
+ IY RD+K NILLD + + K++DFGL + E +H F GT+ Y+ P
Sbjct: 118 QQGI--IY-RDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFC---GTIEYMAP 169
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTS---------KKAID 539
E D +S G ++ ++LT KK ID
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 332 FSKDNLIGTGGFGEVFKGIL--DDGTV--TAIKRAKLGNTKGTDL--VLNEVRILCQVNH 385
F+ ++G G FG V + L +DG+ A+K K +D+ L E + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 386 RSLVRLLGCCVE------LDQTLMIYEYIPNGTLFDHLHCDFTGKWP---PLPWHLRLVI 436
++++L+G + L ++I ++ +G L L G+ P PL +R +I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
IA G+ YL S HRD+ + N +L+E + V+DFGLS+ + + D +
Sbjct: 121 --DIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSK---KIYSGDYY--- 169
Query: 497 TAQGTMGYLDPEYYRNFQLTD-----KSDVYSFGVVLLELLT 533
QG L ++ L D SDV++FGV + E++T
Sbjct: 170 -RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 25/210 (11%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVR------ILCQVNHRSLVR 390
IG G +G V+K G A+K ++ + L L+ VR L +H ++VR
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCD---FTGKWPP--LPWHLRLVIAHQIAEGLT 445
L+ C T +F+H+ D + K PP LP + Q GL
Sbjct: 67 LMDVCA----TSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
+LH+ I HRD+K NIL+ K++DFGL+R+ T T+ Y
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-----LTPVVVTLWYR 174
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
PE D++S G + E+ K
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 20/153 (13%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKL-GNTKGT-DLVLNEVRILCQVNHRSLVRLLGC 394
IG G +G V+K G + A+K+ +L +G + E+ +L ++NH ++VRLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCD---FTGKWPPLPWHLRLV--IAHQIAEGLTYLHS 449
V + L Y+ +F+ L D + P L+ +Q+ +G+ Y HS
Sbjct: 67 -VHSENKL----YL----VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
+ HRD+K N+L+D + K++DFGL+R
Sbjct: 118 HR---VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 69/311 (22%), Positives = 119/311 (38%), Gaps = 67/311 (21%)
Query: 337 LIGTGGFGEVFKGILDD---GTVTAIKRAK---LGNTKGTDLVLNEVRILCQVNHRSLVR 390
LIG GG GEV+ D A+K+ + N L E +I + H +V
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLR------LVIAHQIAEGL 444
+ C + D YI TL L + + + L I H+I +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ----- 499
Y+HS + HRD+K NILL + D+G + + E + +
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE--EDLLDIDVDERNIC 181
Query: 500 -----------GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548
GT Y+ PE ++ +D+Y+ GV+L ++LT + + R++
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL--SFPYRRKK---- 235
Query: 549 LVVYMKKIMDEERLM---EV-----VDPVLKERATHLDLETMKALGLLAASCLDERRQNR 600
+KI + ++ EV + P L + A MKAL + + +
Sbjct: 236 ----GRKISYRDVILSPIEVAPYREIPPFLSQIA-------MKALAV-------DPAERY 277
Query: 601 PSMKEVADEIE 611
S++E+ ++E
Sbjct: 278 SSVQELKQDLE 288
|
Length = 932 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
++G G FG+V KG + V A+K+ + + + E R+L + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 393 GCCVEL-DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
C + + + E++ G L H+ G++ + A +I GL +LHS
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQ--DKGRFD---LYRATFYAAEIVCGLQFLHSKG 116
Query: 452 VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR 511
I +RD+K N++LD + K++DFG+ + + S T GT Y+ PE +
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS----TFCGTPDYIAPEILQ 169
Query: 512 NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
+ T D +SFGV+L E+L + + E+E
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 331 NFSKDNLIGTGGFGEVF----KGILDDGTVTAIK----RAKLGNTKGTDLVLNEVRILCQ 382
NF ++GTG +G+VF D G + A+K A + K + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 383 VNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHLHC--DFTGKWPPLPWHLRLVIAHQ 439
V + L + + L +I +Y+ G +F HL+ +F+ +R +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED------EVRFYSG-E 113
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
I L +LH I +RD+K NILLD + + ++DFGLS+ E ++ F
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC--- 167
Query: 500 GTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT 533
GT+ Y+ PE R K+ D +S G+++ ELLT
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 35/214 (16%)
Query: 335 DNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGNTKGTDL-VLNEVRILCQVNHRSLV 389
+ ++GTG FGE+ +G L AI + G + L E L Q +H ++V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQ-------IAE 442
RL G + +++ EY+ NG L L H ++A Q +A
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLR-----------KHEGQLVAGQLMGMLPGLAS 118
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE-RTETNDSHIFTTAQGT 501
G+ YL H+ + + +L++ L K+S F RL E ++E I+TT G
Sbjct: 119 GMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEA----IYTTMSGK 169
Query: 502 MGYL--DPEYYRNFQLTDKSDVYSFGVVLLELLT 533
L PE + + SDV+SFG+V+ E+++
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 39/106 (36%), Positives = 60/106 (56%), Gaps = 12/106 (11%)
Query: 431 HLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490
H++ +I +QI GL Y+HSA I HRD+K SN+ ++E K+ DFGL+R T+
Sbjct: 121 HVQFLI-YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTD 171
Query: 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSK 535
D T T Y PE N+ +++ D++S G ++ ELLT +
Sbjct: 172 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 37/106 (34%), Positives = 56/106 (52%), Gaps = 14/106 (13%)
Query: 436 IAHQIAEGLTYL---HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492
I+ + GLTYL H I HRDVK SNIL++ + K+ DFG+S + DS
Sbjct: 104 ISIAVLRGLTYLREKHK-----IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDS 153
Query: 493 HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538
+ + GT Y+ PE + T +SD++S G+ L+E+ + I
Sbjct: 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 332 FSKDNLIGTGGFGEVFKGILDDGT--VTAIKRAKLGNT-KGT-DLVLNEVRILCQVNHRS 387
+ K IG G +G V+K D T A+K+ +L +G + E+ +L ++ H +
Sbjct: 4 YEKVEKIGEGTYGVVYKA-RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV--IAHQIAEGLT 445
+VRL + +++EY+ L H D + P + RL+ +QI G+
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIA 116
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNA-KVSDFGLSR---LVERTETNDSHIFTTAQGT 501
Y HS V HRD+K N+L+D + NA K++DFGL+R + RT FT T
Sbjct: 117 YCHSHRV---LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-------FTHEVVT 166
Query: 502 MGYLDPE-YYRNFQLTDKSDVYSFGVVLLELLTSK 535
+ Y PE + + D++S G + E++ K
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 67/228 (29%), Positives = 98/228 (42%), Gaps = 45/228 (19%)
Query: 332 FSKDNL-----IGTGGFGEVFKGILDD-GTVTAIKRAKLGNTKGTD---LVLNEVRILCQ 382
F+ ++L IG G FG V K + GT+ A+KR + + L+++ ++
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRS-TVDEKEQKRLLMDLDVVMRS 59
Query: 383 VNHRSLVRLLG-------C--CVELDQTLM--IYEYIPNGTLFDHLHCDFTGKWPPLPWH 431
+ +V+ G C C+EL + Y+Y+ L + + GK
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYV-YEVLKSVIPEEILGK------- 111
Query: 432 LRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETN 490
IA + L YL I HRDVK SNILLD N K+ DFG+S +LV
Sbjct: 112 ----IAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV------ 159
Query: 491 DSHIFTTAQGTMGYLDPEYYRNFQLTD---KSDVYSFGVVLLELLTSK 535
DS T G Y+ PE +SDV+S G+ L E+ T K
Sbjct: 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 325 IRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
+R F ++G G +G+V+KG + G + AIK + + ++ L E+ +L +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL-EINMLKKY 69
Query: 384 NH-RSLVRLLGCCVEL------DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
+H R++ G ++ DQ ++ E+ G++ D + K L I
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK---NTKGNALKEDWIAYI 126
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
+I GL +LH+ V HRD+K N+LL E K+ DFG+S ++RT +
Sbjct: 127 CREILRGLAHLHAHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN---- 179
Query: 497 TAQGTMGYLDPEYYRNFQLTD-----KSDVYSFGVVLLEL 531
T GT ++ PE + D +SD++S G+ +E+
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 26/229 (11%)
Query: 337 LIGTGGFGEVFKGIL----DDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNHRSLV 389
L+G G FG+V IL G A+K K D V L E R+L H L
Sbjct: 2 LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAEGLTYL 447
L D+ + EY G LF HL + F+ R A +I L YL
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGA-EIVSALDYL 111
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
HS + +RD+K N++LD+ + K++DFGL + D T GT YL P
Sbjct: 112 HSEK--NVVYRDLKLENLMLDKDGHIKITDFGLC----KEGIKDGATMKTFCGTPEYLAP 165
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556
E + D + GVV+ E++ + +N++ E + ++ M++I
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 337 LIGTGGFGEVFKGIL----DDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNHRSLV 389
L+G G FG+V IL G A+K + D V + E R+L H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAEGLTYL 447
L D+ + EY G LF HL + FT + R A +I L YL
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE------RARFYGA-EIVSALEYL 111
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
HS V +RD+K N++LD+ + K++DFGL + +D T GT YL P
Sbjct: 112 HSRDV---VYRDIKLENLMLDKDGHIKITDFGLC----KEGISDGATMKTFCGTPEYLAP 164
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556
E + D + GVV+ E++ + +N++ E + ++ M++I
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 38/117 (32%), Positives = 63/117 (53%), Gaps = 10/117 (8%)
Query: 419 CDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478
D WP L L + Q+A+G+ +L A HRDV + N+LL + AK+ DF
Sbjct: 201 EDTEDSWPLDLDDL-LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDF 256
Query: 479 GLSRLVERTETNDSH--IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
GL+R + NDS+ + A+ + ++ PE + T +SDV+S+G++L E+ +
Sbjct: 257 GLARDIM----NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 49/201 (24%), Positives = 75/201 (37%), Gaps = 21/201 (10%)
Query: 338 IGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLNEVRIL-CQVNHRSLVRLL 392
I G FG V+ + D + +K++ + V E I+ Q + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
D ++ EY+ G LP ++ G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDC-----ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG- 117
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
I HRD+K N+L+D+ + K++DFGLSR + GT YL PE
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK----KFV----GTPDYLAPETILG 167
Query: 513 FQLTDKSDVYSFGVVLLELLT 533
SD +S G V+ E L
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 32/287 (11%)
Query: 338 IGTGGFGEVFKGILDDGTVTA---IKRAKLGNTKGTDL-VLNEVRILCQVNHRSLVRLLG 393
IG G FG+V G ++ G A +K ++ + + L E + + H +L++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLH-CDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
C E+ L++ E+ P G L +L C P P L+ +A +IA GL +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR-MACEIALGLLHLHKNN- 120
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE---TNDSHIFTTAQGTMGYLDPEY 509
H D+ N LL L K+ D+GLS + + T D ++ + L E
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD-QLWVPLRWIAPELVDEV 177
Query: 510 YRNFQLTDK---SDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565
+ N + D+ S+V+S GV + EL + +E+ + V E+ +++
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-------REQQLKL 230
Query: 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612
P LK + E M+ L + + RPS +EV + Y
Sbjct: 231 PKPRLKLPLSDRWYEVMQFCWL--------QPEQRPSAEEVHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 58/248 (23%), Positives = 95/248 (38%), Gaps = 34/248 (13%)
Query: 330 NNFSKDNLIGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH 385
+F +L+G G FGEV K D + +K++ L + E IL N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIAEG 443
+ +L + D ++ EY P G L L + D + +AE
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED------QFDEDM---AQFYLAEL 111
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQ-GT 501
+ +HS HRD+K N+L+D + K++DFG + RL T + + + GT
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-----TANKMVNSKLPVGT 166
Query: 502 MGYLDPEYYRNFQLTDKS------DVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK 555
Y+ PE K D +S GV+ E++ + E
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF----HEGTS--AKTYNN 220
Query: 556 IMDEERLM 563
IM+ +R +
Sbjct: 221 IMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
+Q+ L Y+H+A V +HRD+K NIL + K+ DFGL+R V +T + +T
Sbjct: 110 YQLLRALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTD 165
Query: 498 AQGTMGYLDPEYYRNF--QLTDKSDVYSFGVVLLELLTSK 535
T Y PE +F + T D++S G + E+LT K
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 19/228 (8%)
Query: 338 IGTGGFGEVFK-GILDDGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
+G GGFGEV + + G + A K+ +L G + L E IL +VN +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 394 CCVELDQTLMIYEYIPNGTLFDHL-HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
++ + G L H+ + G L + + QI G+ +LHS
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSMD- 115
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
I +RD+K N+LLD++ N ++SD GL+ E D T GT GY+ PE +
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGLA-----VELKDGKTITQRAGTNGYMAPEILKE 168
Query: 513 FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
+ D ++ G + E++ + F +E V ++ +++E
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR--TPFKDHKEKVAKEELKRRTLEDE 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 71/286 (24%), Positives = 120/286 (41%), Gaps = 52/286 (18%)
Query: 338 IGTGGFGEVFKGI----LDDG----TVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV 389
+G G F ++FKGI D G T +K + ++ ++ Q++H+ LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
G CV D+++M+ EY+ G+L +L + + W +L +A Q+A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN--KNLINISW--KLEVAKQLAWALHFLED 118
Query: 450 AAVPPIYHRDVKSSNILL----DEKLNA----KVSDFGLSRLVERTETNDSHIFTTAQGT 501
+ H +V + N+LL D K K+SD G+S V E I
Sbjct: 119 KGLT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI------- 168
Query: 502 MGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
++ PE N Q L+ +D +SFG L E+ F+ ++ ++ + KK+ E
Sbjct: 169 -PWVPPECIENPQNLSLAADKWSFGTTLWEI--------FSGGDKPLSALDSQKKLQFYE 219
Query: 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
++ P E L L C+D RPS + +
Sbjct: 220 DRHQLPAPKWTE------------LANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGT-DLVLNEVRILCQVNHRS 387
++F K + +G G G VFK G + A K L + ++ E+++L + N
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V G + + E++ G+L L K +P + ++ + +GLTYL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYL 119
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
I HRDVK SNIL++ + K+ DFG+S + + N + GT Y+ P
Sbjct: 120 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN------SFVGTRSYMSP 171
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538
E + + +SD++S G+ L+E+ + I
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 337 LIGTGGFGEVFK-GILDDGTVTAIKRAKLGNTKGTDLV----LNEVRILCQVNHRSLVRL 391
L+G G +G V K + G + AIK K ++ +V + E+R+L Q+ H +LV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK--KFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP-LPWHLRLVIAHQIAEGLTYLHSA 450
+ + +++E++ + T+ D L K+P L QI G+ + HS
Sbjct: 66 IEVFRRKKRLYLVFEFVDH-TVLDDLE-----KYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
I HRD+K NIL+ + K+ DFG + RT ++T T Y PE
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFA----RTLAAPGEVYTDYVATRWYRAPE-- 170
Query: 511 RNFQLTDKS-----DVYSFGVVLLELLT 533
+ D D+++ G ++ E+LT
Sbjct: 171 --LLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 56/223 (25%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL----VLNEVRILCQVNHRSLVRL 391
+G+G +G V I G AIK KL +++ E+ +L + H +++ L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE--------- 442
L + + D DF P + L+ ++ H ++E
Sbjct: 80 L-------------DVFTSAVSGDEFQ-DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ 125
Query: 443 ---GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
GL Y+HSA I HRD+K N+ ++E K+ DFGL+R + T
Sbjct: 126 MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT---------- 172
Query: 500 GTMGYLDPEYYRN-------FQLTDKSDVYSFGVVLLELLTSK 535
GY+ +YR D++S G ++ E+LT K
Sbjct: 173 ---GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 43/137 (31%), Positives = 71/137 (51%), Gaps = 24/137 (17%)
Query: 431 HLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490
H++ +I +Q+ GL Y+HSA I HRD+K SN+ ++E ++ DFGL+R + +
Sbjct: 119 HVQFLI-YQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QAD 169
Query: 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSKKAIDFNREEENVNL 549
D T T Y PE N+ +++ D++S G ++ ELL K N
Sbjct: 170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND------- 220
Query: 550 VVYMKKIMDEERLMEVV 566
Y+ ++ +R+MEVV
Sbjct: 221 --YIDQL---KRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 337 LIGTGGFGEVFKGILDDGT-VTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL---- 391
++G G FG+V L AIK K D+VL + + C + R ++ L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEH 55
Query: 392 -----LGCCVELDQTLM-IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
L C + + L + EY+ G L H+ +G++ R A +I GL
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS--SGRFDE--ARARFYAA-EIICGLQ 110
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
+LH I +RD+K N+LLD+ + K++DFG+ + E S T GT Y+
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS----TFCGTPDYI 163
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
PE + + + D +SFGV+L E+L + E+E
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 15/183 (8%)
Query: 359 IKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL 417
IK+ + + + D V E + NH LV L C + + E++ G L H+
Sbjct: 28 IKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM 87
Query: 418 HCDFTGKWPPLPW-HLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476
+ LP H R A +I+ L +LH + IY RD+K N+LLD + + K++
Sbjct: 88 Q-----RQRKLPEEHARFYSA-EISLALNFLHERGI--IY-RDLKLDNVLLDAEGHIKLT 138
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK 536
D+G+ + E D+ +T GT Y+ PE R D ++ GV++ E++ +
Sbjct: 139 DYGMCK--EGIRPGDTT--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
Query: 537 AID 539
D
Sbjct: 195 PFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 35/223 (15%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILC-QVNHRSLVRL 391
++G G FG+V KG + + +K+ + D + E RIL H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 392 LGCCVELDQTLMIYEYIPNGTL---------FDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
C D+ + EY+ G L FD F A ++
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF--------------YAAEVTL 107
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
L +LH V IY RD+K NILLD + + K++DFG+ + + TT GT
Sbjct: 108 ALMFLHRHGV--IY-RDLKLDNILLDAEGHCKLADFGMC----KEGILNGVTTTTFCGTP 160
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545
Y+ PE + + D ++ GV++ E++ + + + E++
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 7e-09
Identities = 26/106 (24%), Positives = 43/106 (40%), Gaps = 15/106 (14%)
Query: 27 RCGNCGPTPVPYPLSTGPNCGH-QSYKIRC----AAGILWFDARNGSSYMIASINPLSQR 81
RCGN +PYP GP C +++ C + L +Y + SI+ +
Sbjct: 7 RCGN---VSIPYPFGIGPGCARDPGFELTCNNTTSPPRLLL---GNGNYEVLSISLANGT 60
Query: 82 IIIRPPGPAGSTC-TATDMRTQGIQLDDNLPF-NITSSNTIMLLNC 125
+ + P S C ++ RT L PF +S N +++ C
Sbjct: 61 VRVL--DPISSNCYNSSGKRTDNGSLSLGGPFFFSSSRNKFVVVGC 104
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 43/216 (19%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL----VLNEVRILCQVNHRSLVRLLG 393
+G+G +G V LD T + KL ++L E+R+L + H +++ LL
Sbjct: 23 VGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWP-------PLPWHLRL------VIAHQI 440
+ P+ +L D H DF P L H +L + +Q+
Sbjct: 82 V------------FTPDLSL-DRFH-DFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
+GL Y+H+A I HRD+K N+ ++E K+ DFGL+R DS + T
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR------QTDSEM-TGYVV 177
Query: 501 TMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSK 535
T Y PE N+ T D++S G ++ E+LT K
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 35/252 (13%)
Query: 323 KEIRR---ATNNFSKDNLIGTGGFGEV----FKGILDDGTVTAIKRAKLGNTKGTDLVLN 375
++IR+ ++ +IG G FGEV K + + + ++ +
Sbjct: 33 RKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHL-HCDFTGKWPPLPWHLR 433
E I+ N +V+L C + D+ L M+ EY+P G L + + + D KW +
Sbjct: 93 ERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF-YTAE 150
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493
+V+A L +HS + HRDVK N+LLD+ + K++DFG ++ ET
Sbjct: 151 VVLA------LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVR 199
Query: 494 IFTTAQGTMGYLDPEYYRNFQLTD-----KSDVYSFGVVLLELLTSKKAIDFNREEENVN 548
TA GT Y+ PE ++ Q D + D +S GV L E+L + +
Sbjct: 200 C-DTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD------S 251
Query: 549 LVVYMKKIMDEE 560
LV KIMD +
Sbjct: 252 LVGTYSKIMDHK 263
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 15/157 (9%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN-TKGT-DLVLNEVRILCQVNHRS 387
+ K IG G +G VFK + + A+KR +L + +G L E+ +L ++ H++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 388 LVRLLGCCVELDQTLMIYEYIPNG--TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+VRL + +++EY FD + G P + Q+ +GL
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCN----GDIDP---EIVKSFMFQLLKGLA 113
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
+ HS V HRD+K N+L+++ K++DFGL+R
Sbjct: 114 FCHSHNV---LHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 354 GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413
G A+K L + +L+ NEV I+ H+++V + + ++ ++ E++ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 414 FDHLHCDFTGKWPPLPWHLRL------VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467
D + RL + + + L YLHS V HRD+KS +ILL
Sbjct: 106 TDIVS------------QTRLNEEQIATVCESVLQALCYLHSQGV---IHRDIKSDSILL 150
Query: 468 DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVV 527
K+SDFG + + D + GT ++ PE + D++S G++
Sbjct: 151 TLDGRVKLSDFGFCAQISK----DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 528 LLELL 532
++E++
Sbjct: 207 VIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 56/274 (20%), Positives = 115/274 (41%), Gaps = 40/274 (14%)
Query: 346 VFKGILDDGTVT--AIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG----CCVELD 399
++KGI ++ V K+ G+ D+ NE++ L +++ +++++ G +L
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRD 459
+ +I EY G L + L K L + +L +A +GL L+ P +++
Sbjct: 96 RLSLILEYCTRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 460 VKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF--QLTD 517
+ S + L+ E K+ GL +++ + + M Y + + + T
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN-------FMVYFSYKMLNDIFSEYTI 201
Query: 518 KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHL 577
K D+YS GVVL E+ T K I F + + + +++ + K + L
Sbjct: 202 KDDIYSLGVVLWEIFTGK--IPFEN--------------LTTKEIYDLI--INKNNSLKL 243
Query: 578 DLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
L+ + + +C RP++KE+ +
Sbjct: 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 39/154 (25%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGT-DLVLNEVRILCQVNHRSL 388
NF + +G G + V+KG G + A+K L +GT + E+ ++ ++ H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
VRL ++ ++++EY+ + D G L + +Q+ +G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDL---KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
V HRD+K N+L++++ K++DFGL+R
Sbjct: 118 ENRV---LHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDDGT--VTAIKR-AKLGNTKGTD--LVLNEV 377
+++R ++ +IG G FGEV + + T V A+K +K K +D E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 378 RILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-HCDFTGKWPPLPWHLRLVI 436
I+ N +V+L + M+ EY+P G L + + + D KW R
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA------RFYT 148
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI-F 495
A ++ L +HS HRDVK N+LLD+ + K++DFG + + + +
Sbjct: 149 A-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK----EGMVRC 200
Query: 496 TTAQGTMGYLDPEYYRNFQLTD-----KSDVYSFGVVLLELL 532
TA GT Y+ PE ++ Q D + D +S GV L E+L
Sbjct: 201 DTAVGTPDYISPEVLKS-QGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 43/219 (19%)
Query: 338 IGTGGFGEVFKGILDDGTVTA---IKRAKL-GNTKGTDLVLNE---VRILCQVNHRSLVR 390
IG G FG+V + T A +K K ++K + L + RIL H ++++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL---QHPNILQ 59
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLR-------LVIAHQIAEG 443
LG CVE L+++EY G L +L + WH R +A +IA G
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE--------QWHRRNSQLLLLQRMACEIAAG 111
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL--SRLVER-TETNDSHIFTTAQG 500
+T++H H D+ N L L KV D+G+ SR E ET D
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV----- 163
Query: 501 TMGYLDPEYYRNFQ-------LTDKSDVYSFGVVLLELL 532
+ +L PE F T S+V++ GV L EL
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 54/218 (24%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 338 IGTGGFGEVFKG--ILDDGTVTAIKRAKLGNTKGTDLV-LNEVRILCQVNHRSLVRLLGC 394
+G G + VFKG L + V A+K +L + +G + EV +L + H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 395 CVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
V D++L +++EY+ + D G + H + +QI GL Y H V
Sbjct: 73 -VHTDKSLTLVFEYLDKDL---KQYMDDCGNI--MSMHNVKIFLYQILRGLAYCHRRKV- 125
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR-N 512
HRD+K N+L++E+ K++DFGL+ R ++ + ++ T+ Y P+ +
Sbjct: 126 --LHRDLKPQNLLINERGELKLADFGLA----RAKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 513 FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550
+ + + D++ G + E+ + + + E+ ++L+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 34/102 (33%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493
L ++Q+A+G+++L S HRD+ + NILL K+ DFGL+R + NDS+
Sbjct: 217 LSFSYQVAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDI----RNDSN 269
Query: 494 --IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ A+ + ++ PE N T +SDV+S+G++L E+ +
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 60/253 (23%), Positives = 115/253 (45%), Gaps = 37/253 (14%)
Query: 297 KKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGT 355
KKL ++R NA ++ R ++ N+IG G FG V++ I +D
Sbjct: 33 KKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSE 92
Query: 356 VTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL-----LGCCVELDQTL---MIYEY 407
AIK+ L + + + E+ I+ +NH +++ L C + ++ + ++ E+
Sbjct: 93 KVAIKKV-LQDPQYKN---RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEF 148
Query: 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467
IP T+ ++ + LP L + ++Q+ L Y+HS I HRD+K N+L+
Sbjct: 149 IPQ-TVHKYMK-HYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLI 203
Query: 468 DEKLNA-KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-------TDKS 519
D + K+ DFG ++ + Q ++ Y+ +YR +L T
Sbjct: 204 DPNTHTLKLCDFGSAKNL-----------LAGQRSVSYICSRFYRAPELMLGATNYTTHI 252
Query: 520 DVYSFGVVLLELL 532
D++S G ++ E++
Sbjct: 253 DLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 338 IGTGGFGEV---FKGILDDGTVTAIKR--AKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
IG+G G V F +L G A+K+ N E+ +L VNH++++ LL
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 393 GC-----CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL-VIAHQIAEGLTY 446
+E Q + + + + L +H + H R+ + +Q+ G+ +
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD--------HERMSYLLYQMLCGIKH 138
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
LHSA I HRD+K SNI++ K+ DFGL+R TN + T T Y
Sbjct: 139 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTN--FMMTPYVVTRYYRA 190
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELL 532
PE + D++S G ++ EL+
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 13/166 (7%)
Query: 373 VLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHL 432
++ E+++L + N +V G + + E++ G+L L + +P +
Sbjct: 50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----EAKRIPEEI 104
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492
++ + GL YL I HRDVK SNIL++ + K+ DFG+S + + N
Sbjct: 105 LGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-- 160
Query: 493 HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538
+ GT Y+ PE + + +SD++S G+ L+EL + I
Sbjct: 161 ----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 54/217 (24%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 338 IGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLV-LNEVRILCQVNHRSLVRLLGCC 395
+G G + VFKG + A+K +L + +G + EV +L + H ++V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI- 71
Query: 396 VELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPP 454
+ ++ L +++EY+ + L +L D G + H + Q+ GL+Y H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYL--DNCGNL--MSMHNVKIFMFQLLRGLSYCHKRK--- 123
Query: 455 IYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE-YYRNF 513
I HRD+K N+L++EK K++DFGL+ R ++ + ++ T+ Y P+ +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLA----RAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 514 QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550
+ + D++ G +L E+ T + + +E ++L+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 338 IGTGGFGEVFKGILDDGTVT-AIKRAKLGNTKGT-DLVLNEVRILCQVNHRSLVRLLGCC 395
+G G +G V+K + VT A+K +L + + ++ E+ IL + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPI 455
M EY+ G+L D L+ +P + I + + +GL +L I
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLY-AGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NI 124
Query: 456 YHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL 515
HRDVK +N+L++ K+ DFG+S + + + T G Y+ PE ++
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS------LAKTNIGCQSYMAPERIKSGGP 178
Query: 516 TD------KSDVYSFGVVLLEL 531
+SDV+S G+ +LE+
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKL-GNTKGT-DLVLNEVRILCQVNHR 386
+ + K IG G +G+V+K + G + A+K+ +L + +G L E+ +L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 387 S-LVRLLGCCVE-------LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH 438
+VRLL VE +++EY+ + L + + G PLP +
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSR 482
Q+ +G+ + H V HRD+K N+L+D +K K++D GL R
Sbjct: 118 QLLKGVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 53/237 (22%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLN---EVRILCQVNHRSLVRLLGC 394
+G G +G V+K DG K L +GT + ++ E+ +L ++ H +++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDE--KEYALKQIEGTGISMSACREIALLRELKHPNVI----- 61
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCDF-----------TGKWP-PLPWHLRLVIAHQIAE 442
L + + + LFD+ D K P LP + + +QI +
Sbjct: 62 --ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
G+ YLH+ V HRD+K +NIL+ E+ K++D G +RL F +
Sbjct: 120 GIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARL-----------FNSP 165
Query: 499 QGTMGYLDPE----YYRNFQL-------TDKSDVYSFGVVLLELLTSKKAIDFNREE 544
+ LDP +YR +L T D+++ G + ELLTS+ +E+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 35/112 (31%), Positives = 49/112 (43%), Gaps = 39/112 (34%)
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q+A G+ +L S HRD+ + NILL E K+ DFGL+R +
Sbjct: 181 QVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDI-------------- 223
Query: 499 QGTMGYLDPEYYRN---------------FQ--LTDKSDVYSFGVVLLELLT 533
Y DP+Y R F T +SDV+SFGV+L E+ +
Sbjct: 224 -----YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 47/156 (30%), Positives = 70/156 (44%), Gaps = 30/156 (19%)
Query: 394 CCVELDQTL-MIYEYIPNG---TLFDHLHCDFTGKWPPLPWHL-RLVIAHQIAEGLTYLH 448
C E + L M+ EY+ G TL ++ LP + R+ A + L YLH
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNIG--------ALPVDMARMYFAETVL-ALEYLH 118
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR--LVERTETN--------DSHIFTTA 498
+ I HRD+K N+L+ + K++DFGLS+ L+ T TN D+ F
Sbjct: 119 NYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT-TNLYEGHIEKDTREFLDK 174
Query: 499 Q--GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
Q GT Y+ PE D ++ G++L E L
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q+A G+ +L S HRD+ + NILL E K+ DFGL+R + + D +A
Sbjct: 182 QVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGSA 236
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 338 IGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLV-LNEVRILCQVNHRSLVRLLGCC 395
+G G + V+KGI +G + A+K + +G + E +L + H ++V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHDI 71
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCD---FTGKWPP--LPWHLRLVIAHQIAEGLTYLHSA 450
+ +TL +F+++H D + + P P+++RL + Q+ GL Y+H
Sbjct: 72 IHTKETLTF--------VFEYMHTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYIHGQ 122
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
I HRD+K N+L+ K++DFGL+ R ++ S +++ T+ Y P+
Sbjct: 123 H---ILHRDLKPQNLLISYLGELKLADFGLA----RAKSIPSQTYSSEVVTLWYRPPDVL 175
Query: 511 RNFQLTDKS---DVYSFGVVLLELL 532
TD S D++ G + +E+L
Sbjct: 176 --LGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q+A+G+ +L S HRD+ + NILL E K+ DFGL+R + + D A
Sbjct: 187 QVAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGDA 241
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 27/207 (13%)
Query: 343 FGEVFKGIL--------DDGTVTAIKRAKLGNTKGTDLVL--NEVRILCQVNHRSLVRLL 392
G+ F+ ++ T+ A+K+ L + DL L E+ Q+ H +++ +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE---GLTYLHS 449
+ + ++ + G+ D L F P L IA + + L Y+HS
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNALDYIHS 119
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR-LVERTETNDS-HIFTT-AQGTMGYLD 506
HR VK+S+ILL +S S +++ + H F + + +L
Sbjct: 120 KG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 507 PE-YYRNFQ-LTDKSDVYSFGVVLLEL 531
PE +N Q +KSD+YS G+ EL
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 53/237 (22%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLN---EVRILCQVNHRSLVRLLGC 394
+G G +G V+K DG + L +GT + ++ E+ +L ++ H +++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDD--RDYALKQIEGTGISMSACREIALLRELKHPNVI----- 61
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCDF-----------TGKWP-PLPWHLRLVIAHQIAE 442
L + + + LFD+ D K P LP + + +QI +
Sbjct: 62 --SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
G+ YLH+ V HRD+K +NIL+ E+ K++D G +RL F +
Sbjct: 120 GIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARL-----------FNSP 165
Query: 499 QGTMGYLDPE----YYRNFQL-------TDKSDVYSFGVVLLELLTSKKAIDFNREE 544
+ LDP +YR +L T D+++ G + ELLTS+ +E+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 338 IGTGGFGEVFKGILD--DGTVTAIKRAKLGNTKGTDLVLN-EVRILCQV-NHRSLVRLLG 393
IG G +G+VFK +L+ +G+ A+K L D + E IL + +H ++V+ G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVK--ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 394 C-----CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
DQ ++ E G++ D L F + + + I H+ GL +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTD-LVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
V HRDVK +NILL + K+ DFG+S + T+ T+ GT ++ PE
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL----TSTRLRRNTSVGTPFWMAPE 194
Query: 509 YYRNFQLTDKS-----DVYSFGVVLLEL 531
Q D + DV+S G+ +EL
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 9/110 (8%)
Query: 426 PPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485
P L + + ++Q+A G+ +L S HRD+ + N+L+ E K+ DFGL+R +
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 486 RTETNDSHIFTTAQG--TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
R DS+ + + ++ PE N T SDV+SFG++L E+ T
Sbjct: 291 R----DSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 6e-07
Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 44/240 (18%)
Query: 338 IGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
IG G FGEVF K + AI L + + LV+ EV ++ ++ H+++VR +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMRELKHKNIVRYID 79
Query: 394 CCV-ELDQTLMI-YEYIPNGTLFDHLH-C-DFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
+ + +Q L I E+ G L ++ C GK + H + I Q+ L Y H+
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK---IEEHAIVDITRQLLHALAYCHN 136
Query: 450 AAVPP----IYHRDVKSSNILLD-------------EKLN----AKVSDFGLSRLVERTE 488
P + HRD+K NI L LN AK+ DFGLS+ +
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 489 TNDSHIFTTAQGTMGYLDPEY--YRNFQLTDKSDVYSFGVVLLELLTSK----KAIDFNR 542
S + GT Y PE + DKSD+++ G ++ EL + K KA +F++
Sbjct: 197 MAHSCV-----GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251
|
Length = 1021 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 338 IGTGGFGEVFKGILDD-GTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
IG G FG+V++ D + A+K + ++ K + E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 394 C--CVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
+ D L ++ +Y+ G LF HL + G++ + IA + L +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE--GRFSED--RAKFYIAELVL-ALEHLHKY 115
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR--LVERTETNDSHIFTTAQGTMGYLDPE 508
I +RD+K NILLD + + DFGLS+ L + TN T GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN------TFCGTTEYLAPE 166
Query: 509 YYRNFQ-LTDKSDVYSFGVVLLEL 531
+ + T D +S GV++ E+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 44/177 (24%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 360 KRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI---YEYIPNGTLFDH 416
KR K G ++ + NE+ L ++NH +++++ T MI Y++ ++D
Sbjct: 198 KRVKAG-SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE 256
Query: 417 LHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476
F K PL R I Q+ + Y+H + HRD+K NI L+ +
Sbjct: 257 ---AFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLG 309
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
DFG + E+ + + GT+ PE + +D++S G++LL++L+
Sbjct: 310 DFGTAMPFEKEREAFDYGWV---GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 57/237 (24%), Positives = 91/237 (38%), Gaps = 43/237 (18%)
Query: 331 NFSKDNLIGTGGFGEV-FKGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHR 386
+F +IG G FGEV D G V A+K +A + + + E IL + +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+V++ + +I E++P G + L T ++ IAE +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY--------IAETVLA 113
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL-------------------------- 480
+ S HRD+K N+LLD K + K+SDFGL
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 481 -----SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
R E + N + + GT Y+ PE + D +S GV++ E+L
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/224 (24%), Positives = 109/224 (48%), Gaps = 19/224 (8%)
Query: 332 FSKDNLIGTGGFGEVFKG--ILDDGTVTAIKRAKLGNTKGTDLV-LNEVRILCQVNHRSL 388
+ K + +G G + V+KG L D V A+K +L + +G + EV +L + H ++
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 389 VRLLGCCVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
V L + +++L +++EY+ + L +L D G + H + Q+ GL Y
Sbjct: 67 VTLHDI-IHTEKSLTLVFEYL-DKDLKQYL--DDCGN--SINMHNVKLFLFQLLRGLNYC 120
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
H V HRD+K N+L++E+ K++DFGL+ R ++ + ++ T+ Y P
Sbjct: 121 HRRKV---LHRDLKPQNLLINERGELKLADFGLA----RAKSIPTKTYSNEVVTLWYRPP 173
Query: 508 E-YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550
+ + + + D++ G + E+ T + + EE ++ +
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 43/184 (23%), Positives = 75/184 (40%), Gaps = 44/184 (23%)
Query: 330 NNFSKDNLIGTGGFGEV-FKGILDDGTVTAI---------KRAKLGNTKGTDLVLNEVRI 379
+F +IG G FGEV D G + A+ K+ +L + K E +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKA------ERDV 54
Query: 380 LCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQ 439
L + + +V L + +I E++P G L + ++I +
Sbjct: 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL------------------MTMLIKYD 96
Query: 440 I-AEGLTYLHSA----AVPPIY-----HRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489
+E +T + A A+ ++ HRD+K NIL+D + K+SDFGLS +
Sbjct: 97 TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156
Query: 490 NDSH 493
+ +
Sbjct: 157 SAYY 160
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 63/248 (25%), Positives = 98/248 (39%), Gaps = 59/248 (23%)
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL-----FDHLHCDFTGKWPPLPWHLR 433
++ QV+H L + G CV + +M+ E++ +G L + P+ W +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-------PVAW--K 119
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA-------KVSDFGLSRLVER 486
+ +A Q+A L+YL + H +V + NILL A K+SD G+S
Sbjct: 120 ITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 487 TETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNR--- 542
E I ++ PE L+ +D +SFG LLE+ + R
Sbjct: 177 REERVERI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228
Query: 543 EEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS 602
E+E Y KK RL E P KE AT L + CL RPS
Sbjct: 229 EKER----FYEKK----HRLPE---PSCKELAT------------LISQCLTYEPTQRPS 265
Query: 603 MKEVADEI 610
+ + ++
Sbjct: 266 FRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDD-GTVTAIKRAK--LGNTKGTDLVLNEVRILCQVNHR 386
N F ++G G +G V K + + AIK+ K N + + L E+++L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWP--PLPWHLRLVIAHQIAEGL 444
++V L + +++EY+ L + + P P +R I +Q+ + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNML------ELLEEMPNGVPPEKVRSYI-YQLIKAI 113
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR-LVERTETNDSHIFTTAQGTMG 503
+ H I HRD+K N+L+ K+ DFG +R L E + N +T T
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN----YTEYVATRW 166
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLEL 531
Y PE D++S G +L EL
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 25/207 (12%)
Query: 338 IGTGGFGEV---FKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGC 394
IG+G G V + +LD N E+ ++ VNH++++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 395 -----CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL-VIAHQIAEGLTYLH 448
+E Q + + + + L + + H R+ + +Q+ G+ +LH
Sbjct: 85 FTPQKSLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLLYQMLCGIKHLH 136
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
SA I HRD+K SNI++ K+ DFGL+R S + T T Y PE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPE 188
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSK 535
+ D++S G ++ E++ K
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 55/238 (23%), Positives = 92/238 (38%), Gaps = 43/238 (18%)
Query: 330 NNFSKDNLIGTGGFGEV-FKGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNH 385
++F +IG G FGEV D G + A+K +A + + + E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+V++ + +I E++P G + L T ++ IAE +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY--------IAETVL 112
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL------------------------- 480
+ + HRD+K N+LLD K + K+SDFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 481 ------SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
R E + N + + GT Y+ PE + D +S GV++ E+L
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 25/207 (12%)
Query: 338 IGTGGFGEV---FKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGC 394
IG+G G V + IL+ N E+ ++ VNH++++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 395 -----CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL-VIAHQIAEGLTYLH 448
+E Q + I + + L + + H R+ + +Q+ G+ +LH
Sbjct: 92 FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD--------HERMSYLLYQMLCGIKHLH 143
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
SA I HRD+K SNI++ K+ DFGL+R S + T T Y PE
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPE 195
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSK 535
+ D++S G ++ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
+Q+ G+ +LHSA I HRD+K SNI++ K+ DFGL+R S + T
Sbjct: 125 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTP 176
Query: 498 AQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
T Y PE + D++S G ++ E++
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 330 NNFSKDNLIGTGGFGEV-FKGILDDGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVNH 385
++F +IG G FGEV D G + A+K+ +++ + V E IL + ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 386 RSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIAE 442
+V+L + + L +I EY+P G + L FT + IAE
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE----------ETRFYIAE 109
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491
+ + S HRD+K N+LLD K + K+SDFGL ++++ +
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 16/181 (8%)
Query: 363 KLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFT 422
K G GT E IL +NH S+++L G T +I +P L+C
Sbjct: 123 KAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYK--TDLYCYLA 174
Query: 423 GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
K + L I + + YLH I HRD+K+ NI ++ + + DFG +
Sbjct: 175 AK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA- 229
Query: 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNR 542
+ N + + A GT+ PE D++S G+VL E+ T ++ F +
Sbjct: 230 -CFPVDINANKYYGWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL-FEK 286
Query: 543 E 543
+
Sbjct: 287 D 287
|
Length = 391 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLN-EVRILCQV-NH 385
T+ + IG G +G+V+K DG++ A+K L D + E IL + NH
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK--ILDPISDVDEEIEAEYNILQSLPNH 78
Query: 386 RSLVRLLGCCVELD-----QTLMIYEYIPNGTLFDH----LHCDFTGKWPPLPWHLRLVI 436
++V+ G + D Q ++ E G++ + L C + + I
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY-----I 133
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
+ GL +LH+ I HRDVK +NILL + K+ DFG+S + T +
Sbjct: 134 LYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN---- 186
Query: 497 TAQGTMGYLDPEYYRNFQLTDKS-----DVYSFGVVLLEL 531
T+ GT ++ PE Q D S DV+S G+ +EL
Sbjct: 187 TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 332 FSKDNLIGTGGFGEV-FKGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRS 387
F K +G G FGEV +D + A+K + + N V E IL + ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V+L + D + +YIP G + L + P L ++ + +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-----RMEVFPEVLARFYIAELTLAIESV 117
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480
H HRD+K NIL+D + K++DFGL
Sbjct: 118 HKMG---FIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 9/102 (8%)
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493
L +Q+A G+ +L S HRD+ + N+LL + K+ DFGL+R + +DS+
Sbjct: 240 LSFTYQVARGMEFLASKNC---VHRDLAARNVLLAQGKIVKICDFGLARDI----MHDSN 292
Query: 494 IFTTAQGTM--GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + ++ PE + T SDV+S+G++L E+ +
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
++A L YLH I HRD+K N+L+ + + K++DFGLS++ E N I TT
Sbjct: 112 EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 32/163 (19%)
Query: 332 FSKDNLIGTGGFGEV-FKGILDDGTVTAIKRAKLGNTKGTDLVLNEVR-------ILCQV 383
F K +G G FGEV +D + A+K + K L+ N+V IL +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR----KKDVLLRNQVAHVKAERDILAEA 58
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQ---- 439
++ +VRL + D + +YIP G + L +R+ I +
Sbjct: 59 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--------------IRMGIFPEDLAR 104
Query: 440 --IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480
IAE + S HRD+K NIL+D + K++DFGL
Sbjct: 105 FYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 38/148 (25%), Positives = 64/148 (43%), Gaps = 15/148 (10%)
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V L V D ++ ++ G L+ H+ K+ +P + AE + L
Sbjct: 47 MVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-----SKFLNIPEEC---VKRWAAEMVVAL 98
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
+ I RD+ +NILLD++ + +++ F VE + + A M Y P
Sbjct: 99 DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE------AVENM-YCAP 151
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSK 535
E + T+ D +S G +L ELLT K
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 28/156 (17%)
Query: 338 IGTGGFGEVFKGI--LDDGTVTAIKRAKLGNTKGTDLV-LNEVRILCQVNHRSLVRLLGC 394
+G G + V+KG L V A+K +L + +G + E +L + H ++V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLV-ALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 395 CVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH-------QIAEGLTY 446
+ +TL +++EY L D + + H Q+ GL Y
Sbjct: 71 IIHTKKTLTLVFEY---------LDTDLKQY---MDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
H + HRD+K N+L+ E+ K++DFGL+R
Sbjct: 119 CHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 57/244 (23%)
Query: 382 QVNHRSLVRLLGCCVELDQTLMIYEYIPNG--TLFDHLHCDFTGKWPPLPWHLRLVIAHQ 439
QV+H+ +V L G CV + +M+ E++ G LF H D PW + +A Q
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT----PWKFK--VAKQ 113
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILL-DEKLNA------KVSDFGLSRLV-ERTETND 491
+A L+YL + H +V + NILL E ++ K+SD G+ V R E +
Sbjct: 114 LASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE 170
Query: 492 SHIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550
+ ++ PE + + L+ +D +SFG L E I +N E +
Sbjct: 171 R---------IPWIAPECVEDSKNLSIAADKWSFGTTLWE-------ICYNGE-----IP 209
Query: 551 VYMKKIMDEERLME----VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ K + ++ER E +V P KE A L C++ RP + +
Sbjct: 210 LKDKTLAEKERFYEGQCMLVTPSCKELAD------------LMTHCMNYDPNQRPFFRAI 257
Query: 607 ADEI 610
+I
Sbjct: 258 MRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 40/129 (31%), Positives = 61/129 (47%), Gaps = 15/129 (11%)
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
IAE + +HS HRD+K N+LLD + +++DFG + + T S + A
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV---AV 164
Query: 500 GTMGYLDPEYYRNFQ-----LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554
GT Y+ PE + + + D +S GV + E+L + F E +LV
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP--FYAE----SLVETYG 218
Query: 555 KIMD-EERL 562
KIM+ EER
Sbjct: 219 KIMNHEERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 332 FSKDNLIGTGGFGEV-FKGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRS 387
F K IG G FGEV +D + A+K +A + V E IL + ++
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHL-RLVIAHQIAEGLTY 446
+V+L + D + +YIP G + L + L R IA ++ +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-----RLGIFEEDLARFYIA-ELTCAIES 116
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480
+H HRD+K NIL+D + K++DFGL
Sbjct: 117 VHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 61/235 (25%), Positives = 88/235 (37%), Gaps = 45/235 (19%)
Query: 332 FSKDNLIGTGGFGEVFKGILDD-GTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRS 387
F K L+G G G VF L G + A+K + ++ VL E IL ++H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHL-----HCDFTGKWPPLPWHLRLVIAHQIAE 442
L L ++ +Y P G LF L C + + R A +
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC-LSEE------VARFYAAEVLL- 114
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS--------------RLVERTE 488
L YLH + +Y RD+K NILL E + +SDF LS R R
Sbjct: 115 ALEYLHLLGI--VY-RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 489 TNDSHIFTTAQ-----------GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
+ +S T GT Y+ PE D ++ G++L E+L
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 76/308 (24%), Positives = 112/308 (36%), Gaps = 88/308 (28%)
Query: 332 FSKDNL-----IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLN------EVRIL 380
F KD+ +G G FG V+K L + K++K K VL V I
Sbjct: 129 FKKDDFVLGKKLGEGAFGVVYKASLVN------KQSK----KEGKYVLKKATEYGAVEIW 178
Query: 381 CQVNHRSLVRLLGCCVEL-------------DQTLMIYEYIPNGTLFDHLHC-DF----- 421
+N R C + D+ +++ Y TL D + +F
Sbjct: 179 --MNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236
Query: 422 ---TGKWPPLPWHLRL------VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472
GK LP L I QI L LHS I HRDVK NI+ E
Sbjct: 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSG 293
Query: 473 A-KVSDFGLSR--------------LVERTETNDSHIFTT------AQGTMGYLDPEYYR 511
+ K+ D G + L R + +I +T + L P ++
Sbjct: 294 SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353
Query: 512 NFQLTDKSDVYSFGVVLLE-----LLTSKKAIDFNR--EEENVNLVVYMKKI-----MDE 559
L D+ D+YS G++ L+ L + I FNR + + +LV + K + D
Sbjct: 354 -LNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDL 412
Query: 560 ERLMEVVD 567
R EV+D
Sbjct: 413 RRGFEVLD 420
|
Length = 566 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
+AE + + S HRD+K N+LLD+ + +++DFG + T S++ A
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV---AV 164
Query: 500 GTMGYLDPEYYRNFQ-----LTDKSDVYSFGVVLLELL 532
GT Y+ PE + + + D +S GV + E+L
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 332 FSKDNL-----IGTGGFGEVFK------GILDDGTVTAIKRAKL-GNTKGTDLVLNEVRI 379
F +DNL +G G FG+V + G D+ A+K K +T + +++E++I
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKI 94
Query: 380 LCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL 417
L + H+++V LLG C L+I EY G L + L
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 624 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.11 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.9 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.9 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 97.83 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.81 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.61 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.48 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.26 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.07 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.03 | |
| PLN02236 | 344 | choline kinase | 96.99 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.58 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.48 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.29 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.03 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.89 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.7 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.7 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.42 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.42 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.27 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.27 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.11 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 95.06 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.03 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-57 Score=464.12 Aligned_cols=293 Identities=52% Similarity=0.833 Sum_probs=255.8
Q ss_pred CccccCHHHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEE
Q 039681 316 SARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCC 395 (624)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 395 (624)
..+.|++.++..+|++|+..++||+|+||.||+|.+.+++.||||++.........+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999987754433145599999999999999999999999
Q ss_pred EeCC-ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 396 VELD-QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 396 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
.+.+ +.+||||||++|+|.++|+..... .|+|.+|++||.++|+||+|||....++||||||||+|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999 499999999999999999853211 899999999999999999999999988999999999999999999999
Q ss_pred EeecCCcccccccCCCCcceeecc-cccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTA-QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 553 (624)
|+|||+|+..... ... .... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.....+...+..|+
T Consensus 218 lsDFGLa~~~~~~---~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG---DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred ccCccCcccCCcc---ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999999765420 111 1222 8999999999999999999999999999999999999998876655666799999
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
...+.+..+.+++|+.+.... ..+......+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~-~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGE-YPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHCcchhheeCCCccCCC-CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999999999987411 11126778899999999999999999999999999776654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=393.89 Aligned_cols=260 Identities=33% Similarity=0.501 Sum_probs=213.6
Q ss_pred CCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcch--hHHHHHHHHHHHhcCCCceeeEeeEEEeCC-ceeEEEeec
Q 039681 332 FSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQVNHRSLVRLLGCCVELD-QTLMIYEYI 408 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 408 (624)
+...+.||+|+||+||+|.+.+...||||++....... .+.|.+|+.+|++++|||||+++|+|.+.. ...+|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34455699999999999999766669999987554332 558999999999999999999999999988 799999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeecCCccccccc
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSRLVERT 487 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~ 487 (624)
++|+|.++++.. ....+++..+++||.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999853 35689999999999999999999999985 89999999999999997 9999999999876532
Q ss_pred CCCCcceeecccccccccCccccc--ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYR--NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
. ...+...||+.|||||++. ...++.|+||||||++||||+||+.||..... ...+........
T Consensus 198 ~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~---- 263 (362)
T KOG0192|consen 198 K----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGL---- 263 (362)
T ss_pred c----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC----
Confidence 1 2234478999999999999 56899999999999999999999999974332 111111111111
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.+..+..+...+..|+.+||+.||.+||++.|++..|+.+.....
T Consensus 264 --------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 264 --------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred --------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 111122356678889999999999999999999999999987443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=370.99 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=207.2
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc-eeEEEeec
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ-TLMIYEYI 408 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~ 408 (624)
.+..+.||+|..|+|||++++ +++.+|+|++.... .....++.+|++++++.+|||||.++|.|..... ..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344678999999999999975 68899999996543 3446789999999999999999999999999984 99999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
.+|+|++++. ..+.+++...-+|+.+|++||.|||+ .+ ||||||||+|||++..|++||+|||.+..+.++
T Consensus 161 DgGSLd~~~k-----~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 161 DGGSLDDILK-----RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred CCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999986 33579999999999999999999996 55 999999999999999999999999999877533
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... ....+....+.....+
T Consensus 233 ------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~-------- 297 (364)
T KOG0581|consen 233 ------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDE-------- 297 (364)
T ss_pred ------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcC--------
Confidence 3467789999999999999999999999999999999999999987641 1122222222222221
Q ss_pred hhhhhccCcCcH-HHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 PVLKERATHLDL-ETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+..+. ....++..++..||++||.+|||++|+++
T Consensus 298 -----ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 298 -----PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -----CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122222 36678899999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=386.34 Aligned_cols=257 Identities=31% Similarity=0.476 Sum_probs=211.2
Q ss_pred CCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 332 FSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
++..+.||+|.||.||.|.+++...||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++..+||||||++|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456789999999999999998889999998865 344578999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
+|.++|+. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++ .
T Consensus 287 sLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~---~ 357 (468)
T KOG0197|consen 287 SLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD---E 357 (468)
T ss_pred cHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC---c
Confidence 99999985 24567999999999999999999999999 999999999999999999999999999954321 1
Q ss_pred cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........-...|.|||.+....++.|||||||||+||||+| |+.|+..-... ..+....+..++
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ev~~~le~GyRl-------- 423 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------EVLELLERGYRL-------- 423 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------HHHHHHhccCcC--------
Confidence 111223345678999999999999999999999999999999 55555432221 112222222211
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
.-+..++..+.+|+..||+.+|++|||++.+...|+.+....
T Consensus 424 -----p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 424 -----PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -----CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 112357778899999999999999999999999999887643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=382.31 Aligned_cols=247 Identities=29% Similarity=0.458 Sum_probs=211.4
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.+|...++||+|||+.+|+++. ..|+.||+|++... .....+...+|++|.++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999996 88999999998642 4456778999999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
|++++++|.++++ ++.++++.+++.++.||+.||.|||+.+ |||||||..|+||+++.++||+|||||..+.
T Consensus 98 ELC~~~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999999986 4578999999999999999999999999 9999999999999999999999999998875
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
. +.....+.+||+.|+|||++.....+..+||||+||+||-|+.|++||+...-.+.. .+ +... +
T Consensus 170 ~----~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety------~~-Ik~~---~- 234 (592)
T KOG0575|consen 170 Y----DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY------NK-IKLN---E- 234 (592)
T ss_pred C----cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH------HH-HHhc---C-
Confidence 3 223346789999999999999888999999999999999999999999754332211 11 1111 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. ..+.....+..+||.++|+.+|.+|||+++|+.
T Consensus 235 --Y-------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 --Y-------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --c-------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 111234456778999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=362.45 Aligned_cols=202 Identities=33% Similarity=0.524 Sum_probs=182.0
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
..+|...+.||+|+|++||+|++ +++..||||.+... +.+..+....|+.+|+.++|||||.+++++...+..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45788888899999999999996 46899999998765 5566778899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC------CCeEEeecC
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK------LNAKVSDFG 479 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~------~~~kl~DfG 479 (624)
|||.+|+|.+||+ +++.+++.+...++.|||.||++||+++ ||||||||.||||+.+ -.+||+|||
T Consensus 89 EyC~gGDLs~yi~-----~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR-----RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999998 3457999999999999999999999999 9999999999999764 468999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNRE 543 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~ 543 (624)
+|+.+.. .....+.+|++.|||||+++..+|+.|+|+||.|++|||+++|+.||.....
T Consensus 161 fAR~L~~-----~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 161 FARFLQP-----GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhhCCc-----hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9998763 2334678899999999999999999999999999999999999999975443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=352.19 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=210.1
Q ss_pred CCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEee-EEEeCCc-eeEEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLG-CCVELDQ-TLMIY 405 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~ 405 (624)
+|.+.+.||+|.||+||++. +.+|..+|.|.++.. +.+..++...|+.+|++|+|||||++++ -+.++.+ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46778899999999999999 678999999988754 3455678999999999999999999998 4555555 89999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV-PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~-~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
||+..|+|...++.- ..+.+.+++..+++++.|+++||..+|++-. ..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~-K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHF-KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHH-HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998632 3456789999999999999999999999421 23999999999999999999999999999988
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... .......+||+.||+||.+....|+.||||||+||++|||...+.||.+. ++.. +.+.+..+....
T Consensus 179 ~s~----~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 179 SSK----TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPP 247 (375)
T ss_pred cch----hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCC
Confidence 632 22345678999999999999999999999999999999999999999864 2222 233333332221
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
+. +.-....+.+|+..|+..||+.||+...++..+..
T Consensus 248 ~p-----------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LP-----------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred Cc-----------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 24566788999999999999999996555554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=363.26 Aligned_cols=253 Identities=28% Similarity=0.373 Sum_probs=204.0
Q ss_pred HhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcc-------hhHHHHHHHHHHHhcCCCceeeEeeEEEeCC
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-------GTDLVLNEVRILCQVNHRSLVRLLGCCVELD 399 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 399 (624)
..+.|-+.+.||+|+||.|-+|. .++|+.||||++...... ......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567788999999999999999 567999999998643221 1233579999999999999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC---CCeEEe
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK---LNAKVS 476 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~---~~~kl~ 476 (624)
..||||||++||+|.+++-. .+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999863 356778888899999999999999999 9999999999999765 789999
Q ss_pred ecCCcccccccCCCCcceeecccccccccCcccccccC--C-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 039681 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ--L-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 553 (624)
|||+|+... ....+.+.+||+.|.|||++.+.. + ..|.|+||+|||||-+++|.+||....... .+
T Consensus 322 DFGlAK~~g-----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl---- 390 (475)
T KOG0615|consen 322 DFGLAKVSG-----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL---- 390 (475)
T ss_pred ccchhhccc-----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH----
Confidence 999999854 344567889999999999997553 3 348899999999999999999997543321 11
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...+..++.. + .+....+..++..+||.+||..||++|||+.|+++
T Consensus 391 ~eQI~~G~y~--f-------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 391 KEQILKGRYA--F-------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHhcCccc--c-------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1112222111 1 11123456778899999999999999999999974
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=357.05 Aligned_cols=243 Identities=28% Similarity=0.375 Sum_probs=202.4
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
..++|++.++||+|+||+||.++. ++++.+|+|+++.. ...+.+...+|..+|.+++||.||+++..|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356799999999999999999995 56899999987643 23456788999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|+||+.||.|..+|+ +.+.+++..+..++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++.
T Consensus 103 Vld~~~GGeLf~hL~-----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ-----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEeccCCccHHHHHH-----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 999999999999997 3467999999999999999999999999 99999999999999999999999999985
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
... .+....+.+||+.|||||++....|+..+|+||+|+++|||++|.+||...+.. .+..+... +++
T Consensus 175 ~~~----~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~-~k~- 242 (357)
T KOG0598|consen 175 DLK----DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILK-GKL- 242 (357)
T ss_pred ccc----CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhc-CcC-
Confidence 432 222334578999999999999999999999999999999999999999854422 12222221 110
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP 601 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 601 (624)
...+.-...+..+++.+.|+.+|++|.
T Consensus 243 -----------~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -----------PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----------CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111112344567799999999999995
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=390.12 Aligned_cols=266 Identities=30% Similarity=0.436 Sum_probs=217.8
Q ss_pred CCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
.+....+.||+|+||.||+|... +...||||.++..... ..++|.+|++++..++|||||+|+|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455678999999999999843 3568999999877665 6788999999999999999999999999999999
Q ss_pred EEEeeccCCCcccccccccCC-----C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 403 MIYEYIPNGTLFDHLHCDFTG-----K----WPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~-----~----~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
||+|||..|||.+||...... . ..+|+..+.+.||.|||.||+||-++. +|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 999999999999999643111 1 345999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 552 (624)
||+||||++.+...+.... -....-.++||+||.+..+++|.+||||||||+|||+++ |+.|+.+-..++
T Consensus 643 KIsDfGLsRdiYssDYYk~--~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------- 713 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKV--RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------- 713 (774)
T ss_pred Eecccccchhhhhhhhhcc--cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence 9999999998764432211 113334679999999999999999999999999999998 777776443322
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
+...+..+++. ..+..++.++..|+..||+.+|.+||+++||-..|+........
T Consensus 714 VIe~i~~g~lL------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 714 VIECIRAGQLL------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHHHHHcCCcc------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 22333344332 22346778899999999999999999999999999988765443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=354.76 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=211.8
Q ss_pred CCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeC--CceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 404 (624)
+.|+..++||+|.||.||+|+ ..+|+.||+|+++..+.+ ......+|+.||++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 346667789999999999999 678999999999877633 355678999999999999999999999887 689999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
+|||++ +|..++.. ..-.+++.++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 197 FeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999965 88888863 3456999999999999999999999999 999999999999999999999999999988
Q ss_pred cccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.. .....++..+-|.+|+|||++.+. .|+...|+||.||||.||+.|++.|.+..+.++...+..+-.-..++.+.
T Consensus 269 ~~---~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TP---SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred cC---CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 63 333447888899999999999766 69999999999999999999999999877766554443332222222221
Q ss_pred --ccc-----------chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 --EVV-----------DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 --~~~-----------d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
++. ...+.+.. .......++|+..+|..||++|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~----~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETF----KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHh----ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 11111111 112345678999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=377.66 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=213.8
Q ss_pred CCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 332 FSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
..+.++||.|.||.|++|+++- ...||||.++.... +...+|+.|+.||.+++||||++|.|+.......++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3567899999999999999752 45799999987654 456789999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
||+||+|+.||+.+ .+.+++.+...++++||.||+||.+.+ +|||||.++|||++.+...|++|||+++.+++
T Consensus 711 yMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999753 356999999999999999999999999 99999999999999999999999999998864
Q ss_pred cCCCCcceeecccc--cccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 487 TETNDSHIFTTAQG--TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 487 ~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
+. ...++...| ..+|.|||.+....++..|||||||+||||.++ |.+|+= +..+ .+ +.+.++++
T Consensus 784 d~---~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW-dmSN--Qd----VIkaIe~g--- 850 (996)
T KOG0196|consen 784 DP---EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW-DMSN--QD----VIKAIEQG--- 850 (996)
T ss_pred CC---CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc-ccch--HH----HHHHHHhc---
Confidence 32 222333333 469999999999999999999999999999886 777752 1111 11 11111111
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
-....+++++..|.+|++.|||+|..+||.+.+|+..|+++++-+
T Consensus 851 ---------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 851 ---------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ---------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 112335678899999999999999999999999999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=333.88 Aligned_cols=263 Identities=25% Similarity=0.342 Sum_probs=206.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
+.|+...++|+|+||+||+++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677788999999999999965 699999999875433 223457899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|++..-| +-|+.. ...++.+.+.+++.|++.|+.|+|+++ +|||||||+||||+.++.+||+|||.|+.+..
T Consensus 82 ~~dhTvL-~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVL-HELERY----PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHH-HHHHhc----cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9976444 444322 235899999999999999999999999 99999999999999999999999999998752
Q ss_pred cCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHh
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM--------KKIM 557 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~ 557 (624)
....++..+.|.+|+|||.+.+ .+|...+||||.||++.||++|.+.|++..+.+...++... ...+
T Consensus 154 ----pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 154 ----PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred ----CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 3445778889999999999977 68999999999999999999999999877665544333221 1111
Q ss_pred cccc------cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 558 DEER------LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 558 ~~~~------~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
.... +.+.-+++-.++. -+....-+++++..||+.||++|++.++++
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k---~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERK---YPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ccCCceeeeecCCCCCccchhhh---cccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1111 1111111111110 012344688999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=354.57 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=209.4
Q ss_pred HHhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCce
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 401 (624)
+..++|.+++.||+|+|++|++|+ ...++.+|||++... .+...+.+..|-++|.+| .||.|++|+-.|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345679999999999999999999 457899999987532 233345678899999999 799999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
|+|+||.++|+|.++|+ +.+.|++...+.+|.||+.||+|||+.| ||||||||+|||||+|+++||+|||.|
T Consensus 150 YFvLe~A~nGdll~~i~-----K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK-----KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEEecCCCcHHHHHH-----HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999997 5578999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCC-----Cc--ce--eecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 482 RLVERTETN-----DS--HI--FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 482 ~~~~~~~~~-----~~--~~--~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
+.+...... .. .. ....+||..|.+||++.....+..+|+|+|||+||+|+.|.+||...++.- .
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------i 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------I 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------H
Confidence 988653222 11 11 134789999999999999999999999999999999999999997554321 1
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+++.+.- |..+ +...++.+.+|+.+.|..||.+|+|.++|-+
T Consensus 296 FqkI~~l-------~y~f-------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 296 FQKIQAL-------DYEF-------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHHh-------cccC-------CCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 2222211 1111 1223356778999999999999999988754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=321.05 Aligned_cols=268 Identities=23% Similarity=0.304 Sum_probs=211.9
Q ss_pred CCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcch--hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.+|...++||+|.||.||+|+ ..+|+.||||+++..+.++ ....++|++.|+.++|+||+.++++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 457778899999999999999 5679999999998875543 3457999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
||+ .+|+..++. +...|+..++..++.++++||+|+|++. |+||||||.|+|++++|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 995 589988863 4567999999999999999999999999 99999999999999999999999999998864
Q ss_pred cCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc-
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME- 564 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 564 (624)
... ..+..+-|.+|+|||.+.+. .|+...|+||.||++.||+-|.+-|.+..+-++...+-.+.....++.+.+
T Consensus 154 p~~----~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 154 PNR----IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred CCc----ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 322 23444789999999998665 599999999999999999999888876655444333322222222332222
Q ss_pred --ccchhhhhccCc-----CcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 --VVDPVLKERATH-----LDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 --~~d~~l~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
+.|..-....+. .-.....++.+|+..++..||.+|+++.|++++
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 222111110110 112244567899999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=344.63 Aligned_cols=256 Identities=30% Similarity=0.471 Sum_probs=203.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC--ceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD--QTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 406 (624)
.++...+.||+|+||+||++... +|...|||.+...+....+.+.+|+.+|++++|||||+.+|.....+ .+.+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677889999999999999965 48999999887664444677899999999999999999999855555 6899999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecCCccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFGLSRLVE 485 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfGla~~~~ 485 (624)
|+++|+|.+++... . ..|++..+.+++.||++||+|||+++ |||+||||+|||++. ++.+||+|||+++...
T Consensus 97 y~~~GsL~~~~~~~---g-~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRY---G-GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred ccCCCcHHHHHHHc---C-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999743 1 26999999999999999999999999 999999999999999 7999999999998765
Q ss_pred ccCCCCcceeecccccccccCcccccccC-CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.. ..........+||+.|||||++.++. ...++|||||||++.||+||+.||... .....++..........
T Consensus 170 ~~-~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P- 242 (313)
T KOG0198|consen 170 SK-GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP- 242 (313)
T ss_pred cc-cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-
Confidence 31 11122234578999999999998633 345999999999999999999998632 11112222222121111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
..+.....+..+++.+|++.+|++|||++|+++.-
T Consensus 243 -----------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 -----------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 22233556678899999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=338.92 Aligned_cols=264 Identities=23% Similarity=0.348 Sum_probs=211.3
Q ss_pred HHhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcch-hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
...+.|++.++||.|..++||+|+ ...+..||||++....... .+.+.+|+..|+.++||||++.+..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 345779999999999999999999 5678999999998765433 58899999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|.||.+|++.+.++..... .+++..+..|++++++||.|||++| -||||||+.||||+++|.+||+|||.+-.+
T Consensus 103 mpfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ehhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999765432 4999999999999999999999999 899999999999999999999999998766
Q ss_pred cccCCCCcceeecccccccccCcccccc--cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..........+...+||+.|||||+++. ..|+.|+||||||++..||.+|..||....+.. ......-.....
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-----vLl~tLqn~pp~ 251 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-----VLLLTLQNDPPT 251 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-----HHHHHhcCCCCC
Confidence 5433222223356789999999999643 369999999999999999999999997433221 111111111100
Q ss_pred --ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 --MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 --~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....|.+ ........+.+++..||+.||++|||++++++
T Consensus 252 ~~t~~~~~d-------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGLDKD-------EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccCChH-------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0111111 11234457889999999999999999999974
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=357.14 Aligned_cols=269 Identities=27% Similarity=0.495 Sum_probs=215.6
Q ss_pred CHHHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeC
Q 039681 321 TGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL 398 (624)
Q Consensus 321 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 398 (624)
..++++...+.+.+.+.||+|.||+||+|.+.+ .||||+++.... +..+.|++|+.++++.+|.||+-+.|+|...
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 346667777778888999999999999999753 489999876543 4577899999999999999999999999987
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
.. .||+.+++|.+|..+||-. ...++..+.++||+||++||.|||.++ |||||||+.||||.++++|||+||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred ce-eeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence 77 9999999999999999843 356899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccc---cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN---FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 555 (624)
|++..-..- .....+....|...|||||+++. .+|++.+||||||+|+|||++|..|+.....+ .+.|
T Consensus 533 GLatvk~~w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIif--- 603 (678)
T KOG0193|consen 533 GLATVKTRW--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QIIF--- 603 (678)
T ss_pred cceeeeeee--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heEE---
Confidence 998643321 12223445568889999999863 46999999999999999999999998722211 1111
Q ss_pred HhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 556 IMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 556 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
++..+.+ ..|.. .....+.+++.+|+..||..++++||.+.+|+..|+.++..
T Consensus 604 mVGrG~l--~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 604 MVGRGYL--MPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred Eeccccc--Cccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111111 11111 11134667889999999999999999999999999988873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=352.72 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=211.7
Q ss_pred HhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhH-HHHHHHHHHHhcC-CCceeeEeeEEEeCC-ceeE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTD-LVLNEVRILCQVN-HRSLVRLLGCCVELD-QTLM 403 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 403 (624)
..++|...+.||.|.||.||+|+ ...+..||||+.+..-....+ .=++|+..|++++ ||||++|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34578888999999999999999 567899999988754333222 2478999999999 999999999999988 9999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||| ..+|.++++. +...+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.
T Consensus 88 VfE~M-d~NLYqLmK~----R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKD----RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eHHhh-hhhHHHHHhh----cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 99999 5689999873 4678999999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCCCcceeecccccccccCcccc-cccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYY-RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
+... ..++..+.|.+|+|||++ +..-|+.+.|+|++|||++|+.+-++.|.+..+-++...+-.+........+
T Consensus 160 v~Sk-----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 160 VRSK-----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cccC-----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 7543 236778899999999987 5667999999999999999999999999887665443333222221211111
Q ss_pred cc------ccchhhhhcc----CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 563 ME------VVDPVLKERA----THLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 563 ~~------~~d~~l~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+ .+.-.+.... ...-.....+..+|+.+|++.||++|||+.|+++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11 1111111000 00111255678899999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=339.10 Aligned_cols=276 Identities=26% Similarity=0.402 Sum_probs=209.3
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc--CCCceeeEeeEEEeCC----ceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV--NHRSLVRLLGCCVELD----QTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l 403 (624)
......++||+|.||.||||++. ++.||||++.. .+.+.|.+|-+|.+.. +|+||+++++.-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556788999999999999986 48999999874 4567789999888765 7999999999877655 8999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA------AVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~------~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
|+||.++|+|.+||.. ..++|....+|+..+++||+|||+. ..++|+|||||++||||.+|++..|+|
T Consensus 286 Vt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999963 4799999999999999999999974 346799999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccC-CC-----CccchhhHHHHHHHHHhCCCCCCCCC-ccccccHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ-LT-----DKSDVYSFGVVLLELLTSKKAIDFNR-EEENVNLV 550 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDv~s~G~vl~elltg~~p~~~~~-~~~~~~~~ 550 (624)
||+|..+........ ....+||.+|||||++.+.- +. .+.||||+|.|||||+++..-+.... ++-.....
T Consensus 360 FGLAl~~~p~~~~~d--~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGD--THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred cceeEEecCCCCCcc--hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999988874432222 23478999999999997542 22 36899999999999999876654211 11111111
Q ss_pred HHHHHHhccccccccc-----chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 551 VYMKKIMDEERLMEVV-----DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 551 ~~~~~~~~~~~~~~~~-----d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
..+.....-+++++.+ -|.+..... ....+..+.+.+..||..|++-|.|+.=|.+.+.++.....+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~--~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWR--KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhh--cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1222222222222211 122221111 113566788999999999999999999999999998887654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=316.65 Aligned_cols=236 Identities=28% Similarity=0.358 Sum_probs=198.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|+..+.||.|+||.|.+.+.+ +|..+|+|++.... .++.+...+|..+|+.+.||.++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45778899999999999999954 68899999986543 355677899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||++||.|..+++ +.+.+++..++.+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||.|+.+.
T Consensus 124 eyv~GGElFS~Lr-----k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR-----KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHH-----hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999997 4467999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
. ...+.+||+.|+|||.+....+...+|+|||||++|||+.|..||...++. . +...+-++++
T Consensus 196 ~-------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~-iY~KI~~~~v--- 258 (355)
T KOG0616|consen 196 G-------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------Q-IYEKILEGKV--- 258 (355)
T ss_pred C-------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------H-HHHHHHhCcc---
Confidence 2 145789999999999999999999999999999999999999999855431 1 1111211111
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCC
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNR 600 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 600 (624)
..+.-...++.+|+...|+.|-.+|
T Consensus 259 ----------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ----------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1111223456678888999998888
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=349.16 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=209.8
Q ss_pred CCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
..|...+.||+|+.|.||.+. ..+++.||||++........+.+++|+.+|+..+|+|||++++.|...+++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 346677889999999999998 5678999999998887777888999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.+.+.. ..+++.++..|..++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999852 35999999999999999999999999 9999999999999999999999999998775432
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
. .-.+.+||+.|||||+.....|..|.||||||++++||+-|++||-.+.+. ..++ .+...-..
T Consensus 424 ~----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAly-LIa~ng~P----- 487 (550)
T KOG0578|consen 424 S----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALY-LIATNGTP----- 487 (550)
T ss_pred C----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHH-HHhhcCCC-----
Confidence 2 234678999999999999999999999999999999999999998643221 1111 11111111
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.. .......+.+++.+||+.|+++||++.|+++
T Consensus 488 ~lk~-----~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KLKN-----PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CcCC-----ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1211 1234567888999999999999999999975
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=354.13 Aligned_cols=264 Identities=24% Similarity=0.397 Sum_probs=204.7
Q ss_pred hCCCCccceeccCCcEEEEEEEE------cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEEEeCC-
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCCVELD- 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 399 (624)
.++|.+.+.||+|+||.||+|.. .++..||||+++.... ...+.+.+|+.++.++ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788999999999999999974 2356899999874432 3356789999999999 8999999999887644
Q ss_pred ceeEEEeeccCCCcccccccccCC--------------------------------------------------------
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTG-------------------------------------------------------- 423 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 423 (624)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999988642100
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccc
Q 039681 424 -KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502 (624)
Q Consensus 424 -~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~ 502 (624)
....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ........++.
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~~ 240 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSARLPL 240 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc--hhcccCCCCCc
Confidence 0235889999999999999999999999 99999999999999999999999999986532111 11112344667
Q ss_pred cccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHH
Q 039681 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLET 581 (624)
Q Consensus 503 ~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 581 (624)
.|+|||++.+..++.++||||||++||||++ |..||......+. +......+.... . +...
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~-----~-------~~~~ 302 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRMR-----A-------PENA 302 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCCC-----C-------CCCC
Confidence 8999999988889999999999999999997 9999875332110 111111111100 0 1123
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 582 MKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 582 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
...+.+|+.+||+.+|++|||+.|+++.|++++.
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3467889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=377.71 Aligned_cols=268 Identities=28% Similarity=0.458 Sum_probs=214.4
Q ss_pred CCCCccceeccCCcEEEEEEEEcC--CC----EEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD--GT----VTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
+..+..+.||+|.||.||+|...+ +. .||||.++.. +.....+|++|..+|++++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667899999999999999643 33 4899988754 4456788999999999999999999999999999999
Q ss_pred EEEeeccCCCcccccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 403 MIYEYIPNGTLFDHLHCDFTG--KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
+++|||++|+|..||+..+.. +...|+....+.++.|||+|++||++++ +|||||..+|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999854221 2467999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhcc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTS-KKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
|+.+...+..... ....-...|||||.++.+.++.|+|||||||+|||++|. ..|+...+.. ..+....+.
T Consensus 849 ArDiy~~~yyr~~--~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~~~~~g 920 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKH--GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLLDVLEG 920 (1025)
T ss_pred hHhhhhchheecc--CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHHHHHhC
Confidence 9965532221111 112345689999999999999999999999999999995 4555432211 111222233
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccCC
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRI 621 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~ 621 (624)
+++ ..+..++..+.+|+..||+.+|++||++..+++.++.+.+...+..
T Consensus 921 gRL-------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 921 GRL-------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred Ccc-------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 322 1233567778899999999999999999999999999998766543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=339.39 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=207.2
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
+...++|...++||+|+||.||+++. ++|..+|+|+++... ..+.+.++.|-++|...++|+||+|+..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34567899999999999999999994 569999999987653 34567789999999999999999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
||||||+|||++..+|. +...|++..+..++.+++-|++-||+.| +|||||||+|+|||..|++||+||||+
T Consensus 217 YLiMEylPGGD~mTLL~-----~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM-----RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EEEEEecCCccHHHHHH-----hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccccc
Confidence 99999999999999997 4568999999999999999999999999 999999999999999999999999998
Q ss_pred cccccc--------------------CCCCc-----------------------ceeecccccccccCcccccccCCCCc
Q 039681 482 RLVERT--------------------ETNDS-----------------------HIFTTAQGTMGYLDPEYYRNFQLTDK 518 (624)
Q Consensus 482 ~~~~~~--------------------~~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~k 518 (624)
..+... ..... ......+||+.|||||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 533210 00000 01113579999999999999999999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCC
Q 039681 519 SDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQ 598 (624)
Q Consensus 519 sDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~ 598 (624)
.|+||+|||+||||.|.+||..+.+.+....+......+... .......+..+||.+|+. ||+
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP----------------~~~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP----------------EEVDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC----------------CcCcccHHHHHHHHHHhc-CHH
Confidence 999999999999999999998776654433222111111110 012233667889999999 999
Q ss_pred CCCC---HHHHH
Q 039681 599 NRPS---MKEVA 607 (624)
Q Consensus 599 ~RPs---~~ev~ 607 (624)
+|.- ++||-
T Consensus 432 ~RLG~~G~~EIK 443 (550)
T KOG0605|consen 432 NRLGSKGAEEIK 443 (550)
T ss_pred HhcCcccHHHHh
Confidence 9964 55553
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=389.15 Aligned_cols=267 Identities=25% Similarity=0.404 Sum_probs=216.4
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
....|...++||+|+||.||+|+. .++..||||+++..... ...|++++++++|||||+++|++.+....++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345677888999999999999996 57899999988643221 2356889999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|.++++ .++|.++.+|+.||++||+|||+...++|+||||||+||++++++..++. ||.+.....
T Consensus 764 y~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 764 YIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999999995 38999999999999999999996654559999999999999999988875 665543321
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
. ....++..|+|||++.+..++.|+|||||||++|||+||+.||+.... ....+..|............++
T Consensus 835 ~--------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 835 D--------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred C--------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhhee
Confidence 1 123578999999999988999999999999999999999999864322 2344566666555555556667
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
|+.+.... ..+.+...++.+++.+||+.+|++||||+||+++|+++.+..
T Consensus 906 ~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 906 DPSIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CccccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 77664322 233456677889999999999999999999999999987743
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=338.01 Aligned_cols=247 Identities=22% Similarity=0.337 Sum_probs=199.9
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcch---hHHHHHHHHHHHhcCCCceeeEeeEEEe----CCceeEEEee
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKG---TDLVLNEVRILCQVNHRSLVRLLGCCVE----LDQTLMIYEY 407 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 407 (624)
...||+|++|.||+|.. +|+.||||+++...... .+.|.+|+.+|++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 68899999987543332 4678899999999999999999999987 3467899999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
+++|+|.+++.. ...+++...++++.|++.||+|||+. + ++||||||+|||+++++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 104 CTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 999999999963 34689999999999999999999985 6 78999999999999999999999999986542
Q ss_pred cCCCCcceeecccccccccCcccccc--cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.. ....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ........+..
T Consensus 176 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~~~-- 240 (283)
T PHA02988 176 PP-------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKNNS-- 240 (283)
T ss_pred cc-------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCCC--
Confidence 11 13457889999999976 579999999999999999999999997432211 11111111100
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
...+......+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 241 ----------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 ----------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ----------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 00111345568899999999999999999999999998864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=346.94 Aligned_cols=264 Identities=28% Similarity=0.409 Sum_probs=210.0
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEEcC--C--CE-EEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEE
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGILDD--G--TV-TAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCV 396 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 396 (624)
++...++....++||+|+||.||+|++.. + .. ||||..+.. ......+|++|+++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33444555666899999999999999643 2 23 899988752 3566788999999999999999999999999
Q ss_pred eCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEe
Q 039681 397 ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476 (624)
Q Consensus 397 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~ 476 (624)
....+++|||+++||+|.++|+.. ...++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence 999999999999999999999742 236999999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 039681 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 555 (624)
|||+++....- ........-...|+|||.+....++.++|||||||++||+++ |..|+.+-... + +..
T Consensus 305 DFGLs~~~~~~----~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~-v~~ 373 (474)
T KOG0194|consen 305 DFGLSRAGSQY----VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------E-VKA 373 (474)
T ss_pred ccccccCCcce----eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------H-HHH
Confidence 99998754311 000112245689999999999999999999999999999998 77787643322 1 111
Q ss_pred Hh-cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 556 IM-DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 556 ~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.+ ..+.... .+...+.++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus 374 kI~~~~~r~~------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 374 KIVKNGYRMP------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHhcCccCC------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 12 2111111 111344567778889999999999999999999999987654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=338.63 Aligned_cols=265 Identities=27% Similarity=0.392 Sum_probs=201.7
Q ss_pred CCCCccceeccCCcEEEEEEEEcC-----------------CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD-----------------GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRL 391 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 391 (624)
++|.+.+.||+|+||.||++..++ +..||+|.+..... ....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997532 33699998875432 335679999999999999999999
Q ss_pred eeEEEeCCceeEEEeeccCCCccccccccc--------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 039681 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDF--------------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYH 457 (624)
Q Consensus 392 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH 457 (624)
++++.+.+..++||||+++|+|.+++.... ......+++.++++++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 112245889999999999999999999999 999
Q ss_pred ecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhC--C
Q 039681 458 RDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTS--K 535 (624)
Q Consensus 458 ~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg--~ 535 (624)
|||||+|||+++++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||+++ .
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999986542211 1112234457889999999888899999999999999999975 4
Q ss_pred CCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 536 KAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 536 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
.||...... .....+............ ...+...+..+.+++.+||+.+|++|||+.||.+.|+
T Consensus 240 ~p~~~~~~~---~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDE---QVIENAGEFFRDQGRQVY---------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHH---HHHHHHHHHhhhcccccc---------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 455432211 111112111111100000 0001123456888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.08 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=207.9
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC----Cc-chhHHHHHHHHHHHhcC-CCceeeEeeEEEeCC
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG----NT-KGTDLVLNEVRILCQVN-HRSLVRLLGCCVELD 399 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 399 (624)
...+.|.+.+.||+|+||.|+.|.. .++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999984 57899999976543 11 23456678999999999 999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC-CCeEEeec
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDF 478 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~-~~~kl~Df 478 (624)
..++||||+.+|+|.+++.. ...+.+..+.+++.|++.|++|+|+.+ |+||||||+|||+|.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 99999999999999999973 457899999999999999999999999 9999999999999999 99999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccccC-CC-CccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ-LT-DKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
|++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... ......
T Consensus 166 G~s~~~~----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k- 234 (370)
T KOG0583|consen 166 GLSAISP----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK- 234 (370)
T ss_pred ccccccC----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-
Confidence 9998763 2233456789999999999999877 75 789999999999999999999975221 111121
Q ss_pred hcccccccccchhhhhccCcCcHHH-HHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 557 MDEERLMEVVDPVLKERATHLDLET-MKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
+..+.. ..+... ..++..|+.+||..+|.+|+|+.||+ .-.-++
T Consensus 235 i~~~~~-------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 235 IRKGEF-------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred HhcCCc-------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 111110 111112 45678899999999999999999998 444444
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=334.95 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=199.8
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
|+..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999995 578999999876432 22334678999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 82 MNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred cCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999998887532 2346899999999999999999999999 999999999999999999999999999765321
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ...+........
T Consensus 156 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~------ 221 (285)
T cd05631 156 -----ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQ------ 221 (285)
T ss_pred -----CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhccc------
Confidence 112345689999999999988999999999999999999999999975432211 111111111100
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
..........+.+|+.+||+.||++||+ ++|+++
T Consensus 222 -------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 -------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0011123456788999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=339.10 Aligned_cols=246 Identities=28% Similarity=0.394 Sum_probs=208.3
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|.+.+.||+|.||.||||+. .+.+.||+|.+... .+++...+.+|++|+++++|||||.++++|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4677888999999999999995 46889999987644 33456678999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+.+ +|..+|.. ...|+++++..|+.|++.||.|||+.+ |+|||+||.|||++..+.+|++|||+|+.+.
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~- 151 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS- 151 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc-
Confidence 9966 99999973 357999999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
....+.+...||+.|||||+..+..|+..+|.||+||++||+.+|++||.... +...+.....++.
T Consensus 152 ---~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v----- 217 (808)
T KOG0597|consen 152 ---TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPV----- 217 (808)
T ss_pred ---cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCC-----
Confidence 34556788899999999999999999999999999999999999999997332 1222222222211
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+......+..++...|++||.+|.+..+++.
T Consensus 218 ---------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 ---------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 112245556788999999999999999988874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=340.10 Aligned_cols=241 Identities=28% Similarity=0.458 Sum_probs=198.7
Q ss_pred CccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCC
Q 039681 333 SKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
...+-||.|+.|.||+|++. ++.||||+++.-. ..+++.|++|+||||+.+.|+|.....++|||||++.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34677999999999999986 5678999876432 346888999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCc
Q 039681 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492 (624)
Q Consensus 413 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 492 (624)
|.+.|+ ....++......|..+||.||.|||.+. |||||||+-||||..+..+||+|||.++.... .+
T Consensus 199 L~~VLk-----a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~----~S 266 (904)
T KOG4721|consen 199 LYEVLK-----AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD----KS 266 (904)
T ss_pred HHHHHh-----ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh----hh
Confidence 999997 3467899999999999999999999999 99999999999999999999999999987642 12
Q ss_pred ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhh
Q 039681 493 HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKE 572 (624)
Q Consensus 493 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 572 (624)
......||..|||||++.+.+.++|+||||||||||||+||..|+..-+ ....++. +..+.+
T Consensus 267 -TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd------ssAIIwG-VGsNsL---------- 328 (904)
T KOG4721|consen 267 -TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD------SSAIIWG-VGSNSL---------- 328 (904)
T ss_pred -hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc------hheeEEe-ccCCcc----------
Confidence 2345679999999999999999999999999999999999999975211 1111111 011111
Q ss_pred ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 573 RATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 573 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
....+..+++-+..|+++||+..|..||++++++..|+-
T Consensus 329 -~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 329 -HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred -cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 011234566778889999999999999999999998863
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=308.50 Aligned_cols=271 Identities=22% Similarity=0.334 Sum_probs=217.9
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC----
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD---- 399 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 399 (624)
+....++|++.+.||+|||+-||.++ ..++..+|+|++...+.++.+..++|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34456789999999999999999999 6789999999998877788899999999999999999999999876544
Q ss_pred -ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 400 -QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 400 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
..||+++|+..|+|.+.++.. ..++..+++.+.+.|+.+|.+||++||+.. +|+.||||||.|||+.+++.++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~-k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERL-KIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHH-hhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence 489999999999999999753 334568999999999999999999999987 57999999999999999999999999
Q ss_pred CCcccccccCCCC-----cceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHH
Q 039681 479 GLSRLVERTETND-----SHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550 (624)
Q Consensus 479 Gla~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 550 (624)
|.+....-.-... -..+....-|..|+|||.+. +...++++|||||||+||+|+.|.-||+...+.
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------ 247 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------ 247 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc------
Confidence 9987543211111 01122345688999999984 556899999999999999999999999743221
Q ss_pred HHHHHHhccccc-ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 551 VYMKKIMDEERL-MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 551 ~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
.+.+ ..+..+.+.. +. +...++.+.+++++|++.||.+||+..+++..++.++
T Consensus 248 --------GgSlaLAv~n~q~s~--P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 --------GGSLALAVQNAQISI--PN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------CCeEEEeeecccccc--CC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 1122222211 11 1126678899999999999999999999999998875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=324.76 Aligned_cols=271 Identities=23% Similarity=0.321 Sum_probs=215.9
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcc--cCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEe-----C
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAK--LGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE-----L 398 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 398 (624)
.....|...+.||+|+||.|..++. .+|+.||||++. ..+....+.-.+|+.+|+.++|+||+.+.+.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3445666678999999999999995 578999999987 4556667788999999999999999999999875 3
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
+..|+|+|+| ..+|...++. .+.|+......+..||++||+|+|+.+ |+||||||+|+|++.+..+||+||
T Consensus 99 ~DvYiV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence 5789999999 6789988863 345999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCccccc-ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR-NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
|+|+..... .....++..+.|.+|.|||++. ...|+...||||.||++.||++|+.-|.+.+..++..++.......
T Consensus 170 GLAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 170 GLARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred cceeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 999987643 2333457788999999999875 4479999999999999999999999999877766666555444333
Q ss_pred cccccccccchhhh----hcc--CcCc-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DEERLMEVVDPVLK----ERA--THLD-----LETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~~~~~~~~d~~l~----~~~--~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.++.+..+-.+... ... +..+ ........+|+.+||..||.+|+|++|+++
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 33333333221111 000 0000 123346778999999999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=346.11 Aligned_cols=262 Identities=27% Similarity=0.389 Sum_probs=203.6
Q ss_pred hCCCCccceeccCCcEEEEEEEE------cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 400 (624)
.++|++.+.||+|+||.||+++. .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999973 235689999986433 23456789999999999 89999999999999999
Q ss_pred eeEEEeeccCCCcccccccccC----------------------------------------------------------
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFT---------------------------------------------------------- 422 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 422 (624)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998863210
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 423 ------------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 423 ------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
.....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence 01235899999999999999999999999 99999999999999999999999999986542211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
........++..|+|||++.+..++.++||||||+++|||++ |..||....... . +......+.... .
T Consensus 270 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~~--~-- 338 (375)
T cd05104 270 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYRML--S-- 338 (375)
T ss_pred -ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCccCC--C--
Confidence 111122345678999999998899999999999999999998 777875432111 1 111111111000 0
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
+.....++.+|+.+||+.+|++|||+.||++.|++.
T Consensus 339 --------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 --------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.22 Aligned_cols=245 Identities=27% Similarity=0.392 Sum_probs=206.5
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCc
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQ 400 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 400 (624)
....++|...++||+|.||+|+++..+ +++.+|||+++... ..+.+..+.|.+|+...+ ||.+++|+.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999965 57899999988653 345677888999988885 9999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||||..||++..+.+ ...+++..+..+|..|+.||+|||+++ ||+||||.+|||||.+|++||+|||+
T Consensus 444 l~fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred EEEEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccc
Confidence 999999999999655554 346999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
++... .......+.+||+.|||||++.+..|+..+|+|||||+||||+.|..||.++++++-. .....++
T Consensus 515 cKe~m----~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F------dsI~~d~ 584 (694)
T KOG0694|consen 515 CKEGM----GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF------DSIVNDE 584 (694)
T ss_pred ccccC----CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHhcCC
Confidence 98642 2333457889999999999999999999999999999999999999999977665422 1111111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
...+.....+...++.++|..+|++|.-+
T Consensus 585 --------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 --------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --------------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12234566778889999999999999776
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=328.43 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=202.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc----CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++|++.+.||+|+||.||+|.++ .+..||+|.++.... ...+.|.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999853 356899999875432 3346789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+|++|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999998632 246899999999999999999999999 999999999999999999999999987653
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ........++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ ... ........
T Consensus 158 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~-~~~~~~~~ 227 (266)
T cd05064 158 KSEA---IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIK-AVEDGFRL 227 (266)
T ss_pred cccc---hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHH-HHHCCCCC
Confidence 2111 011112234678999999988899999999999999999875 999986433221 111 11111000
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
......+..+.+++.+||+.+|++||++++|.+.|+++
T Consensus 228 ------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00112445688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=328.41 Aligned_cols=267 Identities=24% Similarity=0.299 Sum_probs=205.4
Q ss_pred HHHhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCc--------------chhHHHHHHHHHHHhcCCCceee
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNT--------------KGTDLVLNEVRILCQVNHRSLVR 390 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~ 390 (624)
....++|++.+.||+|.||.|-+|+ ..+++.||||++..... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3445779999999999999999999 45799999998753211 12357899999999999999999
Q ss_pred EeeEEEe--CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC
Q 039681 391 LLGCCVE--LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD 468 (624)
Q Consensus 391 l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~ 468 (624)
|+.+..+ .+..|||+||+..|.+...=. ....|++.++++++.+++.||+|||.++ ||||||||+|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 9999876 468999999999988754332 2233999999999999999999999999 99999999999999
Q ss_pred CCCCeEEeecCCcccccccC-CCCcceeecccccccccCcccccccC----CCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 039681 469 EKLNAKVSDFGLSRLVERTE-TNDSHIFTTAQGTMGYLDPEYYRNFQ----LTDKSDVYSFGVVLLELLTSKKAIDFNRE 543 (624)
Q Consensus 469 ~~~~~kl~DfGla~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~s~G~vl~elltg~~p~~~~~~ 543 (624)
++|++||+|||.+....... ......+...+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||..+..
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 99999999999998663321 12223345688999999999987632 45688999999999999999999975432
Q ss_pred cccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 544 EENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.+ ...+..++ .+.. ....+...++.+|++++|++||++|.+..+|....-.-.....
T Consensus 325 ~~------l~~KIvn~---------pL~f---P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 325 LE------LFDKIVND---------PLEF---PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred HH------HHHHHhcC---------cccC---CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 21 12222221 1111 1112455678889999999999999999998765544433333
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.05 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=204.7
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCC
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELD 399 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 399 (624)
..++|.+.+.||+|+||.||+++.. ++..||||+++... ....+.+.+|+++++.+ +|+||+++++++....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457889999999999999998742 23579999987543 23356788999999999 8999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccC---------------------------------------------------------
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFT--------------------------------------------------------- 422 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 422 (624)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998853210
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcce
Q 039681 423 --------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI 494 (624)
Q Consensus 423 --------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 494 (624)
.....+++.++++|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ....
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~--~~~~ 270 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS--NYVV 270 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCc--ceee
Confidence 01235889999999999999999999999 9999999999999999999999999997654221 1111
Q ss_pred eecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 495 FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 495 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||....... . ......... ....+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~--~~~~~----- 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGY--QMSRP----- 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHccc--CccCC-----
Confidence 123345678999999988889999999999999999997 999986432211 0 111111110 00000
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
...+.++.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 338 -----~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 -----DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 012356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=314.45 Aligned_cols=267 Identities=24% Similarity=0.286 Sum_probs=210.8
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcch--hHHHHHHHHHHHhcCCCceeeEeeEEEe--CCcee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQVNHRSLVRLLGCCVE--LDQTL 402 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 402 (624)
..++|...+.|++|.||.||+|+. ++++.||+|+++....+. .-.-++|+.+|.+.+|||||.+..+... -+..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 345688889999999999999994 578999999998765332 2346899999999999999999998774 35799
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
|||||+++ +|..+++.. ..++...++.-++.|+++|++|||++. |+|||||++|+|+.+.|.+||+|||+|+
T Consensus 154 ~VMe~~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred eeHHHHHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhh
Confidence 99999965 888888643 257899999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
.+... ...++..+.|.+|+|||.+.+. .|+...|+||+|||+.||+++++.|.+..+.++.+.+........+..
T Consensus 226 ~ygsp----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 226 EYGSP----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred hhcCC----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 87643 2345777889999999998765 599999999999999999999999988776665555444333333332
Q ss_pred cccccchhhh--------------hccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVLK--------------ERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~--------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+......... ..... ....+.-.+|+...|..||.+|.|++|.++
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~--~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGA--LSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccc--cccchhHHHHHHHHhccCccccccHHHhhc
Confidence 2222211110 10100 113356678999999999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=323.52 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=201.8
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC-----ceeEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD-----QTLMI 404 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 404 (624)
.|...+++|.|+||.||+|+. .+++.||||+...... .-.+|+++|+.++|||||+|+-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466788999999999999995 4579999998764432 2257999999999999999999987543 34589
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC-CCeEEeecCCccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDFGLSRL 483 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~-~~~kl~DfGla~~ 483 (624)
|||||. +|.+.++. ....+..++...+.-++.||.+||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.
T Consensus 101 leymP~-tL~~~~r~-~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRH-YTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhchH-HHHHHHHH-HhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999975 89888863 2234567888888899999999999999998 9999999999999965 9999999999999
Q ss_pred ccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
+...+.+.+ ..-|..|+|||.+.+. .|+.+.||||.|||+.||+-|+.-|.+....++...+..+......+.+
T Consensus 176 L~~~epniS-----YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPNIS-----YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCcee-----EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 876554433 3467899999998765 6999999999999999999999999876554444333333222222322
Q ss_pred ccc-------cchhhhhccCc--CcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEV-------VDPVLKERATH--LDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~-------~d~~l~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+ ..|.+...... .......+..+|+.++|+.+|.+|.++.|++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 221 12222221110 12234567889999999999999999999984
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=330.13 Aligned_cols=248 Identities=29% Similarity=0.413 Sum_probs=206.5
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
..|+..++||+|.||.||+|.. ..++.||+|++..... ...+++.+|+.+|.+++++||.+.+|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577778999999999999994 5689999999987644 4467899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+.+|++.+.++. ...+++....-|+++++.||.|||+++ .+|||||+.|||+..+|.+||+|||.+-.+...
T Consensus 93 ~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999999963 344588888889999999999999999 899999999999999999999999999876532
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
. ....+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+..-.+..-.. .+.+...
T Consensus 165 ~----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~P 228 (467)
T KOG0201|consen 165 V----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAP 228 (467)
T ss_pred h----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCC
Confidence 2 12256789999999999998899999999999999999999999986433311110 0111112
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
|.+ +......+.+++..||+.+|+.||++.++++
T Consensus 229 P~L-------~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRL-------DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred Ccc-------ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 222 2245566889999999999999999999975
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=338.73 Aligned_cols=265 Identities=26% Similarity=0.394 Sum_probs=218.4
Q ss_pred HHHHHHhCCCCccceeccCCcEEEEEEEEcC-CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 323 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
.+++....+....++||-|.||.||.|+++. .-.||||.++. +....++|+.|..+|+.++|||+|+|+|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4455555567778899999999999999865 45689999874 456788999999999999999999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
|||+|||..|+|.+||+.- .+..++.-..+.+|.||+.||+||..++ +|||||..+|+|+.++..+||+||||+
T Consensus 339 YIiTEfM~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred EEEEecccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999999742 4456888889999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+++..+ .-.......-.+.|.|||.+....++.|+|||+|||+|||+.| |..|+.+-+ +.+ ++.+++.+
T Consensus 413 RlMtgD---TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSq-VY~LLEkg 482 (1157)
T KOG4278|consen 413 RLMTGD---TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQ-VYGLLEKG 482 (1157)
T ss_pred hhhcCC---ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHH-HHHHHhcc
Confidence 998632 1112234445779999999999999999999999999999998 666765432 222 22223222
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
- ++ ..+..++..+.+|++.||+.+|.+||++.|+-+.+|.+.+.
T Consensus 483 y-------RM-----~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 483 Y-------RM-----DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred c-------cc-----cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 1 11 11245777889999999999999999999999999998764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=331.63 Aligned_cols=268 Identities=19% Similarity=0.238 Sum_probs=201.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999965 57899999886542 2335678899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|++++.+..+.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE-----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999877655442 2346899999999999999999999999 99999999999999999999999999987642
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH---------Hh
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK---------IM 557 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~---------~~ 557 (624)
.. ........|+..|+|||++.+..++.++||||||+++|||++|+.||......+.......... ..
T Consensus 153 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 153 GS---NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cc---cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 21 1112345689999999999888899999999999999999999999975433221111111000 00
Q ss_pred cccccccccchhhhhcc---CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DEERLMEVVDPVLKERA---THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..........+...... ..........+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000 0000113456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=338.57 Aligned_cols=241 Identities=27% Similarity=0.331 Sum_probs=195.3
Q ss_pred ceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 336 NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
++||+|+||.||+++. .+|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999886432 233456889999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~----~ 148 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS----D 148 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc----C
Confidence 99998863 356899999999999999999999999 99999999999999999999999999875321 1
Q ss_pred cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhh
Q 039681 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLK 571 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 571 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....... +. ..+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~-~~------~~~- 214 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILM-EE------IRF- 214 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHHHHc-CC------CCC-
Confidence 112234568999999999998899999999999999999999999996432211 1111111 10 000
Q ss_pred hccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 572 ERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 572 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
+......+.+++.+||+.||++|| ++.++++
T Consensus 215 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 ------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 112345678899999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=331.58 Aligned_cols=267 Identities=22% Similarity=0.309 Sum_probs=200.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|...+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999964 688999998865432 2345678999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
++ ++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LD-SDLKQYLDN----CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CC-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 97 589888853 2245889999999999999999999999 999999999999999999999999999764321
Q ss_pred CCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
. .......++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+..............+....+.
T Consensus 157 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 157 T----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred C----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 1 11234567899999999865 468999999999999999999999997654333222111111000111111110
Q ss_pred ---------chhhhhcc-CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 ---------DPVLKERA-THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 ---------d~~l~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+...... .........+..+|+.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 0000112346788999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=326.89 Aligned_cols=256 Identities=28% Similarity=0.446 Sum_probs=206.2
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..++|+||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3568889999999999999999888889999987643 334578999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.++++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999998643 2346899999999999999999999998 9999999999999999999999999998654211
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
........++..|+|||++....++.++||||||+++|||++ |..||......+ ....+. .....
T Consensus 158 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~~~---- 223 (261)
T cd05072 158 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ----RGYRM---- 223 (261)
T ss_pred ---eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCCCC----
Confidence 111123345678999999988889999999999999999998 888886432211 111111 11000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
+. ....+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 224 ~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PR--------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CC--------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00 012335678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=329.08 Aligned_cols=263 Identities=28% Similarity=0.413 Sum_probs=208.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|.+.+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888899999999999999842 345689998876555566789999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEE
Q 039681 404 IYEYIPNGTLFDHLHCDFT--------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl 475 (624)
|+||+++++|.+++..... .+...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 9999999999999864311 12345999999999999999999999999 999999999999999999999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 554 (624)
+|||+++...... .........++..|+|||++.+..++.++||||||++++||++ |..||......+ ...
T Consensus 162 ~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~~ 233 (288)
T cd05093 162 GDFGMSRDVYSTD--YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIE 233 (288)
T ss_pred ccCCccccccCCc--eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 9999998654211 1111123345778999999988889999999999999999998 888876433211 111
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
. ...+.... . .......+.+++.+||+.+|.+|||++||.+.|+++...
T Consensus 234 ~-i~~~~~~~-----~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 C-ITQGRVLQ-----R-------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred H-HHcCCcCC-----C-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1 11111110 0 011234578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.52 Aligned_cols=251 Identities=26% Similarity=0.425 Sum_probs=201.3
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|++.+.||+|+||.||++..+++..+|+|.+... ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788899999999999999888889999987643 3335678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+|+|.++++.. ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05114 83 NGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE- 154 (256)
T ss_pred CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc-
Confidence 99999988632 235899999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
........++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..+........ ...+
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~~~i~~~~~---~~~~ 223 (256)
T cd05114 155 --YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVVEMISRGFR---LYRP 223 (256)
T ss_pred --eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHCCCC---CCCC
Confidence 111122335568999999988889999999999999999999 88888643221 11111111111 0011
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
. .....+.+++.+||+.+|++||+++|+++.|
T Consensus 224 ~----------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 K----------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred C----------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 1234578899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=328.47 Aligned_cols=250 Identities=34% Similarity=0.530 Sum_probs=192.8
Q ss_pred ccceeccCCcEEEEEEEEc-----CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 334 KDNLIGTGGFGEVFKGILD-----DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 334 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
..+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 357899999965433 3478899999999999999999999999988889999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++|+|.++|+.. ....+++.+++.|+.||++||+|||+.+ ++|+||+++|||+++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999753 3457999999999999999999999998 999999999999999999999999999876321
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
. .............|+|||.+....++.++||||||+++|||++ |+.|+.... ........ .......
T Consensus 157 ~--~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~~-~~~~~~~-- 225 (259)
T PF07714_consen 157 S--KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEKL-KQGQRLP-- 225 (259)
T ss_dssp S--SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHHH-HTTEETT--
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccc-cccccce--
Confidence 1 1111233456789999999988889999999999999999999 567764321 11122222 1111111
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
.+......+.+++.+||+.+|++|||++++++.|
T Consensus 226 ----------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ----------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0112345577899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=327.48 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=209.9
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
...+|+..+.||+|+||.||+|...++..+++|.+........+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999888999999998866655677899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++... ....+++.++++++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 84 MEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred cccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999743 2346899999999999999999999999 999999999999999999999999999765321
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
........++..|+|||.+.+..++.++||||||++++||++ |+.||......+ .. .........
T Consensus 158 ----~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~---~~~~~~~~~---- 223 (261)
T cd05148 158 ----VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VY---DQITAGYRM---- 223 (261)
T ss_pred ----cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HH---HHHHhCCcC----
Confidence 111123345678999999988889999999999999999998 788886433211 11 111111000
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
......+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 224 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 ---------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00123345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.71 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=204.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|+..+.||+|+||.||+++.. ++..+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367899999999999999999964 688899998875432 335679999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+. |+||||||+|||+++++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999863 3468999999999999999999998642 99999999999999999999999999876532
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---ccc-
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---ERL- 562 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~- 562 (624)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||......+ +...+...... +..
T Consensus 157 ~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 157 S------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred c------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCcc
Confidence 1 1234468999999999998889999999999999999999999996433211 11111000000 000
Q ss_pred --------------------------ccccchhhhhccCcC-cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 563 --------------------------MEVVDPVLKERATHL-DLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 563 --------------------------~~~~d~~l~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+..+.......+.. ......++.+|+.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 11244678899999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=333.61 Aligned_cols=245 Identities=27% Similarity=0.342 Sum_probs=199.6
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999964 68999999986432 234566889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999999863 346899999999999999999999999 9999999999999999999999999998653
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+ ...... ....
T Consensus 153 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~-~~~~--- 215 (291)
T cd05612 153 DR-------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKIL-AGKL--- 215 (291)
T ss_pred CC-------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCc---
Confidence 21 123468999999999988889999999999999999999999987533211 111111 1100
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVADE 609 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~~ 609 (624)
..+......+.+|+.+||+.||.+||+ ++|+++.
T Consensus 216 ----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 001112345778999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=339.22 Aligned_cols=253 Identities=24% Similarity=0.336 Sum_probs=203.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 58899999986432 234566889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999963 346899999999999999999999999 9999999999999999999999999997653
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+.. .....
T Consensus 153 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i~~---~~~~~-- 217 (333)
T cd05600 153 T-------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKY---WKETL-- 217 (333)
T ss_pred c-------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHHHh---ccccc--
Confidence 2 123456899999999999889999999999999999999999999754332211 11111 00000
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+.... .......++.+++.+||+.+|++||+++|+++.
T Consensus 218 ~~~~~~~----~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 QRPVYDD----PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCCCCCc----cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000000 001234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.18 Aligned_cols=259 Identities=29% Similarity=0.428 Sum_probs=205.4
Q ss_pred CCCCccceeccCCcEEEEEEEEcC-C-----CEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD-G-----TVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
++|++.+.||+|+||.||+|.... + ..||+|.++.... ...+.|.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357888999999999999998543 2 5799998864432 33467899999999999999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGK-----------WPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL 471 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~ 471 (624)
++|||+++++|.+++....... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 9999999999999986432111 156899999999999999999999999 99999999999999999
Q ss_pred CeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 039681 472 NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLV 550 (624)
Q Consensus 472 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~ 550 (624)
.+||+|||+++...... .........++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 162 ~~~L~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~----- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSAD--YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE----- 234 (283)
T ss_pred cEEECCCcceeeccccc--cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 99999999997653221 1111223446788999999988889999999999999999998 999986433221
Q ss_pred HHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 551 VYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 551 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
+...+...... ......+..+.+|+.+||+.+|.+||++.||++.|+.
T Consensus 235 --~~~~i~~~~~~------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 --VIEMIRSRQLL------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHcCCcC------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111111 1112345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.82 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=207.6
Q ss_pred CCccceeccCCcEEEEEEEE-cCC----CEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDG----TVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
....++||+|+||+||+|.+ .+| -+||||++... ..+..+++++|+-+|.+++|||+++|+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34578999999999999995 344 46899987543 3455788999999999999999999999999866 88999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
+|||.|+|.+|++. .+..+..+..+.|..|||+||.|||.+. ++||||..+|||+.+-..+||.|||+++++.
T Consensus 777 q~mP~G~LlDyvr~----hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE----HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HhcccchHHHHHHH----hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999975 3457888999999999999999999999 9999999999999999999999999999886
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
..+. ........-.+.|||=|.+....++.++|||||||++||++| |.+|+.....++ +...++.+..
T Consensus 850 ~d~~--ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geR-- 918 (1177)
T KOG1025|consen 850 PDEK--EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGER-- 918 (1177)
T ss_pred cccc--cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcccc--
Confidence 4322 222223344678999999999999999999999999999998 888876544332 2222222210
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
...++-+..++..++.+||..|+..||+++++..++.++.+.
T Consensus 919 ----------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 ----------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ----------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 111234566788899999999999999999999999887653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=323.60 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=204.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.+|...+.||+|+||.||+|... .++.||+|.+... ....+++.+|++++++++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34777889999999999999954 5889999988643 344667899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 85 TYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999998632 2346899999999999999999999998 9999999999999999999999999998654321
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
. .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .... .... ..
T Consensus 159 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~-~~~~-----~~ 223 (263)
T cd05052 159 Y---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYEL-LEKG-----YR 223 (263)
T ss_pred e---eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH-HHCC-----CC
Confidence 1 11112234568999999988889999999999999999998 888886432211 1111 1111 00
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
+. .+...+..+.+++.+||+.+|++||++.+++++|+++
T Consensus 224 ~~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 ME-------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CC-------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00 0112345688899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=335.53 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=206.7
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
+-|++++-||.|+-|.|-.|++ .+|+.+|||++..... .....+.+|+.+|+-+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3477889999999999999995 6799999999865422 22445889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|.|++++. +.++|++.++.+++.||+.|+.|.|..+ |+||||||+|+|||..+++||+|||+|.+-.
T Consensus 92 Eyv~gGELFdylv-----~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLV-----RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHH-----hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999996 4578999999999999999999999999 9999999999999999999999999997643
Q ss_pred ccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
......+.+|++.|.|||++++.+| ..++||||.|||||.|+||+.||+.. ++...+.+ +..+.
T Consensus 164 -----~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlK-V~~G~--- 228 (786)
T KOG0588|consen 164 -----PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLK-VQRGV--- 228 (786)
T ss_pred -----CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHH-HHcCc---
Confidence 2344678899999999999999987 46899999999999999999999722 22222221 11111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+.+.....+..+|+.+|+..||+.|.|++||.+.
T Consensus 229 ----------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 ----------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 11122345567889999999999999999999863
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.29 Aligned_cols=270 Identities=23% Similarity=0.315 Sum_probs=205.9
Q ss_pred CCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcc-h-hHHHHHHHHHHHhcCCCc-eeeEeeEEEeCC------c
Q 039681 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-G-TDLVLNEVRILCQVNHRS-LVRLLGCCVELD------Q 400 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~ 400 (624)
.|...+.||+|+||+||+|+ ..+|+.||+|+++....+ + .....+|+.++++++|+| ||+|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 35556779999999999999 457899999999876542 2 345789999999999999 999999999877 7
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++|+||+ .-+|..++....... ..++...+..++.||++||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 88999999 568999986432111 45777899999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
|+.... ....++..++|..|+|||++.+. .|+...|+||+||++.||++++..|.+..+.+....+-.......+
T Consensus 167 Ara~~i----p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSI----PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcC----CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 996542 23336677899999999999776 6999999999999999999999999876653322222212111222
Q ss_pred ccccccc---chhhhhccCc----CcH---HHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 560 ERLMEVV---DPVLKERATH----LDL---ETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 560 ~~~~~~~---d~~l~~~~~~----~~~---~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+.... +......... ... .......+++.+||+.+|.+|.|++.++.+
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 2222111 1111100000 001 111367889999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=340.02 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=206.7
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcC-CCceeeEeeEEEeC
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVN-HRSLVRLLGCCVEL 398 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 398 (624)
...++|.+.++||+|+||.||+|+.. .+..||||+++.... ...+.+.+|++++++++ ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 34567888999999999999999852 134699999875433 33567999999999996 99999999999999
Q ss_pred CceeEEEeeccCCCcccccccccC--------------------------------------------------------
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFT-------------------------------------------------------- 422 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 422 (624)
...++||||+++|+|.++++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999998853210
Q ss_pred -----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE
Q 039681 423 -----------------------------------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 423 -----------------------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill 467 (624)
.....+++.++++++.||++||+|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 01135889999999999999999999999 9999999999999
Q ss_pred CCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 039681 468 DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEEN 546 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~ 546 (624)
++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred eCCCEEEEEeCCcceecccccc--ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 9999999999999986542211 111123346778999999988889999999999999999997 8888864321110
Q ss_pred ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
+......+... .........+.+++.+||+.+|++||++.+|.++|+++..
T Consensus 349 ------~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 ------FYNKIKSGYRM------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------HHHHHhcCCCC------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111111000 0112334568889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=322.31 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=205.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688899999999999999998778889999987543 34567899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++... ....+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 84 KYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999998642 2346899999999999999999999999 9999999999999999999999999998764211
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
. ........+..|+|||++.+..++.++||||||+++|||++ |+.||....... . ..........
T Consensus 158 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~~~~~~~~~----- 223 (261)
T cd05068 158 Y---EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---V---LQQVDQGYRM----- 223 (261)
T ss_pred c---cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H---HHHHHcCCCC-----
Confidence 1 01112223457999999988889999999999999999999 888886432111 1 1111111000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
.........+.+++.+|++.+|++||+++++++.|+.+
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 --------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00112345688899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=327.38 Aligned_cols=263 Identities=27% Similarity=0.379 Sum_probs=209.3
Q ss_pred CCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.+|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999742 345689998876655556789999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC
Q 039681 404 IYEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~ 472 (624)
||||+++++|.+++..... .....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999864321 11245899999999999999999999999 999999999999999999
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVV 551 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 551 (624)
+||+|||++....... .........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 162 ~~l~dfg~a~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------ 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTD--YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------ 233 (291)
T ss_pred EEECCCCcccccCCCc--eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 9999999997654221 1111123446788999999988889999999999999999999 888876433221
Q ss_pred HHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 552 YMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 552 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
.......+..... ....+..+.+++.+||+.+|++||++++|+++|+++...
T Consensus 234 -~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 234 -VIECITQGRVLER------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHHhCCCCCCC------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111111111110 112345688999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.26 Aligned_cols=244 Identities=26% Similarity=0.349 Sum_probs=199.0
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999964 6889999988643 2234567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999863 346899999999999999999999999 9999999999999999999999999998653
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .... ...+...
T Consensus 170 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~-i~~~~~~-- 233 (329)
T PTZ00263 170 DR-------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEK-ILAGRLK-- 233 (329)
T ss_pred CC-------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHH-HhcCCcC--
Confidence 21 123468999999999998889999999999999999999999996432211 1111 1111100
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
+ +......+.+|+.+||+.||.+||+ +++++.
T Consensus 234 ----~-------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 ----F-------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----C-------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 0112345678999999999999987 677763
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.04 Aligned_cols=238 Identities=25% Similarity=0.315 Sum_probs=192.2
Q ss_pred eccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 338 IGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 338 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
||+|+||.||++... +++.||+|+++.. .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5889999988642 233456788999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ..
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----~~ 148 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD----DD 148 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC----CC
Confidence 999863 346899999999999999999999999 999999999999999999999999999754321 11
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~------------- 209 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP------------- 209 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC-------------
Confidence 223456899999999999888999999999999999999999999643221 1111111110
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCC---HHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPS---MKEVA 607 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~ 607 (624)
...+......+.+++.+||+.||.+||+ +.|++
T Consensus 210 -~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 210 -LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred -CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 0011123356778999999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.79 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=203.3
Q ss_pred CCCccceeccCCcEEEEEEEEc-C-CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-D-GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.|.+.+.||+|++|.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999843 3 6778888876555555667889999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.++++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999886432 23456899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+....... . +
T Consensus 224 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~-~----~- 289 (478)
T PTZ00267 224 --SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGK-Y----D- 289 (478)
T ss_pred --ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-C----C-
Confidence 111223456899999999999888999999999999999999999998643221 1111111110 0 0
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 290 -------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 001123356788999999999999999999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=319.81 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=206.6
Q ss_pred CCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.+|++.+.||+|.||.|-+|. ...|+.||||.++...- .+.-.+.+|++||+.|+||||++++.+|...+..+|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 356777889999999999999 57899999998875433 33445889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||..+|.|.+|+. +.+.|++.+...++.||..|+.|.|.++ ++|||||.+|||+|+|+++||+|||++.++.
T Consensus 133 EYaS~GeLYDYiS-----er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 133 EYASGGELYDYIS-----ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EecCCccHHHHHH-----HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999996 4568999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
. .....+.+|++-|.+||.+.+.+| .+..|-|||||+||-|+.|..||++.+.. ..+++ +..+...+
T Consensus 205 ~-----~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQ-Is~GaYrE 272 (668)
T KOG0611|consen 205 D-----KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQ-ISRGAYRE 272 (668)
T ss_pred c-----ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHH-hhcccccC
Confidence 2 334678899999999999999887 57899999999999999999999864321 11111 11221111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
++.+....-||+|||..+|++|.|+.+|....
T Consensus 273 --------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 --------------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 12233455699999999999999999998654
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.45 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=205.4
Q ss_pred CCCCccceeccCCcEEEEEEEEcC------CCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD------GTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
++|.+.+.||+|+||.||+|...+ +..||||.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788899999999999998633 478999998755444 4578999999999999999999999999999999
Q ss_pred EEEeeccCCCccccccccc---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 403 MIYEYIPNGTLFDHLHCDF---------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
+||||+++++|.+++.... ......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996431 122356899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 552 (624)
||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 162 kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIEC 236 (280)
T ss_pred EECCcccceecccCcc--eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH
Confidence 9999999976532111 111123345778999999998899999999999999999998 999986433221 1111
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
...+.... ........+.+++.+||+.+|++||++.||++.|+
T Consensus 237 ----~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ----ITQGRLLQ------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----HHcCCcCC------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111100 01123456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.11 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=206.3
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|++++.||+|-||.||.|+. +++-.||+|++.... ..-..++.+|++|-+.|+||||++++++|.+....+|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35789999999999999999995 567899999875432 22345789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
+||.++|+|...|... ....+++.....+..|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||-+...
T Consensus 101 lEya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999743 4456899999999999999999999999 999999999999999999999999988653
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
. ...-.+.+||..|.+||+..+...+.+.|+|++|++.||++.|.+||......+. ..+ +.. .+
T Consensus 175 p------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------Ykr-I~k---~~ 238 (281)
T KOG0580|consen 175 P------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKR-IRK---VD 238 (281)
T ss_pred C------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHH-HHH---cc
Confidence 2 2223467899999999999999999999999999999999999999975432111 111 110 11
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
+.+| ........++|.+|+..+|.+|.+..|+++.
T Consensus 239 ~~~p----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 LKFP----------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccCC----------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1122 2344567889999999999999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=320.88 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=204.2
Q ss_pred CCCCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++|+..+.||+|+||.||+|.+.. ...||||.++.... .....|.+|+.++++++||||+++++.+.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999999642 45799998865433 3356789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++... ...+++.++++++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999998632 236899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... .........++..|+|||.+.+..++.++||||||+++|||++ |..||...... .. ..........
T Consensus 157 ~~~~--~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~ 227 (266)
T cd05033 157 EDSE--ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DV----IKAVEDGYRL 227 (266)
T ss_pred cccc--cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCCCC
Confidence 4211 1111112334678999999988889999999999999999998 88887532211 11 1111111000
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
+ .....+..+.+++.+||+.+|++||+++||++.|+++
T Consensus 228 ----~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ----P--------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----C--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0112345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=331.25 Aligned_cols=264 Identities=27% Similarity=0.378 Sum_probs=210.2
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcch-hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+...+.+.||+|.||+|.++...++..||||.++....+. ..+|.+|+++|.+++||||++++|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 3456678999999999999999888999999999776555 488999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|..|+..+. .+.+......+|+.||+.||+||.+.+ +|||||.++|+|+|.++++||+|||+++.+...+
T Consensus 618 EnGDLnqFl~ahe---apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 618 ENGDLNQFLSAHE---LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred hcCcHHHHHHhcc---CcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999997542 223566677889999999999999999 9999999999999999999999999999665322
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh--CCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT--SKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
. .+.-...+-.++|||||.+..++++.+||||+||++|||+++ ..+|+..-..+ +.+.......+.+.....
T Consensus 692 y--y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~- 765 (807)
T KOG1094|consen 692 Y--YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVV- 765 (807)
T ss_pred c--eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCccee-
Confidence 1 112234456789999999999999999999999999999875 66776532221 122222222222211111
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
..-+.-++..+.+++.+||..+-++||+++++...|.+.
T Consensus 766 --------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 --------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111234567788999999999999999999999888764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.72 Aligned_cols=268 Identities=21% Similarity=0.335 Sum_probs=196.3
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC-----cee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD-----QTL 402 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 402 (624)
+|++.+.||+|+||.||+|+. .+++.||||++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999995 46899999987642 2233456889999999999999999999886432 479
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 688888852 346999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccc--cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH-----
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK----- 555 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~----- 555 (624)
....... .........||..|+|||++.+ ..++.++||||||+++|||++|+.||.................
T Consensus 152 ~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 152 VAFNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccccC-ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6532211 1112244578999999999865 5789999999999999999999999975432211111100000
Q ss_pred ---HhcccccccccchhhhhccC-cC---cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 556 ---IMDEERLMEVVDPVLKERAT-HL---DLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 556 ---~~~~~~~~~~~d~~l~~~~~-~~---~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+..+...+.++. +..... .. -......+.+++.+||+.+|++|||++|+++.
T Consensus 231 ~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000 000000 00 00123456789999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.91 Aligned_cols=242 Identities=26% Similarity=0.327 Sum_probs=195.5
Q ss_pred ceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 336 NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
++||+|+||.||++.. .+++.||+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 46899999998643 2234567889999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---- 148 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---- 148 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc----
Confidence 99988852 346899999999999999999999999 999999999999999999999999998753211
Q ss_pred cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhh
Q 039681 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLK 571 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 571 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... ..+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~~~-------~~~- 214 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMED-------IKF- 214 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhccCC-------ccC-
Confidence 112234568999999999988889999999999999999999999996432211 111111100 000
Q ss_pred hccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 039681 572 ERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVADE 609 (624)
Q Consensus 572 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 609 (624)
+......+.+++.+||+.+|++|| ++.|+++.
T Consensus 215 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 ------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112334577899999999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.07 Aligned_cols=241 Identities=26% Similarity=0.336 Sum_probs=194.5
Q ss_pred ceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 336 NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
+.||+|+||.||++.. .+|+.||+|+++.. .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 46899999998643 2234556788999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---- 148 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---- 148 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC----
Confidence 99888852 346899999999999999999999999 999999999999999999999999998753211
Q ss_pred cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhh
Q 039681 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLK 571 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 571 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... . .+
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~-~------~~- 214 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE-I------RF- 214 (323)
T ss_pred CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCC-C------CC-
Confidence 112234568999999999988889999999999999999999999986433221 111111110 0 00
Q ss_pred hccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 572 ERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 572 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
+......+.+++.+||+.+|++|| ++.++++
T Consensus 215 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 ------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 112335677899999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=331.74 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=211.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc-eeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ-TLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 405 (624)
++|...+++|+|+||.++..+.+ +++.+|+|.+..... ...+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999988854 578899998876543 334568999999999999999999999999998 99999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
+|++||+|.+.|... +...++++.+.+++.|++.|++|||++. |+|||||+.|||++.+..+||+|||+|+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999754 3467999999999999999999999888 9999999999999999999999999999886
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
... ....+..||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.. .++. +...
T Consensus 158 ~~~----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~---ki~~------- 220 (426)
T KOG0589|consen 158 PED----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELIL---KINR------- 220 (426)
T ss_pred Cch----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHH---HHhh-------
Confidence 432 2345678999999999999999999999999999999999999999754321 1221 1111
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
......+.....++..++..|++.+|+.||++.+++.+
T Consensus 221 ------~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 ------GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ------ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11122234566778899999999999999999999987
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=331.29 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=202.8
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCC----EEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGT----VTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.+|+..+.||+|+||.||+|++. ++. .||+|+++... ....+++.+|+.+++.++||||++++|++... ...+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 343 38999986443 34456789999999999999999999999864 5779
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|+||+++|+|.+++... ...+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999998632 346899999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
...... .........+..|+|||++.+..++.++||||||+++|||++ |+.||......+ +.........
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~ 229 (316)
T cd05108 159 LGADEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGER 229 (316)
T ss_pred ccCCCc--ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCC
Confidence 653211 111122334678999999998899999999999999999998 899886432211 1111111100
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
... .......+.+++.+||+.+|++||++.+++..|..+..-.
T Consensus 230 --~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 --LPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --CCC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 000 0112345778999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.35 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=208.3
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||+|+. .+++.||||.+... .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999999995 47899999987532 2333457899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++... ..+...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYF-KKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHh-hhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999888532 123356899999999999999999999999 9999999999999999999999999988654
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... +...+... .....
T Consensus 158 ~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~-~~~~~---- 224 (267)
T cd08228 158 SKT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQK-IEQCD---- 224 (267)
T ss_pred chh----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHH-HhcCC----
Confidence 221 111234578899999999888899999999999999999999999864321 11111111 11110
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
.+.. ........+.+++.+||+.+|++||++.||++.|++++
T Consensus 225 -~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 -YPPL------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCCC------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0000 11234466889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=326.05 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=195.4
Q ss_pred CCCCccceeccCCcEEEEEEEE--cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhc---CCCceeeEeeEEEe-----
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL--DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQV---NHRSLVRLLGCCVE----- 397 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 397 (624)
++|++.+.||+|+||.||+++. .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999985 2468899998764332 2234567788877766 69999999999863
Q ss_pred CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
....++|+||++ ++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence 456899999996 6898888632 2345899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
||+++..... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..+....
T Consensus 154 fg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~ 225 (290)
T cd07862 154 FGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVI 225 (290)
T ss_pred ccceEeccCC-----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHh
Confidence 9999765422 1223456899999999998888999999999999999999999999755432211 1111111
Q ss_pred c---cccccc---ccchhhhhccC----cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 D---EERLME---VVDPVLKERAT----HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~---~~~~~~---~~d~~l~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. .+.... .....+..... .........+.+++.+||+.+|++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000 00000000000 000123356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=319.72 Aligned_cols=252 Identities=28% Similarity=0.428 Sum_probs=201.4
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|++.+.||+|+||+||++...++..+|+|.++... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577888999999999999998777789999887433 335679999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+|+|.+++... ...+++.+++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05113 83 NGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE- 154 (256)
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc-
Confidence 99999998632 236899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
........++..|+|||++.+..++.++||||||+++|||++ |..||......+ ........... .
T Consensus 155 --~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~-~---- 221 (256)
T cd05113 155 --YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQGLRL-Y---- 221 (256)
T ss_pred --eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcCCCC-C----
Confidence 111112335678999999988889999999999999999998 888886433211 11111111100 0
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
........+.+++.+||+.+|++||++.++++.|+
T Consensus 222 --------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 --------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00112356788999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=334.19 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=191.9
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
|+..+.||+|+||.||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999954 689999999864432 334678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+|+|.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 156 ~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 156 GGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 99986533 3567788899999999999999999 9999999999999999999999999998764221
Q ss_pred CCcceeecccccccccCcccccc-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRN-----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||......+. ...........
T Consensus 223 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~---- 292 (353)
T PLN00034 223 ---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW---ASLMCAICMSQ---- 292 (353)
T ss_pred ---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhccC----
Confidence 11234568999999998743 2245689999999999999999999973322211 11111110000
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..........++.+|+.+||+.+|++|||+.|+++.
T Consensus 293 ---------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ---------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111234568889999999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.85 Aligned_cols=200 Identities=27% Similarity=0.393 Sum_probs=173.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467899999999999999999965 678899998765422 334678999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+. |+|+||||+|||+++++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999863 3468999999999999999999998532 99999999999999999999999999876532
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~ 541 (624)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 112346889999999998888999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=349.15 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=206.1
Q ss_pred HHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC-
Q 039681 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD- 399 (624)
Q Consensus 324 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 399 (624)
+.....++|.+.+.||+|+||+||+++. .+++.||||++.... ......+.+|+..+..++|+|+++++..+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3445567899999999999999999984 578999999986543 334566889999999999999999988776432
Q ss_pred -------ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC
Q 039681 400 -------QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472 (624)
Q Consensus 400 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~ 472 (624)
..++||||+++|+|.++++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 3679999999999999986432 23457999999999999999999999999 999999999999999999
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..
T Consensus 182 vkL~DFGls~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~ 253 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVS--DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EV 253 (496)
T ss_pred EEEEecccCeecccccc--ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HH
Confidence 99999999987543211 11223456899999999999888999999999999999999999999643221 11
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
+..... +.. + ..+.....++.+++.+||+.+|.+||++.++++.
T Consensus 254 ~~~~~~-~~~----~--------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 254 MHKTLA-GRY----D--------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHhc-CCC----C--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 100 0 1112234567889999999999999999999763
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=331.88 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=199.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC--CCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD--GTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.++|.+.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999998543 368999987542 23345678899999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 109 v~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999863 346899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .+..
T Consensus 181 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~-~~~~- 245 (340)
T PTZ00426 181 VDTR-------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKIL-EGII- 245 (340)
T ss_pred cCCC-------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHh-cCCC-
Confidence 5321 12456899999999998888999999999999999999999999743221 1111111 1110
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVADE 609 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 609 (624)
..+......+.+++.+||+.+|++|+ +++|+++.
T Consensus 246 ------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00111234567899999999999995 88888653
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=324.11 Aligned_cols=261 Identities=28% Similarity=0.395 Sum_probs=202.6
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
..++|+..+.||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999753 24679999875432 2345578999999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEE
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTG-----KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl 475 (624)
.++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998642111 1235788999999999999999999998 999999999999999999999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 554 (624)
+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 161 ~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------VLR 232 (277)
T ss_pred CCCCCccccCCccee--ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence 999998765422110 11112345778999999988889999999999999999999 677876432211 111
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
... ...... .+......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 233 ~~~-~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVM-EGGLLD------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHH-cCCcCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111 111100 011233567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.11 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=197.4
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|++.+.||+|+||.||++.. .+++.||+|+.. .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999995 568899999753 23568999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+. ++|..++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 165 ~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 165 YK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred CC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 94 788888752 246899999999999999999999999 999999999999999999999999999754321
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcccc----ccHHHHHHHHhcc--cc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN----VNLVVYMKKIMDE--ER 561 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~--~~ 561 (624)
.........||+.|+|||++.+..++.++||||||+++|||++|+.|+......+. ......+...... ..
T Consensus 236 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 236 ---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ---cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 11122345799999999999888899999999999999999999988754322110 0111111111000 00
Q ss_pred c----ccccchhh----h------hccC--cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 L----MEVVDPVL----K------ERAT--HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~----~~~~d~~l----~------~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. ...++... . ...+ ........++.+|+.+||+.||.+|||++|+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000000 0 0000 000123457889999999999999999999985
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.22 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=204.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeC-C
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL-D 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 399 (624)
.++|++.++||+|+||.||+|... +++.||+|+++... ....+.+..|++++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 356888999999999999999732 24789999987443 23345688999999999 799999999988754 5
Q ss_pred ceeEEEeeccCCCcccccccccCC--------------------------------------------------------
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTG-------------------------------------------------------- 423 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 423 (624)
..++++||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999888532110
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeeccccccc
Q 039681 424 KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503 (624)
Q Consensus 424 ~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~ 503 (624)
....++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..... ........++..
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--~~~~~~~~~~~~ 240 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLK 240 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc--hhhccCCCCCcc
Confidence 0136899999999999999999999998 99999999999999999999999999987642211 111123445678
Q ss_pred ccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHH
Q 039681 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETM 582 (624)
Q Consensus 504 y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 582 (624)
|+|||++.+..++.++|||||||++|||++ |..||......+. ............ .+....
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~ 302 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR------------APEYAT 302 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC------------CCccCC
Confidence 999999999899999999999999999998 9888864322111 111111111000 011233
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 583 KALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 583 ~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
..+.+++.+||+.+|++||++.||++.|+++++
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 567889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=316.72 Aligned_cols=255 Identities=29% Similarity=0.421 Sum_probs=202.6
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|++.+.||+|+||.||+|+..+...||+|+++... ...+.+.+|++++++++||||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5688999999999999999998777789999987433 23467899999999999999999999874 456899999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+|+|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999642 2346899999999999999999999999 99999999999999999999999999976643211
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.......++..|+|||+..+..++.++||||||+++|||++ |..||......+ . ........
T Consensus 158 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~---~~~~~~~~-------- 220 (262)
T cd05071 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V---LDQVERGY-------- 220 (262)
T ss_pred ---ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---H---HHHHhcCC--------
Confidence 11123346678999999988889999999999999999999 777775332111 0 11111000
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
........+..+.+++.+|++.+|++||++.++++.|+...
T Consensus 221 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 221 -----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 00111234566889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=324.95 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=207.4
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVE 397 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 397 (624)
....++|+..+.||+|+||.||++... +...+|+|...... ......+.+|+++++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344567888899999999999999853 23679999886432 23446688999999999 79999999999999
Q ss_pred CCceeEEEeeccCCCccccccccc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDF-----------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
....+++|||+++|+|.++++... ......+++..+++++.|++.||+|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 999999999999999999986421 023457999999999999999999999998 999999999999
Q ss_pred ECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccc
Q 039681 467 LDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEE 545 (624)
Q Consensus 467 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~ 545 (624)
+++++.+||+|||+++.+..... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDY--YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EcCCCeEEeCccccccccccccc--eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999999987643211 111122335678999999988889999999999999999998 888876432211
Q ss_pred cccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
+.......... ..+......+.+|+.+||+.+|++|||+.|+++.|++++
T Consensus 243 -------~~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -------LFKLLKEGYRM------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -------HHHHHHcCCcC------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111100 011123456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=329.65 Aligned_cols=241 Identities=28% Similarity=0.366 Sum_probs=193.4
Q ss_pred ceeccCCcEEEEEEEE----cCCCEEEEEEcccC----CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 336 NLIGTGGFGEVFKGIL----DDGTVTAIKRAKLG----NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+.||+|+||.||+++. .+++.||+|+++.. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 35789999988642 223345678999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999998863 346888999999999999999999999 999999999999999999999999998753221
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......... ..
T Consensus 154 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~-~~----- 217 (323)
T cd05584 154 ----GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKG-KL----- 217 (323)
T ss_pred ----CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcC-CC-----
Confidence 11123456899999999998888999999999999999999999999743321 111111111 00
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
..+......+.+++.+||+.+|++|| +++++++
T Consensus 218 --------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 --------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 00112234577899999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=321.07 Aligned_cols=269 Identities=27% Similarity=0.410 Sum_probs=201.1
Q ss_pred CCccceeccCCcEEEEEEEE-----cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeC--CceeE
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-----DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTLM 403 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 403 (624)
|...+.||+|+||+||++.. .++..||+|.++.... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 3578899999875432 3456788999999999999999999998764 35789
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++++|.+++.. ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999853 35999999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
....... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+......- ...............+.
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 157 VPEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cCCcchh-hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhh
Confidence 6432110 011112235667999999988889999999999999999999999975332110 00000000000000111
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
+..+.... ...+...+..+.+++.+||+.+|++|||+++|++.|+++.
T Consensus 235 ~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111110 0111234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=316.84 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=199.7
Q ss_pred CCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+|++.+.||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++||||+++++++.+....++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 47788999999999999999877788999987643 23345788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 84 GCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 9999998632 236899999999999999999999999 99999999999999999999999999876532110
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ... .... ....
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~-~~~~-----~~~~ 221 (256)
T cd05059 156 --TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V---VES-VSAG-----YRLY 221 (256)
T ss_pred --cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H---HHH-HHcC-----CcCC
Confidence 01112234467999999988889999999999999999999 788886432211 1 111 1111 0000
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
.+...+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 222 -------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 -------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0112345688899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=323.37 Aligned_cols=268 Identities=26% Similarity=0.415 Sum_probs=202.2
Q ss_pred CCCCccceeccCCcEEEEEEEEc-----CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEe--CCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-----DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE--LDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 402 (624)
++|++.+.||+|+||.||++..+ ++..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999999742 578999999876666667789999999999999999999998754 34678
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+|+||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 84 lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 99999999999999863 2346899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
........ ........++..|+|||++.+..++.++||||||+++|||++|..++...... +. ........
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~-~~~~~~~~ 227 (284)
T cd05081 157 VLPQDKEY-YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FM-RMMGNDKQ 227 (284)
T ss_pred cccCCCcc-eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hh-hhcccccc
Confidence 76432111 00011122345699999998888999999999999999999988765422110 00 00000000
Q ss_pred ccccchh----hhh-ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 563 MEVVDPV----LKE-RATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 563 ~~~~d~~----l~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
....... +.. ............+.+++.+||+.+|++|||++||++.|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000 000 00011122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=316.41 Aligned_cols=253 Identities=28% Similarity=0.434 Sum_probs=201.3
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|++.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888899999875433 3467899999999999999999999875 456889999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+++|.++++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05070 84 KGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc-
Confidence 99999998642 2345899999999999999999999999 9999999999999999999999999997654221
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
........++..|+|||++.+..++.++||||||+++|||++ |..||...... .. ..........
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~---~~~~~~~~~~------ 222 (260)
T cd05070 157 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EV---LEQVERGYRM------ 222 (260)
T ss_pred --cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HH---HHHHHcCCCC------
Confidence 111112335668999999988889999999999999999999 78888643211 11 1111111000
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
..+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 -------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111234568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.46 Aligned_cols=266 Identities=20% Similarity=0.300 Sum_probs=198.6
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999965 688999999875432 223467899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 84 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDK----HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 995 678777753 2346899999999999999999999999 99999999999999999999999999875432
Q ss_pred cCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---ccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---ERL 562 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 562 (624)
. ........+++.|+|||++.+ ..++.++||||||+++|||++|+.||...... ......+...... ...
T Consensus 156 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 156 P----SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred C----CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhc
Confidence 1 112234568899999999865 45888999999999999999999999753221 1111111111110 000
Q ss_pred cc-----ccchhhhhccCcC-------cHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 ME-----VVDPVLKERATHL-------DLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~-----~~d~~l~~~~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. ..++......... .......+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 0000000000000 0012245778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.77 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=205.0
Q ss_pred CCCCccceeccCCcEEEEEEEEcC-C--CEEEEEEcccC-CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD-G--TVTAIKRAKLG-NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 404 (624)
++|++.++||+|+||.||+|+..+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998643 3 24788887642 233456789999999999 799999999999999999999
Q ss_pred EeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 405 YEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
+||+++++|.++++.... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999864211 11245899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 552 (624)
||+|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||......+ .
T Consensus 159 kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~ 227 (297)
T cd05089 159 KIADFGLSRGEEVY-----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------L 227 (297)
T ss_pred EECCcCCCccccce-----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------H
Confidence 99999998643211 00111223557999999988889999999999999999997 999986433211 1
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
...... +. .+ ..+......+.+++.+||+.+|.+||+++++++.|+++....++.
T Consensus 228 ~~~~~~-~~-----~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 228 YEKLPQ-GY-----RM-------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred HHHHhc-CC-----CC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 111111 10 00 001123356788999999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.50 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=198.1
Q ss_pred CCccceeccCCcEEEEEEEEcC-CC--EEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC------Cc
Q 039681 332 FSKDNLIGTGGFGEVFKGILDD-GT--VTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL------DQ 400 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 400 (624)
|.+.+.||+|+||.||+|+..+ +. .+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999654 33 5899987654 234466789999999999999999999987542 24
Q ss_pred eeEEEeeccCCCcccccccccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFT-GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
.++|+||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988743221 23345899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+ .....
T Consensus 158 ~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~ 228 (272)
T cd05075 158 LSKKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EI----YDYLR 228 (272)
T ss_pred cccccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHH
Confidence 99876432110 01112345678999999998889999999999999999999 77887543211 11 11111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
.+.... ........+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 229 ~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNRLK------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111100 0112344578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=330.98 Aligned_cols=251 Identities=26% Similarity=0.336 Sum_probs=197.0
Q ss_pred CCCccceeccCCcEEEEEEEE----cCCCEEEEEEcccC----CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCce
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKRAKLG----NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 401 (624)
+|++.+.||+|+||.||+++. .+++.||+|++... .....+.+..|+.+++++ +|+||+++++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 35789999987632 223345688999999999 499999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999999862 346899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+...... ........||..|+|||++.+. .++.++||||||+++|||++|+.||......... ..........
T Consensus 153 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~- 226 (332)
T cd05614 153 KEFLSEE---KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKC- 226 (332)
T ss_pred ccccccC---CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhcC-
Confidence 7653221 1112345689999999998765 4788999999999999999999999643322111 1111111110
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
++.+ .......+.+++.+||+.||++|| +++++++
T Consensus 227 ------~~~~-------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 ------DPPF-------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ------CCCC-------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 112334577899999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=317.65 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=200.7
Q ss_pred CCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc-----
Q 039681 332 FSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ----- 400 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 400 (624)
|.+.+.||+|+||.||+|+... +..||+|+++... ....+.+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 3679999887542 2345678999999999999999999999876554
Q ss_pred -eeEEEeeccCCCcccccccccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 401 -TLMIYEYIPNGTLFDHLHCDFT-GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 401 -~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
.++|+||+++|+|..++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 7899999999999998854322 12346999999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHh
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
|+++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..||...... .. .....
T Consensus 158 g~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~---~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EI---YDYLR 229 (273)
T ss_pred cceeecccccccc--ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHH
Confidence 9998664321111 1112234678999999988889999999999999999999 77887543211 11 11111
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
. .... .........+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 230 ~-~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 H-GNRL------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred c-CCCC------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1100 01112345688899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=319.16 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=199.9
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCC----EEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGT----VTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|+..+.||+|+||+||+|+.. +++ .+++|....... ....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35777889999999999999953 444 477787653322 23456788888999999999999999875 456788
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
++||+++|+|.+++.. ....+++..++.|+.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ----HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 9999999999999963 2346899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... .........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+..
T Consensus 159 ~~~~~--~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~ 229 (279)
T cd05111 159 LYPDD--KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGER 229 (279)
T ss_pred ccCCC--cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCc
Confidence 54221 1112234456778999999988889999999999999999998 888886433211 1111111110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
...+. .....+.+++.+||..+|++|||+.|+++.|..+.+-
T Consensus 230 --~~~~~----------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 --LAQPQ----------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --CCCCC----------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00111 1223467789999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=318.19 Aligned_cols=254 Identities=23% Similarity=0.370 Sum_probs=201.4
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++.+......++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688999999999999999995 568899999987655555667889999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.++++. ...+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999998862 346899999999999999999999998 9999999999999999999999999998653211
Q ss_pred CCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||......+.. . ..... ..
T Consensus 161 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~-~~~~~---~~ 226 (267)
T cd06646 161 ----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------F-LMSKS---NF 226 (267)
T ss_pred ----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------e-eeecC---CC
Confidence 1112345788999999874 345788999999999999999999998533211110 0 00000 00
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
..+.... .......+.+++.+||+.+|++||+++++++.|
T Consensus 227 ~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLKD-----KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCcc-----ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0111100 112345688899999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=314.69 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=209.2
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999975 7899999987632 2233567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++... ......+++.+++.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHF-KKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHh-cccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999988632 123456899999999999999999999999 9999999999999999999999999987654
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... .+....... ...+.....
T Consensus 158 ~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~~~~~~ 228 (267)
T cd08224 158 SKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKK-IEKCDYPPL 228 (267)
T ss_pred CCCc----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhh-hhcCCCCCC
Confidence 2211 1123457889999999988889999999999999999999999986432 111111111 111110000
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
........+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 229 -----------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 -----------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01134456788999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.45 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=202.0
Q ss_pred CCCCccceeccCCcEEEEEEEE-----cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-----DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|++.+.||+|+||.||+|.. .++..+++|.+.... ......+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 245789999987433 2334678999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC
Q 039681 404 IYEYIPNGTLFDHLHCDFT------------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL 471 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~ 471 (624)
||||+++++|.+++..... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 11245899999999999999999999999 99999999999999999
Q ss_pred CeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 039681 472 NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLV 550 (624)
Q Consensus 472 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~ 550 (624)
.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~----- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADY--YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE----- 234 (283)
T ss_pred cEEeccccccccccCCcc--eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 999999999976542211 111223345678999999988889999999999999999998 888876432111
Q ss_pred HHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 551 VYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 551 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
+........... .+......+.+++.+||+.+|++||++.+|.++|..
T Consensus 235 --~~~~~~~~~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 --VIEMVRKRQLLP------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHcCCcCC------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111100 011233567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.66 Aligned_cols=268 Identities=24% Similarity=0.394 Sum_probs=209.1
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc--------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD--------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVE 397 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 397 (624)
..++|.+.+.||+|+||.||+++.. ++..||+|...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3456888899999999999999741 24579999886432 34456789999999999 89999999999999
Q ss_pred CCceeEEEeeccCCCcccccccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTG-----------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
....++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 99999999999999999998643211 1246899999999999999999999999 999999999999
Q ss_pred ECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccc
Q 039681 467 LDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEE 545 (624)
Q Consensus 467 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~ 545 (624)
+++++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EcCCCcEEECCCccceecccccc--cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 99999999999999986643211 111123345678999999988889999999999999999998 67777533211
Q ss_pred cccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
..... ........ ........+.+++.+||+.+|++|||+.||++.|+++.....+
T Consensus 247 -----~~~~~-~~~~~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 247 -----ELFKL-LKEGHRMD------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred -----HHHHH-HHcCCcCC------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 11111 11111000 0112345678899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=320.70 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=203.9
Q ss_pred CCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
+|.+.+.||+|+||.||+|+.. +...+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 235788888764432 335678999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 039681 404 IYEYIPNGTLFDHLHCDFT-------------------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSN 464 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~N 464 (624)
|+||+++++|.+++..... .....+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999998753211 11246899999999999999999999998 9999999999
Q ss_pred eEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCc
Q 039681 465 ILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNRE 543 (624)
Q Consensus 465 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~ 543 (624)
||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999765322111 11122345678999999988889999999999999999998 8888864322
Q ss_pred cccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 544 EENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
.+ +........ .. ..+......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 236 ~~-------~~~~~~~~~-----~~-------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ER-------LFNLLKTGY-----RM-------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH-------HHHHHhCCC-----CC-------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 111111110 00 0011233567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.01 Aligned_cols=243 Identities=25% Similarity=0.385 Sum_probs=190.6
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||.||+++.. +++.+|+|+++.. .....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 6789999998743 223445678899988877 799999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--- 149 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--- 149 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC---
Confidence 999888752 346999999999999999999999999 999999999999999999999999998753211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHhcccccccccch
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE--NVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
........||..|+|||++.+..++.++||||||+++|||++|+.||....... ......++.........
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 222 (329)
T cd05618 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 222 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------
Confidence 111234568999999999998899999999999999999999999996322111 11111222222211111
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
..+......+.+++.+||+.||++||+.
T Consensus 223 -------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0111233457789999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.13 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=194.1
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||.||+++.. +++.||+|+++.. .....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999964 6889999998743 223345688999999998 699999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 149 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--- 149 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC---
Confidence 999988852 346999999999999999999999999 999999999999999999999999998743211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHhcccccccccch
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE--NVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
........||..|+|||++.+..++.++||||||+++|||++|+.||......+ ......+..........
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 222 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------ 222 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------
Confidence 112234578999999999998889999999999999999999999996432211 11111122222211110
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC------HHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPS------MKEVA 607 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs------~~ev~ 607 (624)
..+......+.+++.+||+.||.+||+ +++++
T Consensus 223 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 223 -------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 011123345788999999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=323.95 Aligned_cols=267 Identities=25% Similarity=0.394 Sum_probs=207.8
Q ss_pred hCCCCccceeccCCcEEEEEEEEc--------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeC
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD--------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL 398 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 398 (624)
.++|.+.+.||+|+||.||++... +...+|+|.++... .....++.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356889999999999999999742 23579999887542 33456788999999999 799999999999999
Q ss_pred CceeEEEeeccCCCcccccccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTG-----------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill 467 (624)
...++||||+++|+|.+++...... ....+++.++++++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 9999999999999999999643211 1235899999999999999999999998 9999999999999
Q ss_pred CCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 039681 468 DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEEN 546 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~ 546 (624)
++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--
Confidence 99999999999998765321110 11112234568999999988889999999999999999998 77777533211
Q ss_pred ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
.... ........ ..+.....++.+++.+||+.+|++|||+.||++.|++++.....
T Consensus 250 ----~~~~-~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 250 ----ELFK-LLKEGHRM------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred ----HHHH-HHHcCCCC------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 1111 11111100 01112345678899999999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.10 Aligned_cols=275 Identities=22% Similarity=0.319 Sum_probs=208.7
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc--CCCceeeEeeEEEeC----C
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV--NHRSLVRLLGCCVEL----D 399 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~ 399 (624)
+...++..+.+.||+|.||.||+|.+. |+.||||++.. .+.+.+.+|.+|.+.+ +|+||+.+++.-..+ .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 445567888999999999999999986 78899999864 3456688999998875 899999999875543 3
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeecCCCCCeEECCCCCeE
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-----AAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-----~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
+++||.+|.++|+|.|||.. ..++....++++..+|.||++||. ++.|.|.|||||+.|||+..++...
T Consensus 283 QLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 68999999999999999963 579999999999999999999995 5778899999999999999999999
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCccccccc------CCCCccchhhHHHHHHHHHhCC----------CCC
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF------QLTDKSDVYSFGVVLLELLTSK----------KAI 538 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~vl~elltg~----------~p~ 538 (624)
|+|+|||.........-.......+||.+|||||++... +.-..+||||||.|+||+..+. .||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999999977654433333344677899999999998532 2334689999999999997632 333
Q ss_pred CCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 539 DFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
..--+.+. ....+.+.+=..++.-.++... .+.+.+..+.++++.||..+|.-|-|+--+-+.|.++.+..+
T Consensus 437 yd~Vp~DP--s~eeMrkVVCv~~~RP~ipnrW------~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 437 YDVVPSDP--SFEEMRKVVCVQKLRPNIPNRW------KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred ccCCCCCC--CHHHHhcceeecccCCCCCccc------ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 32111110 0111111111111111111111 134677889999999999999999999999999999986443
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=317.20 Aligned_cols=257 Identities=31% Similarity=0.491 Sum_probs=203.2
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CC---CEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DG---TVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++|+..+.||+|+||.||+|+.. ++ ..+++|.++... ....+.+.+|++++++++|+|++++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999964 33 379999886542 33456789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++.. ....+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++...
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 85 TEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999863 2356899999999999999999999999 999999999999999999999999999766
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
...... .........+..|+|||++.+..++.++||||||+++|||++ |+.||......+ ...........
T Consensus 158 ~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~i~~~~~~- 229 (268)
T cd05063 158 EDDPEG-TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAINDGFRL- 229 (268)
T ss_pred cccccc-ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhcCCCC-
Confidence 432111 111111223457999999988889999999999999999997 999986432211 11111111000
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
.........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=330.93 Aligned_cols=241 Identities=26% Similarity=0.329 Sum_probs=193.5
Q ss_pred ceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 336 NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
+.||+|+||.||++.. .+++.||+|+++.. .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46899999988643 2233456788999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--- 149 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--- 149 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC---
Confidence 99988852 3468999999999999999999997 67 999999999999999999999999998753211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........||..|+|||++.+..++.++||||||+++|||++|+.||......+. ..... .... .+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~-~~~~------~~ 215 (325)
T cd05594 150 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELIL-MEEI------RF 215 (325)
T ss_pred -CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHh-cCCC------CC
Confidence 1112345689999999999888999999999999999999999999964332111 11111 1100 00
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
+......+.+++.+||+.||++|+ ++.++++
T Consensus 216 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 -------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 111234577899999999999996 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=316.29 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=208.1
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|++|.||++.. .+++.++||.+... .....+++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999995 57899999977543 2234567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++... ......+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHF-KKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHh-hccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999988632 123456899999999999999999999999 9999999999999999999999999987654
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
... .......++..|+|||++.+..++.++||||||+++|||++|..||...... ......... . .
T Consensus 158 ~~~----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~-----~ 223 (267)
T cd08229 158 SKT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-Q-----C 223 (267)
T ss_pred cCC----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhh-c-----C
Confidence 221 1122345888999999998888999999999999999999999998643211 111111111 0 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
..+.+ ........+.+++.+||+.+|++||||.+|+++++++.
T Consensus 224 ~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 DYPPL------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCC------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00101 01124456888999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.51 Aligned_cols=244 Identities=27% Similarity=0.390 Sum_probs=192.5
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHH---HhcCCCceeeEeeEEEeCCceeEE
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRIL---CQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
|++.+.||+|+||.||++... +++.||||+++... ....+.+.+|.+++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999854 68999999986432 23345567776665 566799999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|..+++. ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999888752 36999999999999999999999999 999999999999999999999999998753
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... ........|++.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 152 ~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~-~-- 218 (324)
T cd05589 152 MGF----GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDE-V-- 218 (324)
T ss_pred CCC----CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-C--
Confidence 211 111234568999999999998889999999999999999999999997543221 111111110 0
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
..+......+.+++.+||+.||.+||+ +.++++
T Consensus 219 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 001123355778999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=315.84 Aligned_cols=254 Identities=30% Similarity=0.450 Sum_probs=203.4
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++|.+.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..++|+||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45688899999999999999998889999999887443 34567899999999999999999999864 56789999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 83 ENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999998643 2346899999999999999999999998 9999999999999999999999999997654211
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
........++..|+|||++....++.++||||||+++|||++ |+.||......+ . ... .......
T Consensus 157 ---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~---~~~-~~~~~~~---- 222 (260)
T cd05067 157 ---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---V---IQN-LERGYRM---- 222 (260)
T ss_pred ---cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---H---HHH-HHcCCCC----
Confidence 111123345678999999988889999999999999999999 999986432211 1 111 1111000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
.. ......++.+++.+||+.+|++||+++++.+.|+.
T Consensus 223 -~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -PR-------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00 01223468889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.70 Aligned_cols=265 Identities=22% Similarity=0.357 Sum_probs=211.9
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEcCC-CEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeE-EEe-----
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILDDG-TVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGC-CVE----- 397 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~----- 397 (624)
.....+.++.+.|.+|||+.||.+....+ ..+|+|+.-..++...+.+.+|+++|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34445677889999999999999997665 999999988778888899999999999997 9999999993 222
Q ss_pred -CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEe
Q 039681 398 -LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476 (624)
Q Consensus 398 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~ 476 (624)
.-+.+|.||||.+|.|.+++..... ..|++.++++|+.|+++|+++||... +||||||||-+||||+++++.||+
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeC
Confidence 1357899999999999999975422 34999999999999999999999997 789999999999999999999999
Q ss_pred ecCCcccccccCCCCcce-e----ecccccccccCcccc---cccCCCCccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 039681 477 DFGLSRLVERTETNDSHI-F----TTAQGTMGYLDPEYY---RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~-~----~~~~gt~~y~aPE~~---~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~ 548 (624)
|||.+.-........... + -...-|+.|+|||++ .+..+++|+|||+|||+||-|.....||+.....
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---- 264 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---- 264 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----
Confidence 999986432221110000 0 122358899999987 5778999999999999999999999999743211
Q ss_pred HHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 549 LVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
.+++... ..+. ...+...+..||..||+.+|++||++.+|+..+-+|+..
T Consensus 265 ---------------aIlng~Y--~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 ---------------AILNGNY--SFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---------------eEEeccc--cCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111111 1111 146788899999999999999999999999999888763
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.98 Aligned_cols=238 Identities=25% Similarity=0.380 Sum_probs=188.8
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++... +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 57899999886431 23344566777777654 799999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 999988863 246899999999999999999999999 9999999999999999999999999997543211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~---------- 212 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILNDR---------- 212 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC----------
Confidence 22234568999999999998889999999999999999999999997543211 111111100
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKE 605 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 605 (624)
...+.....++.+++.+||+.+|++||++.+
T Consensus 213 ----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 213 ----PHFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 0011123345678999999999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.73 Aligned_cols=241 Identities=23% Similarity=0.377 Sum_probs=192.9
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||.||+|+.. +++.||+|+++.. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 5789999988643 223445678899998876 799999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--- 149 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--- 149 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC---
Confidence 999988862 346899999999999999999999999 999999999999999999999999998754221
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........||..|+|||++.+..++.++||||||+++|||++|+.||......+ .......... .
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~~~~----~---- 214 (321)
T cd05591 150 -GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILHDDV----L---- 214 (321)
T ss_pred -CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCC----C----
Confidence 111234568999999999998889999999999999999999999997543221 1111111110 0
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCC-------CHHHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRP-------SMKEVAD 608 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~ev~~ 608 (624)
.+.....++.+++.+||+.+|++|| +++++++
T Consensus 215 ------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 ------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0111234577899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.87 Aligned_cols=267 Identities=24% Similarity=0.368 Sum_probs=206.6
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcC-CCceeeEeeEEE
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVN-HRSLVRLLGCCV 396 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 396 (624)
+....++|.+.+.||+|+||.||+|++. .++.||+|+++.... ...+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3444456788899999999999999853 246799999875432 23457899999999997 999999999999
Q ss_pred eCCceeEEEeeccCCCcccccccccC------------------------------------------------------
Q 039681 397 ELDQTLMIYEYIPNGTLFDHLHCDFT------------------------------------------------------ 422 (624)
Q Consensus 397 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 422 (624)
.....++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999864211
Q ss_pred ---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 039681 423 ---------------------------------------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSS 463 (624)
Q Consensus 423 ---------------------------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~ 463 (624)
.....+++..+++|+.||+.||+|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 11235788899999999999999999998 999999999
Q ss_pred CeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 039681 464 NILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNR 542 (624)
Q Consensus 464 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~ 542 (624)
|||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999865321110 11123346788999999988889999999999999999998 888875432
Q ss_pred ccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 543 EEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
..+ ........+. .. ..+.....++.+++.+||+.+|++||+++||++.|++++
T Consensus 347 ~~~------~~~~~~~~~~--~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNE------QFYNAIKRGY--RM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chH------HHHHHHHcCC--CC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111 0111111110 00 001123456888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.87 Aligned_cols=236 Identities=24% Similarity=0.384 Sum_probs=190.1
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||+||+++.. +++.||+|+++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 6889999988643 223456678899998877 699999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--- 149 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--- 149 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---
Confidence 999988863 346899999999999999999999999 999999999999999999999999998753211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~-~-------- 213 (320)
T cd05590 150 -GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDE-V-------- 213 (320)
T ss_pred -CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCC-C--------
Confidence 112234568999999999998889999999999999999999999997543221 111111111 0
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
..+......+.+++.+||+.||++||++
T Consensus 214 -----~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 -----VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0011233467789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.08 Aligned_cols=251 Identities=27% Similarity=0.364 Sum_probs=199.5
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.|+..++||+|+||+||++.. .+++.||+|++..... .....+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 377788999999999999995 4689999998864322 223457889999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999888532 2346999999999999999999999999 99999999999999999999999999976532
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ...+.......
T Consensus 155 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~------ 220 (285)
T cd05605 155 GE-----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKED------ 220 (285)
T ss_pred CC-----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhc------
Confidence 11 12344689999999999888899999999999999999999999975332111 11111111110
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
...........+.+|+.+||+.||++|| +++++++
T Consensus 221 -------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 -------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0011122445678899999999999999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.81 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=195.6
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999985 568899999986432 3345678999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999999863 346899999999999999999999999 99999999999999999999999999864321
Q ss_pred cCCC-------------------------------------------CcceeecccccccccCcccccccCCCCccchhh
Q 039681 487 TETN-------------------------------------------DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYS 523 (624)
Q Consensus 487 ~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s 523 (624)
.... .........||..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 0000 000012346999999999998888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHH--chhcCCCCCC
Q 039681 524 FGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAAS--CLDERRQNRP 601 (624)
Q Consensus 524 ~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RP 601 (624)
|||++|||++|+.||......+. ............ +.. ......++.+|+.+ |+..+|..||
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~-----~~~-----~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTET------QLKVINWENTLH-----IPP-----QVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHH------HHHHHccccccC-----CCC-----CCCCCHHHHHHHHHHccCcccccCCC
Confidence 99999999999999975432211 111111000000 000 01123445667766 5566777799
Q ss_pred CHHHHHH
Q 039681 602 SMKEVAD 608 (624)
Q Consensus 602 s~~ev~~ 608 (624)
++.|+++
T Consensus 298 ~~~~~l~ 304 (381)
T cd05626 298 GADDIKA 304 (381)
T ss_pred CHHHHhc
Confidence 9999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=313.39 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=194.2
Q ss_pred eeccCCcEEEEEEEE---cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 337 LIGTGGFGEVFKGIL---DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
.||+|+||.||+|.+ .++..+|+|+++.... ...+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 3578899998864432 23567899999999999999999999875 45778999999999
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
+|.+++.. ...+++..+.+++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~- 151 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY- 151 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe-
Confidence 99999863 246899999999999999999999999 999999999999999999999999999876432111
Q ss_pred cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........++..|+|||.+....++.++||||||+++|||++ |+.||......+ . .. ....+....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~-~i~~~~~~~------ 218 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V---TQ-MIESGERME------ 218 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HH-HHHCCCCCC------
Confidence 011112234578999999988889999999999999999998 888986432211 1 11 111111100
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
.+.....++.+++.+||+.+|++||++.+|.+.|++
T Consensus 219 ------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 ------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 011234567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.77 Aligned_cols=241 Identities=26% Similarity=0.374 Sum_probs=192.7
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCC-ceeeEeeEEEeCCceeEEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHR-SLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 405 (624)
+|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999964 5789999988643 233456788899999999765 6888999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999998863 346899999999999999999999999 9999999999999999999999999987432
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. ........||..|+|||++.+..++.++||||||+++|||++|+.||......+ . ...... ..
T Consensus 153 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~---~~~i~~-~~---- 217 (324)
T cd05587 153 FG----GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L---FQSIME-HN---- 217 (324)
T ss_pred CC----CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHHc-CC----
Confidence 11 112334568999999999998889999999999999999999999997443211 1 111111 10
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
.. .+......+.+++.+||+.+|.+|++.
T Consensus 218 --~~-------~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 --VS-------YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CC-------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 011233457789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=312.79 Aligned_cols=250 Identities=31% Similarity=0.478 Sum_probs=203.4
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|+..+.||+|++|.||+++.. +++.|++|.+... .....+.+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999964 6899999987643 334567789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.++++.. ....+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999743 2357999999999999999999999998 999999999999999999999999998866432
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
. .......++..|+|||++.+..++.++||||||+++|||++|+.||......+ ...... .+..
T Consensus 155 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~----- 218 (256)
T cd08529 155 T----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILKII-RGVF----- 218 (256)
T ss_pred c----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-cCCC-----
Confidence 1 11233457889999999998889999999999999999999999986443211 111111 1110
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 -------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 -------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111344568889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.26 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=207.4
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcC-----CCEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEe-CCc
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDD-----GTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE-LDQ 400 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 400 (624)
..++|.+.++||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.+ ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678889999999999999999765 688999987643 23445678999999999999999999998776 467
Q ss_pred eeEEEeeccCCCcccccccccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTG---KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
.++++||+++++|.+++...... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998643211 1256999999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
||+++.+..... ........++..|+|||++.+..++.++||||||+++||+++ |+.||...... .+..+ .
T Consensus 161 ~g~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~---~ 232 (280)
T cd05043 161 NALSRDLFPMDY--HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAY---L 232 (280)
T ss_pred CCCcccccCCce--EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHH---H
Confidence 999986542211 111122345678999999988889999999999999999999 99988643221 11111 1
Q ss_pred hcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 557 MDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
....... .....+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 233 ~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGYRLA-------------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCCCCC-------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111100 011233567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=330.36 Aligned_cols=205 Identities=24% Similarity=0.364 Sum_probs=175.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|+..+.||+|+||+||++... +++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 68899999986432 233456888999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999863 356999999999999999999999999 9999999999999999999999999987543
Q ss_pred ccCCC-------------------------------CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhC
Q 039681 486 RTETN-------------------------------DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTS 534 (624)
Q Consensus 486 ~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg 534 (624)
..... .........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 21000 00011235799999999999988999999999999999999999
Q ss_pred CCCCCCCC
Q 039681 535 KKAIDFNR 542 (624)
Q Consensus 535 ~~p~~~~~ 542 (624)
+.||....
T Consensus 233 ~~Pf~~~~ 240 (363)
T cd05628 233 YPPFCSET 240 (363)
T ss_pred CCCCCCCC
Confidence 99997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.17 Aligned_cols=263 Identities=28% Similarity=0.420 Sum_probs=203.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCC--EEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGT--VTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 404 (624)
++|++.+.||+|+||.||+|... ++. .+++|..+... ......+.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56888899999999999999964 444 45777765432 33456788999999999 899999999999999999999
Q ss_pred EeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 405 YEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
+||+++++|.++++.... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999864321 12246899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 552 (624)
||+|||+++..... .. .....++..|+|||++.+..++.++||||||+++|||+| |..||......+ .
T Consensus 164 kl~dfg~~~~~~~~---~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~ 232 (303)
T cd05088 164 KIADFGLSRGQEVY---VK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------L 232 (303)
T ss_pred EeCccccCcccchh---hh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------H
Confidence 99999998643211 00 111224567999999988889999999999999999998 999986432211 1
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
.... ...... .........+.+|+.+||+.+|++||+++++++.|+++......
T Consensus 233 ~~~~-~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 233 YEKL-PQGYRL------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred HHHH-hcCCcC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 1111 111000 00111234578899999999999999999999999988775543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=312.00 Aligned_cols=248 Identities=28% Similarity=0.408 Sum_probs=194.9
Q ss_pred ceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 336 NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
+.||+|+||.||+|+. .+++.+|+|...... .+....+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999996 478999999876433 23456799999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++....... ...
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 151 (252)
T cd05084 81 LTFLRT----EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV--YAS 151 (252)
T ss_pred HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc--ccc
Confidence 999863 2346899999999999999999999999 9999999999999999999999999987543211 000
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhhhh
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKE 572 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 572 (624)
.......+..|+|||.+.+..++.++||||||+++|||++ |..||......+ ......... .
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~-----~----- 214 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGV-----R----- 214 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCC-----C-----
Confidence 0111223457999999988889999999999999999998 777775322111 111111100 0
Q ss_pred ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 573 RATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 573 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
...+...+..+.+++.+||+.+|++|||+.||.++|+
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 --LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0011123456888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=318.04 Aligned_cols=247 Identities=24% Similarity=0.332 Sum_probs=194.2
Q ss_pred eccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 338 IGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 338 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
||+|+||+||++.. .+++.+|+|++..... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 4688999998764322 2345678899999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++... ......+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+.... .
T Consensus 81 ~~~~~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~----~ 152 (280)
T cd05608 81 RYHIYNV-DEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----S 152 (280)
T ss_pred HHHHHhc-cccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC----c
Confidence 8877532 123457999999999999999999999999 9999999999999999999999999997654221 1
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
......||..|+|||++.+..++.++||||||+++|||++|+.||........ .......... . ..
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~-~--------~~--- 218 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILN-D--------SV--- 218 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcc-c--------CC---
Confidence 12345689999999999988999999999999999999999999975332111 0010111000 0 00
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
..+......+.+++.+||+.+|++|| +++++++
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 --TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11122445678899999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.46 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=197.6
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|...++||+|+||.||+++. .+++.||+|++.... ......+.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999985 578899999886442 33456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 9999986442 4788899999999999999999999 999999999999999999999999999765321
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcccccc-HHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN-LVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 566 (624)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+... ............
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 216 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------ 216 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------
Confidence 1234568899999999988889999999999999999999999986432221111 111111111100
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+.+. ......++.+++.+||+.+|++||+++|+++.
T Consensus 217 ~~~~~------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLP------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCC------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000 01123457889999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=317.77 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=200.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC------CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD------GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
.++|.+.+.||+|++|.||+|...+ +..|++|....... .....|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568889999999999999999643 56789998764332 3345689999999999999999999999999999
Q ss_pred eEEEeeccCCCcccccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC---CeEEe
Q 039681 402 LMIYEYIPNGTLFDHLHCDFT--GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL---NAKVS 476 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~---~~kl~ 476 (624)
++||||+++++|.++++.... .....+++..+++++.||+.||+|||+.+ ++||||||+|||+++++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999864321 12236999999999999999999999999 99999999999998754 59999
Q ss_pred ecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 039681 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 555 (624)
|||+++....... .........+..|+|||++.+..++.++||||||+++|||++ |..||......+ . ...
T Consensus 162 dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~---~~~ 233 (277)
T cd05036 162 DFGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V---MEF 233 (277)
T ss_pred cCccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHH
Confidence 9999987632111 000112223568999999988889999999999999999997 888886433221 1 111
Q ss_pred HhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 556 IMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 556 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
....... ..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~~~~-------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRL-------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcC-------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111100 001123456788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.57 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=201.2
Q ss_pred CCCccceeccCCcEEEEEEEEcC------CCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDD------GTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
+|.+.+.||+|+||.||+|...+ +..||+|+++..... ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35667889999999999998532 478999998754332 24668899999999999999999999999999999
Q ss_pred EEeeccCCCccccccccc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC
Q 039681 404 IYEYIPNGTLFDHLHCDF-----------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~ 472 (624)
++||+++++|.+++.... ......+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999885211 112345899999999999999999999999 999999999999999999
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVV 551 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 551 (624)
+||+|||+++...... .........+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 163 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~ 234 (283)
T cd05091 163 VKISDLGLFREVYAAD--YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D 234 (283)
T ss_pred eEecccccccccccch--heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence 9999999988654221 1111233446788999999988889999999999999999998 77777543221 1
Q ss_pred HHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 552 YMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 552 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
...... ..... .........+.+++.+||+.+|++||+++||++.|+.
T Consensus 235 ~~~~i~-~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIR-NRQVL------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHH-cCCcC------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 11110 0112344567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=334.17 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=203.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|.+.+.||+|+||+||+++.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999964 68999999986432 234567889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 99999999999963 256999999999999999999999998 9999999999999999999999999998664
Q ss_pred ccCC-------------------------CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCC
Q 039681 486 RTET-------------------------NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDF 540 (624)
Q Consensus 486 ~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~ 540 (624)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 3220 001122345689999999999988999999999999999999999999975
Q ss_pred CCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-HHHHHHH
Q 039681 541 NREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-MKEVADE 609 (624)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~~ 609 (624)
....+ .......... .. .+. ........+.+++.+|++ +|.+||+ ++|+++.
T Consensus 233 ~~~~~------~~~~i~~~~~--~~---~~p-----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTLQE------TYNKIINWKE--SL---RFP-----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCHHH------HHHHHhccCC--cc---cCC-----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 43211 1111111000 00 000 001134567789999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=315.07 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=192.8
Q ss_pred eccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 338 IGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 338 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
||+|+||.||++.. .+|+.+|+|++.... ......+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 468999999875322 12234566799999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-----~ 149 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-----K 149 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC-----c
Confidence 9888532 2345899999999999999999999999 999999999999999999999999998765421 1
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
......|+..|+|||++.+..++.++||||||+++|||++|+.||....... ............ .+...
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~---------~~~~~ 218 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLED---------EVKFE 218 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcc---------ccccc
Confidence 2234568999999999988889999999999999999999999986432211 111111111110 00000
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
......++.+|+.+||+.+|++||+++|+++.
T Consensus 219 ----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 219 ----HQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ----cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 01234467889999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=318.43 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=199.7
Q ss_pred CCCCccceeccCCcEEEEEEEEcC---------------CCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD---------------GTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLG 393 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 393 (624)
++|++.+.||+|+||.||++...+ ...||+|.++... ....+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 568889999999999999987532 2358999887542 233567999999999999999999999
Q ss_pred EEEeCCceeEEEeeccCCCcccccccccC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFT-------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 394 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
++......++||||+++++|.+++..... .....+++..++.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998853211 11235789999999999999999999999 999999999999
Q ss_pred ECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhC--CCCCCCCCcc
Q 039681 467 LDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTS--KKAIDFNREE 544 (624)
Q Consensus 467 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg--~~p~~~~~~~ 544 (624)
+++++.+||+|||++....... .........++..|+|||++.+..++.++||||||++++||+++ ..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD--YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EcCCCcEEecccccccccccCc--ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999997653221 11111233456789999999888899999999999999999984 4555432221
Q ss_pred ccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
+ .................. ......+..+.+|+.+||+.+|++|||+++|++.|+
T Consensus 240 ~---~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 Q---VIENTGEFFRNQGRQIYL---------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H---HHHHHHHhhhhccccccC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1 111111111111000000 001112356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=325.24 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=213.2
Q ss_pred CCCCccceeccCCcEEEEEEEEc---CC--CEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD---DG--TVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~---~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
+..+..++||+|.||.||+|++. .| -.||||..+.. .....+.|+.|..+|++++||||++|+|+|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34456778999999999999953 23 35889988763 34557889999999999999999999999986 57899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|||.++-|.|..||+. +...|+......++.||..||+|||+.. +|||||..+|||+.+...+||+|||+++.
T Consensus 468 vmEL~~~GELr~yLq~----nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ----NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred EEecccchhHHHHHHh----ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 9999999999999974 3457999999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
++.+... ..+...-.+.|||||.+.-.+++.+||||-|||.+||++. |.+||.+-...+..
T Consensus 541 ~ed~~yY---kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------------- 602 (974)
T KOG4257|consen 541 LEDDAYY---KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------------- 602 (974)
T ss_pred ccccchh---hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------------
Confidence 8743322 2233445779999999999999999999999999999885 88999764332211
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccCC
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRI 621 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~ 621 (624)
..+ -.+.....+..++..+..|+.+||+.+|.+||.+.|+...|+.+++.+.+..
T Consensus 603 ~~i----EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~ 657 (974)
T KOG4257|consen 603 GHI----ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINS 657 (974)
T ss_pred EEe----cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhh
Confidence 110 0112223344577778899999999999999999999999999998655443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=324.40 Aligned_cols=243 Identities=23% Similarity=0.358 Sum_probs=192.2
Q ss_pred ceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||+||++.. .+++.+|+|+++... ....+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999996 467899999987432 23455688999999888 599999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--- 149 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--- 149 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC---
Confidence 999988852 346999999999999999999999999 999999999999999999999999998753211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||.............+..........
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 220 (327)
T cd05617 150 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-------- 220 (327)
T ss_pred -CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--------
Confidence 11223456899999999999889999999999999999999999999653332222222222222211110
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
..+......+.+++.+||+.||++||++
T Consensus 221 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 -----RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 0011223456789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.78 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=198.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|+..+.||+|+||+||+++.. +++.||||++.... ......+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999964 68999999986432 233456789999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.
T Consensus 81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999863 346999999999999999999999999 9999999999999999999999999987543
Q ss_pred ccCCCC----------------------------------cceeecccccccccCcccccccCCCCccchhhHHHHHHHH
Q 039681 486 RTETND----------------------------------SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLEL 531 (624)
Q Consensus 486 ~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~el 531 (624)
...... ........||+.|+|||++.+..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211000 0001124689999999999888899999999999999999
Q ss_pred HhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC---HHHHHH
Q 039681 532 LTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS---MKEVAD 608 (624)
Q Consensus 532 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~ 608 (624)
++|..||......+ .............. + . .......+.+++.+|+. +|.+|++ ++|+++
T Consensus 233 ~~G~~Pf~~~~~~~------~~~~i~~~~~~~~~--~---~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 233 LVGYPPFCSDNPQE------TYRKIINWKETLQF--P---D-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCCCCCHHH------HHHHHHcCCCccCC--C---C-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999997543211 11111111000000 0 0 01123456778889986 9999997 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=312.13 Aligned_cols=253 Identities=28% Similarity=0.417 Sum_probs=200.7
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|.+.+.||+|++|.||++...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998777789999876433 33467899999999999999999999875 456889999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+++|.++++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 84 KGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999642 2345899999999999999999999999 99999999999999999999999999976542211
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.......++..|+|||...+..++.++||||||+++|||++ |..||......+ .. ........ +
T Consensus 158 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~---~~~~~~~~------~ 222 (260)
T cd05069 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL---EQVERGYR------M 222 (260)
T ss_pred ---cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHHcCCC------C
Confidence 11122345678999999988889999999999999999999 888876432211 11 11111100 0
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 223 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=311.44 Aligned_cols=248 Identities=24% Similarity=0.416 Sum_probs=194.1
Q ss_pred eccCCcEEEEEEEEc---CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 338 IGTGGFGEVFKGILD---DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 338 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
||+|+||.||+|++. ++..||+|++..... ...+.+.+|+.++++++||||+++++++. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999853 355799998875533 23467899999999999999999999875 4578999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++.. ....+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++.......... .
T Consensus 82 ~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~ 153 (257)
T cd05115 82 NKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-K 153 (257)
T ss_pred HHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce-e
Confidence 998863 2346899999999999999999999998 9999999999999999999999999998654221111 1
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhhhh
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKE 572 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 572 (624)
......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ . .........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~---------- 216 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---V----MSFIEQGKR---------- 216 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHCCCC----------
Confidence 1112233578999999988889999999999999999996 999986432211 1 111111110
Q ss_pred ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 573 RATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 573 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
...+.....++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 217 --~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 --LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 011122345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.27 Aligned_cols=258 Identities=27% Similarity=0.395 Sum_probs=202.6
Q ss_pred CCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|...+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777899999999999999732 356789998876666667789999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 404 IYEYIPNGTLFDHLHCDFT----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
|+||+++++|.+++..... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864311 11245899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 552 (624)
||+|||++........ ........++..|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 162 kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------ 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------ 233 (280)
T ss_pred EECCCCceeEcCCCce--eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------
Confidence 9999999976532111 011122335678999999988889999999999999999998 8888753322111
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
......... . ..+...+..+.+++.+||+.+|++||+++||++.|+
T Consensus 234 ~~~~~~~~~-~------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 IECITQGRE-L------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHcCcc-C------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111000 0 001123345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.98 Aligned_cols=263 Identities=26% Similarity=0.362 Sum_probs=198.4
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC-----cee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD-----QTL 402 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 402 (624)
+|+..+.||+|+||.||++.. .+++.||||++... +......+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 57899999988643 2234567889999999999999999999998776 789
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+|+||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIV-----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence 9999996 57877775 2346999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
..... .........++..|+|||++.+. .++.++||||||+++|||++|+.||......+.... +........
T Consensus 152 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~g~~~ 225 (372)
T cd07853 152 VEEPD---ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL---ITDLLGTPS 225 (372)
T ss_pred ecccC---ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCC
Confidence 65422 11223345678999999998764 478999999999999999999999975543322111 111111000
Q ss_pred cccc----------c-----c-hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 562 LMEV----------V-----D-PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 562 ~~~~----------~-----d-~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..++ + . +.... ..........++.+|+.+||+.||++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPV-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHH-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 0 0 00000 000011224567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.01 Aligned_cols=241 Identities=25% Similarity=0.367 Sum_probs=192.7
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 405 (624)
+|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 57899999886432 22344577788888877 5899999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988862 346899999999999999999999999 9999999999999999999999999987542
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ........ .
T Consensus 153 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~---~~~i~~~~-~--- 218 (323)
T cd05616 153 WD----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L---FQSIMEHN-V--- 218 (323)
T ss_pred CC----CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCC-C---
Confidence 11 112234568999999999998899999999999999999999999997543221 1 11111110 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
..+.....++.+++.+||+.+|++|++.
T Consensus 219 ----------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ----------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0011234567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=317.76 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=201.5
Q ss_pred CCCccceeccCCcEEEEEEEE-----cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--Ccee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-----DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTL 402 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 402 (624)
.|++.+.||+|+||.||.+.. .++..||+|.++... ....+.+.+|++++++++||||+++.+++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999974 357889999987543 33456789999999999999999999998875 5688
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 85 lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 999999999999998532 236899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcc---------ccccHHHHH
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE---------ENVNLVVYM 553 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~---------~~~~~~~~~ 553 (624)
.+...... ........++..|+|||++.+..++.++||||||+++|||++++.|....... .........
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 158 AIETDKEY-YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccccCccc-eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 76432111 11112345677899999998888999999999999999999987764321100 000000000
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
....... ........+..+.+|+.+||+.+|++|||++++++.|+.+
T Consensus 237 -~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 -RVLEEGK------------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHHHcCc------------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0011100 0001112446788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=312.97 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=193.6
Q ss_pred ceeccCCcEEEEEEEEc----CCCEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEe-CCceeEEEeecc
Q 039681 336 NLIGTGGFGEVFKGILD----DGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE-LDQTLMIYEYIP 409 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 409 (624)
+.||+|+||.||+|... +...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357999987543 23446778999999999999999999998764 556889999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999998632 234788888999999999999999998 99999999999999999999999999976532111
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCC-CCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKA-IDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
..........++..|+|||.+.+..++.++||||||+++|||++|+.| |..... .............
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~~------ 221 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGRRL------ 221 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCCCC------
Confidence 111111233456789999999888899999999999999999996554 432211 1111111111100
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
..+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 222 -------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 -------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0011223467889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=314.51 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=202.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-C---CCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-D---GTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.+|++.+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 2 3478999886543 23356789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++..+
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999998632 246899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
..... .........++..|+|||++.+..++.++||||||+++||+++ |..||......+ ....+ .+....
T Consensus 157 ~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~---~~~~~~- 228 (267)
T cd05066 157 EDDPE-AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI---EEGYRL- 228 (267)
T ss_pred ccccc-eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH---hCCCcC-
Confidence 43211 0011112223568999999998889999999999999999886 999986432211 11111 111000
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
......+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 229 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00112345678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.19 Aligned_cols=240 Identities=26% Similarity=0.383 Sum_probs=190.4
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57899999886431 23345567788888764 899999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 149 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--- 149 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC---
Confidence 999998862 246899999999999999999999999 999999999999999999999999998753211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........||..|+|||++.+..++.++||||||+++|||++|+.||......+ + ... .... .+..
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~~~-i~~~------~~~~ 215 (316)
T cd05619 150 -DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L---FQS-IRMD------NPCY 215 (316)
T ss_pred -CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H---HHH-HHhC------CCCC
Confidence 111234568999999999998889999999999999999999999997533211 1 111 1100 0000
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMK-EVA 607 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~ 607 (624)
+......+.+++.+||+.+|++||++. ++.
T Consensus 216 -------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 -------PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -------CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111234567899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=322.85 Aligned_cols=267 Identities=20% Similarity=0.310 Sum_probs=199.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|...+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999954 6788999988754332 334678999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LDK-DLKQYMDD----CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCC-CHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 974 78777753 2345899999999999999999999999 999999999999999999999999999764321
Q ss_pred CCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..............+....+.
T Consensus 158 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 158 ----TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ----ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 111233457899999998865 468899999999999999999999997654333222211111000000000000
Q ss_pred ------chhhhhccC----cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 ------DPVLKERAT----HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 ------d~~l~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+........ ........++.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 000123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.14 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=192.4
Q ss_pred ceeccCCcEEEEEEEEcC---CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 336 NLIGTGGFGEVFKGILDD---GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 45789998865432 33457899999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
+|.++++..........++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 9999997432223345778888999999999999999999 99999999999999999999999999875432111
Q ss_pred cceeecccccccccCccccccc-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 492 SHIFTTAQGTMGYLDPEYYRNF-------QLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
........++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ .... ... +...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~ 228 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQL 228 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccC
Confidence 0111234467889999998532 35789999999999999996 999986433221 1111 111 1111
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
...++.+. ......+.+++.+|+ .+|++|||++||++.|+
T Consensus 229 ~~~~~~~~-------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK-------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC-------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222221 112344677889998 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.06 Aligned_cols=252 Identities=29% Similarity=0.428 Sum_probs=195.9
Q ss_pred ceeccCCcEEEEEEEEcC-CC--EEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILDD-GT--VTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||.||+|+..+ +. .+++|..+... ....+.+.+|+++++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999643 43 46888876432 34456789999999999 799999999999999999999999999
Q ss_pred CCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 411 GTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 411 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
|+|.+++..... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999864321 12245899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
++...... . .......+..|+|||++....++.++||||||+++|||++ |..||...... ........
T Consensus 158 l~~~~~~~---~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVY---V--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLPQ 226 (270)
T ss_pred Cccccchh---h--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHhC
Confidence 98632211 0 0111223567999999988889999999999999999997 99998543211 11111111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
.... + ........+.+++.+||+.+|.+|||+.++++.|++++
T Consensus 227 ~~~~-~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYRL-E------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC-C------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1000 0 01123346788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=315.19 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=203.1
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCC----EEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGT----VTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
.++|+..+.||+|+||+||+|+. .+++ .||+|+++.... .....+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35688889999999999999984 3444 489998865433 335678899999999999999999999875 4577
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+++||+++|+|.++++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence 99999999999999863 2346899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+ +... .....
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~ 228 (279)
T cd05109 158 LLDIDET--EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL----LEKGE 228 (279)
T ss_pred ecccccc--eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCC
Confidence 7642211 111112334678999999988889999999999999999998 888875332111 1111 11110
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.. .........+.+++.+||+.+|++||++.|+++.|+++...+.
T Consensus 229 ~~------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 229 RL------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred cC------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 00 0011234567889999999999999999999999988876553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.47 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=196.8
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCcc
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLF 414 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 414 (624)
++||+|+||.||+|...+++.+|+|++..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988899999998875433 23456889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcce
Q 039681 415 DHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI 494 (624)
Q Consensus 415 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 494 (624)
+++.. ....+++.+++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~ 150 (250)
T cd05085 81 SFLRK----KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---SS 150 (250)
T ss_pred HHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc---cc
Confidence 98863 2345899999999999999999999999 99999999999999999999999999875432111 00
Q ss_pred eecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 495 FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 495 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
.....++..|+|||++.+..++.++||||||+++||+++ |..||......+ .... ........
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~------~~~~-~~~~~~~~--------- 214 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ------AREQ-VEKGYRMS--------- 214 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHH-HHcCCCCC---------
Confidence 112234567999999988889999999999999999998 888886432211 1111 11110000
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
........+.+++.+|++.+|++||++.|++++|.
T Consensus 215 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 ---CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 01123456888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=310.99 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=204.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++|.+.+.||+|+||.||++... ++.||+|.++.... ..+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888899999999999999864 78899999875543 5678999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999998642 2236999999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
.....+..|+|||++....++.++||||||+++|||++ |..||......+ + ...........
T Consensus 157 -------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~~--- 219 (256)
T cd05039 157 -------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPHVEKGYRME--- 219 (256)
T ss_pred -------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhcCCCCC---
Confidence 12334668999999988889999999999999999997 888886432211 1 11111110000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
.+...+..+.+++.+||+.+|++|||+.|++++|+++
T Consensus 220 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 ---------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0112345678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.11 Aligned_cols=265 Identities=25% Similarity=0.388 Sum_probs=200.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-----------------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-----------------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRL 391 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 391 (624)
++|++.+.||+|+||.||++... +...+|+|+++... ....+++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998532 23468999887542 3345679999999999999999999
Q ss_pred eeEEEeCCceeEEEeeccCCCcccccccccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 039681 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFT------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNI 465 (624)
Q Consensus 392 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Ni 465 (624)
++++...+..++||||+++++|.+++..... .....+++.+++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999864321 11235889999999999999999999999 99999999999
Q ss_pred EECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh--CCCCCCCCCc
Q 039681 466 LLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT--SKKAIDFNRE 543 (624)
Q Consensus 466 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt--g~~p~~~~~~ 543 (624)
|+++++.+||+|||+++.+..... ........++..|+|||......++.++||||||+++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc--eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999986542211 111122334678999999888889999999999999999998 5566643222
Q ss_pred cccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 544 EENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
.+ ................. .+ .....+..+.+++.+||+.+|++||++.||++.|+
T Consensus 240 ~~---~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQ---VIENTGEFFRDQGRQVY-LP--------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHHHhhcccccc-CC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 11111111111100000 00 01123356888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.88 Aligned_cols=237 Identities=30% Similarity=0.390 Sum_probs=187.8
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHH-HHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVR-ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||+||+++.. +++.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986432 223344555555 56789999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--- 149 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC---
Confidence 999998863 346899999999999999999999999 999999999999999999999999998753211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... . .+
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~-~------~~ 215 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNKP-L------RL 215 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCC-C------CC
Confidence 112234568999999999998889999999999999999999999997432211 111111110 0 00
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMK 604 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 604 (624)
.......+.+++.+||+.+|.+||++.
T Consensus 216 -------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 -------KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -------CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112245678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=317.49 Aligned_cols=264 Identities=24% Similarity=0.361 Sum_probs=204.5
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999999753 245799998764432 234568899999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEE
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFT-----GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl 475 (624)
.++||||+++|+|.+++..... .....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964211 11345678889999999999999999999 999999999999999999999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 554 (624)
+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....++ ...
T Consensus 161 ~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~~~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------VLK 232 (288)
T ss_pred CcCCccccccccccc--cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 999999865422111 11122235678999999988889999999999999999998 677875432211 111
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
.....+.. .........+.+++.+||+.+|++|||+.++++.|++...
T Consensus 233 ~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 233 FVMDGGYL-------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHHcCCCC-------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 11111100 0011223568889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=317.77 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=203.2
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC-----------------CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD-----------------GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVR 390 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 390 (624)
.++|++.+.||+|+||.||++...+ +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568889999999999999988542 24589998875432 34667899999999999999999
Q ss_pred EeeEEEeCCceeEEEeeccCCCcccccccccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 039681 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTG------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSN 464 (624)
Q Consensus 391 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~N 464 (624)
+++++......++|+||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 999999999999999999999999998643211 1236899999999999999999999999 9999999999
Q ss_pred eEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh--CCCCCCCCC
Q 039681 465 ILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT--SKKAIDFNR 542 (624)
Q Consensus 465 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt--g~~p~~~~~ 542 (624)
|++++++.++|+|||+++...... .........++..|+|||++.+..++.++||||||+++|||++ +..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD--YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCc--ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999997654221 1111234456788999999988889999999999999999998 556664322
Q ss_pred ccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 543 EEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
.. ...................+ .....+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 239 ~~---~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQ---QVIENAGHFFRDDGRQIYLP---------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hH---HHHHHHHhccccccccccCC---------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 11111111111111000000 01123356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=312.87 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=205.4
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
..++|.+.+.||+|+||.||++..+++..+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788999999999999999998888889999887433 3456789999999999999999999999998999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++... ....+++.++..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 83 MSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred cCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999642 2346899999999999999999999999 999999999999999999999999998765421
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
. .........+..|+|||.+.+..++.++||||||++++||++ |+.||......+ . ......... .
T Consensus 157 ~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~---~~~~~~~~~---~- 223 (261)
T cd05034 157 E---YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---V---LEQVERGYR---M- 223 (261)
T ss_pred h---hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHcCCC---C-
Confidence 1 001112234568999999988889999999999999999998 888885432211 1 111111000 0
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
..+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 ---------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011224568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=329.36 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=199.3
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
..++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457889999999999999999964 6889999988532 22334557899999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999998852 24888999999999999999999999 99999999999999999999999999976
Q ss_pred ccccCCCCcceeecccccccccCccccccc----CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNF----QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .........
T Consensus 192 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~ 262 (370)
T cd05596 192 MDANG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDH 262 (370)
T ss_pred ccCCC---cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcC
Confidence 54211 1112345799999999998643 4789999999999999999999999754321 111111111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCC--CCCHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQN--RPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~ 608 (624)
...... + .......++.+++.+||+.+|.+ ||+++|+++
T Consensus 263 ~~~~~~--~--------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 263 KNSLTF--P--------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCcCCC--C--------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 100000 0 01123456788999999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=323.14 Aligned_cols=240 Identities=24% Similarity=0.363 Sum_probs=190.5
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||.||++... +++.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 68899999886432 23345567788888765 899999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 148 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---- 148 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc----
Confidence 999988863 346899999999999999999999999 99999999999999999999999999874321
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
.........||..|+|||++.+..++.++||||||+++|||++|+.||......+ + ... .... .+.+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~---~~~-~~~~------~~~~ 215 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L---FES-IRVD------TPHY 215 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHH-HHhC------CCCC
Confidence 1112345678999999999998899999999999999999999999997443211 1 111 1110 0001
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMK-EVA 607 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~ 607 (624)
+.....++.+++.+||+.||++||++. ++.
T Consensus 216 -------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 -------PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111234577899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=323.84 Aligned_cols=241 Identities=25% Similarity=0.390 Sum_probs=193.0
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+|+||+||++... +++.||+|+++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999988743 223455678899999888 699999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 149 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--- 149 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC---
Confidence 999988863 346999999999999999999999999 999999999999999999999999998753211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........|+..|+|||++.+..++.++|||||||++|||++|+.||......+ ......... .
T Consensus 150 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i~~~~-~-------- 213 (318)
T cd05570 150 -GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSILEDE-V-------- 213 (318)
T ss_pred -CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCC-C--------
Confidence 111233468999999999998899999999999999999999999996433211 111111110 0
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH-----HHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSM-----KEVAD 608 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~ 608 (624)
..+......+.+++.+||+.||.+||++ .++++
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 -----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0011233567889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.53 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=200.1
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|.+.+.||+|+||+||++.. .+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999995 468999999987432 234556889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+.
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999998632 246999999999999999999999999 9999999999999999999999999998664
Q ss_pred ccCCCCcceeecccccccccCccccc------ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYR------NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
... ........||+.|+|||++. ...++.++||||||+++|||++|+.||......+ .+......
T Consensus 154 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~ 224 (330)
T cd05601 154 ANK---MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNF 224 (330)
T ss_pred CCC---ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcC
Confidence 221 11223456899999999986 4467899999999999999999999996433211 11222111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....... ........+.+|+.+|++ +|.+||+++++++
T Consensus 225 ~~~~~~~----------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 QRFLKFP----------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCccCCC----------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111100 011234557789999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=310.83 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=201.4
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+.+....++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999954 6889999987643 2344567889999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 153 (255)
T cd08219 81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP- 153 (255)
T ss_pred CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc-
Confidence 999999988632 2346899999999999999999999999 999999999999999999999999999765421
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
........++..|+|||++.+..++.++|+||||+++|+|++|+.||...... ....... .+....
T Consensus 154 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~---- 219 (255)
T cd08219 154 ---GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVC-QGSYKP---- 219 (255)
T ss_pred ---ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHh-cCCCCC----
Confidence 11123456888999999998888999999999999999999999998643211 1111111 111110
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+......+.+++.+||+.+|++||++.|++..
T Consensus 220 --------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 --------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011233457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=316.29 Aligned_cols=259 Identities=26% Similarity=0.396 Sum_probs=204.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC------CCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD------GTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
.++|.+.+.||+|+||.||+|...+ +..||+|...... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3568888999999999999998642 3689999976443 23456789999999999999999999999999999
Q ss_pred eEEEeeccCCCcccccccccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEe
Q 039681 402 LMIYEYIPNGTLFDHLHCDFT-----GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~ 476 (624)
++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 12345899999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 039681 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 555 (624)
|||+++.+...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ . ..
T Consensus 162 dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~---~~- 232 (277)
T cd05032 162 DFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V---LK- 232 (277)
T ss_pred CcccchhhccCccc--ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H---HH-
Confidence 99999865432111 11123346788999999988889999999999999999998 888876432221 1 11
Q ss_pred HhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 556 IMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 556 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
.......... +......+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FVIDGGHLDL------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHhcCCCCCC------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111110 1122456888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.36 Aligned_cols=260 Identities=26% Similarity=0.385 Sum_probs=204.2
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCC
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELD 399 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 399 (624)
..++|...+.||+|+||.||++... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3456888999999999999999742 24579999886543 23356789999999999 7999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++|+||+++|+|.++++.. ....+++.++..++.|++.||+|||+++ |+|+||||+|||+++++.+||+|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999998632 2234899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+++...... .........++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .+.....
T Consensus 187 ~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~ 258 (302)
T cd05055 187 LARDIMNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIK 258 (302)
T ss_pred ccccccCCC--ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHH
Confidence 998654221 1111122345678999999988889999999999999999998 888876432211 1111111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
.+... ........++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 259 ~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 EGYRM------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCcC------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11000 00011234688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.27 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=195.6
Q ss_pred ceeccCCcEEEEEEEEcC----CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+|+||.||+|+... +..+|+|....... ...+.+.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998432 26899998875443 34567899999999999999999999876 4568999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++........
T Consensus 80 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKK-----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 999999963 236899999999999999999999999 999999999999999999999999999866432111
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
. .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+ ......
T Consensus 152 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~----~~~~~~------ 217 (257)
T cd05060 152 Y-RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML----ESGERL------ 217 (257)
T ss_pred c-ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----HcCCcC------
Confidence 0 00112223568999999988889999999999999999998 89988643221 111111 111100
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
......+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 218 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 001123456788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.79 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=200.9
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc-----chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT-----KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|...+.||+|++|.||++.. .+++.+|+|.+..... ...+.+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999985 4689999998764321 224568899999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999998863 246899999999999999999999999 99999999999999999999999999876
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
...... .........++..|+|||++.+..++.++||||||+++|||++|+.||...... ............
T Consensus 154 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~- 225 (263)
T cd06625 154 LQTICS-SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN- 225 (263)
T ss_pred cccccc-ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCC-
Confidence 542111 111112345788999999999888999999999999999999999998632211 111111111100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
+ ..+......+.+++.+||+.+|++|||+.|+++.
T Consensus 226 ----~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ----P-------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----C-------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 1111234567889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.92 Aligned_cols=204 Identities=26% Similarity=0.385 Sum_probs=172.9
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.|+..+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999995 568899999886432 2345678899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 9999999999863 246899999999999999999999999 99999999999999999999999999753311
Q ss_pred cCC-------------------------------------------CCcceeecccccccccCcccccccCCCCccchhh
Q 039681 487 TET-------------------------------------------NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYS 523 (624)
Q Consensus 487 ~~~-------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s 523 (624)
... ..........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 000 0000012346899999999998888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 039681 524 FGVVLLELLTSKKAIDFNR 542 (624)
Q Consensus 524 ~G~vl~elltg~~p~~~~~ 542 (624)
|||+||||++|+.||....
T Consensus 234 lGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred chHHHHHHHhCCCCCCCCC
Confidence 9999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.15 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=196.6
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999985 57899999987542 2234567889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999863 346899999999999999999999999 9999999999999999999999999996432
Q ss_pred ccCCC------------C-------------------------------cceeecccccccccCcccccccCCCCccchh
Q 039681 486 RTETN------------D-------------------------------SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVY 522 (624)
Q Consensus 486 ~~~~~------------~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~ 522 (624)
..... . ........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 0 0000124689999999999888899999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCC--
Q 039681 523 SFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNR-- 600 (624)
Q Consensus 523 s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-- 600 (624)
||||++|||++|+.||......+. ..............+ ......++.+++.+|++ +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~p~----------~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHET------YRKIINWRETLYFPD----------DIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHH------HHHHHccCCccCCCC----------CCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 999999999999999965432211 111111000000000 01123457789999997 66665
Q ss_pred -CCHHHHHHH
Q 039681 601 -PSMKEVADE 609 (624)
Q Consensus 601 -Ps~~ev~~~ 609 (624)
+++.|+++.
T Consensus 296 r~~~~~~l~h 305 (377)
T cd05629 296 RGGAHEIKSH 305 (377)
T ss_pred CCCHHHHhcC
Confidence 699998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.53 Aligned_cols=238 Identities=28% Similarity=0.339 Sum_probs=191.4
Q ss_pred ceeccCCcEEEEEEEE----cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 336 NLIGTGGFGEVFKGIL----DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
+.||+|+||.||+++. .+|+.+|+|++..... .....+..|++++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999999864322 234457889999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-- 151 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 151 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--
Confidence 9999998852 346899999999999999999999999 999999999999999999999999998765322
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
........|+..|+|||.+.+..++.++||||||+++|||++|+.||......+ ........ ..
T Consensus 152 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~~~-~~------- 215 (318)
T cd05582 152 --EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMILKA-KL------- 215 (318)
T ss_pred --CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHHcC-CC-------
Confidence 112234568999999999988889999999999999999999999996433211 11111111 00
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKE 605 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 605 (624)
..+......+.+|+.+||+.||++||++.+
T Consensus 216 ------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 001123345778999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=313.54 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=201.3
Q ss_pred CCCccceeccCCcEEEEEEEEcC-C---CEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDD-G---TVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
+|++.+.||+|+||.||+|.... + ..||||.+... .......|..|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 47788999999999999999643 3 36999998754 2334568999999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 85 EFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999998632 346899999999999999999999999 9999999999999999999999999987664
Q ss_pred ccCCCCcceeeccc--ccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 486 RTETNDSHIFTTAQ--GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 486 ~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
....... ...... .+..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+ ......
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i---~~~~~~ 230 (269)
T cd05065 158 DDTSDPT-YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI---EQDYRL 230 (269)
T ss_pred cCccccc-cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH---HcCCcC
Confidence 3211111 111111 2457999999988889999999999999999886 99888643221 111111 111000
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
....+.+..+.+++.+||+.+|++||++++|++.|+++
T Consensus 231 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 -------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112345678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=326.75 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=206.3
Q ss_pred CCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-C-----CceeeEeeEEEeCCceeE
Q 039681 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-H-----RSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 403 (624)
+|.+.++||+|.||+|.++. .++++.||||+++. ......+...|+.+|..++ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78889999999999999999 56799999999974 3455667789999999997 5 489999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC--CCCeEEeecCCc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE--KLNAKVSDFGLS 481 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~--~~~~kl~DfGla 481 (624)
|+|.+ .-+|.++|+.+ +...|+...++.|+.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||+|
T Consensus 266 VfELL-~~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eehhh-hhhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999 56999999854 4567999999999999999999999999 999999999999965 346999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc-
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE- 560 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 560 (624)
..... ..+ ...-+..|+|||++.+.+|+.+.|+||||||++||.+|.+.|.++.+.+....+..+.......
T Consensus 339 c~~~q------~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 339 CFESQ------RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccCC------cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 86532 223 4557889999999999999999999999999999999988888777665554443322111110
Q ss_pred -----ccccccch-----------h------------------hhhccC--------cCcHHHHHHHHHHHHHchhcCCC
Q 039681 561 -----RLMEVVDP-----------V------------------LKERAT--------HLDLETMKALGLLAASCLDERRQ 598 (624)
Q Consensus 561 -----~~~~~~d~-----------~------------------l~~~~~--------~~~~~~~~~l~~l~~~cl~~~p~ 598 (624)
+....++. . .....+ ......-..+.+++++||..||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00000110 0 000011 00112335678999999999999
Q ss_pred CCCCHHHHHH
Q 039681 599 NRPSMKEVAD 608 (624)
Q Consensus 599 ~RPs~~ev~~ 608 (624)
+|+|..|+++
T Consensus 492 ~R~tp~qal~ 501 (586)
T KOG0667|consen 492 ERITPAQALN 501 (586)
T ss_pred hcCCHHHHhc
Confidence 9999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=327.72 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=197.8
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
..++|+..+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999964 5789999987532 22334568899999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 121 VMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999998852 24889999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCCCcceeecccccccccCccccccc----CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNF----QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
.... .........||+.|+|||++.+. .++.++||||||+++|||++|+.||......+ ........
T Consensus 192 ~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~ 262 (370)
T cd05621 192 MDET---GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDH 262 (370)
T ss_pred cccC---CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhC
Confidence 5421 11112356799999999998653 37889999999999999999999997543211 11111111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQN--RPSMKEVADE 609 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~ 609 (624)
...... .........+.+++.+|++.++.+ ||++.|+++.
T Consensus 263 ~~~~~~----------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLNF----------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCC----------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 100000 001123455677888999755543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.92 Aligned_cols=266 Identities=24% Similarity=0.403 Sum_probs=205.6
Q ss_pred hCCCCccceeccCCcEEEEEEEEc--------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeC
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD--------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL 398 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 398 (624)
.++|.+.+.||+|+||.||+++.. ....+|+|.++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356788899999999999999742 24578999877432 23456789999999999 699999999999999
Q ss_pred CceeEEEeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill 467 (624)
...++|+||+++|+|.+++..... .....+++.++.+++.|++.||+|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999864211 11246899999999999999999999998 9999999999999
Q ss_pred CCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 039681 468 DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEEN 546 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~ 546 (624)
++++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYK--KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE- 244 (314)
T ss_pred cCCCcEEEcccccccccccccccc--ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999998654221111 1112234467999999988889999999999999999999 788875432211
Q ss_pred ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
+ .. ........+ ........+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 245 --~---~~-~~~~~~~~~------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 245 --L---FK-LLREGHRMD------------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred --H---HH-HHHcCCCCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 1 11 111111000 011233467789999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.95 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=202.9
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.+|+..+.||+|+||.||+|+. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4688889999999999999985 568899999987666666678899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999998852 35889999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||......+. ........ ...
T Consensus 171 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~-~~~---- 235 (296)
T cd06654 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG-TPE---- 235 (296)
T ss_pred ----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCC-CCC----
Confidence 112234688899999999888899999999999999999999999964332111 11111110 000
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+ .........+.+++.+||+.+|++||++.|+++
T Consensus 236 -~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 -L-----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -C-----CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 001123456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.71 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=201.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|++.+.||+|+||.||++... ++..+|+|.+..... ...+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999954 578899998765422 2345688999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
+++++|.++++. ...+++..+..++.|+++||.|||+. + ++|+||||+|||+++++.+||+|||++.....
T Consensus 81 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 999999999963 25689999999999999999999984 6 99999999999999999999999999875532
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc-----
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER----- 561 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 561 (624)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .............
T Consensus 153 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 153 S------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESH 223 (308)
T ss_pred c------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCc
Confidence 1 1123467899999999988889999999999999999999999986433211 1111100000000
Q ss_pred ---------------cccccchhhhhccCcC-cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 562 ---------------LMEVVDPVLKERATHL-DLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 562 ---------------~~~~~d~~l~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+..+.......+.. ......++.+++.+||+.+|++|||+.||++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000000 01134568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.38 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=206.9
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999964 58999999986432 223467899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 406 EYIPNGTLFDHLHCDFT------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
||+++|+|.+++..... .....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998863211 11235678889999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCC--------------cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 039681 480 LSRLVERTETND--------------SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545 (624)
Q Consensus 480 la~~~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~ 545 (624)
+++......... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998662111000 001123468999999999998899999999999999999999999986432211
Q ss_pred cccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCC-CCHHHHHHHHHHHHHh
Q 039681 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNR-PSMKEVADEIEYIISI 616 (624)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~ev~~~L~~i~~~ 616 (624)
. .. . . ...++.-.. .....+..+.+++.+|++.+|++| ++++++.+.|+..+..
T Consensus 239 i----~~-~-----~---~i~~P~~~~----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 I----SY-R-----D---VILSPIEVA----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred h----hh-h-----h---hccChhhcc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 00 0 0 001110000 001234567889999999999999 5788888889888764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.11 Aligned_cols=240 Identities=30% Similarity=0.375 Sum_probs=188.9
Q ss_pred ceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHH-HHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVR-ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+|+||+||+++. .+|+.+|+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 46899999988643 2233445566665 46778999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--- 149 (325)
T cd05604 81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--- 149 (325)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC---
Confidence 99998885 2356899999999999999999999999 999999999999999999999999998753211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........||..|+|||++.+..++.++||||||+++|||++|+.||...... .......... . .+.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~-~--~~~--- 216 (325)
T cd05604 150 -SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKP-L--VLR--- 216 (325)
T ss_pred -CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCC-c--cCC---
Confidence 11123456899999999999888999999999999999999999999743321 1111111111 0 000
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
......+.+++.+|++.+|.+||++++.+
T Consensus 217 --------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 --------PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --------CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 11234567799999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.71 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=198.2
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEE-eCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCV-ELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 408 (624)
++|.+.+.||+|+||.||++... +..+|+|..+.. ...+.+.+|+.++++++|+|++++++++. +....++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999764 778899987643 33567899999999999999999999765 456789999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++... ....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999998642 2345899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||..... ....... ..+...
T Consensus 157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~-~~~~~~---- 218 (256)
T cd05082 157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRV-EKGYKM---- 218 (256)
T ss_pred -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-hcCCCC----
Confidence 12334568999999988889999999999999999998 8888753221 1111111 111000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
.. ....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 219 -~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 -DA-------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CC-------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 112345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=309.53 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=187.9
Q ss_pred ceeccCCcEEEEEEEEcC-------------CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 336 NLIGTGGFGEVFKGILDD-------------GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
+.||+|+||.||+|+..+ ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358889876655555667899999999999999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC-------eEE
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN-------AKV 475 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~-------~kl 475 (624)
+||||+++|+|..++.. +...+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|+
T Consensus 81 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR----KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999888753 2346899999999999999999999999 999999999999987664 899
Q ss_pred eecCCcccccccCCCCcceeecccccccccCccccc-ccCCCCccchhhHHHHHHHHH-hCCCCCCCCCccccccHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR-NFQLTDKSDVYSFGVVLLELL-TSKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~vl~ell-tg~~p~~~~~~~~~~~~~~~~ 553 (624)
+|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+......+ .
T Consensus 154 ~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~ 218 (262)
T cd05077 154 SDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------K 218 (262)
T ss_pred CCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------H
Confidence 999998754311 1335778899999886 456899999999999999998 5777765322111 0
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
....... . .. .......+.+|+.+||+.+|++||++.+|++.|
T Consensus 219 ~~~~~~~-~-~~------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 ERFYEGQ-C-ML------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHhcC-c-cC------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111110 0 00 011234578899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.72 Aligned_cols=260 Identities=26% Similarity=0.377 Sum_probs=202.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
.++|+..+.||+|+||.||++... ++..||+|++..... .....+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999853 467899998875432 3356789999999999999999999999999999
Q ss_pred eEEEeeccCCCccccccccc-----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 039681 402 LMIYEYIPNGTLFDHLHCDF-----------------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSN 464 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~N 464 (624)
++|+||+++|+|.+++.... ......+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 112245899999999999999999999998 9999999999
Q ss_pred eEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCc
Q 039681 465 ILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNRE 543 (624)
Q Consensus 465 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~ 543 (624)
||+++++.+||+|||++........ .........+..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred eEecCCCceEECccccceecccCcc--ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999876532111 001112234567999999988889999999999999999998 7778753322
Q ss_pred cccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 544 EENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
.+ ... ....+.... .+......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 ~~------~~~-~~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EE------VIY-YVRDGNVLS------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH------HHH-HHhcCCCCC------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 111 111111110 011234568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=295.58 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=203.4
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc--------hhHHHHHHHHHHHhc-CCCceeeEeeEEEeC
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK--------GTDLVLNEVRILCQV-NHRSLVRLLGCCVEL 398 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 398 (624)
-..|...+.||+|..++|-+... .+|...|+|++...... -.+.-.+|+.||+++ .||+|+++.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 34567778899999999988875 46788898887543221 123456799999999 599999999999999
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
...++|+|.|+.|.|.|+|. ....++++...+|+.|+..|++|||..+ ||||||||+|||+|++.++||+||
T Consensus 96 sF~FlVFdl~prGELFDyLt-----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT-----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred chhhhhhhhcccchHHHHhh-----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 99999999999999999997 3467999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCccccc------ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR------NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
|.|..+... ...+..+||++|+|||.+. ...|+...|.|+.||+||-|+.|.+||-+... ..
T Consensus 168 GFa~~l~~G-----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------ml 235 (411)
T KOG0599|consen 168 GFACQLEPG-----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------ML 235 (411)
T ss_pred ceeeccCCc-----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HH
Confidence 999987643 3467889999999999885 23588999999999999999999999864321 11
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+++.+++.. .-. ..-.+......+|+.+||+.||++|.|.+|+++
T Consensus 236 MLR~ImeGkyq-F~s--------peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 MLRMIMEGKYQ-FRS--------PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHhcccc-cCC--------cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 22222233211 001 112356667889999999999999999999985
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.69 Aligned_cols=266 Identities=22% Similarity=0.278 Sum_probs=196.7
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC-----
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD----- 399 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 399 (624)
..++|+..+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999985 46899999998643 2334567889999999999999999999987543
Q ss_pred -ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 400 -QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 400 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
..++||||+++ +|.+.++ ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence 46899999964 5666553 24788999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHH-------
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV------- 551 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~------- 551 (624)
|+++..... .......+|..|+|||++.+..++.++||||||+++|||++|+.||......+......
T Consensus 168 g~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 168 GLARTACTN-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred CCccccccC-----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999754321 11234568999999999998899999999999999999999999997543221100000
Q ss_pred ---------HHHHHhcc-ccc-----ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 552 ---------YMKKIMDE-ERL-----MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 552 ---------~~~~~~~~-~~~-----~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+...... ... .+....................+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000 00000000000000011123567889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=324.38 Aligned_cols=241 Identities=28% Similarity=0.347 Sum_probs=188.3
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHH-HHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVR-ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+|+||+||+++.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 57889999876422 122334445544 56788999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--- 149 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--- 149 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC---
Confidence 999998863 345888899999999999999999999 999999999999999999999999999754221
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~-~-------- 213 (325)
T cd05602 150 -NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKP-L-------- 213 (325)
T ss_pred -CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC-c--------
Confidence 111234568999999999998899999999999999999999999997433211 111111110 0
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.........+.+++.+||+.+|.+||++.+.+.
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 214 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 001123445778999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=309.67 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=203.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++|.+.+.||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999999878888999987643 3345678999999999999999999999887 7789999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 83 AKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999643 2346899999999999999999999998 9999999999999999999999999997654211
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
........++..|+|||++....++.++|+||||+++||+++ |+.||......+ +.. .........
T Consensus 157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~----~~~~~~~~~--- 223 (260)
T cd05073 157 ---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR----ALERGYRMP--- 223 (260)
T ss_pred ---cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHhCCCCCC---
Confidence 111122345678999999988889999999999999999999 888886432211 111 111110000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011233567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.63 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=203.0
Q ss_pred CCCCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++|.+.+.||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998543 3468999876544 3456689999999999999999999998875 567899
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999632 235899999999999999999999998 999999999999999999999999999865
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ........++..|+|||.+....++.++||||||+++|||++ |..||......+ . ..........
T Consensus 158 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~~~~~~~~~~- 227 (270)
T cd05056 158 EDES---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---V---IGRIENGERL- 227 (270)
T ss_pred cccc---ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHHHcCCcC-
Confidence 4321 111122334568999999988889999999999999999986 999986543221 1 1111111100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
......+..+.+++.+|+..+|++|||+.++++.|+++..-
T Consensus 228 ------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 ------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00112345688899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=308.60 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=200.7
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
.+|+..+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4577889999999999999998778899999886432 334678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999998863 2346899999999999999999999999 99999999999999999999999999876532111
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ..... ..+ .....+
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~--~~~~~~ 223 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETI-NAG--FRLYKP 223 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHH-hCC--CCCCCC
Confidence 11112234578999999988889999999999999999998 888886432211 11111 111 011111
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
. .....+.+|+.+||+.+|++|||+.|++++|
T Consensus 224 ~----------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 R----------LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred C----------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1 1235688899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.70 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=201.1
Q ss_pred CCCCccceeccCCcEEEEEEEE------cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEEEeC-Cc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL-DQ 400 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 400 (624)
++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688999999999999999973 3468899999875432 3356788999999999 689999999988754 46
Q ss_pred eeEEEeeccCCCcccccccccCC---------------------------------------------------------
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTG--------------------------------------------------------- 423 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------- 423 (624)
.++||||+++|+|.++++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999988632100
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecc
Q 039681 424 -----KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498 (624)
Q Consensus 424 -----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 498 (624)
....+++.++.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........ .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~ 241 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDA 241 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc--hhhcCCC
Confidence 0134789999999999999999999999 99999999999999999999999999976532111 1111223
Q ss_pred cccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcC
Q 039681 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHL 577 (624)
Q Consensus 499 ~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 577 (624)
.++..|+|||.+.+..++.++||||||+++|||++ |..||....... . +......+..... +
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~--~--------- 304 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMRA--P--------- 304 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H----HHHHHhccCCCCC--C---------
Confidence 45678999999988889999999999999999997 888876432211 0 1111111110000 0
Q ss_pred cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 578 DLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 578 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
......+.+++.+||+.+|++|||+.||++.|+.+.+
T Consensus 305 -~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 305 -DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0122357789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=309.16 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=189.1
Q ss_pred eeccCCcEEEEEEEEcC---CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCC
Q 039681 337 LIGTGGFGEVFKGILDD---GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
.||+|+||.||+|...+ ...+++|.+..... .....+.+|+.+++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998543 35688887654332 334578899999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCc
Q 039681 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492 (624)
Q Consensus 413 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 492 (624)
|.+++...........++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 999997543222344678889999999999999999999 999999999999999999999999998754321110
Q ss_pred ceeecccccccccCcccccc-------cCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 493 HIFTTAQGTMGYLDPEYYRN-------FQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 493 ~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||......+ ......... ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-DIK 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-Ccc
Confidence 01123345678999998742 356889999999999999999 667775332211 111111111 111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
..++.+ +......+.+++..|+ .+|++|||++||++.|.
T Consensus 230 ~~~~~~-------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL-------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc-------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 112211 1123345666788888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=331.43 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=195.7
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999995 468999999876422 233456889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 81 E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999999999863 346899999999999999999999999 9999999999999999999999999975321
Q ss_pred ccCC---------------------------------------CCcceeecccccccccCcccccccCCCCccchhhHHH
Q 039681 486 RTET---------------------------------------NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGV 526 (624)
Q Consensus 486 ~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~ 526 (624)
.... ..........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 0000 0000012346999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC---CH
Q 039681 527 VLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP---SM 603 (624)
Q Consensus 527 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~ 603 (624)
++|||++|+.||......+. ............ .+. .......+.+++.+|+ .+|.+|+ ++
T Consensus 233 ilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~~--~~~--------~~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAET------QLKVINWETTLH--IPS--------QAKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred eeeehhhCCCCCCCCCHHHH------HHHHhccCcccc--CCC--------CCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 99999999999975433211 111110000000 000 0112344566777765 5999999 88
Q ss_pred HHHHHH
Q 039681 604 KEVADE 609 (624)
Q Consensus 604 ~ev~~~ 609 (624)
.|+++.
T Consensus 296 ~ell~h 301 (376)
T cd05598 296 DEIKAH 301 (376)
T ss_pred HHHhCC
Confidence 888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.08 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=204.3
Q ss_pred CCCCccceeccCCcEEEEEEEEc-----CCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEe--CCce
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-----DGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVE--LDQT 401 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 401 (624)
+.|+..+.||+|+||.||+++.. ++..+|||++...... ..+.|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999853 3678999998755443 46789999999999999999999999887 5578
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++|+||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 9999999999999999632 235999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccc--------cHHHHH
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV--------NLVVYM 553 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~--------~~~~~~ 553 (624)
........ .........++..|+|||.+.+..++.++||||||++++||++|+.|+......... .....+
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKD-YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccccCCc-ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 87652211 111111234556799999998888999999999999999999999987543221100 000001
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
....... . ..........++.+++.+||+.+|++|||+.||+++|+++
T Consensus 236 ~~~~~~~---------~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEG---------E---RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcC---------C---cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111110 0 0011122346688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.80 Aligned_cols=241 Identities=24% Similarity=0.367 Sum_probs=192.0
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 405 (624)
+|+..+.||+|+||+||++.. .+++.||+|++... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367788999999999999985 46899999988643 2233456788999998886 577888999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999998862 346999999999999999999999999 9999999999999999999999999987542
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. ........||..|+|||++.+..++.++||||||+++|||++|+.||....... ....... ...
T Consensus 153 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~-~~~--- 218 (323)
T cd05615 153 VD----GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIME-HNV--- 218 (323)
T ss_pred CC----CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCC---
Confidence 21 111234568999999999988889999999999999999999999997543211 1111111 100
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
..+......+.+++.+||+.+|.+|++.
T Consensus 219 ----------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ----------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0011233457789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.56 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=197.2
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
|+..++||+|+||+||++.. .+++.+|+|.+.... ......+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66678899999999999995 468899999886432 22334578899999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999888632 2346999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
.......|+..|+|||++.+..++.++|+||||+++|||++|..||......... ..+........ .
T Consensus 156 -----~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~--~--- 222 (285)
T cd05632 156 -----ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETE--E--- 222 (285)
T ss_pred -----CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccc--c---
Confidence 1123456899999999998888999999999999999999999999743321111 11111111100 0
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
.........+.+|+.+||+.+|++||+ +.+++.
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 --------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 001123345678999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=334.27 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=191.8
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--------C
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--------D 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 399 (624)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999996 468899999875322 2345799999999999999999987542 2
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeec
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDF 478 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~Df 478 (624)
..++||||++ ++|.+++... ......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHY-ARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 3668999997 4777766422 123457999999999999999999999999 99999999999999664 6999999
Q ss_pred CCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
|+++.+.... ......+|+.|+|||++.+. .++.++|||||||++|||++|..||......+.. ..+....
T Consensus 216 Gla~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~---~~i~~~~ 287 (440)
T PTZ00036 216 GSAKNLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL---VRIIQVL 287 (440)
T ss_pred ccchhccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHh
Confidence 9998654221 12245679999999998654 6899999999999999999999999754432211 1111111
Q ss_pred cc---ccccc------------ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DE---ERLME------------VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~---~~~~~------------~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. +.+.. +....+... .+.....++.+|+.+||+.+|.+|||+.|+++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKV---FPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHH---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 10 00000 000001000 01123356889999999999999999999983
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=311.45 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=197.8
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
|+..++||+|+||+||++.. .+++.||+|.+..... ...+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999995 4688999998764322 2234578899999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999988532 2245899999999999999999999998 999999999999999999999999998765321
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||......... .......... .
T Consensus 156 ~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~--~---- 221 (285)
T cd05630 156 Q-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEV--Q---- 221 (285)
T ss_pred c-----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhh--h----
Confidence 1 122346899999999998888999999999999999999999999753221110 0011110000 0
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
... .......+.+|+.+||+.+|++||| ++|+++
T Consensus 222 ~~~-------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEY-------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhc-------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 0122345778999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.37 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=193.2
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc--hhHHHHHHHHHHHhc---CCCceeeEeeEEEeC-----C
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK--GTDLVLNEVRILCQV---NHRSLVRLLGCCVEL-----D 399 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 399 (624)
+|+..+.||+|+||+||++... +++.||+|.++..... ....+.+|+++++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999964 6889999988653222 223466777777665 699999999998652 4
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++|+||++ ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence 5789999997 5888887632 2345899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc-
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD- 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 558 (624)
+++...... ......++..|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+.....
T Consensus 154 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~ 225 (288)
T cd07863 154 LARIYSCQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGL 225 (288)
T ss_pred ccccccCcc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH---HHHHHHhCC
Confidence 998654221 123346789999999998888999999999999999999999998654332211 11111110
Q ss_pred --cccccc-------ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 --EERLME-------VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 --~~~~~~-------~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...... ...+................+.+++.+||+.||++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 00000000000001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.84 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=205.6
Q ss_pred hCCCCccceeccCCcEEEEEEEEc--------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeC
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD--------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL 398 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 398 (624)
..+|++.+.||+|+||.||++... +...||+|.++... ....+++.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346888999999999999999742 12368999876432 33456789999999999 799999999999999
Q ss_pred CceeEEEeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill 467 (624)
...++++||+++|+|.+++..... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 999999999999999999864211 12346899999999999999999999999 9999999999999
Q ss_pred CCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 039681 468 DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEEN 546 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~ 546 (624)
++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.....++
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 244 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 244 (334)
T ss_pred cCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence 99999999999999765422111 01122234567999999988889999999999999999998 778875432211
Q ss_pred ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
..... ....... ........+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 245 -----~~~~~-~~~~~~~------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 -----LFKLL-KEGHRMD------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -----HHHHH-HcCCCCC------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11111 1111000 01123356788999999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=309.06 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=199.6
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
+.+++.+.....||+|+||.||+|+. .++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34556666677899999999999995 46788999988766666677899999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecCCc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPL--PWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFGLS 481 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfGla 481 (624)
+||+++++|.+++... ...+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 84 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 84 MEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999998642 1234 88889999999999999999998 999999999999976 679999999998
Q ss_pred ccccccCCCCcceeecccccccccCccccccc--CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNF--QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
........ ......++..|+|||++... .++.++||||||+++|||++|+.||....... ...+......
T Consensus 157 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~- 228 (268)
T cd06624 157 KRLAGINP----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK- 228 (268)
T ss_pred eecccCCC----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-
Confidence 76532111 11233578899999998654 37889999999999999999999986322111 0000000000
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+..+.....++.+++.+||+.+|++|||+.|+++
T Consensus 229 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 001111223456788999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.53 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=199.4
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|...+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++.+.+.+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4577788899999999999985 468899999987665555667889999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999998863 346899999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.......|+..|+|||++. ...++.++||||||+++|||++|+.||........ ...... .. .
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~-~~---~ 226 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTK-SN---F 226 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhc-cC---C
Confidence 1123446889999999874 44588999999999999999999999864322111 000000 00 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+.... .......+.+++.+||+.+|++||++++|++
T Consensus 227 ~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLKD-----KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCcccc-----cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0011100 0112345778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.19 Aligned_cols=264 Identities=21% Similarity=0.337 Sum_probs=199.0
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|...+.||+|+||.||+++.. +++.||+|.++.... .....+.+|+.++++++||||+++++++......++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999864 678999998875433 2345678999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
++ ++|.+++.. ....+++..+..++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||++......
T Consensus 86 ~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDD----CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 96 688888753 2346899999999999999999999999 999999999999999999999999999764321
Q ss_pred CCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc---ccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD---EERLM 563 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 563 (624)
. .......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+. ...+..... .+...
T Consensus 158 ~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 158 T----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWP 230 (301)
T ss_pred C----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhch
Confidence 1 112334568899999988654 578899999999999999999999975443221 111111111 11111
Q ss_pred cccc---------hhhhhc-cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVVD---------PVLKER-ATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~d---------~~l~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+ +..... ...........+.+|+.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1110 000000 00000123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=307.15 Aligned_cols=252 Identities=33% Similarity=0.465 Sum_probs=201.9
Q ss_pred ceeccCCcEEEEEEEEcC----CCEEEEEEcccCCcch-hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+|+||.||++.... +..+++|.+....... .+.+.+|+++++.++|+|++++++++.+....++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 7889999987654433 67899999999999999999999999999999999999999
Q ss_pred CCcccccccccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 411 GTLFDHLHCDFTG----KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 411 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
++|.+++...... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999742110 1367999999999999999999999999 99999999999999999999999999987653
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
... ........++..|+|||.+....++.++||||||++++||++ |..||...... ............
T Consensus 158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~--- 226 (262)
T cd00192 158 DDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRKGYRL--- 226 (262)
T ss_pred ccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC---
Confidence 221 112234557889999999988889999999999999999999 58888644221 111111111000
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
........++.+++.+||+.+|++|||+.|+++.|+
T Consensus 227 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ----------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011123456888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=305.82 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=202.5
Q ss_pred CCCCccceeccCCcEEEEEEEEcC-CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|+..+.||+|+||.||+++..+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999754 78999998865422 678999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 81 GAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999853 2357899999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
. ......++..|+|||++.+..++.++||||||+++|||++|+.||......... .. ... ...+
T Consensus 154 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~-----~~~~ 217 (256)
T cd06612 154 A----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPN-----KPPP 217 (256)
T ss_pred c----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hcc-----CCCC
Confidence 1 122345788999999998888999999999999999999999998643221110 00 000 0000
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+ ..+......+.+++.+||+.+|++|||+.||++
T Consensus 218 ~~-----~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TL-----SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CC-----CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 011223456888999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=306.21 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=203.2
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|+..++||+|+||.||.++. .+++.+++|.+... +......+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999884 56889999987654 234456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999998643 2356899999999999999999999999 999999999999999999999999999866432
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||...... ........ .....
T Consensus 155 ~~----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~-~~~~~--- 220 (256)
T cd08221 155 YS----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQ-GNYTP--- 220 (256)
T ss_pred cc----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc-CCCCC---
Confidence 21 123456889999999998888999999999999999999999998643221 11111111 11110
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.......++.+++.+||+.+|++||+++++++.
T Consensus 221 ---------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 ---------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 012234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.16 Aligned_cols=252 Identities=33% Similarity=0.510 Sum_probs=199.3
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhH--HHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTD--LVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
|+..+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999965 4668999998866544332 3456999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++. ....+++..++.++.|+++||++||+.+ ++|+||||+||++++++.++|+|||.+....
T Consensus 81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--- 149 (260)
T PF00069_consen 81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--- 149 (260)
T ss_dssp TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST---
T ss_pred cccccccccc-----cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc---
Confidence 9999999996 2356899999999999999999999999 9999999999999999999999999997541
Q ss_pred CCCcceeecccccccccCccccc-ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYR-NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
..........++..|+|||++. +...+.++||||+|+++++|++|..||......+... .+.......
T Consensus 150 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~------- 218 (260)
T PF00069_consen 150 -ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE---IIEKILKRP------- 218 (260)
T ss_dssp -STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH---HHHHHHHTH-------
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh---hhhhccccc-------
Confidence 1122334567899999999998 7789999999999999999999999987542111111 111111100
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+..... ........+.+++.+||+.+|++||++.++++
T Consensus 219 --~~~~~~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 --LPSSSQ-QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HHHHTT-SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cccccc-ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00011267889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.22 Aligned_cols=239 Identities=24% Similarity=0.365 Sum_probs=186.6
Q ss_pred eeccCCcEEEEEEEEcC-------------------------CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeE
Q 039681 337 LIGTGGFGEVFKGILDD-------------------------GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRL 391 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 391 (624)
.||+|+||.||+|.+.. ...|++|++..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998421 13588898865544445678899999999999999999
Q ss_pred eeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC
Q 039681 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL 471 (624)
Q Consensus 392 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~ 471 (624)
++++.+....++||||+++|+|..++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 9999999999999999999999988853 2346899999999999999999999998 99999999999997643
Q ss_pred -------CeEEeecCCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHH-hCCCCCCCCC
Q 039681 472 -------NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELL-TSKKAIDFNR 542 (624)
Q Consensus 472 -------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~ell-tg~~p~~~~~ 542 (624)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999988643211 12346788999998865 46899999999999999995 6888876432
Q ss_pred ccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 543 EEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
..+. ...... ... + .......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 227 ~~~~---~~~~~~---~~~--------~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 PSEK---ERFYEK---KHR--------L-------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hHHH---HHHHHh---ccC--------C-------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 2111 111110 000 0 0011235788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.93 Aligned_cols=266 Identities=20% Similarity=0.259 Sum_probs=197.3
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
....|.+.+.||+|+||.||++... .++.||||... ...+.+|++++++++|+|||++++++......++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3457999999999999999999965 57889999643 2346789999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
++ .++|.+++.. ....+++.+++.|+.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 241 ~~-~~~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 241 KY-RSDLYTYLGA----RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred cc-CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99 5788888753 2346999999999999999999999999 99999999999999999999999999986542
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCc-cccccHHHHHHHHhcccc----
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNRE-EENVNLVVYMKKIMDEER---- 561 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~---- 561 (624)
.. .........||..|+|||++.+..++.++|||||||+||||++|..++..... .........+.+.+....
T Consensus 313 ~~--~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 313 SW--STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred cc--ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 21 11112345699999999999988999999999999999999998876543221 111111111111111110
Q ss_pred -cccccchhhhh----------c----cC--cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 562 -LMEVVDPVLKE----------R----AT--HLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 562 -~~~~~d~~l~~----------~----~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
........+.. . .. .........+.+|+.+||+.||.+|||+.|+++.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000000 0 00 0000122357789999999999999999999863
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=322.02 Aligned_cols=237 Identities=27% Similarity=0.346 Sum_probs=186.4
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHH-HHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVR-ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|+||.||+++.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68899999876432 222344555654 67889999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--- 149 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC---
Confidence 999888852 346889999999999999999999999 999999999999999999999999998753211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~-~-------- 213 (321)
T cd05603 150 -EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILHKP-L-------- 213 (321)
T ss_pred -CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhcCC-C--------
Confidence 11123456899999999998888999999999999999999999999653221 1111111110 0
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMK 604 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 604 (624)
..+......+.+++.+||+.+|.+||+..
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 -----QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01112334577899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.84 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=203.5
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|++.+.||+|+||+||++.. .+++.+|+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4577788999999999999995 468899999876543 23456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
+++++|.+++.. .+.+++..+..++.+++.||.|||+. + ++||||||+||++++++.++|+|||++.....
T Consensus 85 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 85 MDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred CCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999988852 34689999999999999999999974 6 99999999999999999999999999865432
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcccc-----ccHHHHHHHHhcccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN-----VNLVVYMKKIMDEER 561 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~ 561 (624)
.. .....++..|+|||++.+..++.++||||||+++|||++|+.||......+. ..+.........+.
T Consensus 157 ~~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 229 (284)
T cd06620 157 SI------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP- 229 (284)
T ss_pred hc------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-
Confidence 11 1234688999999999888899999999999999999999999975433211 01111111111110
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
.+.+. .......+.+|+.+||+.+|++|||+.|++++.--
T Consensus 230 -----~~~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 230 -----PPRLP------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred -----CCCCC------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00000 11244568889999999999999999999987443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.40 Aligned_cols=258 Identities=25% Similarity=0.340 Sum_probs=199.4
Q ss_pred HHHHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC
Q 039681 324 EIRRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD 399 (624)
Q Consensus 324 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 399 (624)
++....++|++.+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++.+.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445578999999999999999999965 6789999987532 2233456789999999999999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999998852 24888999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCccccccc----CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF----QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 555 (624)
+++...... ........||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....
T Consensus 188 ~a~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~ 258 (371)
T cd05622 188 TCMKMNKEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSK 258 (371)
T ss_pred ceeEcCcCC---cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 998654211 1112345799999999998653 3789999999999999999999999754321 11122
Q ss_pred HhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 039681 556 IMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQN--RPSMKEVADE 609 (624)
Q Consensus 556 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~ 609 (624)
...........+ .......+.+++.+||+.++.+ ||+++|+++.
T Consensus 259 i~~~~~~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 259 IMNHKNSLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHcCCCcccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 221111011100 1123456778999999844433 7888888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.42 Aligned_cols=267 Identities=21% Similarity=0.259 Sum_probs=197.6
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL----- 398 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 398 (624)
...++|...+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999985 468899999886432 23356788999999999999999999998653
Q ss_pred -CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 399 -DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 399 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEee
Confidence 346899999964 6666664 24889999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH-----
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY----- 552 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~----- 552 (624)
||+++..... .......+|..|+|||++.+..++.++||||||+++|||++|+.||......+.......
T Consensus 163 fg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 163 FGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred CcccccCCCc-----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999865321 112345689999999999988899999999999999999999999975432211110000
Q ss_pred -----------HHHHhcc-cccccccchhh-hhc----cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 553 -----------MKKIMDE-ERLMEVVDPVL-KER----ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 553 -----------~~~~~~~-~~~~~~~d~~l-~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
....... ........+.. ... ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00000000000 000 000011123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=313.31 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=203.1
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788899999999999999995 578999999987665566677899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999998852 35899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .....+ .+
T Consensus 170 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~------~~ 233 (297)
T cd06656 170 S----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TP 233 (297)
T ss_pred c----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC------CC
Confidence 1 1123457889999999988889999999999999999999999996543221110 000000 00
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+ .........+.+++.+||+.+|++||+++++++
T Consensus 234 ~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 234 EL-----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CC-----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001123455778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=313.14 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=202.5
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|+..+.||.|++|.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588889999999999999984 578999999887655555678899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999998852 35899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||......+. ........ ...
T Consensus 170 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~~-~~~---- 234 (296)
T cd06655 170 S----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-TPE---- 234 (296)
T ss_pred c----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcC-Ccc----
Confidence 1 11234578899999999888899999999999999999999999975433211 11111000 000
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+ .........+.+++.+||+.+|++||++.++++
T Consensus 235 -~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 -L-----QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -c-----CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 001123345778999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.12 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=197.8
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeC------
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL------ 398 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 398 (624)
.+++.|+..+.||+|+||.||+|... +++.||+|+..... .....+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 34567888899999999999999954 58899999986543 3456788999999998 699999999998763
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 4578999999999999998642 2346899999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 553 (624)
|++....... .......|+..|+|||++. ...++.++||||||+++|||++|+.||....... ..
T Consensus 156 g~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~- 225 (272)
T cd06637 156 GVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----AL- 225 (272)
T ss_pred CCceeccccc----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HH-
Confidence 9997653211 1123456889999999985 3358889999999999999999999985322111 00
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..... ..... +. .......+.+|+.+||+.+|.+|||+.|+++
T Consensus 226 ~~~~~-~~~~~-----~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 FLIPR-NPAPR-----LK------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHhc-CCCCC-----CC------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00010 00000 00 0123346788999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=306.35 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=201.0
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|+..+.||+|+||.+|++.. .+++.+|+|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999985 46889999987643 233456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++... ....+++.++++++.|++.||+|||+.+ ++|+||+|+|||+++++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999988632 2235899999999999999999999998 999999999999999999999999999765421
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
. .......++..|+|||++.+..++.++|+||||++++||++|+.||...... ..+.......
T Consensus 155 ~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~------- 217 (256)
T cd08218 155 V----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRGS------- 217 (256)
T ss_pred h----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcCC-------
Confidence 1 1112345788999999998888999999999999999999999998643221 1111111111
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...........+.+++.+||+.+|++||++.||++
T Consensus 218 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 218 ------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00111233456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=306.16 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=204.3
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|+..+.||.|+||.||++.. .+++.+++|.+........+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788899999999999999996 457889999988665566788999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ....+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQV----TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999998863 2246899999999999999999999999 9999999999999999999999999987654211
Q ss_pred CCCcceeecccccccccCccccccc---CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNF---QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.. .... ....
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~~~-~~~~--- 221 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FLIS-KSNF--- 221 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hccC---
Confidence 112344678899999999776 7899999999999999999999998643321110 0000 0000
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+.+ .........+.+++.+||+.+|.+|||+.+|+.
T Consensus 222 ~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 PPPKL-----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCccc-----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00001 011234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=306.90 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=198.6
Q ss_pred ceeccCCcEEEEEEEEcC--C--CEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILDD--G--TVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
++||+|++|.||+|...+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689999876655 556789999999999999999999999988 889999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999997431 146899999999999999999999999 999999999999999999999999999876432111
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
. .......++..|+|||++.+..++.++||||||+++|||++ |..||......+ . ...........
T Consensus 154 ~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~~~~~~~~~~------ 220 (257)
T cd05040 154 Y-VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---I---LKKIDKEGERL------ 220 (257)
T ss_pred e-ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHhcCCcC------
Confidence 0 01113456789999999988889999999999999999999 999986432221 1 11111110000
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
......+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001123456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.62 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=197.4
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456678999999999999965 4778899988766556677899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
++|..++.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 87 ~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--- 156 (282)
T cd06643 87 GAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--- 156 (282)
T ss_pred CcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc---
Confidence 999888753 2346999999999999999999999999 999999999999999999999999998764321
Q ss_pred CcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 491 DSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
........++..|+|||++. +..++.++||||||+++|||++|+.||......+ ..........
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~---- 225 (282)
T cd06643 157 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEP---- 225 (282)
T ss_pred -ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcCC----
Confidence 11123446889999999984 3457889999999999999999999986432111 1111111100
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+. .+......+.+++.+||+.+|++||++.++++
T Consensus 226 --~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 226 --PTLA-----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCCC-----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01123356788999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=308.83 Aligned_cols=258 Identities=26% Similarity=0.442 Sum_probs=202.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCC----EEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGT----VTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.+|+..+.||+|+||.||+|... ++. .+|+|....... ...+.+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45778899999999999999854 333 589998765433 345678999999999999999999999987 78899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 86 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999998642 345999999999999999999999988 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... .........++..|+|||.+....++.++||||||+++||+++ |+.||......+ . .........
T Consensus 159 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~ 229 (279)
T cd05057 159 LDVDE--KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---I----PDLLEKGER 229 (279)
T ss_pred ccCcc--cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---H----HHHHhCCCC
Confidence 64221 1111112223568999999988889999999999999999998 999986543221 1 111111100
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
. ..+......+.+++.+||..+|.+||++.++++.|+++...
T Consensus 230 --~----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 --L----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred --C----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0 00011223567899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.80 Aligned_cols=270 Identities=21% Similarity=0.254 Sum_probs=195.5
Q ss_pred HHHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC------CceeeEeeE
Q 039681 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH------RSLVRLLGC 394 (624)
Q Consensus 322 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~ 394 (624)
.+++....++|.+.++||+|+||+||++.. ..++.||||+++.. ......+..|+++++.++| .++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344455678899999999999999999995 46788999998643 2233456678888777754 458999998
Q ss_pred EEeC-CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCC-
Q 039681 395 CVEL-DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKL- 471 (624)
Q Consensus 395 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~- 471 (624)
+... ...++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDT 270 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCc
Confidence 8765 4678899988 7788888862 35699999999999999999999984 7 99999999999998765
Q ss_pred ---------------CeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCC
Q 039681 472 ---------------NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK 536 (624)
Q Consensus 472 ---------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~ 536 (624)
.+||+|||++..... ......||..|+|||++.+..++.++|||||||++|||++|+.
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 499999998754321 1234578999999999999899999999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHHhcc------------------cccccccchhhhh----ccCcCcHHHHHHHHHHHHHchh
Q 039681 537 AIDFNREEENVNLVVYMKKIMDE------------------ERLMEVVDPVLKE----RATHLDLETMKALGLLAASCLD 594 (624)
Q Consensus 537 p~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~d~~l~~----~~~~~~~~~~~~l~~l~~~cl~ 594 (624)
||......+...++......+.. ..+....++.... ............+.+|+.+||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 99765433222211111000000 0000001110000 0000001123457799999999
Q ss_pred cCCCCCCCHHHHHH
Q 039681 595 ERRQNRPSMKEVAD 608 (624)
Q Consensus 595 ~~p~~RPs~~ev~~ 608 (624)
.||++|||++|+++
T Consensus 424 ~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 424 YDRQKRLNARQMTT 437 (467)
T ss_pred cChhhCCCHHHHhc
Confidence 99999999999986
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=311.78 Aligned_cols=262 Identities=23% Similarity=0.319 Sum_probs=197.6
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|+..+.||+|++|.||+|+.. ++..||+|+++.... ...+.+.+|+.++++++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999964 689999998865432 2346788999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
++ ++|.+++... .....+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcC--CCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 6888887532 12356999999999999999999999999 999999999999999999999999999755321
Q ss_pred CCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc--ccc---
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD--EER--- 561 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~--- 561 (624)
........++..|+|||.+.+. .++.++||||||++++||++|+.||......+.. ......... ...
T Consensus 155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 155 ----VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPG 228 (285)
T ss_pred ----cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhc
Confidence 1122334578899999988654 5789999999999999999999998754322111 000000000 000
Q ss_pred ----------cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 ----------LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ----------~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
........+... ......++.+++.+||+.||++|||+++|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSA----VKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred chhhHHHHhhccccCcchhHHh----cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 0113456778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=324.75 Aligned_cols=264 Identities=24% Similarity=0.311 Sum_probs=198.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc---CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD---DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 46889999999999999999753 3577899987532 235689999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
++. ++|.+++. ....+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 167 ~~~-~~l~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 167 KYK-CDLFTYVD-----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hcC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 995 68888874 3357999999999999999999999999 99999999999999999999999999976543
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc--c
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM--E 564 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 564 (624)
.. .........||..|+|||++....++.++|||||||++|||++|+.||..............+.......... .
T Consensus 238 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 238 HP--DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc--ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 21 1112234568999999999998889999999999999999999999997654332222221121111110000 0
Q ss_pred ccc----hhhh----h-ccC-cC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVD----PVLK----E-RAT-HL-----DLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d----~~l~----~-~~~-~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
... ..+. . +.. .. ......++.+++.+||+.+|++|||+.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000 0 000 00 00123457789999999999999999999864
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.19 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=195.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||+++.+ +++.+|+|++... .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 5788999987532 1223445888999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 99999999999963 1246899999999999999999999999 9999999999999999999999999987553
Q ss_pred ccCCCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
.. .........||+.|+|||++. ...++.++||||||+++|||++|+.||...... ..........
T Consensus 154 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~ 224 (332)
T cd05623 154 ED---GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHK 224 (332)
T ss_pred cC---CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCC
Confidence 21 111223456899999999986 345889999999999999999999999743221 1122221111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCC--CCCCHHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQ--NRPSMKEVADE 609 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~--~RPs~~ev~~~ 609 (624)
.... .+.........+.+|+.+|+..++. .|++++|+++.
T Consensus 225 ~~~~---------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 ERFQ---------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccc---------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 0000112345567788888855444 46899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=306.45 Aligned_cols=253 Identities=27% Similarity=0.470 Sum_probs=200.4
Q ss_pred CCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc------chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT------KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
+|+..+.||+|+||+||+|...+++.+|+|.++.... ...+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998764321 2235688999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999863 246899999999999999999999999 999999999999999999999999998765
Q ss_pred cccCC--CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 485 ERTET--NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 485 ~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... ..........++..|+|||++.+..++.++||||||+++|||++|+.||........ ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~ 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------MFYIGAHRGL 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------HHHhhhccCC
Confidence 32111 111122345688999999999888899999999999999999999999864321110 0000000000
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+ +......+.+++.+||+.+|++||++.|+++
T Consensus 227 ----~~~~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ----MPRL-------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCC-------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111 1123456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=306.85 Aligned_cols=255 Identities=24% Similarity=0.444 Sum_probs=200.8
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc------chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT------KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
+|+..+.||+|++|.||++.. .+++.+|+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999984 5789999998864321 134678999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeecCCcc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSR 482 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGla~ 482 (624)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999999863 246899999999999999999999999 99999999999998776 59999999997
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.................++..|+|||.+.+..++.++||||+|++++||++|..||........ ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~-- 227 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASAT-- 227 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccC--
Confidence 7653211111112234578899999999888899999999999999999999999864332111 11111111000
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.....+......+.+++.+|++.+|++||++.|+++
T Consensus 228 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ----------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001112234466788999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=304.28 Aligned_cols=249 Identities=28% Similarity=0.416 Sum_probs=199.1
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-CceeEEEe
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-DQTLMIYE 406 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 406 (624)
+|++.+.||+|++|.||+++.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999954 57889999886432 23456789999999999999999999987644 45789999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999998642 2346899999999999999999999999 99999999999999999999999999986642
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
.. .......++..|+|||++.+..++.++||||||++++||++|+.||...... ........ +...
T Consensus 155 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~-~~~~--- 220 (257)
T cd08223 155 QC----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIE-GKLP--- 220 (257)
T ss_pred cC----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-cCCC---
Confidence 21 1223455788999999999888999999999999999999999998643211 11111111 1110
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.........+.+++.+|++.+|++||++.|+++
T Consensus 221 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 ---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111234456888999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.75 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=195.0
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||+||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999954 5899999998632 2233456889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSK----FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 99999999999853 2346899999999999999999999999 9999999999999999999999999987654
Q ss_pred ccCCCCcceeecccccccccCcccccc-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRN-----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
.... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||...... ..........
T Consensus 154 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~ 224 (331)
T cd05597 154 ADGT---VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHK 224 (331)
T ss_pred CCCC---ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCC
Confidence 2211 11123468999999999863 35788999999999999999999999643221 1111111111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhc--CCCCCCCHHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDE--RRQNRPSMKEVADE 609 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~ev~~~ 609 (624)
..... . .........+.+++.+|+.. ++..||+++++++.
T Consensus 225 ~~~~~-~--------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 225 EHFQF-P--------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CcccC-C--------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 10000 0 00011344567788887754 33447899988765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.09 Aligned_cols=264 Identities=21% Similarity=0.256 Sum_probs=197.6
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL----- 398 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 398 (624)
...++|...+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3457899999999999999999995 46889999998643 233456788999999999999999999987643
Q ss_pred -CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 399 -DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 399 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
...++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEe
Confidence 35799999996 46766664 24888999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
||+++..... .......+|..|+|||++.+..++.++||||||+++|||++|+.||......+.... +....
T Consensus 170 fG~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---~~~~~ 241 (364)
T cd07875 170 FGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---VIEQL 241 (364)
T ss_pred CCCccccCCC-----CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhc
Confidence 9999865321 112345689999999999988999999999999999999999999975443221111 10000
Q ss_pred ccc--ccccccch----------------------hh-hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 558 DEE--RLMEVVDP----------------------VL-KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 558 ~~~--~~~~~~d~----------------------~l-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
... .....+.+ .. ..............+.+|+.+||+.||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00000000 00 000000011123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.44 Aligned_cols=251 Identities=28% Similarity=0.479 Sum_probs=198.8
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc---------hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK---------GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999985 46789999987643221 22568899999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence 9999999999999999963 346899999999999999999999998 99999999999999999999999999
Q ss_pred cccccccCCCC--cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 481 SRLVERTETND--SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 481 a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
++......... ........++..|+|||.+.+..++.++||||||+++|||++|+.||....... .+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~ 226 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIGE 226 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHhc
Confidence 98764211110 111123457889999999988889999999999999999999999986432110 0111110
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...+. .+......+.+++.+||+.+|++||++.||++
T Consensus 227 ------~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ------NASPE-------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------cCCCc-------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01111 11223456788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.41 Aligned_cols=201 Identities=24% Similarity=0.377 Sum_probs=161.6
Q ss_pred cceeccCCcEEEEEEEEc---CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEe--CCceeEEEeecc
Q 039681 335 DNLIGTGGFGEVFKGILD---DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE--LDQTLMIYEYIP 409 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 409 (624)
.+.||+|+||+||+|+.. +++.+|+|.+... .....+.+|++++++++||||+++++++.. ....++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999854 4678999988643 223457899999999999999999999865 346789999985
Q ss_pred CCCccccccccc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE----CCCCCeEEeecCCc
Q 039681 410 NGTLFDHLHCDF----TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLS 481 (624)
Q Consensus 410 ~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill----~~~~~~kl~DfGla 481 (624)
++|.+++.... ..+...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57877764221 112346899999999999999999999999 9999999999999 46678999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNR 542 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~ 542 (624)
+....... .........+|+.|+|||++.+. .++.++||||+|+++|||++|+.||....
T Consensus 160 ~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCc-cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643211 11122345689999999998764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=323.78 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=195.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|+..+.||+|+||+||++... +++.||+|+++.. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999964 6899999988642 2234566888999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999863 356899999999999999999999999 9999999999999999999999999987543
Q ss_pred ccCCC-------------------------------CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhC
Q 039681 486 RTETN-------------------------------DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTS 534 (624)
Q Consensus 486 ~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg 534 (624)
..... .........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 21000 00011234699999999999988999999999999999999999
Q ss_pred CCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC---HHHHHH
Q 039681 535 KKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS---MKEVAD 608 (624)
Q Consensus 535 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~ 608 (624)
+.||......+ ............ .+.+. .....++.+++.+++ .+|.+|++ ++|+++
T Consensus 233 ~~Pf~~~~~~~------~~~~i~~~~~~~-~~p~~---------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 233 YPPFCSETPQE------TYRKVMNWKETL-VFPPE---------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCCHHH------HHHHHHcCCCce-ecCCC---------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 99997543221 111111100000 00000 012345666777766 49999985 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=301.54 Aligned_cols=253 Identities=24% Similarity=0.268 Sum_probs=202.3
Q ss_pred CCCccceeccCCcEEEEEEEEcC-CCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.|+..+.||.|.-|+||++.+++ +...|+|++..... +.......|-+||+.++||.++.|++.+..++..++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45667889999999999999764 58999999865432 334557789999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
||+||+|..+++.+ ....+++..+..+|.+|+-||+|||..| ||.|||||+||||.++|++.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999998754 4467999999999999999999999999 99999999999999999999999998753211
Q ss_pred c-------C------------------------CCC---------------------cceeecccccccccCcccccccC
Q 039681 487 T-------E------------------------TND---------------------SHIFTTAQGTMGYLDPEYYRNFQ 514 (624)
Q Consensus 487 ~-------~------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 514 (624)
. . ... .......+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 000 01112357999999999999999
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchh
Q 039681 515 LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLD 594 (624)
Q Consensus 515 ~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~ 594 (624)
.+.++|+|+|||+||||+.|..||.+....+.. ..++-..+.. ......+..+.+||++.|.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~F---p~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKF---PEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcC---CCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999999876554322 1122211211 1112455678899999999
Q ss_pred cCCCCCCC----HHHHH
Q 039681 595 ERRQNRPS----MKEVA 607 (624)
Q Consensus 595 ~~p~~RPs----~~ev~ 607 (624)
+||.+|.. +.||-
T Consensus 374 KdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIK 390 (459)
T ss_pred cChhhhhccccchHHhh
Confidence 99999987 55553
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=308.77 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=199.3
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|+..+.||+|++|.||+++.. +++.||+|++..... ...+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999965 589999998764322 234568899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|..++. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 999988877764 2346899999999999999999999998 99999999999999999999999999987643
Q ss_pred cCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc------
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE------ 559 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 559 (624)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ..+......
T Consensus 153 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 225 (286)
T cd07847 153 PGD----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL---YLIRKTLGDLIPRHQ 225 (286)
T ss_pred Ccc----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChHHh
Confidence 211 1223457789999999865 45789999999999999999999999754432211 111111100
Q ss_pred -----ccc-ccccchhhhhccC--cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 -----ERL-MEVVDPVLKERAT--HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 -----~~~-~~~~d~~l~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... .....+....... .........+.+++.+||+.+|++||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0000000000000 000122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=306.66 Aligned_cols=251 Identities=26% Similarity=0.341 Sum_probs=200.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+.|++.+.||+|+||.||+|... +++.+++|..........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999964 58899999987666666778999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|..++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 92 PGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 99999887753 2346899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
........++..|+|||++. ...++.++||||||+++|||++|+.||...... ..........
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~--- 231 (292)
T cd06644 164 ---LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE--- 231 (292)
T ss_pred ---ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcCC---
Confidence 11123445788999999984 345788999999999999999999998643211 1111111110
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+. ........+.+++.+||+.+|++||+++++++
T Consensus 232 ---~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 ---PPTLS-----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CccCC-----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 01123346788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.25 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=196.8
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCcc
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLF 414 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 414 (624)
++||+|+||.||++...+++.|++|+....... ..+.+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999777999999988755433 4567999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcce
Q 039681 415 DHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI 494 (624)
Q Consensus 415 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 494 (624)
+++... ...+++..++.++.+++.||+|||+++ ++||||||+|||+++++.+||+|||++.......... .
T Consensus 81 ~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (251)
T cd05041 81 TFLRKK----KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV--S 151 (251)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee--c
Confidence 998632 246899999999999999999999999 9999999999999999999999999997653211000 0
Q ss_pred eecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 495 FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 495 ~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
......+..|+|||.+.+..++.++||||||+++|||++ |..||....... . ........ ..
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~----~~~~~~~~--~~-------- 214 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---T----RERIESGY--RM-------- 214 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---H----HHHHhcCC--CC--------
Confidence 011233567999999988889999999999999999999 777775432211 1 11111100 00
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
..+.....++.+++.+||+.+|++||++.|+++.|+
T Consensus 215 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 --PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 001123456888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.66 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=195.9
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|.+.+.||+|+||+||+++.. +++.||+|++... .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999964 6788999987532 2233455888999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999631 246899999999999999999999999 9999999999999999999999999997654
Q ss_pred ccCCCCcceeecccccccccCcccccc-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRN-----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
... ........||+.|+|||++.+ ..++.++||||||++||||++|+.||...... ..........
T Consensus 154 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~ 224 (331)
T cd05624 154 QDG---TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHE 224 (331)
T ss_pred CCC---ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCC
Confidence 221 111223568999999999865 45788999999999999999999999643321 1111111111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCC--CCCHHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQN--RPSMKEVADE 609 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~ 609 (624)
.... +.+.+ ......+.+++.+|+..++++ |++++++++.
T Consensus 225 ~~~~-~p~~~--------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ERFQ-FPSHI--------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Cccc-CCCcc--------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 00000 123456777888988865544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=307.51 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=196.9
Q ss_pred ceeccCCcEEEEEEEEcC-------CCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 336 NLIGTGGFGEVFKGILDD-------GTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+++++.++||||+++++++......++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2578999875432 23456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-----CeEEeecCC
Q 039681 408 IPNGTLFDHLHCDFTG--KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-----NAKVSDFGL 480 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-----~~kl~DfGl 480 (624)
+++++|.+++...... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++++. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999643221 2345899999999999999999999998 99999999999999877 899999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
++....... ........++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..... ...
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~ 228 (269)
T cd05044 158 ARDIYKSDY--YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQH----VTA 228 (269)
T ss_pred ccccccccc--cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHH----Hhc
Confidence 976532211 111122345678999999998899999999999999999998 88888633221 11111 111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
+... ......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 229 ~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGRL------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcc------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1000 0112234567889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.60 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=201.3
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999954 68899999987543 34456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999863 27899999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
. .......++..|+|||++.+..++.++||||||+++|||++|+.||....... . ... .... ..
T Consensus 152 ~----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~---~~~-~~~~-----~~ 215 (274)
T cd06609 152 M----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---V---LFL-IPKN-----NP 215 (274)
T ss_pred c----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---H---HHH-hhhc-----CC
Confidence 1 11234457889999999988889999999999999999999999986433111 1 110 1111 01
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+.. ......+.+++.+||..+|++|||++++++
T Consensus 216 ~~~~~------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEG------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCcc------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11110 013445778999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.12 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=194.3
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-----cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--Cce
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-----TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQT 401 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 401 (624)
.+|...+.||+|+||.||++.. .++..|++|++.... .+..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999985 468899999876432 12345688999999999999999999998763 567
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 899999999999999863 245899999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
+......... .......++..|+|||++.+..++.++||||||+++|||++|+.||...... ..+.......
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~- 225 (266)
T cd06651 154 KRLQTICMSG-TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP- 225 (266)
T ss_pred cccccccccC-CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC-
Confidence 7654211111 1122345788999999998888999999999999999999999998632211 1111111111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+.+ +......+..++ +||..+|++||+++||++
T Consensus 226 ----~~~~~-------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 ----TNPQL-------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCCCC-------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01111 112234455566 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=311.84 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=199.8
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCC----EEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGT----VTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|+..+.||+|+||.||+|+. .++. .+|+|.+..... ....++.+|+.++++++||||+++++++... ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4577788999999999999985 3443 478888764432 2344688999999999999999999998754 5678
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
++||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 9999999999999863 2346899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
...... ........++..|+|||++.+..++.++||||||+++|||++ |+.||......+ . .........
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~ 229 (303)
T cd05110 159 LEGDEK--EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---I----PDLLEKGER 229 (303)
T ss_pred ccCccc--ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHCCCC
Confidence 642211 111122345678999999988889999999999999999997 888886432111 1 111111100
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
. .. .......+.+++.+||..+|++||+++++++.|+.+..-.
T Consensus 230 ~--~~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 L--PQ----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C--CC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 00 0112345778999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.24 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=201.0
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.|+..+.||.|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999964 58899999876443 344567899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999998852 35889999999999999999999998 9999999999999999999999999997654221
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.......++..|+|||++.+..++.++||||||+++|||++|..||........ .. .....
T Consensus 156 ----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~~~~~-------- 216 (277)
T cd06640 156 ----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LF-LIPKN-------- 216 (277)
T ss_pred ----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hh-hhhcC--------
Confidence 112234578899999999888899999999999999999999999864322110 00 00000
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+.........+.+++.+||+.+|++||++.++++.
T Consensus 217 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 ----NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0111123455678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=303.27 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=188.5
Q ss_pred eeccCCcEEEEEEEEcCC---CEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCC
Q 039681 337 LIGTGGFGEVFKGILDDG---TVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985433 346677665433 2345789999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCc
Q 039681 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492 (624)
Q Consensus 413 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 492 (624)
|.++++.... ....+++..++.++.||++||+|||+.+ ++||||||+|||+++++.+||+|||++...... ...
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~--~~~ 155 (268)
T cd05086 82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE--DYI 155 (268)
T ss_pred HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcc--hhh
Confidence 9999974321 2345778888999999999999999998 999999999999999999999999998643211 001
Q ss_pred ceeecccccccccCcccccc-------cCCCCccchhhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 493 HIFTTAQGTMGYLDPEYYRN-------FQLTDKSDVYSFGVVLLELLTS-KKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 493 ~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.......++..|+|||++.. ..++.++||||||+++|||+++ ..||..... ...+...... ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~ 228 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVK 228 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccc
Confidence 11123457889999998743 2457899999999999999975 556643221 1112222211 1122
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
..++.+.. .....+.+++..|| .+|++||+++||++.|.
T Consensus 229 ~~~~~~~~-------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLEL-------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCC-------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 23333321 13345677888999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=318.36 Aligned_cols=191 Identities=29% Similarity=0.415 Sum_probs=164.3
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.+|.+.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++.+....++|+|++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 46899999999999999999964 5678999975422 2357999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
.++|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 140 -~~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 140 -SSDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred -CCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 5688888753 3356999999999999999999999999 999999999999999999999999999753211
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCC
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAID 539 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~ 539 (624)
.......||..|+|||++.+..++.++||||||+++|||+++..++.
T Consensus 211 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 ----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 11234568999999999998899999999999999999999776653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=309.74 Aligned_cols=246 Identities=29% Similarity=0.452 Sum_probs=198.2
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 55567799999999999985 457889999876443 3345678999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++..+....
T Consensus 86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 86 GGSALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 9999998852 46899999999999999999999998 9999999999999999999999999997654221
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
.......++..|+|||++.+..++.++||||||+++|||++|+.|+....... . .. ..... ..+.
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~---~~-~~~~~-----~~~~ 220 (277)
T cd06642 156 ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---V---LF-LIPKN-----SPPT 220 (277)
T ss_pred ---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---H---Hh-hhhcC-----CCCC
Confidence 11123457889999999988889999999999999999999999986322111 0 00 01111 0111
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 -------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 112344567889999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=305.41 Aligned_cols=240 Identities=24% Similarity=0.398 Sum_probs=188.1
Q ss_pred ceeccCCcEEEEEEEEcC--------CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 336 NLIGTGGFGEVFKGILDD--------GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+.||+|+||+||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888887655555567889999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC--------eEEeecC
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN--------AKVSDFG 479 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~--------~kl~DfG 479 (624)
+++|+|.++++.. ...+++..+++++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999632 236899999999999999999999999 999999999999987765 6999999
Q ss_pred CcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCC-CCCCCCccccccHHHHHHHHh
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKK-AIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~-p~~~~~~~~~~~~~~~~~~~~ 557 (624)
++...... ....++..|+|||++.+. .++.++||||||+++|||++|.. |+....... ... ..
T Consensus 154 ~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~-~~ 218 (258)
T cd05078 154 ISITVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQ-FY 218 (258)
T ss_pred cccccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHH-HH
Confidence 88654321 224577889999999764 58999999999999999999964 443221111 000 00
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
... .. + +.....++.+++.+||+.+|++|||++++++.|+
T Consensus 219 ~~~--~~-----~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 EDR--HQ-----L-------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred Hcc--cc-----C-------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00 0 1112245788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=301.06 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=199.2
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC-----cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN-----TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
+|+..+.||+|++|+||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999975 78999999876543 23456789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999999863 246899999999999999999999999 999999999999999999999999998765
Q ss_pred cccCCCCcceeecccccccccCcccccccC-CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ......++..|+|||.+.... ++.++|+||||+++|||++|+.||...... .............
T Consensus 153 ~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~ 221 (258)
T cd06632 153 VEFS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELP 221 (258)
T ss_pred cccc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCC
Confidence 4221 123456888999999987666 899999999999999999999998643211 1111111101110
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. .+......+.+++.+||+.+|++||++.+++.
T Consensus 222 ~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 P------------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred C------------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0 11123355778999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=304.38 Aligned_cols=258 Identities=28% Similarity=0.398 Sum_probs=201.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
++|+..+.||+|+||+||+|+.+ +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999953 3467999987654333 4567999999999999999999999999999999
Q ss_pred EEEeeccCCCcccccccccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 403 MIYEYIPNGTLFDHLHCDFTG----KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
+||||+++|+|.++++..... +...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999743211 1226899999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHh
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
|++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......
T Consensus 162 ~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~~~~~~- 231 (275)
T cd05046 162 SLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------EVLNRL- 231 (275)
T ss_pred ccccccCccc---ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------HHHHHH-
Confidence 9987543211 111223345678999999988888999999999999999999 67777532211 111111
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
........ .....+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 232 ~~~~~~~~-----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELP-----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCC-----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111000 01123356888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.63 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=201.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|++.+.||+|+||.||++... ++..+|+|..........+.+.+|++++++++||||+++++.+......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888889999999999999964 68899999987666666778999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 85 DGGALDSIMLE----LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred CCCcHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999998863 2246999999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ..+.......
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--- 224 (280)
T cd06611 158 ----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSE--- 224 (280)
T ss_pred ----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCC---
Confidence 1122345888999999874 335778999999999999999999998643211 1111111110
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+.+. .+......+.+++.+||+.+|++||++.++++.
T Consensus 225 ---~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 ---PPTLD-----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCCcC-----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000 011234567889999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.99 Aligned_cols=252 Identities=25% Similarity=0.307 Sum_probs=209.5
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEcC-CCEEEEEEcccCCcc---hhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCce
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNTK---GTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQT 401 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 401 (624)
.....|.+.+.||+|.||.||+++.+. |+.+|+|.+...... ..+.+.+|+.+|+++. |||||.+.+.+.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 344578888999999999999999654 999999988654433 3468999999999998 99999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC----CCCeEEee
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE----KLNAKVSD 477 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~----~~~~kl~D 477 (624)
++|||++.+|.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+.. ++.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999632 3999999999999999999999999 999999999999964 35799999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... . +
T Consensus 183 FGla~~~~~-----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~-i 250 (382)
T KOG0032|consen 183 FGLAKFIKP-----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------A-I 250 (382)
T ss_pred CCCceEccC-----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------H-H
Confidence 999998652 445678899999999999999999999999999999999999999998654332211 1 1
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..... .+.. ..-......+.+++..++..||..|+|+.++++
T Consensus 251 ~~~~~------~f~~---~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 251 LRGDF------DFTS---EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HcCCC------CCCC---CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11111 1111 111245667888999999999999999999988
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.83 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=202.8
Q ss_pred cCHHHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEE-
Q 039681 320 FTGKEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCV- 396 (624)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 396 (624)
+....+....++|++.+.||+|+||.||++.. .+++.+|+|++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 33455667788999999999999999999985 45789999987643 22345688999999999 6999999999885
Q ss_pred ----eCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC
Q 039681 397 ----ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472 (624)
Q Consensus 397 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~ 472 (624)
.....++||||+++++|.+++.... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 3456899999999999999875322 23356899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCcccccc-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccc
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV 547 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~ 547 (624)
+||+|||+++...... .......|+..|+|||++.. ..++.++||||||+++|||++|+.|+........
T Consensus 163 ~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~- 237 (286)
T cd06638 163 VKLVDFGVSAQLTSTR----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA- 237 (286)
T ss_pred EEEccCCceeecccCC----CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-
Confidence 9999999987654211 11234468999999998753 3478899999999999999999999864322110
Q ss_pred cHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 548 NLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.... .........++ ......+.+++.+||+.+|++|||+.||++.
T Consensus 238 -----~~~~-~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 -----LFKI-PRNPPPTLHQP----------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -----Hhhc-cccCCCcccCC----------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 00000011111 1123457889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.87 Aligned_cols=238 Identities=27% Similarity=0.436 Sum_probs=187.6
Q ss_pred ceeccCCcEEEEEEEEcCCC-----------EEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 336 NLIGTGGFGEVFKGILDDGT-----------VTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
+.||+|+||.||+|...+.. .+++|........ ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975433 5778876644333 6788999999999999999999999988 788999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-------CeEEee
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-------NAKVSD 477 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-------~~kl~D 477 (624)
+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999998632 226899999999999999999999998 99999999999999887 799999
Q ss_pred cCCcccccccCCCCcceeecccccccccCccccccc--CCCCccchhhHHHHHHHHHhC-CCCCCCCCccccccHHHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF--QLTDKSDVYSFGVVLLELLTS-KKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~ 554 (624)
||++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+......+ . ..
T Consensus 152 fg~a~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~---~~ 217 (259)
T cd05037 152 PGIPITVLS--------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---K---ER 217 (259)
T ss_pred CCccccccc--------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---H---HH
Confidence 999976532 1123466789999999776 789999999999999999995 66664332111 0 00
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
....... . + ......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 218 ~~~~~~~--------~----~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 218 FYQDQHR--------L----P---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHhcCCC--------C----C---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 0 0 001156788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=318.57 Aligned_cols=263 Identities=21% Similarity=0.297 Sum_probs=195.2
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL----- 398 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 398 (624)
...++|...+.||+|+||.||++.. .+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457799999999999999999985 5688999998864322 2345678999999999999999999987643
Q ss_pred -CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 399 -DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 399 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
...++++|++ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3568999988 788887774 235999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
||+++..... .....+|..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ...+...
T Consensus 162 fg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~ 231 (343)
T cd07878 162 FGLARQADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEV 231 (343)
T ss_pred CccceecCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHH
Confidence 9999865321 234468999999999876 4689999999999999999999999965432211 1111111
Q ss_pred hcc---cccccccchhh---hhccCcCc--------HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 557 MDE---ERLMEVVDPVL---KERATHLD--------LETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 557 ~~~---~~~~~~~d~~l---~~~~~~~~--------~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
... +....+..... ........ ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000000 00000000 0112346789999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=303.57 Aligned_cols=247 Identities=27% Similarity=0.456 Sum_probs=196.7
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|++.+.||+|+||.||++.. +++.||+|..+.. ...+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999875 6778999987643 2346789999999999999999999998764 5799999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 82 KGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 99999998643 2346899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
......+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+ .. ......... +
T Consensus 154 -----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~-~~~~~~~~~---~- 217 (254)
T cd05083 154 -----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VK-ECVEKGYRM---E- 217 (254)
T ss_pred -----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HH-HHHhCCCCC---C-
Confidence 112234567999999988889999999999999999998 888886433211 11 111111000 0
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
.....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 218 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 --------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011234567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.37 Aligned_cols=244 Identities=26% Similarity=0.412 Sum_probs=202.4
Q ss_pred eeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCccc
Q 039681 337 LIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFD 415 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 415 (624)
+||+|.||+||.|+. ++...+|||-+...+....+-+..|+.+.++++|.|||+.+|.+.+++..-+.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999995 4566789999887777778889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-CCCCeEEeecCCcccccccCCCCc
Q 039681 416 HLHCDFTGKWPPL--PWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRLVERTETNDS 492 (624)
Q Consensus 416 ~l~~~~~~~~~~l--~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~ 492 (624)
+|+. +-++| .+.+.-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||.++.+..- .
T Consensus 662 LLrs----kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi----n 730 (1226)
T KOG4279|consen 662 LLRS----KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI----N 730 (1226)
T ss_pred HHHh----ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC----C
Confidence 9974 34566 78888999999999999999999 99999999999996 5899999999999876422 2
Q ss_pred ceeecccccccccCccccccc--CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 493 HIFTTAQGTMGYLDPEYYRNF--QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 493 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
....+..||..|||||++..+ .|...+|||||||++.||.||++||..-.... . .++.-+ +
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----A----AMFkVG---------m 793 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----A----AMFKVG---------M 793 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----H----hhhhhc---------c
Confidence 223456799999999999654 48999999999999999999999996322211 1 111111 1
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
-...+..+.+...+...++.+|..++|.+||+++++++
T Consensus 794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11223345677788899999999999999999999875
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.67 Aligned_cols=271 Identities=17% Similarity=0.213 Sum_probs=197.0
Q ss_pred ccceeccC--CcEEEEEEEE-cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 334 KDNLIGTG--GFGEVFKGIL-DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 334 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+.++||+| +|++||++.. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 7899999985 5789999999875432 33456778999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.+++... ....+++..+++++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.........
T Consensus 82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999998632 2235899999999999999999999999 9999999999999999999999998754332110
Q ss_pred CCC---cceeecccccccccCcccccc--cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 489 TND---SHIFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 489 ~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
... ........++..|+|||++.+ ..++.++||||||+++|||++|+.||....... . ...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~----~~~~~~-~~~~ 228 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--M----LLEKLN-GTVP 228 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--H----HHHHhc-CCcc
Confidence 000 000122346778999999875 358999999999999999999999986422111 0 000000 0000
Q ss_pred cccc-------------------hhhhh--------------ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--
Q 039681 564 EVVD-------------------PVLKE--------------RATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD-- 608 (624)
Q Consensus 564 ~~~d-------------------~~l~~--------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~-- 608 (624)
...+ ..+.. ............+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 0000 00000 000011223457889999999999999999999986
Q ss_pred HHHHHHHhc
Q 039681 609 EIEYIISIA 617 (624)
Q Consensus 609 ~L~~i~~~~ 617 (624)
.+.++...+
T Consensus 309 ~f~~~~~~~ 317 (327)
T cd08227 309 FFKQIKRRA 317 (327)
T ss_pred hhhhcchhh
Confidence 344444333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.67 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=197.9
Q ss_pred CCccceeccCCcEEEEEEEEc----CCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC------
Q 039681 332 FSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD------ 399 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 399 (624)
|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999853 3678999988643 2334567899999999999999999999887542
Q ss_pred ceeEEEeeccCCCcccccccccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFT-GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
..++++||+++|+|.+++..... .+...+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 24788999999999988753221 22345899999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHh
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
|+++......... ......++..|++||.+.+..++.++||||||+++|||++ |+.||...... .+..+. .
T Consensus 158 g~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~---~ 229 (273)
T cd05074 158 GLSKKIYSGDYYR--QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL---I 229 (273)
T ss_pred cccccccCCccee--cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH---H
Confidence 9998654221110 1112335578999999988889999999999999999999 77887543221 111111 1
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
...... ........+.+++.+||+.+|++||++.|+++.|+++
T Consensus 230 ~~~~~~-------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRLK-------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111100 0112335688899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.75 Aligned_cols=201 Identities=24% Similarity=0.380 Sum_probs=161.0
Q ss_pred cceeccCCcEEEEEEEEc---CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEe--CCceeEEEeecc
Q 039681 335 DNLIGTGGFGEVFKGILD---DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE--LDQTLMIYEYIP 409 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 409 (624)
...||+|+||+||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999964 35789999876432 23467899999999999999999999864 456789999986
Q ss_pred CCCccccccccc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE----CCCCCeEEeecCCc
Q 039681 410 NGTLFDHLHCDF----TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLS 481 (624)
Q Consensus 410 ~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill----~~~~~~kl~DfGla 481 (624)
++|.+++.... ......+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57777764221 112346899999999999999999999999 9999999999999 56788999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNR 542 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~ 542 (624)
+....... .........+|..|+|||++.+. .++.++||||||+++|||+||+.||....
T Consensus 160 ~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcc-cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 87643211 11112345688999999998764 58999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=310.04 Aligned_cols=264 Identities=24% Similarity=0.347 Sum_probs=198.9
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|+..+.||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 589999998754322 234568899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.++... ...+++.+++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999888877642 235899999999999999999999998 99999999999999999999999999886543
Q ss_pred cCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc--cccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE--ERLM 563 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 563 (624)
.. .......++..|+|||++.+. .++.++||||||+++|||++|+.||......+. ...+...... ....
T Consensus 153 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 153 PG----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ---LYHIIKCLGNLIPRHQ 225 (286)
T ss_pred Cc----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH---HHHHHHHhCCCchhhH
Confidence 21 122344578899999998653 478899999999999999999988864432111 1111110000 0000
Q ss_pred ccc----------chhhhhcc--CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVV----------DPVLKERA--THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~----------d~~l~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.. .+...... ..........+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 00000000 0001123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=306.13 Aligned_cols=263 Identities=23% Similarity=0.292 Sum_probs=203.6
Q ss_pred cCHHHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 039681 320 FTGKEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVE 397 (624)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 397 (624)
++..++..+.++|...+.||+|+||.||++.. .+++.+|+|++.... ...+.+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44556667788999999999999999999996 568899999886432 3345678899999999 79999999999875
Q ss_pred C-----CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC
Q 039681 398 L-----DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472 (624)
Q Consensus 398 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~ 472 (624)
. ...++|+||+++++|.++++... .....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 4 35799999999999999886321 13356899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCccccccc-----CCCCccchhhHHHHHHHHHhCCCCCCCCCccccc
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-----QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV 547 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~ 547 (624)
+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||......+.
T Consensus 167 ~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~- 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT- 241 (291)
T ss_pred EEEeecccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence 99999999886542111 11234678899999987543 368899999999999999999999864322111
Q ss_pred cHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 548 NLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+..... .....+.+ .......+.+++.+||+.+|++||++.|+++
T Consensus 242 -----~~~~~~-~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 -----LFKIPR-NPPPTLLH----------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -----HHHHhc-CCCCCCCc----------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 11111111 1123346888999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=311.83 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=197.7
Q ss_pred ccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCC
Q 039681 334 KDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 334 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
....||+|+||.||++.. .++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 345699999999999985 4688999999876555666779999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCc
Q 039681 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492 (624)
Q Consensus 413 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 492 (624)
|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 106 L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~---- 172 (292)
T cd06658 106 LTDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV---- 172 (292)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc----
Confidence 9998742 35899999999999999999999999 9999999999999999999999999987653211
Q ss_pred ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhh
Q 039681 493 HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKE 572 (624)
Q Consensus 493 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 572 (624)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+. ....+.+..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~---------~~~~~~~~~ 240 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRIR---------DNLPPRVKD 240 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH---------hcCCCcccc
Confidence 11123457899999999988889999999999999999999999986432211 111111 011111111
Q ss_pred ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 573 RATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 573 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.......+..++.+||+.+|.+|||++|+++.
T Consensus 241 -----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -----SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01233457789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.90 Aligned_cols=241 Identities=29% Similarity=0.482 Sum_probs=194.2
Q ss_pred CccceeccCCcEEEEEEEE-cCCCEEEEEEccc----CCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc--eeEEE
Q 039681 333 SKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKL----GNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ--TLMIY 405 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 405 (624)
+...+||+|+|-+||+|.. .+|-.||--.++. .+....+.|..|+.+|+.|+||||++++..+.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4567899999999999985 3566676433322 234456789999999999999999999999998765 77899
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfGla~~~ 484 (624)
|.|..|+|..|++ +.+.++...+..|++||++||.|||++. |||||||||-+||||+. .|.|||+|+|||...
T Consensus 123 EL~TSGtLr~Y~k-----k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRK-----KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHH-----HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 9999999999997 3456888899999999999999999987 78999999999999975 588999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc----
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE---- 560 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 560 (624)
..+. ...+.||+.|||||++. ..|++.+||||||+.|+||+|+..|+..-. +..+ +++.+..+
T Consensus 197 r~s~------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQ-IYKKV~SGiKP~ 263 (632)
T KOG0584|consen 197 RKSH------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQ-IYKKVTSGIKPA 263 (632)
T ss_pred hccc------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHH-HHHHHHcCCCHH
Confidence 5321 23478999999999998 589999999999999999999999985322 2222 33333332
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+..+-|| ++.++|.+||.. ..+|||+.|+++
T Consensus 264 sl~kV~dP---------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ALSKVKDP---------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhhccCCH---------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 23333333 356699999999 899999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=291.52 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=200.3
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++.|++.+.||+|.|+.||+... .+|+.+|+|++... ...+.+++.+|+.|-+.|+|||||+|.+...+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677888999999999999884 46888888876532 2346778999999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEEeecCCcc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKVSDFGLSR 482 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl~DfGla~ 482 (624)
|+|.|++|..-|-. +-.+++..+-..++||+++|.|.|.++ |||||+||+|+|+-+ .--+||+|||+|.
T Consensus 90 e~m~G~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA-----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ecccchHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999776642 245788888999999999999999999 999999999999954 3348999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.+. ....+...+||++|||||++...+|+..+|||+.||+||-|+.|..||...... .+.+. +..+.
T Consensus 162 ~l~-----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~----I~~g~- 228 (355)
T KOG0033|consen 162 EVN-----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQ----IKAGA- 228 (355)
T ss_pred EeC-----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHH----Hhccc-
Confidence 775 334456788999999999999999999999999999999999999999753322 11111 11111
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+| +.... -....+...+|+.+||..||.+|.|+.|.+.
T Consensus 229 ---yd--~~~~~---w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 ---YD--YPSPE---WDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---cC--CCCcc---cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11 00000 0123445678999999999999999999863
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=299.51 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=201.4
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|...+.||+|+||.||++.. .+++.|++|.++..... ..+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999999995 46899999998765443 567899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999863 245889999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCcceeecccccccccCcccccccC---CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQ---LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
............++..|+|||++.... .+.++||||||+++|||++|+.||...... .. . ..... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~-~--~~~~~-~~~--- 223 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQ-I--MFHVG-AGH--- 223 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HH-H--HHHHh-cCC---
Confidence 221111122356788999999997765 889999999999999999999998643211 10 0 11000 010
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+.. .......+.+++.+||+.+|++||++.|++.
T Consensus 224 --~~~~~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 --KPPIPD-----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCc-----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011100 0122455678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=303.67 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=200.1
Q ss_pred CCCccceeccCCcEEEEEEEEcC--CCEEEEEEcccCC----------cchhHHHHHHHHHHHh-cCCCceeeEeeEEEe
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDD--GTVTAIKRAKLGN----------TKGTDLVLNEVRILCQ-VNHRSLVRLLGCCVE 397 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 397 (624)
+|++.+.||+|+||.||++.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999754 6889999875321 2234557789988875 799999999999999
Q ss_pred CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEECCCCCeEEe
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSNILLDEKLNAKVS 476 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~Nill~~~~~~kl~ 476 (624)
.+..++||||+++++|.+++... ......+++..+++++.|++.||.|||+ .+ ++|+||+|+|||+++++.+||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHH-HhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEe
Confidence 99999999999999999887532 1233569999999999999999999996 56 9999999999999999999999
Q ss_pred ecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ......
T Consensus 157 dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~ 225 (269)
T cd08528 157 DFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKI 225 (269)
T ss_pred cccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHH
Confidence 999998654321 234556889999999998888999999999999999999999998633211 111111
Q ss_pred hcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 557 MDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
. ....... ........+.+++.+||+.+|++||++.||.++++
T Consensus 226 ~-~~~~~~~-----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 V-EAVYEPL-----------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred h-hccCCcC-----------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 1111000 00123356788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=319.02 Aligned_cols=240 Identities=23% Similarity=0.276 Sum_probs=185.4
Q ss_pred eccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhc---CCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 338 IGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQV---NHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 338 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
||+|+||+||+++.. +++.||+|++.... ......+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999954 68999999875321 12234456677777665 699999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--- 149 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--- 149 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---
Confidence 999988862 356899999999999999999999999 999999999999999999999999998754221
Q ss_pred CcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
........||..|+|||++.+. .++.++||||||+++|||++|+.||......+ .... ...+.. .
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~-i~~~~~------~ 215 (330)
T cd05586 150 -NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRN-IAFGKV------R 215 (330)
T ss_pred -CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHH-HHcCCC------C
Confidence 1112345689999999998754 48999999999999999999999996433211 1111 111110 0
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC----HHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPS----MKEVAD 608 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~ev~~ 608 (624)
+. .......+.+++.+||+.+|.+||+ +.++++
T Consensus 216 ~~------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 FP------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CC------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00 0112345678999999999999984 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.34 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=199.0
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|++.+.||+|+||.||++... ++..||+|.++.. .....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999965 6899999988653 233456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
+++++|..++.... ....+++..+..++.|++.||.|||+. + ++|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 81 MDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred cCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999998886321 134689999999999999999999974 6 99999999999999999999999999876532
Q ss_pred cCCCCcceeecccccccccCccccccc------CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNF------QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ....+..... .
T Consensus 156 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~-~ 225 (286)
T cd06622 156 S------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVD-G 225 (286)
T ss_pred C------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhh-c
Confidence 1 11234578899999998543 35889999999999999999999986432111 1111111110 0
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
. ..........++.+++.+||+.+|++||++++++..
T Consensus 226 ~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 D------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred C------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 011112345667889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=308.44 Aligned_cols=264 Identities=20% Similarity=0.286 Sum_probs=196.1
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|+..+.||+|+||.||+++.. +|+.+|+|+++.... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999964 688999998864322 2235678899999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
++ ++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDS----CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 578777753 2346999999999999999999999999 999999999999999999999999999765321
Q ss_pred CCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc-----
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER----- 561 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 561 (624)
........++..|+|||++.+. .++.++||||||+++|||++|+.|+......+ .....+........
T Consensus 153 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 153 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ----CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhH
Confidence 1112344578899999998664 47899999999999999999999865332211 11111111110000
Q ss_pred -cccccchhhhhcc------CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 -LMEVVDPVLKERA------THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 -~~~~~d~~l~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+..+....... .........++.+++.+||+.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000000 0001123456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.19 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=200.4
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|++.+.||+|++|.||+|+. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999999996 468999999987544 23356789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+ +++|.+++... ...+++.+++.++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999988632 256999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc---ccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE---RLM 563 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 563 (624)
. ........++..|+|||.+.+. .++.++||||+|++++||++|..+|......+ ....+....... ...
T Consensus 153 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 153 E---PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWP 226 (286)
T ss_pred C---CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHh
Confidence 1 1123345688999999998654 46899999999999999999977775433221 111111111100 000
Q ss_pred ---cccc------hhhhh-ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 ---EVVD------PVLKE-RATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ---~~~d------~~l~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
++.+ +.... ............+.+++.+||+.+|++||++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 00000 000000123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=300.68 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=195.3
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-----cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--Cce
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-----TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQT 401 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 401 (624)
.+|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999996 458999999875322 12345788999999999999999999998764 467
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++|+||+++++|.+++.. ...+++...++++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence 899999999999998862 245889999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
......... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+.......
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~- 225 (265)
T cd06652 154 KRLQTICLS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP- 225 (265)
T ss_pred ccccccccc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCC-
Confidence 865421111 11123345888999999998888999999999999999999999998632111 1111111110
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+ ..+......+..++.+|+. +|.+||+++||++
T Consensus 226 ----~~~-------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ----TNP-------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCC-------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 001 1122344567778888885 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=339.59 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=197.8
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--Cce
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQT 401 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 401 (624)
...++|.+.+.||+|+||+||+++.. ++..+|+|.+.... ......|..|+.++++++|||||++++++.+. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34468999999999999999999954 57789999876432 33456789999999999999999999998654 468
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEeecCCCCCeEECC--------
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV----PPIYHRDVKSSNILLDE-------- 469 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----~~iiH~Dik~~Nill~~-------- 469 (624)
+|||||+++|+|.++|..... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 999999999999999864211 23569999999999999999999998542 23999999999999964
Q ss_pred ---------CCCeEEeecCCcccccccCCCCcceeecccccccccCcccccc--cCCCCccchhhHHHHHHHHHhCCCCC
Q 039681 470 ---------KLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLELLTSKKAI 538 (624)
Q Consensus 470 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~elltg~~p~ 538 (624)
...+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~-----s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE-----SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc-----ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 334899999999865321 11234568999999999854 45889999999999999999999999
Q ss_pred CCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 539 DFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...... ...+.. +... +.+. .......+.+|+.+||+.+|.+||++.|++.
T Consensus 244 ~~~~~~-----~qli~~-lk~~-------p~lp------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNF-----SQLISE-LKRG-------PDLP------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcH-----HHHHHH-HhcC-------CCCC------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 643221 111111 1111 0000 0112356788999999999999999999984
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=300.21 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=198.9
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|+..+.||+|+||.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 468899999876442 33456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC-CCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~-~~~kl~DfGla~~~~~ 486 (624)
+++++|.+++... ....+++..+.+++.|++.||+|||+++ ++|+||||+||+++++ +.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999642 2346899999999999999999999999 9999999999999855 4589999999986643
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ...
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~-~~~-- 220 (256)
T cd08220 155 KSK-----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSGT-FAP-- 220 (256)
T ss_pred Ccc-----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhcC-CCC--
Confidence 211 12345788999999998888999999999999999999999998643221 1111111110 000
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
........+.+++.+||+.+|++|||++|+++
T Consensus 221 ----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ----------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=301.25 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=197.4
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc----------chhHHHHHHHHHHHhcCCCceeeEeeEEEeCC
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT----------KGTDLVLNEVRILCQVNHRSLVRLLGCCVELD 399 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 399 (624)
+|...+.||+|+||.||+|.. .+++.+|+|.++.... ...+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466788999999999999985 4688999998753211 11346788999999999999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.++|+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT-----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence 99999999999999999863 246899999999999999999999998 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccC--CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ--LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
+++...... .........++..|+|||.+.... ++.++||||||+++|||++|..||...... .......
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~ 225 (272)
T cd06629 154 ISKKSDDIY--DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLG 225 (272)
T ss_pred ccccccccc--cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhh
Confidence 997653211 111123456888999999987654 889999999999999999999998532211 1111111
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... ....+++.. .......+.+++.+||+.+|++||++++|++
T Consensus 226 ~~~-~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 226 NKR-SAPPIPPDV-------SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccc-cCCcCCccc-------cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111 011111111 1123467888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=300.23 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=205.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|++.+.||+|++|.||+++.. +++.|++|++..... ...+.+.+|+..+++++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999965 589999999876544 4467899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
+++++|.+++.. ...+++..++.++.|+++||+|||+ .+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKK-----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999963 2578999999999999999999999 88 99999999999999999999999999987643
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......+ ............ .
T Consensus 153 ~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~-~---- 220 (264)
T cd06623 153 TLD----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAICDGP-P---- 220 (264)
T ss_pred CCC----cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHhcCC-C----
Confidence 211 1124457889999999988889999999999999999999999986543211 111111111110 0
Q ss_pred chhhhhccCcCcHH-HHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 567 DPVLKERATHLDLE-TMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 567 d~~l~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
...+.. .+..+.+++.+||+.+|++||++.|+++.
T Consensus 221 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 --------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011112 44678889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.05 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=201.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|+..+.||+|++|.||+|... +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999965 5889999987643 23345678999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|++++.+..+.. +...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEA-----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 999877765553 2345899999999999999999999999 99999999999999999999999999987653
Q ss_pred cCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc------
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE------ 559 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 559 (624)
... .......++..|+|||++.+. .++.++||||||+++|||++|+.||......+.. .........
T Consensus 153 ~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 226 (288)
T cd07833 153 RPA---SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL---YLIQKCLGPLPPSHQ 226 (288)
T ss_pred Ccc---ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHh
Confidence 221 122345678899999999887 7899999999999999999999998754332211 111110000
Q ss_pred ------c-----ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ------E-----RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ------~-----~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. ...+..++..... ........++.+++.+||+.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLER--RYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHH--hcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0000111100000 001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=310.52 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=197.4
Q ss_pred cceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 335 DNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
...||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34699999999999985 46899999998765555667789999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....... .
T Consensus 106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~----~ 172 (297)
T cd06659 106 TDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----P 172 (297)
T ss_pred HHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc----c
Confidence 987742 35899999999999999999999999 9999999999999999999999999987553221 1
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+. ... ..... .+....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~-----~~~~~~- 239 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKR-LRDSP-----PPKLKN- 239 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HhccC-----CCCccc-
Confidence 12345688999999999888899999999999999999999999864332111 111 11100 000000
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.......+.+++.+||+.+|++||+++++++.
T Consensus 240 ----~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 ----AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ----cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 01123457789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.33 Aligned_cols=243 Identities=30% Similarity=0.428 Sum_probs=198.2
Q ss_pred CCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcch---hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKG---TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
|...+-||.|+||.||.++ ..+..+||||+........ -.+++.|+..|.+++|||++.+.|+|......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4556779999999999999 4678999999986543332 35689999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
| -|+-.|++.- ..++|.+..+..|..+.+.||+|||+.+ .||||||+.|||+++.|.|||+|||.|....+
T Consensus 108 C-lGSAsDlleV----hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred H-hccHHHHHHH----HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 9 4677777753 2357999999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
....+||+.|||||++. .+.|+-|+||||||++..||...++|+..-+ ....++ .+..+.
T Consensus 179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALY-HIAQNe--- 241 (948)
T KOG0577|consen 179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALY-HIAQNE--- 241 (948)
T ss_pred -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHH-HHHhcC---
Confidence 23567999999999984 4579999999999999999999998875221 111111 111111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.|.+. ..+..+.+..++..||++-|.+|||.+++++
T Consensus 242 --sPtLq------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 --SPTLQ------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CCCCC------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12222 3467788999999999999999999999875
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=299.29 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=203.9
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|++.+.||.|+||+||+|.. .++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999995 467899999886433 23567799999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999964211 246899999999999999999999999 999999999999999999999999998766532
Q ss_pred CCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
............++..|+|||++... .++.++||||||+++|||++|+.||....... .........
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------ 223 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------ 223 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------
Confidence 21111112344688999999998776 78999999999999999999999986432211 011111110
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+... .........+.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETG--ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCc--cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0011000 000134466788999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=307.27 Aligned_cols=264 Identities=22% Similarity=0.259 Sum_probs=198.3
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc-----hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK-----GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
+|+..+.||+|++|.||+|... +++.||||+++..... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999964 6899999998754332 234577899999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+ +++|.+++... ...+++..++.++.||++||+|||+.+ ++|+||||+|||++.++.+||+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 99999998632 136999999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---c
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---E 560 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 560 (624)
.... .......++..|+|||.+.+ ..++.++||||||++++||++|..+|......+. .......... .
T Consensus 153 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~ 225 (298)
T cd07841 153 GSPN----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEE 225 (298)
T ss_pred cCCC----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchh
Confidence 4321 11233456788999998854 4578999999999999999999777754332211 1111111000 0
Q ss_pred cc---ccccchhhhhccCcC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 561 RL---MEVVDPVLKERATHL-----DLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 561 ~~---~~~~d~~l~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.. ....+.......... .......+.+++.+||+.+|++|||+.||++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 000000000000000 01234678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.43 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=200.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc---hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK---GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|+..+.||+|++|.||++... +++.+|+|.+...... ..+.+.+|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999965 5899999988654322 4567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998632 2356999999999999999999999999 9999999999999999999999999987553
Q ss_pred ccCCCCc-------------------------ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCC
Q 039681 486 RTETNDS-------------------------HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDF 540 (624)
Q Consensus 486 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~ 540 (624)
....... .......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 2111000 001123578899999999888899999999999999999999999864
Q ss_pred CCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC----HHHHHH
Q 039681 541 NREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS----MKEVAD 608 (624)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~ev~~ 608 (624)
....+. ........ . .. .........+.+++.+||+.+|++||+ ++|++.
T Consensus 235 ~~~~~~------~~~~~~~~-~------~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRDET------FSNILKKE-V------TF-----PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchHHH------HHHHhcCC-c------cC-----CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 432211 11111110 0 00 001124567889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.56 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=205.0
Q ss_pred CCccceeccCCcEEEEEEEEc--CCC--EEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 332 FSKDNLIGTGGFGEVFKGILD--DGT--VTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
....++||+|.||.|++|.+. +|+ .||||.++..... ..++|++|+.+|.+|+|+|+++|+|+..+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 345678999999999999975 344 5899999876554 57889999999999999999999999988 78889999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
..+.|+|.+.|+. .....|.......++.|||.||.||.+++ +|||||..+|+||-....+||+||||.+.+..
T Consensus 191 LaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999985 35567889999999999999999999999 99999999999999999999999999998864
Q ss_pred cCCCCcceee-cccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 487 TETNDSHIFT-TAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 487 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.+. .+.+. ...-...|.|||.+....++.+||||+|||+||||+| |+.||.+-... ..+. .++++
T Consensus 265 ned--~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------qIL~-~iD~~---- 331 (1039)
T KOG0199|consen 265 NED--MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------QILK-NIDAG---- 331 (1039)
T ss_pred CCc--ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------HHHH-hcccc----
Confidence 332 22222 2334678999999999999999999999999999998 66788654322 1111 11111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
+...-+..+.+++.++++.||..+|.+|||+..|.+.+-
T Consensus 332 --------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 332 --------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred --------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 111123457888999999999999999999999975443
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=298.55 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=198.7
Q ss_pred CCccceeccCCcEEEEEEEEcC-----CCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 332 FSKDNLIGTGGFGEVFKGILDD-----GTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
|++.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999653 388999998755433 5678999999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 81 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 999999999998632 1112899999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
...... .....++..|+|||.+.+..++.++||||+|++++||++ |..||..... ........... ...
T Consensus 155 ~~~~~~---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~~-~~~ 224 (258)
T smart00219 155 DDDYYK---KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKKGY-RLP 224 (258)
T ss_pred cccccc---cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcCC-CCC
Confidence 321111 112336789999999988889999999999999999998 6777653211 11111111111 000
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
.......++.+++.+|++.+|++|||+.|+++.|
T Consensus 225 ------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0112345688899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=301.76 Aligned_cols=249 Identities=27% Similarity=0.351 Sum_probs=203.0
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.+.|+.-++||+||||.||-.+. .+|+.+|.|++... ........++|-.+|.+++.+.||.+-..|...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 35688889999999999999984 57999999976432 334455689999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
+..|.||+|.-+|.+. ..+.+++..++.+|.+|+.||++||... ||.||+||+|||||+.|+++|+|+|||..+
T Consensus 264 LtlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999999753 2367999999999999999999999999 999999999999999999999999999877
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... ...+..+||.+|||||++.+..|+...|+||+||+||||+.|+.||....+.... +
T Consensus 338 ~~g-----~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------------e 396 (591)
T KOG0986|consen 338 PEG-----KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------------E 396 (591)
T ss_pred CCC-----CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----------------H
Confidence 532 2244568999999999999999999999999999999999999999643322111 1
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 604 (624)
-+|..........+....++...+....|+.||.+|.-.+
T Consensus 397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1122222211122234456677788889999999996544
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.96 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=200.4
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEe--CCceeEEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE--LDQTLMIY 405 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 405 (624)
+|++.+.||.|+||.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999985 467899999876432 3345678899999999999999999998764 34578999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH-----SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-----~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
||+++++|.+++.... .....+++..++.++.||+.||+||| +.+ ++|+||||+||++++++.+||+|||+
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999986431 23457999999999999999999999 666 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+....... .......++..|+|||.+.+..++.++||||||+++++|++|+.||...... . +.......
T Consensus 157 ~~~~~~~~----~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~ 225 (265)
T cd08217 157 AKILGHDS----SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------Q-LASKIKEG 225 (265)
T ss_pred cccccCCc----ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------H-HHHHHhcC
Confidence 98764321 1123446889999999998888999999999999999999999998754311 1 11111111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.. ..........+.+++.+|++.+|++||++++|++.
T Consensus 226 ~~------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 KF------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 01112344678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.53 Aligned_cols=261 Identities=25% Similarity=0.326 Sum_probs=201.3
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeC--CceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 405 (624)
++|...+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3577889999999999999996 4688999998875433 3456789999999999999999999998754 3689999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++..... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988753211 3456899999999999999999999999 9999999999999999999999999987543
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ............ ...
T Consensus 157 ~~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~--- 225 (287)
T cd06621 157 NSL------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVN-MPN--- 225 (287)
T ss_pred ccc------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhc-CCc---
Confidence 211 113346789999999988889999999999999999999999997543211 111111111111 000
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+.. ...........+.+++.+||+.+|++|||+.|+++
T Consensus 226 --~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 --PELKD-EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --hhhcc-CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11110 00111224567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.10 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=197.1
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|+..+.||.|++|.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999864 688999998864432 2335788999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+. ++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 6888888632 3356899999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCcceeecccccccccCcccccccC-CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc-cc---
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE-RL--- 562 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~--- 562 (624)
. .......++..|+|||++.+.. ++.++||||||+++|||+||+.||......+. ............ ..
T Consensus 154 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 154 V----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred c----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhh
Confidence 1 1123345688999999886644 68899999999999999999999975433221 111111100000 00
Q ss_pred -----------ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 -----------MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 -----------~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.......+... .......+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFSKV----VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhHHHHHHhhcccccccCHHHH----cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 0112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.16 Aligned_cols=253 Identities=28% Similarity=0.391 Sum_probs=201.9
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|++++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999965 688999998865432 3456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
+++++|.+++... ...+++..+.+++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 9999999998632 1578999999999999999999999 88 99999999999999999999999999876532
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ......+........
T Consensus 154 ~~~------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~----- 221 (265)
T cd06605 154 SLA------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP----- 221 (265)
T ss_pred HHh------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC-----
Confidence 111 11557889999999988889999999999999999999999986432211 111111221111110
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+. .......+.+++.+||..+|++|||+.+++.
T Consensus 222 -~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 -PRLP------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -CCCC------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0010 0114456888999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=303.48 Aligned_cols=259 Identities=25% Similarity=0.374 Sum_probs=200.4
Q ss_pred CHHHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEe-
Q 039681 321 TGKEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVE- 397 (624)
Q Consensus 321 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 397 (624)
+..++....+.|+..+.||+|+||.||+|.. .+++.+|+|+..... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3344455667899999999999999999996 568899999876432 3445688999999998 69999999999863
Q ss_pred -----CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC
Q 039681 398 -----LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472 (624)
Q Consensus 398 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~ 472 (624)
....+++|||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 45789999999999999988642 2345889999999999999999999999 999999999999999999
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccc
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV 547 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~ 547 (624)
++|+|||++....... .......++..|+|||.+. ...++.++||||||+++|||++|+.||......+..
T Consensus 160 ~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 160 VKLVDFGVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred EEEeeCcchhhhhccc----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 9999999987653211 1123356888999999875 345888999999999999999999998643211100
Q ss_pred cHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 548 NLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... ....+.+. .......+.+++.+||+.+|.+|||+.|+++
T Consensus 236 ------~~~~------~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ------FLIP------RNPPPKLK------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------hhHh------hCCCCCCc------ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 00001110 1123456888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=304.94 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=196.8
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCc-----
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQ----- 400 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 400 (624)
++|+..+.||+|+||.||+|... +++.||+|+.+.... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999964 689999998765432 23456889999999995 6999999999987666
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFG 479 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfG 479 (624)
.++||||+++ +|.+++..........+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8888886433322457899999999999999999999999 999999999999998 8999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+++...... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||......+. +.. +.....
T Consensus 157 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPV----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLH-IFKLLG 229 (295)
T ss_pred cceecCCCc----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHhC
Confidence 987653211 11223356788999998865 4578999999999999999999999875432211 111 111110
Q ss_pred cc---cccccc------------chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 EE---RLMEVV------------DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ~~---~~~~~~------------d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. ...... ...+.. ........+.+++.+||+.+|.+||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSR----AVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHH----hccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 000000 000000 00124456888999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=305.08 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=196.8
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999964 6899999988654322 234578899999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ~~-~~L~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LD-TDLKQYMDD----CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CC-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 97 589888753 2246899999999999999999999999 999999999999999999999999998754321
Q ss_pred CCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---cccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---ERLM 563 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 563 (624)
........++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ......+...... +...
T Consensus 157 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 157 ----SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred ----CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhh
Confidence 111223346789999999865 45889999999999999999999998644311 1111111111110 0000
Q ss_pred cc--------------cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EV--------------VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~--------------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. ....+..... .......+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAP--RLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhccccccccccccCChhHHHhCc--CCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000100000 0111256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=307.09 Aligned_cols=258 Identities=21% Similarity=0.265 Sum_probs=200.0
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|...+.||+|+||.||++... .++.|++|.+..... ...+.+.+|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999964 578999998765432 33457889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999963 246899999999999999999999998 9999999999999999999999999987421
Q ss_pred ccCCC-----------CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 039681 486 RTETN-----------DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 486 ~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 554 (624)
..... .........++..|+|||.+.+..++.++|+||||+++|||++|..||...... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~ 226 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFG 226 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 10000 000111245788999999998888999999999999999999999998643221 1111
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
...... ...+.. .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 227 ~~~~~~----~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 227 QVISDD----IEWPEG-------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHhcc----cCCCCc-------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111110 000000 01234567889999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=303.36 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=202.8
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|...+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788899999999999999985 468899999987655556678899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999852 35789999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
. ......++..|+|||.+....++.++||||||+++||+++|+.||......+... .....+. +
T Consensus 170 ~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~------~ 233 (293)
T cd06647 170 S----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT------P 233 (293)
T ss_pred c----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC------C
Confidence 1 1223458889999999988889999999999999999999999997543221110 0000000 0
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.. .........+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 EL-----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CC-----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0111234567889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.63 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=199.0
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
-|+..+.||+|+||.||+|.. .++..+|+|...... ....+.+.+|+.++++++||||+++++++.+....++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778899999999999985 468899999876433 234567889999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999998852 35899999999999999999999999 9999999999999999999999999987654221
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..... ...... +
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~~~-----~ 219 (277)
T cd06641 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFL-IPKNNP-----P 219 (277)
T ss_pred ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHH-HhcCCC-----C
Confidence 1122345788999999998888899999999999999999999998632211 11111 111100 0
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 -------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111234567889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=305.92 Aligned_cols=272 Identities=23% Similarity=0.291 Sum_probs=196.4
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc-----
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ----- 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 400 (624)
.++|+..+.||+|+||.||++... +++.||||.+...... ....+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356889999999999999999964 6899999987643222 23456789999999999999999999876543
Q ss_pred ---eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 401 ---TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 401 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
.++||||+. ++|.+++.. ....+++.+++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence 499999996 578777753 2246899999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
||++..................++..|+|||.+.+. .++.++||||||+++|||++|+.||..............+...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999987653322221222345578899999988654 4788999999999999999999998754432222211111111
Q ss_pred hcccccccccchhhhh--ccCcC----------cHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 557 MDEERLMEVVDPVLKE--RATHL----------DLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~--~~~~~----------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...+......+..... ..+.. .......+.+++.+||+.+|++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1111000000000000 00000 0001235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=299.09 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=199.1
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999964 58889999876532 23456788999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGla~~~~~ 486 (624)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999998632 2345899999999999999999999999 99999999999999885 469999999976542
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
.. .......|+..|+|||++.+..++.++||||||++++||++|+.||..... ...+..... +....
T Consensus 155 ~~----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~-- 221 (257)
T cd08225 155 SM----ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFAP-- 221 (257)
T ss_pred Cc----ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCCC--
Confidence 21 112234588899999999888899999999999999999999999864321 111211111 11110
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
........+.+++.+||+.+|++|||+.|+++
T Consensus 222 ----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ----------ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01123346788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.96 Aligned_cols=243 Identities=28% Similarity=0.387 Sum_probs=197.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999964 68999999876432 234567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+|||+++++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999863 256899999999999999999999999 9999999999999999999999999998754
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .....+++.|+|||.+.+...+.++||||||+++|||++|+.||......+ ...... .+..
T Consensus 153 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~--- 215 (290)
T cd05580 153 GR-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKIL-EGKV--- 215 (290)
T ss_pred CC-------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCCc---
Confidence 22 123458899999999988888999999999999999999999986433111 011111 1100
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVA 607 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~ 607 (624)
.+ +......+.+++.+||+.+|.+|| +++|++
T Consensus 216 ---~~-------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 ---RF-------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ---cC-------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 00 111235677899999999999998 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=302.44 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=199.4
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 46889999998765555567789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+.......
T Consensus 101 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 101 GALTDIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred CCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 999998852 35899999999999999999999999 9999999999999999999999999887553211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ....... ... .+.+
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~-~~~-----~~~~ 235 (285)
T cd06648 170 --PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR-DNL-----PPKL 235 (285)
T ss_pred --cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-hcC-----CCCC
Confidence 1122345889999999998888999999999999999999999998643221 1111111 110 0111
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. .......+.+++.+||+.+|++||++.++++
T Consensus 236 ~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 KN-----LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cc-----cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00 0113356888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.26 Aligned_cols=266 Identities=20% Similarity=0.276 Sum_probs=195.7
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcch-hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
+++|...+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+++++.++|+||+++.+++.+....++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46788999999999999999985 468899999986543322 3467899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 84 YMH-TDLAQYMIQ----HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred ccc-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 995 677766642 2245788899999999999999999999 99999999999999999999999999876432
Q ss_pred cCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---c--
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---E-- 560 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~-- 560 (624)
. ........++..|+|||++.+. .++.++||||||+++|||++|+.||...... ............. .
T Consensus 156 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 156 P----SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred C----CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhh
Confidence 1 1112234568899999998654 5788999999999999999999998743321 1111111111000 0
Q ss_pred ----ccccccchhhhhccC------cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 ----RLMEVVDPVLKERAT------HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ----~~~~~~d~~l~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+............. .........+.+++.+|++.+|.+|||++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 000112356778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.82 Aligned_cols=267 Identities=21% Similarity=0.318 Sum_probs=199.3
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEe----CCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE----LDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 401 (624)
.++|+..+.||+|++|.||+++. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788899999999999999995 468999999886532 2345667889999999999999999998763 3467
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999995 689888852 345999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc--
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD-- 558 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 558 (624)
..................++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~ 231 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSP 231 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCC
Confidence 7664322222222234568899999999865 4589999999999999999999999965432211 111111100
Q ss_pred ---------ccccccccchhhhhccCc----CcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 ---------EERLMEVVDPVLKERATH----LDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ---------~~~~~~~~d~~l~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+.+..+ ........ ........+.+++.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHhhhhhchhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000111000 00000000 00123567889999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.42 Aligned_cols=208 Identities=26% Similarity=0.409 Sum_probs=171.0
Q ss_pred CCCccceeccCCcEEEEEEEEc---CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--Ccee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD---DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTL 402 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 402 (624)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999964 47899999987632 33346788999999999999999999999988 7899
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC----CCCeEEeec
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE----KLNAKVSDF 478 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~----~~~~kl~Df 478 (624)
+||||+++ +|.+++..........+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 6777665332223347899999999999999999999999 999999999999999 999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNRE 543 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~ 543 (624)
|++......... ........++..|+|||.+.+. .++.++||||||++++||++|+.||.....
T Consensus 157 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999876432111 1112234678899999988654 578999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.45 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=193.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHH-HHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRI-LCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|++.+.||+|+||.||+++.. +|+.||+|+++.... .....+..|+.+ ++.++||||+++++++......++|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999964 689999998875432 234456667665 566789999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
|++ |+|.+++..... ....+++..++.++.||+.||+|||++ + ++||||||+|||+++++.+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 788887754322 235799999999999999999999997 6 9999999999999999999999999997653
Q ss_pred ccCCCCcceeecccccccccCcccccc----cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRN----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
.. .......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... . ..........
T Consensus 156 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~~~~~~~- 224 (283)
T cd06617 156 DS-----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--F---QQLKQVVEEP- 224 (283)
T ss_pred cc-----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--H---HHHHHHHhcC-
Confidence 21 11123457889999998854 35688999999999999999999998532111 0 1111111110
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+. ......++.+++.+||+.+|++||+++++++
T Consensus 225 -----~~~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 -----SPQLP------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -----CCCCC------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0123456888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.34 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=198.5
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcC---CCceeeEeeEEEeCCceeEEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVN---HRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 405 (624)
.|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999995 578999999886542 344567889999999996 999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999998852 26899999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.||....... .... ....
T Consensus 153 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~-~~~~---- 217 (277)
T cd06917 153 QNS----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-IPKS---- 217 (277)
T ss_pred CCc----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc-cccC----
Confidence 321 112344688899999998654 57899999999999999999999986432211 0100 0000
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+.+.. .....++.+++.+||+.+|++||++.|+++.
T Consensus 218 -~~~~~~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 218 -KPPRLED------NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -CCCCCCc------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0111111 0134568889999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.19 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=197.8
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC-----ce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD-----QT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 401 (624)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 568999999886432 234566889999999999999999999876543 57
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++|+||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 89999996 577777642 46999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc-
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE- 559 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 559 (624)
......... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+......
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~ 229 (336)
T cd07849 154 RIADPEHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTP 229 (336)
T ss_pred eeccccccc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCC
Confidence 765432111 112234567899999998754 468999999999999999999999986533211 11111111111
Q ss_pred --cccccccchhhhh------ccCcC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 560 --ERLMEVVDPVLKE------RATHL-----DLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 560 --~~~~~~~d~~l~~------~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
+....+.+..... ..... ......++.+++.+||+.+|++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111110000 00000 01124568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.02 Aligned_cols=268 Identities=20% Similarity=0.311 Sum_probs=199.3
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+|+..+.||+|++|.||+|+.. +++.||||+++..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999964 6889999988755332 3466789999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
+ ++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~- 153 (284)
T cd07836 81 D-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP- 153 (284)
T ss_pred C-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC-
Confidence 7 48888875321 2346999999999999999999999999 999999999999999999999999999765321
Q ss_pred CCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
........++..|++||.+.+. .++.++||||||+++|||++|+.||......+...................+.+
T Consensus 154 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 154 ---VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred ---ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1112334578899999988654 578899999999999999999999875443221111100000000000000000
Q ss_pred -hhhhhccC--------cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 -PVLKERAT--------HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 -~~l~~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+....+ .........+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.21 Aligned_cols=262 Identities=25% Similarity=0.321 Sum_probs=197.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeC--CceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 404 (624)
++|+..+.||+|+||.||+|... +++.+++|.++..... ....+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999965 5889999988754322 234578899999999999999999999887 889999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
+||++ ++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99996 5898888632 236999999999999999999999999 999999999999999999999999999866
Q ss_pred cccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc----
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---- 559 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 559 (624)
.... .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+... .+......
T Consensus 157 ~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~ 229 (293)
T cd07843 157 GSPL----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN---KIFKLLGTPTEK 229 (293)
T ss_pred cCCc----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchH
Confidence 4321 112334578899999998654 46899999999999999999999987543221111 11110000
Q ss_pred -------------cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 -------------ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 -------------~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..........+....+. ......+.+++.+||+.+|++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPA--LSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccc--cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000111111110 012556788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.24 Aligned_cols=246 Identities=30% Similarity=0.413 Sum_probs=195.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
+.|+..+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++.+++.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999964 689999998764332 23456889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....
T Consensus 95 e~~~-g~l~~~~~~----~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHH----cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9996 677776642 2246899999999999999999999999 9999999999999999999999999987653
Q ss_pred ccCCCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.. ....++..|+|||++. ...++.++||||||+++|||++|+.||....... ........+ .
T Consensus 167 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~~~~-~ 231 (307)
T cd06607 167 PA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND-S 231 (307)
T ss_pred CC--------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHhcCC-C
Confidence 21 1345788999999874 3468899999999999999999999986432211 111111000 0
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
+.+ ........+.+++.+||+.+|++||++.+|+..
T Consensus 232 -----~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -----PTL------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCC------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 012345568899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.67 Aligned_cols=255 Identities=27% Similarity=0.369 Sum_probs=199.6
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCC------
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELD------ 399 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 399 (624)
.+++|++.+.||+|++|.||+|... +++.+++|++.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999964 57889999887543 3456789999999999 6999999999997654
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999886421 12357899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccc-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 554 (624)
++....... .......++..|+|||++.. ..++.++||||||++++||++|+.||....... ...
T Consensus 159 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~ 228 (275)
T cd06608 159 VSAQLDSTL----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALF 228 (275)
T ss_pred cceecccch----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHH
Confidence 987653211 11234558889999998753 246789999999999999999999986322111 011
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... ... +.+. ........+.+++.+||..||++|||+.++++
T Consensus 229 ~~~~-~~~-----~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 KIPR-NPP-----PTLK-----SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred Hhhc-cCC-----CCCC-----chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 100 0110 11224567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.11 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=196.0
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
|+..+.||.|++|.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|||++++++++.+....++|+||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678899999999999995 478999999886543 223456889999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
+ ++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++......
T Consensus 81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~- 152 (283)
T cd07835 81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP- 152 (283)
T ss_pred C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC-
Confidence 4 6899888632 1246899999999999999999999998 999999999999999999999999999765321
Q ss_pred CCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc-ccc-c-
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE-RLM-E- 564 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~-~- 564 (624)
........++..|+|||++.+. .++.++||||||+++|||++|+.||......+. +........... ... .
T Consensus 153 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 153 ---VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred ---ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhh
Confidence 1112234568899999988654 578999999999999999999999865432211 111111100000 000 0
Q ss_pred ccchhhhhcc--------CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERA--------THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...+...... ..........+.+++.+||+.+|++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 0001122356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.37 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=193.0
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcC-CCceeeEeeEEEeC--CceeEEEe
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVN-HRSLVRLLGCCVEL--DQTLMIYE 406 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 406 (624)
|+..+.||+|+||.||++.. .+++.+|+|+.+... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678899999999999995 468899999876532 222334567999999885 99999999999987 88999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|++ ++|.+++.. ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 996 588887753 2346899999999999999999999999 999999999999999 9999999999987643
Q ss_pred cCCCCcceeecccccccccCccccc-ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc------
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYR-NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE------ 559 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 559 (624)
... .....++..|+|||++. +..++.++||||||+++|||++|..||......+ ...........
T Consensus 152 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 152 KPP-----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVL 223 (282)
T ss_pred CCC-----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 211 12345788999999764 4457889999999999999999999997543322 11111111100
Q ss_pred -----cccccccchhhhh-ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 -----ERLMEVVDPVLKE-RATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 -----~~~~~~~d~~l~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
........+.... ............+.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000000 000001134578899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.50 Aligned_cols=272 Identities=20% Similarity=0.253 Sum_probs=187.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC--CCEEEEE------------------EcccCCcchhHHHHHHHHHHHhcCCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD--GTVTAIK------------------RAKLGNTKGTDLVLNEVRILCQVNHRSL 388 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ni 388 (624)
.++|++.+.||+|+||+||++..+. +...++| .+. ........+.+|+.+|++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999987532 2222222 111 112234568899999999999999
Q ss_pred eeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC
Q 039681 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD 468 (624)
Q Consensus 389 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~ 468 (624)
+++++++.+.+..++|+|++ .++|.+++..............+...|+.||+.||+|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 99999999999999999998 467777765322111223446677889999999999999999 99999999999999
Q ss_pred CCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCc-cccc
Q 039681 469 EKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNRE-EENV 547 (624)
Q Consensus 469 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~-~~~~ 547 (624)
.++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|+.++..... ....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKER---EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CCCCEEEEeCCCceecCccc---ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999998764321 1112245689999999999988999999999999999999998864432221 1111
Q ss_pred cHHHHHHHHh-cccc-------cccccchhhhhccCcC------cHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 548 NLVVYMKKIM-DEER-------LMEVVDPVLKERATHL------DLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 548 ~~~~~~~~~~-~~~~-------~~~~~d~~l~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+...+.... ..+. +.+.++.......... .......+.+++.+||+.||.+|||+.|+++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111111000 0000 0000000000000000 0012235677899999999999999999986
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=301.97 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=193.5
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|...+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.++.++. |+||+++++++......++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 345567899999999999995 468999999886543 234567899999999996 99999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
+. ++|.++...........+++..+.+++.|++.||+|||+. + ++||||||+||++++++.+||+|||++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 4554433211111235799999999999999999999985 6 99999999999999999999999999976542
Q ss_pred cCCCCcceeecccccccccCccccccc---CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNF---QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.||.... .....+.......
T Consensus 161 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~--- 227 (288)
T cd06616 161 SI-----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD--- 227 (288)
T ss_pred CC-----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC---
Confidence 11 11234578899999998765 68999999999999999999999986332 1111111111111
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+.+.. .........+.+|+.+||+.+|++|||+++|++.
T Consensus 228 ---~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 ---PPILSN---SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CCcCCC---cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 1112345568899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=291.20 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=205.7
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
|.+.++||+|+||.||++.++ .|+++|||++.. ..+.+++..|+.+|++...|++|+++|.+.....+++||||+..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556788999999999999964 699999999864 45678899999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|++.+.++. ++++|++.++..|++.-++||+|||... -||||||+.|||++-+|.+||+|||.|-.+...
T Consensus 113 GSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--- 182 (502)
T KOG0574|consen 113 GSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--- 182 (502)
T ss_pred CcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh---
Confidence 999999963 5678999999999999999999999998 799999999999999999999999999765421
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
-..-.++.||+.|||||++..-.|..++||||+|+...||..|++|+..-.+-.. .-++ .....|.+
T Consensus 183 -MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IFMI-----PT~PPPTF 249 (502)
T KOG0574|consen 183 -MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IFMI-----PTKPPPTF 249 (502)
T ss_pred -HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eEec-----cCCCCCCC
Confidence 2223567899999999999998999999999999999999999999863222100 0000 00011111
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+.....++.+++++||-+.|++|-|+.++++
T Consensus 250 -----~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 -----KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -----CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 123567788999999999999999999988864
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.60 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=202.9
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
..+.|+..+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|++++++++|+|++++++.+......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4456788889999999999999975 688999999876544 56778999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999742 137999999999999999999999998 99999999999999999999999999865532
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ......... .....
T Consensus 169 ~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~~~ 237 (286)
T cd06614 169 EKS----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLITTKG-IPPLK 237 (286)
T ss_pred chh----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-CCCCc
Confidence 211 1123447789999999988889999999999999999999999986432211 011111110 00000
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+ .......+.+++.+||+.+|.+||++.++++
T Consensus 238 ~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 N----------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred c----------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 1123456888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.49 Aligned_cols=260 Identities=26% Similarity=0.340 Sum_probs=197.5
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--CceeEEEe
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTLMIYE 406 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 406 (624)
|++.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++.+. ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999965 58899999987653 33446788999999999999999999999988 89999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|++ ++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 997 4888887532 247999999999999999999999998 99999999999999999999999999987653
Q ss_pred cCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc---cccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD---EERL 562 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 562 (624)
.. ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ..+..... ....
T Consensus 153 ~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 226 (287)
T cd07840 153 RN---SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENW 226 (287)
T ss_pred CC---cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhc
Confidence 21 112234456788999998764 45789999999999999999999998754432211 11111110 0000
Q ss_pred cccc--------------chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVV--------------DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~--------------d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... ...+.... .......+.+++.+||+.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFF---KHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhhhhccccccchhHHHHHh---cccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000 00000000 0012567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=299.28 Aligned_cols=262 Identities=17% Similarity=0.208 Sum_probs=184.6
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCCcchh-----------HHHHHHHHHHHhcCCCceeeEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNTKGT-----------DLVLNEVRILCQVNHRSLVRLLG 393 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 393 (624)
.++|.+.++||+|+||+||+|...+ +..+|+|+......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999999644 45667776543332211 11223444556678999999999
Q ss_pred EEEeCC----ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC
Q 039681 394 CCVELD----QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE 469 (624)
Q Consensus 394 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~ 469 (624)
++.... ..++++|++. .++.+.+. .....++..+..|+.|++.||+|||+.+ |+||||||+|||+++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFK-----RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHH-----hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 876543 3356777663 35555543 1234678889999999999999999998 999999999999999
Q ss_pred CCCeEEeecCCcccccccCCCC---cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcccc
Q 039681 470 KLNAKVSDFGLSRLVERTETND---SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN 546 (624)
Q Consensus 470 ~~~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~ 546 (624)
++.+||+|||+|+.+....... ........||+.|+|||++.+..++.++||||||++++||++|+.||.......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~- 240 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG- 240 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch-
Confidence 9999999999998664221110 011123468999999999999899999999999999999999999997542211
Q ss_pred ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
........ +.+..+....+. . ...+..+.+++..|++.+|++||++.++.+.|+
T Consensus 241 -~~~~~~~~----~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 -NLIHAAKC----DFIKRLHEGKIK--I----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -HHHHHhHH----HHHHHhhhhhhc--c----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111110 001111111110 0 122466888999999999999999999998763
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.26 Aligned_cols=271 Identities=23% Similarity=0.301 Sum_probs=201.1
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----Cc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-----DQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 400 (624)
.++|...+.||+|+||+||+++. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788899999999999999995 46899999987643 233345678899999999999999999988654 34
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR-----SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999995 78888875 2346999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc-
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD- 558 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 558 (624)
+....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 155 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~ 227 (337)
T cd07858 155 ARTTSEKG----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGS 227 (337)
T ss_pred ccccCCCc----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCC
Confidence 98654221 11234457889999998864 4689999999999999999999999965432211 111111110
Q ss_pred --ccccccccchhhhh-------cc----CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHHHH
Q 039681 559 --EERLMEVVDPVLKE-------RA----THLDLETMKALGLLAASCLDERRQNRPSMKEVADE--IEYIIS 615 (624)
Q Consensus 559 --~~~~~~~~d~~l~~-------~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~i~~ 615 (624)
.+....+.+..... .. ..........+.+++.+||+.+|++|||++|+++. ++.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00010000100000 00 00011234667899999999999999999999976 655433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=289.08 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=202.7
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999965 688999999876655566789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 99999988632 257999999999999999999999988 99999999999999999999999999987653211
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
.....++..|+|||.+.+...+.++||||||++++||++|+.||......+ . ...... .......+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~---~~~~~~-~~~~~~~~-- 219 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---A---LFKIAT-NGPPGLRN-- 219 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---H---HHHHHh-cCCCCcCc--
Confidence 234457889999999988889999999999999999999999986432111 0 111000 10111100
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.......+.+++.+||+.+|++|||+.|+++
T Consensus 220 --------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 --------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112456888999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=288.93 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=203.5
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeC--CceeEEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTLMIY 405 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 405 (624)
+|...+.||+|++|.||+|+.. +++.|++|+...... ...+.+.+|++++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999975 689999998865442 4567899999999999999999999999988 8899999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||.+....
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 99999999999863 237999999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
..... .......++..|+|||.+.....+.++||||||+++++|++|+.||.... +...............
T Consensus 153 ~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-- 223 (260)
T cd06606 153 DIETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP-- 223 (260)
T ss_pred ccccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc--
Confidence 32210 01234567889999999988889999999999999999999999987543 1111111111101100
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+......+.+++.+|++.+|++||++.++++
T Consensus 224 ----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 ----------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111223567888999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.29 Aligned_cols=268 Identities=27% Similarity=0.374 Sum_probs=198.1
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCC----
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELD---- 399 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 399 (624)
...++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45578999999999999999999965 588999999875432 23356788999999999999999999987655
Q ss_pred ------ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 400 ------QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 400 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
..++|+||+++ +|..++.. ....+++..++.++.||+.||+|||+.+ |+|+||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcE
Confidence 78999999975 67676653 2346899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
||+|||++........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+ ....
T Consensus 156 kl~dfg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~ 229 (302)
T cd07864 156 KLADFGLARLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLEL 229 (302)
T ss_pred EeCcccccccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHH
Confidence 9999999987643211 112233467789999988643 57899999999999999999999986433221 1111
Q ss_pred HHHHhccc---cccccc--------chhhh--hccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 553 MKKIMDEE---RLMEVV--------DPVLK--ERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 553 ~~~~~~~~---~~~~~~--------d~~l~--~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+....... ....+. ++.-. ..........+..+.+++.+||+.+|++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111110 000000 00000 0000000113456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.65 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=195.2
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|+..+.||+|++|+||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999964 688999998865432 234568899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecCCccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFGLSRLVE 485 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfGla~~~~ 485 (624)
|++ ++|.+++... ....+++..+..++.||+.||+|||+++ ++|+||+|+||++++ ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 995 5787777532 2234688899999999999999999998 999999999999985 5679999999997653
Q ss_pred ccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---cc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---ER 561 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 561 (624)
.. ........++..|+|||++.+. .++.++||||||+++|||++|+.||......+.. ..+...... ..
T Consensus 155 ~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 227 (294)
T PLN00009 155 IP----VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL---FKIFRILGTPNEET 227 (294)
T ss_pred CC----ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChhh
Confidence 21 1112334578899999988654 5789999999999999999999998754332111 111111000 00
Q ss_pred ccc---c----------cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LME---V----------VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~---~----------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... . ....+... ......++.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATV----VPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHh----CcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0 00000000 1123355788999999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.90 Aligned_cols=247 Identities=26% Similarity=0.289 Sum_probs=200.1
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
+|++.+.||.|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999965 58999999886432 2346789999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQ-----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999999863 247899999999999999999999999 99999999999999999999999999876543
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ...+....... .
T Consensus 153 ~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~--~--- 218 (258)
T cd05578 153 DT-----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQETA--D--- 218 (258)
T ss_pred Cc-----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhccc--c---
Confidence 21 1234568889999999988889999999999999999999999987543321 11111111110 0
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH--HHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM--KEVA 607 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~ev~ 607 (624)
...+......+.+++.+||+.+|.+||++ +|++
T Consensus 219 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 --------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 01111234677889999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.65 Aligned_cols=265 Identities=26% Similarity=0.320 Sum_probs=196.2
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeC--CceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 403 (624)
.++|+..+.||+|+||.||+|... +|+.||+|+++..... ....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999964 6899999988654322 233567899999999999999999998765 46899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|+||+. ++|.+++... ...+++.+++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 86 v~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence 999996 5788887532 256999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc--
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE-- 560 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 560 (624)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+.......
T Consensus 158 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~ 230 (309)
T cd07845 158 YGLPA----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNE 230 (309)
T ss_pred cCCcc----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCh
Confidence 64321 11223345788999999865 4588999999999999999999999975433221 11111111100
Q ss_pred ccccccc-------hhhhhccCc----CcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 RLMEVVD-------PVLKERATH----LDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ~~~~~~d-------~~l~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
......+ ..+...... ........+.+++.+||+.||++|||++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 000000000 00012456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=295.62 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=185.6
Q ss_pred eeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHH---hcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 337 LIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILC---QVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
+||+|+||.||++.. .+++.+|+|.+..... .....+.+|..+++ ..+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999996 4689999998754321 22233445554443 3479999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999988862 346999999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.....|+..|+|||.+.+ ..++.++||||||++++||++|..||......... .+..... ..+.
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~------~~~~ 216 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL------TVNV 216 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhh------cCCc
Confidence 123468999999999864 46899999999999999999999999744322111 1111100 0011
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVADE 609 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 609 (624)
. .+......+.+++.+||+.+|++|| |++|+++.
T Consensus 217 ~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 E-------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred C-------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 1122345678899999999999999 59888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=298.79 Aligned_cols=244 Identities=22% Similarity=0.347 Sum_probs=196.2
Q ss_pred cceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 335 DNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
...||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35699999999999986 46899999998765555667799999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++.. ..+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++....... .
T Consensus 105 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----~ 171 (292)
T cd06657 105 TDIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----P 171 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc----c
Confidence 987742 35899999999999999999999998 9999999999999999999999999987654211 1
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
......++..|+|||.+.+..++.++||||||+++|||++|..||......+. ...+. .. ..+.+..
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~----~~-----~~~~~~~- 238 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIR----DN-----LPPKLKN- 238 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hh-----CCcccCC-
Confidence 12334578899999999888889999999999999999999999864332211 11111 00 0011100
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.......+.+++.+||+.+|.+||++.++++
T Consensus 239 ----~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 ----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ----cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0112345677999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=295.28 Aligned_cols=248 Identities=24% Similarity=0.310 Sum_probs=207.5
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
..-|.+.+-||+|.|..|-+|++ -.|..||||++...... ...++..|++-|+.++|||||+|+.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45678888999999999999984 58999999998765433 3457899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-CCCCeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-~~~~~kl~DfGla~~~ 484 (624)
|.=.+|+|++||..+ ...+.+....+++.||+.|+.|.|+.. +|||||||+||.+- .-|-+||+|||++..+
T Consensus 97 ELGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999999999999643 346999999999999999999999999 99999999999875 5678999999999766
Q ss_pred cccCCCCcceeecccccccccCcccccccCCC-CccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLT-DKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.+ ....++.+|+..|-|||.+.+..|+ +..||||||||||.|++|+.||...+..+.. .
T Consensus 170 ~P-----G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------T 229 (864)
T KOG4717|consen 170 QP-----GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------T 229 (864)
T ss_pred CC-----cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------h
Confidence 53 3346788999999999999998886 5789999999999999999999865544332 1
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.++|= ....+.....+..+||..||..||.+|.+.+||+.
T Consensus 230 mImDC-----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 230 MIMDC-----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhcc-----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 22221 11223456677889999999999999999999864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.20 Aligned_cols=264 Identities=21% Similarity=0.264 Sum_probs=197.9
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL----- 398 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 398 (624)
...++|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3457899999999999999999995 47899999987643 233456678899999999999999999998643
Q ss_pred -CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 399 -DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 399 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
...++|+||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence 35699999995 588877742 2889999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
||+++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+.. ..+....
T Consensus 162 fg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~ 233 (353)
T cd07850 162 FGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW---NKIIEQL 233 (353)
T ss_pred CccceeCCCCC-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhc
Confidence 99998654221 122345788999999999889999999999999999999999999754322111 1010000
Q ss_pred cc--cc-----------------------cccccchhhhh-ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 558 DE--ER-----------------------LMEVVDPVLKE-RATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 558 ~~--~~-----------------------~~~~~d~~l~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.. .. ..+.....+.. ............+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00 00000000000 0000011235567899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.50 Aligned_cols=243 Identities=24% Similarity=0.330 Sum_probs=186.4
Q ss_pred hCCCCcccee--ccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLI--GTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|.+.+.+ |+|+||.||++.. .++..+|+|.......... |+.....+ +||||+++++.+...+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3455555555 9999999999995 4678899998764322211 22222222 699999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeecCCccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSRL 483 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGla~~ 483 (624)
|||+++++|.+++... ..+++.++..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999632 37999999999999999999999999 99999999999999988 999999999876
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ....++..|+|||++.+..++.++||||||+++|||++|+.||.....+ ..+...+.... ....
T Consensus 160 ~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~~- 227 (267)
T PHA03390 160 IGTP--------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QKKL- 227 (267)
T ss_pred cCCC--------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--cccC-
Confidence 5321 1235788999999998888999999999999999999999999743222 11111111111 0000
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-HHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-MKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~ 608 (624)
.........+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 ------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 ------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000123456788999999999999996 688874
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=290.30 Aligned_cols=251 Identities=30% Similarity=0.430 Sum_probs=203.8
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|...+.||+|+||.||++... +++.+++|++..... ...+.+.+|++++++++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999964 688999999875533 4566789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++..... ....+++.++..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999874321 2367999999999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
. .......++..|+|||.+.+..++.++||||+|+++++|++|+.||...... ........ .....
T Consensus 157 ~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~--- 222 (258)
T cd08215 157 V----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILK-GQYPP--- 222 (258)
T ss_pred c----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhc-CCCCC---
Confidence 1 1223446888999999998888999999999999999999999998643211 11111111 11110
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+......+.+++.+||+.+|++|||+.|+++
T Consensus 223 ---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 ---------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.83 Aligned_cols=246 Identities=28% Similarity=0.402 Sum_probs=194.5
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
|+..+.||+|+||.||+++. .++..+|+|++..... +....+.+|++++++++|||++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66778899999999999995 4688999998764322 2345788999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
++ |+|.+.+.. ....+++.++..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 107 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CC-CCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 96 577777642 2346899999999999999999999999 999999999999999999999999998754321
Q ss_pred CCCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
....++..|+|||++. ...++.++||||||+++|||++|+.||......+ ........+..
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~-- 242 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNESP-- 242 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccCC--
Confidence 2345788999999974 4568899999999999999999999986432111 11111111100
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
..........+.+++.+||+.+|.+||++.++++.+-
T Consensus 243 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 ----------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ----------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 0001123456788999999999999999999997544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.93 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=196.0
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC-----CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--Cce
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG-----NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQT 401 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 401 (624)
.+|.+.+.||+|+||.||++.. .+++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999995 46899999987432 123345788999999999999999999998764 457
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++|+||+++++|.+++.. ...+++....+++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999998862 245889999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
+....... .........++..|+|||++.+..++.++||||||++++||++|+.||...... ..+........
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~ 226 (264)
T cd06653 154 KRIQTICM-SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQPT 226 (264)
T ss_pred cccccccc-cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCCC
Confidence 86542111 111123456889999999998888999999999999999999999998632111 11111111100
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+ ..+....+.+.+++.+||+ +|..||+..+++.
T Consensus 227 -----~~-------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 -----KP-------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CC-------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00 1122344568889999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.78 Aligned_cols=263 Identities=24% Similarity=0.288 Sum_probs=194.4
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc--hhHHHHHHHHHHHhc---CCCceeeEeeEEEeCCc-----
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK--GTDLVLNEVRILCQV---NHRSLVRLLGCCVELDQ----- 400 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 400 (624)
|++.+.||+|+||.||+++.. +++.+|+|+++..... ....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999975 4899999998743222 234567788877666 59999999999998776
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.+++|||++ ++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCc
Confidence 899999996 5888887632 2236899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+........ .....++..|+|||.+.+..++.++||||||+++|||++|..||......+.. ...........
T Consensus 154 ~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 226 (287)
T cd07838 154 ARIYSFEMA-----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPS 226 (287)
T ss_pred ceeccCCcc-----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCC
Confidence 977643211 12334788999999998888999999999999999999999888654332211 11111000000
Q ss_pred --ccc-------cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 --RLM-------EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 --~~~-------~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... .....................+.+++.+||+.+|++||+++|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000000000000011234567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=304.73 Aligned_cols=272 Identities=23% Similarity=0.310 Sum_probs=198.4
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC--CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeC--Cce
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL--DQT 401 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 401 (624)
..++|+..+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999964 6889999987532 233455678899999999 999999999998754 368
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++|+||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999996 589888752 26889999999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCC-CcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc-
Q 039681 482 RLVERTETN-DSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD- 558 (624)
Q Consensus 482 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 558 (624)
......... .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 866432111 0112234468899999998754 4578999999999999999999999865433221111100000000
Q ss_pred -------ccccccccchhhhhcc---CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 559 -------EERLMEVVDPVLKERA---THLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 559 -------~~~~~~~~d~~l~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
......+++....... .........++.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000001100000000 00001134678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=303.86 Aligned_cols=280 Identities=25% Similarity=0.297 Sum_probs=207.2
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC-----cee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD-----QTL 402 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 402 (624)
+|.+.+.||+|++|.||+++.. +++.+|||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999964 58999999886543 334567899999999999999999999998775 789
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||++ ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 588888852 237999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
........ ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+.........+.
T Consensus 152 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 152 GVDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred eecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 76532110 1112344578899999999877 789999999999999999999999975543221111110000000000
Q ss_pred cccccchhh----hhcc-------CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHHHHhcccC
Q 039681 562 LMEVVDPVL----KERA-------THLDLETMKALGLLAASCLDERRQNRPSMKEVADE--IEYIISIAKGR 620 (624)
Q Consensus 562 ~~~~~d~~l----~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~i~~~~~~~ 620 (624)
......... .... ..........+.+++.+||+.+|++||+++++++. ++++..-....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~ 302 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP 302 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence 000000000 0000 00001134568899999999999999999999974 66665544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=288.78 Aligned_cols=242 Identities=25% Similarity=0.319 Sum_probs=193.6
Q ss_pred eccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 338 IGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 338 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
||.|++|.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++.+.+....++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 48899999886432 23456789999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----- 147 (262)
T cd05572 81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----- 147 (262)
T ss_pred HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----
Confidence 999963 245899999999999999999999998 9999999999999999999999999998764321
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
......++..|++||.+.+..++.++|+||||+++|||++|..||...... .............
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~------------ 211 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG------------ 211 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC------------
Confidence 112345788999999998888999999999999999999999998754321 1111111111000
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
....+......+.+++.+||+.+|++||+ ++|+++
T Consensus 212 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 212 KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 00111122456888999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.32 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=203.5
Q ss_pred HHhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
..+-++.....||.|.||.||-+. .++|...|+|-++... .+......+|+.++..++|||+|+.+|+-.+++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 344456677899999999999999 6779999999765443 3446678999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
.||||++|+|.+.+. ...-+++.....+..|++.|++|||+++ ||||||||.||||+.+|.+|++|||.|..
T Consensus 1312 FMEyC~~GsLa~ll~-----~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE-----HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHhccCcHHHHHH-----hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999996 3345777777888999999999999999 99999999999999999999999999998
Q ss_pred ccccCCCCcceeecccccccccCccccccc---CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNF---QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+...............||+.|||||++.+. ....++||||+|||++||+||++||..-+.+ . .+. ..+..
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~-aIM---y~V~~- 1456 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--W-AIM---YHVAA- 1456 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--h-HHH---hHHhc-
Confidence 875432333334567899999999999654 3556899999999999999999999632211 1 111 11111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+..++.+.....+-.+++.+||+.||++|-++.|+++
T Consensus 1457 -----------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 -----------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -----------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1223334446666778999999999999966665543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=290.66 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=202.4
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|++.+.||+|+||.||+++. .+++.+++|.+.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477888999999999999985 467899999886532 33456788999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999986422 22357899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
......++..|++||.+.+..++.++|+||||+++|||++|+.||......+ +.........
T Consensus 157 ------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~----- 218 (256)
T cd08530 157 ------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKY----- 218 (256)
T ss_pred ------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC-----
Confidence 1223457889999999988889999999999999999999999986443211 1111111111
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.........++.+++.+|++.+|++||++.|+++
T Consensus 219 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 -------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111234566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.01 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=199.4
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
|+..+.||+|++|.||++.. .+++.+++|++...... ....+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45678899999999999996 46889999988654332 4567889999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++ +|.+++.. ....+++.+++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKD----RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHh----hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 64 88887753 2257999999999999999999999999 9999999999999999999999999997764321
Q ss_pred CCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---ccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---ERLME 564 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 564 (624)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. .......... .....
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhccc
Confidence 122334578899999998776 789999999999999999999999865443221 1111111100 00000
Q ss_pred ccc------hhhhhc----cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVD------PVLKER----ATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d------~~l~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+ ...... ..........++.+++.+||+.+|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 000000 00011234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=285.24 Aligned_cols=247 Identities=27% Similarity=0.455 Sum_probs=200.7
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|+..+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++++++|+|++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999864 678999999876543 4567899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK-----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999863 256999999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
... .....++..|+|||...+...+.++||||+|++++||++|+.||...... .. ..... .....
T Consensus 153 ~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~-~~~~~-~~~~~---- 217 (254)
T cd06627 153 SKD----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AA-LFRIV-QDDHP---- 217 (254)
T ss_pred ccc----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HH-HHHHh-ccCCC----
Confidence 211 22345788999999998777899999999999999999999998633211 11 11111 00000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+......+.+++.+||+.+|++|||+.+++.
T Consensus 218 --------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 --------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 011123456778999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=296.44 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=199.2
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEccc--CCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCcee
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKL--GNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 402 (624)
......|++.++||.||.+.||++...+.+.+|+|++.. .+....+-|.+|+.+|.+++ |.+|++|++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 344566899999999999999999988889999887653 34455778999999999995 999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
|||||= ..+|..+|+.. ...++.-.+..+..|++.++.++|..+ |||.||||.|+|+-+ |.+||+|||+|.
T Consensus 437 mvmE~G-d~DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred EEeecc-cccHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhc
Confidence 999987 56899988632 223332378889999999999999999 999999999999865 589999999999
Q ss_pred cccccCCCCcceeecccccccccCccccccc-----------CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNF-----------QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV 551 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 551 (624)
.+.... .+......+||..||+||.+... ..+.+|||||+||+||+|+.|+.||... .+..
T Consensus 508 aI~~DT--TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~- 579 (677)
T KOG0596|consen 508 AIQPDT--TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQI- 579 (677)
T ss_pred ccCccc--cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHH-
Confidence 886432 22333567899999999998532 2567999999999999999999998621 1111
Q ss_pred HHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 552 YMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 552 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.++..+.||.-.-..+..+ ...++.++++.||+.||.+||+..|+++
T Consensus 580 --------aKl~aI~~P~~~Iefp~~~--~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 --------AKLHAITDPNHEIEFPDIP--ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --------HHHHhhcCCCccccccCCC--CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1233444442211122211 1223889999999999999999999974
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.73 Aligned_cols=244 Identities=27% Similarity=0.366 Sum_probs=190.8
Q ss_pred eccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 338 IGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 338 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
||+|+||+||++.. .+++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999985 468899999876432 22344578899999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++... ....+++.+++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++...... .
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-----~ 149 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-----K 149 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC-----C
Confidence 9998643 2246899999999999999999999999 999999999999999999999999998765421 1
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
......++..|+|||.+.+..++.++||||||++++||++|+.||.......... .+.......
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~------------- 213 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLEM------------- 213 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhccccc-------------
Confidence 1223457889999999988889999999999999999999999986543311110 011000000
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
...........+.+++.+||+.+|++|| ++.++++
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0001112345678899999999999999 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=305.05 Aligned_cols=275 Identities=25% Similarity=0.359 Sum_probs=210.0
Q ss_pred CCccceeccCCcEEEEEEE-EcCCCEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC------CceeE
Q 039681 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL------DQTLM 403 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 403 (624)
+...+.||+|+||.||+|+ ...|+.||||.++.. .....+...+|+++|++++|+|||++++.-.+. ...++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456789999999999999 457999999998754 345577889999999999999999999986543 36789
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC--CCC--CeEEeecC
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD--EKL--NAKVSDFG 479 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~--~~~--~~kl~DfG 479 (624)
||||+++|+|...|+.. .+...|++.+.+.+..++..||.|||+++ |+||||||.||++- .+| ..||+|||
T Consensus 95 vmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999743 34467999999999999999999999999 99999999999983 333 47999999
Q ss_pred CcccccccCCCCcceeecccccccccCccccc-ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYR-NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
.|+.++.. ..++...||..|.+||++. ...|+...|.|||||++||.+||..||.+...........|....-.
T Consensus 170 ~Arel~d~-----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 170 AARELDDN-----SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ccccCCCC-----CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 99987532 2678899999999999998 47899999999999999999999999987655543333333322222
Q ss_pred ccccccccchhhhh---------ccCcCcHHHHHHHHHHHHHchhcCCCCCC--CHHHHHHHHHHHHHh
Q 039681 559 EERLMEVVDPVLKE---------RATHLDLETMKALGLLAASCLDERRQNRP--SMKEVADEIEYIISI 616 (624)
Q Consensus 559 ~~~~~~~~d~~l~~---------~~~~~~~~~~~~l~~l~~~cl~~~p~~RP--s~~ev~~~L~~i~~~ 616 (624)
...+.-...+...+ ...+........+......+|..+|.+|- ...+.-..+..|+..
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 22111111111110 01122334445566677778888999887 777777777776653
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=294.29 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=195.5
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEeec
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
|.+.+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+++++ |+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999975 578899998764322 22334567999999999 999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
+|+|.+++... ....+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 88999888642 2246899999999999999999999999 9999999999999999999999999997654221
Q ss_pred CCCcceeecccccccccCccccc-ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc--------
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYR-NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE-------- 559 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 559 (624)
......++..|+|||++. ...++.++|+||||++++||++|+.||......+... ........
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY---KICSVLGTPTKQDWPE 225 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH---HHHHhcCCCChhhhhh
Confidence 122345788999999885 4458999999999999999999999987554322111 00000000
Q ss_pred -cccccccchhhhhccCc----CcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 -ERLMEVVDPVLKERATH----LDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 -~~~~~~~d~~l~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+....+..+...... ........+.+++.+||+.+|++|||++|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000001000000000 00011356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=292.28 Aligned_cols=248 Identities=27% Similarity=0.360 Sum_probs=195.3
Q ss_pred eccCCcEEEEEEEEc-CCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 338 IGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 338 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
||+|+||.||+++.. +++.+++|.+..... ...+.+.+|++++++++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 489999998865433 3456789999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC--
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND-- 491 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~-- 491 (624)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLEN-----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 999863 236899999999999999999999999 9999999999999999999999999987643221100
Q ss_pred --cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 492 --SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 492 --~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
........++..|+|||.......+.++||||||++++||++|..||......+ ....... +...
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~------ 219 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILN-GKIE------ 219 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhc-CCcC------
Confidence 111234457889999999988889999999999999999999999986443211 1111111 1000
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
. .........+..++.+||+.+|++|||+.++.+.|+
T Consensus 220 ~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 W-----PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C-----CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 000112456788999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=280.65 Aligned_cols=241 Identities=26% Similarity=0.333 Sum_probs=198.1
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|...++||+|.||.|.+++. ..++.+|+|+++..- ......-+.|-++|+..+||.+..|...|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788999999999999999984 578999999987543 23345567899999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||..||.|.-+|. +...+++...+.+-.+|+.||.|||+++ ||.||||.+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLs-----rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLS-----RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehh-----hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999996 3457899999999999999999999999 999999999999999999999999999753
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
........+.+||+.|+|||++....|....|+|.+|||+|||++|+.||...+.+. +...+. +.+-+.
T Consensus 319 ----I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLIl--~ed~kF-- 387 (516)
T KOG0690|consen 319 ----IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELIL--MEDLKF-- 387 (516)
T ss_pred ----ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHHH--hhhccC--
Confidence 334445678899999999999999999999999999999999999999997433221 111110 111111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP 601 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 601 (624)
+.....+...|+...|.+||.+|.
T Consensus 388 -------------Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 388 -------------PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -------------CccCCHHHHHHHHHHhhcChHhhc
Confidence 122334556688889999999994
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=295.28 Aligned_cols=256 Identities=26% Similarity=0.319 Sum_probs=198.6
Q ss_pred CCCccceeccCCcEEEEEEEE----cCCCEEEEEEcccCC----cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCce
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKRAKLGN----TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 401 (624)
+|++.+.||+|++|.||+++. .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999884 357889999876432 22345688999999999 599999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999998862 246899999999999999999999998 999999999999999999999999998
Q ss_pred ccccccCCCCcceeecccccccccCcccccccC--CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ--LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
+...... ........++..|+|||.+.+.. .+.++||||||+++|||++|..||....... ............
T Consensus 153 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~ 227 (288)
T cd05583 153 KEFLAEE---EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS 227 (288)
T ss_pred ccccccc---ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc
Confidence 7654321 11112345788999999987654 7889999999999999999999986332111 111111111111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
. + .........+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 ~-------~-------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 K-------P-------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred C-------C-------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 0 01112334577899999999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=303.20 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=195.5
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD------ 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 399 (624)
.++|...+.||+|+||.||+|+. .+++.||+|++.... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46788899999999999999995 468999999876432 223456889999999999999999999987543
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence 4689999995 46655442 35899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 163 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~ 232 (342)
T cd07879 163 LARHADAE-------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTG 232 (342)
T ss_pred CCcCCCCC-------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcC
Confidence 98764321 123456888999999866 4688999999999999999999999975432211 111111000
Q ss_pred c--ccccccc-chhh---hh---ccCcC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH--HHHHHHh
Q 039681 559 E--ERLMEVV-DPVL---KE---RATHL-----DLETMKALGLLAASCLDERRQNRPSMKEVADE--IEYIISI 616 (624)
Q Consensus 559 ~--~~~~~~~-d~~l---~~---~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~i~~~ 616 (624)
. ....+.. +... .. ..... .......+.+++.+||+.+|++||++.|++.. ++.++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0 0000000 0000 00 00000 00123457889999999999999999999954 6666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=302.19 Aligned_cols=272 Identities=22% Similarity=0.333 Sum_probs=199.4
Q ss_pred CHHHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 039681 321 TGKEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397 (624)
Q Consensus 321 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 397 (624)
...++...+++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 4456677889999999999999999999984 578899999886432 2234668899999999999999999998864
Q ss_pred C------CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC
Q 039681 398 L------DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL 471 (624)
Q Consensus 398 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~ 471 (624)
. ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 3 3467788876 7889887742 35899999999999999999999999 99999999999999999
Q ss_pred CeEEeecCCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHH
Q 039681 472 NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550 (624)
Q Consensus 472 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 550 (624)
.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............
T Consensus 158 ~~kl~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 158 ELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CEEEeccccccccccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999998754321 123457889999998866 46889999999999999999999998654332211111
Q ss_pred HHHHHHhcccccccccchhh----h--hccCcCc-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 551 VYMKKIMDEERLMEVVDPVL----K--ERATHLD-----LETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 551 ~~~~~~~~~~~~~~~~d~~l----~--~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..............+.+... . ...+... ......+.+++.+|++.+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000000000000000 0 0000000 0123457889999999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=300.68 Aligned_cols=269 Identities=23% Similarity=0.285 Sum_probs=191.9
Q ss_pred CCCccceeccCCcEEEEEEEEc-C--CCEEEEEEcccC--CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeC----Cc
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-D--GTVTAIKRAKLG--NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL----DQ 400 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 400 (624)
+|++.+.||+|+||.||+++.. . +..||+|++... .....+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999954 3 778999987642 222345688999999999 599999999976432 35
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++++||+. ++|.+++. ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIR-----SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 678888885 68888885 2346899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
++.................|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......+..............
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 98654321111111234568899999998765 46899999999999999999999998754322111100000000000
Q ss_pred cccccccchhhh----h--ccCc-----CcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ERLMEVVDPVLK----E--RATH-----LDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~----~--~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+..+.++... . .... ........+.+++.+|++.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000111010000 0 0000 00112356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=280.34 Aligned_cols=275 Identities=21% Similarity=0.312 Sum_probs=200.9
Q ss_pred CCCCccceeccCCcEEEEEEEEcC-----CCEEEEEEcccCCcc-h-hHHHHHHHHHHHhcCCCceeeEeeEEEe-CCce
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD-----GTVTAIKRAKLGNTK-G-TDLVLNEVRILCQVNHRSLVRLLGCCVE-LDQT 401 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 401 (624)
..|+....||+|.||.||+|+-.+ ...+|||+++..... + .....+|+.+++.++|||++.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 357778889999999999997432 236899998754221 2 3457899999999999999999999988 7788
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC----CCeEEee
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK----LNAKVSD 477 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~----~~~kl~D 477 (624)
+|++||.+. +|...|+.....+...++...+..|+.||+.|+.|||++. |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 8888887665556678999999999999999999999999 9999999999999877 9999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCcccc------ccHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN------VNLV 550 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~------~~~~ 550 (624)
||+++.+...- ..-.....++.|++|+|||++.+. .||.+.|||+.||+..||+|.++-|......-. .++.
T Consensus 180 lGlaR~~~~pl-kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 180 LGLARLFNNPL-KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred ccHHHHhhccc-cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999876421 111122356789999999998766 589999999999999999999888765433211 1122
Q ss_pred HHHHHHhc---ccccccc---cch-hhhh--c-cCcCcH---H-------HHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 551 VYMKKIMD---EERLMEV---VDP-VLKE--R-ATHLDL---E-------TMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 551 ~~~~~~~~---~~~~~~~---~d~-~l~~--~-~~~~~~---~-------~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+-..+. +.++..+ .+- .+.. + ....+. . ......+|..++|+.||.+|.|++++++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 22222221 1111111 110 0000 0 000000 0 11236678999999999999999998753
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=303.73 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=198.0
Q ss_pred CccceeccCCcEEEEEEEEcC-CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 333 SKDNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
.+..-||.|+||.||+|+.++ +-..|-|++.....+..++|+-|++||....||+||+|++.|+..+.++++.|||.||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 344569999999999999765 4456778888777888899999999999999999999999999999999999999999
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
-....+-. -...|++.++..+..|++.||.|||++. |||||||+.|||++-+|.++|+|||.+-.... .
T Consensus 115 AVDaimlE----L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~----t 183 (1187)
T KOG0579|consen 115 AVDAIMLE----LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS----T 183 (1187)
T ss_pred hHhHHHHH----hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh----H
Confidence 88877642 3457999999999999999999999999 99999999999999999999999999854321 1
Q ss_pred cceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 492 SHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
...-....||++|||||+.+ ..+|+.++||||||+.|.||..+.+|-.. .+....+.+....+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKiaKSe------ 251 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAKSE------ 251 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHhhcC------
Confidence 11123567999999999874 45799999999999999999999988531 11111111111111
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.|.+.. +......+.+++.+||..+|..||++.++++
T Consensus 252 PPTLlq-----PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 252 PPTLLQ-----PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCcccC-----cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 122211 2345567888999999999999999999974
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.13 Aligned_cols=265 Identities=18% Similarity=0.236 Sum_probs=191.4
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCC
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33445555555555544 6899999998654 34456789999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC--
Q 039681 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN-- 490 (624)
Q Consensus 413 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~-- 490 (624)
|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.+.........
T Consensus 86 l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99998743 2235899999999999999999999999 999999999999999999999999988755321110
Q ss_pred -CcceeecccccccccCcccccc--cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh----ccc---
Q 039681 491 -DSHIFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM----DEE--- 560 (624)
Q Consensus 491 -~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~--- 560 (624)
.........++..|+|||++.. ..++.++||||||+++|||++|+.||....... .+........ ...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence 0111123456788999999865 358899999999999999999999997432211 1111110000 000
Q ss_pred ----cccc----ccchhhhh-ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 ----RLME----VVDPVLKE-RATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ----~~~~----~~d~~l~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... ..++.... ...........++.+++.+||+.+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 00111000 000111234467888999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=288.85 Aligned_cols=241 Identities=26% Similarity=0.353 Sum_probs=185.6
Q ss_pred eeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc---hhHHHHHHHH---HHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 337 LIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK---GTDLVLNEVR---ILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
+||+|+||.||++.. .+++.||+|.+...... ....+..|.. .++..+||||+++++++.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 46889999987643221 1223444444 3444579999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 9999988852 346999999999999999999999998 9999999999999999999999999987553211
Q ss_pred CCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.......... ....... .++
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~ 216 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAV 216 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCC
Confidence 1234688999999998754 68999999999999999999999997543221111 1110000 011
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
.+ +......+.+++.+|++.+|.+|| ++.++++
T Consensus 217 ~~-------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 EL-------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC-------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 112245678899999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.37 Aligned_cols=244 Identities=23% Similarity=0.263 Sum_probs=187.8
Q ss_pred ceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHH-HhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRIL-CQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+|+||.||+|.. .+++.||+|.+..... .....+..|..++ ...+|+|++++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4699999999999985 4688999998864322 1223345555544 455899999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999999863 246899999999999999999999998 99999999999999999999999999875432
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
.....++..|+|||.+.+..++.++||||||+++|||++|..||......+ ...... ..... ..+
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~--~~~-- 214 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNIL-SRRIN--WPE-- 214 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hcccC--CCC--
Confidence 123457889999999988788999999999999999999999986433211 111111 11000 000
Q ss_pred hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 571 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
.........+.+++.+||+.+|++||++.++.+.|.
T Consensus 215 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 -----EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -----cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 001123456888999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=291.19 Aligned_cols=251 Identities=27% Similarity=0.359 Sum_probs=194.6
Q ss_pred CCCccceeccCCcEEEEEEEE----cCCCEEEEEEcccCC----cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCce
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKRAKLGN----TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 401 (624)
+|++.+.||+|+||.||++.. .+|..||+|+++... ....+.+.+|+++++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 368899999886432 22346688999999999 599999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+|||+++++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999999863 246889999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccc--CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNF--QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
....... ........++..|+|||.+... .++.++||||||+++|||++|+.||....... ............
T Consensus 153 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~ 227 (290)
T cd05613 153 KEFHEDE---VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS 227 (290)
T ss_pred eeccccc---ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc
Confidence 7654221 1112234588899999998653 46889999999999999999999986432211 111111111111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
. + ..+......+.+++.+||+.+|++|| +.++++.
T Consensus 228 ~-------~-------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 E-------P-------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred C-------C-------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 0 00112334577899999999999997 6677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.08 Aligned_cols=263 Identities=24% Similarity=0.268 Sum_probs=195.6
Q ss_pred CCCC-ccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcch--------------hHHHHHHHHHHHhcCCCceeeEee
Q 039681 330 NNFS-KDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKG--------------TDLVLNEVRILCQVNHRSLVRLLG 393 (624)
Q Consensus 330 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 393 (624)
++|. +.+.||+|+||+||++... +++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4578999999999999954 68999999876432221 124789999999999999999999
Q ss_pred EEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 394 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
++...+..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 9999999999999996 689888852 346899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCC----------CCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 039681 474 KVSDFGLSRLVERTET----------NDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNR 542 (624)
Q Consensus 474 kl~DfGla~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~ 542 (624)
||+|||++........ ..........++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999976541110 001112234567889999998764 47899999999999999999999987554
Q ss_pred ccccccHHHHHHHHhcccc---cccc------------cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 543 EEENVNLVVYMKKIMDEER---LMEV------------VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~---~~~~------------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
..+ ....+........ .... ..+..... .......+.+++.+||+.+|++||+++|++
T Consensus 239 ~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 239 EID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI----FPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh----CcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 322 1111111111100 0000 00001000 012245678899999999999999999998
Q ss_pred H
Q 039681 608 D 608 (624)
Q Consensus 608 ~ 608 (624)
.
T Consensus 312 ~ 312 (335)
T PTZ00024 312 K 312 (335)
T ss_pred c
Confidence 5
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=320.56 Aligned_cols=258 Identities=29% Similarity=0.410 Sum_probs=188.0
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL----- 398 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 398 (624)
.+-..+|+..++||+||||.||+++.+ ||+.+|||++.... .+....+.+|+..|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 355677888999999999999999965 89999999987653 23345688999999999999999997543110
Q ss_pred --------------------------------------------------------------------------------
Q 039681 399 -------------------------------------------------------------------------------- 398 (624)
Q Consensus 399 -------------------------------------------------------------------------------- 398 (624)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHH
Q 039681 399 ----------------------------------DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444 (624)
Q Consensus 399 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L 444 (624)
..+||-||||+..+|.++++.+...+ .....++++.+|+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHH
Confidence 01245567777766666665321110 3567899999999999
Q ss_pred HHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc--------------ccCCCCcceeecccccccccCcccc
Q 039681 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE--------------RTETNDSHIFTTAQGTMGYLDPEYY 510 (624)
Q Consensus 445 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~--------------~~~~~~~~~~~~~~gt~~y~aPE~~ 510 (624)
+|+|+++ ||||||||.||++|++..+||+|||+|.... ..........+..+||.-|+|||++
T Consensus 711 aYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999999 9999999999999999999999999998621 0011112234677899999999999
Q ss_pred cccC---CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHH
Q 039681 511 RNFQ---LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGL 587 (624)
Q Consensus 511 ~~~~---~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 587 (624)
.+.. |+.|+|+||+|+|++||+. ||..+.+. +. +....+.+.+..- .....+....-..
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-----a~-iL~~LR~g~iP~~---------~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-----AS-ILTNLRKGSIPEP---------ADFFDPEHPEEAS 849 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHHH-----HH-HHHhcccCCCCCC---------cccccccchHHHH
Confidence 7654 9999999999999999986 45533221 11 1122223322221 1111223334466
Q ss_pred HHHHchhcCCCCCCCHHHHHH
Q 039681 588 LAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 588 l~~~cl~~~p~~RPs~~ev~~ 608 (624)
++.+++++||.+|||+.|++.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999999974
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=298.13 Aligned_cols=268 Identities=26% Similarity=0.337 Sum_probs=195.2
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeCC------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVELD------ 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 399 (624)
.++|++.+.||+|+||.||+|+.. +++.+|+|++...... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999964 6889999987644322 2345789999999999999999999876543
Q ss_pred --ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 400 --QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 400 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
..++|+||+.+ +|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence 46899999964 67666642 2346999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCC-------CcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccH
Q 039681 478 FGLSRLVERTETN-------DSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNL 549 (624)
Q Consensus 478 fGla~~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~ 549 (624)
||++......... .....+...++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999765432111 11122344678889999988654 588999999999999999999999875433221111
Q ss_pred HHHHHHHhcccc------cccc--------cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 550 VVYMKKIMDEER------LMEV--------VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 550 ~~~~~~~~~~~~------~~~~--------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.........+.. +... ..+.+.... ......+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF----GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc----ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111000000000 0000 001110000 112256788999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.97 Aligned_cols=265 Identities=24% Similarity=0.310 Sum_probs=197.5
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEe-CCc
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE-LDQ 400 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 400 (624)
+...+++|+..+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345678899999999999999999985 478999999875422 2334678899999999999999999999876 567
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++|+||+ +++|.+++.. ..+++.....++.|++.||+|||+.+ |+||||+|+|||+++++.+||+|||+
T Consensus 85 ~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred EEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 88999998 5688887742 35888999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc-
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD- 558 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 558 (624)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..+.....
T Consensus 155 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~---~~~~~~~~~ 224 (328)
T cd07856 155 ARIQDPQ-------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF---SIITDLLGT 224 (328)
T ss_pred ccccCCC-------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCC
Confidence 8754321 123456788999998765 56899999999999999999999998654321111 11111100
Q ss_pred --ccccccccchh-------hhhccCc----CcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 559 --EERLMEVVDPV-------LKERATH----LDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 559 --~~~~~~~~d~~-------l~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
++......+.. +...... ........+.+++.+||+.+|++||++.|++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0000000 001134678899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.78 Aligned_cols=249 Identities=26% Similarity=0.334 Sum_probs=204.9
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.....|.+.+.||+|.|+.|..++. ..+..||||.+.... ......+.+|+++|+.++|||||+++.+......+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456788899999999999999995 468999999887543 2334568999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||..+|.+++++.. ...+.+..+..++.|+.+|++|+|++. |+|||||++||||+.+.++||+|||++..
T Consensus 133 V~eya~~ge~~~yl~~-----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK-----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEeccCchhHHHHHh-----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence 9999999999999974 345666888999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
+.. .....+..|++.|.|||++.+..+ .+++|+||+|++||-|+.|..||++..-.+-
T Consensus 205 ~~~-----~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---------------- 263 (596)
T KOG0586|consen 205 FDY-----GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---------------- 263 (596)
T ss_pred ecc-----cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc----------------
Confidence 652 334567789999999999998875 6799999999999999999999975432211
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
-++.+.. ...++.....+..++++++|-.+|.+|++++++.+
T Consensus 264 ---r~rvl~g-k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 264 ---RPRVLRG-KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ---cchheee-eecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1111111 11112223345667899999999999999999865
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=295.26 Aligned_cols=269 Identities=21% Similarity=0.262 Sum_probs=193.7
Q ss_pred ceeccC--CcEEEEEEEE-cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTG--GFGEVFKGIL-DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+| +||+||++.. .+++.||+|+...... ...+.+.+|+.+++.++||||+++++++......++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999996 4789999999865432 3356788999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999886431 235899999999999999999999998 999999999999999999999999865433211111
Q ss_pred Cccee---ecccccccccCccccccc--CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH---------
Q 039681 491 DSHIF---TTAQGTMGYLDPEYYRNF--QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI--------- 556 (624)
Q Consensus 491 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 556 (624)
..... ....++..|+|||++.+. .++.++||||||+++|||++|+.||......+. ........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence 10000 112345679999998653 478999999999999999999999864332110 00000000
Q ss_pred --------------hc----ccccc-----cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHH
Q 039681 557 --------------MD----EERLM-----EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD--EIE 611 (624)
Q Consensus 557 --------------~~----~~~~~-----~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~ 611 (624)
.. +.... .+.+..+. ..........+.+|+.+||+.||++|||+.|+++ .++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR---TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred cchhhhhhccchhhhhcccccchhcccccccccccccc---chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 00 00000 00000000 0112235567899999999999999999999974 344
Q ss_pred HHHH
Q 039681 612 YIIS 615 (624)
Q Consensus 612 ~i~~ 615 (624)
.+..
T Consensus 313 ~~~~ 316 (328)
T cd08226 313 QVKE 316 (328)
T ss_pred HHHH
Confidence 4443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=288.10 Aligned_cols=250 Identities=26% Similarity=0.322 Sum_probs=193.3
Q ss_pred CCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC-----CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG-----NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
+|.+.+.||+|+||.||+++.. .+..+++|..+.. .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999854 3444555554321 122344577899999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
+||+++++|.+++... ......+++..++.++.|++.||+|||+.+ ++|+||||+||++++ +.+||+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEEL-KHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHH-hhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999888632 123457999999999999999999999999 999999999999986 46999999998765
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......... ..
T Consensus 156 ~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~-~~--- 221 (260)
T cd08222 156 MGSC----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVE-GP--- 221 (260)
T ss_pred CCCc----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHc-CC---
Confidence 4221 122345578899999999888889999999999999999999999853221 111111111 10
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. +..+......+.+++.+||+.+|++||++.|+++
T Consensus 222 --~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 --T-------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --C-------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 1112234557888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=316.03 Aligned_cols=268 Identities=26% Similarity=0.371 Sum_probs=207.7
Q ss_pred HHHHHhCCCCccceeccCCcEEEEEEEEc----C----CCEEEEEEcccC-CcchhHHHHHHHHHHHhc-CCCceeeEee
Q 039681 324 EIRRATNNFSKDNLIGTGGFGEVFKGILD----D----GTVTAIKRAKLG-NTKGTDLVLNEVRILCQV-NHRSLVRLLG 393 (624)
Q Consensus 324 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 393 (624)
.++...++..+.+.||+|.||.|++|... . ...||||.++.. ...+.+.+..|+++|+.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34444555566779999999999999843 1 356999998754 334567899999999999 5999999999
Q ss_pred EEEeCCceeEEEeeccCCCccccccccc---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 039681 394 CCVELDQTLMIYEYIPNGTLFDHLHCDF---------TGKW--PPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKS 462 (624)
Q Consensus 394 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~ 462 (624)
+|..+...++|.||+..|+|.++++... .... ..|+....+.++.|||.||+||++.. +|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997654 1111 24999999999999999999999999 99999999
Q ss_pred CCeEECCCCCeEEeecCCcccccccCCCCcceeeccc--ccccccCcccccccCCCCccchhhHHHHHHHHHhC-CCCCC
Q 039681 463 SNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ--GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTS-KKAID 539 (624)
Q Consensus 463 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg-~~p~~ 539 (624)
+|||+.++..+||+|||+|+....... ....... -...|||||.+....++.||||||||++||||+|. ..|+.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~---y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDY---YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCc---eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 999999999999999999997653221 1112222 34569999999999999999999999999999984 45554
Q ss_pred CCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 540 FNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
.-... .+ +....+++...+ .+..+..++.++++.||+.+|++||++.|+.+.++..+.
T Consensus 524 ~~~~~--~~----l~~~l~~G~r~~------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 524 GIPPT--EE----LLEFLKEGNRME------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCcH--HH----HHHHHhcCCCCC------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 31101 11 122333332211 122345667789999999999999999999999999643
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=292.16 Aligned_cols=244 Identities=29% Similarity=0.407 Sum_probs=191.7
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
|+..+.||+|+||.||+|+. .++..+|+|.+... .....+++.+|+++++.++|+|++++++++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 55567899999999999995 46788999987642 223345688999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+. |+|.+++.. ....+++.++..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~----~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 97 CL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred cC-CCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 96 688777642 2345899999999999999999999998 999999999999999999999999998765321
Q ss_pred CCCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
....++..|+|||.+. ...++.++||||||+++|||++|+.||......+ ......... .
T Consensus 169 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~-- 231 (308)
T cd06634 169 --------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-S-- 231 (308)
T ss_pred --------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhcC-C--
Confidence 2345788999999974 3467889999999999999999999975322111 111111110 0
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
+.. ........+.+++.+||+.+|++||++.+++..
T Consensus 232 ---~~~------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 ---PAL------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ---CCc------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 000 011344567889999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=290.64 Aligned_cols=262 Identities=26% Similarity=0.347 Sum_probs=197.9
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
|+..+.||+|++|.||+|+.. +++.+|+|+..... ....+.+..|+.++++++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999965 58999999887543 333467889999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
+ ++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++.......
T Consensus 81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 5899998632 146999999999999999999999999 9999999999999999999999999998654321
Q ss_pred CCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc---cccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD---EERLME 564 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 564 (624)
. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+. ...+..... +.....
T Consensus 153 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 153 R----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPG 225 (282)
T ss_pred c----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHh
Confidence 1 12233457789999998766 789999999999999999999998865432211 111111110 000000
Q ss_pred c-----cchhhhhc----cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 V-----VDPVLKER----ATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~-----~d~~l~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. .+...... ...........+.+++.+||+.+|++||++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 00000000 00000112457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.60 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=193.3
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcC-CCEEEEEEcccCCc-chhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 404 (624)
..++|++.+.||+|+||.||+++.++ ++.||||+++.... .....+..|+.++.+.. |+||+++++++.+....++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34568889999999999999999764 89999999875432 23455777888777775 99999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|||++ ++|.+++.. ....+++..+..++.|++.||+|||+. + |+||||+|+||++++++.+||+|||++..
T Consensus 93 ~e~~~-~~l~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 93 MELMS-TCLDKLLKR----IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eeccC-cCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 99984 567666642 124799999999999999999999974 6 99999999999999999999999999876
Q ss_pred ccccCCCCcceeecccccccccCcccccccC----CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQ----LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
+.... ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ..........
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~ 234 (296)
T cd06618 165 LVDSK-----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQE 234 (296)
T ss_pred ccCCC-----cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcC
Confidence 53211 112335778999999986543 788999999999999999999998632111 1111111111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
. ... +.. ......++.+++.+||+.+|++||+++++++.
T Consensus 235 ~-~~~-----~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 235 E-PPS-----LPP-----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-CCC-----CCC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 000 000 01234567889999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.46 Aligned_cols=267 Identities=22% Similarity=0.342 Sum_probs=194.6
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC---------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--------- 398 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 398 (624)
..+|...+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36788999999999999999995 46889999998776666677889999999999999999999876653
Q ss_pred -----CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-CCCC
Q 039681 399 -----DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLN 472 (624)
Q Consensus 399 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-~~~~ 472 (624)
...++|+||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ ++||||||+||+++ +++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCce
Confidence 35789999996 588877742 35899999999999999999999999 99999999999997 5667
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV 551 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 551 (624)
+||+|||+++........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||......+... .
T Consensus 154 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~--~ 230 (342)
T cd07854 154 LKIGDFGLARIVDPHYSH-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ--L 230 (342)
T ss_pred EEECCcccceecCCcccc-ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H
Confidence 899999999765321111 111123357889999998754 468889999999999999999999996543221110 0
Q ss_pred HHHHHh--cc---cccccccchhhh--hccCcC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 552 YMKKIM--DE---ERLMEVVDPVLK--ERATHL-----DLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 552 ~~~~~~--~~---~~~~~~~d~~l~--~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...... .. ..........+. ...... ......++.+++.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 00 000000000000 000000 0123356788999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=290.59 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=200.3
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 404 (624)
++|...+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999964 7899999987642 2233467889999999998 99999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 999999999999863 347999999999999999999999999 999999999999999999999999999865
Q ss_pred cccCCCC----------------cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 039681 485 ERTETND----------------SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548 (624)
Q Consensus 485 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~ 548 (624)
....... ........++..|+|||.+....++.++||||||++++|+++|+.||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---- 228 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---- 228 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----
Confidence 4322110 01123345788999999998888999999999999999999999998744311
Q ss_pred HHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH----HHHHH
Q 039681 549 LVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM----KEVAD 608 (624)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~ev~~ 608 (624)
..+....... ...+......+.+++.+||+.+|++||++ +++++
T Consensus 229 --~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 --LTFQKILKLE--------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHHHHhcC--------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111100 01111224567889999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=274.89 Aligned_cols=270 Identities=22% Similarity=0.314 Sum_probs=207.7
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcch--hHHHHHHHHHHHhcCCCceeeEeeEEEeC--------C
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQVNHRSLVRLLGCCVEL--------D 399 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 399 (624)
.|....+||+|.||.||+|+. ++|+.||+|++-..+++. ....++|+++|..+.|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 355567899999999999995 457888998766544432 45678999999999999999999988642 3
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++|++++++ +|..+|.. ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||
T Consensus 98 t~ylVf~~ceh-DLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 47999999964 78887752 3356899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+++.+..++......++..+.|..|++||.+.+. .++++.|||..||++.||+||.+-+.++.+.....++..+-.-+.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9988776555555557778889999999998765 699999999999999999999998877665554444444333333
Q ss_pred ccccccccchhhhhccCc---------CcHHH------HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 EERLMEVVDPVLKERATH---------LDLET------MKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~---------~~~~~------~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+.++..-.+...... .-... .++.++|+..++..||.+|+++.+++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 333333222222111100 00111 136778999999999999999999864
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.02 Aligned_cols=266 Identities=22% Similarity=0.292 Sum_probs=197.9
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC--
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD-- 399 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 399 (624)
+....++|+..+.||+|+||.||++.. .++..||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344567899999999999999999984 578999999875432 223456889999999999999999999987654
Q ss_pred ----ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEE
Q 039681 400 ----QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475 (624)
Q Consensus 400 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl 475 (624)
..++|+||+ +++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 358999999 7788887742 36899999999999999999999999 999999999999999999999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 554 (624)
+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ......
T Consensus 160 ~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~ 230 (343)
T cd07880 160 LDFGLARQTDSE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMK 230 (343)
T ss_pred eecccccccccC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 999999765321 123456889999999875 4588999999999999999999999874432111 000000
Q ss_pred H----------Hhcccccc-------cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH--HHHHHH
Q 039681 555 K----------IMDEERLM-------EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA--DEIEYI 613 (624)
Q Consensus 555 ~----------~~~~~~~~-------~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~--~~L~~i 613 (624)
. ........ ......+.. ........+.+++.+|++.+|++|||+.+++ ..++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS----LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHH----hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 00000000 000000000 0012234578899999999999999999998 344443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.87 Aligned_cols=272 Identities=24% Similarity=0.320 Sum_probs=212.7
Q ss_pred HHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC
Q 039681 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD 399 (624)
Q Consensus 324 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 399 (624)
+++...++|.+.++||+|+||.|...+. ..++++|+|++... ...+...|..|-++|..-+.+.|++++..|++..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 4455567899999999999999999996 46899999998652 2344567999999999999999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
++|+|||||+||+|..++. +...+++..+..++..|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 149 ~LYlVMdY~pGGDlltLlS-----k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLS-----KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ceEEEEecccCchHHHHHh-----hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999996 3347999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCccccc----c-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYR----N-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 554 (624)
.+-.+. .+..-.....+|||.|++||++. + +.|....|+||+||++|||+.|..||+...- +.-..
T Consensus 221 sClkm~---~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~ 291 (1317)
T KOG0612|consen 221 SCLKMD---ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYG 291 (1317)
T ss_pred hHHhcC---CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHH
Confidence 987765 23333456789999999999985 2 4689999999999999999999999974322 22222
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC---HHHHHH-------HHHHHHHhcccCCCC
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS---MKEVAD-------EIEYIISIAKGRISE 623 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~-------~L~~i~~~~~~~~~~ 623 (624)
+.++...... .+ .+...+.+..+||.+.+. +|+.|.. .+++-. ...+|+..+.+-+|+
T Consensus 292 KIm~hk~~l~---------FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 292 KIMNHKESLS---------FP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred HHhchhhhcC---------CC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 2222211111 11 112345566777776554 6677776 666643 236666666666554
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=269.57 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=193.5
Q ss_pred CccceeccCCcEEEEEEEE-cCCCEEEEEEcccC-CcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEeecc
Q 039681 333 SKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
.....||.|..|+|++.+. ..|...|||..... +.++.+.++..++++..-+ .|+||+-+|+|..+...++-||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 3456699999999999995 46899999987654 5556677888888877664 8999999999999999999999983
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
.-++.++.. -..++++..+-++...+..||.||..+.. |||||+||+|||+|+.|++||+|||++-.+..
T Consensus 175 -~C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--- 244 (391)
T KOG0983|consen 175 -TCAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD--- 244 (391)
T ss_pred -HHHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec---
Confidence 344555542 23569999999999999999999998875 99999999999999999999999999976543
Q ss_pred CCcceeecccccccccCccccccc---CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNF---QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
+...+...|-+.|||||.+... .|+.++||||||+.|+||.||+.||.....+ ... +.+..+++
T Consensus 245 --SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~---ltkvln~e------ 311 (391)
T KOG0983|consen 245 --SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEV---LTKVLNEE------ 311 (391)
T ss_pred --ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHH---HHHHHhcC------
Confidence 2334566789999999998533 5889999999999999999999999864432 111 11222211
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.|.+... ......+.+++..||++|+.+||...++++
T Consensus 312 PP~L~~~-----~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 312 PPLLPGH-----MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCcc-----cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1222211 124456788999999999999999998875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.11 Aligned_cols=244 Identities=27% Similarity=0.386 Sum_probs=191.4
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
|...+.||+|+||+||+|+. .+++.|++|++..... ...+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567799999999999995 4688999998864322 2345688999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+. |+|.+++.. ....+++.+++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 95 577777752 2346899999999999999999999999 99999999999999999999999998864321
Q ss_pred CCCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.....++..|+|||++. ...++.++||||||+++|||++|..||....... ......... ...
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~ 239 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQND-SPT 239 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC-CCC
Confidence 12345788999999984 3568889999999999999999999986432211 111111111 000
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.. .......+.+++.+||+.+|.+||++.+++..
T Consensus 240 ~~-----------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 LQ-----------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CC-----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 11223457889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.41 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=196.7
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc---
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ--- 400 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 400 (624)
...++|+..+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++|+|++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999964 5789999987643 22344667889999999999999999998876554
Q ss_pred ---eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 401 ---TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 401 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 6799888852 36999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+...
T Consensus 162 fg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~ 231 (343)
T cd07851 162 FGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNL 231 (343)
T ss_pred cccccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHh
Confidence 9999765321 233457889999999865 3678999999999999999999999974432211 1111111
Q ss_pred hc---ccccccccchhh--------hhccC---cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 557 MD---EERLMEVVDPVL--------KERAT---HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 557 ~~---~~~~~~~~d~~l--------~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. +.....+..... ..... .........+.+++.+||+.+|++|||+.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 000000000000 00000 000012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=281.99 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=200.2
Q ss_pred HhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCc-------chhHHHHHHHHHHHhcCCCceeeEeeEEE-eC
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNT-------KGTDLVLNEVRILCQVNHRSLVRLLGCCV-EL 398 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 398 (624)
..++|-...+||+|||+.||++. +...+.||+|+-..... ...+...+|.+|.+.|+||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 44567778899999999999998 56788899997653321 12345789999999999999999999986 55
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC---CCCCeEE
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD---EKLNAKV 475 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~---~~~~~kl 475 (624)
+..+-|+||++|.+|.-||+ ....+++.++..|+.||+.||.||.... +||||-||||.||||- .-|.+||
T Consensus 541 dsFCTVLEYceGNDLDFYLK-----QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK-----QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccceeeeeecCCCchhHHHH-----hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence 67889999999999999997 3467999999999999999999999886 7899999999999994 4578999
Q ss_pred eecCCcccccccCCC--Cc-ceeecccccccccCcccccc----cCCCCccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 039681 476 SDFGLSRLVERTETN--DS-HIFTTAQGTMGYLDPEYYRN----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548 (624)
Q Consensus 476 ~DfGla~~~~~~~~~--~~-~~~~~~~gt~~y~aPE~~~~----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~ 548 (624)
+|||+++.+.....+ +. .......||.+|++||.+.- ..++.|+||||.||++|..+.|++||....... +
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--d 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--D 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--H
Confidence 999999998754332 11 22235579999999998842 258899999999999999999999997543321 1
Q ss_pred HHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 549 LVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.++.+...-.-.+. ..+....+...+|++||+..-++|.+..++..
T Consensus 693 -------ILqeNTIlkAtEVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 -------ILQENTILKATEVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------HHhhhchhcceeccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1112211111111111 11233455677999999999999988887753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=249.80 Aligned_cols=266 Identities=20% Similarity=0.291 Sum_probs=201.7
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcch--hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+|...++||+|.||+||+|+. +.++.||+|+++..+..+ ....++|+-+++.+.|.|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455667899999999999994 568999999988654332 45689999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+ ..+|..+..+ -.+.++.+.+..++.|+++||.+.|+++ +.|||+||.|.||+.+|++|++|||+++.+.
T Consensus 83 c-dqdlkkyfds----lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg-- 152 (292)
T KOG0662|consen 83 C-DQDLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG-- 152 (292)
T ss_pred h-hHHHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC--
Confidence 9 4578777642 3457999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCCcceeecccccccccCcccccccC-CCCccchhhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhcccccc--
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTS-KKAIDFNREEENVNLVVYMKKIMDEERLM-- 563 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 563 (624)
.....+...+.|.+|.+|.++-+.. |+...|+||.||++.|+..- ++.|++.+..++...+-+......++.+.
T Consensus 153 --ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 153 --IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred --CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 2233456677899999999987765 88999999999999999974 44455554444433333333333343322
Q ss_pred -cccchhhhhccC------cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 -EVVDPVLKERAT------HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 -~~~d~~l~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
++.|.......+ +.-+.....=.+|..+.+.-+|.+|.++++.++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 222322111110 001112223356777788889999999998765
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.78 Aligned_cols=250 Identities=22% Similarity=0.255 Sum_probs=195.9
Q ss_pred CCCCc-cceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEe----CCcee
Q 039681 330 NNFSK-DNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVE----LDQTL 402 (624)
Q Consensus 330 ~~~~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~ 402 (624)
++|++ .++||-|-.|.|-.... .+++.+|+|++... ....+|+++.=.. .|||||.+++++.+ ...++
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 34443 25799999999999885 47889999988632 3457888875444 69999999999864 45678
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEEeecC
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKVSDFG 479 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl~DfG 479 (624)
+|||.|+||.|+..++.+ ....+++.++..|+.||..|+.|||+.+ |.||||||+|+|... |-.+||+|||
T Consensus 136 iVmE~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeeecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 999999999999999743 3457999999999999999999999999 999999999999964 5669999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
+|+.-. ....+.+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||....... +.--++..+..
T Consensus 210 FAK~t~-----~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~ 281 (400)
T KOG0604|consen 210 FAKETQ-----EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRT 281 (400)
T ss_pred cccccC-----CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhc
Confidence 998643 2334567889999999999999999999999999999999999999998654321 11111111111
Q ss_pred cccccccchhhhhccCc-CcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ERLMEVVDPVLKERATH-LDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.. ..++ +-...++...++|+.+|..+|++|.|+.|+++
T Consensus 282 gqy----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 282 GQY----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCc----------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 110 1111 11346677889999999999999999999864
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=278.67 Aligned_cols=236 Identities=29% Similarity=0.365 Sum_probs=191.4
Q ss_pred eccCCcEEEEEEEEc-CCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 338 IGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 338 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
||+|+||.||++... +++.+|+|.+..... ...+.+..|++++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 588999998765432 2456789999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 493 (624)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~ 148 (250)
T cd05123 81 FSHLSK-----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----S 148 (250)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC----C
Confidence 999963 236899999999999999999999998 9999999999999999999999999997654321 1
Q ss_pred eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 494 ~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
......++..|+|||...+...+.++|+||||+++|||++|+.||...... ........ ..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~------------ 209 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EIYEKILK-DP------------ 209 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHhc-CC------------
Confidence 123456788999999998888899999999999999999999998643321 11111111 10
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPSMKE 605 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 605 (624)
...+......+.+++.+||..+|++||++.+
T Consensus 210 -~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 -LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0111122456788999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=275.10 Aligned_cols=267 Identities=23% Similarity=0.332 Sum_probs=209.3
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 397 (624)
+.....+++...++-+|.||.||+|.+. +.+.|.+|.++.. +.-+...++.|.-.+..+.|||+.++.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3444566778888999999999999654 3456777776533 34456779999999999999999999999886
Q ss_pred C-CceeEEEeeccCCCcccccc---cccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 398 L-DQTLMIYEYIPNGTLFDHLH---CDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 398 ~-~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
. +.++++|.++.-|+|..||. .......+.++..+...+|.|++.|++|||+.+ +||.||..+|.+||+..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeE
Confidence 4 57788899999999999996 122234467888999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 552 (624)
||+|=.+++.+-+.+ ....-...-....||+||.+.+..|+..+|||||||+||||+| |+.|+..-++.|
T Consensus 436 kltDsaLSRDLFP~D--YhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------- 506 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGD--YHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------- 506 (563)
T ss_pred EeccchhccccCccc--ccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------
Confidence 999999998765321 1111112234668999999999999999999999999999998 666765333322
Q ss_pred HHHHhccc-ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 553 MKKIMDEE-RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 553 ~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
+...+.++ ++ ..+..+++++..++.-||+..|++||++++++.-|.++-..
T Consensus 507 m~~ylkdGyRl-------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 MEHYLKDGYRL-------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHHhcccee-------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 11112221 11 12346788999999999999999999999999999987654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=269.75 Aligned_cols=257 Identities=21% Similarity=0.326 Sum_probs=199.7
Q ss_pred cceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEeeccCCC
Q 039681 335 DNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
.++||+|+|+.|--++ +.+|..+|||++............+|++++.+.+ |+||++|+++|.++...|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999999888 7889999999998776667788999999999995 9999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC---eEEeecCCccccccc--
Q 039681 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN---AKVSDFGLSRLVERT-- 487 (624)
Q Consensus 413 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~---~kl~DfGla~~~~~~-- 487 (624)
|..+|+ ++..+++.++.++.++|+.||.|||.++ |.||||||+|||-.+... +||+||.+..-+...
T Consensus 163 lLshI~-----~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 163 LLSHIQ-----KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred HHHHHH-----HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999997 4467999999999999999999999999 999999999999976544 899999887644321
Q ss_pred -CCCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccc-----cccHHHHHHHH
Q 039681 488 -ETNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE-----NVNLVVYMKKI 556 (624)
Q Consensus 488 -~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~-----~~~~~~~~~~~ 556 (624)
.........+.+|+..|||||+.. ..-|+.+.|.||||||||-|++|..||.+.-..+ ...-..-...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 112223345778999999999863 2248899999999999999999999997654321 11001111111
Q ss_pred hc---ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 557 MD---EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 557 ~~---~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
++ ++. .+..|.+ -.....+..+|+...+-.++.+|.++.+++.
T Consensus 315 FesIQEGk-YeFPdkd--------WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGK-YEFPDKD--------WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccC-CcCChhh--------hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11 110 1111111 1235566778889999999999999988875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=277.57 Aligned_cols=241 Identities=27% Similarity=0.386 Sum_probs=195.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc---chhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---KGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 403 (624)
..+|....+||+|+||.|.+|..+ ..+.+|||+++..-. .+.+--+.|-++|... +-|.+++++.+|+.-+.+++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 456888999999999999999854 467899998875422 2233346677777766 46889999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+.+|+|-.+++ +.+.+.+..+..+|.+||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.
T Consensus 428 VMEyvnGGDLMyhiQ-----Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ-----QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred EEEEecCchhhhHHH-----HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999986 4456888899999999999999999999 99999999999999999999999999975
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
- ........+.+||+.|+|||.+...+|+..+|+|||||+||||+.|+.||+++++++- +...++.
T Consensus 500 n----i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------F~aI~eh---- 565 (683)
T KOG0696|consen 500 N----IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQAIMEH---- 565 (683)
T ss_pred c----ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHHc----
Confidence 3 2233334678899999999999999999999999999999999999999987765432 1111111
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP 601 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 601 (624)
....+...+.+...+.+..|...|.+|.
T Consensus 566 ----------nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ----------NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1112234556677788888999999984
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=271.19 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=195.0
Q ss_pred cceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHh-cCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 335 DNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQ-VNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
...||.|+||+|+|-.++ .|+..|||+++..+. ++..+++.|.+...+ -+.||||+++|.+..++..++-||.| .-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 456999999999999864 699999999987655 567788999986554 47999999999999999999999999 45
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
+|..+.+.-..-+...+++.-.-.|+...+.||.||...-. ||||||||+|||||..|.+||+|||++-.+..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~----- 220 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD----- 220 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH-----
Confidence 77665443223345679999999999999999999998765 99999999999999999999999999876542
Q ss_pred cceeecccccccccCccccccc--CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 492 SHIFTTAQGTMGYLDPEYYRNF--QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
+...+...|-..|||||.+... .|+-+|||||||++|+|+.||+.|+..-. +....+......+ . |.
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gd-p-----p~ 289 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGD-P-----PI 289 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCC-C-----Ce
Confidence 2234566788999999998533 48999999999999999999999975211 1112222221111 1 11
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.. ..........+..++.-|+.+|..+||...++.+
T Consensus 290 l~~--~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 290 LLF--DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ecC--cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 1112345567888999999999999999998865
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=274.62 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=203.2
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-C-C----ceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-H-R----SLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 401 (624)
+++|.+...+|+|.||.|-..... .+..||||+++.. .+..+..+-|+++|.++. + | -+|++.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999998843 4789999998743 345566788999999994 2 2 388899999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC------------
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE------------ 469 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~------------ 469 (624)
++|+|.+ |-++.+++..+ +..+++..+++.|+.|++++++|||+.. ++|-||||+|||+-+
T Consensus 167 Civfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred EEEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999 66999999753 5678999999999999999999999999 999999999999831
Q ss_pred --------CCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 039681 470 --------KLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541 (624)
Q Consensus 470 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~ 541 (624)
+..+||+|||.|..... .....+.|..|+|||++.+-.++.++||||+||||.||.+|...|...
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e-------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHE-------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred cceeccCCCcceEEEecCCcceecc-------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 34589999999976432 125667899999999999999999999999999999999999999876
Q ss_pred CccccccHHHHHHHHhcccccccc----------cc----------------hhhhhccCcCcHHHHHHHHHHHHHchhc
Q 039681 542 REEENVNLVVYMKKIMDEERLMEV----------VD----------------PVLKERATHLDLETMKALGLLAASCLDE 595 (624)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~----------~d----------------~~l~~~~~~~~~~~~~~l~~l~~~cl~~ 595 (624)
+..|.....+.+...+...-+... +| +...............+|.+|+.+||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 644433222221111110000000 00 0000001111223445799999999999
Q ss_pred CCCCCCCHHHHHH
Q 039681 596 RRQNRPSMKEVAD 608 (624)
Q Consensus 596 ~p~~RPs~~ev~~ 608 (624)
||.+|+|+.|++.
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=309.01 Aligned_cols=145 Identities=26% Similarity=0.406 Sum_probs=130.6
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|.+.+.||+|+||.||+|... +++.||||+++... ......+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 68999999986432 223467889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
||+++++|.+++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999863 246889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=282.14 Aligned_cols=243 Identities=25% Similarity=0.361 Sum_probs=195.8
Q ss_pred cceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 335 DNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
+++||.|.||+||-|++ ++|+.||||++... ..+..+++.+|+.||+++.||.||.+.-.|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 57899999999999995 57999999987543 3455678999999999999999999999999999999999999 56
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC---CCeEEeecCCcccccccC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK---LNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~---~~~kl~DfGla~~~~~~~ 488 (624)
+..+.|-.. +.+.|++.....+..||+.||.|||.++ |+|.||||+|||+.+. -.+||+|||.|+.+...
T Consensus 648 DMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 648 DMLEMILSS---EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred hHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 666666533 4567999999999999999999999999 9999999999999643 46999999999987642
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
..-..++||+.|+|||++.+..|...-|+||.||++|--++|..||+.. ++..++++.+.-+...+.+
T Consensus 721 ----sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW------ 788 (888)
T KOG4236|consen 721 ----SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPW------ 788 (888)
T ss_pred ----hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCch------
Confidence 2235788999999999999999999999999999999999999999733 2222333322222222211
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
.+......+||...|+..-.+|-|.+.-+
T Consensus 789 ----------~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 ----------SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ----------hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 23444567788888888888888877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=286.48 Aligned_cols=239 Identities=21% Similarity=0.290 Sum_probs=192.8
Q ss_pred hCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++.|.....+|.|+|+.|-.+. ..+++..++|++... ..+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4567777889999999998888 456888999998754 22335677666665 69999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE-CCCCCeEEeecCCccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL-DEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill-~~~~~~kl~DfGla~~~~ 485 (624)
.+.++-|.+.+... ......+..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++...
T Consensus 397 ~l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999888877532 2223778889999999999999999 9999999999999 699999999999998765
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. ....+-|..|.|||++....+++++||||||++||||++|+.||...... ..+...+..+..
T Consensus 468 ~~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~--- 531 (612)
T KOG0603|consen 468 RS-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKF--- 531 (612)
T ss_pred hh-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcc---
Confidence 32 33556789999999999889999999999999999999999999754332 112222222211
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.....+...+|+.+||+.||.+||+|.++..
T Consensus 532 ------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 ------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1345566788999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=269.71 Aligned_cols=222 Identities=19% Similarity=0.184 Sum_probs=176.1
Q ss_pred CCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCccccccc
Q 039681 341 GGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC 419 (624)
Q Consensus 341 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 419 (624)
|.+|.||+++. .+++.+|+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 568999999986542 234555666667899999999999999999999999999999998863
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeeccc
Q 039681 420 DFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499 (624)
Q Consensus 420 ~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 499 (624)
...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++|||.+...... .....
T Consensus 79 -----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-------~~~~~ 143 (237)
T cd05576 79 -----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-------CDGEA 143 (237)
T ss_pred -----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-------cccCC
Confidence 235899999999999999999999999 999999999999999999999999987655321 12334
Q ss_pred ccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcH
Q 039681 500 GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDL 579 (624)
Q Consensus 500 gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 579 (624)
++..|+|||.+....++.++||||+|+++|||++|+.|+....... .. .....+ +.
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~-----~~~~~~-------~~ 199 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT-----HTTLNI-------PE 199 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc-----ccccCC-------cc
Confidence 5678999999988888999999999999999999998764221100 00 000000 11
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHH
Q 039681 580 ETMKALGLLAASCLDERRQNRPSMKEV 606 (624)
Q Consensus 580 ~~~~~l~~l~~~cl~~~p~~RPs~~ev 606 (624)
.....+.+++.+|++.||++||++.+.
T Consensus 200 ~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 200 WVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred cCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 233457789999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=258.28 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=198.6
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCcee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 402 (624)
.-++|...++||+|+|..|..+.+ ++.+.+|+|+++.. +.++.+....|-.+..+. +||.+|-+..+|+.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 346799999999999999999995 46789999988753 345566778888888776 6999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+|.||+++|+|.-+++ +...|+++.+..+..+|.-||.|||+.+ ||.||||..|||+|..|++||+|+|+.+
T Consensus 328 fvieyv~ggdlmfhmq-----rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEecCcceeeehh-----hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 9999999999988886 3457999999999999999999999999 9999999999999999999999999997
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCc-cccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNRE-EENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 561 (624)
.-- .......+.+||+.|.|||.+.+..|....|+|++||+++||+.|+.||+.-.. ....+--.++-+.+-+..
T Consensus 400 e~l----~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 400 EGL----GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred cCC----CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 532 233345678999999999999999999999999999999999999999974221 111222223322222211
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP 601 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 601 (624)
+. ++.........+++.-|++||.+|.
T Consensus 476 ir-------------iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IR-------------IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cc-------------ccceeehhhHHHHHHhhcCCcHHhc
Confidence 11 1112233445677888999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=283.24 Aligned_cols=262 Identities=20% Similarity=0.249 Sum_probs=180.5
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-----------------cCCCEEEEEEcccCCcchhHH--------------HHHH
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-----------------DDGTVTAIKRAKLGNTKGTDL--------------VLNE 376 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 376 (624)
..++|++.++||+|+||+||+|.. .+++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999963 235689999987543332233 3447
Q ss_pred HHHHHhcCCCce-----eeEeeEEEe--------CCceeEEEeeccCCCcccccccccCC-------------------C
Q 039681 377 VRILCQVNHRSL-----VRLLGCCVE--------LDQTLMIYEYIPNGTLFDHLHCDFTG-------------------K 424 (624)
Q Consensus 377 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~ 424 (624)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677787753 35689999999999999998642110 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccc
Q 039681 425 WPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504 (624)
Q Consensus 425 ~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y 504 (624)
...++|..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~Y 376 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPRY 376 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc---cCccccCCCcce
Confidence 134678889999999999999999998 99999999999999999999999999976532111 111122347899
Q ss_pred cCcccccccC----------------------CCCccchhhHHHHHHHHHhCCC-CCCCCCccc------cccHHHHHHH
Q 039681 505 LDPEYYRNFQ----------------------LTDKSDVYSFGVVLLELLTSKK-AIDFNREEE------NVNLVVYMKK 555 (624)
Q Consensus 505 ~aPE~~~~~~----------------------~~~ksDv~s~G~vl~elltg~~-p~~~~~~~~------~~~~~~~~~~ 555 (624)
+|||.+.... ...+.||||+||+++||++|.. |+....... ..++..| .
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r 454 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--R 454 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--H
Confidence 9999875322 1235799999999999999875 543211000 0000000 0
Q ss_pred HhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCC---CCCCCHHHHHH
Q 039681 556 IMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERR---QNRPSMKEVAD 608 (624)
Q Consensus 556 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~ev~~ 608 (624)
...... .+-.. .........+|+.++|..+| .+|+|++|+++
T Consensus 455 ~~~~~~----~~~~~-------~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 455 MYKGQK----YDFSL-------LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hhcccC----CCccc-------ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 011000 01000 11234567789999999766 68999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=263.40 Aligned_cols=238 Identities=31% Similarity=0.409 Sum_probs=192.1
Q ss_pred CcEEEEEEEEc-CCCEEEEEEcccCCcch-hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCccccccc
Q 039681 342 GFGEVFKGILD-DGTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC 419 (624)
Q Consensus 342 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 419 (624)
+||.||+++.. +++.+++|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999987665544 67899999999999999999999999999999999999999999999863
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeeccc
Q 039681 420 DFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499 (624)
Q Consensus 420 ~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 499 (624)
. ..+++..++.++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 81 ~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~ 147 (244)
T smart00220 81 R-----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFV 147 (244)
T ss_pred c-----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-----cccccc
Confidence 2 23899999999999999999999998 9999999999999999999999999998765321 223456
Q ss_pred ccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcH
Q 039681 500 GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDL 579 (624)
Q Consensus 500 gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 579 (624)
++..|++||.+....++.++||||||++++||++|..||......+ . ............ .....
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-----~-~~~~~~~~~~~~----------~~~~~ 211 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-----E-LFKKIGKPKPPF----------PPPEW 211 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----H-HHHHHhccCCCC----------ccccc
Confidence 7889999999988888999999999999999999999986421111 1 111111111000 00000
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 580 ETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 580 ~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.....+.+++.+|+..+|++||++.++++
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 03456888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=280.55 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=206.4
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEe-----
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVE----- 397 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 397 (624)
+...++.|.+.+.||+|.+|.||+++ .++++.+|+|+.... .+..+++..|.++++.. .|||++.++|++..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34455678899999999999999999 567999999988754 44556788999999988 59999999999874
Q ss_pred CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
.++++||||||.+|+.-|++++-. ...+.|..+..|...++.||.+||... ++|||||-.|||++.++.+||.|
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 568999999999999999998542 567999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccc-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
||++..+... ...-.+..||+.|||||++.- ..|+.++|+||||++..||.-|.+|+..-.+.
T Consensus 167 FGvSaQldsT----~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------- 234 (953)
T KOG0587|consen 167 FGVSAQLDST----VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------- 234 (953)
T ss_pred eeeeeeeecc----cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------
Confidence 9999876532 122346679999999999852 24778999999999999999999998532221
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.++. +.....|.+.. +....+++.++|..||.+|-++||++.++++
T Consensus 235 -raLF~---IpRNPPPkLkr-----p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 -RALFL---IPRNPPPKLKR-----PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -hhhcc---CCCCCCccccc-----hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 11111222221 2456778899999999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=290.25 Aligned_cols=263 Identities=24% Similarity=0.270 Sum_probs=167.4
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-C----CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeE------EE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-D----GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGC------CV 396 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 396 (624)
..++|...+.||+|+||.||+|+.. + +..||+|++..... .+....| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999964 4 68999998753221 1112221 1222222222222221 24
Q ss_pred eCCceeEEEeeccCCCcccccccccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 039681 397 ELDQTLMIYEYIPNGTLFDHLHCDFTG---------------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVK 461 (624)
Q Consensus 397 ~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik 461 (624)
.....++|+||+++++|.++++..... ......+..+..|+.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566889999999999999988632100 0111223456689999999999999998 9999999
Q ss_pred CCCeEECC-CCCeEEeecCCcccccccCCCCcceeecccccccccCccccccc----------------------CCCCc
Q 039681 462 SSNILLDE-KLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF----------------------QLTDK 518 (624)
Q Consensus 462 ~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k 518 (624)
|+|||+++ ++.+||+|||+|+.+... .........+++.|+|||.+... .++.+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~---~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc---cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999985 689999999999865422 11222345688999999965321 23456
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc----ccccccchh----hhhccCcCcHHHHHHHHHHHH
Q 039681 519 SDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE----RLMEVVDPV----LKERATHLDLETMKALGLLAA 590 (624)
Q Consensus 519 sDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~----l~~~~~~~~~~~~~~l~~l~~ 590 (624)
+|||||||+||||+++..++... +..+.......+ .+...+++. +.......+ .......+|+.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~dLi~ 431 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLD-LDGGAGWELLK 431 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhcc-ccchHHHHHHH
Confidence 79999999999999976553311 111111100000 001111111 000000000 01123457999
Q ss_pred HchhcCCCCCCCHHHHHH
Q 039681 591 SCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 591 ~cl~~~p~~RPs~~ev~~ 608 (624)
+||+.||++|||++|+++
T Consensus 432 ~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 432 SMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHccCCcccCCCHHHHhC
Confidence 999999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=269.86 Aligned_cols=208 Identities=27% Similarity=0.401 Sum_probs=175.8
Q ss_pred CCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.-|...+-||-|+||+|.++. .++...+|+|.++..+ .........|-+||...+.+.||+|+..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 458888999999999999988 5567889999887543 234566889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc-
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV- 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~- 484 (624)
||++||++-.+|- +.+-+++..++.++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-+
T Consensus 709 dYIPGGDmMSLLI-----rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI-----RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHH-----HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999886 4467899999999999999999999999 999999999999999999999999997432
Q ss_pred --------cccCCC--Cc---------------------------ceeecccccccccCcccccccCCCCccchhhHHHH
Q 039681 485 --------ERTETN--DS---------------------------HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVV 527 (624)
Q Consensus 485 --------~~~~~~--~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~v 527 (624)
...+.. ++ ......+||..|+|||++....++...|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 111000 00 00113479999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCccc
Q 039681 528 LLELLTSKKAIDFNREEE 545 (624)
Q Consensus 528 l~elltg~~p~~~~~~~~ 545 (624)
||||+.|+.||......+
T Consensus 861 l~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHhhCCCCccCCCCCc
Confidence 999999999997655544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=273.39 Aligned_cols=240 Identities=23% Similarity=0.287 Sum_probs=197.6
Q ss_pred CCccceeccCCcEEEEEEEEcCCC-EEEEEEcc---cCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 332 FSKDNLIGTGGFGEVFKGILDDGT-VTAIKRAK---LGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+....-||-|+||.|=+...+... .+|+|.++ ..+.++.+.+..|-++|...+.|.||+++..|.+....|++||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 334456999999999888865443 36777654 34566778899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
|-||.|+..|+ .++.++..+...++..+++|++|||+++ ||.|||||+|.++|.+|-+||.|||.|+.+...
T Consensus 502 ClGGElWTiLr-----dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 502 CLGGELWTILR-----DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hcCchhhhhhh-----hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999996 4567999999999999999999999999 999999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
....+.+||+.|.|||.+.+...+..+|.||||+++|||++|.+||...++-...+++..-...+
T Consensus 574 -----~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------- 638 (732)
T KOG0614|consen 574 -----RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------- 638 (732)
T ss_pred -----CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------
Confidence 33567899999999999999999999999999999999999999998665433222221111110
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPS 602 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs 602 (624)
..+........+|+++.+..+|.+|.-
T Consensus 639 --------~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 --------EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 112234456778999999999999965
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=241.40 Aligned_cols=259 Identities=22% Similarity=0.364 Sum_probs=200.7
Q ss_pred hCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeC--CceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVEL--DQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 404 (624)
.++|++.+.+|+|-++.||.|. ..+.+.++||+++.. ..+.+.+|+.||..+. ||||++|++...+. ..+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678888999999999999999 567889999998754 3456899999999997 99999999998864 467899
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecCCccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFGLSRL 483 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfGla~~ 483 (624)
+||+.+.+...+. +.|+...+..++.+++.||.|.|++| |+|||+||+|++||. ...++|+|||+|.+
T Consensus 114 FE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 9999887776544 46888899999999999999999999 999999999999995 56799999999998
Q ss_pred ccccCCCCcceeecccccccccCcccccccC-CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.... ..+...+.+..|.-||++...+ |+..-|+|||||+|..|+..+.||..... +.++.+.+.+....+.+
T Consensus 183 YHp~-----~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d--N~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 183 YHPG-----KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVKIAKVLGTDEL 255 (338)
T ss_pred cCCC-----ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC--CHHHHHHHHHHhChHHH
Confidence 7532 2244556778899999997664 78899999999999999999999976543 33444444444433222
Q ss_pred cc-------ccchhhhh---ccC--------cCc-HH-HHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 ME-------VVDPVLKE---RAT--------HLD-LE-TMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~-------~~d~~l~~---~~~--------~~~-~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. .+||.... ... +.+ .. ...+..+++.+.|..|..+|||++|.+.
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11 23333321 000 000 00 1256788999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=285.25 Aligned_cols=246 Identities=28% Similarity=0.387 Sum_probs=188.2
Q ss_pred CCccceeccCCcEE-EEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeecc
Q 039681 332 FSKDNLIGTGGFGE-VFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 332 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
|...+++|.|+.|+ ||+|.. +|+.||||++-. +..+...+|++.|+.- +|||||++++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 45567899999987 699998 578999998763 2344568999999988 4999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-----CCCeEEeecCCcccc
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-----KLNAKVSDFGLSRLV 484 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-----~~~~kl~DfGla~~~ 484 (624)
.-+|.++++.. ............+.+..|++.||++||+.+ ||||||||.||||+. ...++|+|||+++.+
T Consensus 586 ~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 57999999753 111111121445778889999999999999 999999999999975 356999999999988
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHhccc-cc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTS-KKAIDFNREEENVNLVVYMKKIMDEE-RL 562 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 562 (624)
........+ .....||.+|+|||++....-+..+||||+|||+|..++| .+||...-..+ .+....+ .+
T Consensus 662 ~~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L 732 (903)
T KOG1027|consen 662 AGGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTL 732 (903)
T ss_pred CCCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccce
Confidence 755443333 4577899999999999988888899999999999999987 78886332211 0111111 11
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
..+. + ..+. +..+||.+|++.+|..||++.+|+
T Consensus 733 ~~L~--------~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 733 VHLE--------P--LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred eeec--------c--CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1110 0 0111 677899999999999999999996
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=251.49 Aligned_cols=266 Identities=24% Similarity=0.311 Sum_probs=198.0
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----CceeE
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-----DQTLM 403 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 403 (624)
.+-++.||-|+||.||..+. ++|+.||+|++... +....+.+.+|+++|..++|.|++..++...-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34568899999999999884 57999999987532 334456789999999999999999998876643 35678
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
++|.| ..+|...|- ....|+...+.-+..||++||+|||+.+ |.||||||.|.|+++|..+||+|||+++.
T Consensus 135 ~TELm-QSDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHH-Hhhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 88988 568888875 3457888889999999999999999999 99999999999999999999999999997
Q ss_pred ccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.+ .++...++..+.|..|+|||.+++. .|+...||||.||++.||+.++..|....+.+..+++..+......+.+
T Consensus 206 ee---~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 206 WD---QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred cc---hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 65 3334445667788999999999876 5999999999999999999999888766655555554433221111111
Q ss_pred cc--------cc-----chhhhhccC-cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 563 ME--------VV-----DPVLKERAT-HLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 563 ~~--------~~-----d~~l~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.. ++ .|.+..... ........+...+...++..||+.|.+-.+.+..
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 11 11 011110000 0001222345567788899999999988877643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=235.75 Aligned_cols=200 Identities=26% Similarity=0.363 Sum_probs=165.8
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC-CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG-NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+......||+|++|.|-+-++ .+|+..|+|+++.. +.+.....+.|+++..+. .+|.+|.++|...+....++-||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 334456799999999988774 68999999998754 344556788899876554 799999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
| .-+|..+-..- ..+...+++...-+||..+.+||.|||++-. +||||+||+||||+.+|++|++|||++-.+.++
T Consensus 127 M-~tSldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 127 M-DTSLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred h-hhhHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9 45776665432 2356789999999999999999999999875 999999999999999999999999999776432
Q ss_pred CCCCcceeecccccccccCccccc----ccCCCCccchhhHHHHHHHHHhCCCCCC
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYR----NFQLTDKSDVYSFGVVLLELLTSKKAID 539 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~ksDv~s~G~vl~elltg~~p~~ 539 (624)
...+...|-..|||||.+. +..|+-||||||||+.+.||.+++.|++
T Consensus 203 -----iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 203 -----IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred -----hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 2234466888999999884 3368999999999999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=233.15 Aligned_cols=210 Identities=37% Similarity=0.562 Sum_probs=181.8
Q ss_pred eccCCcEEEEEEEEcC-CCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCccc
Q 039681 338 IGTGGFGEVFKGILDD-GTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFD 415 (624)
Q Consensus 338 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 415 (624)
||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998755432 35679999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecCCcccccccCCCCcce
Q 039681 416 HLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFGLSRLVERTETNDSHI 494 (624)
Q Consensus 416 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~ 494 (624)
++... ...+++..++.++.+++++|++||+.+ ++|+||+|.||++++ ++.++|+|||.+........ .
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~ 149 (215)
T cd00180 81 LLKEN----EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----L 149 (215)
T ss_pred HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----h
Confidence 98632 146899999999999999999999998 999999999999999 89999999999986543211 1
Q ss_pred eecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhc
Q 039681 495 FTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER 573 (624)
Q Consensus 495 ~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 573 (624)
.....+...|++||.+... ..+.++|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2334578899999999777 788999999999999999
Q ss_pred cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 574 ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 574 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 236679999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=242.62 Aligned_cols=131 Identities=27% Similarity=0.437 Sum_probs=113.7
Q ss_pred CCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-----C---CceeeEeeEEEe---
Q 039681 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-----H---RSLVRLLGCCVE--- 397 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--- 397 (624)
.+|.+.++||-|.|++||++. ..+.+.||+|+.+. .....+..+.|+.+|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 578889999999999999998 46778999999874 3455677899999999984 3 369999999985
Q ss_pred -CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE
Q 039681 398 -LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 398 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill 467 (624)
+.+.+||+|++ |.+|..+|... ..+.++...+.+|++||+.||.|||.... |||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 45899999999 77898988743 55679999999999999999999999985 9999999999997
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=256.52 Aligned_cols=196 Identities=23% Similarity=0.370 Sum_probs=167.6
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--------chhHHHHHHHHHHHhcC---CCceeeEeeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--------KGTDLVLNEVRILCQVN---HRSLVRLLGCCVE 397 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 397 (624)
.+|+..+.+|+|+||.|+.++++ +...|+||.+....- ...-..-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999965 467889997653211 11123567999999997 9999999999999
Q ss_pred CCceeEEEeec-cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEe
Q 039681 398 LDQTLMIYEYI-PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476 (624)
Q Consensus 398 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~ 476 (624)
++.++|++|-. ++-+|.++|. ..+.+++.++..|+.||+.|+++||+++ |||||||-+||.+|.+|-+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE-----~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE-----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh-----ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 99999999987 4668999997 3467999999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCC
Q 039681 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAID 539 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~ 539 (624)
|||.|..... ..+...+||.+|.|||++.+..| ...-|||++|++||-++....|++
T Consensus 713 dfgsaa~~ks------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKS------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcC------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999976543 23456789999999999999886 456799999999999999888875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=236.31 Aligned_cols=261 Identities=22% Similarity=0.272 Sum_probs=192.3
Q ss_pred CCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC------Cc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL------DQ 400 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 400 (624)
.+|...+.+|.|.- .|-.+. .-.++.||+|+.... +........+|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888887 555554 335889999986533 344456678999999999999999999998754 35
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++|||+| ..+|...++. .++-.+..+|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 78999999 6788888762 4777889999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
|+... ....++..+.|..|.|||++.+..+.+.+||||.||++.||++|..-|.+...-++...+........+.
T Consensus 165 ar~e~-----~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 165 ARTED-----TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred hcccC-----cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 98643 2234677789999999999988889999999999999999999999887543322221111110000000
Q ss_pred cc----------------------cccc-chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 RL----------------------MEVV-DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ~~----------------------~~~~-d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
-. .+.+ |..... ....+.-....+.+++.+||-.+|++|-|.+++++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~-~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPV-VLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccc-cccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 0000 100000 00001112345677999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=232.14 Aligned_cols=198 Identities=33% Similarity=0.508 Sum_probs=171.8
Q ss_pred CCccceeccCCcEEEEEEEEcC-CCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 332 FSKDNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
|...+.||+|++|+||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999765 889999998765554 67789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 410 NGTLFDHLHCDFTGKWPP-LPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
+++|.+++... .. +++..+..++.+++.+|.+||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 81 GGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999998632 22 899999999999999999999998 9999999999999999999999999998765321
Q ss_pred CCCcceeecccccccccCcccc-cccCCCCccchhhHHHHHHHHHhCCCCCCC
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYY-RNFQLTDKSDVYSFGVVLLELLTSKKAIDF 540 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~s~G~vl~elltg~~p~~~ 540 (624)
. .......++..|++||.+ ....++.++|||+||++++||++|+.||+.
T Consensus 153 ~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 A---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0 012234577889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-29 Score=247.76 Aligned_cols=269 Identities=22% Similarity=0.237 Sum_probs=208.8
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC------CCceeeEeeEEEeCC
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN------HRSLVRLLGCCVELD 399 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~ 399 (624)
....+|.+....|+|-|++|.+|.. .-|..||||+++. ++...+.=+.|+++|++|+ --|.++|+..|...+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 4456677777889999999999984 4578999999974 3444555688999999995 348999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC-CCeEEeec
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDF 478 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~-~~~kl~Df 478 (624)
+++||+|-+ ..+|.+.|+. .++...|....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+||+||
T Consensus 508 HLClVFE~L-slNLRevLKK--yG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKK--YGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred eeEEEehhh-hchHHHHHHH--hCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 999999998 5789999974 345567888999999999999999999999 9999999999999864 56899999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH---
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK--- 555 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~--- 555 (624)
|.|......+ .+....+..|.|||++.+.+|+...|+||.||.||||.||+..|++......+.+...+..
T Consensus 582 GSA~~~~ene------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 582 GSASFASENE------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred cccccccccc------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 9998765332 3344456789999999999999999999999999999999999988766655444433221
Q ss_pred --Hhcccc-cccccchh--------------------------------hhh--ccCcCcHHHHHHHHHHHHHchhcCCC
Q 039681 556 --IMDEER-LMEVVDPV--------------------------------LKE--RATHLDLETMKALGLLAASCLDERRQ 598 (624)
Q Consensus 556 --~~~~~~-~~~~~d~~--------------------------------l~~--~~~~~~~~~~~~l~~l~~~cl~~~p~ 598 (624)
++..+. ..+.+|.. +.. ..+........++.+|+..|+..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 111111 11122211 111 12223345667889999999999999
Q ss_pred CCCCHHHHHH
Q 039681 599 NRPSMKEVAD 608 (624)
Q Consensus 599 ~RPs~~ev~~ 608 (624)
+|.|..++++
T Consensus 736 KRit~nqAL~ 745 (752)
T KOG0670|consen 736 KRITVNQALK 745 (752)
T ss_pred hcCCHHHHhc
Confidence 9999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-29 Score=255.74 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=203.8
Q ss_pred hCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|.....+|.|.||.|||++ ...++..|+|+++........-...|+-+++.-+|||||.++|-+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3578888999999999999999 457899999999988777777888999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+.+|+|++.-+ -..+|++.+...+.++.++||+|||+++ =+|||||-.|||+++.+.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~-----~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 94 CGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred cCCCcccceee-----ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999876 3468999999999999999999999999 699999999999999999999999998665421
Q ss_pred CCCCcceeecccccccccCcccc---cccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYY---RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
-..-....||+.|||||+. +.+.|..++|||+.|+...|+-..+.|...-.+. .+..++...
T Consensus 166 ----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTkS---- 230 (829)
T KOG0576|consen 166 ----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTKS---- 230 (829)
T ss_pred ----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhcc----
Confidence 1122456799999999986 3557999999999999999998877775422111 111111111
Q ss_pred ccc-hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVD-PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d-~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.++ |.+.+ .......+.++++.++..+|.+||+++.++.
T Consensus 231 ~~qpp~lkD-----k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTLKD-----KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcccC-----CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 11211 1234566888999999999999999988754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=232.30 Aligned_cols=268 Identities=23% Similarity=0.321 Sum_probs=196.5
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEc----CCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCc
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQ 400 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 400 (624)
....+.|...++||+|.|++||+++.. .+..||+|.+... .....+.+|+++|..+. +.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 334456888899999999999999943 4678999988754 34456899999999995 9999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFG 479 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfG 479 (624)
..+|+||+++.+..+++. .++...+..++..++.||+++|++| ||||||||+|+|.+. .+.-.|.|||
T Consensus 110 v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 999999999998888874 4778899999999999999999999 999999999999974 5678999999
Q ss_pred CcccccccC--------------C--------------------------CCcceeecccccccccCccccccc-CCCCc
Q 039681 480 LSRLVERTE--------------T--------------------------NDSHIFTTAQGTMGYLDPEYYRNF-QLTDK 518 (624)
Q Consensus 480 la~~~~~~~--------------~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k 518 (624)
+|...+... . ..........||++|.|||++... ..+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997211000 0 000111235799999999998654 57899
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc----------ccc--cccc----cchhhhhccC-------
Q 039681 519 SDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD----------EER--LMEV----VDPVLKERAT------- 575 (624)
Q Consensus 519 sDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~--~~~~----~d~~l~~~~~------- 575 (624)
+||||.|||++-+++++.||.....+ ...+..+...+. .++ +.+. ..+++.....
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd--~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDD--ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred cceeeccceeehhhccccccccCccc--cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 99999999999999999999754322 222221111111 122 1110 0000000000
Q ss_pred -----------cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 576 -----------HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 576 -----------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
......+..+.+|..+|+..||.+|.|++|.++
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 001112336789999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=217.30 Aligned_cols=254 Identities=18% Similarity=0.245 Sum_probs=186.5
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeE-EEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGC-CVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~lv~ 405 (624)
.+.|++.+.||+|.||.+-++.++ ..+.+|+|-+... .....+|.+|...--.|. |.||+.-+++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 456889999999999999999965 5678899987643 455678999998766664 8999987765 56677888999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC--CCCCeEEeecCCccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD--EKLNAKVSDFGLSRL 483 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~--~~~~~kl~DfGla~~ 483 (624)
||+|.|+|..-+.. ..+.+....+++.|+++||.|||+++ +||||||.+||||- +..++||+|||+.+.
T Consensus 102 E~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred ccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999987752 45778888999999999999999999 99999999999993 455799999999875
Q ss_pred ccccCCCCcceeecccccccccCcccccc---c--CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRN---F--QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
.... ......+..|.+||.... . ...+.+|||.||++++.++||+.||..... .......|.. ..
T Consensus 173 ~g~t-------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~--w~ 242 (378)
T KOG1345|consen 173 VGTT-------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQ--WL 242 (378)
T ss_pred cCce-------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHH--Hh
Confidence 4321 223334567899997642 2 356789999999999999999999983322 2222222222 22
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
...... +..... .....+.++.++-+.+++++|--..++.++-.
T Consensus 243 ~rk~~~-----~P~~F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 243 KRKNPA-----LPKKFN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cccCcc-----Cchhhc----ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 221111 111111 12344667888899999999966666665543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=266.18 Aligned_cols=198 Identities=21% Similarity=0.198 Sum_probs=138.1
Q ss_pred hcCC-CceeeEeeEE-------EeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 039681 382 QVNH-RSLVRLLGCC-------VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453 (624)
Q Consensus 382 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~ 453 (624)
.++| +||++++++| .+....++++||+ +++|.++|.. ....+++.+++.|+.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4456 6888888877 3334567788988 6699999963 2356999999999999999999999999
Q ss_pred CeEeecCCCCCeEECCC-------------------CCeEEeecCCcccccccCCC------------Ccceeecccccc
Q 039681 454 PIYHRDVKSSNILLDEK-------------------LNAKVSDFGLSRLVERTETN------------DSHIFTTAQGTM 502 (624)
Q Consensus 454 ~iiH~Dik~~Nill~~~-------------------~~~kl~DfGla~~~~~~~~~------------~~~~~~~~~gt~ 502 (624)
|+||||||+||||+.. +.+|++|||+++........ .........||+
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999654 44566666666532110000 000011245788
Q ss_pred cccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHH
Q 039681 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETM 582 (624)
Q Consensus 503 ~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 582 (624)
.|||||++.+..++.++|||||||+||||++|..|+.... ........ ...++... ...
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~--------~~~~~~~~--------~~~ 238 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRH--------RVLPPQIL--------LNW 238 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHH--------hhcChhhh--------hcC
Confidence 9999999998899999999999999999999887754211 00000000 01111110 112
Q ss_pred HHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 583 KALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 583 ~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.....++.+||+.+|.+||+|.||++
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhh
Confidence 23456888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=207.02 Aligned_cols=169 Identities=22% Similarity=0.231 Sum_probs=126.4
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.++++. ....+++.+++.|+.||+.||+|||+.+ ||+|||+++++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEV----RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc---
Confidence 688888863 2346999999999999999999999986 999999999999999 9998765421
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 570 (624)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......+....... ++..
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~------~~~~ 128 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPAD------DPRD 128 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccC------Cccc
Confidence 125789999999999989999999999999999999999998643221 11111111111110 0000
Q ss_pred hhccCcCcHHHH--HHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 571 KERATHLDLETM--KALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 571 ~~~~~~~~~~~~--~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
. ....... ..+.+++.+||+.+|++||++.|+++.+..+..
T Consensus 129 --~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 --R--SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred --c--ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0 0011222 268899999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=219.93 Aligned_cols=173 Identities=20% Similarity=0.197 Sum_probs=132.8
Q ss_pred HHHHHHhCCCCccceeccCCcEEEEEEEEc--CCCEEEEEEcccC-----CcchhHHHHHHHHHHHhcCCCceeeEeeEE
Q 039681 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILD--DGTVTAIKRAKLG-----NTKGTDLVLNEVRILCQVNHRSLVRLLGCC 395 (624)
Q Consensus 323 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 395 (624)
..+....++|...+.||+|+||+||+|+.. +++.||||++... .....+.|.+|+++|++++|+|+++.+..
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 344556678999999999999999999864 5788899986532 12235568999999999999999863322
Q ss_pred EeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC-CCCCeEECCCCCeE
Q 039681 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDV-KSSNILLDEKLNAK 474 (624)
Q Consensus 396 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Di-k~~Nill~~~~~~k 474 (624)
....++||||+++++|.. +. . .. ...++.|+++||+|||+.+ |+|||| ||+|||++.++.+|
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~~-----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-AR-----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-hC-----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 256899999999999963 21 1 01 1467889999999999999 999999 99999999999999
Q ss_pred EeecCCcccccccCCCCc----ceeecccccccccCccccccc
Q 039681 475 VSDFGLSRLVERTETNDS----HIFTTAQGTMGYLDPEYYRNF 513 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 513 (624)
|+|||+|+.+........ ...+...+++.|+|||.+...
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999987654321111 112466788899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-23 Score=209.18 Aligned_cols=265 Identities=18% Similarity=0.166 Sum_probs=195.6
Q ss_pred CCCccceeccCCcEEEEEEEEcCC--CEEEEEEcccCCcchhHHHHHHHHHHHhcCC----CceeeEeeEE-EeCCceeE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDDG--TVTAIKRAKLGNTKGTDLVLNEVRILCQVNH----RSLVRLLGCC-VELDQTLM 403 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 403 (624)
+|.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 5789998765433333367889999998873 6889999888 47778899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC-----CCeEEeec
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK-----LNAKVSDF 478 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~-----~~~kl~Df 478 (624)
||+.+ +.+|.++..... .+.++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99988 889999775332 467999999999999999999999999 9999999999999754 46999999
Q ss_pred CCcc--cccccCCC--Ccc-e-eecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 479 GLSR--LVERTETN--DSH-I-FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 479 Gla~--~~~~~~~~--~~~-~-~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
|+++ ........ ... . .....||..|.++..+.+.+.+.+.|+||++.++.|++.|..||........ ...
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~ 248 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSK 248 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHH
Confidence 9998 32211111 001 1 1235599999999999999999999999999999999999999864432211 111
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
+........... .. ...+.++.++...+-..+..++|....+...|+......
T Consensus 249 ~~~~~~~~~~~~---------~~---~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 FEKDPRKLLTDR---------FG---DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHhhhhcccc---------cc---CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111111111100 00 112233444444455589999999999999988877654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=201.97 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=188.9
Q ss_pred CccceeccCCcEEEEEEEEcCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 333 SKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
....+|.+...|..|+|+++++..| .|++... ......+|..|.-.|+.+.||||++++|.|....++.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgndiv-akil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGNDIV-AKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCcchh-hhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3445688899999999999765554 4555432 233346789999999999999999999999999999999999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|...|+.. ..-..+..++.++|.+||+|++|||+... -|.---|.++.++||++.+++|+- +-.++
T Consensus 272 gslynvlhe~---t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf------- 339 (448)
T KOG0195|consen 272 GSLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF------- 339 (448)
T ss_pred hHHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee-------
Confidence 9999999853 33457888999999999999999999873 244456899999999999988752 11111
Q ss_pred CcceeecccccccccCcccccccCC---CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQL---TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
+-.-......+.||+||.++..+. -..+|+|||+++||||.|...||..-.+-+-. ..+.
T Consensus 340 -sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mkia--------- 402 (448)
T KOG0195|consen 340 -SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKIA--------- 402 (448)
T ss_pred -eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhhh---------
Confidence 111123345788999999976543 34789999999999999999999633222110 1111
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
+.+...++++.....+.+|+.-|++.||.+||.+..|+-.||+++
T Consensus 403 --leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 --LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 111222334556677888999999999999999999999999875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=193.29 Aligned_cols=267 Identities=16% Similarity=0.188 Sum_probs=202.7
Q ss_pred hCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 406 (624)
.-.|.+.++||+|.||..+.|+ +-+++.||||.... .....++..|.+..+.|. .++|...+.+-.++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4569999999999999999999 67899999997643 334567888999999885 6999999998889999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-----CCCeEEeecCCc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-----KLNAKVSDFGLS 481 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-----~~~~kl~DfGla 481 (624)
.+ |.+|+|++.- -...++.+++..||.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|
T Consensus 105 LL-GPSLEDLFD~----CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL----CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hh-CcCHHHHHHH----hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 99 7888887742 2357999999999999999999999999 999999999999964 345899999999
Q ss_pred ccccccCCCCccee---ecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 482 RLVERTETNDSHIF---TTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 482 ~~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+.+-.........+ ....||.+||+=..+.+.+.+.+.|.-|+|-++...+-|..||.+-.........+.+ .
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI----G 252 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI----G 252 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh----c
Confidence 98765544443333 3567999999999999999999999999999999999999999875544332211111 1
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
+.+-..- -..+. ...+.++..-+.-.=..+-++-|+.+-+...+..++...
T Consensus 253 e~Kr~T~-i~~Lc-------~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 253 ETKRSTP-IEVLC-------EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred cccccCC-HHHHH-------hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 1100000 01111 122333333333334567788899998888888877643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=184.98 Aligned_cols=266 Identities=17% Similarity=0.233 Sum_probs=200.2
Q ss_pred HhCCCCccceeccCCcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC-CceeeEeeEEEeCCceeEEE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH-RSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 405 (624)
....|...+.||.|+||.+|.|. ..+|..||||+... .....++..|..+...++| ..|..+..+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34679999999999999999999 67899999998653 2334567889999999975 78888888899999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEEeecCCcc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKVSDFGLSR 482 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl~DfGla~ 482 (624)
|.+ +.+|++++.- -...++..+++.+|.|++.-++|+|.++ +|||||||+|+|..- ...+.++|||+|+
T Consensus 91 dLL-GPsLEdLfnf----C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF----CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ecc-CccHHHHHHH----HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence 999 8899888752 2246889999999999999999999999 999999999999863 4468999999998
Q ss_pred cccccCCCCccee---ecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 483 LVERTETNDSHIF---TTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 483 ~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
.+..........+ +...||.+|.+-..+.+.+.+.+.|+-|+|.+|..+--|..||.+-......+..+.+..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E---- 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE---- 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH----
Confidence 7654333222222 345689999998888888889999999999999999999999986554333222221111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
.++.- .-. ......+.++...+.-|=...-++-|+..-+-+.+.-+..
T Consensus 239 kK~s~-~ie-------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 239 KKMST-PIE-------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred hhcCC-CHH-------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 11110 001 1112234455666777777788888888777776665554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-21 Score=197.00 Aligned_cols=264 Identities=29% Similarity=0.370 Sum_probs=196.1
Q ss_pred CCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc---hhHHHHHHHHHHHhcCCC-ceeeEeeEEEeCCceeEEEee
Q 039681 332 FSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK---GTDLVLNEVRILCQVNHR-SLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 407 (624)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999976 78899987654332 367799999999999988 799999999777778999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGla~~~~~ 486 (624)
+.++++.+++...... ..++......++.|++.++.|+|+.+ ++|||+||+||+++... .+++.|||+++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999766532111 36899999999999999999999999 99999999999999988 799999999985543
Q ss_pred cCCCCc--ceeecccccccccCcccccc---cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 487 TETNDS--HIFTTAQGTMGYLDPEYYRN---FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 487 ~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
...... .......++..|+|||.+.+ ...+...|+||+|++++++++|..|+...... .........+....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELP 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcC
Confidence 221111 13456789999999999987 57889999999999999999999996543321 00011111111111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.. .......... .......+.+++..++..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSN---PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccc---cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 0000000000 01223457788999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-23 Score=223.59 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=189.4
Q ss_pred CccceeccCCcEEEEEEEE-cCCCEEEEEEccc-----CCcch-hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 333 SKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKL-----GNTKG-TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~-----~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
...+++|.|++|.|+.... ...+..+.|..+. ..... ...+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998777763 3344444443321 11111 112566888888899999998888887777666679
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||++. +|..++.. ...++...+..++.|+..|++|||+.+ |.|||+|++|++++.++.+||+|||.+....
T Consensus 401 E~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 99999863 246888889999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCC-ccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTD-KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
..............|+..|+|||.+.+.+|.+ ..||||.|+++..|++|+.||......++.. ...........
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~ 546 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNI 546 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccccc
Confidence 43333335566788999999999999988876 5799999999999999999997655443321 00000000000
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. ..........+..-..++.++|+.+|.+|-|+++|++
T Consensus 547 ~------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 F------EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c------cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 0111122345566778999999999999999999986
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-22 Score=167.58 Aligned_cols=98 Identities=27% Similarity=0.567 Sum_probs=76.4
Q ss_pred CCCC-CCCCccccccCCCCCCCCC-CCceeEecCCC-cccccCCCCeeEEEEEccCCcEEEEcCCCCCCCcccccCC---
Q 039681 26 LRCG-NCGPTPVPYPLSTGPNCGH-QSYKIRCAAGI-LWFDARNGSSYMIASINPLSQRIIIRPPGPAGSTCTATDM--- 99 (624)
Q Consensus 26 ~~C~-~CG~~~i~yPF~~~~~C~~-~~f~l~C~~~~-~~~~~~~~~~~~v~~i~~~~~~~~~~~~~~~~~~c~~~~~--- 99 (624)
++|+ +|||++||||||++++|++ |+|+|+|++++ ++.+++.+..|+|++|+|++++++|.++. .+.|.....
T Consensus 2 ~~C~~~CGnv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~--~~~~~~~~~~~~ 79 (106)
T PF13947_consen 2 PGCPSSCGNVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPI--SSNCYSSSSSNS 79 (106)
T ss_pred CCCCCccCCEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEecc--ccceecCCCCcc
Confidence 6899 8999999999999999998 99999999873 33333466679999999999999999854 345554332
Q ss_pred CCcccccCCCCCcccc-CCCeEEEEcCCc
Q 039681 100 RTQGIQLDDNLPFNIT-SSNTIMLLNCTD 127 (624)
Q Consensus 100 ~~~~~~~~~~~~f~~s-~~n~~~~~~C~~ 127 (624)
...++++ ..||.++ .+|.|+++||++
T Consensus 80 ~~~~~~~--~~~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 80 SNSNLSL--NGPFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred cccEEee--cCCceEccCCcEEEEECCCC
Confidence 1223444 3488887 789999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=182.48 Aligned_cols=139 Identities=18% Similarity=0.146 Sum_probs=108.4
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc--h-------h-----------------HHHHHHHHHHHhcCCCce
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK--G-------T-----------------DLVLNEVRILCQVNHRSL 388 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 388 (624)
...||+|++|.||+|...+|+.||||+++..... . . .....|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999998754211 0 1 122359999999988776
Q ss_pred eeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeecCCCCCeEE
Q 039681 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL-HSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 389 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~iiH~Dik~~Nill 467 (624)
.....+.. ...++||||++++++..... ....+++.....++.|++.+|.|| |+.+ |+||||||+|||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL-----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh-----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 44333222 23489999998877765432 124688999999999999999999 6888 9999999999999
Q ss_pred CCCCCeEEeecCCcccc
Q 039681 468 DEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~ 484 (624)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-21 Score=184.42 Aligned_cols=172 Identities=15% Similarity=0.082 Sum_probs=133.5
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhH---------HHHHHHHHHHhcCCCceeeEeeEEEeC
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTD---------LVLNEVRILCQVNHRSLVRLLGCCVEL 398 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~ 398 (624)
..++|+..++||.|+||.||.... ++..+|||.++........ .+.+|++.+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999655 5778999998754333222 267899999999999999999886643
Q ss_pred --------CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC
Q 039681 399 --------DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK 470 (624)
Q Consensus 399 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~ 470 (624)
...+|||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 35789999999999977632 222 24559999999999999 9999999999999998
Q ss_pred CCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh
Q 039681 471 LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533 (624)
Q Consensus 471 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt 533 (624)
+ ++|+|||........... ..+.....+..++|+||||+.+..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a~----------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK----------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhH----------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 999999988654321100 013334456679999999999876653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-22 Score=215.45 Aligned_cols=252 Identities=19% Similarity=0.234 Sum_probs=184.1
Q ss_pred CCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCC-cchhHHHHHHHHH--HHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN-TKGTDLVLNEVRI--LCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++...+.||.+.|=.|.+++.++|. |+||++-... .-..+.|.++++- ...++|||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677889999999999999988887 7888865443 4444555554444 4445899999999887777788899999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc--
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE-- 485 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~-- 485 (624)
. ..+|.|.|. .++.|...+..-|+.|++.||.-.|..+ |+|||||.+||||+.-.-+.|+||..-+...
T Consensus 103 v-khnLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 V-KHNLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred H-hhhhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9 458998885 4567888899999999999999999999 9999999999999999999999998755322
Q ss_pred -ccCCCCcceeecccccccccCccccccc----------C-CCCccchhhHHHHHHHHHhC-CCCCCCCCccccccHHHH
Q 039681 486 -RTETNDSHIFTTAQGTMGYLDPEYYRNF----------Q-LTDKSDVYSFGVVLLELLTS-KKAIDFNREEENVNLVVY 552 (624)
Q Consensus 486 -~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~ksDv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~ 552 (624)
+...+....+.+...-..|+|||.+... . .+++.||||+||+++||++- +++|..+ +.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL 244 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QL 244 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HH
Confidence 1222233344455566789999987531 2 67889999999999999985 6666421 11
Q ss_pred HHHHhcccccccccchhh-hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVL-KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
+...-. ...|++. .+.... ..+..++..|++.||++|.++++.++.-+.
T Consensus 245 ~aYr~~-----~~~~~e~~Le~Ied------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 245 LAYRSG-----NADDPEQLLEKIED------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HhHhcc-----CccCHHHHHHhCcC------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 111111 0111111 111110 136679999999999999999999987443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=198.89 Aligned_cols=220 Identities=30% Similarity=0.501 Sum_probs=168.1
Q ss_pred HHhcCCCceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 039681 380 LCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRD 459 (624)
Q Consensus 380 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~D 459 (624)
|+.+.|.|+.+++|.+.+....+.|.+|+..|+|+|.+.. ....++|.....+.++|+.||+|||+... ..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeee
Confidence 4578899999999999999999999999999999999974 34579999999999999999999999873 39999
Q ss_pred CCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCccccccc---C----CCCccchhhHHHHHHHHH
Q 039681 460 VKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF---Q----LTDKSDVYSFGVVLLELL 532 (624)
Q Consensus 460 ik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~ksDv~s~G~vl~ell 532 (624)
++++|.++|..+.+||+|||+....... ..........-..-|.|||.+... . .+.+.||||||++++|++
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~--~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEET--AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eccccceeeeeEEEEechhhhccccccc--ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999998876431 111111222345679999998753 1 467899999999999999
Q ss_pred hCCCCCCCCCccccc-cHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 533 TSKKAIDFNREEENV-NLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 533 tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
+.+.||+.....+.. .++.++.+ .....+-|.+... .+...++..++.+||..+|++||+++.|-..++
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~-----~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL-----NELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred hccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhh-----hhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 999999864433222 22222222 1112222222211 133346888999999999999999999999998
Q ss_pred HHHHhc
Q 039681 612 YIISIA 617 (624)
Q Consensus 612 ~i~~~~ 617 (624)
.+....
T Consensus 223 ~~~~~~ 228 (484)
T KOG1023|consen 223 TINKGG 228 (484)
T ss_pred hhcccc
Confidence 877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=176.08 Aligned_cols=140 Identities=19% Similarity=0.160 Sum_probs=111.2
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcch--------------------------hHHHHHHHHHHHhcCCCce
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKG--------------------------TDLVLNEVRILCQVNHRSL 388 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 388 (624)
.+.||+|++|+||+|...+|+.||||+.+...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999997789999999987542110 1124578999999999987
Q ss_pred eeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEE
Q 039681 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 389 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~Nill 467 (624)
.....+... ..++||||++++++..... ....++......++.|++.+|.+||+ .+ |+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL-----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh-----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 554444333 3489999998876544321 12357888999999999999999999 88 9999999999999
Q ss_pred CCCCCeEEeecCCccccc
Q 039681 468 DEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~~ 485 (624)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=205.99 Aligned_cols=203 Identities=22% Similarity=0.279 Sum_probs=166.9
Q ss_pred CHHHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC---CCceeeEeeEEEe
Q 039681 321 TGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN---HRSLVRLLGCCVE 397 (624)
Q Consensus 321 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 397 (624)
...+.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+..+..+ |.--.+++.+|+ -+-|..+...+.-
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3445566677899999999999999999998889999999988766543 222223444444 3455666666677
Q ss_pred CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-------CC
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-------EK 470 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-------~~ 470 (624)
.+..+||+||.+.|+|.+++. ..+.++|..+..++.|+++-++.||..+ ||||||||+|.||. ++
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred CCcceeeeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcc
Confidence 788899999999999999997 3467999999999999999999999999 99999999999993 34
Q ss_pred CCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCC
Q 039681 471 LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK 536 (624)
Q Consensus 471 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~ 536 (624)
..++|+|||-+-.+..- .+...+....+|-.+-.+|+..+..++.+.|.|.++.+++-|+.|+.
T Consensus 838 ~~l~lIDfG~siDm~lf--p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLF--PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceEEEecccceeeeEc--CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 56999999998766432 22346778889999999999999999999999999999999999973
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=168.35 Aligned_cols=188 Identities=16% Similarity=0.114 Sum_probs=137.3
Q ss_pred CccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcch----hHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEee
Q 039681 333 SKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKG----TDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.....|++|+||+||.+.. ++..++.+.+....... ...+.+|+++|++++ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997655 67777777665432211 125789999999995 5889999886 457999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC-CCCCeEECCCCCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDV-KSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Di-k~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
+.+.+|...+. . ....++.|++++|+++|+.+ |+|||| ||+|||++.++.++|+|||++.....
T Consensus 80 I~G~~L~~~~~-----~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPP-----R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhh-----h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 99988865431 0 11357789999999999999 999999 79999999999999999999985442
Q ss_pred cCCC----C----ccee-ecccccccccCccccccc-CCC-CccchhhHHHHHHHHHhCCCCCCC
Q 039681 487 TETN----D----SHIF-TTAQGTMGYLDPEYYRNF-QLT-DKSDVYSFGVVLLELLTSKKAIDF 540 (624)
Q Consensus 487 ~~~~----~----~~~~-~~~~gt~~y~aPE~~~~~-~~~-~ksDv~s~G~vl~elltg~~p~~~ 540 (624)
.... . .... .-...++.|++|+...-- +.+ ...++++-|.-+|.++|++.+.-.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 2110 0 0000 012357778888764322 233 467999999999999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=168.58 Aligned_cols=137 Identities=18% Similarity=0.198 Sum_probs=106.9
Q ss_pred CCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-----CCCceeeEeeEEEeCC---c-ee
Q 039681 332 FSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-----NHRSLVRLLGCCVELD---Q-TL 402 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 402 (624)
++..++||+|+||.||. +.+....+||+.........+.+.+|+.+++++ +||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 433333479988765555667899999999999 5799999999999874 3 33
Q ss_pred EEEee--ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeecCCCCCeEECC----CCCeEE
Q 039681 403 MIYEY--IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL-TYLHSAAVPPIYHRDVKSSNILLDE----KLNAKV 475 (624)
Q Consensus 403 lv~e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L-~yLH~~~~~~iiH~Dik~~Nill~~----~~~~kl 475 (624)
+|+|| .++++|.+++.. ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 557999999953 135555 35577888777 9999999 999999999999974 347999
Q ss_pred eecCCc
Q 039681 476 SDFGLS 481 (624)
Q Consensus 476 ~DfGla 481 (624)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-20 Score=194.05 Aligned_cols=225 Identities=28% Similarity=0.321 Sum_probs=175.5
Q ss_pred eeccCCcEEEEEEE----EcCCCEEEEEEcccCCcch--hHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEeecc
Q 039681 337 LIGTGGFGEVFKGI----LDDGTVTAIKRAKLGNTKG--TDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|+|.||.|+... .+.|..+|+|+++...... ......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998755 3457788888776543221 124567888898887 9999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+|.|...+. +...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++..-..+
T Consensus 81 gg~lft~l~-----~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~- 151 (612)
T KOG0603|consen 81 GGDLFTRLS-----KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK- 151 (612)
T ss_pred cchhhhccc-----cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence 999988885 3456777778888889999999999999 9999999999999999999999999998764321
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
..+||..|||||++. .....+|.||||++++||+||-.||.. +. .......
T Consensus 152 -------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~---~~~Il~~---------- 202 (612)
T KOG0603|consen 152 -------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DT---MKRILKA---------- 202 (612)
T ss_pred -------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HH---HHHHhhh----------
Confidence 127899999999998 567789999999999999999999874 11 1111111
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
....+.+....+..++..+...+|..|.-.
T Consensus 203 ----~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 ----ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ----ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 111223444556667777888888887544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=175.36 Aligned_cols=234 Identities=19% Similarity=0.267 Sum_probs=148.4
Q ss_pred CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCC----------CceeeEeeEEE-
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNH----------RSLVRLLGCCV- 396 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~- 396 (624)
+...+.||.|+++.||.++.. +++.+|+|+...... ...+.+.+|.-....+.+ -.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345688999999999999975 589999998754432 234566666655555322 22332222221
Q ss_pred --------eCC--------ceeEEEeeccCCCccccccccc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 039681 397 --------ELD--------QTLMIYEYIPNGTLFDHLHCDF--TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHR 458 (624)
Q Consensus 397 --------~~~--------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~ 458 (624)
... +.+++|+-+ .++|.+++..-. ......+....++.+..|+++.+++||+.+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 235667766 578877754210 111234556677888899999999999999 9999
Q ss_pred cCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccc--------cCCCCccchhhHHHHHHH
Q 039681 459 DVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN--------FQLTDKSDVYSFGVVLLE 530 (624)
Q Consensus 459 Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~s~G~vl~e 530 (624)
||||+|+|++.+|.++|+||+....... .......+..|.+||.... ..++.+.|.|++|+++|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~-------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT-------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE-------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc-------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999987654321 1222345578999997643 257889999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCC
Q 039681 531 LLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNR 600 (624)
Q Consensus 531 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 600 (624)
|++++.||........... .+ .... +.++.+..||..+|+.+|++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-------------------~f----~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-------------------DF----SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-------------------GG----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-------------------cc----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999975433221100 11 1112 567778899999999999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=162.94 Aligned_cols=144 Identities=17% Similarity=0.138 Sum_probs=112.5
Q ss_pred CCCCccceeccCCcEEEEEEE--EcCCCEEEEEEcccCCcc------------------------hhHHHHHHHHHHHhc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGI--LDDGTVTAIKRAKLGNTK------------------------GTDLVLNEVRILCQV 383 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 383 (624)
..|.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347788999999999999998 568999999988754211 012356899999999
Q ss_pred CCC--ceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 039681 384 NHR--SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVK 461 (624)
Q Consensus 384 ~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik 461 (624)
.+. .+.+.++. ...++||||+++++|...... ...+.......++.||+.+|++||+.+. ++|||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik 176 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS 176 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence 753 34444443 245899999999888765531 2345666778999999999999999884 8999999
Q ss_pred CCCeEECCCCCeEEeecCCccccc
Q 039681 462 SSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 462 ~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=159.46 Aligned_cols=134 Identities=25% Similarity=0.343 Sum_probs=113.0
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc--------hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK--------GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
+.||+|++|.||+|.. +|..+++|+....... ....+.+|++++..++|+++.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6677888875532211 124578899999999999998888888788889999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988521 12 78899999999999999999 99999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-17 Score=155.63 Aligned_cols=141 Identities=21% Similarity=0.232 Sum_probs=110.5
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc----------------------hhHHHHHHHHHHHhcC
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK----------------------GTDLVLNEVRILCQVN 384 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~ 384 (624)
.....|...+.||+|+||.||++...+|+.||||+.+..... ....+..|+.++..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 333347778899999999999999888999999986543210 0123677899999998
Q ss_pred CC--ceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 039681 385 HR--SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKS 462 (624)
Q Consensus 385 h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~ 462 (624)
|+ .+++.++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ |+||||||
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 77 4444443 2456899999999998765420 234678899999999999998 99999999
Q ss_pred CCeEECCCCCeEEeecCCccccc
Q 039681 463 SNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 463 ~Nill~~~~~~kl~DfGla~~~~ 485 (624)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=155.67 Aligned_cols=130 Identities=25% Similarity=0.322 Sum_probs=106.3
Q ss_pred eeccCCcEEEEEEEEcCCCEEEEEEcccCCcc--------hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 337 LIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK--------GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+||+|+||.||+|.. ++..+++|+....... ..+.+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5678889975432211 1355778999999999887666666666777789999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
++++|.+++... . ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~-----~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG-----N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc-----H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999877421 0 078999999999999999 99999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-17 Score=160.11 Aligned_cols=200 Identities=22% Similarity=0.261 Sum_probs=137.1
Q ss_pred CCCceeeEeeEEEeC---------------------------CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHH
Q 039681 384 NHRSLVRLLGCCVEL---------------------------DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436 (624)
Q Consensus 384 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i 436 (624)
+|||||++.++|.+. ..+|+||.-++ .+|.+++-. ...+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 589999988877542 24578887774 588888853 24556677788
Q ss_pred HHHHHHHHHHHHhcCCCCeEeecCCCCCeEE--CCCC--CeEEeecCCcccccccC--CCCcceeecccccccccCcccc
Q 039681 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILL--DEKL--NAKVSDFGLSRLVERTE--TNDSHIFTTAQGTMGYLDPEYY 510 (624)
Q Consensus 437 ~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill--~~~~--~~kl~DfGla~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~ 510 (624)
+.|+++|+.|||.++ |.|||+|++|||| |+|. .+.|+|||.+---+... ...........|...-||||+.
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 899999999999999 9999999999998 4444 47899999874322100 0011112344577889999998
Q ss_pred cccC------CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHH
Q 039681 511 RNFQ------LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKA 584 (624)
Q Consensus 511 ~~~~------~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 584 (624)
...+ -..|+|.|+.|.+.||+++...||+... +-..+...| .+.++ +..+...+..
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Y-----qe~qL------------Palp~~vpp~ 485 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTY-----QESQL------------PALPSRVPPV 485 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhh-----hhhhC------------CCCcccCChH
Confidence 5432 2358999999999999999999997522 211221111 11111 1112234455
Q ss_pred HHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 585 LGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 585 l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
+.+|+...|+.||.+|++.+-....|.
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHHH
Confidence 778999999999999999876655543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.8e-17 Score=178.37 Aligned_cols=137 Identities=24% Similarity=0.318 Sum_probs=111.4
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccC-Cc------chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLG-NT------KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
..|...+.||+|+||+||+|.+.+...++.++.... .. ...+.+.+|+++++.++|++++....++.+....+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 345667899999999999998765544333222211 11 12356889999999999999998888888878889
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 413 lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 9999999999988774 35678999999999999999 9999999999999 67799999999997
Q ss_pred c
Q 039681 483 L 483 (624)
Q Consensus 483 ~ 483 (624)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.6e-18 Score=171.79 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=154.7
Q ss_pred ccceeccCCcEEEEEEEEcC----CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEee-------EEEe-----
Q 039681 334 KDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG-------CCVE----- 397 (624)
Q Consensus 334 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-------~~~~----- 397 (624)
+.+..+...++.+......+ ...++.+..+..+........+++-.+....|.+..-+.+ ....
T Consensus 248 ~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~ 327 (516)
T KOG1033|consen 248 ISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGK 327 (516)
T ss_pred ccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccc
Confidence 34455666666665554322 2334444444333222233334444444444433333322 1111
Q ss_pred CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
...+++.|+++...+|.++|..... ....++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence 2357899999999999999975433 3457788899999999999999 66 89999999999999999999999
Q ss_pred cCCcccccccCCC--CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhC-CCCCCCCCccccccHHHHHH
Q 039681 478 FGLSRLVERTETN--DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTS-KKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 478 fGla~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~ 554 (624)
||+.......... .....+...||..||+||.+.+..|+.|+||||||++|+||+.- ..+++- ....
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~ 469 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATL 469 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhh
Confidence 9998765433210 12234667899999999999999999999999999999999972 111110 0001
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHH
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKE 605 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e 605 (624)
..++++ .++|......+ +-..|+.+++.+.|.+||++.+
T Consensus 470 ~d~r~g----~ip~~~~~d~p--------~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 470 TDIRDG----IIPPEFLQDYP--------EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhcC----CCChHHhhcCc--------HHHHHHHHhcCCCcccCchHHH
Confidence 111112 22323222111 1235888999999999994443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-17 Score=178.87 Aligned_cols=211 Identities=27% Similarity=0.347 Sum_probs=144.8
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
..++|...++|..|+||.||..+++ ..+..|+|+-+ .+ .+++- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee-----------------
Confidence 3467999999999999999999865 46777875422 11 11111 22223333333
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+-...++ ..++++.. ++.+++|||+.+ |+|||+||+|.||+.-|++|++|||+++....
T Consensus 136 ----gDc~tllk-----~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----GDCATLLK-----NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----chhhhhcc-----cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 44444443 22344432 378899999999 99999999999999999999999999875321
Q ss_pred cCC---------CCccee--ecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 039681 487 TET---------NDSHIF--TTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 487 ~~~---------~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 555 (624)
... .+.+.+ ..++||+.|+|||++....|...+|+|++|+++||.+-|+.||.++..++-...+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v----- 270 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV----- 270 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh-----
Confidence 100 011111 2457999999999998889999999999999999999999999987665432221
Q ss_pred HhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCC
Q 039681 556 IMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNR 600 (624)
Q Consensus 556 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 600 (624)
+.++.. .++.+.....++.+++.+.|+.+|..|
T Consensus 271 -isd~i~-----------wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 271 -ISDDIE-----------WPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred -hhhhcc-----------ccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 111110 011122344567789999999999999
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=144.01 Aligned_cols=137 Identities=22% Similarity=0.248 Sum_probs=99.8
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc--hhHH----------------------HHHHHHHHHhcCCC--ce
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK--GTDL----------------------VLNEVRILCQVNHR--SL 388 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni 388 (624)
.+.||+|+||+||+|...+++.||||+.+..... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999987643221 1111 13566666666543 34
Q ss_pred eeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEE
Q 039681 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 389 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~Nill 467 (624)
.+.+++ ...++||||++++++........ ... .....++.+++.++.++|. .+ |+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 445443 34689999999865432211110 011 5678899999999999999 87 9999999999999
Q ss_pred CCCCCeEEeecCCccccc
Q 039681 468 DEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~~ 485 (624)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=3e-15 Score=135.64 Aligned_cols=135 Identities=21% Similarity=0.176 Sum_probs=114.2
Q ss_pred ccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC--CceeeEeeEEEeCCceeEEEeeccCC
Q 039681 334 KDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH--RSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 334 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34679999999999999755 7889998765433 5678999999999976 58999999888888899999999887
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76533 5567788899999999999997544599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.1e-15 Score=143.47 Aligned_cols=135 Identities=24% Similarity=0.315 Sum_probs=104.1
Q ss_pred cceec-cCCcEEEEEEEEcCCCEEEEEEcccCC-------------cchhHHHHHHHHHHHhcCCCce--eeEeeEEEeC
Q 039681 335 DNLIG-TGGFGEVFKGILDDGTVTAIKRAKLGN-------------TKGTDLVLNEVRILCQVNHRSL--VRLLGCCVEL 398 (624)
Q Consensus 335 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 398 (624)
...|| .||.|+||+.... +..++||+..... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8899999998875 6678888764321 1223457889999999998775 6777765443
Q ss_pred C----ceeEEEeeccC-CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 399 D----QTLMIYEYIPN-GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 399 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
. ..++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence 2 23599999997 688888752 235544 3568999999999999 9999999999999998899
Q ss_pred EEeecCCccc
Q 039681 474 KVSDFGLSRL 483 (624)
Q Consensus 474 kl~DfGla~~ 483 (624)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.3e-16 Score=168.87 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=187.5
Q ss_pred hCCCCccceeccCCcEEEEEEEEc--CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD--DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 403 (624)
...|...+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345777788999999999887753 34556667655433 223344555888888887 9999999999999999999
Q ss_pred EEeeccCCCccccc-ccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeecCCCCCeEECCCC-CeEEeecCC
Q 039681 404 IYEYIPNGTLFDHL-HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH-SAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGL 480 (624)
Q Consensus 404 v~e~~~~g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGl 480 (624)
+.+|..++++.+.+ +.+ ....+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..|++|||+
T Consensus 99 ~~~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred ccCcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchh
Confidence 99999999999988 432 124566677788999999999999 777 99999999999999999 999999999
Q ss_pred cccccccCCCCcceeecccc-cccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 481 SRLVERTETNDSHIFTTAQG-TMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
|...... ...........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+......+.. ...|....
T Consensus 172 At~~~~~-~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~-- 247 (601)
T KOG0590|consen 172 ATAYRNK-NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK-- 247 (601)
T ss_pred hcccccc-CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc--
Confidence 9876541 122333455677 9999999999874 4567899999999999999999998755433211 11111110
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
... ..............+..+++..+|..|.+.+++.
T Consensus 248 -~~~-----------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 -GRF-----------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -ccc-----------ccCccccCChhhhhcccccccCCchhcccccccc
Confidence 000 0000112334456677888889999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-13 Score=146.39 Aligned_cols=144 Identities=19% Similarity=0.222 Sum_probs=103.7
Q ss_pred CCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchh----------------------------------------
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGT---------------------------------------- 370 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------- 370 (624)
.|. .+.||.|++|+||+|++.+|+.||||+.+....+..
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 468999999999999999999999999865421110
Q ss_pred HHHHHHHHHHHhcC----CCceeeEeeEEE-eCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHH-HH
Q 039681 371 DLVLNEVRILCQVN----HRSLVRLLGCCV-ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE-GL 444 (624)
Q Consensus 371 ~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~L 444 (624)
-+|.+|...+.+++ |.+-+.+-.++. .....+|||||++|++|.++..... ... .+.+++.+++. .+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGL---DRKALAENLARSFL 270 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCC---CHHHHHHHHHHHHH
Confidence 02555666666652 333333333332 2456799999999999988764211 112 23456777766 47
Q ss_pred HHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 445 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
..+|..+ ++|+|+||.||++++++.+++.|||++..+.
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8899988 9999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.6e-14 Score=137.19 Aligned_cols=208 Identities=21% Similarity=0.262 Sum_probs=141.5
Q ss_pred HHHHHHhcCCCceeeEeeEEEeC-----CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 039681 376 EVRILCQVNHRSLVRLLGCCVEL-----DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450 (624)
Q Consensus 376 E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~ 450 (624)
-+.-|-++.|.|||+++.|+.+. ....++.|||..|+|..+|++.. .....+......+|..||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 34556667799999999998754 35688999999999999997542 2346688888899999999999999998
Q ss_pred CCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC-CCCcceeecccccccccCcccccccCCCCccchhhHHHHHH
Q 039681 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE-TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLL 529 (624)
Q Consensus 451 ~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ 529 (624)
. |+|+|+++..+-|++..++-+|+.- +.-....... ...........+-++|.|||+=.....+..+|||+||+..+
T Consensus 196 ~-PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 196 D-PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred C-CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 7 7899999999999999999888752 1111110000 00001111234568999999877767788999999999999
Q ss_pred HHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 530 ELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 530 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
||.-+......+. ... ..++.+...+ ... ... .=..++..|++..|..||+|++++.
T Consensus 274 emailEiq~tnse--S~~---------~~ee~ia~~i----~~l----en~---lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 274 EMAILEIQSTNSE--SKV---------EVEENIANVI----IGL----ENG---LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHheeccCCCc--cee---------ehhhhhhhhe----eec----cCc---cccCcCcccccCCCCCCcchhhhhc
Confidence 9988775422111 100 0011110000 000 000 0123778999999999999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.9e-13 Score=139.61 Aligned_cols=250 Identities=21% Similarity=0.240 Sum_probs=180.5
Q ss_pred CCCccceecc--CCcEEEEEEEE---cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCcee
Q 039681 331 NFSKDNLIGT--GGFGEVFKGIL---DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 331 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 402 (624)
.|...+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....+++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3555677899 99999999986 3577889997443322 22333356777777775 999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeecCCCCCeEECCC-CCeEEee
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE----GLTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSD 477 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~L~yLH~~~~~~iiH~Dik~~Nill~~~-~~~kl~D 477 (624)
+-+|++ +.+|..+.+. ....++....+.+..+..+ ||.++|+.. ++|-|+||.||+..++ ...+++|
T Consensus 195 iqtE~~-~~sl~~~~~~----~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHT----PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeccc-cchhHHhhhc----ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 999998 5788888864 2345777788888888888 999999999 9999999999999999 8899999
Q ss_pred cCCcccccccCCCCc-ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 478 FGLSRLVERTETNDS-HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 478 fGla~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
||+...+........ .......+...|++||...+ .++..+|+|++|.+.+|..++..+........ |. .
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~--~ 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS--Q 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc--c
Confidence 999988765432222 11223367788999998866 77889999999999999999887654331111 00 0
Q ss_pred hcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 557 MDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.. .+-+ ++. ......+..++..+++.+|..|++.+.+..
T Consensus 338 ~r~~---~ip~-e~~-------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQG---YIPL-EFC-------EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc---cCch-hhh-------cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 0111 110 112233445888899999999998877653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.1e-12 Score=116.60 Aligned_cols=130 Identities=17% Similarity=0.111 Sum_probs=96.6
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceee-EeeEEEeCCceeEEEeeccCCCcc
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR-LLGCCVELDQTLMIYEYIPNGTLF 414 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~L~ 414 (624)
+.|+.|.++.||+.... +..+++|....... ....+..|+.+++.+.+.++++ ++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 56889999999999865 77899998754322 2335688999999987655544 4443 234468999999998875
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 415 DHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA--VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 415 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
+.- . ....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 431 0 11345678999999999987 22359999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.5e-12 Score=134.25 Aligned_cols=146 Identities=16% Similarity=0.169 Sum_probs=96.4
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC-CCEEEEEEcccCCcch----------------------------------h---
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNTKG----------------------------------T--- 370 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~--- 370 (624)
...|+. +.||.|++|+||+|++++ |+.||||+.+..-.+. .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999877 9999999987542110 0
Q ss_pred ---HHHHHHHHHHHhcC----CCceeeEeeEEEe-CCceeEEEeeccCCCcccccccccCC-CCCCCCHHHHHHHHHHHH
Q 039681 371 ---DLVLNEVRILCQVN----HRSLVRLLGCCVE-LDQTLMIYEYIPNGTLFDHLHCDFTG-KWPPLPWHLRLVIAHQIA 441 (624)
Q Consensus 371 ---~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~i~ 441 (624)
-+|.+|+..+.+++ +.+.+.+=.++.+ ....+|||||++|+++.+.-.-...+ ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 12455665555552 3444443344433 45778999999999997742111000 01123333333334443
Q ss_pred HHHHHHHhcCCCCeEeecCCCCCeEECCCC----CeEEeecCCccccc
Q 039681 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKL----NAKVSDFGLSRLVE 485 (624)
Q Consensus 442 ~~L~yLH~~~~~~iiH~Dik~~Nill~~~~----~~kl~DfGla~~~~ 485 (624)
...+ ++|+|+||.||+++.++ .+++.|||+...+.
T Consensus 277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3466 99999999999999888 99999999987664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.2e-11 Score=126.33 Aligned_cols=166 Identities=19% Similarity=0.184 Sum_probs=128.1
Q ss_pred EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCH
Q 039681 351 LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPW 430 (624)
Q Consensus 351 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~ 430 (624)
..++.+|.|...+..+....+...+-++.|+.++||||++++..+......|||+|-+ -.|..++.. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE--------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH--------hHH
Confidence 4578888888887766655667888899999999999999999999999999999988 456666642 335
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccc
Q 039681 431 HLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510 (624)
Q Consensus 431 ~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 510 (624)
......+.||+.||.|||+.+. ++|++|.-.-|+++..|..||++|.+......... .......-..|..|+.+
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChhhc
Confidence 5666678999999999997765 99999999999999999999999988765432111 01111122346677655
Q ss_pred cccCCCCccchhhHHHHHHHHHhC
Q 039681 511 RNFQLTDKSDVYSFGVVLLELLTS 534 (624)
Q Consensus 511 ~~~~~~~ksDv~s~G~vl~elltg 534 (624)
.... -..|.|-||++++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 3322 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-10 Score=108.32 Aligned_cols=137 Identities=16% Similarity=0.071 Sum_probs=99.6
Q ss_pred ceeccCCcEEEEEEEEcC-------CCEEEEEEcccCCc----------------------chhHHH----HHHHHHHHh
Q 039681 336 NLIGTGGFGEVFKGILDD-------GTVTAIKRAKLGNT----------------------KGTDLV----LNEVRILCQ 382 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~~ 382 (624)
..||.|--+.||.|...+ +..+|||+.+.... .....+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47899997542110 011223 389999999
Q ss_pred cC--CCceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeec
Q 039681 383 VN--HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL-HSAAVPPIYHRD 459 (624)
Q Consensus 383 l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yL-H~~~~~~iiH~D 459 (624)
+. .-++.+++++ ...++||||+.+..+....- +...++..+...+..+++.+|..| |+.+ ++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 95 3567777764 56789999997654422111 112355566778889999999999 7888 99999
Q ss_pred CCCCCeEECCCCCeEEeecCCccccc
Q 039681 460 VKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 460 ik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
|++.|||+++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 679999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.9e-10 Score=111.52 Aligned_cols=142 Identities=23% Similarity=0.307 Sum_probs=111.3
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCC--CceeeEeeEEEeCC---ceeEEEeecc
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNH--RSLVRLLGCCVELD---QTLMIYEYIP 409 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 409 (624)
+.|+.|..+.||+....+|+.+++|....... .....+..|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899998764322 134578999999999975 44677777766542 5689999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA-------------------------------------- 451 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------------------------------------- 451 (624)
+.++.+.+.. ..++..++..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888776531 35778888889999999999999531
Q ss_pred ---------------CCCeEeecCCCCCeEECC--CCCeEEeecCCccc
Q 039681 452 ---------------VPPIYHRDVKSSNILLDE--KLNAKVSDFGLSRL 483 (624)
Q Consensus 452 ---------------~~~iiH~Dik~~Nill~~--~~~~kl~DfGla~~ 483 (624)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 133799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.7e-11 Score=128.23 Aligned_cols=260 Identities=22% Similarity=0.233 Sum_probs=181.9
Q ss_pred cccCHHH-HHHHhCCCCccceeccCCcEEEEEEEE--cCCCEEEEEEcccCCcchhHH--HHHHHHHHHhc-CCCceeeE
Q 039681 318 RIFTGKE-IRRATNNFSKDNLIGTGGFGEVFKGIL--DDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQV-NHRSLVRL 391 (624)
Q Consensus 318 ~~~~~~~-~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l 391 (624)
.++...+ ......+|.....||.|.|+.|++... .++..+++|.+...-....++ -+.|+.+...+ .|.+++..
T Consensus 252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 3444444 334456788889999999999998774 367888999765443332222 35566666666 48899998
Q ss_pred eeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC-
Q 039681 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK- 470 (624)
Q Consensus 392 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~- 470 (624)
...+....+.++=-||++++++...+. -...+++..++++..|++.++.++|+.. ++|+|+||+||++..+
T Consensus 332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 332 NSSWSQLRQGYIPLEFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCccccccccCchhhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccch
Confidence 888888888889999999998876653 2345778888999999999999999998 9999999999999876
Q ss_pred CCeEEeecCCcccccccCCCCcceeecccccccc-cCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccH
Q 039681 471 LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY-LDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNL 549 (624)
Q Consensus 471 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~ 549 (624)
+.-++.|||.+..+..... .....+..| .+++......+-.+.|++|||.-+.|.+++..-...... .
T Consensus 404 ~~~~~~~~~~~t~~~~~~~------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----~ 472 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSSG------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----S 472 (524)
T ss_pred hhhhccccccccccceecc------cccccccccccchhhccccccccccccccccccccccccCcccCccccc-----c
Confidence 8889999999864321100 111122334 356666777889999999999999999998754321100 0
Q ss_pred HHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 550 VVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 550 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
..+..+... .. ....+++..+...++..++..||.+.++....+-..
T Consensus 473 -----~~i~~~~~p------------~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 -----LTIRSGDTP------------NL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred -----eeeeccccc------------CC-CchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 001111110 00 112255667888899999999999998877665543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2e-09 Score=110.20 Aligned_cols=172 Identities=19% Similarity=0.275 Sum_probs=131.5
Q ss_pred CcEEEEEEE-EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEe----CCceeEEEeeccC-CCccc
Q 039681 342 GFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE----LDQTLMIYEYIPN-GTLFD 415 (624)
Q Consensus 342 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~ 415 (624)
.-.+.|++. ..||..+++|++.............-++.++++.|.|+|++..++.. +..+++||+|+|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 345679998 45899999999943322223334567889999999999999999873 4568899999985 57777
Q ss_pred cccccc----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 416 HLHCDF----------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 416 ~l~~~~----------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
+..... ......+++...|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 554221 123456889999999999999999999999 7789999999999999999999999887665
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCC
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKA 537 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p 537 (624)
.+. . |-+ +--.+-|.=.||.+++.|.||...
T Consensus 445 ~d~---~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDP---T---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---C---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 321 0 111 112367899999999999999754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-09 Score=98.56 Aligned_cols=131 Identities=24% Similarity=0.293 Sum_probs=99.1
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEE-cccCCc-c------hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKR-AKLGNT-K------GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~-~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++++|+-+.+|.+.+.+.. +++|. +...-. . ..+.-.+|+.++.++.--.|.-..=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999764433 55553 222111 1 123467899999999765655555566777888999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
+++-.|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++.++. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888531 2556777888889999999 99999999999998775 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.1e-09 Score=96.05 Aligned_cols=143 Identities=23% Similarity=0.236 Sum_probs=104.8
Q ss_pred ccceeccCCcEEEEEEEEcCCCEEEEEE-cccCCc-------chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 334 KDNLIGTGGFGEVFKGILDDGTVTAIKR-AKLGNT-------KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 334 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
...+|-+|+-+.|+++.+. |+..+||. +...-. -.....++|+++|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999885 55555663 322111 12345688999999987656666566677777888999
Q ss_pred eeccC-CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC---CeEEeecCCc
Q 039681 406 EYIPN-GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL---NAKVSDFGLS 481 (624)
Q Consensus 406 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~---~~kl~DfGla 481 (624)
||+++ .++.+++..... ..........++.+|-+.+.-||.++ ||||||..+||+|.+++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 99976 478888764322 12233333788899999999999999 99999999999996544 3589999998
Q ss_pred cc
Q 039681 482 RL 483 (624)
Q Consensus 482 ~~ 483 (624)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=6e-11 Score=130.36 Aligned_cols=252 Identities=21% Similarity=0.213 Sum_probs=168.1
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
..+.+.+.+.+-.|.++.++.+.-. .|...++|...... ..+.+....+-.++-..+||-++...--+.......|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456777778889999999887632 34333344332211 1222333444444444556777766555666788999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|++|+.+++|...|+.. +.++..-.......+.++++|||... +.|+|++|.|.|+..+++.+++|||....
T Consensus 882 ~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 99999999999988743 23454445556667889999999997 89999999999999999999999984332
Q ss_pred cccc---------------------C------CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCC
Q 039681 484 VERT---------------------E------TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK 536 (624)
Q Consensus 484 ~~~~---------------------~------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~ 536 (624)
...- . .++........+|+.|.+||...+......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 1100 0 000011234568999999999999999999999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHH
Q 039681 537 AIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604 (624)
Q Consensus 537 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 604 (624)
||+....... +.... ...+. .+............++.+.+..+|.+|-.+.
T Consensus 1034 p~na~tpq~~------f~ni~---------~~~~~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI------FENIL---------NRDIP--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhh------hhccc---------cCCCC--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9875443221 11111 10010 1111223344566688888899999996655
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.8e-09 Score=98.23 Aligned_cols=125 Identities=26% Similarity=0.328 Sum_probs=82.3
Q ss_pred EEEEEEEcCCCEEEEEEcccCCcc--------------------------hhHHHHHHHHHHHhcCCC--ceeeEeeEEE
Q 039681 345 EVFKGILDDGTVTAIKRAKLGNTK--------------------------GTDLVLNEVRILCQVNHR--SLVRLLGCCV 396 (624)
Q Consensus 345 ~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 396 (624)
.||.|...+|..+|||+.+..... ......+|++.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 389999888999999975532110 012367899999999755 56667654
Q ss_pred eCCceeEEEeecc--CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 397 ELDQTLMIYEYIP--NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY-LHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 397 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~y-LH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
....|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 35579999998 54454433211 1133456677788886665 56888 9999999999999988 99
Q ss_pred EEeecCCcccc
Q 039681 474 KVSDFGLSRLV 484 (624)
Q Consensus 474 kl~DfGla~~~ 484 (624)
.|+|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.3e-08 Score=97.68 Aligned_cols=141 Identities=16% Similarity=0.086 Sum_probs=100.3
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc-----------hhHHHHHHHHHHHhcCC--CceeeEeeEEEe-----
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK-----------GTDLVLNEVRILCQVNH--RSLVRLLGCCVE----- 397 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h--~niv~l~~~~~~----- 397 (624)
+++-+-....|++..+ +|+.+.||+....... ....+.+|...+.++.. -..++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667655 5678999976432211 11137889999988853 334455666543
Q ss_pred CCceeEEEeeccCC-CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-------
Q 039681 398 LDQTLMIYEYIPNG-TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE------- 469 (624)
Q Consensus 398 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~------- 469 (624)
....++|+|++++- +|.+++.... ....+...+..++.+++..+.-||..+ |+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23578999999875 7888874211 134566778899999999999999999 999999999999975
Q ss_pred CCCeEEeecCCccc
Q 039681 470 KLNAKVSDFGLSRL 483 (624)
Q Consensus 470 ~~~~kl~DfGla~~ 483 (624)
+..+.|+||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 56899999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.7e-08 Score=93.35 Aligned_cols=136 Identities=22% Similarity=0.235 Sum_probs=100.8
Q ss_pred CCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc----------------------hhHHHHHHHHHHHhcCCC--c
Q 039681 332 FSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK----------------------GTDLVLNEVRILCQVNHR--S 387 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~--n 387 (624)
..+.+.||.|--+.||.|...+|..+|||.-+..... ......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567889999999999999999999999954332110 122367899999999644 7
Q ss_pred eeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE
Q 039681 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 388 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill 467 (624)
+.+.+++ +...+||||+++-.|...- ++.+..-.|+..|+.-+.-+-..| +||+|+++-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 7777764 6678999999886554321 123334455555666666555777 9999999999999
Q ss_pred CCCCCeEEeecCCcccc
Q 039681 468 DEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~ 484 (624)
+++|.+.++||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 99999999999876544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.4e-07 Score=94.54 Aligned_cols=267 Identities=13% Similarity=0.137 Sum_probs=159.4
Q ss_pred CccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEE------EeCC-ceeEE
Q 039681 333 SKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCC------VELD-QTLMI 404 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~-~~~lv 404 (624)
...+.||+|+.+.+|.--.- +..|| |+..........+ -+..|... .||-+-.-+.+= -+.. ..-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh-hchhh-eeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 45678999999999964321 22233 4443222222222 12233333 455333211111 0111 24456
Q ss_pred EeeccCC-Cccccccc-ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 405 YEYIPNG-TLFDHLHC-DFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 405 ~e~~~~g-~L~~~l~~-~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
|..+++. ....++.- ......+...|...++++..+|.+.+-||..| .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 6666543 22222221 11234567899999999999999999999999 7889999999999999999999854332
Q ss_pred cccccCCCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhC-CCCCCCCCcc--ccccHHHHHH
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTS-KKAIDFNREE--ENVNLVVYMK 554 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg-~~p~~~~~~~--~~~~~~~~~~ 554 (624)
. ......+...+|...|.+||... +..-+..+|-|.+|+++++++.| ++||.+-... .....-.
T Consensus 166 i-----~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--- 237 (637)
T COG4248 166 I-----NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--- 237 (637)
T ss_pred e-----ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---
Confidence 2 23344567788999999999754 45677889999999999999887 8898653211 1111000
Q ss_pred HHhcccccccccchhhhhccC--cCc-HHHHHHHHHHHHHchhc--CCCCCCCHHHHHHHHHHHHHh
Q 039681 555 KIMDEERLMEVVDPVLKERAT--HLD-LETMKALGLLAASCLDE--RRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~--~~~-~~~~~~l~~l~~~cl~~--~p~~RPs~~ev~~~L~~i~~~ 616 (624)
.+..+......|........ ..+ .-....+..|..+|... ++.-|||.+-.+..|..+.+.
T Consensus 238 -~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 238 -DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred -hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 01111111111111100000 111 11234556677788764 367899999999999888764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=7.6e-09 Score=110.01 Aligned_cols=152 Identities=20% Similarity=0.296 Sum_probs=103.0
Q ss_pred HHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC-----CcceeecccccccccCcccccc
Q 039681 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN-----DSHIFTTAQGTMGYLDPEYYRN 512 (624)
Q Consensus 438 ~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~ 512 (624)
.+++.||.|+|.... +||++|.|++|.++.++..||+.|+.+......... +.....-.+....|.|||++.+
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 355699999998875 999999999999999999999999987654431111 1111112345678999999998
Q ss_pred cCCCCccchhhHHHHHHHHHhCCCCC-CCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHH
Q 039681 513 FQLTDKSDVYSFGVVLLELLTSKKAI-DFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAAS 591 (624)
Q Consensus 513 ~~~~~ksDv~s~G~vl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~ 591 (624)
...+.++|+||+|+++|-+..|+++. ....... ....... ..+.. ........+.++.+=+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~~~~~~--------~~~~~----~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SYSFSRN--------LLNAG----AFGYSNNLPSELRESLKK 247 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc----hhhhhhc--------ccccc----cccccccCcHHHHHHHHH
Confidence 88899999999999999998555543 2211110 0000000 00000 011123455677778888
Q ss_pred chhcCCCCCCCHHHHH
Q 039681 592 CLDERRQNRPSMKEVA 607 (624)
Q Consensus 592 cl~~~p~~RPs~~ev~ 607 (624)
.+..++..||++.++.
T Consensus 248 ~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLL 263 (700)
T ss_pred HhcCCcccCcchhhhh
Confidence 9999999999888774
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.1e-07 Score=83.95 Aligned_cols=139 Identities=15% Similarity=0.112 Sum_probs=102.7
Q ss_pred eccCCcEEEEEEEEcCCCEEEEEEcccC---C---cchhHHHHHHHHHHHhcC--CCceeeEeeEEEeC----CceeEEE
Q 039681 338 IGTGGFGEVFKGILDDGTVTAIKRAKLG---N---TKGTDLVLNEVRILCQVN--HRSLVRLLGCCVEL----DQTLMIY 405 (624)
Q Consensus 338 lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~----~~~~lv~ 405 (624)
-|+||.+.|++-.+.+ +.+-+|+.... . .-....|.+|+..|.++. .-.+.++...-... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 3678999999977654 46888875411 0 235678999999999995 33355555222221 2468999
Q ss_pred eeccC-CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC--eEEeecCCcc
Q 039681 406 EYIPN-GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN--AKVSDFGLSR 482 (624)
Q Consensus 406 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~--~kl~DfGla~ 482 (624)
|-+++ -+|.+++... ...+.+..++..+..++++.++-||+.+ +.|+|+.+.|||++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98864 5788887532 2235677888999999999999999999 999999999999986667 9999998665
Q ss_pred c
Q 039681 483 L 483 (624)
Q Consensus 483 ~ 483 (624)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.6e-07 Score=87.33 Aligned_cols=106 Identities=25% Similarity=0.239 Sum_probs=84.4
Q ss_pred hHHHHHHHHHHHhcC--CCceeeEeeEEEeCC----ceeEEEeeccCC-CcccccccccCCCCCCCCHHHHHHHHHHHHH
Q 039681 370 TDLVLNEVRILCQVN--HRSLVRLLGCCVELD----QTLMIYEYIPNG-TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442 (624)
Q Consensus 370 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 442 (624)
.....+|...+..+. .-...+.+++..... ..++|+|++++. +|.+++... ..++......++.++++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHH
Confidence 345788888888885 344666777766533 458999999874 788888632 12666778899999999
Q ss_pred HHHHHHhcCCCCeEeecCCCCCeEECCCC---CeEEeecCCccc
Q 039681 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKL---NAKVSDFGLSRL 483 (624)
Q Consensus 443 ~L~yLH~~~~~~iiH~Dik~~Nill~~~~---~~kl~DfGla~~ 483 (624)
.++-||..+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999 99999999999999877 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.8e-07 Score=97.63 Aligned_cols=145 Identities=16% Similarity=0.186 Sum_probs=96.5
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcch----------------------------------------
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKG---------------------------------------- 369 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------- 369 (624)
..|+ .+.|+.++-|+||+|++++|+.||||+.+.+-.+.
T Consensus 126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3444 36899999999999999999999999876543221
Q ss_pred hHHHHHHHHHHHhcC-----CCceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHH-
Q 039681 370 TDLVLNEVRILCQVN-----HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG- 443 (624)
Q Consensus 370 ~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~- 443 (624)
.-++.+|...+.+++ .+++.-..=+..-....+|+|||++|-.+.+....+ ...++.+ .++..++++
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d~k---~ia~~~~~~f 277 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK----SAGIDRK---ELAELLVRAF 277 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH----hcCCCHH---HHHHHHHHHH
Confidence 012455666666652 344332222333457789999999998888875321 1234432 333333332
Q ss_pred HHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 444 L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
+.-+=..+ ++|.|.+|.||+++.++++.+.|||+...+.
T Consensus 278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 22222345 8999999999999999999999999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.1e-06 Score=83.12 Aligned_cols=132 Identities=17% Similarity=0.115 Sum_probs=84.9
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCc--eeeEeeEEEeCCceeEEEeeccCCC-
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS--LVRLLGCCVELDQTLMIYEYIPNGT- 412 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~- 412 (624)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24456788876422 3345788999999986433 4667777777777889999998863
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHHH---------------------------------------HHHHhc-CC
Q 039681 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL---------------------------------------TYLHSA-AV 452 (624)
Q Consensus 413 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L---------------------------------------~yLH~~-~~ 452 (624)
+.+.+. .+......++.++++.+ .+|... ..
T Consensus 82 ~~~~~~---------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 82 FSRIIS---------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred hhhhhc---------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 221111 01111111122222222 222211 12
Q ss_pred CCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 453 ~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3478999999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.5e-06 Score=77.74 Aligned_cols=152 Identities=20% Similarity=0.200 Sum_probs=104.7
Q ss_pred cCHHHHHHHhCCCCccce---eccCCcEEEEEEEEcCCCEEEEEEcccCCcch------------------------hHH
Q 039681 320 FTGKEIRRATNNFSKDNL---IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKG------------------------TDL 372 (624)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~ 372 (624)
.+.+.+....++..+... |..|--+.||+|...++..+|+|+.+...... ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 344555666566555554 55677778999998889999999876432110 012
Q ss_pred HHHHHHHHHhcC--CCceeeEeeEEEeCCceeEEEeeccCCCccc-ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 039681 373 VLNEVRILCQVN--HRSLVRLLGCCVELDQTLMIYEYIPNGTLFD-HLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449 (624)
Q Consensus 373 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~ 449 (624)
...|+..|+++. +-.+.+.+++. +-.|||||+....+.. .| +...+.......+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L------kDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL------KDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc------ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 456888888884 56666777664 3479999995431111 11 11233333677778888898888887
Q ss_pred -cCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 450 -AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 450 -~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
.+ +||+||+.=|||+. ++.+.|+|||-|....
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 55 99999999999999 7899999999886544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.4e-05 Score=75.28 Aligned_cols=137 Identities=18% Similarity=0.156 Sum_probs=89.9
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHH---------HHHHHHHHHhcC---CCceeeEeeEE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL---------VLNEVRILCQVN---HRSLVRLLGCC 395 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~ 395 (624)
..++|...+++-.....-|.+-.. +|+.+++|..+......... ..+++..+.+++ --....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346677777777766666665554 56888999877554332222 233444444443 22222322222
Q ss_pred E-----eCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC
Q 039681 396 V-----ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK 470 (624)
Q Consensus 396 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~ 470 (624)
. -....+|+|||++|..|.++.. +++ .++..+++++.-||+.| ++|+|..|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 2 2345678999999988876542 222 35567788899999999 9999999999999966
Q ss_pred CCeEEeecCCcc
Q 039681 471 LNAKVSDFGLSR 482 (624)
Q Consensus 471 ~~~kl~DfGla~ 482 (624)
+ +++.||+..+
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 4 9999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.2e-06 Score=77.64 Aligned_cols=105 Identities=25% Similarity=0.349 Sum_probs=84.3
Q ss_pred HHHHHHHHhcCC-CceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 039681 374 LNEVRILCQVNH-RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452 (624)
Q Consensus 374 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~ 452 (624)
.+|.-+++.+++ +++++++|.|- .++|.||...+++...-. ...+...-+|..|.+||.++++.+.+|++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~--~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR--PLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc--ccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 458889999976 69999999994 378999998776643210 00122347999999999999999999999776
Q ss_pred CCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 453 ~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
..+.-.|++++|+-+++++++|++|.......
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 66999999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.8e-05 Score=77.91 Aligned_cols=140 Identities=16% Similarity=0.080 Sum_probs=85.1
Q ss_pred eccCCc-EEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEeeccCCCccc
Q 039681 338 IGTGGF-GEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEYIPNGTLFD 415 (624)
Q Consensus 338 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 415 (624)
|-.|.. ..||+.... +..+++|+..... .....+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 778998764 4678888865432 345678999988884 4456677887776667899999999877764
Q ss_pred cc-------------------ccccCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----c
Q 039681 416 HL-------------------HCDFTGKWPPLPWH--LRLVIAH--------------------QIAEGLTYLHS----A 450 (624)
Q Consensus 416 ~l-------------------~~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~L~yLH~----~ 450 (624)
.. |.- .....++... ..+.... .+...+..|-. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHAL-PVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcC-CcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 32 110 0000011100 0000000 01111222211 1
Q ss_pred CCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 451 ~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12448999999999999998778999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=8.8e-06 Score=86.90 Aligned_cols=140 Identities=19% Similarity=0.202 Sum_probs=91.7
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcch-------------------------------------hHHHHHHH
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKG-------------------------------------TDLVLNEV 377 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~ 377 (624)
.+.||.-+.|+||+|++++|+.||||+.+..-++. .-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 46799999999999999999999999876543221 11256666
Q ss_pred HHHHhc----CCCc------eeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 039681 378 RILCQV----NHRS------LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447 (624)
Q Consensus 378 ~~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yL 447 (624)
+...+. .|-+ |.+++. .-.....|+||||+|..+.|.-.- ....++...+. ..+.++ |+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i----~~~gi~~~~i~---~~l~~~--~~ 314 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI----DKRGISPHDIL---NKLVEA--YL 314 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH----HHcCCCHHHHH---HHHHHH--HH
Confidence 655554 3444 333322 224578999999999887775321 11234444333 333332 22
Q ss_pred HhcCCCCeEeecCCCCCeEECC----CCCeEEeecCCccccc
Q 039681 448 HSAAVPPIYHRDVKSSNILLDE----KLNAKVSDFGLSRLVE 485 (624)
Q Consensus 448 H~~~~~~iiH~Dik~~Nill~~----~~~~kl~DfGla~~~~ 485 (624)
+..-...++|.|=+|.||+++. ++.+.+-|||+...+.
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2221222899999999999984 6789999999987664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.7e-05 Score=77.27 Aligned_cols=144 Identities=22% Similarity=0.243 Sum_probs=84.1
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCC--ceeeEeeEEEe---CCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR--SLVRLLGCCVE---LDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~ 410 (624)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999877 68899986543 4556788899998888533 35666664433 2346899999998
Q ss_pred CCccc----------------cc---ccccCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 039681 411 GTLFD----------------HL---HCDFTGKWPPLPWHLR---------LVI------------AHQIAE-GLTYLHS 449 (624)
Q Consensus 411 g~L~~----------------~l---~~~~~~~~~~l~~~~~---------~~i------------~~~i~~-~L~yLH~ 449 (624)
.++.. .+ +... .....+.+... ... ...+.+ .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 87776 11 1100 01111111110 000 111222 3333332
Q ss_pred c----CCCCeEeecCCCCCeEEC-CCCCeEEeecCCccc
Q 039681 450 A----AVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRL 483 (624)
Q Consensus 450 ~----~~~~iiH~Dik~~Nill~-~~~~~kl~DfGla~~ 483 (624)
. ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 233499999999999999 666668999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.6e-05 Score=88.20 Aligned_cols=80 Identities=16% Similarity=0.322 Sum_probs=57.8
Q ss_pred cceeccCCcEEEEEEEEcCC---CEEEEEEcccCCc-chhHHHHHHHHHHHhcC-CCce--eeEeeEEEeC---CceeEE
Q 039681 335 DNLIGTGGFGEVFKGILDDG---TVTAIKRAKLGNT-KGTDLVLNEVRILCQVN-HRSL--VRLLGCCVEL---DQTLMI 404 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 404 (624)
.+.|+.|.+..+|+....++ ..+++|+...... .....+.+|+++|+.+. |.++ .+++.++.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688999999999876554 3677777543321 23456889999999995 6654 7788887664 467899
Q ss_pred EeeccCCCcc
Q 039681 405 YEYIPNGTLF 414 (624)
Q Consensus 405 ~e~~~~g~L~ 414 (624)
|||+++..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=7.3e-07 Score=94.07 Aligned_cols=185 Identities=20% Similarity=0.074 Sum_probs=132.3
Q ss_pred CCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCc-eeeEeeEEEeCCceeEEEeeccC
Q 039681 332 FSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS-LVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+...+-.++|+++.++|.+-...+...++.+... ....-++++|.+++||| .++.++-+..+...++++++...
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3334457899999999987443444445554432 44567899999999999 77777777777888999999977
Q ss_pred C-CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 411 G-TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 411 g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+ +-..... ...-.+...+...+...-+++|+|||+.. =+|+| ||+..+ ...|..||+....+....
T Consensus 319 ~rs~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 319 GRSSALEMT----VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred CccccccCC----hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 6 2222111 11122344445556667788999999985 48998 777766 578999999987665321
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCC
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~ 538 (624)
.-+...+++.|+|||+.....+..+.|+|+.|+--.++--|-.|-
T Consensus 386 ----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234567899999999999989999999999998766776666554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00013 Score=68.65 Aligned_cols=129 Identities=22% Similarity=0.239 Sum_probs=91.8
Q ss_pred ccceeccCCcEEEEEEEEcCCCEEEEEEcccCC----------------cchhHHHHHHHHHHHhcC------CCceeeE
Q 039681 334 KDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN----------------TKGTDLVLNEVRILCQVN------HRSLVRL 391 (624)
Q Consensus 334 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l 391 (624)
...+||+|+.-.||. +.+.....||+..... .....+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 456899999999996 4556667788876554 223456677777666665 8899999
Q ss_pred eeEEEeCCceeEEEeeccC--C----CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 039681 392 LGCCVELDQTLMIYEYIPN--G----TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNI 465 (624)
Q Consensus 392 ~~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Ni 465 (624)
+|+...+...-+|+|.+.+ | ||.+++.. ..++. . +...+-+-.+||-+.+ |+.+|++|+||
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NI 149 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE------GGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNI 149 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc------CCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccE
Confidence 9999999999999998743 3 56666632 23554 2 3334445566778888 99999999999
Q ss_pred EECCC--C--CeEEee
Q 039681 466 LLDEK--L--NAKVSD 477 (624)
Q Consensus 466 ll~~~--~--~~kl~D 477 (624)
++..+ + .+.|+|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 99532 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00011 Score=71.95 Aligned_cols=74 Identities=16% Similarity=0.182 Sum_probs=46.2
Q ss_pred ceeccCCcE-EEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCC---ceeeEeeEEEeC---CceeEEEeec
Q 039681 336 NLIGTGGFG-EVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR---SLVRLLGCCVEL---DQTLMIYEYI 408 (624)
Q Consensus 336 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~ 408 (624)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.+++..+... .+.+.++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457767766 48874 23467776543 22345788999999888532 344444433322 2358899999
Q ss_pred cCCCccc
Q 039681 409 PNGTLFD 415 (624)
Q Consensus 409 ~~g~L~~ 415 (624)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9977754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00025 Score=71.83 Aligned_cols=76 Identities=9% Similarity=0.103 Sum_probs=56.8
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC---CceeeEeeEEEe---CCceeEEEeec
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH---RSLVRLLGCCVE---LDQTLMIYEYI 408 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~ 408 (624)
.+.||.|..+.||+....+++ +++|..+. ......+..|.+.|+.+.- ..+.++++++.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 467999999999998765564 56676432 1233578999999998852 468888888754 36689999999
Q ss_pred cCCCc
Q 039681 409 PNGTL 413 (624)
Q Consensus 409 ~~g~L 413 (624)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=97.83 E-value=7.6e-05 Score=61.13 Aligned_cols=65 Identities=23% Similarity=0.444 Sum_probs=45.6
Q ss_pred CCCcceeeeeeecCCCC-------CCCCCCCCCceEEEeeCCCCCCCCCccccCCCCCCccccCCCCCCcceeecCCC
Q 039681 163 NGGCTAYQSFVNLDANW-------VPGKTWPEPGMELEWELPPEPICKTPEDCKDLLHSNCLADPMYPGLKRCLCNPG 233 (624)
Q Consensus 163 ~~~C~~~~~~~~~~~~~-------~~~~~~~~~~~~L~W~~~~~~~C~~~~~C~~~~~~~C~~~~~~~~~~~C~c~~~ 233 (624)
...|.....+.+..... ..+...+..||+|+|.... ..|. +|+.+ +|+|+++... ..+.|+|++|
T Consensus 22 ~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~-~~C~---~C~~S-gG~Cgy~~~~-~~f~C~C~dg 93 (94)
T PF14380_consen 22 AGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADS-GDCR---ECEAS-GGRCGYDSNS-EQFTCFCSDG 93 (94)
T ss_pred CCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCC-CcCc---ChhcC-CCEeCCCCCC-ceEEEECCCC
Confidence 55788754444333211 1122236899999999733 3698 99998 9999999876 6799999986
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00018 Score=71.33 Aligned_cols=139 Identities=14% Similarity=0.057 Sum_probs=78.6
Q ss_pred eccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCce-eeEeeEEEeCCceeEEEeeccCCCcccc
Q 039681 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL-VRLLGCCVELDQTLMIYEYIPNGTLFDH 416 (624)
Q Consensus 338 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~~ 416 (624)
+..|-...+|+.. .+++.+++|........-.-...+|..+++.+....+ .++++.. .-.+|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 4567778899887 4566788887543322211235789999998864333 3344432 23689999998766431
Q ss_pred -----------------cccccCCCCCCCCHHHH-HHHHH---------HHHHHHHHHHhcC-----CCCeEeecCCCCC
Q 039681 417 -----------------LHCDFTGKWPPLPWHLR-LVIAH---------QIAEGLTYLHSAA-----VPPIYHRDVKSSN 464 (624)
Q Consensus 417 -----------------l~~~~~~~~~~l~~~~~-~~i~~---------~i~~~L~yLH~~~-----~~~iiH~Dik~~N 464 (624)
||.... ...+++.... ..+.. .+...+..+.... ...++|+|+.|.|
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 111100 1112222211 11111 1112222222211 1248999999999
Q ss_pred eEECCCCCeEEeecCCccc
Q 039681 465 ILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 465 ill~~~~~~kl~DfGla~~ 483 (624)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999997753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00028 Score=68.88 Aligned_cols=74 Identities=19% Similarity=0.139 Sum_probs=48.3
Q ss_pred ceeccCCcEEEEEEEEcC--CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCce-eeEeeEEEeCCceeEEEeeccCCC
Q 039681 336 NLIGTGGFGEVFKGILDD--GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL-VRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
+.|..|-...+|+....+ +..+++|+....... .-...+|+.+++.+...++ +++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999988664 678889976543222 1233578888888854333 34444322 248999999877
Q ss_pred cc
Q 039681 413 LF 414 (624)
Q Consensus 413 L~ 414 (624)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0007 Score=63.11 Aligned_cols=125 Identities=26% Similarity=0.409 Sum_probs=89.5
Q ss_pred CCCCccceeccCCc-EEEEEEEEcCCCEEEEEEccc---CCc------------------chhHHHHHHHHHHHhcC---
Q 039681 330 NNFSKDNLIGTGGF-GEVFKGILDDGTVTAIKRAKL---GNT------------------KGTDLVLNEVRILCQVN--- 384 (624)
Q Consensus 330 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 384 (624)
.+++..+.||.|.. |.||+..+ +|+.+|+|.++. ... ...+.|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 467999998321 110 12235788998888775
Q ss_pred CCce--eeEeeEEEeCC------------------ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHH
Q 039681 385 HRSL--VRLLGCCVELD------------------QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444 (624)
Q Consensus 385 h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L 444 (624)
+.++ |+.+||..-.. ...||.||.+... .+. .+-+.+|.+-|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~dl 177 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRDL 177 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHHH
Confidence 4566 89999874321 1246677665432 122 22345677888
Q ss_pred HHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 445 ~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999999 999999999986 3589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00068 Score=70.74 Aligned_cols=75 Identities=16% Similarity=0.147 Sum_probs=54.0
Q ss_pred ceeccCCcEEEEEEEEcCC-CEEEEEEcccC-----C--cchhHHHHHHHHHHHhcC---CCceeeEeeEEEeCCceeEE
Q 039681 336 NLIGTGGFGEVFKGILDDG-TVTAIKRAKLG-----N--TKGTDLVLNEVRILCQVN---HRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 404 (624)
+.||.|.+..||+....+| +.++||..... . ....+.+..|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999998777 48999975311 1 124566778888888763 2456667665 44668899
Q ss_pred EeeccCCC
Q 039681 405 YEYIPNGT 412 (624)
Q Consensus 405 ~e~~~~g~ 412 (624)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00047 Score=62.17 Aligned_cols=128 Identities=16% Similarity=0.180 Sum_probs=87.4
Q ss_pred ccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 334 KDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 334 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
..+.|++|.+|.||++.+.+ ..+|+|+-+.. .....+..|+++|..+.-.++-+=+-.+ +.-++.|||+.|-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG-GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeeccC-ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcch
Confidence 35679999999999999864 47788876643 3345688999999999877665543322 233455999988787
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC--CCeEECCCCCeEEeecCCccc
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKS--SNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~--~Nill~~~~~~kl~DfGla~~ 483 (624)
.+.-.. .+.++.. .+++.---|...+ |-|+.|.- +||++.++ .+.|+||..|..
T Consensus 100 ~~~~~~--------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIG--------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred hhhhhc--------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 665431 1233333 3444444455556 88998874 56666655 899999998864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0016 Score=66.06 Aligned_cols=144 Identities=18% Similarity=0.173 Sum_probs=85.5
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCC--ceeeEeeE------EEeCCceeEEEe
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR--SLVRLLGC------CVELDQTLMIYE 406 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e 406 (624)
.+.|..|....+|+....++ .+++|+... ...+....|++++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 44577787789999876544 678888654 2334567788888877432 24454432 223456789999
Q ss_pred eccCCCcccc--------------cccc---cCC---CCCCCCHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 039681 407 YIPNGTLFDH--------------LHCD---FTG---KWPPLPWHLRL----------VIAHQIAEGLTYLHSA----AV 452 (624)
Q Consensus 407 ~~~~g~L~~~--------------l~~~---~~~---~~~~l~~~~~~----------~i~~~i~~~L~yLH~~----~~ 452 (624)
|++|..+... +|.. ... ......|.... .....+..++.++... ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776431 1100 000 00112222211 0112234455555541 12
Q ss_pred CCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 453 ~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 348999999999999998778899999775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00026 Score=80.31 Aligned_cols=196 Identities=20% Similarity=0.205 Sum_probs=135.3
Q ss_pred HHHHHHHHHhcCCCceeeEeeEEEeCCcee----EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 039681 373 VLNEVRILCQVNHRSLVRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448 (624)
Q Consensus 373 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH 448 (624)
-.-|+..+.++.|+|++.++.|..++...- +..|+++.-++...+. .-..++..+.+.+..++..||+|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-----~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-----SVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-----hccccCHHHHHHHHHHHhhhHHHHH
Confidence 345777788889999999999987654333 3346777777777775 3457888999999999999999999
Q ss_pred hcCCCCeEeecCCCC---CeEECCCCCeEEe--ecCCcccccccCCCCcceeecccccccccCcccccccCCCC--ccch
Q 039681 449 SAAVPPIYHRDVKSS---NILLDEKLNAKVS--DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTD--KSDV 521 (624)
Q Consensus 449 ~~~~~~iiH~Dik~~---Nill~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDv 521 (624)
+.. ..|.-+..+ +.-.+..+...++ ||+.++......... ...-+..+.+||.......+. ..|+
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-----~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-----SDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch-----hhcCccccccccccccccchhhhhhHH
Confidence 986 666666555 5566777788888 999887665322211 223455678888876655444 4799
Q ss_pred hhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC
Q 039681 522 YSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP 601 (624)
Q Consensus 522 ~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP 601 (624)
|.+|..+..+..|..+...... ....++. .....+.....+|+..++++|+
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~------------------~~~~l~~-----------~~~~~~~d~~~~~~~~~~~~Rl 426 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAV------------------PVSLLDV-----------LSTSELLDALPKCLDEDSEERL 426 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccc------------------hhhhhcc-----------ccchhhhhhhhhhcchhhhhcc
Confidence 9999999999988755321110 0011110 0111345577789999999999
Q ss_pred CHHHHHHHH
Q 039681 602 SMKEVADEI 610 (624)
Q Consensus 602 s~~ev~~~L 610 (624)
+..+++...
T Consensus 427 ~~~~ll~~~ 435 (1351)
T KOG1035|consen 427 SALELLTHP 435 (1351)
T ss_pred chhhhhhch
Confidence 999988653
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0023 Score=65.62 Aligned_cols=143 Identities=13% Similarity=0.071 Sum_probs=76.1
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC--CceeeEee------EEEeCCceeEEEee
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH--RSLVRLLG------CCVELDQTLMIYEY 407 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 407 (624)
+.|+.|....+|+....+| .+++|+.... ..+....|+.++..+.. -.+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788999876655 5788876521 22333445555555531 11333332 12234567899999
Q ss_pred ccCCCcccc--------------cccccC---C---CCCCCCH-HHHHH-------------HHHHHHHHHHHHHhc---
Q 039681 408 IPNGTLFDH--------------LHCDFT---G---KWPPLPW-HLRLV-------------IAHQIAEGLTYLHSA--- 450 (624)
Q Consensus 408 ~~~g~L~~~--------------l~~~~~---~---~~~~l~~-~~~~~-------------i~~~i~~~L~yLH~~--- 450 (624)
++|..+... +|.... . ....+.| ..... +...+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 988754221 111000 0 0011222 11111 111122222333311
Q ss_pred -CCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 451 -AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 451 -~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
-...++|+|+.|.|||++++...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12349999999999999977666899999775
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0012 Score=67.10 Aligned_cols=142 Identities=23% Similarity=0.249 Sum_probs=83.1
Q ss_pred ceeccCCcEEEEEEEEcC-------CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCce-eeEeeEEEeCCceeEEEee
Q 039681 336 NLIGTGGFGEVFKGILDD-------GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL-VRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 407 (624)
+.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345667777899988655 5788899865432 233456788888888853333 345554432 368999
Q ss_pred ccCCCcccc-----------------cccccCC--C----CCCCCHHHHHH--------------------------HHH
Q 039681 408 IPNGTLFDH-----------------LHCDFTG--K----WPPLPWHLRLV--------------------------IAH 438 (624)
Q Consensus 408 ~~~g~L~~~-----------------l~~~~~~--~----~~~l~~~~~~~--------------------------i~~ 438 (624)
++|.++... +|..... . ..+.-|....+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 1111010 0 00111111111 112
Q ss_pred HHHHHHHHHHh------cCCCCeEeecCCCCCeEECCC----CCeEEeecCCcc
Q 039681 439 QIAEGLTYLHS------AAVPPIYHRDVKSSNILLDEK----LNAKVSDFGLSR 482 (624)
Q Consensus 439 ~i~~~L~yLH~------~~~~~iiH~Dik~~Nill~~~----~~~kl~DfGla~ 482 (624)
.+...++.|.. .....++|+|+.+.|||++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22333444432 123458999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0056 Score=62.42 Aligned_cols=145 Identities=14% Similarity=0.132 Sum_probs=82.0
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCC--ceeeEeeE------EEeCCceeEEEe
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR--SLVRLLGC------CVELDQTLMIYE 406 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e 406 (624)
.+.++.|....+|+....++ .+++|+..... ..+....|.+++..|... .+.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34577777788998876555 56778764321 234456677777777422 23444332 122456789999
Q ss_pred eccCCCcccc--------------cccccC---CCC----CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 039681 407 YIPNGTLFDH--------------LHCDFT---GKW----PPLPWHLRL------------VIAHQIAEGLTYLHS---- 449 (624)
Q Consensus 407 ~~~~g~L~~~--------------l~~~~~---~~~----~~l~~~~~~------------~i~~~i~~~L~yLH~---- 449 (624)
|++|..+... +|.... ... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988654321 111000 000 001121110 111223445555543
Q ss_pred cCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 450 ~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
.....++|+|+++.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112349999999999999998777899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0035 Score=62.66 Aligned_cols=30 Identities=23% Similarity=0.470 Sum_probs=25.4
Q ss_pred CeEeecCCCCCeEECCCCC-eEEeecCCccc
Q 039681 454 PIYHRDVKSSNILLDEKLN-AKVSDFGLSRL 483 (624)
Q Consensus 454 ~iiH~Dik~~Nill~~~~~-~kl~DfGla~~ 483 (624)
.++|+|+++.|||+++++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0037 Score=62.53 Aligned_cols=73 Identities=16% Similarity=0.244 Sum_probs=49.2
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC---CCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN---HRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
.+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999877 677889999865 334567888999888883 456788898888888889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0011 Score=65.39 Aligned_cols=136 Identities=16% Similarity=0.162 Sum_probs=95.9
Q ss_pred CCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc----------------------hhHHHHHHHHHHHhcC-C-C
Q 039681 331 NFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK----------------------GTDLVLNEVRILCQVN-H-R 386 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~-h-~ 386 (624)
-++..+.||-|--+.||.+...+|++.++|.-+..... ..-...+|+..|+.+. | =
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 36778999999999999999989999999954332110 0112567888888885 3 2
Q ss_pred ceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 387 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
-+.+.+++ ...++|||++.+-.|...-+ ..+..+ +...+..-+.-|...| +||+|..--||+
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~--------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH--------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee--------cCChHH---HHHHHHHHHHHHHHcC---ceecccchheeE
Confidence 34555554 56689999998887765442 122223 3334444455666777 999999999999
Q ss_pred ECCCCCeEEeecCCcccc
Q 039681 467 LDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 467 l~~~~~~kl~DfGla~~~ 484 (624)
++++..++++||--....
T Consensus 235 v~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMVST 252 (465)
T ss_pred EecCCCEEEeechHhhcc
Confidence 999999999999765443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0091 Score=60.18 Aligned_cols=130 Identities=20% Similarity=0.292 Sum_probs=83.3
Q ss_pred EEEEEEEcCCCEEEEEEcc-cCCcchhHHHHHHHHHHHhcCC--CceeeEeeEEEeCC--ceeEEEeeccCCCccccccc
Q 039681 345 EVFKGILDDGTVTAIKRAK-LGNTKGTDLVLNEVRILCQVNH--RSLVRLLGCCVELD--QTLMIYEYIPNGTLFDHLHC 419 (624)
Q Consensus 345 ~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~ 419 (624)
.+|..... ++.+++++.. ...........+|+.+|+.+.- .-+...++.|.++. ..+.||+|.+|..+...+..
T Consensus 40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 34444332 6777777321 1223445566788888888753 34556677777665 77999999988655444421
Q ss_pred ccCCCCCCCCHHHHHHHH-HHHHHHHHHHHhc------------------------------------------------
Q 039681 420 DFTGKWPPLPWHLRLVIA-HQIAEGLTYLHSA------------------------------------------------ 450 (624)
Q Consensus 420 ~~~~~~~~l~~~~~~~i~-~~i~~~L~yLH~~------------------------------------------------ 450 (624)
. ... .+++ ..+++.|+-||+-
T Consensus 119 ~------~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 119 E------SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred c------cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 1 011 1222 3556666666632
Q ss_pred --C-----CCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 451 --A-----VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 451 --~-----~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
. .+.++|+|+++.|++++++.-+=|.||+++.+-.
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 1 1359999999999999998889999999997643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.008 Score=62.23 Aligned_cols=142 Identities=20% Similarity=0.187 Sum_probs=81.5
Q ss_pred eeccCCcEEEEEEEEcC-----CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCcee-eEeeEEEeCCceeEEEeeccC
Q 039681 337 LIGTGGFGEVFKGILDD-----GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV-RLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 410 (624)
.|-.|-.-.+|+....+ ++.+++|+.........+ -.+|..+++.+...++. ++++.+... .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45457777889887532 367888987654333233 36788998888644443 455555332 58999987
Q ss_pred CCcccc-----------------ccccc-CCCCCCCCHHHHHHHHHHH-----------------HHHHHHHH----h-c
Q 039681 411 GTLFDH-----------------LHCDF-TGKWPPLPWHLRLVIAHQI-----------------AEGLTYLH----S-A 450 (624)
Q Consensus 411 g~L~~~-----------------l~~~~-~~~~~~l~~~~~~~i~~~i-----------------~~~L~yLH----~-~ 450 (624)
.+|... +|... ........|.+..++..++ ...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 11110 1111122233333333221 11122222 1 1
Q ss_pred CCCCeEeecCCCCCeEECC-CCCeEEeecCCccc
Q 039681 451 AVPPIYHRDVKSSNILLDE-KLNAKVSDFGLSRL 483 (624)
Q Consensus 451 ~~~~iiH~Dik~~Nill~~-~~~~kl~DfGla~~ 483 (624)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1234899999999999986 46899999988753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.034 Score=57.98 Aligned_cols=73 Identities=14% Similarity=0.066 Sum_probs=49.6
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCC----c---chhHHHHHHHHHHHhcC---CCceeeEeeEEEeCCceeEE
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN----T---KGTDLVLNEVRILCQVN---HRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 404 (624)
.+.||.|..-.||+.... +..++||+..... . ...+.-..|.+.|+.+. -.++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 456899999999997764 5568899754211 1 13344455677776653 247777888776 557889
Q ss_pred EeeccC
Q 039681 405 YEYIPN 410 (624)
Q Consensus 405 ~e~~~~ 410 (624)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0003 Score=81.65 Aligned_cols=161 Identities=14% Similarity=0.045 Sum_probs=117.6
Q ss_pred HHHHHHHHHhcCCCceeeEeeEEEe--CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 039681 373 VLNEVRILCQVNHRSLVRLLGCCVE--LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450 (624)
Q Consensus 373 ~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~ 450 (624)
.+.|.+.++...|+++.....-... ..+.+.+++|+..|.+.+.|-.. ..+.+.++..-+...-.+...+..-.|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg-~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKG-LEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhc-cccCCcchhchHHHHHHHHHhccchhhhc
Confidence 4556666666789988776554433 34668899999999999988643 23445555555555545546666665554
Q ss_pred C--CCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHH
Q 039681 451 A--VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVL 528 (624)
Q Consensus 451 ~--~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl 528 (624)
. ...-+|+++|+-|.+|..+..+|++++|+.+...+ .........+++.|++|+....-.++.++|+|..|+.+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp----~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP----VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCc----hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 3 34479999999999999999999999999984322 22233455678889999998888889899999999999
Q ss_pred HHHHhCCCCC
Q 039681 529 LELLTSKKAI 538 (624)
Q Consensus 529 ~elltg~~p~ 538 (624)
|++-.|..+|
T Consensus 1431 y~rs~~n~~f 1440 (2724)
T KOG1826|consen 1431 YLRSDGNAYF 1440 (2724)
T ss_pred HHHhcccHHH
Confidence 9988777665
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.026 Score=56.98 Aligned_cols=142 Identities=18% Similarity=0.122 Sum_probs=97.4
Q ss_pred CccceeccCCcEEEEEEEEcCCCEEEEEEcccCC-----cc--------------------h-hHHHHHHHHHHHhcCCC
Q 039681 333 SKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN-----TK--------------------G-TDLVLNEVRILCQVNHR 386 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~--------------------~-~~~~~~E~~~l~~l~h~ 386 (624)
.+...|..|--+-||.++-.+|..+|||+.+-.- .. . .-....|++.|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3446788899999999999999999999754210 00 0 01245688888888654
Q ss_pred ceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 387 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
.|.-.--... ...+|||+|+.......-. -+...++...+..+-.|++.-|.-|-+.+. +||.||+--|+|
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPk-----LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPK-----LKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLL 297 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcc-----cccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhhe
Confidence 4332211111 2457999999532221111 123457777888888999999999988775 999999999999
Q ss_pred ECCCCCeEEeecCCcccc
Q 039681 467 LDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 467 l~~~~~~kl~DfGla~~~ 484 (624)
+-+ |.+.|+|-+-+...
T Consensus 298 yhd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 298 YHD-GKLYIIDVSQSVEH 314 (520)
T ss_pred EEC-CEEEEEEccccccC
Confidence 965 57999998877543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.033 Score=57.06 Aligned_cols=74 Identities=18% Similarity=0.184 Sum_probs=48.7
Q ss_pred eeccCCcEEEEEEEEcCC-CEEEEEEcc----c---CCcchhHHHHHHHHHHHhcC--CCceeeEeeEEEeCCceeEEEe
Q 039681 337 LIGTGGFGEVFKGILDDG-TVTAIKRAK----L---GNTKGTDLVLNEVRILCQVN--HRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~----~---~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e 406 (624)
.||.|...-||++...+| +.|+||... . ......+...-|.+.|+... -|..++-+- +.+.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence 379999999999997654 589999642 1 12334455667888887763 354444332 245566779999
Q ss_pred eccCC
Q 039681 407 YIPNG 411 (624)
Q Consensus 407 ~~~~g 411 (624)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 99654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.046 Score=56.27 Aligned_cols=143 Identities=18% Similarity=0.167 Sum_probs=79.1
Q ss_pred ceeccCCcEEEEEEEEcC----CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCcee-eEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV-RLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.|..|-.-.+|+....+ +..|++|+....... .-.-.+|..+++.+..-++- ++++++. .. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345457777789887543 237888887644332 22236788888888655553 4555552 22 58999977
Q ss_pred CCcccc-----------------ccccc-CCCCCCCCHHHHHHHHHHH----------------------HHHHH----H
Q 039681 411 GTLFDH-----------------LHCDF-TGKWPPLPWHLRLVIAHQI----------------------AEGLT----Y 446 (624)
Q Consensus 411 g~L~~~-----------------l~~~~-~~~~~~l~~~~~~~i~~~i----------------------~~~L~----y 446 (624)
.+|..- +|... .....+-.|....++..++ .+-+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665320 11110 1111111233332222221 11111 1
Q ss_pred HHhcC-CCCeEeecCCCCCeEECC-CCCeEEeecCCccc
Q 039681 447 LHSAA-VPPIYHRDVKSSNILLDE-KLNAKVSDFGLSRL 483 (624)
Q Consensus 447 LH~~~-~~~iiH~Dik~~Nill~~-~~~~kl~DfGla~~ 483 (624)
+.+.+ ..-+.|.|+.+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 21111 123799999999999975 57899999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.1 Score=53.29 Aligned_cols=29 Identities=31% Similarity=0.401 Sum_probs=25.0
Q ss_pred CCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 453 ~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
..++|+|+.+.||++++ +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999988 578999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.02 Score=54.75 Aligned_cols=29 Identities=28% Similarity=0.509 Sum_probs=20.9
Q ss_pred eEeecCCCCCeEE-CCCCCeEEeecCCccc
Q 039681 455 IYHRDVKSSNILL-DEKLNAKVSDFGLSRL 483 (624)
Q Consensus 455 iiH~Dik~~Nill-~~~~~~kl~DfGla~~ 483 (624)
+.|+|+.+.|||+ +.++.++++||..|..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 8999999999999 8899999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.052 Score=55.38 Aligned_cols=30 Identities=20% Similarity=0.292 Sum_probs=27.2
Q ss_pred CeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 454 ~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
.++|+|+.++|||+++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.15 Score=52.10 Aligned_cols=138 Identities=20% Similarity=0.277 Sum_probs=81.3
Q ss_pred CcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC---CCc---eeeEeeEEE--eCC--ceeEEEeeccCC
Q 039681 342 GFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN---HRS---LVRLLGCCV--ELD--QTLMIYEYIPNG 411 (624)
Q Consensus 342 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~n---iv~l~~~~~--~~~--~~~lv~e~~~~g 411 (624)
.--.+|+....+|+. ++|+.+.. ....++..|...|..+. .+= +..+-|-.. -.. ..+-|++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 455688888777777 88887754 44556677777777773 221 222222211 123 678899999998
Q ss_pred Cccc-cc--------------cc---cc----CCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhcC----C
Q 039681 412 TLFD-HL--------------HC---DF----TGKWPPLPWHL-------------RLVIAHQIAEGLTYLHSAA----V 452 (624)
Q Consensus 412 ~L~~-~l--------------~~---~~----~~~~~~l~~~~-------------~~~i~~~i~~~L~yLH~~~----~ 452 (624)
.+.. .- |. .. ........|.. ......++...+..+.+.- .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8873 11 10 00 01112234431 0112334444455444321 1
Q ss_pred ---CCeEeecCCCCCeEECCCCC-eEEeecCCcc
Q 039681 453 ---PPIYHRDVKSSNILLDEKLN-AKVSDFGLSR 482 (624)
Q Consensus 453 ---~~iiH~Dik~~Nill~~~~~-~kl~DfGla~ 482 (624)
..+||+|+.|.|||++++.. ..+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22899999999999999875 8999999764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.092 Score=49.40 Aligned_cols=153 Identities=20% Similarity=0.205 Sum_probs=89.8
Q ss_pred CCcEEEEEEEEcCCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCccccccc
Q 039681 341 GGFGEVFKGILDDGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC 419 (624)
Q Consensus 341 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 419 (624)
++..+.-+++.+-|.. .+|+++..... ....|.++.+++.++. .|+++..- +.-..-++.|++.....
T Consensus 73 ~gNsTl~~~kt~iG~L-~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPL-FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccchh-hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 3444444444333433 44554433232 4456788899988775 46666621 33455678888843111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeeccc
Q 039681 420 DFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499 (624)
Q Consensus 420 ~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 499 (624)
+ ..-.|..+ +.+|.-.|+.. +..+|||-.|+||+-|..|.+||.|=+.. ++.
T Consensus 142 --------~---~~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L--l~~------------- 193 (308)
T PF07387_consen 142 --------N---FSNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL--LEN------------- 193 (308)
T ss_pred --------c---hhHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh--hhh-------------
Confidence 1 11122222 46677888554 33899999999999999999999997633 111
Q ss_pred ccccccCcccccccCCCCccchhhHHHHHHHHHhCCC
Q 039681 500 GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK 536 (624)
Q Consensus 500 gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~ 536 (624)
+.-|.--| ....+.++.+-+|=.-++++.....
T Consensus 194 -~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 194 -QVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred -eeeEEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 11122211 1245778888888877888776443
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.39 Score=49.31 Aligned_cols=72 Identities=13% Similarity=0.033 Sum_probs=45.3
Q ss_pred CCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC--CceeeEe---e--EEEeCCceeEEEeeccCCCc
Q 039681 341 GGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH--RSLVRLL---G--CCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 341 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~---~--~~~~~~~~~lv~e~~~~g~L 413 (624)
+.-..||+....++..+++|+.+.. .....+...|++.+..+.. -.++... | ....++..+.|+++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 4556799988878888999987532 2344566778888777631 1122211 2 12234567889999987654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.19 Score=52.63 Aligned_cols=74 Identities=18% Similarity=0.192 Sum_probs=44.3
Q ss_pred ceeccCCcEEEEEEEEcCC--C-----EEEEEEcccCCcchhHHHHHHHHHHHhcCCCceee-EeeEEEeCCceeEEEee
Q 039681 336 NLIGTGGFGEVFKGILDDG--T-----VTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR-LLGCCVELDQTLMIYEY 407 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~ 407 (624)
+.|..|-...+|+....++ . .|.++.......... +-.+|+++++.+...++-+ +++.+.. .+|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 3455588888999875433 1 244443221111112 2367899999997555544 5555532 599999
Q ss_pred ccCCCcc
Q 039681 408 IPNGTLF 414 (624)
Q Consensus 408 ~~~g~L~ 414 (624)
+++.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.073 Score=55.29 Aligned_cols=75 Identities=17% Similarity=0.154 Sum_probs=50.4
Q ss_pred cceeccCCcEEEEEEEEcC-CCEEEEEEcc----c--CCcchhHHHHHHHHHHHhcC--CCceee-EeeEEEeCCceeEE
Q 039681 335 DNLIGTGGFGEVFKGILDD-GTVTAIKRAK----L--GNTKGTDLVLNEVRILCQVN--HRSLVR-LLGCCVELDQTLMI 404 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~----~--~~~~~~~~~~~E~~~l~~l~--h~niv~-l~~~~~~~~~~~lv 404 (624)
.+.||.|.-.-||++...+ ++.|+||... . ...-..+...-|.+.|+... -|..|+ ++. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 3568999999999999743 5679999632 1 11334566777888888774 454444 443 355667789
Q ss_pred EeeccCC
Q 039681 405 YEYIPNG 411 (624)
Q Consensus 405 ~e~~~~g 411 (624)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.054 Score=55.55 Aligned_cols=61 Identities=15% Similarity=0.195 Sum_probs=44.5
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD 468 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~ 468 (624)
...|+=+|+++-++..++.. ...++..+.+++.--++||--+--..+ ++|.|+.|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~------~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW------KSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhc------ccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEE
Confidence 34566678888888888853 345667777888777777664444333 89999999999994
|
|
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.055 Score=44.86 Aligned_cols=73 Identities=12% Similarity=0.284 Sum_probs=39.4
Q ss_pred CCCCCCCCCceeeeeCCC-Ccceecccc--------CCCcceeee----eeecCCC-CCCCCCCCCCceEEEeeCCCCCC
Q 039681 136 PPCMTASSLCCVFKTGGS-QTAYTIRVH--------NGGCTAYQS----FVNLDAN-WVPGKTWPEPGMELEWELPPEPI 201 (624)
Q Consensus 136 ~~C~~~~~~cc~~~~~~~-~~~~~~~~~--------~~~C~~~~~----~~~~~~~-~~~~~~~~~~~~~L~W~~~~~~~ 201 (624)
.+|. |.+|||+.+|.+ ++.+.+.+. ..+|.+.+- |...+.. ...+......+++|+|.+.....
T Consensus 2 ~~Cs--G~~CCQt~iP~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n~t~p~~~~~~~y~pv~L~W~i~t~~~ 79 (103)
T PF08488_consen 2 SSCS--GIGCCQTSIPSGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSNITDPEDFHAMGYVPVVLDWFIDTSDS 79 (103)
T ss_pred CccC--CcceeccCCCCCCceEEEEEeEecCCCcccCCCceEEEEeccccccccCCChHHhccCCeeEEEEEEEEecCCc
Confidence 3676 899999999875 444554332 258875321 1111110 01122224578999999964321
Q ss_pred C-CCccccCC
Q 039681 202 C-KTPEDCKD 210 (624)
Q Consensus 202 C-~~~~~C~~ 210 (624)
. ...+.|..
T Consensus 80 ~~~~s~~C~~ 89 (103)
T PF08488_consen 80 SFSNSLACKN 89 (103)
T ss_pred CcCcCccCCC
Confidence 1 12356665
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.073 Score=53.83 Aligned_cols=55 Identities=29% Similarity=0.271 Sum_probs=48.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 427 ~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
...|++.+.|+.+.+.-+.-+..+-. .=|||+.-.||||+ +|++-|+||-++++-
T Consensus 317 ~~~~~e~lsff~s~~sil~~lekkf~--fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEKKFP--FEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhhcCC--cccccccccceeee-cCceEEEEeeeeecc
Confidence 46788999999999998888887764 88999999999999 999999999999853
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 624 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-40 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 386 bits (995), Expect = e-131
Identities = 119/330 (36%), Positives = 182/330 (55%), Gaps = 9/330 (2%)
Query: 292 MKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGIL 351
M + K + + ++ + ++ ATNNF LIG G FG+V+KG+L
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 352 DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNG 411
DG A+KR +++G + E+ L H LV L+G C E ++ ++IY+Y+ NG
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL 471
L HL+ + W RL I A GL YLH+ I HRDVKS NILLDE
Sbjct: 121 NLKRHLY-GSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENF 176
Query: 472 NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLEL 531
K++DFG+S+ TE + +H+ T +GT+GY+DPEY+ +LT+KSDVYSFGVVL E+
Sbjct: 177 VPKITDFGISKKG--TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 532 LTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAAS 591
L ++ AI + E VNL + + + +L ++VDP L + + E+++ G A
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD---KIRPESLRKFGDTAVK 291
Query: 592 CLDERRQNRPSMKEVADEIEYIISIAKGRI 621
CL ++RPSM +V ++EY + + + I
Sbjct: 292 CLALSSEDRPSMGDVLWKLEYALRLQESVI 321
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-120
Identities = 113/294 (38%), Positives = 179/294 (60%), Gaps = 10/294 (3%)
Query: 316 SARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL-VL 374
+ F+ +E++ A++NFS N++G GGFG+V+KG L DGT+ A+KR K T+G +L
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 375 NEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL 434
EV ++ HR+L+RL G C+ + L++Y Y+ NG++ L + PPL W R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQ 134
Query: 435 VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI 494
IA A GL YLH P I HRDVK++NILLDE+ A V DFGL++L++ D+H+
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY---KDTHV 191
Query: 495 FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNR--EEENVNLVVY 552
T +GT+G++ PEY + ++K+DV+ +GV+LLEL+T ++A D R +++V L+ +
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+K ++ E++L +VD L+ ++E + + LL C RP M EV
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL---CTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 342 bits (881), Expect = e-114
Identities = 108/321 (33%), Positives = 176/321 (54%), Gaps = 26/321 (8%)
Query: 306 EMLNAKAAGKSARIFTGKEIRRATNNFSK------DNLIGTGGFGEVFKGILDDGTVTAI 359
E + + + F+ E++ TNNF + N +G GGFG V+KG +++ TV A+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AV 59
Query: 360 KRAKLGNTK----GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFD 415
K+ E++++ + H +LV LLG + D ++Y Y+PNG+L D
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 416 HLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475
L C PPL WH+R IA A G+ +LH HRD+KS+NILLDE AK+
Sbjct: 120 RLSC--LDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKI 174
Query: 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
SDFGL+R + + + + GT Y+ PE R ++T KSD+YSFGVVLLE++T
Sbjct: 175 SDFGLARAS--EKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGL 231
Query: 536 KAIDFNREEENVNLVVYMKKIMDEER-LMEVVDPVLKERATHLDLETMKALGLLAASCLD 594
A+D +RE + L+ ++I DEE+ + + +D + + D +++A+ +A+ CL
Sbjct: 232 PAVDEHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMND----ADSTSVEAMYSVASQCLH 285
Query: 595 ERRQNRPSMKEVADEIEYIIS 615
E++ RP +K+V ++ + +
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 3e-74
Identities = 78/322 (24%), Positives = 123/322 (38%), Gaps = 35/322 (10%)
Query: 316 SARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLN 375
S + + + + G FG V+K L + V A+K + + +
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSW-QNEY 67
Query: 376 EVRILCQVNHRSLVRLLGCCVE----LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWH 431
EV L + H ++++ +G +I + G+L D L + W+
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWN 121
Query: 432 LRLVIAHQIAEGLTYLHSAAV-------PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484
IA +A GL YLH P I HRD+KS N+LL L A ++DFGL+
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 485 ERTETNDSHIFTTAQ-GTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAI 538
E ++ T Q GT Y+ PE + D+Y+ G+VL EL + A
Sbjct: 182 EAGKSAGD---THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 539 DFNREEENVNLVVYMKKIMDEERLMEVV-----DPVLKERATHLDLETMKALGLLAASCL 593
D +E + + + E + EVV PVL++ M L C
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ--KHAGMAMLCETIEECW 296
Query: 594 DERRQNRPSMKEVADEIEYIIS 615
D + R S V + I +
Sbjct: 297 DHDAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 9e-64
Identities = 85/293 (29%), Positives = 133/293 (45%), Gaps = 36/293 (12%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRSLVRLLGCC 395
IG G FG V + V A+K + + L EV I+ ++ H ++V +G
Sbjct: 45 IGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPI 455
+ ++ EY+ G+L+ LH + L RL +A+ +A+G+ YLH+ PPI
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGARE--QLDERRRLSMAYDVAKGMNYLHNRN-PPI 160
Query: 456 YHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL 515
HR++KS N+L+D+K KV DFGLSRL T + +A GT ++ PE R+
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS----KSAAGTPEWMAPEVLRDEPS 216
Query: 516 TDKSDVYSFGVVLLELLTSKKAIDFNREE--ENVNLVVYMKKIMDEERLMEVVDPVLKER 573
+KSDVYSFGV+L EL T ++ N+N +VV V +
Sbjct: 217 NEKSDVYSFGVILWELAT--------LQQPWGNLN-------------PAQVVAAVGFKC 255
Query: 574 ATHLDL--ETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRISES 624
L++ + + C RPS + D + +I A + S
Sbjct: 256 KR-LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 9e-62
Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 32/287 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV 389
+ ++G G FG V K V AIK ++ + + E+R L +VNH ++V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIK--QIESESERKAFIVELRQLSRVNHPNIV 64
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
+L G C L+ ++ EY G+L++ LH P + Q ++G+ YLHS
Sbjct: 65 KLYGAC--LNPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 450 AAVPPIYHRDVKSSNILLDEKLN-AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
+ HRD+K N+LL K+ DFG + ++ T +G+ ++ PE
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-------MTNNKGSAAWMAPE 173
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568
+ ++K DV+S+G++L E++T +K F +E M + + R
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKP--F--DEIGGPAFRIMWAVHNGTRP------ 223
Query: 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615
L K + L C + RPSM+E+ + +++
Sbjct: 224 -------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-61
Identities = 68/328 (20%), Positives = 126/328 (38%), Gaps = 42/328 (12%)
Query: 320 FTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRI 379
E +N LIG G +G V+KG LD+ V A+K N + +NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFANRQN---FINEKNI 58
Query: 380 --LCQVNHRSLVRLLGCCVELDQT-----LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHL 432
+ + H ++ R + + L++ EY PNG+L +L W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVS 112
Query: 433 RLVIAHQIAEGLTYLHSAAV------PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486
+AH + GL YLH+ P I HRD+ S N+L+ +SDFGLS +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 487 TET----NDSHIFTTAQGTMGYLDPEYYRN-------FQLTDKSDVYSFGVVLLELLTSK 535
+ + + GT+ Y+ PE + D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 536 KAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKER-------ATHLDLETMKALGLL 588
+ + + ++ + ++ V +E+ A + +++L
Sbjct: 233 TDLFPGESVPEYQM-AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 589 AASCLDERRQNRPSMKEVADEIEYIISI 616
C D+ + R + + + + ++ I
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 8e-59
Identities = 75/290 (25%), Positives = 126/290 (43%), Gaps = 47/290 (16%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGN----TKGTDLVLNEVRILCQVNHRSLVRLLG 393
IG GGFG+V++ V A+K A+ ++ + V E ++ + H +++ L G
Sbjct: 15 IGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
C++ ++ E+ G L L +P + + A QIA G+ YLH A+
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 454 PIYHRDVKSSNILLDEKL--------NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
PI HRD+KSSNIL+ +K+ K++DFGL+R RT +A G ++
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK------MSAAGAYAWM 181
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE--ENVNLVVYMKKIMDEERLM 563
PE R + SDV+S+GV+L ELLT E ++ + + + +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLT--------GEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
+ + L C + +RPS + D++ I
Sbjct: 234 PIPS------------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 51/294 (17%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLV-------LNEVRILCQVNHRSLV 389
IG GGFG V KG + D +V AIK LG+++G + EV I+ +NH ++V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
+L G + M+ E++P G L+ L K P+ W ++L + IA G+ Y+ +
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLL----DKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 450 AAVPPIYHRDVKSSNILLDEK-----LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
PPI HRD++S NI L + AKV+DFGLS+ + + G +
Sbjct: 141 QN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-------VSGLLGNFQW 192
Query: 505 LDPE--YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE-ER 561
+ PE T+K+D YSF ++L +LT + F +E + + ++ I +E R
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--F--DEYSYGKIKFINMIREEGLR 248
Query: 562 LM--EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
E P L+ + C + RP + E+ +
Sbjct: 249 PTIPEDCPPRLRN---------------VIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-58
Identities = 63/304 (20%), Positives = 107/304 (35%), Gaps = 49/304 (16%)
Query: 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRSLVRLLG 393
LIG G FG+V+ G G V AI+ + L EV Q H ++V +G
Sbjct: 39 ELIGKGRFGQVYHGRWH-GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
C+ +I TL+ + L + IA +I +G+ YLH+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVR----DAKIVLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND-SHIFTTAQGTMGYLDPEYYRN 512
I H+D+KS N+ D ++DFGL + + G + +L PE R
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 513 FQL---------TDKSDVYSFGVVLLELLTSKKAIDFNREE--ENVNLVVYMKKIMDEER 561
+ SDV++ G + EL RE +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHA--------REWPFKTQP------------- 247
Query: 562 LMEVVDPVLK-ERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620
++ + + + K + + C ++ RP+ ++ D +E + K
Sbjct: 248 AEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE---KLPKRN 304
Query: 621 ISES 624
S
Sbjct: 305 RRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-58
Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 33/283 (11%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLV--LNEVRILCQVNHRSLVRLLGCC 395
IG+G FG V+KG G V A+K + L NEV +L + H +++ +G
Sbjct: 32 IGSGSFGTVYKGKWH-GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPI 455
Q ++ ++ +L+ HLH + IA Q A G+ YLH+ I
Sbjct: 90 TA-PQLAIVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 456 YHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL 515
HRD+KS+NI L E K+ DFGL+ R SH F G++ ++ PE R
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS--GSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 516 ---TDKSDVYSFGVVLLELLTSKKA-IDFNREEENVNLVVYMKKIMDEERLMEVVDPVLK 571
+ +SDVY+FG+VL EL+T + + N ++ + +V D ++ +K
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 572 ERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614
L A CL ++R RPS + EIE +
Sbjct: 260 R---------------LMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-57
Identities = 71/306 (23%), Positives = 118/306 (38%), Gaps = 41/306 (13%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILC 381
+ R ++ ++G G FG+ K + G V +K + + L EV+++
Sbjct: 5 RIFRP--SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 382 QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441
+ H ++++ +G + + I EYI GTL + PW R+ A IA
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK----SMDSQYPWSQRVSFAKDIA 118
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET----------ND 491
G+ YLHS I HRD+ S N L+ E N V+DFGL+RL+ +T D
Sbjct: 119 SGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV 551
T G ++ PE +K DV+SFG+VL E++ A + +
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRTMD 231
Query: 552 YMKKIMDEERLM--EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609
+ + P + C D + RPS ++
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFP---------------ITVRCCDLDPEKRPSFVKLEHW 276
Query: 610 IEYIIS 615
+E +
Sbjct: 277 LETLRM 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-56
Identities = 54/288 (18%), Positives = 109/288 (37%), Gaps = 49/288 (17%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRSLVRLLGCC 395
+ GE++KG + +K K+ + E L +H +++ +LG C
Sbjct: 18 LNENHSGELWKGRWQGNDI-VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 396 VE--LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
+I ++P G+L++ LH G + + A +A G+ +LH+ P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFLHTLE-P 132
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF 513
I + S ++++DE + A++S + + ++ PE +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQS---------PGRMYAPAWVAPEALQKK 183
Query: 514 QL---TDKSDVYSFGVVLLELLTSKKAIDFNRE---EENVNLVVYMKKIMDEERLM--EV 565
+D++SF V+L EL+T RE + N+ + MK ++ R
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVT--------REVPFADLSNMEIGMKVALEGLRPTIPPG 235
Query: 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
+ P + + L C++E RP + +E +
Sbjct: 236 ISPHVSK---------------LMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 6e-55
Identities = 60/299 (20%), Positives = 112/299 (37%), Gaps = 33/299 (11%)
Query: 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCC 395
+G G +GEV++G V A+K + K + E+ + H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQGENV-AVKIFSSRDEK-SWFRETELYNTVMLRHENILGFIASD 71
Query: 396 VELD----QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA 451
+ Q +I Y G+L+D+L L L I IA GL +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 452 V-----PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
P I HRD+KS NIL+ + ++D GL+ + ++ GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 507 PE------YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
PE F + D+++FG+VL E+ + + + + + ++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK----PPFYDVVPNDP 241
Query: 561 RLMEVVDPVLKER------ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
++ V ++ T+ +L L C + R + + + I
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-53
Identities = 64/302 (21%), Positives = 116/302 (38%), Gaps = 33/302 (10%)
Query: 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGC 394
IG G +GEV+ G V A+K + + E+ + H +++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWRGEKV-AVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAA 99
Query: 395 CVE----LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
++ Q +I +Y NG+L+D+L L L +A+ GL +LH+
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 451 AV-----PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
P I HRD+KS NIL+ + ++D GL+ T GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 506 DPE------YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559
PE +FQ +D+YSFG++L E+ + E + + Y + +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ----LPYHDLVPSD 269
Query: 560 ERLMEVVDPVLKER------ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
++ + V ++ E ++ +G L C +R + V + +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 614 IS 615
Sbjct: 330 SE 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 57/302 (18%), Positives = 116/302 (38%), Gaps = 33/302 (10%)
Query: 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGC 394
IG G FGEV++G V A+K + E+ + H +++ +
Sbjct: 47 QESIGKGRFGEVWRGKWRGEEV-AVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 104
Query: 395 CVELDQT----LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
+ + T ++ +Y +G+LFD+L+ + + +A A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHME 158
Query: 451 AV-----PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
V P I HRD+KS NIL+ + ++D GL+ + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 506 DPE------YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559
PE ++F+ ++D+Y+ G+V E+ + + + + Y + +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----LPYYDLVPSD 274
Query: 560 ERLMEVVDPVLKER------ATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
+ E+ V +++ E ++ + + C R + + + +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 614 IS 615
Sbjct: 335 SQ 336
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 56/320 (17%), Positives = 112/320 (35%), Gaps = 38/320 (11%)
Query: 309 NAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNT 367
+ ++G+ F G + ++ +G GGF V L DG A+KR
Sbjct: 8 HHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ 67
Query: 368 KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT----LMIYEYIPNGTLFDHLHCDFTG 423
+ + E + NH +++RL+ C+ ++ + GTL++ +
Sbjct: 68 QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKD 126
Query: 424 KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483
K L L + I GL +H+ HRD+K +NILL ++ + D G
Sbjct: 127 KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
Query: 484 VERTETNDSHI-----FTTAQGTMGYLDPE---YYRNFQLTDKSDVYSFGVVLLELLTSK 535
+ + T+ Y PE + + +++DV+S G VL ++ +
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 536 KAIDFNREEENVNLVVYMKKIMDEERL--MEVVDPVLKERATHLDLETMKALGLLAASCL 593
+ + + ++ + L + L S +
Sbjct: 244 GP--Y--DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ---------------LLNSMM 284
Query: 594 DERRQNRPSMKEVADEIEYI 613
RP + + ++E +
Sbjct: 285 TVDPHQRPHIPLLLSQLEAL 304
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 30/282 (10%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNH 385
NF + IG G F EV++ L DG A+K+ ++ + K + E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 386 RSLVRLLGCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
++++ +E D L I E G L + F + +P Q+ L
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
++HS + HRD+K +N+ + K+ D GL R T + GT Y
Sbjct: 150 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYY 202
Query: 505 LDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564
+ PE KSD++S G +L E+ + F ++ N+ + KKI +
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSL--CKKIEQCD---- 254
Query: 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
P+ + + + L L C++ + RP + V
Sbjct: 255 -YPPLPSDHYS-------EELRQLVNMCINPDPEKRPDVTYV 288
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 23/217 (10%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVT-AIKRAKLGNTKGTDLV-LNEVRILC 381
+ + IG G FGEVF G L A+K + L E RIL
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167
Query: 382 QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441
Q +H ++VRL+G C + ++ E + G L + L L + A
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR----TEGARLRVKTLLQMVGDAA 223
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
G+ YL S HRD+ + N L+ EK K+SDFG+SR A G
Sbjct: 224 AGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-------YAASGG 273
Query: 502 MGYL-----DPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + PE + + +SDV+SFG++L E +
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 58/250 (23%), Positives = 106/250 (42%), Gaps = 29/250 (11%)
Query: 334 KDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRSLVR 390
D IG G F V+KG+ + A + ++ E +L + H ++VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 391 LLGCCVEL---DQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+ +++ E + +GTL +L ++ + + QI +GL +
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQF 144
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
LH+ PPI HRD+K NI + + K+ D GL+ L + GT ++
Sbjct: 145 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK------AVIGTPEFM 197
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER---L 562
PE Y + + DVY+FG+ +LE+ TS+ ++ + N +++ +
Sbjct: 198 APEMYEE-KYDESVDVYAFGMCMLEMATSE--YPYSECQ---NAAQIYRRVTSGVKPASF 251
Query: 563 MEVVDPVLKE 572
+V P +KE
Sbjct: 252 DKVAIPEVKE 261
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 7e-39
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVT-AIKRAKLGNTKGTDLVLNEVRILCQ 382
E+ R + + + +G G +GEV++G+ ++T A+K K + + L E ++ +
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-LKEAAVMKE 272
Query: 383 VNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
+ H +LV+LLG C +I E++ G L D+L + + L +A QI+
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISS 329
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT- 501
+ YL I HR++ + N L+ E KV+DFGLSRL+ +T G
Sbjct: 330 AMEYLEKKNF--I-HRNLAARNCLVGENHLVKVADFGLSRLMT------GDTYTAHAGAK 380
Query: 502 --MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ + PE + + KSDV++FGV+L E+ T
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 81/310 (26%), Positives = 128/310 (41%), Gaps = 61/310 (19%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH 385
R ++F + ++G G FG+V K D AIK+ + K +L+EV +L +NH
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNH 61
Query: 386 RSLVRLLGCCVELDQTLM----------IY---EYIPNGTLFDHLHCDFTGKWPPLPWHL 432
+ +VR +E + ++ EY NGTL+D +H +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDE 117
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT----- 487
+ QI E L+Y+HS I HRD+K NI +DE N K+ DFGL++ V R+
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 488 -----ETNDSHIFTTAQGTMGYLDPE------YYRNFQLTDKSDVYSFGVVLLELLTSKK 536
S T+A GT Y+ E +Y +K D+YS G++ E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP-- 227
Query: 537 AIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDER 596
F+ E VN+ +KK+ E D MK + +D
Sbjct: 228 ---FSTGMERVNI---LKKLRSVS----------IEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 597 RQNRPSMKEV 606
RP + +
Sbjct: 272 PNKRPGARTL 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 68/228 (29%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 326 RRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN 384
+R +F + LIG+GGFG+VFK DG IKR K N K EV+ L +++
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK----AEREVKALAKLD 62
Query: 385 HRSLVRLLGCCVELD---------------QTLMIY-EYIPNGTLFDHLHCDFTGKWPPL 428
H ++V GC D + L I E+ GTL + + L
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE---KRRGEKL 119
Query: 429 PWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488
L L + QI +G+ Y+HS + +RD+K SNI L + K+ DFGL ++
Sbjct: 120 DKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK 536
T ++GT+ Y+ PE + + D+Y+ G++L ELL
Sbjct: 177 K-----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 35/286 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHR 386
++ IGTG +G K DG + K G ++++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 387 SLVRLLGCCVE-LDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
++VR ++ + TL I EY G L + T + L L + Q+ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 445 TYLHS--AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
H + HRD+K +N+ LD K N K+ DFGL+R++ +D+ T GT
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----HDTSFAKTFVGTP 180
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE--E 560
Y+ PE +KSD++S G +L EL F + KI +
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAF----SQKELAGKIREGKFR 234
Query: 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
R+ L E + L+ + +RPS++E+
Sbjct: 235 RIPYRYSDELNE---------------IITRMLNLKDYHRPSVEEI 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-38
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILC 381
EI R + + +G G FGEV+ + T A+K K G+ L E ++
Sbjct: 182 AWEIPR--ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAF-LAEANVMK 238
Query: 382 QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441
+ H LV+L + + +I E++ G+L D L + + P + + QIA
Sbjct: 239 TLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLK---SDEGSKQPLPKLIDFSAQIA 294
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
EG+ ++ HRD++++NIL+ L K++DFGL+R++E E +T +G
Sbjct: 295 EGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE------YTAREGA 345
Query: 502 MG---YLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ PE T KSDV+SFG++L+E++T
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 71/302 (23%), Positives = 113/302 (37%), Gaps = 48/302 (15%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVN 384
R +F +G GGFG VF+ D AIKR +L N + V+ EV+ L ++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 385 HRSLVRLLGCCVE---------LDQTLMIY---EYIPNGTLFDHLHCDFTGKWPPLPWHL 432
H +VR +E + +Y + L D + + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSV 119
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE---- 488
L I QIAE + +LHS + HRD+K SNI KV DFGL +++ E
Sbjct: 120 CLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 489 ----TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544
T GT Y+ PE + K D++S G++L ELL F+ +
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FSTQM 231
Query: 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604
E V + + + + P+ ++ ++ L RP
Sbjct: 232 ERVRT---LTDVRNLK-----FPPLFTQK--------YPCEYVMVQDMLSPSPMERPEAI 275
Query: 605 EV 606
+
Sbjct: 276 NI 277
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 72/218 (33%), Positives = 110/218 (50%), Gaps = 29/218 (13%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
E+ R +G G FGEV+ G + T A+K K G+ L E ++ Q+
Sbjct: 9 EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-LAEANLMKQL 65
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
H+ LVRL + + +I EY+ NG+L D L T L + L +A QIAEG
Sbjct: 66 QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQIAEG 121
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT-- 501
+ ++ HRD++++NIL+ + L+ K++DFGL+RL+E E +T +G
Sbjct: 122 MAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNE------YTAREGAKF 172
Query: 502 ----MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
PE Y F T KSDV+SFG++L E++T
Sbjct: 173 PIKWTA---PEAINYGTF--TIKSDVWSFGILLTEIVT 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-38
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 322 GK-EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRIL 380
G E++R + +G+G FG V G A+K K G+ + E + +
Sbjct: 1 GHMELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEF-FQEAQTM 57
Query: 381 CQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQI 440
+++H LV+ G C + ++ EYI NG L ++L L L + + +
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR----SHGKGLEPSQLLEMCYDV 113
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
EG+ +L S HRD+ + N L+D L KVSDFG++R V + + ++ G
Sbjct: 114 CEGMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ------YVSSVG 164
Query: 501 T------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
T PE +Y + + KSDV++FG+++ E+ +
Sbjct: 165 TKFPVKWSA---PEVFHYFKY--SSKSDVWAFGILMWEVFS 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-37
Identities = 75/253 (29%), Positives = 112/253 (44%), Gaps = 24/253 (9%)
Query: 286 NKLNEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGE 345
+L + K L + +K + EI R + + +G G FGE
Sbjct: 143 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDA-WEIPR--ESLRLEVKLGQGCFGE 199
Query: 346 VFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405
V+ G + T AIK K G L E +++ ++ H LV+L E + ++
Sbjct: 200 VWMGTWNGTTRVAIKTLKPGTMSPEAF-LQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257
Query: 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNI 465
EY+ G+L D L L + +A QIA G+ Y+ HRD++++NI
Sbjct: 258 EYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 311
Query: 466 LLDEKLNAKVSDFGLSRLVERTETNDSH-----IFTTAQGTMGYLDPEYYRNFQLTDKSD 520
L+ E L KV+DFGL+RL+E E I TA PE + T KSD
Sbjct: 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA--------PEAALYGRFTIKSD 363
Query: 521 VYSFGVVLLELLT 533
V+SFG++L EL T
Sbjct: 364 VWSFGILLTELTT 376
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 68/283 (24%), Positives = 112/283 (39%), Gaps = 38/283 (13%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHR 386
+ + IG G FG+ +DG IK + +K + EV +L + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 387 SLVRLLGCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
++V+ E + +L I +Y G LF ++ K L QI L
Sbjct: 84 NIVQYRESFEE-NGSLYIVMDYCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALK 139
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
++H I HRD+KS NI L + ++ DFG++R++ + + GT YL
Sbjct: 140 HVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN----STVELARACIGTPYYL 192
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE--RLM 563
PE N +KSD+++ G VL EL T K A F E ++ + KI+ +
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHA--F----EAGSMKNLVLKIISGSFPPVS 246
Query: 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
L+ L + ++RPS+ +
Sbjct: 247 LHYSYDLRS---------------LVSQLFKRNPRDRPSVNSI 274
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
EI + + +GTG FG V G AIK K G+ + + E +++ +
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEF-IEEAKVMMNL 76
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
+H LV+L G C + +I EY+ NG L ++L L + + E
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEA 132
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT-- 501
+ YL S HRD+ + N L++++ KVSDFGLSR V E +T++ G+
Sbjct: 133 MEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE------YTSSVGSKF 183
Query: 502 ----MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
PE Y F + KSD+++FGV++ E+ +
Sbjct: 184 PVRWSP---PEVLMYSKF--SSKSDIWAFGVLMWEIYS 216
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
I + + IG+G FG V G + AIK + G D + E ++ ++
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDF-IEEAEVMMKL 60
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
+H LV+L G C+E ++ E++ +G L D+L + L + + EG
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEG 116
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM- 502
+ YL A V HRD+ + N L+ E KVSDFG++R V + +T++ GT
Sbjct: 117 MAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ------YTSSTGTKF 167
Query: 503 --GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
+ PE + + + KSDV+SFGV++ E+ +
Sbjct: 168 PVKWASPEVFSFSRY--SSKSDVWSFGVLMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL--DDGTVT---AIKRAKLGNT-KGTDLVLNE 376
+ ++ F K ++G+G FG V+KG+ + V AIK + + K +L+E
Sbjct: 10 RILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
++ V++ + RLLG C+ +I + +P G L D++ + L
Sbjct: 68 AYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR----EHKDNIGSQYLLNW 122
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
QIA+G+ YL + HRD+ + N+L+ + K++DFGL++L+ E
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EY 174
Query: 497 TAQGTM---GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
A+G ++ E +R + T +SDV+S+GV + EL+T
Sbjct: 175 HAEGGKVPIKWMALESILHRIY--THQSDVWSYGVTVWELMT 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-37
Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILC 381
EI R + + +G G FGEV+ G + T AIK K G L E +++
Sbjct: 261 AWEIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAF-LQEAQVMK 317
Query: 382 QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441
++ H LV+L E + ++ EY+ G+L D L L + +A QIA
Sbjct: 318 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIA 373
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH-----IFT 496
G+ Y+ + HRD++++NIL+ E L KV+DFGL+RL+E E I
Sbjct: 374 SGMAYVERMNY--V-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 497 TAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
TA PE + T KSDV+SFG++L EL T
Sbjct: 431 TA--------PEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVT-AIKRAKLGNTKGTDLVLNEVRILCQ 382
E+ R + + + +G G +GEV++G+ ++T A+K K + + L E ++ +
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-LKEAAVMKE 65
Query: 383 VNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
+ H +LV+LLG C +I E++ G L D+L + + L +A QI+
Sbjct: 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISS 122
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT- 501
+ YL I HRD+ + N L+ E KV+DFGLSRL+ +T G
Sbjct: 123 AMEYLEKKNF--I-HRDLAARNCLVGENHLVKVADFGLSRLMT------GDTYTAHAGAK 173
Query: 502 -----MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
PE Y F + KSDV++FGV+L E+ T
Sbjct: 174 FPIKWTA---PESLAYNKF--SIKSDVWAFGVLLWEIAT 207
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-36
Identities = 63/217 (29%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
+ IG G FG+V G V A+K K T L E ++ Q+
Sbjct: 189 ALNM--KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATA-QAF-LAEASVMTQL 243
Query: 384 NHRSLVRLLGCCVELDQTLMI-YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
H +LV+LLG VE L I EY+ G+L D+L + L L + + E
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCE 300
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT- 501
+ YL + HRD+ + N+L+ E AKVSDFGL++ +T
Sbjct: 301 AMEYLEGNNF--V-HRDLAARNVLVSEDNVAKVSDFGLTK----------EASSTQDTGK 347
Query: 502 -----MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
PE R + + KSDV+SFG++L E+ +
Sbjct: 348 LPVKWTA---PEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 77/323 (23%), Positives = 130/323 (40%), Gaps = 57/323 (17%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILD-----DGTVTAIKRAKLGNTKGTDLVLNEV 377
+ + +G G FG V D G + A+K+ + E+
Sbjct: 18 TIFEE--RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 75
Query: 378 RILCQVNHRSLVRLLGCCVELDQ--TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV 435
+IL ++ +V+ G + ++ EY+P+G L D L L L+
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ----RHRARLDASRLLL 131
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER-------TE 488
+ QI +G+ YL S HRD+ + NIL++ + + K++DFGL++L+ E
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 489 TNDSHIFTTAQGTMGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN 546
S IF A PE F + +SDV+SFGVVL EL T + E
Sbjct: 189 PGQSPIFWYA--------PESLSDNIF--SRQSDVWSFGVVLYELFT-YCDKSCSPSAEF 237
Query: 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDL---------ETMKALGLLAASCLDERR 597
+ ++ + + RL+E++ E L E MK C
Sbjct: 238 LRMMGCERDVPALSRLLELL-----EEGQRLPAPPACPAEVHELMK-------LCWAPSP 285
Query: 598 QNRPSMKEVADEIEYIISIAKGR 620
Q+RPS + +++ + S ++G
Sbjct: 286 QDRPSFSALGPQLDMLWSGSRGC 308
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 71/320 (22%), Positives = 119/320 (37%), Gaps = 54/320 (16%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILD-----DGTVTAIKRAKLGNTKGTDLVLNEVR 378
+ + +G G FG V D G V A+K+ + + E+
Sbjct: 37 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 379 ILCQVNHRSLVRLLGCCVELDQT--LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
IL + H ++V+ G C + +I EY+P G+L D+L + L
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQY 150
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
QI +G+ YL + HRD+ + NIL++ + K+ DFGL++++ D +
Sbjct: 151 TSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEYYK 203
Query: 497 TAQGT------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548
+ PE F + SDV+SFGVVL EL T + E
Sbjct: 204 VKEPGESPIFWYA---PESLTESKF--SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258
Query: 549 LVVYMKKIMDEERLMEVVDPVLKERATHLDL---------ETMKALGLLAASCLDERRQN 599
+ + M L+E++ + L M C +
Sbjct: 259 IGNDKQGQMIVFHLIELL-----KNNGRLPRPDGCPDEIYMIMT-------ECWNNNVNQ 306
Query: 600 RPSMKEVADEIEYIISIAKG 619
RPS +++A ++ I G
Sbjct: 307 RPSFRDLALRVDQIRDQMAG 326
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 72/322 (22%), Positives = 118/322 (36%), Gaps = 58/322 (18%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILD-----DGTVTAIKRAKLGNTKGTDLVLNEVR 378
+ + +G G FG V D G V A+K+ + + E+
Sbjct: 6 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 379 ILCQVNHRSLVRLLGCCVELDQT--LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
IL + H ++V+ G C + +I EY+P G+L D+L + L
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQY 119
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
QI +G+ YL + HRD+ + NIL++ + K+ DFGL++++ D F
Sbjct: 120 TSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEFFK 172
Query: 497 TAQGT------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT--SKKAIDFNREEEN 546
+ PE F + SDV+SFGVVL EL T K
Sbjct: 173 VKEPGESPIFWYA---PESLTESKF--SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227
Query: 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDL---------ETMKALGLLAASCLDERR 597
+ + M L+E++ + L M C +
Sbjct: 228 IGNDKQGQ--MIVFHLIELL-----KNNGRLPRPDGCPDEIYMIMT-------ECWNNNV 273
Query: 598 QNRPSMKEVADEIEYIISIAKG 619
RPS +++A ++ I G
Sbjct: 274 NQRPSFRDLALRVDQIRDNMAG 295
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 58/222 (26%), Positives = 88/222 (39%), Gaps = 28/222 (12%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL--DDGTVT--AIKRAKLGNTKGTDLV---LNE 376
I + +G G FG V +G G A+K K + + + E
Sbjct: 14 LIGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
V + ++HR+L+RL G + M+ E P G+L D L
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLR----KHQGHFLLGTLSRY 126
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
A Q+AEG+ YL S HRD+ + N+LL + K+ DFGL R + + +
Sbjct: 127 AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP----QNDDHYV 179
Query: 497 TAQGTM---GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
+ + PE R F + SD + FGV L E+ T
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTF--SHASDTWMFGVTLWEMFT 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL--DDGTVT--AIKRAKLGNTKGTDLV-LNEVR 378
I R + + ++G G FGEV++G+ G A+K K T ++E
Sbjct: 8 GIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-IA 437
I+ ++H +V+L+G E + T +I E P G L +L + L LV +
Sbjct: 66 IMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERN-----KNSLKVLTLVLYS 119
Query: 438 HQIAEGLTYLHSAAVPPIY-HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
QI + + YL S HRD+ NIL+ K+ DFGLSR +E + +
Sbjct: 120 LQICKAMAYLESIN----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED------YY 169
Query: 497 TAQGT------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
A T M PE +R F T SDV+ F V + E+L+
Sbjct: 170 KASVTRLPIKWMS---PESINFRRF--TTASDVWMFAVCMWEILS 209
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL----DDGTVT-AIKRAKLGNT-KGTDLVLNE 376
+ + K ++G+G FG V KG+ + + IK + + + V +
Sbjct: 8 RIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
+ + ++H +VRLLG C ++ +Y+P G+L DH+ L L L
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVR----QHRGALGPQLLLNW 120
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
QIA+G+ YL + HR++ + N+LL +V+DFG++ L+ +
Sbjct: 121 GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-----QL 172
Query: 497 TAQGTM---GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
++ E ++ + T +SDV+S+GV + EL+T
Sbjct: 173 LYSEAKTPIKWMALESIHFGKY--THQSDVWSYGVTVWELMT 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 72/226 (31%), Positives = 108/226 (47%), Gaps = 35/226 (15%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL---DDGTVT-AIKRAKLGNTKGTDLV-LNEV 377
+EI + + +IG+G GEV G L V AIK K G T+ L+E
Sbjct: 44 REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 378 RILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-I 436
I+ Q +H +++RL G +++ EY+ NG+L L G++ + +LV +
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIM----QLVGM 156
Query: 437 AHQIAEGLTYLHSAAVPPIY-HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
+ G+ YL Y HRD+ + N+L+D L KVSDFGLSR++E +D
Sbjct: 157 LRGVGAGMRYLSDLG----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE----DDPDAA 208
Query: 496 TTAQGT------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
T G PE +R F + SDV+SFGVV+ E+L
Sbjct: 209 YTTTGGKIPIRWTA---PEAIAFRTF--SSASDVWSFGVVMWEVLA 249
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 35/219 (15%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
+ IG G FG+V G V A+K K T L E ++ Q+
Sbjct: 17 ALNM--KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATA-QAF-LAEASVMTQL 71
Query: 384 NHRSLVRLLGCCVELDQTLMI-YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
H +LV+LLG VE L I EY+ G+L D+L + L L + + E
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCE 128
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT------ 496
+ YL + HRD+ + N+L+ E AKVSDFGL++ T+
Sbjct: 129 AMEYLEGNNF--V-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKW 180
Query: 497 TAQGTMGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
TA PE + F + KSDV+SFG++L E+ +
Sbjct: 181 TA--------PEALREKKF--STKSDVWSFGILLWEIYS 209
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILD-----DGTVTAIKRAKLGNTKGT--DLVLNE 376
+ + +G G FG+V D G A+K K + DL E
Sbjct: 17 HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL-KKE 73
Query: 377 VRILCQVNHRSLVRLLGCCVE--LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL 434
+ IL + H ++V+ G C E + +I E++P+G+L ++L + +L
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP----KNKNKINLKQQL 129
Query: 435 VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI 494
A QI +G+ YL S HRD+ + N+L++ + K+ DFGL++ +E D
Sbjct: 130 KYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE----TDKEY 182
Query: 495 FTTAQGT------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
+T PE F SDV+SFGV L ELLT
Sbjct: 183 YTVKDDRDSPVFWYA---PECLMQSKF--YIASDVWSFGVTLHELLT 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 334 KDNLIGTGGFGEVFKGILDDGTVT---AIKRAKLGNT--KGTDLVLNEVRILCQVNHRSL 388
+D +G+G FG V KG V A+K K D +L E ++ Q+++ +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
VR++G C + +++ E G L +L + + + + HQ++ G+ YL
Sbjct: 81 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE 134
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT------M 502
+ HRD+ + N+LL + AK+SDFGLS+ + D + +
Sbjct: 135 ESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWY 187
Query: 503 GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
PE Y F + KSDV+SFGV++ E +
Sbjct: 188 A---PECINYYKF--SSKSDVWSFGVLMWEAFS 215
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 75/226 (33%), Positives = 109/226 (48%), Gaps = 34/226 (15%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVT-----AIKRAKLGNTKGTDLV-LNE 376
EI + ++ +IG G FGEV+KG+L + AIK K G T+ + L E
Sbjct: 39 TEIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
I+ Q +H +++RL G + ++I EY+ NG L L K + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR----EKDGEFSVLQLVGM 152
Query: 437 AHQIAEGLTYLHSAAVPPIY-HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
IA G+ YL + Y HRD+ + NIL++ L KVSDFGLSR++E +D
Sbjct: 153 LRGIAAGMKYLANMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEAT 204
Query: 496 TTAQGT------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
T G PE YR F T SDV+SFG+V+ E++T
Sbjct: 205 YTTSGGKIPIRWTA---PEAISYRKF--TSASDVWSFGIVMWEVMT 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 48/229 (20%), Positives = 92/229 (40%), Gaps = 38/229 (16%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL--------DDGTVTAIKRAKLGNTKGTDLVLN 375
+IR + + +G G F ++FKG+ T +K + ++
Sbjct: 4 KIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV 435
++ +++H+ LV G CV D+ +++ E++ G+L +L + +L
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK----KNKNCINILWKLE 117
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN--------AKVSDFGLSRLVERT 487
+A Q+A + +L + H +V + NILL + + K+SD G+S V
Sbjct: 118 VAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 488 ETNDSHIFTTAQGTMGYLDPE---YYRNFQLTDKSDVYSFGVVLLELLT 533
+ I PE +N +D +SFG L E+ +
Sbjct: 175 DILQERIPWVP--------PECIENPKNL--NLATDKWSFGTTLWEICS 213
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 6e-35
Identities = 47/304 (15%), Positives = 94/304 (30%), Gaps = 24/304 (7%)
Query: 314 GKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDD------GTVTAIKRAKLGNT 367
K I E + + +L+G G F +V++ D +K K N
Sbjct: 49 CKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP 108
Query: 368 KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP 427
+ + L ++ + + ++++ E GTL + ++
Sbjct: 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168
Query: 428 LPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL-----------DEKLNAKVS 476
+P L + A ++ + +H I H D+K N +L D +
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK 536
D G S ++ IFT T G+ E N + D + + +L
Sbjct: 226 DLGQSIDMKLFPKGT--IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-T 282
Query: 537 AIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDER 596
+ E +++ + E +L H L ++ L +
Sbjct: 283 YMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH-HLPSLDLLRQKLKKVFQQH 341
Query: 597 RQNR 600
N+
Sbjct: 342 YTNK 345
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 52/244 (21%), Positives = 94/244 (38%), Gaps = 23/244 (9%)
Query: 312 AAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGT 370
A+G+ F G+ + ++ GGF V++ + G A+KR +
Sbjct: 10 ASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN 69
Query: 371 DLVLNEVRILCQV-NHRSLVRLLGCCVELDQT-------LMIYEYIPNGTLFDHLHCDFT 422
++ EV + ++ H ++V+ + ++ + G L + L +
Sbjct: 70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES 129
Query: 423 GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
PL L I +Q + ++H PPI HRD+K N+LL + K+ DFG +
Sbjct: 130 RG--PLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
Query: 483 LVERTETNDSHIFT--------TAQGTMGYLDPE---YYRNFQLTDKSDVYSFGVVLLEL 531
+ T T Y PE Y NF + +K D+++ G +L L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
Query: 532 LTSK 535
+
Sbjct: 247 CFRQ 250
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 69/228 (30%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILD---DGTVT--AIKRAKLGNTKGT--DLVLNE 376
+ K +G G FG+V D DGT A+K K E
Sbjct: 27 VFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW-KQE 83
Query: 377 VRILCQVNHRSLVRLLGCCVELDQ--TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL 434
+ IL + H +++ GCC + ++ EY+P G+L D+L + L
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLL 137
Query: 435 VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER-------T 487
+ A QI EG+ YLH+ HRD+ + N+LLD K+ DFGL++ V
Sbjct: 138 LFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 194
Query: 488 ETNDSHIFTTAQGTMGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
E DS +F A PE F SDV+SFGV L ELLT
Sbjct: 195 EDGDSPVFWYA--------PECLKEYKF--YYASDVWSFGVTLYELLT 232
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 18/217 (8%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILC 381
E R + + +G G FGEV + G A+K+ +L + + E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 382 QVNHRSLVRLLGCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQI 440
++ +V L G E + I+ E + G+L + + LP L Q
Sbjct: 106 GLSSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLIK-----QMGCLPEDRALYYLGQA 159
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDFGLSRLVERTETNDSHIFT-TA 498
EGL YLH+ I H DVK+ N+LL A + DFG + ++ S +
Sbjct: 160 LEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
GT ++ PE K D++S ++L +L
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL--DDGTVT---AIKRAKLGNT-KGTDLVLNE 376
+ ++ F K ++G+G FG V+KG+ + V AIK + + K +L+E
Sbjct: 10 RILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
++ V++ + RLLG C+ +I + +P G L D++ + L
Sbjct: 68 AYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR----EHKDNIGSQYLLNW 122
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
QIA+G+ YL + HRD+ + N+L+ + K++DFGL++L+ E
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EY 174
Query: 497 TAQGTM---GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
A+G ++ E +R + T +SDV+S+GV + EL+T
Sbjct: 175 HAEGGKVPIKWMALESILHRIY--THQSDVWSYGVTVWELMT 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 75/226 (33%), Positives = 112/226 (49%), Gaps = 35/226 (15%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL---DDGTVT-AIKRAKLGNT-KGTDLVLNEV 377
KE+ N S D ++G G FGEV G L ++ AIK K+G T K L E
Sbjct: 40 KELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 378 RILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-I 436
I+ Q +H +++RL G + +++ EY+ NG+L L ++ + +LV +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVI----QLVGM 152
Query: 437 AHQIAEGLTYLHSAAVPPIY-HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
IA G+ YL Y HRD+ + NIL++ L KVSDFGL R++E +D
Sbjct: 153 LRGIASGMKYLSDMG----YVHRDLAARNILINSNLVCKVSDFGLGRVLE----DDPEAA 204
Query: 496 TTAQGT------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
T +G PE YR F T SDV+S+G+VL E+++
Sbjct: 205 YTTRGGKIPIRWTS---PEAIAYRKF--TSASDVWSYGIVLWEVMS 245
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL-----DDGTVT-AIKRAKLGNTKG--TDLVL 374
E+ R + +G G FG V++G+ D+ AIK + + L
Sbjct: 20 WEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF-L 76
Query: 375 NEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-----HCDFTGKWPPLP 429
NE ++ + N +VRLLG + TL+I E + G L +L P
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 430 WHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489
+ +A +IA+G+ YL++ HRD+ + N ++ E K+ DFG++R + T+
Sbjct: 137 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 192
Query: 490 NDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
+G G L PE F T SDV+SFGVVL E+ T
Sbjct: 193 ------YYRKGGKGLLPVRWMSPESLKDGVF--TTYSDVWSFGVVLWEIAT 235
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 338 IGTGGFGEVFKGIL--DDGTVT-AIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLG 393
+G G FG V +G+ + AIK K G T+ ++ E +I+ Q+++ +VRL+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
C + +++ E G L L GK +P + HQ++ G+ YL
Sbjct: 78 VCQA-EALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 454 PIY-HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT------MGYLD 506
+ HRD+ + N+LL + AK+SDFGLS+ + D +T
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTARSAGKWPLKWYA--- 181
Query: 507 PE--YYRNFQLTDKSDVYSFGVVLLELLT 533
PE +R F + +SDV+S+GV + E L+
Sbjct: 182 PECINFRKF--SSRSDVWSYGVTMWEALS 208
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 334 KDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
++G G +G V+ G L + AIK +++ + + E+ + + H+++V+ L
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 393 GCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLV--IAHQIAEGLTYLHS 449
G E + + I+ E +P G+L L KW PL + + + QI EGL YLH
Sbjct: 86 GSFSE-NGFIKIFMEQVPGGSLSALLR----SKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 450 AAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
I HRD+K N+L++ K+SDFG S+ + T GT+ Y+ PE
Sbjct: 141 NQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE----TFTGTLQYMAPE 193
Query: 509 YYRNFQL--TDKSDVYSFGVVLLELLTSK 535
+D++S G ++E+ T K
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL---DDGTVT-AIKRAKLGNTKGTDLV-LNEVR 378
EI+R IG G FG+V +GI ++ + AIK K + L E
Sbjct: 11 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH 438
+ Q +H +V+L+G E + +I E G L L + L ++ A+
Sbjct: 69 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ----VRKYSLDLASLILYAY 123
Query: 439 QIAEGLTYLHSAAVPPIY-HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
Q++ L YL S + HRD+ + N+L+ K+ DFGLSR +E + +
Sbjct: 124 QLSTALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST------YYK 173
Query: 498 AQGT------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
A M PE +R F T SDV+ FGV + E+L
Sbjct: 174 ASKGKLPIKWMA---PESINFRRF--TSASDVWMFGVCMWEILM 212
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 31/225 (13%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDG----TVTAIKRAKLGNTKGT--DLVLNEV 377
I D +IG G FG V+ G D AIK L E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF-LREG 73
Query: 378 RILCQVNHRSLVRLLGCCVELDQTLMI-YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV- 435
++ +NH +++ L+G + + + Y+ +G L + + P + L+
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVK---DLIS 128
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
Q+A G+ YL HRD+ + N +LDE KV+DFGL+R + E +
Sbjct: 129 FGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE-----YY 180
Query: 496 TTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
+ Q L E F T KSDV+SFGV+L ELLT
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRF--TTKSDVWSFGVLLWELLT 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDG----TVTAIKRAKLGNTKGTDLV--LNEV 377
I R N ++G G FG V +G L A+K KL N+ ++ L+E
Sbjct: 30 VIDR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA 87
Query: 378 RILCQVNHRSLVRLLGCCVELDQT-----LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHL 432
+ +H +++RLLG C+E+ ++I ++ G L +L P
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 433 RLV-IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491
L+ IA G+ YL + HRD+ + N +L + + V+DFGLS+ + +
Sbjct: 148 TLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD--- 201
Query: 492 SHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
QG + + E R + T KSDV++FGV + E+ T
Sbjct: 202 ----YYRQGRIAKMPVKWIAIESLADRVY--TSKSDVWAFGVTMWEIAT 244
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 42/234 (17%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVT---AIKRAKLGNTKG--TDLVLNEVR 378
+ N+ ++IG G FG+V K + + AIKR K +K D E+
Sbjct: 21 VLDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELE 77
Query: 379 ILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-----------HCDFTGKWP 426
+LC++ +H +++ LLG C + EY P+G L D L
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486
L L A +A G+ YL HRD+ + NIL+ E AK++DFGLSR
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---- 190
Query: 487 TETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
++ + TMG L E Y + T SDV+S+GV+L E+++
Sbjct: 191 ----GQEVYV--KKTMGRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIVS 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDDG------TVTAIKRAKLGNTKGTDLVLNE 376
I+R + +G G FG+VF + + A+K K + E
Sbjct: 36 HHIKRRDIVLKWE--LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE 93
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL----------HCDFTGKWP 426
+L + H+ +VR G C E LM++EY+ +G L L
Sbjct: 94 AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486
PL L +A Q+A G+ YL HRD+ + N L+ + L K+ DFG+SR +
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 487 TETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
T+ G L PE YR F T +SDV+SFGVVL E+ T
Sbjct: 211 TD-------YYRVGGRTMLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIFT 255
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 6e-34
Identities = 60/248 (24%), Positives = 101/248 (40%), Gaps = 30/248 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKR-AKLGNTKGTDLVLNEVRILCQVNHRS 387
+ + +++G G VF+G G + AIK + + D+ + E +L ++NH++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 388 LVRLLGCCVELDQTLMIY---EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
+V+L E T E+ P G+L+ L LP L++ + G+
Sbjct: 69 IVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125
Query: 445 TYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
+L I HR++K NI+ D + K++DFG +R +E D F + G
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-----DDEQFVSLYG 177
Query: 501 TMGYLDPEYYRNFQLTD--------KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552
T YL P+ Y L D++S GV T + F E
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS--LPFRPFEGPRRNKEV 235
Query: 553 MKKIMDEE 560
M KI+ +
Sbjct: 236 MYKIITGK 243
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 70/244 (28%), Positives = 100/244 (40%), Gaps = 38/244 (15%)
Query: 314 GKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNT 367
G + I+R ++ +G G FG+VF D + A+K K
Sbjct: 1 GAMHSGIHVQHIKRRDIVLKRE--LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL 58
Query: 368 KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-------HCD 420
E +L + H +V+ G C + D +M++EY+ +G L L
Sbjct: 59 AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 421 FTGKWPPLPWHLRLV----IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476
G+ L L IA QIA G+ YL S HRD+ + N L+ L K+
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIG 175
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLL 529
DFG+SR V T+ G L PE YR F T +SDV+SFGV+L
Sbjct: 176 DFGMSRDVYSTD-------YYRVGGHTMLPIRWMPPESIMYRKF--TTESDVWSFGVILW 226
Query: 530 ELLT 533
E+ T
Sbjct: 227 EIFT 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 64/239 (26%), Positives = 99/239 (41%), Gaps = 45/239 (18%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDDG------TVTAIKRAKLGNTKGT--DLVL 374
KEI + F ++ +G FG+V+KG L AIK K +
Sbjct: 4 KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF-R 60
Query: 375 NEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-------HCDFTGKWPP 427
+E + ++ H ++V LLG + MI+ Y +G L + L T
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 428 LPWHLRLV----IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483
+ L + QIA G+ YL S + H+D+ + N+L+ +KLN K+SD GL R
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 484 VERTETNDSHIFTTAQGT-------MGYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
V + G M PE Y F + SD++S+GVVL E+ +
Sbjct: 178 VYAADY------YKLLGNSLLPIRWMA---PEAIMYGKF--SIDSDIWSYGVVLWEVFS 225
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNH 385
+F +G G FG V+ + A+K +A+L + EV I + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+++RL G + + +I EY P GT++ L K ++A L+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALS 123
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
Y HS V HRD+K N+LL K++DFG S S T GT+ YL
Sbjct: 124 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHA------PSSRRTDLCGTLDYL 174
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLT 533
PE +K D++S GV+ E L
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 27/221 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRS 387
+S IG+GG +VF+ + + + AIK L L NE+ L ++ S
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 388 L--VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+RL + M+ E N L L K + R + E +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVH 141
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
+H I H D+K +N L+ + K+ DFG++ ++ T+ + + GT+ Y+
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS--VVKDSQVGTVNYM 195
Query: 506 DPE-----------YYRNFQLTDKSDVYSFGVVLLELLTSK 535
PE +++ KSDV+S G +L + K
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 34/230 (14%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDG----TVTAIKRAKLGNTKGTDLV--LNEV 377
I F+ ++G G FG V + L A+K K +D+ L E
Sbjct: 19 LIPE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 378 RILCQVNHRSLVRLLGCCVE------LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWH 431
+ + +H + +L+G + L ++I ++ +G L L G+ P
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 432 LRLV-IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490
LV IA G+ YL S HRD+ + N +L E + V+DFGLSR + +
Sbjct: 137 QTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-- 191
Query: 491 DSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
QG L E + T SDV++FGV + E++T
Sbjct: 192 -----YYRQGCASKLPVKWLALESLADNLY--TVHSDVWAFGVTMWEIMT 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 309 NAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRA 362
N AGK++ I KE+ R N + +G G FGEV++G + A+K
Sbjct: 11 NYCFAGKTSSISDLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68
Query: 363 KLGNTKGT--DLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL--H 418
++ D L E I+ + NH+++VR +G ++ ++ E + G L L
Sbjct: 69 PEVCSEQDELDF-LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127
Query: 419 CDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD---EKLNAKV 475
+ L L +A IA G YL HRD+ + N LL AK+
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184
Query: 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVL 528
DFG++R + R +G L PE F T K+D +SFGV+L
Sbjct: 185 GDFGMARDIYRAS-------YYRKGGCAMLPVKWMPPEAFMEGIF--TSKTDTWSFGVLL 235
Query: 529 LELLT 533
E+ +
Sbjct: 236 WEIFS 240
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDG----TVTAIKRAKLGNTKG--TDLVLNEV 377
I ++ + +IG G FG V+ G L D A+K G + L E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF-LTEG 77
Query: 378 RILCQVNHRSLVRLLGCCVELDQTLM-IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVI 436
I+ +H +++ LLG C+ + + + + Y+ +G L + + + +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----NETHNPTVKDLIGF 133
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
Q+A+G+ YL S HRD+ + N +LDEK KV+DFGL+R + E ++
Sbjct: 134 GLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY-----YS 185
Query: 497 TAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
T L E + F T KSDV+SFGV+L EL+T
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKF--TTKSDVWSFGVLLWELMT 227
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-33
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL---DDGTVT-AIKRAKLGNT-KGTDLVLNEV 377
EI+R IG G FG+V +GI ++ + AIK K + + L E
Sbjct: 385 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 378 RILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIA 437
+ Q +H +V+L+G E + +I E G L L + L ++ A
Sbjct: 443 LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ----VRKFSLDLASLILYA 497
Query: 438 HQIAEGLTYLHSAAVPPIY-HRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
+Q++ L YL S + HRD+ + N+L+ K+ DFGLSR +E + +
Sbjct: 498 YQLSTALAYLESKR----FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST------YY 547
Query: 497 TAQGTM---GYLDPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
A ++ PE +R F T SDV+ FGV + E+L
Sbjct: 548 KASKGKLPIKWMAPESINFRRF--TSASDVWMFGVCMWEILM 587
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 27/221 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRS 387
+S IG+GG +VF+ + + + AIK L L NE+ L ++ S
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 388 L--VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+RL + M+ E N L L K + R + E +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVH 122
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
+H I H D+K +N L+ + K+ DFG++ ++ T+ + + GT+ Y+
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS--VVKDSQVGTVNYM 176
Query: 506 DPE-----------YYRNFQLTDKSDVYSFGVVLLELLTSK 535
PE +++ KSDV+S G +L + K
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 60/248 (24%), Positives = 101/248 (40%), Gaps = 30/248 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKR-AKLGNTKGTDLVLNEVRILCQVNHRS 387
+ + +++G G VF+G G + AIK + + D+ + E +L ++NH++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 388 LVRLLGCCVELDQTLMIY---EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
+V+L E T E+ P G+L+ L LP L++ + G+
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125
Query: 445 TYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
+L I HR++K NI+ D + K++DFG +R +E D F + G
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-----DDEQFVSLYG 177
Query: 501 TMGYLDPEYYRNFQLTD--------KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552
T YL P+ Y L D++S GV T + F E
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS--LPFRPFEGPRRNKEV 235
Query: 553 MKKIMDEE 560
M KI+ +
Sbjct: 236 MYKIITGK 243
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 338 IGTGGFGEVFKGIL--DDGTVT-AIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLG 393
+G G FG V +G+ + AIK K G T+ ++ E +I+ Q+++ +VRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
C + +++ E G L L GK +P + HQ++ G+ YL
Sbjct: 404 VCQA-EALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 454 PIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM---GYLDPE-- 508
HR++ + N+LL + AK+SDFGLS+ + D +T + PE
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTARSAGKWPLKWYAPECI 511
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLT 533
+R F + +SDV+S+GV + E L+
Sbjct: 512 NFRKF--SSRSDVWSYGVTMWEALS 534
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 27/221 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRS 387
+S IG+GG +VF+ + + + AIK L L NE+ L ++ S
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 388 L--VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+RL + M+ E N L L K + R + E +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVH 169
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
+H I H D+K +N L+ + K+ DFG++ ++ T+ + + G + Y+
Sbjct: 170 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS--VVKDSQVGAVNYM 223
Query: 506 DPE-----------YYRNFQLTDKSDVYSFGVVLLELLTSK 535
PE +++ KSDV+S G +L + K
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 31/225 (13%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDDG----TVTAIKRAKLGNTKGT--DLVLNE 376
+F++ +IG G FG V+ G L D A+K G L E
Sbjct: 84 IGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF-LTE 140
Query: 377 VRILCQVNHRSLVRLLGCCVELD-QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV 435
I+ +H +++ LLG C+ + L++ Y+ +G L + + + +
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR----NETHNPTVKDLIG 196
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
Q+A+G+ +L S HRD+ + N +LDEK KV+DFGL+R + E
Sbjct: 197 FGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF-----D 248
Query: 496 TTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
+ T L E + F T KSDV+SFGV+L EL+T
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKF--TTKSDVWSFGVLLWELMT 291
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 54/215 (25%), Positives = 83/215 (38%), Gaps = 28/215 (13%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHR 386
+ + +G GGF + F+ D V A K ++ L + + E+ I + H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL------VIAHQI 440
+V G + D ++ E +L + L QI
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEARYYLRQI 124
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
G YLH V HRD+K N+ L+E L K+ DFGL+ VE D G
Sbjct: 125 VLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEY----DGERKKVLCG 177
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
T Y+ PE + + DV+S G ++ LL K
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 56/216 (25%), Positives = 84/216 (38%), Gaps = 22/216 (10%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLV--LNEVRILCQV 383
+F + + +G G +GEVFK +DG + A+KR+ D L EV +V
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 384 -NHRSLVRLLGCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWP-PLPWHLRLVIAHQI 440
H VRL E L + E +L H W LP
Sbjct: 114 GQHPCCVRLEQAWEE-GGILYLQTELC-GPSLQQHCE-----AWGASLPEAQVWGYLRDT 166
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
L +LHS + H DVK +NI L + K+ DFGL + + G
Sbjct: 167 LLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-----G 218
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK 536
Y+ PE + +DV+S G+ +LE+ + +
Sbjct: 219 DPRYMAPELLQG-SYGTAADVFSLGLTILEVACNME 253
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 15/214 (7%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRI 379
I +F NL+G G F V++ + G AIK + + V NEV+I
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 380 LCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQ 439
CQ+ H S++ L + + ++ E NG + +L + P + HQ
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK----NRVKPFSENEARHFMHQ 120
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
I G+ YLHS + HRD+ SN+LL +N K++DFGL+ ++ T
Sbjct: 121 IITGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLK----MPHEKHYTLC 173
Query: 500 GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
GT Y+ PE +SDV+S G + LL
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI 207
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 35/231 (15%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNTKGT--DLVL 374
KE+ R N + +G G FGEV++G + A+K ++ D L
Sbjct: 66 KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF-L 122
Query: 375 NEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL--HCDFTGKWPPLPWHL 432
E I+ + NH+++VR +G ++ ++ E + G L L + L
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD---EKLNAKVSDFGLSRLVERTET 489
L +A IA G YL HRD+ + N LL AK+ DFG++R + R
Sbjct: 183 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG- 238
Query: 490 NDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
+G L PE F T K+D +SFGV+L E+ +
Sbjct: 239 ------YYRKGGCAMLPVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIFS 281
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 20/211 (9%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHR 386
+ + +G GGF + F+ D V A K ++ L + + E+ I + H+
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIAEGL 444
+V G + D ++ E +L + T R + QI G
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT------EPEARYYL-RQIVLGC 154
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
YLH V HRD+K N+ L+E L K+ DFGL+ VE D GT Y
Sbjct: 155 QYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEY----DGERKKVLCGTPNY 207
Query: 505 LDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
+ PE + + DV+S G ++ LL K
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 44/239 (18%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL--------DDGTVTAIKRAKLGNTKG--TDLV 373
E R + + +G G FG+V + A+K K T+ +DL
Sbjct: 31 EFPR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL- 87
Query: 374 LNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-----------HCDF 421
++E+ ++ + H++++ LLG C + +I EY G L ++L +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 422 TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481
+ + + +Q+A G+ YL S HRD+ + N+L+ E K++DFGL+
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 482 RLVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
R + + + T G L PE + R + T +SDV+SFGV++ E+ T
Sbjct: 205 RDINNIDYYK-------KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 38/234 (16%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQV 383
R T F + IG+G FG VFK + DG + AIKR+K D L EV +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 384 -NHRSLVRLLGCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441
H +VR E D ++I EY G+L D + + + Q+
Sbjct: 68 GQHSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAIS-ENYRIMSYFKEAELKDLLLQVG 125
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDE-------------------KLNAKVSDFGLSR 482
GL Y+HS + + H D+K SNI + K+ K+ D G
Sbjct: 126 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 483 LVERTETNDSHIFTTAQGTMGYLDPEYYR-NFQLTDKSDVYSFGVVLLELLTSK 535
+ +G +L E + N+ K+D+++ + ++ ++
Sbjct: 183 RISSP--------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 18/201 (8%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
+G G FG V+ + + A+K +++L + E+ I + H +++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
+ + ++ E+ P G L+ L K ++A+ L Y H V
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQ-----KHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
HRD+K N+L+ K K++DFG S T GT+ YL PE
Sbjct: 136 ---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR------TMCGTLDYLPPEMIEG 186
Query: 513 FQLTDKSDVYSFGVVLLELLT 533
+K D++ GV+ E L
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLV 207
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 69/244 (28%), Positives = 102/244 (41%), Gaps = 49/244 (20%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL-----DDGTVT-AIKRAKLGNTKG--TDLVLN 375
E R N +G G FG+V K G T A+K K + DL L+
Sbjct: 19 EFPR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL-LS 75
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL------------------ 417
E +L QVNH +++L G C + L+I EY G+L L
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 418 -HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476
L + A QI++G+ YL + HRD+ + NIL+ E K+S
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKIS 192
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLL 529
DFGLSR V ++ + + G + E + + T +SDV+SFGV+L
Sbjct: 193 DFGLSRDVYEEDSYV-------KRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLW 243
Query: 530 ELLT 533
E++T
Sbjct: 244 EIVT 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 46/240 (19%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL--------DDGTVTAIKRAKLGNTKG--TDLV 373
E R + + +G G FG+V + A+K K T+ +DL
Sbjct: 77 EFPR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL- 133
Query: 374 LNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL------------HCD 420
++E+ ++ + H++++ LLG C + +I EY G L ++L +
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 421 FTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480
+ L + +Q+A G+ YL S HRD+ + N+L+ E K++DFGL
Sbjct: 194 RVPEEQMTFKDL-VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 249
Query: 481 SRLVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
+R + + + T G L PE + R + T +SDV+SFGV++ E+ T
Sbjct: 250 ARDINNIDYYK-------KTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 300
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 43/288 (14%)
Query: 331 NFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLV 389
+F +++G G G + + D A+KR + EV++L + + H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 390 RLLGCCVELDQTLMIY---EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
R C E D+ Y E TL +++ K + + Q GL +
Sbjct: 82 RYF--CTEKDRQ-FQYIAIELCA-ATLQEYV----EQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 447 LHSAAVPPIYHRDVKSSNILLDEK-----LNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
LHS I HRD+K NIL+ + A +SDFGL + + + S + GT
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR-RSGVPGT 189
Query: 502 MGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558
G++ PE T D++S G V +++ F + + ++ +D
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-FGKSLQRQANILLGACSLD 248
Query: 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ D + +E L + Q RPS K V
Sbjct: 249 CLHPEKHEDVIARE---------------LIEKMIAMDPQKRPSAKHV 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 2e-31
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKR-AKLGNTKGTDLVLNEVRILCQVN 384
+ + +GTGGFG V + I D G AIK+ + + K + E++I+ ++N
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 385 HRSLVRLL------GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH 438
H ++V D L+ EY G L +L+ L +
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN--QFENCCGLKEGPIRTLLS 128
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLD---EKLNAKVSDFGLSRLVERTETNDSHIF 495
I+ L YLH I HRD+K NI+L ++L K+ D G ++ ++ +
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-----QGELC 180
Query: 496 TTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
T GT+ YL PE + T D +SFG + E +T
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 44/239 (18%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL--------DDGTVTAIKRAKLGNTKG--TDLV 373
E+ R + +G G FG+V + T A+K K T+ +DL
Sbjct: 65 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL- 121
Query: 374 LNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-------HCDFTGKW 425
++E+ ++ + H++++ LLG C + +I EY G L ++L
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 426 PPLPWHLR----LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481
L + A+Q+A G+ YL S HRD+ + N+L+ E K++DFGL+
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 482 RLVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
R + + + T G L PE + R + T +SDV+SFGV+L E+ T
Sbjct: 239 RDIHHIDYYK-------KTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 44/239 (18%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL-----DDGTVT-AIKRAKLGNTKG--TDLVLN 375
E R N S +G G FG+V + D +T A+K K L ++
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL-MS 75
Query: 376 EVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL-------------HCDF 421
E+++L + NH ++V LLG C TL+I EY G L + L
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 422 TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481
L L ++Q+A+G+ +L S HRD+ + NILL K+ DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 192
Query: 482 RLVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
R ++ L PE + + T +SDV+S+G+ L EL +
Sbjct: 193 RDIKNDSNYVV-------KGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 43/238 (18%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKG----ILDDGTVT--AIKRAKLGNTKG--TDLVLN 375
E R + +G G FG+V + I T A+K K G T L ++
Sbjct: 23 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL-MS 79
Query: 376 EVRILCQV-NHRSLVRLLGCCVELDQ-TLMIYEYIPNGTLFDHL-------HCDFTGKWP 426
E++IL + +H ++V LLG C + ++I E+ G L +L
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 427 PLPWHLR----LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
L + + Q+A+G+ +L S HRD+ + NILL EK K+ DFGL+R
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 483 LVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
+ + + L PE + R + T +SDV+SFGV+L E+ +
Sbjct: 197 DIYKDPDYV-------RKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 49/244 (20%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL-----DDGTVT-AIKRAKLGNTKG--TDLVLN 375
E R + +D IG G FG VF+ + A+K K + D
Sbjct: 43 EYPRNNIEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF-QR 99
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL------------------ 417
E ++ + ++ ++V+LLG C +++EY+ G L + L
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 418 HCDFTGKWPPLPWHLRLV-IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476
+ PP + IA Q+A G+ YL HRD+ + N L+ E + K++
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIA 216
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLL 529
DFGLSR + + + PE +Y + T +SDV+++GVVL
Sbjct: 217 DFGLSRNIYSAD-------YYKADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLW 267
Query: 530 ELLT 533
E+ +
Sbjct: 268 EIFS 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 61/235 (25%), Positives = 96/235 (40%), Gaps = 40/235 (17%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL-----DDGTVT-AIKRAKLGNTKG--TDLVLN 375
E R NN +G G FG+V + +D + A+K K L ++
Sbjct: 42 EFPR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL-MS 98
Query: 376 EVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC---------DFTGKW 425
E++I+ + H ++V LLG C L+I EY G L + L F
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 426 PPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485
L + Q+A+G+ +L S HRDV + N+LL AK+ DFGL+R +
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 486 RTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLLELLT 533
L PE + + T +SDV+S+G++L E+ +
Sbjct: 216 NDSNYIV-------KGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFS 261
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 56/244 (22%), Positives = 101/244 (41%), Gaps = 49/244 (20%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL-----DDGTVT-AIKRAKLGNTKG--TDLVLN 375
E R N ++G+G FG+V ++ A+K K L ++
Sbjct: 41 EFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL-MS 97
Query: 376 EVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL----------------- 417
E++++ Q+ +H ++V LLG C +I+EY G L ++L
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 418 -HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476
+ L + L A+Q+A+G+ +L + HRD+ + N+L+ K+
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKIC 214
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYL-----DPE--YYRNFQLTDKSDVYSFGVVLL 529
DFGL+R + + L PE + + T KSDV+S+G++L
Sbjct: 215 DFGLARDI-----MSDSNYV--VRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLW 265
Query: 530 ELLT 533
E+ +
Sbjct: 266 EIFS 269
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 31/226 (13%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIK-----------------RAKLGNTKGTDL 372
N++ + G F ++ D A+K K+ D
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 373 VLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDF---TGKWPPLP 429
NE++I+ + + + G D+ +IYEY+ N ++ F +P
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 430 WHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489
+ I + +Y+H+ I HRDVK SNIL+D+ K+SDFG S +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMV---- 203
Query: 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTD--KSDVYSFGVVLLELLT 533
D I + GT ++ PE++ N + K D++S G+ L +
Sbjct: 204 -DKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 69/305 (22%), Positives = 115/305 (37%), Gaps = 54/305 (17%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSL 388
N + ++G G G V G A+KR + D+ L E+++L + +H ++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNV 71
Query: 389 VRLLGCCVELDQTLMIY---EYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIAEG 443
+R C E +Y E N L D + + + + QIA G
Sbjct: 72 IRYY--CSETTDR-FLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEK-------------LNAKVSDFGLSRLVERTETN 490
+ +LHS I HRD+K NIL+ L +SDFGL + ++ +++
Sbjct: 128 VAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 491 DSHIFTTAQGTMGYLDPE-------YYRNFQLTDKSDVYSFGVVLLELLTSKKA--IDFN 541
GT G+ PE +LT D++S G V +L+ K D
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 542 REEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP 601
E N+ ++ I + + + D L AT L + +D RP
Sbjct: 245 SRESNI-----IRGIFSLDEMKCLHDRSLIAEATD-----------LISQMIDHDPLKRP 288
Query: 602 SMKEV 606
+ +V
Sbjct: 289 TAMKV 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 34/208 (16%)
Query: 337 LIGTGGFGEVFKG---ILDDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNHRSLVR 390
I GG G ++ ++ V +K L ++ + + E + L +V H S+V+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPV-VLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 391 LL--GCCVELDQTLMIY---EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+ + + Y EY+ +L LP + +I L+
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALS 196
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
YLHS + + D+K NI+L E+ K+ D G + +++ GT G+
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLY----GTPGFQ 244
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLT 533
PE R T +D+Y+ G L L
Sbjct: 245 APEIVRT-GPTVATDIYTVGRTLAALTL 271
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 62/268 (23%), Positives = 96/268 (35%), Gaps = 48/268 (17%)
Query: 311 KAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGN 366
++G+ F G + + IG G +G V I + AIK + K+
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 367 TKGTDL--VLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL------- 417
D+ + EVR++ +++H ++ RL + ++ E G L D L
Sbjct: 67 INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126
Query: 418 -----HCDFTGKWPPLPWHLRLV-----------------------IAHQIAEGLTYLHS 449
+ P P I QI L YLH+
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186
Query: 450 AAVPPIYHRDVKSSNILLDEKLNA--KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
I HRD+K N L + K+ DFGLS+ + + + TT GT ++ P
Sbjct: 187 QG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 508 E--YYRNFQLTDKSDVYSFGVVLLELLT 533
E N K D +S GV+L LL
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 337 LIGTGGFGEVFKG---ILDDGTVTAIKRAKLGNTKGTDLVL---NEVRILCQVNHRSLVR 390
+G GG V+ IL+ AIK + + + + EV Q++H+++V
Sbjct: 18 KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
++ E D ++ EYI TL +++ PL + +QI +G+ + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV-ERTETNDSHIFTTAQGTMGYLDPEY 509
I HRD+K NIL+D K+ DFG+++ + E + T +H+ T Q Y PE
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ----YFSPEQ 183
Query: 510 YRNFQLTDKSDVYSFGVVLLELLT 533
+ + +D+YS G+VL E+L
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLV 207
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 49/232 (21%)
Query: 325 IRRATNNFSKD----NLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNE 376
++ +T FS ++G G FGEV G A+K + ++ + +L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV- 435
V++L Q++H ++++L + ++ E G LFD ++
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD-----------------EIIS 119
Query: 436 -----------IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLS 481
I Q+ G+TY+H I HRD+K N+LL + N ++ DFGLS
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
E S GT Y+ PE +K DV+S GV+L LL+
Sbjct: 177 THFE-----ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS 222
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 337 LIGTGGFGEVFKG---ILDDGTVTAIKRAKLGNTKGTDLVL---NEVRILCQVNHRSLVR 390
++G GG EV V A+K + + L E + +NH ++V
Sbjct: 19 ILGFGGMSEVHLARDLRDHR-DV-AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 391 LLGCCVELDQTLMIY----EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+ + EY+ TL D +H P+ + + + L +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNF 131
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE---TNDSHIFTTAQGTMG 503
H I HRDVK +NI++ KV DFG++R + + T + + TAQ
Sbjct: 132 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ---- 184
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
YL PE R + +SDVYS G VL E+LT
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDL-VLNEVRILCQVNHRSLVRL 391
L+G G +G+V + + + A+K + KL + V E+++L ++ H+++++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 392 LG-CCVELDQTL-MIYEYIPNGT--LFDHLHCDFTGKWPPLPWHLRLVIAH----QIAEG 443
+ E Q + M+ EY G + D + + + AH Q+ +G
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSV---PEKR-------FPVCQAHGYFCQLIDG 121
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
L YLHS I H+D+K N+LL K+S G++ + T+QG+
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH--PFAADDTCRTSQGSPA 176
Query: 504 YLDPEYYRNFQLTD--KSDVYSFGVVLLELLT 533
+ PE K D++S GV L + T
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-26
Identities = 25/265 (9%), Positives = 56/265 (21%), Gaps = 45/265 (16%)
Query: 303 QREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK- 360
E + A ++A + + + G VF ++ A+K
Sbjct: 35 AMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKV 94
Query: 361 --RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT----------------- 401
+ + + ++ S L +
Sbjct: 95 FTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG 154
Query: 402 -----------LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
LM + LF L ++ Q+ L S
Sbjct: 155 QDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK 213
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
+ H N+ + + D + + Y E+
Sbjct: 214 G---LVHGHFTPDNLFIMPDGRLMLGDVSALW-------KVGTRGPASSVPVTYAPREFL 263
Query: 511 --RNFQLTDKSDVYSFGVVLLELLT 533
T + + G+ + +
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWC 288
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 66/287 (22%), Positives = 107/287 (37%), Gaps = 65/287 (22%)
Query: 325 IRRATNNFSKD----NLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNE 376
I + S+ +G+G +GEV AIK + + +T +L E
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEE 86
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV- 435
V +L ++H ++++L + ++ E G LFD ++
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD-----------------EIIH 129
Query: 436 -----------IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLS 481
I Q+ G+TYLH I HRD+K N+LL ++ K+ DFGLS
Sbjct: 130 RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541
+ E + GT Y+ PE R + +K DV+S GV+L LL
Sbjct: 187 AVFE-----NQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQ 240
Query: 542 REEENVNLVVYMKKIMDEE-------------RLMEVVDPVLKERAT 575
++E + V K D + M D + R +
Sbjct: 241 TDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDS--QRRIS 285
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 37/279 (13%)
Query: 315 KSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGT 370
+ ++ GKE + + L+G+GGFG V+ GI + D AIK + ++ +
Sbjct: 28 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL 87
Query: 371 DL---VLNEVRILCQVNHRS--LVRLLGCCVELDQTLMIYEYI-PNGTLFDHLHCDFTGK 424
V EV +L +V+ ++RLL D ++I E P LFD + +
Sbjct: 88 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----E 142
Query: 425 WPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRL 483
L L Q+ E + + H+ V HRD+K NIL+D + K+ DFG L
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGAL 199
Query: 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTD--KSDVYSFGVVLLELLTSKKAIDFN 541
++ T +T GT Y PE+ R + V+S G++L +++ I F
Sbjct: 200 LKDTV------YTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVC--GDIPFE 250
Query: 542 REEENVNLVVYMKKIMDEE-----RLMEVVDPVLKERAT 575
+EE + V+ ++ + E R + P +R T
Sbjct: 251 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRP--SDRPT 287
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 39/213 (18%)
Query: 337 LIGTGGFGEVFKG---ILDDGTVTAIK--RAKLGNTKGTDLVL-----NEVRILCQVNHR 386
L+G GG G+V++ + + + A+K L + D V E R ++
Sbjct: 41 LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSS----DPVFRTRMQREARTAGRLQEP 94
Query: 387 SLVRL--LGCCVELDQTLMIY-EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
+V + G E+D L + I L L PL + I QI
Sbjct: 95 HVVPIHDFG---EIDGQLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSA 146
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE---RTETNDSHIFTTAQG 500
L H+A HRDVK NIL+ A + DFG++ T+ G
Sbjct: 147 LDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG------NTVG 197
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
T+ Y+ PE + T ++D+Y+ VL E LT
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLT 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 29/245 (11%), Positives = 64/245 (26%), Gaps = 55/245 (22%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIK----------------------RAKLGNTK 368
+ ++G + + G + L K
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 369 GTDLVLNEVRILCQV------NHRSLVRLLGC----CVELDQTLMIYEYIPNGTLFDHLH 418
+R + + ++R+ V L T + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 419 CDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478
+ L H RL + Q+ L LH + H ++ +I+LD++ ++ F
Sbjct: 200 -SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEY----------YRNFQLTDKSDVYSFGVVL 528
+ + G+ PE + +T D ++ G+ +
Sbjct: 256 EHLVRDGAS--------AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307
Query: 529 LELLT 533
+
Sbjct: 308 YWIWC 312
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 62/258 (24%), Positives = 108/258 (41%), Gaps = 15/258 (5%)
Query: 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKL-GNTKGTDLVLNEVRILCQVNHRS 387
++F K + +G G G VFK G V A K L + ++ E+++L + N
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V G + + E++ G+L L K +P + ++ + +GLTYL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYL 147
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
I HRDVK SNIL++ + K+ DFG+S + + N + GT Y+ P
Sbjct: 148 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN------SFVGTRSYMSP 199
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567
E + + +SD++S G+ L+E+ + I +E + + E
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259
Query: 568 PVLKERATHLDLETMKAL 585
P +D A+
Sbjct: 260 PGRPLNKFGMDSRPPMAI 277
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 33/294 (11%), Positives = 84/294 (28%), Gaps = 56/294 (19%)
Query: 284 VYNKLNEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGF 343
++N++ + + T + + + +++ E+ + ++G
Sbjct: 27 LFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDP 86
Query: 344 GEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQV---------------- 383
+ + G + + + + EV L +
Sbjct: 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146
Query: 384 ---------NHRSLVRLLGCCVELDQT----LMIYEYIPNGTLFDHLHCDFTGKWPPLPW 430
+ ++R+ ++ L T + L + L
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVH 205
Query: 431 HLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490
H RL + Q+ L LH + H ++ +I+LD++ ++ F
Sbjct: 206 HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---- 258
Query: 491 DSHIFTTAQGTMGYLDPEY-----------YRNFQLTDKSDVYSFGVVLLELLT 533
+ + G+ PE R +T D ++ G+V+ +
Sbjct: 259 ----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 48/201 (23%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR 390
+++ IG G G V+ + + G AI++ L +L++NE+ ++ + + ++V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
L + D+ ++ EY+ G+L D + + + + + L +LHS
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSN 135
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
+ HRD+KS NILL + K++DFG + T +T GT ++ PE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKR--STMVGTPYWMAPEVV 188
Query: 511 RNFQLTDKSDVYSFGVVLLEL 531
K D++S G++ +E+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEM 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 70/347 (20%), Positives = 109/347 (31%), Gaps = 93/347 (26%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGT-DLVLNEVRILCQVN 384
R +F +G GGFG VF+ D AIKR +L N + + V+ EV+ L ++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFT---------------------- 422
H +VR +E E + +
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 423 --GKWPPLPWHLRLVIAHQIAEGLT-------------------------------YLHS 449
G+ P + L I Q+ +LHS
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE--------TNDSHIFTTAQGT 501
+ HRD+K SNI KV DFGL +++ E T GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 502 MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE- 560
Y+ PE + K D++S G++L ELL S F+ + E V + + + + +
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRI---ITDVRNLKF 291
Query: 561 -RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
L P + L RP ++
Sbjct: 292 PLLFTQKYPQEHM---------------MVQDMLSPSPTERPEATDI 323
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-25
Identities = 55/242 (22%), Positives = 98/242 (40%), Gaps = 59/242 (24%)
Query: 325 IRRATNNFSKD----NLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGT------ 370
+R+ + +G+G +GEV + + AIK +++ + +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 371 ----DLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWP 426
+ + NE+ +L ++H ++++L + ++ E+ G LF+
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE----------- 135
Query: 427 PLPWHLRLV------------IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKL 471
+++ I QI G+ YLH I HRD+K NILL + L
Sbjct: 136 ------QIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186
Query: 472 NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLEL 531
N K+ DFGLS + GT Y+ PE + + +K DV+S GV++ L
Sbjct: 187 NIKIVDFGLSSFFSKDYK-----LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYIL 240
Query: 532 LT 533
L
Sbjct: 241 LC 242
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-25
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 46/224 (20%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVN 384
++ ++G G FGEV K A+K +A N K T +L EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLD 79
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV--------- 435
H ++++L + ++ E G LFD ++
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFD-----------------EIIKRKRFSEHD 122
Query: 436 ---IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTET 489
I Q+ G+TY+H I HRD+K NILL ++ + K+ DFGLS +
Sbjct: 123 AARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---- 175
Query: 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
+ GT Y+ PE R +K DV+S GV+L LL+
Sbjct: 176 -QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 14/201 (6%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR 390
IG G G V G A+K L + +L+ NEV I+ H ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
+ + ++ ++ E++ G L D + L + + + L YLH+
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHA- 159
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
+ HRD+KS +ILL K+SDFG + ++ + GT ++ PE
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKR--KSLVGTPYWMAPEVI 213
Query: 511 RNFQLTDKSDVYSFGVVLLEL 531
+ D++S G++++E+
Sbjct: 214 SRSLYATEVDIWSLGIMVIEM 234
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 39/274 (14%)
Query: 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLN-- 375
GK+ + L+G GGFG VF G L D AIK R ++ +
Sbjct: 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 376 -EVRILCQVN----HRSLVRLLGCCVELDQTLMIYEY-IPNGTLFDHLHCDFTGKWPPLP 429
EV +L +V H ++RLL + +++ E +P LFD++ G L
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGP---LG 137
Query: 430 WHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRLVERTE 488
Q+ + + HS V HRD+K NIL+D + AK+ DFG L+
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194
Query: 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTD--KSDVYSFGVVLLELLTSKKAIDFNREEEN 546
+T GT Y PE+ + V+S G++L +++ I F R++E
Sbjct: 195 ------YTDFDGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVC--GDIPFERDQEI 245
Query: 547 VNLVVYMKKIMDEE-----RLMEVVDPVLKERAT 575
+ ++ + + R P R +
Sbjct: 246 LEAELHFPAHVSPDCCALIRRCLAPKP--SSRPS 277
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/239 (22%), Positives = 90/239 (37%), Gaps = 58/239 (24%)
Query: 327 RATNNFSKD----NLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDL------ 372
+T+ F ++ ++G G V + I A+K G+ ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 373 VLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWH 431
L EV IL +V+ H ++++L ++++ + G LFD
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD---------------- 113
Query: 432 LRLV------------IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479
L I + E + LH I HRD+K NILLD+ +N K++DFG
Sbjct: 114 -YLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169
Query: 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKS------DVYSFGVVLLELL 532
S ++ GT YL PE + D++S GV++ LL
Sbjct: 170 FSCQLD-----PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 49/227 (21%)
Query: 329 TNNFSKD----NLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRIL 380
+ FS + +G G F V + + G A K KL + + + E RI
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARIC 59
Query: 381 CQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV----- 435
++ H ++VRL E ++++ + G LF+ +V
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE-----------------DIVAREFY 102
Query: 436 -------IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA---KVSDFGLSRLVE 485
QI E + Y HS I HR++K N+LL K K++DFGL+ V
Sbjct: 103 SEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159
Query: 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
DS + GT GYL PE + + D+++ GV+L LL
Sbjct: 160 -----DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 33/208 (15%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
IG G F +V + G AIK + +L N + EVRI+ +NH ++V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL------VIAHQIAEGLTYL 447
+I EY G +FD+L H R+ QI + Y
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVA-----------HGRMKEKEARSKFRQIVSAVQYC 130
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
H I HRD+K+ N+LLD +N K++DFG S G Y P
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-----VGGKLDAFCGAPPYAAP 182
Query: 508 EYYRNFQLTD--KSDVYSFGVVLLELLT 533
E ++ + D + DV+S GV+L L++
Sbjct: 183 ELFQG-KKYDGPEVDVWSLGVILYTLVS 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
+G G FG+V G G A+K R K+ + + E++ L H +++L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 393 GCCVELDQT-LMIY---EYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
++ T + EY+ G LFD++ H G+ + + QI + Y
Sbjct: 78 ----QVISTPTDFFMVMEYVSGGELFDYICKH----GR---VEEMEARRLFQQILSAVDY 126
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
H + HRD+K N+LLD +NAK++DFGLS ++ D T+ G+ Y
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-----DGEFLRTSCGSPNYAA 178
Query: 507 PEYYRNFQLTD--KSDVYSFGVVLLELLT 533
PE +L + D++S GV+L LL
Sbjct: 179 PEVISG-RLYAGPEVDIWSCGVILYALLC 206
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 46/226 (20%)
Query: 327 RATNNFSKD----NLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILC 381
T N K ++G+G F EVF G + A+K K + NE+ +L
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 382 QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------ 435
++ H ++V L ++ + + G LFD R++
Sbjct: 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD-----------------RILERGVYT 104
Query: 436 ------IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVER 486
+ Q+ + YLH I HRD+K N+L +E ++DFGLS++ +
Sbjct: 105 EKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ- 160
Query: 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
+ I +TA GT GY+ PE + D +S GV+ LL
Sbjct: 161 -----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV 389
SK ++G G FG+V K G A K K K + V NE+ ++ Q++H +L+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHL---HCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+L + +++ EY+ G LFD + + T L + QI EG+ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL------DTILFM-KQICEGIRH 202
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNA--KVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
+H I H D+K NIL + K+ DFGL+R + E GT +
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-----LKVNFGTPEF 254
Query: 505 LDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
L PE ++ +D++S GV+ LL+
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 56/281 (19%), Positives = 103/281 (36%), Gaps = 63/281 (22%)
Query: 288 LNEHMKKETKKLLIKQREEMLNAKAAGKS--ARIFTGKEIRRATNNFSKD----NLIGTG 341
+N + + K+ + E+ + + K T + + +G+G
Sbjct: 87 VNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSG 146
Query: 342 GFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDL-----VLNEVRILCQVNHRSLVRLL 392
GEV AI+ + K + V E+ IL ++NH ++++
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------------IAHQI 440
+ + ++ E + G LFD ++V +Q+
Sbjct: 207 NF-FDAEDYYIVLELMEGGELFD-----------------KVVGNKRLKEATCKLYFYQM 248
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
+ YLH I HRD+K N+LL +E K++DFG S+++ ++ + T
Sbjct: 249 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-----ETSLMRT 300
Query: 498 AQGTMGYLDPE-----YYRNFQLTDKSDVYSFGVVLLELLT 533
GT YL PE + D +S GV+L L+
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVILFICLS 339
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLV 389
F+K IG G FGEVFKGI V AIK L + + + E+ +L Q + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
+ G ++ + +I EY+ G+ D L PL I +I +GL YLHS
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS 137
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
I HRD+K++N+LL E K++DFG++ + T+T T GT ++ PE
Sbjct: 138 EKK--I-HRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKR--NTFVGTPFWMAPEV 190
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSK 535
+ K+D++S G+ +EL +
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGE 216
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 23/233 (9%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
+G G +GEV + A+K + + + + E+ I +NH ++V+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFY 71
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
G E + + EY G LFD + D +P HQ+ G+ YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPD--IG---MPEPDAQRFFHQLMAGVVYLHGIG- 125
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
I HRD+K N+LLDE+ N K+SDFGL+ + N + GT+ Y+ PE +
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFR--YNNRERLLNKMCGTLPYVAPELLKR 181
Query: 513 FQLTD--KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563
+ DV+S G+VL +L + +++ ++ Y + L
Sbjct: 182 -REFHAEPVDVWSCGIVLTAMLAG--ELPWDQPSDSCQE--YSDWKEKKTYLN 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 55/259 (21%), Positives = 93/259 (35%), Gaps = 53/259 (20%)
Query: 302 KQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK 360
+ E L ++ G + + + ++IG G V + + G A+K
Sbjct: 66 PKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVK 125
Query: 361 ---RAKLGNTKGT-----DLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNG 411
+ + E IL QV H ++ L+ ++++ + G
Sbjct: 126 IMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG 185
Query: 412 TLFDHLHCDFTGKWPPLPWHLRLV------------IAHQIAEGLTYLHSAAVPPIYHRD 459
LFD L I + E +++LH+ I HRD
Sbjct: 186 ELFD-----------------YLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRD 225
Query: 460 VKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTD-- 517
+K NILLD+ + ++SDFG S +E GT GYL PE +
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLE-----PGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 518 ----KSDVYSFGVVLLELL 532
+ D+++ GV+L LL
Sbjct: 281 GYGKEVDLWACGVILFTLL 299
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 38/220 (17%), Positives = 76/220 (34%), Gaps = 26/220 (11%)
Query: 329 TNNFSKDNLIGTG--GFGEVFKGI-LDDGTVTAIKRAKL--GNTKGTDLVLNEVRILCQV 383
+ +IG G V G ++R L + + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
NH ++V + ++ ++ ++ G+ D + F + I + +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD---GMNELAIAYILQGVLKA 140
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
L Y+H + HR VK+S+IL+ +S + + + + ++
Sbjct: 141 LDYIHHMGY--V-HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 504 ---YLDPE-------YYRNFQLTDKSDVYSFGVVLLELLT 533
+L PE Y KSD+YS G+ EL
Sbjct: 198 VLPWLSPEVLQQNLQGY-----DAKSDIYSVGITACELAN 232
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 49/229 (21%), Positives = 91/229 (39%), Gaps = 31/229 (13%)
Query: 318 RIFTGKEIRRATNNFSK----DNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL 372
+ + + + + +G+G FG V + + G V K
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT 94
Query: 373 VLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHL---HCDFTGKWPPLP 429
V NE+ I+ Q++H L+ L + + ++I E++ G LFD + +
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA----- 149
Query: 430 WHLRLVIAH---QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA--KVSDFGLSRLV 484
+ + Q EGL ++H + I H D+K NI+ + K + K+ DFGL+ +
Sbjct: 150 -----EVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201
Query: 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
E I T + PE + +D+++ GV+ LL+
Sbjct: 202 NPDE-----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 53/218 (24%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 323 KEIRRATN---NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVR 378
+ +RR + + +G G FG+V+K + G + A K + + + + + E+
Sbjct: 9 EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE 68
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH 438
IL +H +V+LLG + ++ E+ P G + + L V+
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCR 124
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q+ E L +LHS + I HRD+K+ N+L+ + + +++DFG+S + +T +
Sbjct: 125 QMLEALNFLHSKRI--I-HRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKR--DSF 177
Query: 499 QGTMGYLDPEYYRNFQLTD-----KSDVYSFGVVLLEL 531
GT ++ PE + D K+D++S G+ L+E+
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 23/233 (9%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
+G G +GEV + A+K + + + + E+ I +NH ++V+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFY 71
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV 452
G E + + EY G LFD + D +P HQ+ G+ YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPD--IG---MPEPDAQRFFHQLMAGVVYLHGIG- 125
Query: 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
I HRD+K N+LLDE+ N K+SDFGL+ + N + GT+ Y+ PE +
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFR--YNNRERLLNKMCGTLPYVAPELLKR 181
Query: 513 FQLTD--KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563
+ DV+S G+VL +L + +++ ++ Y + L
Sbjct: 182 -REFHAEPVDVWSCGIVLTAMLAG--ELPWDQPSDSCQE--YSDWKEKKTYLN 229
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVN- 384
N+FS +IG GGFGEV+ D G + A+K + ++ +G L LNE +L V+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 385 --HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
+V + D+ I + + G L HL G + +R A +I
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEA--DMRFYAA-EIIL 303
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
GL ++H+ V +Y RD+K +NILLDE + ++SD GL+ + + + + GT
Sbjct: 304 GLEHMHNRFV--VY-RDLKPANILLDEHGHVRISDLGLACDFSKKKPH------ASVGTH 354
Query: 503 GYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT 533
GY+ PE + D S D +S G +L +LL
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIK----RAKLGNTKGTDL--VLNEVRILCQVNHRSLVR 390
+G+G F V K G A K R + +G + EV IL QV H +++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLR----LVIAHQIAEGLTY 446
L ++I E + G LFD L L QI +G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNY 130
Query: 447 LHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
LH+ I H D+K NI+L + K+ DFGL+ +E D F GT
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-----DGVEFKNIFGTP 182
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
++ PE L ++D++S GV+ LL+
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 51/254 (20%), Positives = 97/254 (38%), Gaps = 27/254 (10%)
Query: 289 NEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFK 348
+E K K + + + + +++ +GTG FG V +
Sbjct: 116 DEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR 175
Query: 349 GI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407
G A K + + V E++ + + H +LV L + ++ +MIYE+
Sbjct: 176 VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235
Query: 408 IPNGTLFDHL---HCDFTGKWPPLPWHLRLVIAH---QIAEGLTYLHSAAVPPIYHRDVK 461
+ G LF+ + H + Q+ +GL ++H H D+K
Sbjct: 236 MSGGELFEKVADEHNKMSED----------EAVEYMRQVCKGLCHMHENN---YVHLDLK 282
Query: 462 SSNILLDEKLNA--KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKS 519
NI+ K + K+ DFGL+ ++ ++ GT + PE + +
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQS-----VKVTTGTAEFAAPEVAEGKPVGYYT 337
Query: 520 DVYSFGVVLLELLT 533
D++S GV+ LL+
Sbjct: 338 DMWSVGVLSYILLS 351
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 49/246 (19%)
Query: 310 AKAAGKSARIFTGKEIRRATNNFSKD----NLIGTGGFGEVFKGI-LDDGTVTAIK---R 361
A G + + A+ FS + +G G F V + + G A K
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 362 AKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDF 421
KL + + + E RI ++ H ++VRL E ++++ + G LF+
Sbjct: 65 KKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE------ 117
Query: 422 TGKWPPLPWHLRLV------------IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE 469
+V QI E + Y HS I HR++K N+LL
Sbjct: 118 -----------DIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLAS 163
Query: 470 KLNA---KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGV 526
K K++DFGL+ V DS + GT GYL PE + + D+++ GV
Sbjct: 164 KAKGAAVKLADFGLAIEVN-----DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
Query: 527 VLLELL 532
+L LL
Sbjct: 219 ILYILL 224
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNH 385
N F + ++G GGFGEV + G + A K + ++ KG + LNE +IL +VN
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
R +V L D ++ + G L H++ +P A +I GL
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA--RAVFYAA-EICCGLE 300
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
LH + +Y RD+K NILLD+ + ++SD GL+ V E GT+GY+
Sbjct: 301 DLHRERI--VY-RDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV---GTVGYM 352
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLT 533
PE +N + T D ++ G +L E++
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIA 380
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 10/211 (4%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKL-GNTKGTDLVLNEVRILCQVNHRS 387
+++ +IG+G V AIKR L D +L E++ + Q +H +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFD---HLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
+V V D+ ++ + + G++ D H+ K L I ++ EGL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQGTMG 503
YLH I HRDVK+ NILL E + +++DFG+S L + + + T GT
Sbjct: 135 EYLHKNGQ--I-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 504 YLDPEYYRNFQLTD-KSDVYSFGVVLLELLT 533
++ PE + D K+D++SFG+ +EL T
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELAT 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 82/381 (21%), Positives = 138/381 (36%), Gaps = 26/381 (6%)
Query: 195 ELPPEPICKTPEDCKDL-LHSNCLADPMYPGL-KRCLCNPGFIWDPVNGLCQSSKYRHGK 252
+LPP C+ + DL CL P+ L ++ L + Y
Sbjct: 40 KLPPLSKCEALRESLDLGFEGMCLEQPIGKRLFQQFLRTHEQHGPALQLWKDIEDYDTAD 99
Query: 253 GCKRKKKKTMLIAGMVAALGGSLLVVLIGILVYNKLNEHMKKETKKLLIKQREEMLNAK- 311
R +K L A + L V + + L++ L
Sbjct: 100 DALRPQKAQALRAAYLEPQAQLFCSFLDAETV-ARARAGAGDGLFQPLLRAVLAHLGQAP 158
Query: 312 -----AAGKSARIFTGKEIRRAT---NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIK-- 360
+ R K + + F ++G GGFGEVF + G + A K
Sbjct: 159 FQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL 218
Query: 361 -RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC 419
+ +L KG + E +IL +V+ R +V L ++ + G + H++
Sbjct: 219 NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN 278
Query: 420 DFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479
A QI GL +LH + IY RD+K N+LLD+ N ++SD G
Sbjct: 279 VDEDNPGFQEPRAIFYTA-QIVSGLEHLHQRNI--IY-RDLKPENVLLDDDGNVRISDLG 334
Query: 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAID 539
L+ VE GT G++ PE + D ++ GV L E++ ++
Sbjct: 335 LA--VELKAGQTKT--KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP-- 388
Query: 540 FNREEENVNLVVYMKKIMDEE 560
F E V ++++++
Sbjct: 389 FRARGEKVENKELKQRVLEQA 409
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 57/219 (26%), Positives = 85/219 (38%), Gaps = 48/219 (21%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIK----RAKLGNTKGTDL--VLNEVRILCQVNHRSLVR 390
+G+G F V K G A K R + +G + EV IL QV H +++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------------IAH 438
L ++I E + G LFD L
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFD-----------------FLAQKESLSEEEATSFIK 122
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLSRLVERTETNDSHI 494
QI +G+ YLH+ I H D+K NI+L + K+ DFGL+ +E D
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-----DGVE 174
Query: 495 FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
F GT ++ PE L ++D++S GV+ LL+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 46/214 (21%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG 393
+G G FGEV K A+K +A K T +L EV +L +++H ++++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------------IAHQIA 441
+ ++ E G LFD ++ I Q+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFD-----------------EIIKRKRFSEHDAARIIKQVF 131
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
G+TY+H I HRD+K NILL ++ + K+ DFGLS + +
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-----QNTKMKDR 183
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
GT Y+ PE R +K DV+S GV+L LL
Sbjct: 184 IGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 46/214 (21%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTD--LVLNEVRILCQVNHRSLVRLLGC 394
+G G FG V + + K K KGTD LV E+ IL HR+++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV-------------IAHQIA 441
+++ +MI+E+I +F+ R+ HQ+
Sbjct: 70 FESMEELVMIFEFISGLDIFE-----------------RINTSAFELNEREIVSYVHQVC 112
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA--KVSDFGLSRLVERTETNDSHIFTTAQ 499
E L +LHS I H D++ NI+ + ++ K+ +FG +R ++ + F
Sbjct: 113 EALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-----FRLLF 164
Query: 500 GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
Y PE +++ ++ +D++S G ++ LL+
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 51/213 (23%), Positives = 78/213 (36%), Gaps = 35/213 (16%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDL--VLNEVRILCQVNHRSLVRL 391
IG G F V + I + G A+K AK ++ G + E I + H +V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 392 LGCCVELDQTLMIYEYIPNGTLFD------HLHCDFTGKWPPLPWHLRLVIAH---QIAE 442
L M++E++ L ++ V +H QI E
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA----------VASHYMRQILE 141
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
L Y H I HRDVK +LL + K+ FG++ + +
Sbjct: 142 ALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE----SGLVAGGRV 194
Query: 500 GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
GT ++ PE + DV+ GV+L LL
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-23
Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 15/200 (7%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKR-AKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCC 395
+G+G FG+V G IK K + + + E+ +L ++H +++++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPI 455
+ ++ E G L + + + L + Q+ L Y HS +
Sbjct: 90 EDYHNMYIVMETCEGGELLERI-VSAQARGKALSEGYVAELMKQMMNALAYFHSQH---V 145
Query: 456 YHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
H+D+K NIL K+ DFGL+ L + T A GT Y+ PE ++
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-----SDEHSTNAAGTALYMAPEVFKR 200
Query: 513 FQLTDKSDVYSFGVVLLELL 532
+T K D++S GVV+ LL
Sbjct: 201 -DVTFKCDIWSAGVVMYFLL 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 8e-23
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 48/219 (21%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTA---IKRAKLGNTKGT---DLVLNEVRILCQVNHRSLVR 390
+G+G F V K G A IK+ +L +++ + + EV IL ++ H +++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------------IAH 438
L ++I E + G LFD L
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFD-----------------FLAEKESLTEDEATQFLK 115
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA----KVSDFGLSRLVERTETNDSHI 494
QI +G+ YLHS I H D+K NI+L +K K+ DFG++ +E +
Sbjct: 116 QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----AGNE 167
Query: 495 FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
F GT ++ PE L ++D++S GV+ LL+
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 330 NNFSKDNLIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQ 382
++F IG G FG+V D + A+K + K V E++I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKN---DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 383 VNHRSLVRLLGCCVELDQTL----MIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVI 436
+ H LV L Q M+ + + G L HL + F + ++L I
Sbjct: 72 LEHPFLVNLWYSF----QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE------TVKLFI 121
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFT 496
++ L YL + I HRD+K NILLDE + ++DF ++ ++ R T
Sbjct: 122 C-ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-----T 172
Query: 497 TAQGTMGYLDPEYYRNFQLT--DKS-DVYSFGVVLLELLT 533
T GT Y+ PE + + + + D +S GV ELL
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 54/236 (22%), Positives = 89/236 (37%), Gaps = 33/236 (13%)
Query: 315 KSARIFTGKEIRRATNNFSK-----DNLIGTGGFGEVFKGI-LDDGTVTAIK--RAKLGN 366
+ T ++ NF+ +G G F V + I G A K + +
Sbjct: 9 SGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG 68
Query: 367 TKGTDLVLNEVRILCQVNHR-SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKW 425
+L+E+ +L ++ L + ++I EY G +F +
Sbjct: 69 QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE-- 126
Query: 426 PPLPWHL-----RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSD 477
+ +I QI EG+ YLH I H D+K NILL + K+ D
Sbjct: 127 -----MVSENDVIRLI-KQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
FG+SR + + GT YL PE +T +D+++ G++ LLT
Sbjct: 178 FGMSRKIG-----HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
+G G FG+V G G A+K R K+ + + E++ L H +++L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
M+ EY+ G LFD++ + G+ L + QI G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKN----GR---LDEKESRRLFQQILSGVDYCHRH 135
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
V HRD+K N+LLD +NAK++DFGLS ++ D T+ G+ Y PE
Sbjct: 136 MV---VHRDLKPENVLLDAHMNAKIADFGLSNMMS-----DGEFLRTSCGSPNYAAPEVI 187
Query: 511 RNFQLTD--KSDVYSFGVVLLELLT 533
+L + D++S GV+L LL
Sbjct: 188 SG-RLYAGPEVDIWSSGVILYALLC 211
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 53/233 (22%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGT---------------------- 370
IG G +G V +D T A+K + KL G
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 371 -DLVLNEVRILCQVNHRSLVRLLGCCVEL------DQTLMIYEYIPNGTLFDHLHCDFTG 423
+ V E+ IL +++H ++V+L VE+ D M++E + G + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVP------ 129
Query: 424 KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483
PL + +G+ YLH I HRD+K SN+L+ E + K++DFG+S
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLT---DKSDVYSFGVVLLELLT 533
+ +D+ + T GT ++ PE + DV++ GV L +
Sbjct: 187 FKG---SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS 387
F +G G +G V+K I + G + AIK+ + ++ E+ I+ Q +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V+ G + ++ EY G++ D + + L I +GL YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYL 141
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
H HRD+K+ NILL+ + +AK++DFG++ + T T GT ++ P
Sbjct: 142 HFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR----NTVIGTPFWMAP 194
Query: 508 EYYRNFQLTDKSDVYSFGVVLLEL 531
E + +D++S G+ +E+
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEM 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 58/265 (21%), Positives = 102/265 (38%), Gaps = 49/265 (18%)
Query: 289 NEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSK----DNLIGTGGFG 344
+ + T+ L + + + A G ++ + + S ++ +G G
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 345 EVFKGI-LDDGTVTAIKR-AKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402
V++ A+K K T +V E+ +L +++H ++++L +
Sbjct: 68 IVYRCKQKGTQKPYALKVLKK---TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124
Query: 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------------IAHQIAEGLTYLHSA 450
++ E + G LFD R+V QI E + YLH
Sbjct: 125 LVLELVTGGELFD-----------------RIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 451 AVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
I HRD+K N+L K++DFGLS++VE + T GT GY P
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-----HQVLMKTVCGTPGYCAP 219
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELL 532
E R + D++S G++ LL
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILL 244
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 57/224 (25%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDL-----VLNEVRILCQVNHRSL 388
+G+G GEV AIK + K + V E+ IL ++NH +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------------I 436
+++ + + ++ E + G LFD ++V
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFD-----------------KVVGNKRLKEATCKLY 119
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTETNDSH 493
+Q+ + YLH I HRD+K N+LL +E K++DFG S+++ ++
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-----ETS 171
Query: 494 IFTTAQGTMGYLDPE-----YYRNFQLTDKSDVYSFGVVLLELL 532
+ T GT YL PE + D +S GV+L L
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVILFICL 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 57/255 (22%), Positives = 101/255 (39%), Gaps = 35/255 (13%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDL-----VLNEVRILCQVNHRSL 388
+G+G FG V+ + + +K + K+ + V E+ IL +V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 389 VRLLGCCVELDQTLMIYE-YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+++L ++ E + LF + D + L L I Q+ + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHPR---LDEPLASYIFRQLVSAVGYL 146
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
I HRD+K NI++ E K+ DFG + +E +F T GT+ Y P
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-----RGKLFYTFCGTIEYCAP 198
Query: 508 EYYRNFQLTD--KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE----- 560
E + +++S GV L L+ + F EE V ++ ++ +E
Sbjct: 199 EVLMG-NPYRGPELEMWSLGVTLYTLVF--EENPFCELEETVEAAIHPPYLVSKELMSLV 255
Query: 561 RLMEVVDPVLKERAT 575
+ P + R T
Sbjct: 256 SGLLQPVP--ERRTT 268
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 45/211 (21%), Positives = 75/211 (35%), Gaps = 42/211 (19%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCV 396
IG G +GEV + A K+ + D E+ I+ ++H +++RL
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 397 ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------------IAHQIAEGL 444
+ ++ E G LF+ R+V I + +
Sbjct: 77 DNTDIYLVMELCTGGELFE-----------------RVVHKRVFRESDAARIMKDVLSAV 119
Query: 445 TYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
Y H + HRD+K N L K+ DFGL+ + + T GT
Sbjct: 120 AYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-----PGKMMRTKVGT 171
Query: 502 MGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
Y+ P+ + D +S GV++ LL
Sbjct: 172 PYYVSPQVLEG-LYGPECDEWSAGVMMYVLL 201
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLV 389
F L+G G +G+V+KG + G + AIK + + ++ E+ +L + +HR++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK-QEINMLKKYSHHRNIA 84
Query: 390 RLLGC------CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
G DQ ++ E+ G++ D + L I +I G
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRG 141
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
L++LH V I HRD+K N+LL E K+ DFG+S ++RT T GT
Sbjct: 142 LSHLHQHKV--I-HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR----RNTFIGTPY 194
Query: 504 YLDPEYYRNFQLTD-----KSDVYSFGVVLLEL 531
++ PE + D KSD++S G+ +E+
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 17/222 (7%)
Query: 318 RIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKL-GNTKGTDLVLN 375
+I + + IG G +G V K + G + A+KR + + K +L
Sbjct: 10 KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69
Query: 376 EVRILC-QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL 434
++ ++ + +V+ G + E + + + ++ +P +
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG 128
Query: 435 VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSH 493
I + L +L I HRD+K SNILLD N K+ DFG+S +LV DS
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV------DSI 180
Query: 494 IFTTAQGTMGYLDPE----YYRNFQLTDKSDVYSFGVVLLEL 531
T G Y+ PE +SDV+S G+ L EL
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 18/202 (8%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKL-GNTKGTDLVLNEVRILC-QVNHRSLVRLLGC 394
+G G +G V K + G + A+KR + N++ +L ++ I V+ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 395 CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPP 454
+ E + T D + K +P + IA I + L +LHS
Sbjct: 75 LFREGDVWICMELM--DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130
Query: 455 IYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQGTMGYLDPE----Y 509
+ HRDVK SN+L++ K+ DFG+S LV D G Y+ PE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLV------DDVAKDIDAGCKPYMAPERINPE 184
Query: 510 YRNFQLTDKSDVYSFGVVLLEL 531
+ KSD++S G+ ++EL
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL 206
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 71/249 (28%), Positives = 111/249 (44%), Gaps = 35/249 (14%)
Query: 293 KKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVF----K 348
++ K+ L K +E+ L + F + +GTG FG V K
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTA--------QLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 349 GILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405
+ G A+K + K+ K + LNE RIL VN LV+L + M+
Sbjct: 64 ---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNI 465
EY+ G +F HL G++ H R A QI YLHS + IY RD+K N+
Sbjct: 121 EYVAGGEMFSHLRRI--GRFSEP--HARFYAA-QIVLTFEYLHSLDL--IY-RDLKPENL 172
Query: 466 LLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKS-DVYSF 524
L+D++ +V+DFG ++ V+ T T GT L PE + + +K+ D ++
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGR-TW------TLCGTPEALAPEIILS-KGYNKAVDWWAL 224
Query: 525 GVVLLELLT 533
GV++ E+
Sbjct: 225 GVLIYEMAA 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 25/205 (12%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
+G G FG+V A+K R L + V E+ L + H +++L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHL--HCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
+M+ EY G LFD++ + + QI + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEK----KR---MTEDEGRRFFQQIICAIEYCHRH 127
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
I HRD+K N+LLD+ LN K++DFGLS ++ D + T+ G+ Y PE
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT-----DGNFLKTSCGSPNYAAPEVI 179
Query: 511 RNFQLTD--KSDVYSFGVVLLELLT 533
+L + DV+S G+VL +L
Sbjct: 180 NG-KLYAGPEVDVWSCGIVLYVMLV 203
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 48/212 (22%), Positives = 87/212 (41%), Gaps = 22/212 (10%)
Query: 330 NNFSKDNLIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQ 382
+F ++G G F V AIK + + V E ++ +
Sbjct: 30 EDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 383 VNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
++H V+L + ++ Y NG L ++ G + R A +I
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDE--TCTRFYTA-EIVS 141
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
L YLH I HRD+K NILL+E ++ +++DFG ++++ + GT
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA--NSFVGTA 196
Query: 503 GYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT 533
Y+ PE + KS D+++ G ++ +L+
Sbjct: 197 QYVSPELLTE-KSACKSSDLWALGCIIYQLVA 227
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 48/219 (21%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTA---IKRAKLGNTKGT---DLVLNEVRILCQVNHRSLVR 390
+G+G F V K G A IK+ + +++ + + EV IL ++ H +++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------------IAH 438
L ++I E + G LFD L
Sbjct: 79 LHEVYENKTDVILILELVAGGELFD-----------------FLAEKESLTEEEATEFLK 121
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLSRLVERTETNDSHI 494
QI G+ YLHS I H D+K NI+L K K+ DFGL+ ++ +
Sbjct: 122 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----FGNE 173
Query: 495 FTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
F GT ++ PE L ++D++S GV+ LL+
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 41/159 (25%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 328 ATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL-VLNEVRILCQVNH 385
+++ F + +G G + V+KG+ G A+K KL + +GT + E+ ++ ++ H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPN--GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
++VRL ++ +++E++ N D T + L +L Q+ +G
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPR--GLELNLVKYFQWQLLQG 120
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
L + H I HRD+K N+L++++ K+ DFGL+R
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTD---LVLNEVRILCQVNHRS 387
FS IG G FG V+ + + V AIK+ + + ++ EVR L ++ H +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
++ GC + ++ EY G+ D L PL + H +GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYL 170
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVERTETNDSHIFTTAQGTMGYLD 506
HS + I HRDVK+ NILL E K+ DFG + + + GT ++
Sbjct: 171 HSHNM--I-HRDVKAGNILLSEPGLVKLGDFGSASIMAPA---------NSFVGTPYWMA 218
Query: 507 PEYYRNFQLTD---KSDVYSFGVVLLEL 531
PE K DV+S G+ +EL
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 52/226 (23%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 329 TNNFSKD----NLIGTGGFGEVFKGI-LDDGTVTAIK--RAKLGNTKGTDLVLNEVRILC 381
F+++ +G G F V + + + G A K + + + E RI
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 382 QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------ 435
+ H ++VRL E +I++ + G LF+ +V
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE-----------------DIVAREYYS 108
Query: 436 ------IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVER 486
QI E + + H + HR++K N+LL + K++DFGL+ VE
Sbjct: 109 EADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE- 164
Query: 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
+ + GT GYL PE R D+++ GV+L LL
Sbjct: 165 ---GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 24/230 (10%)
Query: 313 AGKSARIFT--GKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKL-GNTK 368
+GK T G+ + N+ +G+G G+V+K G V A+K+ + GN +
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 369 GTDLVLNEVRILC-QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP 427
+L ++ ++ + +V+ G + + E + GT + L G P
Sbjct: 66 ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQG---P 120
Query: 428 LPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS-RLVER 486
+P + + I + L YL + HRDVK SNILLDE+ K+ DFG+S RLV
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-- 176
Query: 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTD-----KSDVYSFGVVLLEL 531
D + G Y+ PE T ++DV+S G+ L+EL
Sbjct: 177 ----DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 35/163 (21%), Positives = 69/163 (42%), Gaps = 18/163 (11%)
Query: 326 RRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK-GTDL-VLNEVRILCQV 383
+ + K +G G +G V+K G + A+KR +L G + E+ +L ++
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTG--KWPPLPWHLRLV--IAHQ 439
+H ++V L+ +++E+ + D + +Q
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEF---------MEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
+ G+ + H I HRD+K N+L++ K++DFGL+R
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 68/293 (23%), Positives = 110/293 (37%), Gaps = 44/293 (15%)
Query: 256 RKKKKTMLIAGMVAALGGSLLVVLIGILVYNKLNEHMKKETKKLLIKQREEMLNAKAAGK 315
R +K L+ + + L+ + LVY+ ++K R + K
Sbjct: 5 RFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKI--- 61
Query: 316 SARIFTGKEIRRATNNFSKDNLIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTK 368
+++R ++ +IG G FGEV K V A+K + ++
Sbjct: 62 -------RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRS 111
Query: 369 GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC-DFTGKWPP 427
+ E I+ N +V+L + M+ EY+P G L + + D KW
Sbjct: 112 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-- 169
Query: 428 LPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487
R A ++ L +HS HRDVK N+LLD+ + K++DFG + +
Sbjct: 170 ----ARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221
Query: 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVY-------SFGVVLLELLT 533
TA GT Y+ PE + Y S GV L E+L
Sbjct: 222 GMVRCD---TAVGTPDYISPEV---LKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDLV-LNEVRILCQV 383
+ + K IG G FGEVFK G A+K+ + N K G + L E++IL +
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTL-FDHLHCDFTG--KWPPLPWHLRLV--IAH 438
H ++V L+ C + + L FD D G + + L + +
Sbjct: 74 KHENVVNLIEICRT--KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
+ GL Y+H I HRD+K++N+L+ K++DFGL+R + + + +T
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 499 QGTMGYLDPE------YYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538
T+ Y PE Y D++ G ++ E+ T + I
Sbjct: 189 VVTLWYRPPELLLGERDY-----GPPIDLWGAGCIMAEMWT-RSPI 228
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 7e-21
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 25/223 (11%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLN 375
K++R +F +IG G FGEV K + V A+K + ++ T
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAETACFRE 123
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV 435
E +L + + + L + + ++ +Y G L L F + P R
Sbjct: 124 ERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEE--MARFY 180
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
+A ++ + +H HRD+K NIL+D + +++DFG + T S
Sbjct: 181 LA-EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS-- 234
Query: 496 TTAQGTMGYLDPEYYRNFQLTDKS-----DVYSFGVVLLELLT 533
A GT Y+ PE + + D +S GV + E+L
Sbjct: 235 -VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL-VLNEVRILCQVNHRS 387
+ K + +G G + V+KG + A+K +L + +G + EV +L + H +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTG--KWPPLPWHLRLV--IAHQIAEG 443
+V L +++EY L D ++ V Q+ G
Sbjct: 62 IVTLHDIIHTEKSLTLVFEY---------LDKDLKQYLDDCGNIINMHNVKLFLFQLLRG 112
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
L Y H + HRD+K N+L++E+ K++DFGL+R
Sbjct: 113 LAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 326 RRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN 384
R +++ +IG G FG V++ L D G + AIK+ E++I+ +++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK----NRELQIMRKLD 105
Query: 385 HRSLVRLLGC-------CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIA 437
H ++VRL E+ L + +Y+P T++ K +++L +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNL-VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM- 162
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA-KVSDFGLSRLVERTETNDSHIFT 496
+Q+ L Y+HS I HRD+K N+LLD K+ DFG ++ + R E N S+I +
Sbjct: 163 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 497 TAQGTMGYLDPEYYR------NFQL-TDKSDVYSFGVVLLELLTSK 535
YYR T DV+S G VL ELL +
Sbjct: 220 -----------RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 34/222 (15%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDL-VLNEVRILCQVNHR 386
+ K IG G +G VFK + + A+KR +L + G L E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTG--KWPPLPWHLRLV--IAHQIAE 442
++VRL + +++E+ D +V Q+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEF---------CDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
GL + HS + HRD+K N+L++ K+++FGL+R ++ T+
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF----GIPVRCYSAEVVTL 165
Query: 503 GYLDPE------YYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538
Y P+ Y + D++S G + EL + + +
Sbjct: 166 WYRPPDVLFGAKLY-----STSIDMWSAGCIFAELANAGRPL 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 2e-20
Identities = 36/159 (22%), Positives = 67/159 (42%), Gaps = 18/159 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK-GTDL-VLNEVRILCQVNHRS 387
+ IG G +G V+K + G A+K+ +L G + E+ IL ++ H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTG--KWPPLPWHLRLV--IAHQIAEG 443
+V+L + ++++E+ L D Q+ G
Sbjct: 62 IVKLYDVIHTKKRLVLVFEH---------LDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
+ Y H + HRD+K N+L++ + K++DFGL+R
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 29/226 (12%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLN 375
KE+R ++F +IG G F EV K G V A+K + +
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMK---QTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL 434
E +L + R + +L + + L ++ EY G L L G+ P R
Sbjct: 111 ERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEM-ARF 166
Query: 435 VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHI 494
+A +I + +H HRD+K NILLD + +++DFG + T S
Sbjct: 167 YLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL- 221
Query: 495 FTTAQGTMGYLDPEYYRNFQLTDKSDVY-------SFGVVLLELLT 533
A GT YL PE + + Y + GV E+
Sbjct: 222 --VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 23/191 (12%)
Query: 303 QREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKR 361
L A+ G + + + + + + +G G +GEV+K I AIKR
Sbjct: 7 HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66
Query: 362 AKLGNTK-GTDL-VLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC 419
+L + + G + EV +L ++ HR+++ L + +I+EY
Sbjct: 67 IRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY---------AEN 117
Query: 420 DFTG---KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA--- 473
D K P + + +Q+ G+ + HS HRD+K N+LL +
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETP 174
Query: 474 --KVSDFGLSR 482
K+ DFGL+R
Sbjct: 175 VLKIGDFGLAR 185
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 2e-20
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDL-VLNEVRILCQVNHR 386
NF K IG G +G V+K G V A+K+ +L G + E+ +L ++NH
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 387 SLVRLLGCCVELDQTLMIYEYIPN--GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
++V+LL ++ +++E++ D +P L Q+ +GL
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS------ALTGIPLPLIKSYLFQLLQGL 116
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
+ HS + HRD+K N+L++ + K++DFGL+R
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILC 381
GK + ++ +IG G FG VF+ L + AIK+ E++I+
Sbjct: 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK----NRELQIMR 87
Query: 382 QVNHRSLVRLLGC-------CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRL 434
V H ++V L E+ L + EY+P T++ K ++L
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNL-VLEYVPE-TVYRASRHYAKLKQTMPMLLIKL 145
Query: 435 VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA-KVSDFGLSRLVERTETNDSH 493
+ +Q+ L Y+HS I HRD+K N+LLD K+ DFG ++++ E N S+
Sbjct: 146 YM-YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 494 IFTTAQGTMGYLDPEYYR-------NFQLTDKSDVYSFGVVLLELLTSK 535
I + YYR T D++S G V+ EL+ +
Sbjct: 202 ICS-----------RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 334 KDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRL 391
+++++G G V I L A+K + V EV +L Q HR+++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
+ E D+ +++E + G++ H+H F +V+ +A L +LH+
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL------EASVVV-QDVASALDFLHN 129
Query: 450 AAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVE---RTETNDSHIFTTAQGTMG 503
I HRD+K NIL ++ K+ DF L ++ + T G+
Sbjct: 130 KG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 504 YLDPEYYRNFQLTDKS-----DVYSFGVVLLELL 532
Y+ PE F D++S GV+L LL
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK----GTDL-VLNEV 377
+++ + K + +G G F V+K + + AIK+ KLG+ G + L E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 378 RILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTG--KWPPLPWHLRLV 435
++L +++H +++ LL +++++ + D K L +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDF---------METDLEVIIKDNSLVLTPSHI 114
Query: 436 --IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
+GL YLH I HRD+K +N+LLDE K++DFGL++
Sbjct: 115 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 47/207 (22%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCC 395
+G G + EVF+ I + + +K K K E++IL + +++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGPNIITLA--D 98
Query: 396 VELDQTLMIYEYIPNGTLFDHL-HCDFTGKWPPLP-WHLRLVIAHQIAEGLTYLHSAAVP 453
+ D + F+H+ + DF + L + +R + ++I + L Y HS
Sbjct: 99 IVKDPVSRTPALV-----FEHVNNTDFKQLYQTLTDYDIRFYM-YEILKALDYCHSMG-- 150
Query: 454 PIYHRDVKSSNILLD-EKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN 512
I HRDVK N+++D E ++ D+GL+ + + + + PE +
Sbjct: 151 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF-----YHPGQEYNVRVASRYFKGPELLVD 204
Query: 513 FQLTDKS-DVYSFGVVLLELLTSKKAI 538
+Q+ D S D++S G +L ++ K+
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 13/160 (8%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDLV-LNEVRILCQV 383
++ + L+G G +G V K D G + AIK+ + + + E+++L Q+
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDH-LHCDFTGKWPPLPWHLRLVIAHQIAE 442
H +LV LL C + + +++E++ DH + D L + + QI
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFV------DHTILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
G+ + HS I HRD+K NIL+ + K+ DFG +R
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 46/236 (19%), Positives = 88/236 (37%), Gaps = 56/236 (23%)
Query: 322 GKEIRRATNNFSKD----NLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLV 373
+++ R + F+ IG G + + I A+K ++K
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------P 62
Query: 374 LNEVRILCQ-VNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHL 432
E+ IL + H +++ L + ++ E + G L D
Sbjct: 63 TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLD----------------- 105
Query: 433 RLV------------IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL-DEKLNA---KVS 476
+++ + I + + YLH+ + HRD+K SNIL DE N ++
Sbjct: 106 KILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRIC 162
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
DFG ++ + ++ + T T ++ PE D++S GV+L +L
Sbjct: 163 DFGFAKQLR----AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 44/212 (20%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRA-KLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCC 395
+G G F K + + A K+ + + E+ L H ++V+L
Sbjct: 19 LGEGSFSICRKCVH---KKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV------------IAHQIAEG 443
+ T ++ E + G LF+ R+ I ++
Sbjct: 76 HDQLHTFLVMELLNGGELFE-----------------RIKKKKHFSETEASYIMRKLVSA 118
Query: 444 LTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
++++H + HRD+K N+L ++ L K+ DFG +RL D+ T
Sbjct: 119 VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP----PDNQPLKTPCF 171
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
T+ Y PE + D++S GV+L +L
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTML 203
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 330 NNFSKDNLIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQ 382
+F +GTG FG V + +G A+K + + K + +E +L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 383 VNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
V H ++R+ G + Q MI +YI G LF L ++P + A ++
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNP--VAKFYAA-EVCL 117
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
L YLHS + IY RD+K NILLD+ + K++DFG ++ V T T GT
Sbjct: 118 ALEYLHSKDI--IY-RDLKPENILLDKNGHIKITDFGFAKYVPDV-TY------TLCGTP 167
Query: 503 GYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT 533
Y+ PE + +KS D +SFG+++ E+L
Sbjct: 168 DYIAPEVVST-KPYNKSIDWWSFGILIYEMLA 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDLV----LNEVRIL 380
AT+ + IG G +G V+K G A+K ++ N G + + EV +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 381 CQVN---HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTG-----KWPPLPWHL 432
++ H ++VRL+ C I + +F+H+ D P LP
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTL----VFEHVDQDLRTYLDKAPPPGLPAET 121
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
+ Q GL +LH+ I HRD+K NIL+ K++DFGL+R
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 62/270 (22%), Positives = 96/270 (35%), Gaps = 59/270 (21%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
IG+G FG + A+K R + V E+ + H ++VR
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFK 82
Query: 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIA------HQIAEGLTY 446
+ +I EY G L++ + C+ R Q+ G++Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERI-CN----------AGRFSEDEARFFFQQLLSGVSY 131
Query: 447 LHSAAVPPIYHRDVKSSNILLDEK--LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
HS + HRD+K N LLD K+ DFG S+ + GT Y
Sbjct: 132 CHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-----LHSQPKSTVGTPAY 183
Query: 505 LDPEYYRNFQLTD--KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM----- 557
+ PE Q D +DV+S GV L +L A F EE + +++I+
Sbjct: 184 IAPEVLLR-QEYDGKIADVWSCGVTLYVMLVG--AYPFEDPEEPRDYRKTIQRILSVKYS 240
Query: 558 ---------DEERL---MEVVDPVLKERAT 575
+ L + V DP R +
Sbjct: 241 IPDDIRISPECCHLISRIFVADP--ATRIS 268
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 71/241 (29%), Positives = 110/241 (45%), Gaps = 36/241 (14%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIKRAK----LGNTKGTDLVLNEVRILCQVNHRS- 387
++GTG +G+VF D G + A+K K + K T+ E ++L +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 388 LVRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIA 441
LV L QT +I +YI G LF HL FT +++ + +I
Sbjct: 121 LVTLHYAF----QTETKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVG-EIV 169
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
L +LH + IY RD+K NILLD + ++DFGLS+ ET ++ F GT
Sbjct: 170 LALEHLHKLGI--IY-RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC---GT 223
Query: 502 MGYLDPEYYR-NFQLTDKS-DVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559
+ Y+ P+ R DK+ D +S GV++ ELLT F + E + ++I+
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKS 281
Query: 560 E 560
E
Sbjct: 282 E 282
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 5e-19
Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTK-GTDLV-LNEVRILCQVNHR 386
+ K IG G +G VFK D G + AIK+ + L E+R+L Q+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
+LV LL + +++EY + T+ L D + +P HL I Q + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQR--GVPEHLVKSITWQTLQAVNF 117
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
H HRDVK NIL+ + K+ DFG +R
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 52/226 (23%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 326 RRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN 384
R+ + F + + G G FG V G G AIK+ + + + + L ++ L ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLH 77
Query: 385 HRSLVRLLGCCVELDQTLM-------IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIA 437
H ++V+L L + + EY+P+ TL + + P P +++ +
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL- 135
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA-KVSDFGLSRLVERTETNDSHIFT 496
Q+ + LH +V + HRD+K N+L++E K+ DFG ++ + +E N ++I +
Sbjct: 136 FQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 497 TAQGTMGYLDPEYYR-------NFQLTDKSDVYSFGVVLLELLTSK 535
YYR N T D++S G + E++ +
Sbjct: 195 R-----------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 51/181 (28%), Positives = 82/181 (45%), Gaps = 27/181 (14%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKG--ILDDGTVTAIKRAKLGNTK-GTDL-VLNEVRILCQ 382
RA + IG G +G+VFK + + G A+KR ++ + G L + EV +L
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 383 VN---HRSLVRLLGCCV--ELDQTLMIYEYIPNGTL-FDHLHCDFTG-----KWPPLPWH 431
+ H ++VRL C D+ + L F+H+ D T P +P
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLT-------LVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 432 LRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL--VERTET 489
+ Q+ GL +LHS + HRD+K NIL+ K++DFGL+R+ + T
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 490 N 490
+
Sbjct: 178 S 178
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 49/237 (20%), Positives = 82/237 (34%), Gaps = 41/237 (17%)
Query: 315 KSARIFTGKEIRRATNNFSKD-----NLIGTGGFGEVFKGI-LDDGTVTAIKR-AKLGNT 367
S + + D ++G G G+V + G A+K
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD---- 64
Query: 368 KGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQT----LMIYEYIPNGTLFDHL----H 418
+ EV Q +V +L + L+I E + G LF +
Sbjct: 65 --SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 122
Query: 419 CDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKV 475
FT + ++ I + +LHS I HRDVK N+L ++ K+
Sbjct: 123 QAFTER------EAAEIM-RDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKL 172
Query: 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
+DFG ++ + T T Y+ PE + D++S GV++ LL
Sbjct: 173 TDFGFAKETTQNA------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 34/212 (16%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIKRAK----LGNTKGTDLVLNEVRILCQVNHRSL 388
++G GG+G+VF + G + A+K K + N K T E IL +V H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 389 VRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAE 442
V L+ QT +I EY+ G LF L + F +A +I+
Sbjct: 84 VDLIYAF----QTGGKLYLILEYLSGGELFMQLEREGIFMED------TACFYLA-EISM 132
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
L +LH + IY RD+K NI+L+ + + K++DFGL + + +H F GT+
Sbjct: 133 ALGHLHQKGI--IY-RDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFC---GTI 185
Query: 503 GYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT 533
Y+ PE +++ D +S G ++ ++LT
Sbjct: 186 EYMAPEILMR-SGHNRAVDWWSLGALMYDMLT 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 61/206 (29%), Positives = 85/206 (41%), Gaps = 25/206 (12%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNHRSLV 389
L+G G FG+V K G A+K K D V L E R+L H L
Sbjct: 155 LLGKGTFGKVILVKEK---ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAEGLTYL 447
L D+ + EY G LF HL + F+ R A +I L YL
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGA-EIVSALDYL 264
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
HS + +RD+K N++LD+ + K++DFGL + D T GT YL P
Sbjct: 265 HSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKE----GIKDGATMKTFCGTPEYLAP 318
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLT 533
E + D + GVV+ E++
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMC 344
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 46/223 (20%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLN-------------EVRILCQVN 384
I +G +G V G+ +G AIK ++ NT +N E+R+L +
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIK--RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDF-----TGKWPPLPWHLRLVIAHQ 439
H +++ L V ++ M Y+ + + + D + P H++ + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYL----VTELMRTDLAQVIHDQRIVISPQHIQYFM-YH 142
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
I GL LH A V HRD+ NILL + + + DF L+R T
Sbjct: 143 ILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADA------NKT-- 191
Query: 500 GTMGYLDPEYYR------NFQLTDKS-DVYSFGVVLLELLTSK 535
Y+ +YR F+ K D++S G V+ E+ K
Sbjct: 192 ---HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 36/212 (16%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIKRAKLGNTKGTDLV--LNEVRILCQVNHRSLVR 390
++G G FG+VF D + A+K K K D V E IL +VNH +V+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 391 LLGCCVELDQTL----MIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAEGL 444
L QT +I +++ G LF L + FT + ++ +A ++A L
Sbjct: 91 LHYAF----QTEGKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLA-ELALAL 139
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR--LVERTETNDSHIFTTAQGTM 502
+LHS + IY RD+K NILLDE+ + K++DFGLS+ + + + GT+
Sbjct: 140 DHLHSLGI--IY-RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY------SFCGTV 190
Query: 503 GYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT 533
Y+ PE + +S D +SFGV++ E+LT
Sbjct: 191 EYMAPEVVNR-RGHTQSADWWSFGVLMFEMLT 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 50/224 (22%), Positives = 82/224 (36%), Gaps = 41/224 (18%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN--TKGTDL--VLNEVRILCQV 383
+ IG+G G V AIK KL T E+ ++ V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 384 NHRSLVRLL------GCCVELDQTLMIYEYIPN------GTLFDHLHCDFTGKWPPLPWH 431
NH++++ LL E ++ E + DH +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY---------- 131
Query: 432 LRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491
+ +Q+ G+ +LHSA + HRD+K SNI++ K+ DFGL+R
Sbjct: 132 ----LLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAG-----T 179
Query: 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
S + T T Y PE + D++S G ++ E++
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN-TKGTDL--VLNEVRILCQVN 384
++ + IG G +G V + AIK K+ T L E++IL +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLREIKILLRFR 83
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTG--KWPPL-PWHLRLVIAHQIA 441
H +++ + M YI + D + D K L H+ + +QI
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYI----VQDLMETDLYKLLKTQHLSNDHICYFL-YQIL 138
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
GL Y+HSA V HRD+K SN+LL+ + K+ DFGL+R+ + + + + T T
Sbjct: 139 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVAD-PDHDHTGFLTEYVAT 194
Query: 502 MGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSK 535
Y PE N + KS D++S G +L E+L+++
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 36/287 (12%), Positives = 79/287 (27%), Gaps = 63/287 (21%)
Query: 337 LIGTGGFGEVFKG---ILDDGTVTAIK--RAKLGNTKG-TDLVLNEVRILCQVNHRSLVR 390
G + ++ LD V A+ + L+ L +++ + R
Sbjct: 38 FHGGVPPLQFWQALDTALDR-QV-ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 391 LLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
+L L++ E+I G+L + P P + +A H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSP-VGAIRAMQSLAAAADAAHRA 148
Query: 451 AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
V S + + + ++ TM +P+
Sbjct: 149 GVA---LSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDANPQ-- 182
Query: 511 RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVL 570
D+ G L LL ++ L + + ++P
Sbjct: 183 --------DDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTAG-----QPIEPAD 227
Query: 571 KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617
+R + +AA + R + + + ++ ++A
Sbjct: 228 IDRDIPFQISA------VAARSVQGDGGIRSAS-TLLNLMQQATAVA 267
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 46/223 (20%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKR----AKLGNTKGTDLVLNEVRILCQVNHRSLVRLL 392
+G G +G V G + AIK+ K T L E++IL H +++ +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIKILKHFKHENIITIF 75
Query: 393 -----GCCVELDQTLMIYEY--------IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQ 439
++ +I E I L H + +Q
Sbjct: 76 NIQRPDSFENFNEVYIIQELMQTDLHRVISTQML-SDDHIQY--------------FIYQ 120
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
+ LH + V HRD+K SN+L++ + KV DFGL+R+++ + ++S
Sbjct: 121 TLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 500 GTMGYLDPEYYR------NFQLTDKS-DVYSFGVVLLELLTSK 535
G + ++ +YR ++ DV+S G +L EL +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 40/223 (17%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN--TKGTDL--VLNEVRILCQV 383
+ +G+G +G V I G AIK KL E+ +L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 384 NHRSLVRLLGCCVELDQTLMIYE--YIPNGTLFDHLHCDFTG--KWPPLPWHLRLVIAHQ 439
H +++ LL +L + Y+ + + D ++ ++ +Q
Sbjct: 81 QHENVIGLLDV-FTPASSLRNFYDFYL----VMPFMQTDLQKIMGLKFSEEKIQYLV-YQ 134
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
+ +GL Y+HSA V HRD+K N+ ++E K+ DFGL+R + T
Sbjct: 135 MLKGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHADAEMT---------- 181
Query: 500 GTMGYLDPEYYR------NFQLTDKS-DVYSFGVVLLELLTSK 535
GY+ +YR ++ +++ D++S G ++ E+LT K
Sbjct: 182 ---GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 56/233 (24%), Positives = 88/233 (37%), Gaps = 52/233 (22%)
Query: 325 IRRATNNFSKD-----NLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVR 378
++ N D ++G G G+V + A+K + EV
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----D-CPKARREVE 106
Query: 379 ILCQV-NHRSLVRLLG----CCVELDQTLMIYEYIPNGTLFDHL----HCDFTGKWPPLP 429
+ + +VR++ L++ E + G LF + FT +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-- 164
Query: 430 WHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL-DEKLNA--KVSDFGLSRLVER 486
I I E + YLHS I HRDVK N+L ++ NA K++DFG ++
Sbjct: 165 -----EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 487 TETNDSHIFTTAQGTMGYLDPE------YYRNFQLTDKS-DVYSFGVVLLELL 532
+ TT T Y+ PE Y DKS D++S GV++ LL
Sbjct: 217 HNS-----LTTPCYTPYYVAPEVLGPEKY-------DKSCDMWSLGVIMYILL 257
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 46/269 (17%)
Query: 302 KQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK 360
+QR++ ++K R + +I + + +LIGTG +G V + + V AIK
Sbjct: 28 QQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK 84
Query: 361 RAKLGNTKGTDL--VLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLH 418
+ D +L E+ IL ++NH +V++L + D Y+ + +
Sbjct: 85 KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV----VLEIAD 140
Query: 419 CDF-----TGKWPPL-PWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472
DF T L H++ + + + G+ Y+HSA + HRD+K +N L+++ +
Sbjct: 141 SDFKKLFRTPV--YLTELHIK-TLLYNLLVGVKYVHSAGI---LHRDLKPANCLVNQDCS 194
Query: 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP------------EY-----YR---- 511
KV DFGL+R V+ E +S + + + L + YR
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254
Query: 512 --NFQLTDKS-DVYSFGVVLLELLTSKKA 537
+ ++ DV+S G + ELL K
Sbjct: 255 ILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 61/210 (29%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLV 389
L+G G FG+V K G A+K + + + E R+L H L
Sbjct: 12 LLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 390 RLLGCCVELDQTL----MIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAEG 443
L QT + EY G LF HL + FT + R A +I
Sbjct: 69 ALKYAF----QTHDRLCFVMEYANGGELFFHLSRERVFTEE------RARFYGA-EIVSA 117
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
L YLHS V +Y RD+K N++LD+ + K++DFGL + +D T GT
Sbjct: 118 LEYLHSRDV--VY-RDIKLENLMLDKDGHIKITDFGLCKE----GISDGATMKTFCGTPE 170
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
YL PE + D + GVV+ E++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 44/223 (19%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLL---- 392
+G GG G VF + D AIK+ L + + L E++I+ +++H ++V++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 393 ----------GCCVELDQTLMIYEY--------IPNGTLFDHLHCDFTGKWPPLPWHLRL 434
G EL+ ++ EY + G L H
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-LEEHARL------------- 124
Query: 435 VIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRLVERTETNDSH 493
+Q+ GL Y+HSA V HRD+K +N+ ++ E L K+ DFGL+R+++ +
Sbjct: 125 -FMYQLLRGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIMD-PHYSHKG 179
Query: 494 IFTTAQGTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSK 535
+ T Y P + K+ D+++ G + E+LT K
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 51/255 (20%), Positives = 99/255 (38%), Gaps = 69/255 (27%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS 387
+ +S +GTG FG V + ++ G A+K+ L + + E+ I+ ++H +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-LQDPRYK---NRELDIMKVLDHVN 61
Query: 388 LVRLLGC---------------------------------------CVELDQTLMIYEYI 408
+++L+ + I EY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV-IMEYV 120
Query: 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD 468
P+ TL L + + I +Q+ + ++HS + HRD+K N+L++
Sbjct: 121 PD-TLHKVLKSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLGI---CHRDIKPQNLLVN 175
Query: 469 EKLNA-KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-------TDKSD 520
K N K+ DFG ++ + +E + ++I + +YR +L T D
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSR-----------FYRAPELMLGATEYTPSID 224
Query: 521 VYSFGVVLLELLTSK 535
++S G V EL+ K
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 52/266 (19%), Positives = 98/266 (36%), Gaps = 56/266 (21%)
Query: 309 NAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN- 366
+ ++G+ F G + +N+ +LIG G +G V+ + AIK K+
Sbjct: 5 HHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRM 62
Query: 367 -TKGTDL--VLNEVRILCQVNHRSLVRLLGCCV-----ELDQTLMIYEY--------IPN 410
D +L E+ IL ++ ++RL + + D+ ++ E
Sbjct: 63 FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT 122
Query: 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK 470
H I + + G ++H + + HRD+K +N LL++
Sbjct: 123 PIFLTEEHIKT--------------ILYNLLLGENFIHESGI---IHRDLKPANCLLNQD 165
Query: 471 LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP-------EY-----YR------N 512
+ KV DFGL+R + + + G + + YR
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225
Query: 513 FQLTDKS-DVYSFGVVLLELLTSKKA 537
+ KS D++S G + ELL ++
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 44/244 (18%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQV-NHRSL 388
+IG G + +V K + A+K + + + + D V E + Q NH L
Sbjct: 16 VIGRGSYAKVLLVRLK---KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 389 VRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
V L C QT + EY+ G L H+ K P H R A +I+ L
Sbjct: 73 VGLHSCF----QTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE--HARFYSA-EISLAL 123
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ--GTM 502
YLH + IY RD+K N+LLD + + K++D+G+ + E D TT+ GT
Sbjct: 124 NYLHERGI--IY-RDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGD----TTSTFCGTP 174
Query: 503 GYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT-----SKKAIDFNREEENVNLVVYMKKI 556
Y+ PE R + S D ++ GV++ E++ N ++ + + + I
Sbjct: 175 NYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--FQVI 231
Query: 557 MDEE 560
++++
Sbjct: 232 LEKQ 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 66/216 (30%), Positives = 93/216 (43%), Gaps = 45/216 (20%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQ-VNHRSL 388
+IG G FG+V K + A+K + + K +++E +L + V H L
Sbjct: 45 VIGKGSFGKVLLARHK---AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 389 VRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAE 442
V L QT + +YI G LF HL + F R A +IA
Sbjct: 102 VGLHFSF----QTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAA-EIAS 150
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV----ERTETNDSHIFTTA 498
L YLHS + +Y RD+K NILLD + + ++DFGL + T T F
Sbjct: 151 ALGYLHSLNI--VY-RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-----FC-- 200
Query: 499 QGTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT 533
GT YL PE Q D++ D + G VL E+L
Sbjct: 201 -GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLY 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 48/246 (19%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQV-NHRSL 388
+IG G + +V K + A++ + + + + D V E + Q NH L
Sbjct: 59 VIGRGSYAKVLLVRLK---KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 389 VRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAE 442
V L C QT + EY+ G L H+ + H R A +I+
Sbjct: 116 VGLHSCF----QTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSA-EISL 164
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ--G 500
L YLH + IY RD+K N+LLD + + K++D+G+ + E D TT+ G
Sbjct: 165 ALNYLHERGI--IY-RDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGD----TTSTFCG 215
Query: 501 TMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT-----SKKAIDFNREEENVNLVVYMK 554
T Y+ PE R + S D ++ GV++ E++ N ++ + + +
Sbjct: 216 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--FQ 272
Query: 555 KIMDEE 560
I++++
Sbjct: 273 VILEKQ 278
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 41/214 (19%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQV-NHRSL 388
++G G FG+V K + G + A+K + + + + E RIL NH L
Sbjct: 30 VLGKGSFGKVMLARVK---ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 389 VRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAE 442
+L C QT + E++ G L H+ F R A +I
Sbjct: 87 TQLFCCF----QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAA-EIIS 135
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ--G 500
L +LH + IY RD+K N+LLD + + K++DFG+ + E TTA G
Sbjct: 136 ALMFLHDKGI--IY-RDLKLDNVLLDHEGHCKLADFGMCK--EGICNGV----TTATFCG 186
Query: 501 TMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLT 533
T Y+ PE + L + D ++ GV+L E+L
Sbjct: 187 TPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLC 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 48/215 (22%), Positives = 84/215 (39%), Gaps = 23/215 (10%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN--TKGTDL--VLNEVRILCQV 383
+ IG+G G V AIK KL T E+ ++ V
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 384 NHRSLVRLLGC-CVELDQTLMIYEYIPNGTLFDHLHCDFTG--KWPPLPWHLRLVIAHQI 440
NH++++ LL + Y+ + + + + + + + +Q+
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYL----VMELMDANLCQVIQMELDHERMS-YLLYQM 173
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
G+ +LHSA + HRD+K SNI++ K+ DFGL+R S + T
Sbjct: 174 LCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAG-----TSFMMTPYVV 225
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK 535
T Y PE + D++S G ++ E++ K
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 37/175 (21%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 323 KEIRRATNNFSKDNL-IGTGGFGEVFKGILDD---GTVTAIKRAKLGNTKGTDLVLNEVR 378
E R + F + +G G +G V+K D A+K+ + + E+
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS--ACREIA 70
Query: 379 ILCQVNHRSLVRLLGCCVE--LDQTLMIYEYIPN--GTLFDHLHCDFTGKWPPLPWHLRL 434
+L ++ H +++ L + + ++++Y + + H P+ +
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKF-HRASKANKKPVQLPRGM 129
Query: 435 V--IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA----KVSDFGLSRL 483
V + +QI +G+ YLH+ + HRD+K +NIL+ + K++D G +RL
Sbjct: 130 VKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 48/224 (21%), Positives = 89/224 (39%), Gaps = 59/224 (26%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGN--TKGTDL--VLNEVRILCQVNHRSLVRLL 392
+G+G +G V + G AIK KL E+R+L + H +++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 393 ------GCCVELDQTLMIYEY--------IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH 438
+ ++ + + + L F + +
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL-GEDRIQF--------------LVY 135
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q+ +GL Y+H+A + HRD+K N+ ++E K+ DFGL+R + T
Sbjct: 136 QMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--------- 183
Query: 499 QGTMGYLDPEYYR------NFQLTDKS-DVYSFGVVLLELLTSK 535
GY+ +YR N+ ++ D++S G ++ E++T K
Sbjct: 184 ----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 53/230 (23%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNH 385
+ + +G+G +G V G A+K+ E+R+L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 386 RSLVRLL------GCCVELDQTLMIYEY-------IPNGTLFDHLHCDFTGKWPPLPWHL 432
+++ LL E + ++ I H F
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------- 136
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492
+ +QI GL Y+HSA + HRD+K SN+ ++E K+ DFGL+R T
Sbjct: 137 ---LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--- 187
Query: 493 HIFTTAQGTMGYLDPEYYR------NFQLTDKS-DVYSFGVVLLELLTSK 535
GY+ +YR N+ +++ D++S G ++ ELLT +
Sbjct: 188 ----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 5e-15
Identities = 64/256 (25%), Positives = 110/256 (42%), Gaps = 28/256 (10%)
Query: 289 NEHMKKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRAT-NNFSKDNLIGTGGFGEVF 347
NE ++++ ++ I Q + K A ++ R +F+ ++G G FG+V
Sbjct: 299 NEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVM 358
Query: 348 ----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELD 399
K + A+K + + + + E R+L L +L C +D
Sbjct: 359 LSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRD 459
+ + EY+ G L H+ G++ H A +IA GL +L S + IY RD
Sbjct: 416 RLYFVMEYVNGGDLMYHIQ--QVGRFKEP--HAVFYAA-EIAIGLFFLQSKGI--IY-RD 467
Query: 460 VKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ--GTMGYLDPEYYRNFQLTD 517
+K N++LD + + K++DFG+ + E TT GT Y+ PE
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCK--ENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 518 KSDVYSFGVVLLELLT 533
D ++FGV+L E+L
Sbjct: 522 SVDWWAFGVLLYEMLA 537
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 39/213 (18%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQV-NHRSL 388
++G G FG+V K + A+K + + + + E R+L L
Sbjct: 27 VLGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 389 VRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAE 442
+L C QT+ + EY+ G L H+ F H A +IA
Sbjct: 84 TQLHSCF----QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAA-EIAI 132
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR--LVERTETNDSHIFTTAQG 500
GL +L S + IY RD+K N++LD + + K++DFG+ + + + T T G
Sbjct: 133 GLFFLQSKGI--IY-RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK------TFCG 183
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
T Y+ PE D ++FGV+L E+L
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 43/215 (20%)
Query: 337 LIGTGGFGEVF----KGILDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQV-NHRSL 388
++G G FG+VF K AIK + + + + E R+L H L
Sbjct: 24 MLGKGSFGKVFLAEFK---KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 389 VRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAE 442
+ QT + EY+ G L H+ F A +I
Sbjct: 81 THMFCTF----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAA-EIIL 129
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV----ERTETNDSHIFTTA 498
GL +LHS + +Y RD+K NILLD+ + K++DFG+ + +T T F
Sbjct: 130 GLQFLHSKGI--VY-RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-----FC-- 179
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
GT Y+ PE + D +SFGV+L E+L
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 34/125 (27%), Positives = 54/125 (43%), Gaps = 15/125 (12%)
Query: 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473
+ L + + Q+A+G+ +L S HRD+ + NILL EK
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVV 232
Query: 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD-----PEYYRNFQLTDKSDVYSFGVVL 528
K+ DFGL+R + + + L PE + T +SDV+SFGV+L
Sbjct: 233 KICDFGLARDIYKDPDY-------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285
Query: 529 LELLT 533
E+ +
Sbjct: 286 WEIFS 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 52/231 (22%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGN--TKGTDL--VLNEVRILCQVN-HRSLVRL 391
+G G +G V+K I G V A+K K+ + TD E+ IL +++ H ++V L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 392 LGCCV-ELDQTL-MIYEY-------IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
L + D+ + ++++Y + + + +H + + +Q+ +
Sbjct: 75 LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY--------------VVYQLIK 120
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
+ YLHS + HRD+K SNILL+ + + KV+DFGLSR ++I +
Sbjct: 121 VIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 503 GYLDPE-----------YYR------NFQLTDKS-DVYSFGVVLLELLTSK 535
D + +YR K D++S G +L E+L K
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 4e-12
Identities = 34/202 (16%), Positives = 57/202 (28%), Gaps = 56/202 (27%)
Query: 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDL--------VLNEVRI 379
T + IG G FGEVF+ I D V AIK + + +L E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 380 LCQV---------NHRSLVRLLGCCV------------------------------ELDQ 400
++ + L + DQ
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDV 460
++ E+ G + + I HQ+ L ++ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL------SSLATAKSILHQLTASLAVAEAS--LRFEHRDL 188
Query: 461 KSSNILLDEKLNAKVSDFGLSR 482
N+LL + K+ +
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGK 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 33/242 (13%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV-RLLGCC 395
IG+G FGE++ G + AIK + TK L L E +I + + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQL-LYESKIYRILQGGTGIPNVRWFG 72
Query: 396 VELDQTLMIYEYI-PN-GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
VE D +++ + + P+ LF+ + K L++A Q+ + ++HS +
Sbjct: 73 VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK-------TVLMLADQMINRVEFVHSKS-- 123
Query: 454 PIYHRDVKSSNILLDEKLNAK---VSDFGLSRLVERTETNDSHI-------FTTAQGTMG 503
HRD+K N L+ A + DFGL++ T T+ HI T GT
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-QHIPYRENKNLT---GTAR 178
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK---KAIDFNREEENVNLVVYMKKIMDEE 560
Y + + + + D+ S G VL+ L + + +++ + K E
Sbjct: 179 YASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238
Query: 561 RL 562
L
Sbjct: 239 AL 240
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 30/209 (14%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV-RLLGCC 395
IG+G FG+++ G + G AIK + TK L E +I + + + C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHPQL-HIESKIYKMMQGGVGIPTIRWCG 74
Query: 396 VELDQTLMIYEYI-PN-GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
E D +M+ E + P+ LF+ F+ K L++A Q+ + Y+HS
Sbjct: 75 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLK-------TVLLLADQMISRIEYIHSKN-- 125
Query: 454 PIYHRDVKSSNILLDEKLNAK---VSDFGLSRLVERTETNDSHI-------FTTAQGTMG 503
HRDVK N L+ + DFGL++ R HI T GT
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY-RDARTHQHIPYRENKNLT---GTAR 180
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELL 532
Y + + + + D+ S G VL+
Sbjct: 181 YASINTHLGIEQSRRDDLESLGYVLMYFN 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 37/180 (20%), Positives = 63/180 (35%), Gaps = 33/180 (18%)
Query: 325 IRRATNNFSKD-----NLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVR 378
++ N D ++G G G+V + A+K + EV
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVE 62
Query: 379 ILCQV-NHRSLVRLLGCC----VELDQTLMIYEYIPNGTLFDHL----HCDFTGKWPPLP 429
+ + +VR++ L++ E + G LF + FT +
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER----- 117
Query: 430 WHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLVER 486
++ I E + YLHS I HRDVK N+L K++DFG ++
Sbjct: 118 -EASEIM-KSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 44/252 (17%), Positives = 88/252 (34%), Gaps = 52/252 (20%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLG-- 393
+G G F V+ + + T A+K + G+ T+ +E+++L +VN +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 394 --CCVELDQTLMIYEYIPNGTLFDHLHC-----------DFTGKWPPLPWHLRLV--IAH 438
++L G H+ K+ L V I+
Sbjct: 85 ANHILKLLDHFNHK-----GPNGVHV-VMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDE------KLNAKVSDFGLSRLVERTETNDS 492
Q+ GL Y+H I H D+K N+L++ + K++D G + + TN
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN-- 194
Query: 493 HIFTTAQGTMGYLDPEYYR------NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN 546
+ YR +D++S ++ EL+T + +
Sbjct: 195 -----------SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243
Query: 547 VNLVVYMKKIMD 558
++ +I++
Sbjct: 244 TKDDDHIAQIIE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 44/244 (18%), Positives = 87/244 (35%), Gaps = 35/244 (14%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV-RLLGCC 395
IG G FG +F+G L + AIK + L +E R + + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLR-DEYRTYKLLAGCTGIPNVYYFG 75
Query: 396 VELDQTLMIYEYI-PN-GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVP 453
E +++ + + P+ L D F+ K + A Q+ + +H +
Sbjct: 76 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVK-------TVAMAAKQMLARVQSIHEKS-- 126
Query: 454 PIYHRDVKSSNILLDEKLNAK-----VSDFGLSRLVERTETNDSHI-------FTTAQGT 501
+ +RD+K N L+ + V DFG+ + R HI + GT
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLS---GT 181
Query: 502 MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK---KAIDFNREEENVNLVVYMKKIMD 558
Y+ + + + + D+ + G V + L + + ++ + K+
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241
Query: 559 EERL 562
L
Sbjct: 242 LREL 245
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 56/216 (25%), Positives = 82/216 (37%), Gaps = 44/216 (20%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR------SLV 389
+IG G FG+V K A+K + + E+RIL + + +++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 390 RLLG--------CCV-E-LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQ 439
+L C E L L YE I K+ L AH
Sbjct: 163 HMLENFTFRNHICMTFELLSMNL--YELIKKN------------KFQGFSLPLVRKFAHS 208
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA--KVSDFGLSRLVERTETNDSHIFTT 497
I + L LH I H D+K NILL ++ + KV DFG S + ++T
Sbjct: 209 ILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ------RVYTY 259
Query: 498 AQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT 533
Q + Y PE + D++S G +L ELLT
Sbjct: 260 IQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 45/174 (25%), Positives = 66/174 (37%), Gaps = 22/174 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL 388
NF IG G FGE+ G L AIK + ++ L L E R Q+
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHL-EYRFYKQLGSGDG 66
Query: 389 V-RLLGCCVELDQTLMIYEYI-PN-GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+ ++ M+ E + P+ LFD F+ K L+IA Q+ +
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLK-------TVLMIAIQLISRME 119
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVS-----DFGLSRLVERTETNDSHI 494
Y+HS + +RDVK N L+ N DF L++ HI
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY-IDPETKKHI 169
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 57/225 (25%), Positives = 84/225 (37%), Gaps = 58/225 (25%)
Query: 336 NLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR------SL 388
+LIG G FG+V K + AIK K + EVR+L +N +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 389 VRLLG--------CCV-E-LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV--I 436
V L C V E L L Y+ + N +F G L L
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNL--YDLLRN--------TNFRG------VSLNLTRKF 162
Query: 437 AHQIAEGLTYLHSAAVPPIYHRDVKSSNILL--DEKLNAKVSDFGLSRLVERTETNDSHI 494
A Q+ L +L + + I H D+K NILL ++ K+ DFG S + I
Sbjct: 163 AQQMCTALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDFGSSCQL------GQRI 215
Query: 495 FTTAQGTMGYLDPEYYR------NFQLTDKSDVYSFGVVLLELLT 533
+ Y+ +YR D++S G +L+E+ T
Sbjct: 216 YQ-------YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 58/265 (21%), Positives = 85/265 (32%), Gaps = 86/265 (32%)
Query: 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH-------RSLV 389
+G G F V+ + A+K K T+ L+E+R+L V + R +V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 390 RLLGCCVELDQTLMIYEYI-PNGT----LFDHLHC---DFTGKWPPLPWHLRLV--IAHQ 439
L LD ++ NGT +F+ L + K L V I Q
Sbjct: 104 VQL-----LDD----FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILL-------------------------------- 467
+ +GL YLH+ I H D+K NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 468 -----------------DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY 510
EKL K++D G + V + T D T Y E
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-------TRQYRSLEVL 265
Query: 511 RNFQLTDKSDVYSFGVVLLELLTSK 535
+D++S + EL T
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGD 290
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 32/169 (18%), Positives = 60/169 (35%), Gaps = 34/169 (20%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV------ 389
IG+GGFG ++ + A K+ + L +E++ +V + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL-FSELKFYQRVAKKDCIKKWIER 102
Query: 390 ---------RLLGC----CVELDQTLMIYEYI-PNGTLFDHLHCDFTGKWPPLPWHLRLV 435
G M+ E + + L + G L
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQKISGQN--GT---FKKSTVLQ 155
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV--SDFGLSR 482
+ ++ + L Y+H H D+K++N+LL K +V +D+GLS
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 31/172 (18%), Positives = 61/172 (35%), Gaps = 37/172 (21%)
Query: 337 LIGTGGFGEVFKGILDDGTVTAIKR---AKLGNTKGTDLVLNEVRILCQVNHRSLV---- 389
IG GGFG ++ ++ K+ + L E++ + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL-FTELKFYQRAAKPEQIQKWI 100
Query: 390 -----------RLLGCCVELDQTL----MIYEYI-PN-GTLFDHLHCDFTGKWPPLPWHL 432
+ G + MI + + +++ F+ K
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRK-------T 153
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV--SDFGLSR 482
L ++ +I + L Y+H H D+K+SN+LL+ K +V D+GL+
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 3e-06
Identities = 64/449 (14%), Positives = 128/449 (28%), Gaps = 160/449 (35%)
Query: 208 CKDLLHSNCLADPMYPGLKRCL-CNPGFIWDPVNGLCQSSKYRHGKGCKRKKKKTMLIAG 266
KD+L C + D + + H K T+ +
Sbjct: 18 YKDILSVF------EDAFVDNFDCK--DVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69
Query: 267 MVAALGGSLLVVLIGILV---YNKLNEHMKKETK------KLLIKQREEMLNAKAAGKSA 317
+ + ++ + ++ Y L +K E + ++ I+QR+ + N
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN------DN 123
Query: 318 RIFTG---------KEIRRATNNFSKDNLI---GTGGFGEVFKGILDDGTVTAIKRAKLG 365
++F ++R+A + G G G K T A+
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K------TWVALD----- 169
Query: 366 NTKGTDLVLNEVRILCQVNHR----SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDF 421
V ++ C+++ + +L C + L + + L + ++
Sbjct: 170 -------VCLSYKVQCKMDFKIFWLNL----KNCNSPETVLEMLQ-----KLLYQIDPNW 213
Query: 422 TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481
T + +++L I H I L L + + ++ ++L V +
Sbjct: 214 TSR-SDHSSNIKLRI-HSIQAELRRL-------LKSKPYENCLLVLLN-----VQN---- 255
Query: 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541
+ + F L+ K LLT+
Sbjct: 256 -------------------------AKAWNAFNLSCKI-----------LLTT------- 272
Query: 542 REEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETM-------KALGLLAASCLD 594
R +V D + TH+ L+ + LL LD
Sbjct: 273 -------------------RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL-LKYLD 312
Query: 595 ERRQNRPSMKEVADEIEYIISIAKGRISE 623
R Q+ P +EV +SI I +
Sbjct: 313 CRPQDLP--REVLTTNPRRLSIIAESIRD 339
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 45/238 (18%), Positives = 78/238 (32%), Gaps = 70/238 (29%)
Query: 337 LIGTGGFGEVFKGI--LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR------SL 388
+G G FG+V + + + A+K + K + E+ +L ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR-NVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 389 VRLLGC-------CVELDQTLMIYE-YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQI 440
V + C + +E N F+ L + P P +A+Q+
Sbjct: 85 VLMSDWFNFHGHMC-------IAFELLGKN--TFEFLKE---NNFQPYPLPHVRHMAYQL 132
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA-------------------KVSDFGLS 481
L +LH + H D+K NIL +V+DFG +
Sbjct: 133 CHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYR------NFQLTDKSDVYSFGVVLLELLT 533
T ++ H TT + +YR DV+S G +L E
Sbjct: 190 -----TFDHEHH--TT------IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 23/190 (12%), Positives = 60/190 (31%), Gaps = 38/190 (20%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI---------LDDGTVTAIK----------RAKLGNTKGT 370
+ + G +++ ++K
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 371 DLVLNEVRILCQVNHRSLVRLLGCCVELDQ-TLMIYEYI-PN-GTLFDHLH-CDFTGKWP 426
L +N+ + L ++ +G V D+ ++ + + + D + +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSER-- 159
Query: 427 PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV--SDFGLSRLV 484
L +A ++ + L +LH H +V + NI +D + ++V + +G +
Sbjct: 160 -----SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF-- 209
Query: 485 ERTETNDSHI 494
R + H+
Sbjct: 210 -RYCPSGKHV 218
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 54/232 (23%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR-----SLVR 390
+G G FG V +D+ A+K + K T E IL ++ + ++V+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 391 LLGC-------CVELDQTLMIYE-YIPNGTLFDHL-HCDFTGKWPPLPWHLRLV--IAHQ 439
G C +I+E P+ L++ + ++ +H+ + +
Sbjct: 101 YHGKFMYYDHMC-------LIFEPLGPS--LYEIITRNNY------NGFHIEDIKLYCIE 145
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDE----KLNAKVSDFGLSRLVERTETNDSHI- 494
I + L YL + + H D+K NILLD+ K V + ++ T + I
Sbjct: 146 ILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 495 ---FTTA----QGTMGYLDPEYYR------NFQLTDKSDVYSFGVVLLELLT 533
F A ++ YR N SD++SFG VL EL T
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 48/243 (19%), Positives = 87/243 (35%), Gaps = 80/243 (32%)
Query: 337 LIGTGGFGEVFKGI--LDDGTVTAIK--RAKLGNTKGTDLVLNEVRILCQVNHR------ 386
+G G FG+V + I G A+K + + + +E+++L +N
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 387 SLVRLLGC-------CVELDQTLMIYE-YIPNGTLFDHL-HCDFTGKWPPLPWHLRLV-- 435
V++L C +++E + +D + F LP+ L +
Sbjct: 78 RCVQMLEWFEHHGHIC-------IVFELLGLS--TYDFIKENGF------LPFRLDHIRK 122
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA-------------------KVS 476
+A+QI + + +LHS + H D+K NIL + KV
Sbjct: 123 MAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR------NFQLTDKSDVYSFGVVLLE 530
DFG + T ++ H + +YR + DV+S G +L+E
Sbjct: 180 DFGSA-----TYDDEHHST--------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
Query: 531 LLT 533
Sbjct: 227 YYL 229
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 624 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.49 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.19 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.05 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.01 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.87 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.75 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.56 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.46 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.16 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.37 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.54 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=451.24 Aligned_cols=264 Identities=27% Similarity=0.395 Sum_probs=209.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|.+.+.||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777889999999999999864 478899999987766677889999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 404 IYEYIPNGTLFDHLHCDFT----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
||||+++|+|.++++.... ....+++|.++++|+.|||+||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999974321 12357999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 552 (624)
||+|||+|+...... .....+...||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +
T Consensus 198 Ki~DFGla~~~~~~~--~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~--- 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTD--YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---A--- 269 (329)
T ss_dssp EECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---H---
T ss_pred EEcccccceeccCCC--cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---H---
Confidence 999999998764321 1222345679999999999999999999999999999999999 899987543221 1
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
+.......+. ..+..++.++.+|+.+||+.||++||||+||++.|+.+.+.+
T Consensus 270 ~~~i~~g~~~-------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 270 IDCITQGREL-------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHHHTCCC-------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHcCCCC-------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 1111111110 111233456888999999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-56 Score=448.28 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=214.2
Q ss_pred CCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|.+.+.||+|+||+||+|++. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999999999999863 477899999987766677889999999999999999999999999999999
Q ss_pred EEeeccCCCccccccccc--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEE
Q 039681 404 IYEYIPNGTLFDHLHCDF--------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl 475 (624)
||||+++|+|.++|+... ......++|.++++|+.|||+||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997431 123457999999999999999999999999 999999999999999999999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 554 (624)
+|||+|+...... .........||+.|||||++.+..++.++|||||||+||||+| |+.||......+ + +.
T Consensus 170 ~DFGla~~~~~~~--~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~---~~ 241 (299)
T 4asz_A 170 GDFGMSRDVYSTD--YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V---IE 241 (299)
T ss_dssp CCCSCHHHHTGGG--CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H---HH
T ss_pred CCcccceecCCCC--ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HH
Confidence 9999998764321 1111223468999999999999999999999999999999999 899997543221 1 11
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
. +..+... ..+..++.++.+|+.+||+.||++||||+||.+.|+++.+.
T Consensus 242 ~-i~~~~~~------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 C-ITQGRVL------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp H-HHHTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-HHcCCCC------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1 1111111 11123445688899999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-55 Score=440.86 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=209.4
Q ss_pred CCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++++.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566788999999999999863 467899999875433 345789999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC
Q 039681 404 IYEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN 472 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~ 472 (624)
||||+++|+|.++|+.... .....++|.++++|+.|||+||+|||+++ ||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999964311 11346999999999999999999999999 999999999999999999
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVV 551 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 551 (624)
+||+|||+|+...... .....+...||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +
T Consensus 184 ~Ki~DFGlar~~~~~~--~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~-- 256 (308)
T 4gt4_A 184 VKISDLGLFREVYAAD--YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V-- 256 (308)
T ss_dssp EEECCSCCBCGGGGGG--CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H--
T ss_pred EEECCcccceeccCCC--ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H--
Confidence 9999999998765322 1222345679999999999999999999999999999999998 889987543221 1
Q ss_pred HHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 552 YMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 552 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
+. .+..+... ..+..++.++.+|+.+||+.||++||||.||++.|+.+
T Consensus 257 -~~-~i~~~~~~------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 -VE-MIRNRQVL------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HH-HHHTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HH-HHHcCCCC------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 12121111 11123456788899999999999999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=435.27 Aligned_cols=262 Identities=29% Similarity=0.479 Sum_probs=205.0
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
..+++.+.+.||+|+||+||+|++++ .||||+++... ....+.|.+|+++|++++|||||+++|++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34678889999999999999998653 58999987543 3445789999999999999999999998864 5789999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.++|+. ....++|.++++|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+...
T Consensus 111 Ey~~gGsL~~~l~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 111 QWCEGSSLYKHLHV----QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp ECCSSCBHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EcCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 99999999999963 2356999999999999999999999998 9999999999999999999999999998765
Q ss_pred ccCCCCcceeecccccccccCcccccc---cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRN---FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
... .........||+.|||||++.+ ..++.++|||||||+||||+||+.||......+ .+......+
T Consensus 184 ~~~--~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~-- 253 (307)
T 3omv_A 184 RWS--GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRG-- 253 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTT--
T ss_pred cCC--cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcC--
Confidence 321 2223456789999999999863 358999999999999999999999997433211 111111111
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
...|.+.. ....++..+.+|+.+||+.||++||||.||++.|+.|++
T Consensus 254 --~~~p~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 254 --YASPDLSK----LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp --CCCCCSTT----SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred --CCCCCccc----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111111 112344678889999999999999999999999998864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=435.44 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=203.0
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999996 469999999986543 3446779999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|.++|... +...+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999643 3456899999999999999999999999 99999999999999999999999999987642
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
. ....+..+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+....... ..
T Consensus 178 ~----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~-~~--- 243 (350)
T 4b9d_A 178 T----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIISGS-FP--- 243 (350)
T ss_dssp H----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTC-CC---
T ss_pred C----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcCC-CC---
Confidence 1 12234567999999999999999999999999999999999999999754322 1122222111 10
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
........++.+|+.+||+.||++|||++|+++
T Consensus 244 ---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 ---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223456788999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=428.10 Aligned_cols=274 Identities=21% Similarity=0.316 Sum_probs=204.0
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC----ceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD----QTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 405 (624)
++|.+.+.||+|+||+||+|++ +|+.||||++.... .....+..|+..+.+++|||||+++|++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577789999999999999998 58899999986432 11222345666667889999999999998764 579999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA-----VPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
||+++|+|.++|+. ..++|..+++|+.|+++||+|||++. .++||||||||+|||||+++++||+|||+
T Consensus 81 Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999963 35999999999999999999999872 23499999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCccccccc------CCCCccchhhHHHHHHHHHhCCCCCCCCCcccc--------
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF------QLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN-------- 546 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~-------- 546 (624)
|+.................||+.|||||++.+. .++.++|||||||+||||+||+.|+......+.
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 987654322212223356799999999998653 477899999999999999999887754322110
Q ss_pred ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
......+......+ .++|.+.... .+.+....+.+|+.+||+.||++||||.||++.|++|.+.+
T Consensus 235 ~~~~~~~~~~~~~~----~~rp~~p~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQ----KLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGG--GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cchHHHHHHHHhcc----cCCCCCCccc--cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 00111112211111 1222222111 12356678899999999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=427.46 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=208.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999964 69999999997766666778999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 154 ~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 223 (346)
T 4fih_A 154 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 223 (346)
T ss_dssp TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred CCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC-
Confidence 99999999863 35999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||......+ . +.... ... .+
T Consensus 224 ---~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~---~~~i~-~~~-----~~ 288 (346)
T 4fih_A 224 ---VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A---MKMIR-DNL-----PP 288 (346)
T ss_dssp ---SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHH-HSS-----CC
T ss_pred ---CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H---HHHHH-cCC-----CC
Confidence 222456789999999999999899999999999999999999999997543221 1 11111 110 11
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+. .......++.+|+.+||+.||++|||++|+++
T Consensus 289 ~~~-----~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLK-----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCS-----CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 110 01123456788999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=432.02 Aligned_cols=275 Identities=24% Similarity=0.345 Sum_probs=218.8
Q ss_pred CHHHHHHHhCCCCccceeccCCcEEEEEEEEcC------CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCC-CceeeEe
Q 039681 321 TGKEIRRATNNFSKDNLIGTGGFGEVFKGILDD------GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNH-RSLVRLL 392 (624)
Q Consensus 321 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~ 392 (624)
...+++...++|++.+.||+|+||+||+|++.+ ++.||||+++.... ...+.|.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344566667889999999999999999998643 36899999875443 345679999999999975 8999999
Q ss_pred eEEEeC-CceeEEEeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 039681 393 GCCVEL-DQTLMIYEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDV 460 (624)
Q Consensus 393 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Di 460 (624)
|+|.+. +..++||||+++|+|.++|+.... .....++|.+++.|+.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 568999999999999999974321 12356999999999999999999999999 999999
Q ss_pred CCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCC
Q 039681 461 KSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAID 539 (624)
Q Consensus 461 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~ 539 (624)
||+|||+++++.+||+|||+|+.+.... .........||+.|||||++.+..++.++|||||||+||||+| |+.||.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~--~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDP--DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CccceeeCCCCCEEECcchhhhhcccCC--CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998765321 1222345678999999999999999999999999999999998 899997
Q ss_pred CCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 540 FNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.....+ .+...+..+.... .+...+.++.+++.+||+.||++|||+.||++.|+++++...
T Consensus 290 ~~~~~~------~~~~~i~~g~~~~------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 290 GVKIDE------EFCRRLKEGTRMR------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp TCCCSH------HHHHHHHHTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCCHHH------HHHHHHHcCCCCC------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 543221 1112222221111 111234567889999999999999999999999999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=421.92 Aligned_cols=258 Identities=21% Similarity=0.239 Sum_probs=207.1
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+.|...+.||+|+||+||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577788899999999999996 4689999999875322 257999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeecCCccccccc
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSRLVERT 487 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~ 487 (624)
++|+|.++|+. ...+++.++..|+.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+...
T Consensus 133 ~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 133 EGGSLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp TTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999973 246999999999999999999999999 99999999999999987 6999999999877543
Q ss_pred CCCCcc-eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSH-IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
...... .....+||+.|||||++.+..++.++|||||||+||||++|+.||......+. ...+ .....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i---~~~~~----- 273 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKI---ASEPP----- 273 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHH---HHSCC-----
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHH---HcCCC-----
Confidence 221111 12345799999999999999999999999999999999999999975443221 1111 11110
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
.+. ..+......+.+|+.+||+.||++|||+.|+++.|...++..
T Consensus 274 --~~~----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 274 --PIR----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp --GGG----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --Cch----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 000 011233456788999999999999999999999998887643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=421.27 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=206.7
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||+||+++. .+++.||||++... .....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999996 56899999998643 2334567999999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++.++..|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+.
T Consensus 112 Ey~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999973 346999999999999999999999999 9999999999999999999999999999775
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
... ........+||+.|||||++.+..++.++||||+||+||||++|+.||......+ .+.+..... .
T Consensus 184 ~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~-~--- 251 (311)
T 4aw0_A 184 PES--KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IFAKIIKLE-Y--- 251 (311)
T ss_dssp TTT--TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-C---
T ss_pred CCC--CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-C---
Confidence 321 1223456789999999999999899999999999999999999999997543221 122221111 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
.+ +.....++.+|+.+||+.||++|||++|++
T Consensus 252 ---~~-------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ---DF-------PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CC-------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CC-------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 01 112234578899999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=412.21 Aligned_cols=246 Identities=23% Similarity=0.384 Sum_probs=196.6
Q ss_pred CccceeccCCcEEEEEEEEc-CCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEe----CCceeEEE
Q 039681 333 SKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE----LDQTLMIY 405 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 405 (624)
.+.+.||+|+||+||+|+.. ++..||+|++... .....+.|.+|+++|++++|||||++++++.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999964 6889999998643 23345679999999999999999999999875 34579999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfGla~~~ 484 (624)
||+++|+|.++++. ...+++..+..|+.||+.||+|||+++ ++||||||||+||||++ ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999973 356999999999999999999999986 45999999999999984 899999999999864
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.. ......+||+.|||||++.+ .++.++|||||||+||||+||+.||...... .... ..+..+...
T Consensus 183 ~~------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~-~~i~~~~~~- 248 (290)
T 3fpq_A 183 RA------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIY-RRVTSGVKP- 248 (290)
T ss_dssp CT------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHH-HHHTTTCCC-
T ss_pred CC------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHH-HHHHcCCCC-
Confidence 32 12346789999999999865 6999999999999999999999999643221 1111 112111111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+. .....++.+|+.+||+.||++|||++|+++
T Consensus 249 ---~~~~-------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ---ASFD-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGG-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCC-------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 112235778999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=428.43 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=209.1
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+.|+..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5688999999999999999996 469999999998776667788999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.++++. ..+++.++..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 231 ~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~- 300 (423)
T 4fie_A 231 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE- 300 (423)
T ss_dssp TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS-
T ss_pred CCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC-
Confidence 99999999863 35999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ . +.. +.... .+
T Consensus 301 ---~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~---~~~-i~~~~-----~~ 365 (423)
T 4fie_A 301 ---VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A---MKM-IRDNL-----PP 365 (423)
T ss_dssp ---CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHH-HHHSC-----CC
T ss_pred ---CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H---HHH-HHcCC-----CC
Confidence 122356789999999999999999999999999999999999999997543221 1 111 11111 11
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.. ......++.+|+.+||+.||++|||+.|+++
T Consensus 366 ~~~~-----~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 RLKN-----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCSC-----TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1100 0123356788999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=405.67 Aligned_cols=245 Identities=27% Similarity=0.360 Sum_probs=190.3
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999995 579999999986432 233567999999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 7899999863 356999999999999999999999999 9999999999999999999999999998754
Q ss_pred ccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.. .......||+.|||||++.+..+ +.++||||+||++|||++|+.||...... ........ ...
T Consensus 164 ~~-----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i~~-~~~-- 229 (275)
T 3hyh_A 164 DG-----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNISN-GVY-- 229 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-TCC--
T ss_pred CC-----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc-CCC--
Confidence 22 22345689999999999988776 57999999999999999999999753321 11121111 110
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+.....++.+|+.+||+.||++|||++|+++
T Consensus 230 -----------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -----------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001122345778999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=413.47 Aligned_cols=247 Identities=27% Similarity=0.320 Sum_probs=196.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc----CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+.+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 47899999986432 2234568899999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999973 346999999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ........||+.|||||++.+..++.++|||||||+||||++|+.||......+ .+....... .
T Consensus 176 ~~~~----~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~-~- 243 (304)
T 3ubd_A 176 SIDH----EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILKAK-L- 243 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-C-
T ss_pred ccCC----CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHcCC-C-
Confidence 5322 122345689999999999999999999999999999999999999997543321 111111111 0
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
..+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 244 ------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 001123346788999999999999998 456653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=400.59 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=188.4
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc-------
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ------- 400 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 400 (624)
++|++.+.||+|+||+||+|+. .+|+.||||+++..+. ...+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588899999999999999996 4689999999875543 345679999999999999999999999986543
Q ss_pred -----eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEE
Q 039681 401 -----TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475 (624)
Q Consensus 401 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl 475 (624)
.++||||+++|+|.+++... ......++..++.|+.||++||+|||+++ |+||||||+||||+.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 68999999999999999743 12234677889999999999999999999 999999999999999999999
Q ss_pred eecCCcccccccCCCCc--------ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccc
Q 039681 476 SDFGLSRLVERTETNDS--------HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV 547 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~ 547 (624)
+|||+|+.+........ ...+..+||+.|||||++.+..++.++|||||||+||||++ ||.... +
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~-- 232 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E-- 232 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H--
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H--
Confidence 99999987754322111 12245679999999999999999999999999999999996 664211 1
Q ss_pred cHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 548 NLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....+.. ...... .+. .......+.+|+.+||+.||++|||+.|+++
T Consensus 233 -~~~~~~~-~~~~~~----p~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 -RVRTLTD-VRNLKF----PPL--------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHH-HHTTCC----CHH--------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHH-HhcCCC----CCC--------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 111110 111 1123344667999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=406.88 Aligned_cols=270 Identities=20% Similarity=0.293 Sum_probs=203.0
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEe------CCc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE------LDQ 400 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 400 (624)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999996 579999999986543 2345678999999999999999999999764 357
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.+|||||++ |+|.+++. +...+++.++..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~-----~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH-----SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp EEEEEECCS-EEHHHHHT-----SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCC-CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 899999995 78999986 3357999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
|+.+..............+||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+....+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 987654333333344567899999999998775 4689999999999999999999999865543322222111111111
Q ss_pred cccccccchhhh---hcc---CcCc-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ERLMEVVDPVLK---ERA---THLD-----LETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~---~~~---~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
............ ... ...+ .....++.+|+.+||+.||++|||++|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111000000000 000 0000 012356788999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=390.96 Aligned_cols=292 Identities=39% Similarity=0.647 Sum_probs=248.7
Q ss_pred cCHHHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC
Q 039681 320 FTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD 399 (624)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 399 (624)
+...++...+++|+..+.||+|+||.||+|+..+++.||||+.........+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44455666788999999999999999999998889999999988766667788999999999999999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+++|+|.+++.... .....+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999996432 12346999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
+++...... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+.......
T Consensus 185 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 185 ISKKGTELD--QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp TCEECSSSS--CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred ccccccccc--ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 998654221 112223456899999999998889999999999999999999999999877766666777776666666
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
+.+...+++.+.. .........+.+++.+||+.||++|||+.||++.|+.+++..+..
T Consensus 263 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~~ 320 (321)
T 2qkw_B 263 GQLEQIVDPNLAD---KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320 (321)
T ss_dssp TCCCSSSSSSCTT---CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCCC
T ss_pred ccHHHhcChhhcc---ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccCc
Confidence 6666666665543 234577888999999999999999999999999999999876654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=387.80 Aligned_cols=203 Identities=23% Similarity=0.351 Sum_probs=171.5
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc----CCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCce
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 401 (624)
...++|++.+.||+|+||+||+|+.+ .++.||||++... .....+.+|+++|+.+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999853 4678999987643 3345688999999998 699999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC-CCeEEeecCC
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDFGL 480 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~-~~~kl~DfGl 480 (624)
++||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 96 ~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 99999999999999884 4899999999999999999999999 9999999999999876 7999999999
Q ss_pred cccccccCCC------------------------CcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCC
Q 039681 481 SRLVERTETN------------------------DSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSK 535 (624)
Q Consensus 481 a~~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~ 535 (624)
|+........ .....+..+||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9865432110 01123456799999999999775 4899999999999999999999
Q ss_pred CCCCCCC
Q 039681 536 KAIDFNR 542 (624)
Q Consensus 536 ~p~~~~~ 542 (624)
.||....
T Consensus 245 ~Pf~~~~ 251 (361)
T 4f9c_A 245 YPFYKAS 251 (361)
T ss_dssp SSSSCCS
T ss_pred CCCCCCC
Confidence 9996543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=380.43 Aligned_cols=290 Identities=39% Similarity=0.672 Sum_probs=241.4
Q ss_pred CccccCHHHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeE
Q 039681 316 SARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGC 394 (624)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~ 394 (624)
..+.++..++....++|+..+.||+|+||.||+|...+++.||||++...... ....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 45678999999999999999999999999999999888999999998754332 23468999999999999999999999
Q ss_pred EEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 395 CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 395 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
+.+....++||||+++|+|.+++.... .....+++..++.|+.|++.||+|||+...+.|+||||||+|||+++++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 999999999999999999999997532 2345699999999999999999999999222299999999999999999999
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCC--ccccccHHHH
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNR--EEENVNLVVY 552 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~--~~~~~~~~~~ 552 (624)
|+|||+++..... .........||+.|+|||++.+..++.++||||||+++|||++|+.||.... .........+
T Consensus 175 l~Dfg~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 175 VGDFGLAKLMDYK---DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp ECCCSSCEECCSS---SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred eccCccccccCcc---cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999876422 2233345569999999999988889999999999999999999999996322 2233445566
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
+.............+..+.. .........+.+++.+||+.+|.+|||+.||++.|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQG---NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTT---SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHhhchhhhhhcChhhcc---ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 66666666666666655543 2346778889999999999999999999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=406.37 Aligned_cols=252 Identities=20% Similarity=0.313 Sum_probs=209.4
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|++.+.||+|+||+||+++. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 35799999999999999999996 46899999999876666678899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC--CCeEEeecCCccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK--LNAKVSDFGLSRLVE 485 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~--~~~kl~DfGla~~~~ 485 (624)
+++|+|.++|.. +...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 236 ~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 236 MSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred cCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999999853 3356999999999999999999999999 9999999999999854 899999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. ......+||+.|||||++.+..++.++||||+||+||||++|+.||......+ .+....... . .
T Consensus 309 ~~-----~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~~~~-~-~- 374 (573)
T 3uto_A 309 PK-----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCD-W-N- 374 (573)
T ss_dssp TT-----SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC-C-C-
T ss_pred CC-----CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHhCC-C-C-
Confidence 32 23456689999999999999999999999999999999999999997544322 111111111 0 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+++... .....++.+|+.+||+.||.+|||+.|+++
T Consensus 375 ~~~~~~-------~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 MDDSAF-------SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCSGGG-------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcccc-------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011110 122345778999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=402.84 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=197.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHH---HHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLN---EVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
++|++.++||+|+||+||+++.. +|+.||||++.... ......+.+ ++.+++.++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57899999999999999999964 69999999985321 122233344 466677789999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
|||||++||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+++|++||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999973 356999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
.+... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......+. ...........
T Consensus 341 ~~~~~------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~~~- 410 (689)
T 3v5w_A 341 DFSKK------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMA- 410 (689)
T ss_dssp ECSSC------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHHCC-
T ss_pred ecCCC------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCCC-
Confidence 76432 1245689999999999964 5799999999999999999999999975433221 11111111111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
. ..+.....++.+|+.+||+.||.+|++ ++||.+
T Consensus 411 ~-------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 V-------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C-------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C-------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0 011123356788999999999999998 677653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=366.85 Aligned_cols=268 Identities=26% Similarity=0.391 Sum_probs=215.8
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|...++||+|+||+||++... +++.||+|++...+....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56888999999999999999964 68999999987666667788999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.+++.. ....+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 90 ~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHH----CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999974 2356999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCc----------ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 489 TNDS----------HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 489 ~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
.... .......||+.|+|||++.+..++.++||||||+++|||++|..|+........... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~--- 238 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LNVRG--- 238 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BCHHH---
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hhhhc---
Confidence 1110 111245799999999999998999999999999999999999999864332211100 00000
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccCC
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRI 621 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~ 621 (624)
..+... +...+..+.+++.+||+.||++|||+.|+++.|+.++....+..
T Consensus 239 ------~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 239 ------FLDRYC-------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp ------HHHHTC-------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred ------cccccC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 000000 01223457789999999999999999999999999988765544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=356.69 Aligned_cols=285 Identities=37% Similarity=0.641 Sum_probs=228.6
Q ss_pred CccccCHHHHHHHhCCCCcc------ceeccCCcEEEEEEEEcCCCEEEEEEcccC----CcchhHHHHHHHHHHHhcCC
Q 039681 316 SARIFTGKEIRRATNNFSKD------NLIGTGGFGEVFKGILDDGTVTAIKRAKLG----NTKGTDLVLNEVRILCQVNH 385 (624)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 385 (624)
....|+..++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999877 8999999999999986 6889999987643 22345679999999999999
Q ss_pred CceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 039681 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNI 465 (624)
Q Consensus 386 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Ni 465 (624)
|||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 999999999999999999999999999999986421 2356999999999999999999999999 99999999999
Q ss_pred EECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 039681 466 LLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545 (624)
Q Consensus 466 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~ 545 (624)
|+++++.+||+|||++....... .........||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCS--SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred EEcCCCcEEEeeccccccccccc--ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999998654321 1122234568999999998865 58899999999999999999999997654433
Q ss_pred cccHHHHHHHHhc-ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 546 NVNLVVYMKKIMD-EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 546 ~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
.... +...... ...+.+.+++.+ ..........+.+++.+||+.+|.+|||+.||++.|+++.+
T Consensus 242 ~~~~--~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LLLD--IKEEIEDEEKTIEDYIDKKM----NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BTTH--HHHHHHTTSCCHHHHSCSSC----SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHH--HHHHhhhhhhhhhhhccccc----cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2211 1111111 112223333322 22345677889999999999999999999999999998854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=373.13 Aligned_cols=267 Identities=24% Similarity=0.401 Sum_probs=213.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEc--------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEEEeC
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD--------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL 398 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 398 (624)
.++|.+.+.||+|+||.||+|... ++..||||+++.... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357888999999999999999852 345799999875432 3456799999999999 899999999999999
Q ss_pred CceeEEEeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill 467 (624)
+..++||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999974321 01245899999999999999999999999 9999999999999
Q ss_pred CCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 039681 468 DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEEN 546 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~ 546 (624)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred CCCCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 99999999999999866432111 11233457789999999998899999999999999999999 999987543221
Q ss_pred ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
+... ...+... ..+.....++.+++.+||+.+|++|||+.|+++.|++++.....
T Consensus 314 --~~~~----~~~~~~~------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 --LFKL----LKEGHRM------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp --HHHH----HHTTCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --HHHH----HhcCCCC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 1111 1111100 11122345688899999999999999999999999999987653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=371.20 Aligned_cols=270 Identities=27% Similarity=0.352 Sum_probs=211.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc----eeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ----TLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv 404 (624)
.++|++.++||+|+||+||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467899999999999999999875 7899999986542 334456779999999999999999999988543 6999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEeecCCCCCeEECCCCCeE
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA----------AVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~----------~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
|||+++|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+|||+++++.+|
T Consensus 101 ~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 999999999999963 3599999999999999999999998 7 99999999999999999999
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCcccccc-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccH
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNL 549 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~ 549 (624)
|+|||+++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 172 L~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 172 IADFGLALKFEAGKS--AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp ECCCTTCEEECTTSC--CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EccCCcccccccccC--ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 999999987653221 112234578999999999876 3567789999999999999999999976544332221
Q ss_pred HHH---------HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 550 VVY---------MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 550 ~~~---------~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
... +......... .+.+.... ........+.+|+.+||+.||++|||+.||++.|++|.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKK----RPVLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCC----CCCCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhccCCchhhhhhhhhcccC----CCCccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111 1111111111 11111100 11245667899999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=364.07 Aligned_cols=272 Identities=29% Similarity=0.451 Sum_probs=205.4
Q ss_pred HHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 323 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
.++....++|++.+.||+|+||+||+|+. +++.||||++..... ...+.+.+|++++++++||||+++++++.+...
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33344456789999999999999999986 588899999865432 335678999999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||||+++|+|.+++... .....+++..++.++.||+.||+|||+.+ ++|+||||||+|||+++++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHST--THHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999999632 11124999999999999999999999987 4589999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 186 a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~ 255 (309)
T 3p86_A 186 SRLKAST----FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKC 255 (309)
T ss_dssp --------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSC
T ss_pred Ccccccc----ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC
Confidence 9764321 111234578999999999999899999999999999999999999997543221 111110000
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
... ..+......+.+|+.+||+.+|++|||+.|+++.|+.++..+...
T Consensus 256 ~~~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 256 KRL------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp CCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred CCC------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 000 011123346788999999999999999999999999998765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=367.12 Aligned_cols=263 Identities=27% Similarity=0.418 Sum_probs=210.2
Q ss_pred CCCCccceeccCCcEEEEEEEEc----CCCEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++|.+.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56788899999999999999974 3456999998754 333456799999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.++++. ....+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 129 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 129 TEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred eeCCCCCcHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999963 2346999999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ ...........
T Consensus 202 ~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~~- 273 (325)
T 3kul_A 202 EDDP-DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEGYRL- 273 (325)
T ss_dssp C-----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCCC-
T ss_pred ccCc-cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHcCCCC-
Confidence 5321 11122233456788999999988889999999999999999999 999986433221 11111111000
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
..+......+.+|+.+||+.||++|||+.||++.|+.++.....
T Consensus 274 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 274 ------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred ------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 01123345688899999999999999999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=359.43 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=207.6
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|+..+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999994 57899999998766666677899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999963 25899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ......... .....
T Consensus 170 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~-~~~~~ 238 (297)
T 3fxz_A 170 Q----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT-PELQN 238 (297)
T ss_dssp T----CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS-CCCSC
T ss_pred c----cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC-CCCCC
Confidence 1 123456799999999999998999999999999999999999999975432211 111111110 00000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 ----------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1123456788999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.40 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=212.4
Q ss_pred cccCHHHHHHHhCC----------CCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCC
Q 039681 318 RIFTGKEIRRATNN----------FSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR 386 (624)
Q Consensus 318 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 386 (624)
..++.++++.+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34667777666653 566778999999999999975 7999999999876666678899999999999999
Q ss_pred ceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 387 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
||+++++++...+..++||||+++++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 999999999999999999999999999998852 36999999999999999999999999 999999999999
Q ss_pred ECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcccc
Q 039681 467 LDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN 546 (624)
Q Consensus 467 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~ 546 (624)
++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~- 248 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDV----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ- 248 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSS----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred ECCCCcEEEeeeeeeeecccCc----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 9999999999999998764321 11235579999999999998889999999999999999999999997543211
Q ss_pred ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....... . ..+.+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 249 -----~~~~~~~-~-----~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 249 -----AMKRLRD-S-----PPPKLKN-----SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -----HHHHHHH-S-----SCCCCTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----HHHHHhc-C-----CCCCcCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 1 0111100 1122345788999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=354.51 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=203.8
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHh--cCCCceeeEeeEEEeC----Ccee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQ--VNHRSLVRLLGCCVEL----DQTL 402 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 402 (624)
.++|++.+.||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46799999999999999999987 6889999998642 34556777777776 7899999999997653 4578
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH--------SAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
+||||+++|+|.++++. ..+++..+++++.||+.||+||| +.+ |+||||||+|||++.++.+|
T Consensus 83 lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 99999999999999952 46999999999999999999999 777 99999999999999999999
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCccccccc------CCCCccchhhHHHHHHHHHhC----------CCCC
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF------QLTDKSDVYSFGVVLLELLTS----------KKAI 538 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~vl~elltg----------~~p~ 538 (624)
|+|||+++.................||+.|+|||++.+. .++.++||||||+++|||++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 999999987653322211112345799999999999776 456799999999999999999 7777
Q ss_pred CCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 539 DFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
......+. .... ...............+. .........+.+|+.+||+.||++|||+.||++.|++|
T Consensus 234 ~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDP-SFED-MRKVVCVDQQRPNIPNR------WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSC-CHHH-HHHHHTTSCCCCCCCGG------GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCc-chhh-hhHHHhccCCCCCCChh------hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54332221 1111 11111111111111100 11235667899999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=371.19 Aligned_cols=262 Identities=29% Similarity=0.447 Sum_probs=200.2
Q ss_pred hCCCCccceeccCCcEEEEEEEEc----CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+.|.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999864 57789999987543 3345679999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.++++. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 124 v~e~~~~~sL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK----HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999963 2346999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
...... .........++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .... ......
T Consensus 197 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~~~~-i~~~~~ 268 (373)
T 2qol_A 197 LEDDPE-AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKA-VDEGYR 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------HHHH-HHTTEE
T ss_pred cccCCc-cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HHcCCC
Confidence 653211 1111122345778999999998899999999999999999998 999986433211 1111 111100
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
..........+.+++.+||+.+|++||++.||++.|++++...
T Consensus 269 ------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 ------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0011123456888999999999999999999999999998743
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=353.77 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=211.5
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++|+..+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35688899999999999999998888999999987543 34567999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 88 ~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 88 EHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp TTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 99999999963 3356999999999999999999999999 9999999999999999999999999998654221
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ......... ....
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~~~~---~~~~ 228 (269)
T 4hcu_A 161 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGF---RLYK 228 (269)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTC---CCCC
T ss_pred ---cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhcCc---cCCC
Confidence 111234456788999999998899999999999999999999 898986433221 111111110 0000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
+......+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 229 ----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 ----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111234578899999999999999999999999998763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=357.74 Aligned_cols=273 Identities=23% Similarity=0.376 Sum_probs=208.3
Q ss_pred hCCCCccceeccCCcEEEEEEEE-----cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--Cce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-----DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 401 (624)
.++|++.+.||+|+||+||++++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35688899999999999999984 35889999999876666678899999999999999999999998653 568
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred EEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 9999999999999999642 235999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
+....... .........++..|+|||.+.+..++.++||||||+++|||++|..|+...... .........
T Consensus 162 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~ 232 (295)
T 3ugc_A 162 KVLPQDKE-FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDK 232 (295)
T ss_dssp C--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTC
T ss_pred ccccCCcc-eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCcc
Confidence 87653211 111223445778899999999889999999999999999999999987632211 000000000
Q ss_pred cc-----cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 562 LM-----EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 562 ~~-----~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
.. ...+..........+...+..+.+++.+||+.+|++|||++|+++.|++++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 00 000000000011112234567889999999999999999999999999998643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=361.90 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=204.3
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.++|++.+.||+|+||.||+|+. .+|+.||||++... +....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999996 57999999998644 2344567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999632 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCCCcceeecccccccccCcccccccCCC-CccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLT-DKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.. .......||+.|+|||++.+..++ .++||||||+++|||++|+.||......+ ....... +..
T Consensus 166 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~~~-- 231 (328)
T 3fe3_A 166 VG-----GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERVLR-GKY-- 231 (328)
T ss_dssp SS-----CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCC--
T ss_pred CC-----CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCC--
Confidence 22 123456799999999999887765 79999999999999999999997543221 1111111 110
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+......+.+|+.+||+.||.+|||++|+++
T Consensus 232 -----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 -----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001122345778999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.80 Aligned_cols=262 Identities=26% Similarity=0.377 Sum_probs=210.2
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
...++|.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34567888999999999999999975 789999999875432 3346789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 191 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 9999999999999642 235899999999999999999999999 999999999999999999999999999864
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
..... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .......+...
T Consensus 264 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~ 334 (377)
T 3cbl_A 264 ADGVY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRL 334 (377)
T ss_dssp TTSEE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCC
T ss_pred CCCce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC
Confidence 32110 000012235678999999988889999999999999999998 888886433211 11111111100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
..+...+..+.+|+.+||+.||++|||+++|++.|+++...
T Consensus 335 ------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 ------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 00112345678899999999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=351.14 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=210.6
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++|++.+.||+|+||.||++...++..||+|+++... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45788899999999999999999888899999987543 34567899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 157 (268)
T 3sxs_A 86 SNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD- 157 (268)
T ss_dssp TTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT-
T ss_pred CCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh-
Confidence 999999999642 235999999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
.........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ......... ....
T Consensus 158 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~---~~~~ 226 (268)
T 3sxs_A 158 --QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGH---RLYR 226 (268)
T ss_dssp --CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTC---CCCC
T ss_pred --hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCC---CCCC
Confidence 1122234456778999999988889999999999999999999 999986443221 111111111 0001
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
+ ......+.+++.+||+.+|++|||+.|+++.|+.++..
T Consensus 227 ~----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 P----------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp C----------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred C----------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1 11234578899999999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=356.70 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=207.5
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999995 468999999875432 23356789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999632 46999999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ......... ..
T Consensus 162 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~-~~- 230 (294)
T 4eqm_A 162 SETS---LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDS-VP- 230 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSC-CC-
T ss_pred cccc---ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhcc-CC-
Confidence 4321 112234568999999999999889999999999999999999999997543211 111111111 00
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHHHHhc
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-SMKEVADEIEYIISIA 617 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~~~ 617 (624)
.... ......+..+.+++.+||+.||.+|| +++++.+.|+.+....
T Consensus 231 ----~~~~---~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 231 ----NVTT---DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ----CHHH---HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ----Ccch---hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0000 00112345688899999999999998 9999999998876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.00 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=207.0
Q ss_pred HHHHHHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 039681 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397 (624)
Q Consensus 322 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 397 (624)
..++....++|++.++||+|+||+||+++.. +++.||+|+++... ....+.+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445556788999999999999999999975 47899999986421 2233458999999999999999999999999
Q ss_pred CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
.+..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~----~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999963 2356999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
||+++..... .........||+.|+|||++. ...++.++||||||+++|||++|+.||......+.
T Consensus 219 FGla~~~~~~---~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------ 289 (437)
T 4aw2_A 219 FGSCLKLMED---GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------ 289 (437)
T ss_dssp CTTCEECCTT---SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------
T ss_pred hhhhhhcccC---CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------
Confidence 9999765422 222234467999999999986 45689999999999999999999999975433221
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCC--CCCHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQN--RPSMKEVAD 608 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~ 608 (624)
............ .+........++.+|+.+||+.+|++ ||+++|+++
T Consensus 290 ~~~i~~~~~~~~---------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 290 YGKIMNHKERFQ---------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHTHHHHCC---------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHhhhhcccccc---------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111111100000 00000113345778999999888887 999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=358.65 Aligned_cols=248 Identities=26% Similarity=0.341 Sum_probs=203.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|++.+.||+|+||+||+++.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357889999999999999999964 6899999998643 233456789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 999999999999863 246999999999999999999999999 999999999999999999999999999864
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 156 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~-~-- 222 (337)
T 1o6l_A 156 ISD----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE-I-- 222 (337)
T ss_dssp CCT----TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-C--
T ss_pred ccC----CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-C--
Confidence 321 112345679999999999998899999999999999999999999997543221 111111111 0
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
..+.....++.+|+.+||+.||++|| +++|+++
T Consensus 223 -----------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 -----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 00112334678899999999999999 8999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=364.60 Aligned_cols=271 Identities=25% Similarity=0.398 Sum_probs=216.5
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEc--------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEE
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILD--------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCC 395 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 395 (624)
....++|.+.+.||+|+||+||+|+.. .+..||||+++.... ...+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 334567899999999999999999852 235799999875433 3457799999999999 899999999999
Q ss_pred EeCCceeEEEeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 039681 396 VELDQTLMIYEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSN 464 (624)
Q Consensus 396 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~N 464 (624)
.+.+..++||||+++|+|.+++..... .....+++.+++.|+.||+.||+|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999974321 11346999999999999999999999999 9999999999
Q ss_pred eEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCc
Q 039681 465 ILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNRE 543 (624)
Q Consensus 465 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~ 543 (624)
||+++++.+||+|||+++....... ........+|..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT--TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEEcCCCcEEEcccCcccccccccc--cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999987643211 112234557889999999999899999999999999999999 9999864432
Q ss_pred cccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 544 EENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
.+ ... .+....... .......++.+++.+||+.+|++|||++||++.|+++......+
T Consensus 300 ~~------~~~-~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 300 EE------LFK-LLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HH------HHH-HHHTTCCCC------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HH------HHH-HHHcCCCCC------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 21 111 111111100 01123356788999999999999999999999999999876544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=347.43 Aligned_cols=269 Identities=15% Similarity=0.147 Sum_probs=214.8
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|.+.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999995 57899999988643 3345689999999999 79999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC-----eEEeecCCc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN-----AKVSDFGLS 481 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~-----~kl~DfGla 481 (624)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 87 ~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 87 LL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99 99999999742 346999999999999999999999999 999999999999987776 999999999
Q ss_pred ccccccCCCCc---ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 482 RLVERTETNDS---HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 482 ~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+.......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87654322111 123456799999999999998999999999999999999999999976443322222221111111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
..... .+. ...+..+.+++.+||+.+|++|||+++|++.|+++......
T Consensus 239 ~~~~~-----~~~-------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 239 STPLR-----ELC-------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HSCHH-----HHT-------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CccHH-----HHH-------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 11000 000 12345688899999999999999999999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=351.47 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=209.5
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
..++|++.+.||+|+||.||++...++..||+|+++... ...+++.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 456788899999999999999999888899999987543 3456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 101 MANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999642 246999999999999999999999999 999999999999999999999999999865422
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
. ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......... ..
T Consensus 174 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~---~~ 241 (283)
T 3gen_A 174 E---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLR---LY 241 (283)
T ss_dssp H---HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTCC---CC
T ss_pred c---cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHhcccC---CC
Confidence 1 111223456788999999998889999999999999999998 999986443221 1111111100 00
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
. +......+.+++.+||+.+|++|||++|+++.|+++...+
T Consensus 242 ~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 242 R----------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp C----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C----------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 0 0112346788999999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=355.78 Aligned_cols=266 Identities=18% Similarity=0.157 Sum_probs=212.0
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999995 578999999986442 345689999999999 89999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC-----eEEeecCCc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN-----AKVSDFGLS 481 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~-----~kl~DfGla 481 (624)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 86 ~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 86 LL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred eC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99 99999999642 357999999999999999999999999 999999999999998887 999999999
Q ss_pred ccccccCCCCcc---eeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 482 RLVERTETNDSH---IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 482 ~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+........... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 876533221111 12456799999999999998999999999999999999999999986533322111111111000
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
... ...+. ...+ ++.+++.+||+.+|.+||++++|.+.|+++....
T Consensus 238 ~~~-----~~~~~-------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 238 ATP-----IEVLC-------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HSC-----HHHHT-------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCC-----HHHHh-------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000 00000 0122 6888999999999999999999999999988753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=367.04 Aligned_cols=275 Identities=24% Similarity=0.365 Sum_probs=216.8
Q ss_pred cCHHHHHHHhCCCCccceeccCCcEEEEEEEE------cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeE
Q 039681 320 FTGKEIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRL 391 (624)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l 391 (624)
+...+++...++|.+.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45566667778999999999999999999984 2457899999875433 3356799999999999 79999999
Q ss_pred eeEEEeCCc-eeEEEeeccCCCcccccccccCC-----------------------------------------------
Q 039681 392 LGCCVELDQ-TLMIYEYIPNGTLFDHLHCDFTG----------------------------------------------- 423 (624)
Q Consensus 392 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------- 423 (624)
++++.+.+. .++||||+++|+|.++++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 89999999999999999743210
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 424 --------------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 424 --------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~- 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP- 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc-
Confidence 0123899999999999999999999999 9999999999999999999999999998664321
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.........+|..|+|||++.+..++.++||||||+++|||++ |+.||......+. +...........
T Consensus 248 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~---- 316 (359)
T 3vhe_A 248 -DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR---- 316 (359)
T ss_dssp -TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCC----
T ss_pred -cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCCC----
Confidence 1222345668899999999998899999999999999999998 9999875433211 111111111100
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
.+......+.+++.+||+.+|++|||+.||++.|++++...
T Consensus 317 --------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 317 --------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 01122345788999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.81 Aligned_cols=266 Identities=20% Similarity=0.286 Sum_probs=203.5
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
..++|++.+.||+|+||+||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3467999999999999999999998899999999865432 23467899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9997 588887753 3346999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc---c
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE---R 561 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 561 (624)
.. ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ..+....... .
T Consensus 171 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 171 IP----VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPRE 243 (311)
T ss_dssp SC----CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTT
T ss_pred CC----cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHH
Confidence 22 122345578999999999876 46899999999999999999999999765443322 2222221111 1
Q ss_pred cccccchhh-hh----ccC-----cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVL-KE----RAT-----HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l-~~----~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.....+... .. ... ........++.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111000000 00 000 000112356788999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=378.28 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=212.4
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++...++|.+.+.||+|+||+||+|..+++..||||+++... ...+.|.+|+++|++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344456788899999999999999999888999999987543 45678999999999999999999999986 6678999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.++++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 261 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp ECCCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 9999999999999742 1235899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ........++..|+|||++....++.++||||||++||||++ |+.||......+ . ........+.
T Consensus 335 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~---~~~i~~~~~~- 404 (454)
T 1qcf_A 335 EDNE---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V---IRALERGYRM- 404 (454)
T ss_dssp CCHH---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H---HHHHHHTCCC-
T ss_pred CCCc---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHcCCCC-
Confidence 4211 111123446788999999988899999999999999999999 999987433221 1 1111111100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
..+...+..+.+|+.+||+.||++|||+++|++.|+.+....
T Consensus 405 ------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 405 ------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 001123456888999999999999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.60 Aligned_cols=276 Identities=24% Similarity=0.303 Sum_probs=208.1
Q ss_pred HHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc--CCCceeeEeeEEEeC--
Q 039681 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV--NHRSLVRLLGCCVEL-- 398 (624)
Q Consensus 323 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-- 398 (624)
.......++|++.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 333445678999999999999999999875 899999998532 334456666666555 899999999999987
Q ss_pred --CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEeecCCCCCeEEC
Q 039681 399 --DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA--------AVPPIYHRDVKSSNILLD 468 (624)
Q Consensus 399 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~--------~~~~iiH~Dik~~Nill~ 468 (624)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+|||++
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVK 176 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEEC
Confidence 678999999999999999963 3599999999999999999999998 6 99999999999999
Q ss_pred CCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCc------cchhhHHHHHHHHHhC--------
Q 039681 469 EKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDK------SDVYSFGVVLLELLTS-------- 534 (624)
Q Consensus 469 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k------sDv~s~G~vl~elltg-------- 534 (624)
.++.+||+|||+++.................||+.|+|||++.+...+.+ +||||||+++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999997664332222212234579999999999987666555 9999999999999999
Q ss_pred --CCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 535 --KKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 535 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
+.||......+.. ..................... .......++.+++.+||+.||++|||+.||++.|++
T Consensus 257 ~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPS--YEDMREIVCIKKLRPSFPNRW------SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGGG------GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cccccHhhhcCCCCc--hhhhHHHHhhhccCccccccc------hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 5555432221111 111111111111111111111 113567789999999999999999999999999999
Q ss_pred HHHhccc
Q 039681 613 IISIAKG 619 (624)
Q Consensus 613 i~~~~~~ 619 (624)
+....+-
T Consensus 329 l~~~~~~ 335 (337)
T 3mdy_A 329 MSESQDI 335 (337)
T ss_dssp HHHTTTC
T ss_pred HHhhccc
Confidence 9987653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=361.57 Aligned_cols=270 Identities=26% Similarity=0.374 Sum_probs=212.4
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCC
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELD 399 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 399 (624)
...++|.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999974 347899999875433 33567999999999999999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTG-------------------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDV 460 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Di 460 (624)
..++||||+++|+|.+++...... ....+++.+++.++.||++||+|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999999743110 1257999999999999999999999999 999999
Q ss_pred CCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCC
Q 039681 461 KSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAID 539 (624)
Q Consensus 461 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~ 539 (624)
||+|||+++++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 99999999999999999999986643211 112234567899999999988889999999999999999999 999986
Q ss_pred CCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 540 FNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
.....+ ... ....+.... .+......+.+++.+||+.+|++|||+.|+++.|+++.....+
T Consensus 279 ~~~~~~------~~~-~~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 279 GMAHEE------VIY-YVRDGNILA------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp TSCHHH------HHH-HHHTTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred CCChHH------HHH-HHhCCCcCC------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 433211 111 111111111 0112335678899999999999999999999999998876554
Q ss_pred C
Q 039681 620 R 620 (624)
Q Consensus 620 ~ 620 (624)
.
T Consensus 340 ~ 340 (343)
T 1luf_A 340 T 340 (343)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=354.60 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=201.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999965 789999999865433 234678999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|.+++. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 999999999996 3346999999999999999999999999 99999999999999999999999999986643
Q ss_pred cCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ . ......... .
T Consensus 158 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~----~~~~~~~~~---~ 227 (323)
T 3tki_A 158 NN--RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E----YSDWKEKKT---Y 227 (323)
T ss_dssp TT--EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-H----HHHHHTTCT---T
T ss_pred CC--cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-H----HHHHhcccc---c
Confidence 21 1222345679999999999987765 7899999999999999999999975433211 0 111111100 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+ .......+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~---------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 LNP---------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp STT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCc---------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 0122345678999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=370.04 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=207.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC-ceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD-QTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 407 (624)
.++|++.+.||+|+||.||+|... ++.||||+++... ..+.|.+|+++|++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456888899999999999999875 7799999987543 5678999999999999999999999988765 78999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999999743 2345899999999999999999999999 999999999999999999999999999854321
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
.....++..|+|||.+.+..++.++||||||++||||++ |+.||......+ .... +..+...
T Consensus 343 -------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~~~--- 405 (450)
T 1k9a_A 343 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKM--- 405 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHTTCCC---
T ss_pred -------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCCC---
Confidence 122356889999999998899999999999999999998 999987543222 1111 1111000
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
..+...+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 406 ---------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 ---------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11123345688899999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=356.05 Aligned_cols=266 Identities=24% Similarity=0.357 Sum_probs=197.7
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcC-C---CEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDD-G---TVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
..++|++.+.||+|+||.||+|+... + ..||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34679999999999999999998543 3 27999998754 344567899999999999999999999999887655
Q ss_pred ------eEEEeeccCCCcccccccccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 402 ------LMIYEYIPNGTLFDHLHCDFT-GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 402 ------~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
++|+||+++|+|.+++..... .....+++.+++.|+.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999864322 12236999999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 553 (624)
|+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...
T Consensus 178 l~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~-- 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDY--YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN-- 250 (323)
T ss_dssp ECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH--
T ss_pred Eeecccccccccccc--ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH--
Confidence 999999987643211 111234456789999999998889999999999999999999 888987543322 111
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
........ .........+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 251 -~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 251 -YLIGGNRL-------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HHHTTCCC-------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -HHhcCCCC-------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111100 111123456888999999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=365.51 Aligned_cols=265 Identities=24% Similarity=0.341 Sum_probs=210.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888999999999999999943 4678999998644 234456789999999999999999999999999999
Q ss_pred eEEEeeccCCCcccccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC---CeEEe
Q 039681 402 LMIYEYIPNGTLFDHLHCDFT--GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL---NAKVS 476 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~---~~kl~ 476 (624)
++||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999974321 22356999999999999999999999999 99999999999999554 59999
Q ss_pred ecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 039681 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 555 (624)
|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 227 DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEF 298 (367)
T ss_dssp CCHHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHH
T ss_pred CCccccccccccc--cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH
Confidence 9999986543211 111234567899999999988899999999999999999998 989986543221 1111
Q ss_pred HhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 556 IMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 556 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
....... .........+.+|+.+||+.+|++|||+.||++.|+.+.+..
T Consensus 299 i~~~~~~-------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 299 VTSGGRM-------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHcCCCC-------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1111100 001123346788999999999999999999999999988744
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=358.95 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=205.6
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc------hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK------GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
..++|.+.+.||+|+||.||+++.. +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467899999999999999999965 6899999998754322 34678999999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC----CeEEe
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL----NAKVS 476 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~----~~kl~ 476 (624)
.++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHT-----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence 999999999999999996 2357999999999999999999999999 99999999999998877 79999
Q ss_pred ecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
|||++...... .......||+.|+|||++.+..++.++||||||+++|||++|..||......+ .+...
T Consensus 162 DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i 230 (361)
T 2yab_A 162 DFGLAHEIEDG-----VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANI 230 (361)
T ss_dssp CCSSCEECCTT-----CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHH
T ss_pred ecCCceEcCCC-----CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 99999876432 12345679999999999998889999999999999999999999997543221 11111
Q ss_pred hcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 557 MDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... . ..+++.... .....+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~-~--~~~~~~~~~-------~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 231 TAV-S--YDFDEEFFS-------QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HTT-C--CCCCHHHHT-------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Hhc-C--CCCCchhcc-------CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 0 001111111 12346788999999999999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=363.15 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=198.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 403 (624)
.++|++.++||+|+||+||+++.. +++.||+|+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457899999999999999999965 5789999998643 223345688999999887 89999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999863 246999999999999999999999999 99999999999999999999999999985
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccc--cHHHHHHHHhcccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV--NLVVYMKKIMDEER 561 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~ 561 (624)
... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .....+...+....
T Consensus 203 ~~~----~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 203 GLR----PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp CCC----TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred ccc----CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 321 112234567999999999999989999999999999999999999999743322111 11111111111111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
. ..+.....++.+|+.+||+.||.+||++
T Consensus 279 ~-------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 I-------------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp C-------------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred c-------------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 1111234567889999999999999995
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.07 Aligned_cols=275 Identities=22% Similarity=0.321 Sum_probs=213.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC--ceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD--QTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 405 (624)
++|.+.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56889999999999999999965 58999999987433 234567889999999999999999999998765 779999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE----CCCCCeEEeecCCc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGLS 481 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill----~~~~~~kl~DfGla 481 (624)
||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp ECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred eCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999997432 2234999999999999999999999999 9999999999999 78888999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccc--------ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccc-cHHHH
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYR--------NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV-NLVVY 552 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~-~~~~~ 552 (624)
+...... ......||..|+|||++. +..++.++||||||+++|||++|+.||......... .....
T Consensus 164 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 164 RELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp EECCTTC-----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred eecCCCC-----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 8764321 123456899999999986 467899999999999999999999999754332222 11111
Q ss_pred HHHHhcccccccccc---------hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 553 MKKIMDEERLMEVVD---------PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d---------~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
+........+..+.. +.+. ............+.+++.+||+.||++|||++|+++...+...
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhhhcccCCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 211111111111100 0000 1112345677889999999999999999999999998876544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=348.34 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=198.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.++|++.+.||+|+||.||+|.... +..||+|+.+.... ...+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678889999999999999998642 45799999875433 34567999999999999999999999974 567899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999963 2346999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+ .....
T Consensus 166 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i---~~~~~- 235 (281)
T 1mp8_A 166 MEDST---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI---ENGER- 235 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH---HTTCC-
T ss_pred cCccc---ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH---HcCCC-
Confidence 64321 111233456789999999988889999999999999999997 888987543322 11111 11110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
. ..+...+..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 236 ~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 236 L------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred C------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0 0111234567889999999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.10 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=201.0
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCC----EEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGT----VTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|+..+.||+|+||+||+|+.. +++ .||+|.++... ....+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 56888999999999999999953 444 35888775432 34457899999999999999999999999875 4789
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|+||+++|+|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 94 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999742 356999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... .........+|..|+|||++.+..++.++||||||+++|||++ |+.||......+ +.. .......
T Consensus 167 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~ 237 (327)
T 3poz_A 167 LGAEE--KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER 237 (327)
T ss_dssp HTTTC--C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCC
T ss_pred ccCCc--ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCC
Confidence 65322 1112234457889999999999899999999999999999999 999997543322 111 1111100
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
. .........+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 238 ~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 238 L------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp C------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred C------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0 00112334678899999999999999999999999998763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=377.56 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=211.0
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcC-CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
..++|++.+.||+|+||.||+|+... +..||||+++.. ....+.|.+|+.+|++++||||+++++++.+....++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34568888999999999999999764 889999998754 3346789999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|.+++... ....+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 297 ~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 297 FMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred ccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999742 3356999999999999999999999999 99999999999999999999999999987642
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
. .........++..|+|||++.+..++.++||||||++||||++ |+.||......+ .... +..+...
T Consensus 371 ~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~-- 438 (495)
T 1opk_A 371 D---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKDYRM-- 438 (495)
T ss_dssp C---CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHTTCCC--
T ss_pred C---ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCCC--
Confidence 2 1111233456789999999988889999999999999999999 888887543221 1111 1111000
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
..+...+..+.+|+.+||+.+|++|||+.||++.|+.+.
T Consensus 439 ----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 011123456788999999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.39 Aligned_cols=254 Identities=29% Similarity=0.478 Sum_probs=196.5
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc----chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT----KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|+..+.||+|+||.||+|... ++.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999974 88999999865432 2246789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC--------CCCeEEe
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE--------KLNAKVS 476 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~--------~~~~kl~ 476 (624)
|||+++++|.+++. ...+++..++.++.|++.||+|||+++..+|+||||||+|||++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999999999885 246999999999999999999999998666899999999999986 7789999
Q ss_pred ecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 477 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
|||++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....
T Consensus 159 Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~ 226 (271)
T 3dtc_A 159 DFGLAREWHRTT------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGV 226 (271)
T ss_dssp CCCC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHH
T ss_pred cCCccccccccc------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhh
Confidence 999998654221 124568999999999998889999999999999999999999997533211 11111
Q ss_pred hcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 557 MDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
.... ... ..+......+.+++.+||+.+|++|||+.|+++.|++|
T Consensus 227 ~~~~-~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNK-LAL-----------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSC-CCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCC-CCC-----------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111 000 01112345688899999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=352.75 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=205.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|.+.+.||+|+||.||+++.. +++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467899999999999999999965 5889999998743 34456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC--CCCeEEeecCCccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE--KLNAKVSDFGLSRLVE 485 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~--~~~~kl~DfGla~~~~ 485 (624)
+++|+|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 83 ~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 83 ISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999963 2346999999999999999999999999 999999999999987 7899999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .......||+.|+|||++.+..++.++||||||+++|||++|..||......+ .+........ .
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~---~ 221 (321)
T 1tki_A 156 PG-----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEY---T 221 (321)
T ss_dssp TT-----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC---C
T ss_pred CC-----CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCCC---C
Confidence 22 22345678999999999988889999999999999999999999997543221 1111111110 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.++... .....++.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~-------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAF-------KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHH-------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhh-------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011100 123456788999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=358.88 Aligned_cols=274 Identities=15% Similarity=0.184 Sum_probs=208.7
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcC------CCEEEEEEcccCCcch-----------hHHHHHHHHHHHhcCCCceee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDD------GTVTAIKRAKLGNTKG-----------TDLVLNEVRILCQVNHRSLVR 390 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 390 (624)
..++|.+.+.||+|+||.||+|...+ ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45679999999999999999999754 4789999976543211 122445666777888999999
Q ss_pred EeeEEEeC----CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 391 LLGCCVEL----DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 391 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
+++++... ...++||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA----NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence 99999875 4589999999 9999999964 2356999999999999999999999999 999999999999
Q ss_pred EC--CCCCeEEeecCCcccccccCCCCc---ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 039681 467 LD--EKLNAKVSDFGLSRLVERTETNDS---HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541 (624)
Q Consensus 467 l~--~~~~~kl~DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~ 541 (624)
++ .++.+||+|||+++.+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 889999999999987653322111 1113445999999999999989999999999999999999999999743
Q ss_pred CccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 542 REEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.... .......... ...+.+++++.+.. ...+.++.+++.+||+.+|++||++.+|++.|+++.....
T Consensus 265 ~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 265 LKDP--KYVRDSKIRY-RENIASLMDKCFPA------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp TTCH--HHHHHHHHHH-HHCHHHHHHHHSCT------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCH--HHHHHHHHHh-hhhHHHHHHHhccc------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 2221 1111111111 11222233222211 1224568889999999999999999999999999987543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=373.93 Aligned_cols=263 Identities=29% Similarity=0.423 Sum_probs=207.8
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
...++|++.+.||+|+||.||+|...++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3456788899999999999999999888889999987543 345789999999999999999999999876 77899999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999642 2245899999999999999999999999 99999999999999999999999999987643
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .........+.
T Consensus 333 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~--- 400 (452)
T 1fmk_A 333 NE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRM--- 400 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCC---
T ss_pred Cc---eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCC---
Confidence 21 111233456789999999988899999999999999999999 899986433211 11111111100
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
..+...+..+.+|+.+||+.+|++|||+++|++.|+.+......
T Consensus 401 ----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 401 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 01123345678899999999999999999999999988765443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=344.01 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=196.0
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc--------------------------chhHHHHHHHHHHH
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT--------------------------KGTDLVLNEVRILC 381 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 381 (624)
.++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36799999999999999999996 4688999999864321 12356899999999
Q ss_pred hcCCCceeeEeeEEEe--CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 039681 382 QVNHRSLVRLLGCCVE--LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRD 459 (624)
Q Consensus 382 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~D 459 (624)
+++||||+++++++.+ ....++||||+++++|.+++. ...+++..++.++.||+.||+|||+.+ |+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 9999999999999987 567899999999999988764 246999999999999999999999999 99999
Q ss_pred CCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccC---CCCccchhhHHHHHHHHHhCCC
Q 039681 460 VKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ---LTDKSDVYSFGVVLLELLTSKK 536 (624)
Q Consensus 460 ik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~s~G~vl~elltg~~ 536 (624)
|||+|||++.++.+||+|||+++..... ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGS----DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSS----SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccc----cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999876422 12234567999999999997654 4778999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 537 AIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 537 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
||...... ..... ....... . +. .......+.+++.+||+.||++|||+.|+++
T Consensus 239 pf~~~~~~------~~~~~-~~~~~~~-~--~~--------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 239 PFMDERIM------CLHSK-IKSQALE-F--PD--------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSCCSSHH------HHHHH-HHHCCCC-C--CS--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCccHH------HHHHH-HhcccCC-C--CC--------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99643221 11111 1111100 0 00 0123356788999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=344.38 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=210.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++|+..+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 35688899999999999999998888999999987543 33467899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 86 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 86 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp TTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999642 346899999999999999999999999 9999999999999999999999999998654211
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......... ...
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i~~~~~---~~~ 226 (267)
T 3t9t_A 159 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFR---LYK 226 (267)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCC---CCC
T ss_pred ---ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHHhcCCc---CCC
Confidence 111223456788999999988889999999999999999999 888886433211 1111111100 000
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
+......+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 227 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 ----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11123457889999999999999999999999999876
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.60 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=199.1
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCcee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 402 (624)
..++|++.+.||+|+||+||+++.. +++.||||+++.. .....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999964 6899999998643 223456688999999998 6999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++
T Consensus 101 lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999963 246999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 173 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~-~ 241 (353)
T 3txo_A 173 EGIC----NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDE-V 241 (353)
T ss_dssp CSCC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-C
T ss_pred eccc----CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-C
Confidence 5432 1122345679999999999998889999999999999999999999997543321 111111111 0
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH------HHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM------KEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~ev~~ 608 (624)
..+......+.+|+.+||+.||++||++ +|+++
T Consensus 242 -------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0011133457789999999999999998 66653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=352.74 Aligned_cols=269 Identities=24% Similarity=0.361 Sum_probs=206.0
Q ss_pred CCCCccceeccCCcEEEEEEEE-----cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--Cce
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-----DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQT 401 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 401 (624)
++|+..+.||+|+||.||++++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 368899999987443 33457789999999999999999999999876 668
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 9999999999999999532 346999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc-
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE- 560 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 560 (624)
........ .........+|..|+|||.+.+..++.++||||||+++|||++|+.|+..... .........
T Consensus 174 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~ 244 (302)
T 4e5w_A 174 KAIETDKE-YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--------LFLKMIGPTH 244 (302)
T ss_dssp EECCTTCC-EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--------HHHHHHCSCC
T ss_pred ccccCCCc-ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--------HHhhccCCcc
Confidence 87653211 11222345688889999999888899999999999999999999988642110 000000000
Q ss_pred ---ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 561 ---RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 561 ---~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
.................+......+.+|+.+||+.||.+|||+.|+++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000000000000011112234467889999999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=352.33 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=204.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc------hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK------GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
.++|.+.+.||+|+||.||++... +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346888999999999999999964 6899999988654322 356799999999999999999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC----CeEEee
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL----NAKVSD 477 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~----~~kl~D 477 (624)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++ .+||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999999962 356999999999999999999999999 99999999999999887 799999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .....
T Consensus 162 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~ 230 (326)
T 2y0a_A 162 FGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVS 230 (326)
T ss_dssp CTTCEECCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHH
T ss_pred CCCCeECCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHH
Confidence 99998764321 12345799999999999988999999999999999999999999975432211 11111
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... ....+... ......+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~---~~~~~~~~-------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 AVN---YEFEDEYF-------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HTC---CCCCHHHH-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcC---CCcCcccc-------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 100 00011110 012345778999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=347.74 Aligned_cols=264 Identities=30% Similarity=0.447 Sum_probs=211.1
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
...++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 3456788999999999999999998888899999987543 34578999999999999999999999976 456899999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 99999999999632 1136999999999999999999999999 99999999999999999999999999987643
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..........
T Consensus 162 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~~---- 228 (279)
T 1qpc_A 162 NE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYR---- 228 (279)
T ss_dssp SC---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC----
T ss_pred cc---cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHhcccC----
Confidence 21 111223456788999999988889999999999999999999 888886433221 1111111100
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
. ..+......+.+++.+||+.+|++|||+.++++.|+++.....++
T Consensus 229 --~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 229 --M-------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp --C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred --C-------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 0 001123356788999999999999999999999999998765543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=359.20 Aligned_cols=278 Identities=24% Similarity=0.347 Sum_probs=210.3
Q ss_pred CCCCccceeccCCcEEEEEEEE-----cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEE--eCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-----DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCV--ELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 402 (624)
++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688899999999999999984 367899999998766666778999999999999999999999987 455688
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+++++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 103 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999642 235999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
...... ..........+|..|+|||++.+..++.++||||||+++|||++|+.||....... .............
T Consensus 176 ~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 176 LLPLDK-DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF----LRMMGCERDVPAL 250 (327)
T ss_dssp ECCTTC-SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHCC----CCHH
T ss_pred ecccCC-ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh----hhhcccccccccH
Confidence 764321 11111234567888999999988889999999999999999999999986432110 0000000000000
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
..+.+..........+......+.+|+.+||+.||++|||+.|+++.|+.+.....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 000000000011111223456788999999999999999999999999998765443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=351.72 Aligned_cols=265 Identities=27% Similarity=0.375 Sum_probs=212.0
Q ss_pred HhCCCCccceeccCCcEEEEEEEE------cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
..++|.+.+.||+|+||.||++.. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 456788999999999999999985 235789999987543 3345778999999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTG-------------------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVK 461 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik 461 (624)
.++||||+++++|.+++...... ....+++.+++.++.||++||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 99999999999999999743210 1234899999999999999999999999 9999999
Q ss_pred CCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 039681 462 SSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDF 540 (624)
Q Consensus 462 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~ 540 (624)
|+|||+++++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hheEEEcCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999986643211 111223456788999999988889999999999999999999 9999875
Q ss_pred CCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 541 NREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
....+ +.. ........ .........+.+++.+||+.||++|||+.|+++.|+++..-
T Consensus 256 ~~~~~---~~~----~~~~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 256 IPPER---LFN----LLKTGHRM------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCGGG---HHH----HHHTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCHHH---HHH----HhhcCCcC------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 43322 111 11111100 01112345678899999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=350.33 Aligned_cols=270 Identities=27% Similarity=0.383 Sum_probs=214.8
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE------cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEEEeC
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL 398 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 398 (624)
...++|++.+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456788999999999999999985 2467899999875433 3457799999999999 899999999999999
Q ss_pred CceeEEEeeccCCCcccccccccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFT-------------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNI 465 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Ni 465 (624)
+..++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999974321 11235999999999999999999999999 99999999999
Q ss_pred EECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCcc
Q 039681 466 LLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREE 544 (624)
Q Consensus 466 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~ 544 (624)
|+++++.+||+|||+++...... .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCT--TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EEcCCCCEEEccccccccccccc--cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999998765321 1112234457889999999988899999999999999999999 99998654322
Q ss_pred ccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
+. ......... ... ........+.+++.+||+.||.+|||+.|+++.|+++++....
T Consensus 255 ~~------~~~~~~~~~-~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 255 SK------FYKMIKEGF-RML-----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HH------HHHHHHHTC-CCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred hH------HHHHhccCC-CCC-----------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 11 111111110 000 0112335678899999999999999999999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=346.10 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=200.3
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|++.+.||+|+||+||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999998899999999865432 2246788999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 974 89888863 2356999999999999999999999999 999999999999999999999999999865421
Q ss_pred CCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc---cc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER---LM 563 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 563 (624)
........+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+. ...+........ ..
T Consensus 154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 154 ----VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWP 226 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTST
T ss_pred ----ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhch
Confidence 1123345689999999998754 589999999999999999999999975433221 111211111100 00
Q ss_pred -----cccchhhhhcc----CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 -----EVVDPVLKERA----THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 -----~~~d~~l~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...++.+.... ..........+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00111110000 0000123456788999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=356.85 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=201.6
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56889999999999999999964 58899999876432 234567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999963 356999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccc---cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRN---FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.. .......||+.|+|||++.. ..++.++||||||+++|||++|+.||........... ..... ...
T Consensus 167 ~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~---~~~~~-~~~- 236 (384)
T 4fr4_A 167 RE-----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI---VHTFE-TTV- 236 (384)
T ss_dssp TT-----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH---HHHHH-HCC-
T ss_pred CC-----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH---HHHHh-hcc-
Confidence 22 22345679999999999864 3589999999999999999999999975433221111 11111 110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-HHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-MKEVA 607 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~ 607 (624)
...+......+.+|+.+||+.+|.+||+ +++|.
T Consensus 237 ------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 237 ------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred ------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 0011123456788999999999999998 66654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=352.09 Aligned_cols=268 Identities=24% Similarity=0.405 Sum_probs=212.0
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc--------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD--------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCCVE 397 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 397 (624)
..++|.+.+.||+|+||.||+|... ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3467899999999999999999863 467899999875432 3456789999999999 89999999999999
Q ss_pred CCceeEEEeeccCCCcccccccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTG-----------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
.+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 99999999999999999999743210 1235899999999999999999999999 999999999999
Q ss_pred ECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccc
Q 039681 467 LDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEE 545 (624)
Q Consensus 467 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~ 545 (624)
++.++.+||+|||+++....... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EcCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 99999999999999987643211 111233456789999999988889999999999999999999 999986443221
Q ss_pred cccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
.... ....... .........+.+++.+||+.+|++|||+.|+++.|+++......
T Consensus 268 ------~~~~-~~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 ------LFKL-LKEGHRM------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ------HHHH-HHHTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ------HHHH-HhcCCCC------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1111 1111100 00112335678899999999999999999999999999987543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=346.02 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=214.2
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
...++|++.+.||+|+||.||+|... ++..||+|++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34567889999999999999999975 4888999998743 445678999999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp ECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999743 3356999999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.. .........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+. .....
T Consensus 163 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~----~~~~~- 231 (288)
T 3kfa_A 163 GD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----KDYRM- 231 (288)
T ss_dssp SS---SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH----TTCCC-
T ss_pred CC---ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----ccCCC-
Confidence 22 2222334557889999999998899999999999999999999 888886543221 111111 11000
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
......+..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 232 -----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 232 -----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 00112345678899999999999999999999999998874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=351.42 Aligned_cols=277 Identities=26% Similarity=0.396 Sum_probs=209.4
Q ss_pred CCccceeccCCcEEEEEEEEc-----CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeC--CceeE
Q 039681 332 FSKDNLIGTGGFGEVFKGILD-----DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTLM 403 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 403 (624)
|++.+.||+|+||+||++.+. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999988642 678999999875432 3456799999999999999999999999984 57899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 113 v~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 9999999999999963 24999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
...... .........++..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.........+.
T Consensus 184 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHE-YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLT 261 (318)
T ss_dssp CCTTCS-EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHH
T ss_pred cccccc-ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHH
Confidence 653211 1112234567888999999998889999999999999999999999986432110 00000000000000000
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccCCC
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRIS 622 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~~ 622 (624)
+.++.. .....+......+.+|+.+||+.||++|||+.|+++.|+.+.....++.+
T Consensus 262 ~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 262 ELLERG---ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred HHHhcc---cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 110000 01111223446788999999999999999999999999999887665543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=359.32 Aligned_cols=261 Identities=28% Similarity=0.412 Sum_probs=195.5
Q ss_pred CCccceeccCCcEEEEEEEEc--CC--CEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEe-CCceeEEE
Q 039681 332 FSKDNLIGTGGFGEVFKGILD--DG--TVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE-LDQTLMIY 405 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 405 (624)
|...+.||+|+||+||+|+.. ++ ..||+|.++.. .....+.|.+|+.++++++||||+++++++.+ .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 566789999999999999853 22 36899988643 33456789999999999999999999998765 45789999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 171 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp ECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred ECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999963 3356899999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||...... +....+. ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~---~~~~--- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL---QGRR--- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHH---TTCC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHH---cCCC---
Confidence 332222222234567889999999998899999999999999999999 55666533222 1211111 1110
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
... +...+..+.+++.+||+.+|++|||+.|+++.|+++.....
T Consensus 315 ~~~----------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 315 LLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000 11233567889999999999999999999999999987544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=343.87 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=208.6
Q ss_pred CCCccceeccCCcEEEEEEEEc-CC---CEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce-eEE
Q 039681 331 NFSKDNLIGTGGFGEVFKGILD-DG---TVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT-LMI 404 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 404 (624)
.|...++||+|+||+||+|... ++ ..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3556789999999999999853 23 3799998875433 3457799999999999999999999999876665 999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
+||+.+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 102 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp ECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 999999999999963 3456899999999999999999999999 999999999999999999999999999866
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
...............++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .....+. ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~----~~~~-- 246 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFLA----QGRR-- 246 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHHH----TTCC--
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHhh----cCCC--
Confidence 4332222222345567899999999999899999999999999999999776654332221 1111111 1100
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
...+......+.+++.+||+.+|.+|||++|+++.|++++....+
T Consensus 247 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 247 ----------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ----------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 000112335678899999999999999999999999999886544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=349.36 Aligned_cols=269 Identities=23% Similarity=0.371 Sum_probs=192.4
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|+..+.||+|+||+||+|.. .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45789999999999999999995 4689999999875433 334678999999999999999999999999999999999
Q ss_pred eccCCCcccccccccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 407 YIPNGTLFDHLHCDFT-GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
|++ |+|.+++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 699998864322 22346999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---cc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---ER 561 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 561 (624)
.. ........+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+.. ..+...... ..
T Consensus 160 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IP----VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESL 232 (317)
T ss_dssp SC----CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTT
T ss_pred CC----cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhH
Confidence 22 1123355789999999998764 6899999999999999999999999765433221 111111111 00
Q ss_pred cccc-----cchhhhhcc---------CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEV-----VDPVLKERA---------THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~-----~d~~l~~~~---------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... ..+.+.... ..........+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 000000000 0000123356889999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.62 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=203.8
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
...++|++.+.||+|+||.||++.. .+|+.+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3456799999999999999999985 4689999999875432 335678999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC---CCCCeEEeecCC
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD---EKLNAKVSDFGL 480 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~---~~~~~kl~DfGl 480 (624)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999999999863 346999999999999999999999999 99999999999998 567899999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+...... ........||+.|+|||++.+..++.++||||||+++|||++|..||......+ .... +..+
T Consensus 160 a~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------~~~~-i~~~ 228 (444)
T 3soa_A 160 AIEVEGE----QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------LYQQ-IKAG 228 (444)
T ss_dssp CBCCCTT----CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHH-HHHT
T ss_pred eEEecCC----CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH------HHHH-HHhC
Confidence 9876432 122345679999999999998899999999999999999999999996543221 1111 1111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. ....+.. ......+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~-~~~~~~~--------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 229 AY-DFPSPEW--------DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CC-CCCTTTT--------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-CCCcccc--------ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11 0001100 123356788999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.75 Aligned_cols=265 Identities=28% Similarity=0.401 Sum_probs=205.1
Q ss_pred CCCCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEe-CCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE-LDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 403 (624)
.+|.+.+.||+|+||+||+|+..+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457888999999999999998542 2358999876533 3345779999999999999999999998654 567899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 105 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999963 3356899999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
................+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ....... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~~---~~~~~-- 250 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQGRR-- 250 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--TTHHHHH---HTTCC--
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHH---hcCCC--
Confidence 6543222222334556788999999999889999999999999999999955544322211 1111111 11100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
.. .+......+.+++.+||+.+|++|||++|+++.|+++...-.+
T Consensus 251 -~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 251 -LL----------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp -CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred -CC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 00 0112234678899999999999999999999999999875443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=354.67 Aligned_cols=271 Identities=23% Similarity=0.374 Sum_probs=209.6
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEE------cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhc-CCCceeeEeeEEEe
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVE 397 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 397 (624)
+...++|.+.+.||+|+||.||+|+. .++..||||++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 33456788999999999999999995 235689999987542 33457799999999999 89999999999999
Q ss_pred CCceeEEEeeccCCCcccccccccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTG------------------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRD 459 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~D 459 (624)
.+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 99999999999999999999743210 1134899999999999999999999999 99999
Q ss_pred CCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCC
Q 039681 460 VKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAI 538 (624)
Q Consensus 460 ik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~ 538 (624)
|||+|||++.++.+||+|||++....... .........+|+.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDS--NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCc--cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999998765321 1122234557889999999988889999999999999999998 99998
Q ss_pred CCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 539 DFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
......+. +.......... ..+......+.+|+.+||+.||.+|||+.|+++.|+.+...+.
T Consensus 276 ~~~~~~~~------~~~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 276 PGIPVDAN------FYKLIQNGFKM------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCSHH------HHHHHHTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ccCCcHHH------HHHHHhcCCCC------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 75432211 11111111000 0011234567889999999999999999999999999987654
Q ss_pred c
Q 039681 619 G 619 (624)
Q Consensus 619 ~ 619 (624)
.
T Consensus 338 ~ 338 (344)
T 1rjb_A 338 E 338 (344)
T ss_dssp -
T ss_pred H
Confidence 4
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=345.09 Aligned_cols=265 Identities=20% Similarity=0.297 Sum_probs=201.2
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57888999999999999999964 689999999875433 334678999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++ +|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 56555542 2356999999999999999999999999 99999999999999999999999999987642
Q ss_pred cCCCCcceeecccccccccCcccccccC-CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---ccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---ERL 562 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 562 (624)
. ........+|+.|+|||++.+.. ++.++||||||+++|||++|+.|+....... .....+...... +..
T Consensus 154 ~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 154 P----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp C----CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTC
T ss_pred c----cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhh
Confidence 2 12234557899999999997765 8999999999999999999998865333221 111222221111 100
Q ss_pred cccc---chh----h--hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVV---DPV----L--KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~---d~~----l--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... +.. . ..............+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 000 0 00000011123456788999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=363.11 Aligned_cols=261 Identities=21% Similarity=0.264 Sum_probs=205.4
Q ss_pred HHHHHHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 039681 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397 (624)
Q Consensus 322 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 397 (624)
.+++....++|++.++||+|+||+||+++.. +++.||||+++... ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3445556688999999999999999999974 68999999986421 2234568999999999999999999999999
Q ss_pred CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
.+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999632 236999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCccccc-------ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR-------NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 550 (624)
||+++..... .........||+.|+|||++. ...++.++||||||+++|||++|+.||......+.
T Consensus 206 FGla~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---- 278 (412)
T 2vd5_A 206 FGSCLKLRAD---GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---- 278 (412)
T ss_dssp CTTCEECCTT---SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----
T ss_pred chhheeccCC---CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH----
Confidence 9999876422 111223457999999999987 35689999999999999999999999975433221
Q ss_pred HHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCC---CCHHHHHH
Q 039681 551 VYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNR---PSMKEVAD 608 (624)
Q Consensus 551 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~ev~~ 608 (624)
............ -+.. ......++.+|+.+||+ +|.+| |+++|+++
T Consensus 279 --~~~i~~~~~~~~--~p~~-------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 --YGKIVHYKEHLS--LPLV-------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp --HHHHHTHHHHCC--CC-----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred --HHHHHhcccCcC--CCcc-------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111100000 0000 11234567889999999 99998 58888864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=362.75 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=205.4
Q ss_pred HHHHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC
Q 039681 324 EIRRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD 399 (624)
Q Consensus 324 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 399 (624)
+++...++|.+.+.||+|+||+||+++.. +++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34455678999999999999999999965 5899999998642 1223456889999999999999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+++|+|.++++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999863 25899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccC----CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ----LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 555 (624)
+++..... .........||+.|+|||++.+.. ++.++||||||+++|||++|+.||......+ ....
T Consensus 214 ~a~~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~ 284 (410)
T 3v8s_A 214 TCMKMNKE---GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSK 284 (410)
T ss_dssp TCEECCTT---SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH
T ss_pred eeEeeccC---CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHHH
Confidence 99876422 112234567999999999997654 7899999999999999999999997543321 1111
Q ss_pred HhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCC--CCCHHHHHH
Q 039681 556 IMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQN--RPSMKEVAD 608 (624)
Q Consensus 556 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~ 608 (624)
.......... |. ......++.+|+.+||+.+|.+ ||+++||++
T Consensus 285 i~~~~~~~~~--p~--------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 285 IMNHKNSLTF--PD--------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHTHHHHCCC--CT--------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHhccccccC--CC--------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111000000 00 0123356788999999999988 999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=343.52 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=207.6
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
..++|.+.+.||+|+||+||+|+..+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678899999999999999998543 2369999987543 3446779999999999999999999999765 5678
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 999999999999999642 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
...... ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+.. ...
T Consensus 162 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~---~~~ 232 (281)
T 3cc6_A 162 YIEDED---YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEK---GDR 232 (281)
T ss_dssp CC------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHH---TCC
T ss_pred cccccc---ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhc---CCC
Confidence 764321 111234457889999999988889999999999999999998 999987543322 1111111 100
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
. ..+......+.+++.+||+.+|++|||+.|+++.|+++.+...+
T Consensus 233 ~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 233 L-------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp C-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred C-------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 0 00112234578899999999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.29 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=206.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|.+.+.||+|+||.||+|... +++.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999964 6899999998766555667899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC--CCCeEEeecCCccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE--KLNAKVSDFGLSRLVE 485 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~--~~~~kl~DfGla~~~~ 485 (624)
+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 130 LSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999863 2346999999999999999999999999 999999999999974 5779999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... . .
T Consensus 203 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~i~~~~-~--~ 268 (387)
T 1kob_A 203 PD-----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCD-W--E 268 (387)
T ss_dssp TT-----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCC-C--C
T ss_pred CC-----cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-C--C
Confidence 32 12344579999999999998889999999999999999999999997543221 111111111 0 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.++.. ......++.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~~-------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 FDEDA-------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCSST-------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCccc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 01111 0123456788999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.08 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=198.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ------ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 400 (624)
.++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999975 789999999875433 345779999999999999999999999876542
Q ss_pred ---------------------------------------------------eeEEEeeccCCCcccccccccCCCCCCCC
Q 039681 401 ---------------------------------------------------TLMIYEYIPNGTLFDHLHCDFTGKWPPLP 429 (624)
Q Consensus 401 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~ 429 (624)
.++||||+++++|.+++.... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccchh
Confidence 789999999999999997432 234567
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCc--------ceeeccccc
Q 039681 430 WHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS--------HIFTTAQGT 501 (624)
Q Consensus 430 ~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~--------~~~~~~~gt 501 (624)
+..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 8889999999999999999999 99999999999999999999999999987654321110 122345799
Q ss_pred ccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHH
Q 039681 502 MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLET 581 (624)
Q Consensus 502 ~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 581 (624)
+.|+|||++.+..++.++||||||+++|||++|..|+.. .. .... ....... +. .....
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~---~~~~-~~~~~~~-----~~-------~~~~~ 298 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RV---RIIT-DVRNLKF-----PL-------LFTQK 298 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HH---HHHH-HHHTTCC-----CH-------HHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HH---HHHH-HhhccCC-----Cc-------ccccC
Confidence 999999999988999999999999999999998766421 00 0011 1111100 00 01233
Q ss_pred HHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 582 MKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 582 ~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...+.+++.+||+.||++|||++|+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 456688999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=355.41 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=204.2
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
..++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999964 68999999986543 23456789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC---CCeEEeecCCc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK---LNAKVSDFGLS 481 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~---~~~kl~DfGla 481 (624)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 107 ~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp ECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 999999999998862 356999999999999999999999999 9999999999999865 45999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ + ... +..+.
T Consensus 179 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~---~~~-i~~~~ 246 (362)
T 2bdw_A 179 IEVNDS-----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L---YAQ-IKAGA 246 (362)
T ss_dssp BCCTTC-----CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHH-HHHTC
T ss_pred eEecCC-----cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H---HHH-HHhCC
Confidence 876432 12345679999999999998899999999999999999999999997543211 1 111 11111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.. ...+.. ......+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~-~~~~~~--------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 YD-YPSPEW--------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC-CCTTGG--------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC-CCcccc--------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 1233567889999999999999999998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.40 Aligned_cols=262 Identities=31% Similarity=0.464 Sum_probs=203.3
Q ss_pred CCCCccceeccCCcEEEEEEEEcC-----CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD-----GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|+..+.||+|+||+||+|.... +..||||+++.... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 457778999999999999998643 23599999875433 345678999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 124 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEeCCCCCcHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999963 2356999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
...... .........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...........
T Consensus 197 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~~~~~~~~~ 269 (333)
T 1mqb_A 197 LEDDPE-ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFRL 269 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCC
T ss_pred hccccc-cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHCCCcC
Confidence 653211 1111223346788999999998889999999999999999999 999986432211 11111111100
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.........+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 270 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 270 -------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp -------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0011234567889999999999999999999999999987544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=353.49 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=198.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 404 (624)
++|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|..+++++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999965 58899999986542 23456688999999988 899999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999998632 46999999999999999999999999 999999999999999999999999999864
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccc--cHHHHHHHHhccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV--NLVVYMKKIMDEERL 562 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 562 (624)
... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .....+...+.....
T Consensus 161 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 161 LRP----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp CCT----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred cCC----CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 321 11234567999999999999989999999999999999999999999643221110 001111111111110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
..+......+.+|+.+||+.||++||++
T Consensus 237 -------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 -------------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -------------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0111233567889999999999999995
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=353.41 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=201.1
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36789999999999999999996 578999999876421 22245789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+ +|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 88 ~E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 7899998863 246999999999999999999999999 999999999999999999999999999875
Q ss_pred cccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......+.. .
T Consensus 159 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~ 218 (336)
T 3h4j_B 159 TDGN-----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------K 218 (336)
T ss_dssp TTSB-----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------C
T ss_pred cCCc-----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------H
Confidence 4321 2245579999999999987765 68999999999999999999999754322111 0
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.. .....+......+.+|+.+||+.||.+|||++|+++
T Consensus 219 ~i~~-----~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 219 KVNS-----CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCS-----SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHc-----CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000 000111123456788999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.52 Aligned_cols=244 Identities=27% Similarity=0.383 Sum_probs=202.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||+++.. +|+.||+|+++... ....+.+.+|..+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56889999999999999999964 68999999986432 234567889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999963 246999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 158 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~-~--- 220 (318)
T 1fot_A 158 DV-------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAE-L--- 220 (318)
T ss_dssp SC-------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCC-C---
T ss_pred Cc-------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-C---
Confidence 21 234579999999999998899999999999999999999999997543211 112211111 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
..+.....++.+++.+||+.||++|| +++|+++
T Consensus 221 ----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00112234577899999999999999 8888874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=339.00 Aligned_cols=271 Identities=19% Similarity=0.240 Sum_probs=208.8
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEE-EeCCceeEE
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCC-VELDQTLMI 404 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 404 (624)
...++|++.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.+++.++|++++..++.+ .+....++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999995 57899999986543 2334688999999999988877766665 567788999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE---CCCCCeEEeecCCc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLS 481 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill---~~~~~~kl~DfGla 481 (624)
|||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 84 MELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EECC-CCBHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEcc-CCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999 9999999863 2346999999999999999999999999 9999999999999 78999999999999
Q ss_pred ccccccCCCCc---ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 482 RLVERTETNDS---HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 482 ~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+.......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 87654322111 112355789999999999998999999999999999999999999986544433333222211111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
.... +.+. ...+..+.+++.+||+.+|++|||+++|++.|+++......
T Consensus 236 ~~~~-----~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 236 STPI-----EVLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HSCH-----HHHT-------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred cchh-----hhhh-------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 1000 0000 11235688899999999999999999999999999886543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=344.93 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=203.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CC-------CEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DG-------TVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
.++|.+.+.||+|+||+||+|+.. ++ ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 356888999999999999999854 23 4799999876666667889999999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC--------
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN-------- 472 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~-------- 472 (624)
.++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999742 234999999999999999999999999 999999999999998887
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV 551 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 551 (624)
+||+|||++...... ....+|..|+|||++.+ ..++.++||||||+++|||++|..|+....... .
T Consensus 160 ~kl~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~ 226 (289)
T 4fvq_A 160 IKLSDPGISITVLPK--------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----R 226 (289)
T ss_dssp EEECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----H
T ss_pred eeeccCcccccccCc--------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----H
Confidence 999999999754321 23457889999999987 679999999999999999999766554322111 1
Q ss_pred HHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 552 YMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 552 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
............. ....++.+++.+||+.||++|||+.|+++.|+++..-.
T Consensus 227 ~~~~~~~~~~~~~---------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 227 KLQFYEDRHQLPA---------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHHHHHTTCCCCC---------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred HHHHhhccCCCCC---------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111111111111 11234677999999999999999999999999887643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=346.68 Aligned_cols=278 Identities=21% Similarity=0.319 Sum_probs=214.2
Q ss_pred cCHHHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHh--cCCCceeeEeeEEEe
Q 039681 320 FTGKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQ--VNHRSLVRLLGCCVE 397 (624)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 397 (624)
.....-....++|.+.+.||+|+||.||+|+. +++.||||++.. ...+.+.+|.+++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 33333455667899999999999999999987 589999999863 334667889999988 789999999999988
Q ss_pred CC----ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeecCCCCCe
Q 039681 398 LD----QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH--------SAAVPPIYHRDVKSSNI 465 (624)
Q Consensus 398 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--------~~~~~~iiH~Dik~~Ni 465 (624)
.. ..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+||
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 76 78999999999999999963 35899999999999999999999 777 99999999999
Q ss_pred EECCCCCeEEeecCCcccccccCCCCcceeecccccccccCccccccc------CCCCccchhhHHHHHHHHHhC-----
Q 039681 466 LLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF------QLTDKSDVYSFGVVLLELLTS----- 534 (624)
Q Consensus 466 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~vl~elltg----- 534 (624)
|++.++.+||+|||++..................||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 999999999999999987653321111122445789999999998765 344789999999999999999
Q ss_pred -----CCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 535 -----KKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 535 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..||......+ .....+ ......... .+.+.... ........+.+|+.+||+.||++|||+.||++.
T Consensus 259 ~~~~~~~p~~~~~~~~-~~~~~~-~~~~~~~~~----~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSD-PSVEEM-RKVVCEQKL----RPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp BCCCCCCTTTTTSCSS-CCHHHH-HHHHTTSCC----CCCCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccccccCccccCcCc-ccHHHH-HHHHHHHHh----CCCCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 66775432221 111111 111211111 11111110 123567789999999999999999999999999
Q ss_pred HHHHHHhcc
Q 039681 610 IEYIISIAK 618 (624)
Q Consensus 610 L~~i~~~~~ 618 (624)
|+++.....
T Consensus 331 L~~i~~~~~ 339 (342)
T 1b6c_B 331 LSQLSQQEG 339 (342)
T ss_dssp HHHHHHTTC
T ss_pred HHHHHHHhc
Confidence 999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=356.46 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=202.3
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCc
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 400 (624)
....++|.+.+.||+|+||.||+++.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999975 68999999986432 23456688899999887 89999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChh
Confidence 9999999999999999963 246999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 165 a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~ 234 (345)
T 1xjd_A 165 CKENMLG----DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDN 234 (345)
T ss_dssp CBCCCCT----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC
T ss_pred hhhcccC----CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC
Confidence 9864321 112345679999999999999899999999999999999999999997543221 111111110
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK-EVA 607 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~ 607 (624)
+.+ +......+.+|+.+||+.||++||++. |++
T Consensus 235 -------~~~-------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -------PFY-------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------CCC-------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCC-------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 000 111234577899999999999999997 554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=347.82 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=202.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCE----EEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTV----TAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|++.+.||+|+||+||+|+.. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888999999999999999954 4443 7888765432 333466889999999999999999999886 567899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999632 346899999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... .........++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ... .......
T Consensus 165 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~ 235 (325)
T 3kex_A 165 LPPDD--KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD----LLEKGER 235 (325)
T ss_dssp SCCCT--TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH----HHHTTCB
T ss_pred cCccc--ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH----HHHcCCC
Confidence 65322 1222345567889999999998899999999999999999999 999997543322 111 1111110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
. ..+ ......+.+++.+||+.+|.+|||+.|+++.|+++...
T Consensus 236 ~--~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 236 L--AQP----------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp C--CCC----------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred C--CCC----------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000 01122466799999999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=352.49 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=203.1
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC-----CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG-----NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
.++|++.+.||+|+||+||+++. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34688999999999999999996 46899999987532 1224577999999999999999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC---eEEeecC
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN---AKVSDFG 479 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~---~kl~DfG 479 (624)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999888854321 2346899999999999999999999999 999999999999986654 9999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+ ......
T Consensus 179 ~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~---~~~i~~- 246 (351)
T 3c0i_A 179 VAIQLGES----GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RL---FEGIIK- 246 (351)
T ss_dssp TCEECCTT----SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HH---HHHHHH-
T ss_pred ceeEecCC----CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HH---HHHHHc-
Confidence 99876432 1123355799999999999988899999999999999999999999975321 11 111111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... ..++... ......+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~--~~~~~~~-------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKY--KMNPRQW-------SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCC--CCCHHHH-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC--CCCcccc-------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 100 0111110 012356788999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=344.25 Aligned_cols=270 Identities=22% Similarity=0.335 Sum_probs=203.5
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35789999999999999999996 57899999998753 233456789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++.... .....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999986321 13456999999999999999999999999 999999999999999999999999999865
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........ ........
T Consensus 187 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~~~~~ 257 (310)
T 2wqm_A 187 SSKT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-IEQCDYPP 257 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHH-HHTTCSCC
T ss_pred cCCC----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHH-hhcccCCC
Confidence 4221 112345689999999999988899999999999999999999999864322 11111111 11111111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccCCC
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRIS 622 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~~ 622 (624)
.. .......+.+++.+||+.||++|||++||++.|+++....+...+
T Consensus 258 ~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 258 LP-----------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp CC-----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred Cc-----------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 00 012335678899999999999999999999999999988776543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.11 Aligned_cols=270 Identities=19% Similarity=0.235 Sum_probs=211.8
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEE-EeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCC-VELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++.++|+++++.+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56899999999999999999996 678999999876543 335689999999999988876666655 56677899999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE---CCCCCeEEeecCCccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRL 483 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill---~~~~~~kl~DfGla~~ 483 (624)
|+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 86 LL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp CC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 99 9999999963 2346999999999999999999999999 9999999999999 4889999999999987
Q ss_pred ccccCCCCc---ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 484 VERTETNDS---HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 484 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.......+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 654322111 11235578999999999999899999999999999999999999998654433333322222111100
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
.. +.+. ...+..+.+++.+||+.+|++|||+.+|++.|+++.......
T Consensus 238 ~~-----~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 238 PI-----EVLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp CH-----HHHT-------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ch-----HHHH-------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 00 0000 122356888999999999999999999999999998865543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.51 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=193.7
Q ss_pred hCCCCccceeccCCcEEEEEEEE----cCCCEEEEEEcccCC----cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKRAKLGN----TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
.++|++.+.||+|+||.||+++. .+++.||+|+++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45789999999999999999996 478999999987542 2344568899999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence 9999999999999999963 246899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+.......
T Consensus 168 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~ 237 (327)
T 3a62_A 168 CKESIHD----GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKILKCK 237 (327)
T ss_dssp C--------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTC
T ss_pred ccccccC----CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCC
Confidence 9754321 112345679999999999998889999999999999999999999997543221 111111110
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
. ..+......+.+++.+||+.||++|| ++.|+++
T Consensus 238 -~-------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -L-------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -C-------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -C-------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 00112335678899999999999999 7777764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=340.97 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=209.7
Q ss_pred CCCCccc-eeccCCcEEEEEEEEc---CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDN-LIGTGGFGEVFKGILD---DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++|.+.+ .||+|+||.||+|+.. ++..||||+++.... ...+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999853 578899999876433 3467799999999999999999999999 56679999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999863 3356999999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. . ........
T Consensus 161 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---~-~i~~~~~~ 232 (287)
T 1u59_A 161 GADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM---A-FIEQGKRM 232 (287)
T ss_dssp TTCSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH---H-HHHTTCCC
T ss_pred ccCcce-eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HH---H-HHhcCCcC
Confidence 432111 111223456889999999988889999999999999999998 999987543221 11 1 11111100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
..+......+.+++.+||+.+|++||++.|+++.|+++.......
T Consensus 233 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 233 ------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 111223456888999999999999999999999999998766544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=353.87 Aligned_cols=268 Identities=23% Similarity=0.298 Sum_probs=205.4
Q ss_pred HHHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC-----CcchhHHHHHHHHHHHhcCCCceeeEeeEE
Q 039681 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG-----NTKGTDLVLNEVRILCQVNHRSLVRLLGCC 395 (624)
Q Consensus 322 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 395 (624)
..++....++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 345567778899999999999999999996 46889999987543 334567899999999999999999999999
Q ss_pred EeCCceeEEEeeccCCCcccccccccCC-----------------------------------CCCCCCHHHHHHHHHHH
Q 039681 396 VELDQTLMIYEYIPNGTLFDHLHCDFTG-----------------------------------KWPPLPWHLRLVIAHQI 440 (624)
Q Consensus 396 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~i 440 (624)
.+.+..++||||+++|+|.+++...... ....+++..++.|+.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999999988521110 01234678889999999
Q ss_pred HHHHHHHHhcCCCCeEeecCCCCCeEECCCC--CeEEeecCCcccccccCCCCcceeecccccccccCcccccc--cCCC
Q 039681 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKL--NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN--FQLT 516 (624)
Q Consensus 441 ~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~ 516 (624)
+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+...............||+.|+|||++.+ ..++
T Consensus 178 ~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 178 FSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 99999999999 99999999999998776 89999999998765432222223456679999999999865 5789
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcC
Q 039681 517 DKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDER 596 (624)
Q Consensus 517 ~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~ 596 (624)
.++||||||+++|||++|+.||......+ ........... ...+.. ......+.+|+.+||+.+
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~--~~~~~~--------~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLC--FENPNY--------NVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC--TTSGGG--------GGSCHHHHHHHHHHSCSC
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcccc--cCCccc--------ccCCHHHHHHHHHHcCCC
Confidence 99999999999999999999997543321 11111111100 001110 113356788999999999
Q ss_pred CCCCCCHHHHHH
Q 039681 597 RQNRPSMKEVAD 608 (624)
Q Consensus 597 p~~RPs~~ev~~ 608 (624)
|.+|||+.|+++
T Consensus 319 p~~Rps~~~~l~ 330 (345)
T 3hko_A 319 VDERFDAMRALQ 330 (345)
T ss_dssp TTTSCCHHHHHH
T ss_pred hhHCCCHHHHhc
Confidence 999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=339.95 Aligned_cols=255 Identities=32% Similarity=0.547 Sum_probs=202.6
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcch-------hHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKG-------TDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
.++|++.+.||+|+||+||+|+. .+++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46789999999999999999996 578999999986543321 167899999999999999999999986544
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC-----eEE
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN-----AKV 475 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~-----~kl 475 (624)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence 799999999999988863 3357999999999999999999999987 45899999999999988776 999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCccccc--ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR--NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 553 (624)
+|||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||......+ ....
T Consensus 171 ~Dfg~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~ 239 (287)
T 4f0f_A 171 ADFGLSQQSVH-------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFI 239 (287)
T ss_dssp CCCTTCBCCSS-------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHH
T ss_pred CCCCccccccc-------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHH
Confidence 99999975432 134567899999999983 4467899999999999999999999997543221 1111
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
....... .. +. ........+.+++.+||+.||++|||++|+++.|++|
T Consensus 240 ~~~~~~~-~~----~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 NMIREEG-LR----PT-------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHSC-CC----CC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHhccC-CC----CC-------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111111 11 00 1112345688899999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=375.60 Aligned_cols=258 Identities=25% Similarity=0.425 Sum_probs=204.0
Q ss_pred eeccCCcEEEEEEEEc---CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCC
Q 039681 337 LIGTGGFGEVFKGILD---DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 337 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
.||+|+||.||+|... ++..||||+++... ....+.|.+|+++|++++|||||++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999987643 3356789999999999999999999999976 66899999999999
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCc
Q 039681 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492 (624)
Q Consensus 413 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 492 (624)
|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++........ .
T Consensus 422 L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 493 (613)
T 2ozo_A 422 LHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-Y 493 (613)
T ss_dssp HHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce-e
Confidence 9999963 3456999999999999999999999999 999999999999999999999999999876432111 1
Q ss_pred ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchhhh
Q 039681 493 HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLK 571 (624)
Q Consensus 493 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 571 (624)
.......+++.|+|||++.+..++.++||||||++||||++ |+.||......+ .. ..+..+...
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~~~-------- 558 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKRM-------- 558 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH----HHHHTTCCC--------
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCC--------
Confidence 11123345689999999998899999999999999999998 999997543321 11 111111110
Q ss_pred hccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccCCC
Q 039681 572 ERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRIS 622 (624)
Q Consensus 572 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~~ 622 (624)
..+...+..+.+|+.+||+.+|++||++.+|++.|+.+........+
T Consensus 559 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 559 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 11123445688899999999999999999999999999876655443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.57 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=204.3
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC--CceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL--DQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 405 (624)
++|.+.+.||+|+||.||+|+.+ ++.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888999999999999999985 8889999987543 23456799999999999999999999999887 7889999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++... ....+++.+++.++.||+.||+|||+.+ ++|+||||||+|||+++++.++|.|||++....
T Consensus 89 e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999742 2346999999999999999999999976 458999999999999999999999999876432
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCC---ccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTD---KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
. ....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||......+ ...........
T Consensus 165 ~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~ 229 (271)
T 3kmu_A 165 S---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGLR 229 (271)
T ss_dssp C---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCCC
T ss_pred c---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCCC
Confidence 1 2345789999999998655444 8999999999999999999997433221 11111111110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
+. .+......+.+++.+||+.||++|||++|+++.|+++.
T Consensus 230 -----~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 -----PT-------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -----CC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----CC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01 11123456788999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.04 Aligned_cols=261 Identities=30% Similarity=0.498 Sum_probs=195.9
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
..++|++.+.||+|+||+||+|+.. ..||+|+++... ....+.+.+|++++++++||||++++++. .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3567999999999999999999854 359999887543 23456799999999999999999999965 556789999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 99 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 99 QWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp ECCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999863 3356999999999999999999999999 9999999999999999999999999997654
Q ss_pred ccCCCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.. ..........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+. +.........
T Consensus 172 ~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~ 243 (289)
T 3og7_A 172 RW--SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSL 243 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSC
T ss_pred cc--cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhccccc
Confidence 21 1122234567899999999986 55688899999999999999999999975432211 1111111111
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
. +.+. ......+..+.+|+.+||+.+|++|||+.|++++|+++.
T Consensus 244 ~----~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 S----PDLS----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C----CCTT----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred C----cchh----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1 1110 011123456888999999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=344.70 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=198.9
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|++.+.||+|+||+||+++.. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999965 5899999987654332 24668899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999888752 346999999999999999999999999 99999999999999999999999999987642
Q ss_pred cCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc------
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE------ 559 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 559 (624)
. ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... +......
T Consensus 155 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~ 227 (311)
T 4agu_A 155 P----SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL---IRKTLGDLIPRHQ 227 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHH
T ss_pred c----ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhcccccccc
Confidence 2 122345578999999999875 5689999999999999999999999976544332211 1111110
Q ss_pred -----ccc-c--cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 -----ERL-M--EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 -----~~~-~--~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... . ...++................+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0 000000000000000123456788999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.72 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=197.0
Q ss_pred cceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 335 DNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
.++||+|+||.||+|.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999996 46899999999876666678899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE--CCCCCeEEeecCCcccccccCCCC
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL--DEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill--~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++......
T Consensus 174 ~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 174 FDRIID----ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp HHHHHH----TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 998863 2246999999999999999999999999 9999999999999 677899999999998764321
Q ss_pred cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhh
Q 039681 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLK 571 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 571 (624)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+........ ...++..
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~--~~~~~~~- 312 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACRW--DLEDEEF- 312 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC--CSCSGGG-
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccC--CCChhhh-
Confidence 1234569999999999988889999999999999999999999997543321 1111111110 0001000
Q ss_pred hccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 572 ERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 572 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.....++.+|+.+||+.||.+|||+.|+++
T Consensus 313 -------~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 -------QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 123356788999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=345.28 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=199.9
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc-----chhHHHHHHHHHHHhcC---CCceeeEeeEEEeC
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT-----KGTDLVLNEVRILCQVN---HRSLVRLLGCCVEL 398 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 398 (624)
..++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999995 5789999999864321 12345677888777764 99999999999876
Q ss_pred C-----ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 399 D-----QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 399 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
. ..++||||+. ++|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 5 4789999996 6999998743 2345999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 553 (624)
||+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+
T Consensus 160 kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i 231 (308)
T 3g33_A 160 KLADFGLARIYSYQ-----MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKI 231 (308)
T ss_dssp EECSCSCTTTSTTC-----CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHH
T ss_pred EEeeCccccccCCC-----cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH
Confidence 99999999865422 1124567899999999999889999999999999999999999999765433221 111
Q ss_pred HHHhc---cccccccc---chhhhhccC----cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 554 KKIMD---EERLMEVV---DPVLKERAT----HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 554 ~~~~~---~~~~~~~~---d~~l~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..... ........ ...+..... .........+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11111 11110000 000000000 000123456788999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.96 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=198.7
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|++.+.||+|+||+||+++.. ++.||||++.. ....+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46888899999999999999875 78899999863 345577999999999999999999999876 45899999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC-eEEeecCCcccccccC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN-AKVSDFGLSRLVERTE 488 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~-~kl~DfGla~~~~~~~ 488 (624)
+|+|.+++... .....+++..++.++.|+++||+|||+.+...|+||||||+|||+++++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 83 GGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TCBHHHHHHCS--SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCHHHHHhcc--CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999742 12235889999999999999999999932222999999999999998886 799999999765321
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
.....||..|+|||++.+..++.++||||||+++|||++|+.||....... ......... .....
T Consensus 160 ------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~---- 224 (307)
T 2eva_A 160 ------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GTRPP---- 224 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TCCCC----
T ss_pred ------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CCCCC----
Confidence 223468999999999998899999999999999999999999996432211 111111111 11000
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
........+.+++.+||+.+|++|||++|+++.|+.+....
T Consensus 225 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 225 --------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp --------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred --------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 01123345788999999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=345.17 Aligned_cols=268 Identities=24% Similarity=0.379 Sum_probs=201.4
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc----CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC-
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD- 399 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 399 (624)
...++|.+.+.||+|+||.||+|... .+..||+|+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888999999999999999854 24589999987543 334567999999999999999999999998755
Q ss_pred ----ceeEEEeeccCCCccccccccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 400 ----QTLMIYEYIPNGTLFDHLHCDF-TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 400 ----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
..++||||+++++|.+++.... ......+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 3499999999999999985322 123467999999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 553 (624)
|+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 188 l~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~-- 260 (313)
T 3brb_A 188 VADFGLSKKIYSGDY--YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD-- 260 (313)
T ss_dssp ECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH--
T ss_pred EeecCcceecccccc--cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH--
Confidence 999999987643211 111234457889999999998899999999999999999999 888886543321 111
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
....... ..........+.+++.+||+.+|++|||+.++++.|+++.....
T Consensus 261 -~~~~~~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 -YLLHGHR-------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp -HHHTTCC-------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -HHHcCCC-------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1111110 00111234568889999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.72 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=202.0
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCcee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 402 (624)
..++|++.+.||+|+||.||+++.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4568999999999999999999975 4789999998643 223456788999999988 7999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++
T Consensus 98 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999632 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 170 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~-~ 238 (353)
T 2i0e_A 170 ENIWD----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHN-V 238 (353)
T ss_dssp CCCCT----TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-C
T ss_pred ccccC----CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HHHHHHhCC-C
Confidence 64321 112345679999999999998899999999999999999999999997543221 111111111 0
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
..+.....++.+|+.+||+.||++||+ ++|+++
T Consensus 239 -------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 -------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 001123356788999999999999995 466653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=347.05 Aligned_cols=273 Identities=24% Similarity=0.403 Sum_probs=201.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHH--HHhcCCCceeeEeeEEEe-----CCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRI--LCQVNHRSLVRLLGCCVE-----LDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 401 (624)
.++|++.+.||+|+||.||+|+. +++.||||++... ..+.+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46789999999999999999976 6899999998643 23344555555 445899999999986653 2256
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEeecCCCCCeEECCCCC
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA---------AVPPIYHRDVKSSNILLDEKLN 472 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~---------~~~~iiH~Dik~~Nill~~~~~ 472 (624)
++||||+++|+|.+++.. ..+++..++.++.||++||+|||+. + |+||||||+|||+++++.
T Consensus 88 ~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 899999999999999963 2458999999999999999999999 7 999999999999999999
Q ss_pred eEEeecCCcccccccCCC----CcceeecccccccccCcccccc-------cCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 039681 473 AKVSDFGLSRLVERTETN----DSHIFTTAQGTMGYLDPEYYRN-------FQLTDKSDVYSFGVVLLELLTSKKAIDFN 541 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~s~G~vl~elltg~~p~~~~ 541 (624)
+||+|||+++.+...... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999876532111 1112234569999999999976 45778999999999999999998887543
Q ss_pred CccccccHH-----------HHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHH
Q 039681 542 REEENVNLV-----------VYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEI 610 (624)
Q Consensus 542 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L 610 (624)
......... ............. +.+... ..........+.+|+.+||+.||++|||++|+++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR----PKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCC----CCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccC----CCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 332211100 0011111111111 111110 111234667799999999999999999999999999
Q ss_pred HHHHHhccc
Q 039681 611 EYIISIAKG 619 (624)
Q Consensus 611 ~~i~~~~~~ 619 (624)
++++..-..
T Consensus 314 ~~ll~~~~~ 322 (336)
T 3g2f_A 314 AELMMIWER 322 (336)
T ss_dssp HHHHHCCCC
T ss_pred HHHHHHHHh
Confidence 999975443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=353.50 Aligned_cols=273 Identities=16% Similarity=0.214 Sum_probs=204.2
Q ss_pred hCCCCccceeccC--CcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 329 TNNFSKDNLIGTG--GFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.++|++.+.||+| +||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999975 68999999987543 2335678889999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999743 2346999999999999999999999999 99999999999999999999999999865
Q ss_pred ccccCCC---CcceeecccccccccCcccccc--cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 484 VERTETN---DSHIFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 484 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
....... .........||..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. .........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~ 255 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVP 255 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCC
Confidence 4321110 1111123478999999999977 57999999999999999999999999754332211 000000000
Q ss_pred ---------ccc-------------cccccchhhhh------ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 559 ---------EER-------------LMEVVDPVLKE------RATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 559 ---------~~~-------------~~~~~d~~l~~------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+. ..+........ ............+.+|+.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 00000000000 0000112234568899999999999999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=363.32 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=195.9
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD------ 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 399 (624)
.++|++.+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999985 46889999998643 3344667899999999999999999999997653
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence 56999999965 4666663 24899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
+++..... ...+...||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... +......
T Consensus 210 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~---i~~~lg~ 281 (464)
T 3ttj_A 210 LARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---VIEQLGT 281 (464)
T ss_dssp CC-----C-----CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCS
T ss_pred eeeecCCC-----cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCC
Confidence 99875422 223456799999999999998999999999999999999999999976543322111 1111110
Q ss_pred ---cccc----------------------cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ---ERLM----------------------EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ---~~~~----------------------~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+. ..+...+.............++.+|+.+||+.||++|||++|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000000000000001123567889999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=376.88 Aligned_cols=264 Identities=28% Similarity=0.421 Sum_probs=212.1
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++...++|++.+.||+|+||.||+|++.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 344456788899999999999999999888889999987543 345789999999999999999999999876 778999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.+++... ....+++.+++.|+.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 340 ~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp ECCCTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eehhcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 9999999999999642 1245899999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ........++..|+|||.+.+..++.++||||||++||||++ |+.||......+ .........++
T Consensus 414 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~- 483 (535)
T 2h8h_A 414 EDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRM- 483 (535)
T ss_dssp CCHH---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH------HHHHHHTTCCC-
T ss_pred CCCc---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCC-
Confidence 4211 111123456789999999988899999999999999999999 898986433211 11111111100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.........+.+|+.+||+.+|++|||+++|++.|+.+.....
T Consensus 484 ------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 484 ------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 0011234567889999999999999999999999998765433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.64 Aligned_cols=244 Identities=26% Similarity=0.332 Sum_probs=202.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999964 68999999986432 234567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999732 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....... +..
T Consensus 193 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~-~~~--- 255 (350)
T 1rdq_E 193 GR-------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVS-GKV--- 255 (350)
T ss_dssp SC-------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCC---
T ss_pred CC-------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHHc-CCC---
Confidence 21 124568999999999998899999999999999999999999997543221 1111111 111
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
..+......+.+++.+||+.||.+||+ ++||++
T Consensus 256 ----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 001122346788999999999999998 787764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=351.46 Aligned_cols=261 Identities=15% Similarity=0.193 Sum_probs=211.3
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEE------EcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC---CCceeeEeeEE
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGI------LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN---HRSLVRLLGCC 395 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 395 (624)
+....++|.+.+.||+|+||+||+|. ..+++.||||+++.. ...++..|+++++.++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34456779999999999999999994 456889999998743 3456788888888887 99999999999
Q ss_pred EeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC------
Q 039681 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE------ 469 (624)
Q Consensus 396 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~------ 469 (624)
...+..++||||+++|+|.+++..........+++..++.|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 99999999999999999999997433323467999999999999999999999999 999999999999998
Q ss_pred -----CCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 039681 470 -----KLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544 (624)
Q Consensus 470 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~ 544 (624)
++.+||+|||+++.+... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLF--PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGS--CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccCCEEEeeCchhhhhhcc--CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 899999999999765422 2233445678999999999999989999999999999999999999998533221
Q ss_pred ccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCC-CCHHHHHHHHHHHHHhc
Q 039681 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNR-PSMKEVADEIEYIISIA 617 (624)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~ev~~~L~~i~~~~ 617 (624)
. ..+... +.. . ...+.+.+++..|++.+|.+| |+++++.+.|+++....
T Consensus 292 ~--------------~~~~~~----~~~-~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 292 E--------------CKPEGL----FRR-L-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp E--------------EEECSC----CTT-C-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred c--------------eeechh----ccc-c-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 1 001111 110 0 123456778999999999999 78999999999987754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.26 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=189.0
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999975 57899999987432 34668899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEEeecCCccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKVSDFGLSRL 483 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl~DfGla~~ 483 (624)
|+++|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 129 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 129 LVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred eCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999863 346999999999999999999999999 999999999999975 88999999999986
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .......... .
T Consensus 201 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~-~- 268 (349)
T 2w4o_A 201 VEHQ-----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCE-Y- 268 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTC-C-
T ss_pred cCcc-----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCC-C-
Confidence 5422 12235578999999999998899999999999999999999999996433221 1111111111 0
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....+. .......+.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 YFISPW--------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCCTTT--------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCch--------hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0123456788999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.30 Aligned_cols=272 Identities=25% Similarity=0.298 Sum_probs=209.0
Q ss_pred ccCHHHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-----CCceeeEe
Q 039681 319 IFTGKEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-----HRSLVRLL 392 (624)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~ 392 (624)
.++..+.....++|.+.+.||+|+||+||+|+. .+++.||||+++. .....+.+..|+.+++.++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344455555678899999999999999999996 5689999999863 2344566788999999996 99999999
Q ss_pred eEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---
Q 039681 393 GCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE--- 469 (624)
Q Consensus 393 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~--- 469 (624)
+++...+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 9999999999999999 99999999743 3346999999999999999999999999 999999999999986
Q ss_pred ----------------------CCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHH
Q 039681 470 ----------------------KLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVV 527 (624)
Q Consensus 470 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~v 527 (624)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 789999999999864321 234568999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCccccccHHHHHHHHhcc---ccc--------ccccchh-hhhcc-----------------CcCc
Q 039681 528 LLELLTSKKAIDFNREEENVNLVVYMKKIMDE---ERL--------MEVVDPV-LKERA-----------------THLD 578 (624)
Q Consensus 528 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~d~~-l~~~~-----------------~~~~ 578 (624)
+|||++|+.||......+.... +...... ... ...++.. +.... +...
T Consensus 249 l~ell~g~~pf~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 325 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHMEHLAM---MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325 (360)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHH---HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred HHHHHHCCCCCCCCcHHHHHHH---HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence 9999999999976543322211 1111110 000 0000000 00000 0000
Q ss_pred HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 579 LETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 579 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
......+.+|+.+||+.||++|||+.|+++
T Consensus 326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 326 IIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 001156779999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=346.79 Aligned_cols=269 Identities=23% Similarity=0.375 Sum_probs=210.6
Q ss_pred hCCCCccceeccCCcEEEEEEEE-----cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC--ce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-----DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD--QT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 401 (624)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999984 368899999998766666788999999999999999999999987654 78
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 9999999999999999742 246999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccc--------c-ccHHHH
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE--------N-VNLVVY 552 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~--------~-~~~~~~ 552 (624)
........ .........++..|+|||.+.+..++.++||||||+++|||++|..|+......- . ......
T Consensus 193 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKE-YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCS-EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhcccccc-ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 87653211 1111123456778999999988889999999999999999999998875321100 0 000000
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
+....... .........+.++.+++.+||+.+|++|||+.||++.|++++..-
T Consensus 272 ~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 272 LIELLKNN------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHTT------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhhcC------------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 01111100 000111234467888999999999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=348.51 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=200.4
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCE----EEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTV----TAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
.++|++.+.||+|+||+||+|... +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357899999999999999999953 4443 577776543 3345678999999999999999999999998754 88
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+|+||+++|+|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 999999999999999642 346999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
...... .........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +... .....
T Consensus 166 ~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~----~~~~~ 236 (327)
T 3lzb_A 166 LLGAEE--KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGE 236 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTC
T ss_pred EccCcc--ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCC
Confidence 764321 1112234456889999999999899999999999999999999 999997543322 1111 11111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
.. .........+.+++.+||+.+|.+|||+.|+++.|+++...
T Consensus 237 ~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 RL------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CC------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CC------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 00 00112334578899999999999999999999999999854
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=353.51 Aligned_cols=275 Identities=23% Similarity=0.337 Sum_probs=214.5
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC--ceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD--QTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 404 (624)
.++|.+.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356889999999999999999965 58999999987433 234567889999999999999999999998765 67999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE----CCCCCeEEeecCC
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSDFGL 480 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill----~~~~~~kl~DfGl 480 (624)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp ECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999997432 2234999999999999999999999999 9999999999999 7888899999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccc--------cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRN--------FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
++...... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||.......... ..
T Consensus 163 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~ 235 (396)
T 4eut_A 163 ARELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EV 235 (396)
T ss_dssp CEECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HH
T ss_pred ceEccCCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HH
Confidence 98764321 2234569999999999864 467889999999999999999999997543322211 11
Q ss_pred HHHHhcc---ccccccc---ch------hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 553 MKKIMDE---ERLMEVV---DP------VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 553 ~~~~~~~---~~~~~~~---d~------~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
+...... ..+.... +. .+. ............+.+++.+||+.||++||+++|+++.+++++..
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 2222211 1111100 00 000 11123456778899999999999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=347.10 Aligned_cols=250 Identities=19% Similarity=0.278 Sum_probs=179.5
Q ss_pred cceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEeeccCCC
Q 039681 335 DNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
.+.||+|+||+||+++.. +++.||||++.. .....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 689999999863 34466789999999997 9999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC---CeEEeecCCcccccccCC
Q 039681 413 LFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL---NAKVSDFGLSRLVERTET 489 (624)
Q Consensus 413 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~---~~kl~DfGla~~~~~~~~ 489 (624)
|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-- 162 (325)
T 3kn6_A 93 LFERIKK-----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-- 162 (325)
T ss_dssp HHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--
Confidence 9999973 356999999999999999999999999 99999999999997665 8999999999865422
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.||..............+...+..+... .+..
T Consensus 163 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~ 238 (325)
T 3kn6_A 163 --NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--FEGE 238 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--CCSH
T ss_pred --CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--CCcc
Confidence 222345668999999999998899999999999999999999999997544321111111111222211110 0000
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. ......++.+|+.+||+.||.+|||++|+++
T Consensus 239 ~-------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 A-------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp H-------HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred c-------ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0 0123456888999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.10 Aligned_cols=276 Identities=24% Similarity=0.364 Sum_probs=215.9
Q ss_pred cCHHHHHHHhCCCCccceeccCCcEEEEEEEE------cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeE
Q 039681 320 FTGKEIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRL 391 (624)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l 391 (624)
+...++....++|++.+.||+|+||+||+|.. .+++.||||+++.... ...+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555678899999999999999999984 2468899999875433 3356789999999999 69999999
Q ss_pred eeEEEeCC-ceeEEEeeccCCCcccccccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 039681 392 LGCCVELD-QTLMIYEYIPNGTLFDHLHCDFTG-----------KWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRD 459 (624)
Q Consensus 392 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~D 459 (624)
++++...+ ..++||||+++++|.+++...... ....+++..++.++.||+.||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99998755 489999999999999999743211 0223899999999999999999999999 99999
Q ss_pred CCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCC
Q 039681 460 VKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAI 538 (624)
Q Consensus 460 ik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~ 538 (624)
|||+|||+++++.+||+|||+++...... .........+|+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDP--DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CccceEEECCCCCEEECCCccccccccCc--cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998764321 1122234567889999999998899999999999999999998 99998
Q ss_pred CCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 539 DFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
......+. +......+.... ........+.+++.+||+.+|.+|||+.|+++.|+++++...
T Consensus 252 ~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 252 PGVKIDEE------FCRRLKEGTRMR------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TTCCCSHH------HHHHHHHTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccchhHH------HHHHhccCccCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 65432211 111111111000 011123457889999999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=341.77 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=206.5
Q ss_pred hCCCCccc-eeccCCcEEEEEEEE---cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 329 TNNFSKDN-LIGTGGFGEVFKGIL---DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 329 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
.++|.+.+ .||+|+||+||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 999999999999964 246789999987543 23357799999999999999999999999 667889
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 94 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999973 246999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
....... .........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +........
T Consensus 166 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~ 237 (291)
T 1xbb_A 166 ALRADEN-YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE 237 (291)
T ss_dssp ECCTTCS-EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC
T ss_pred eeccCCC-cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC
Confidence 7643211 1111223446788999999988889999999999999999999 999987543221 111111111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhccc
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKG 619 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~ 619 (624)
.. ..+......+.+++.+||+.||++|||+.++++.|+++.....+
T Consensus 238 ~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 238 RM------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp CC------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 00 01112345688899999999999999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=343.25 Aligned_cols=244 Identities=24% Similarity=0.275 Sum_probs=193.6
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--chhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|+..+.||+|+||+||+|+.. +++.||||++..... .....+..|+..+.++ +||||+++++++.+....++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56888999999999999999975 799999998764332 3334556666666665 8999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 137 e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp ECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred ecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999 77999888642 346999999999999999999999999 9999999999999999999999999997654
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ....... .
T Consensus 209 ~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~----~ 268 (311)
T 3p1a_A 209 TA-----GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQG----Y 268 (311)
T ss_dssp -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTT----C
T ss_pred cC-----CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhcc----C
Confidence 22 12234568999999999876 799999999999999999999877643211 0111111 1
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+.+.. .....+.+++.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~-------~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPEFTA-------GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHHHHT-------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCccccc-------CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111111 23456888999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.45 Aligned_cols=270 Identities=25% Similarity=0.365 Sum_probs=194.4
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCC--c
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELD--Q 400 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 400 (624)
...++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999995 46899999988543 3344567889999999997 999999999998654 6
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999997 689888863 36899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCC-----------------CCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 039681 481 SRLVERTET-----------------NDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNR 542 (624)
Q Consensus 481 a~~~~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~ 542 (624)
++....... ......+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 986532110 11222345679999999999876 578999999999999999999999998654
Q ss_pred ccccccHHHHHHHHhccc---ccccccchh-------hhhc-------cCc-------------CcHHHHHHHHHHHHHc
Q 039681 543 EEENVNLVVYMKKIMDEE---RLMEVVDPV-------LKER-------ATH-------------LDLETMKALGLLAASC 592 (624)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~---~~~~~~d~~-------l~~~-------~~~-------------~~~~~~~~l~~l~~~c 592 (624)
..+.... +....... .+..+..+. +... ... .......++.+|+.+|
T Consensus 236 ~~~~~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 236 TMNQLER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp HHHHHHH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 4332211 11111110 000000000 0000 000 0001235678999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 039681 593 LDERRQNRPSMKEVADE 609 (624)
Q Consensus 593 l~~~p~~RPs~~ev~~~ 609 (624)
|+.||++|||++|+++.
T Consensus 313 L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 313 LQFNPNKRISANDALKH 329 (388)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hccCcccCCCHHHHhCC
Confidence 99999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.04 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=198.6
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce---
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT--- 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 401 (624)
.++|++.+.||+|+||.||+++. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999995 5789999999875432 2345789999999999999999999998876543
Q ss_pred -eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 402 -LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 402 -~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
++||||+++++|.++++.. ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 9999999999999999632 46999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
++....... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 163 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~ 235 (311)
T 3ork_A 163 ARAIADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVRED 235 (311)
T ss_dssp C-------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCC
T ss_pred ccccccccc-ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCC
Confidence 987653211 1112234568999999999998899999999999999999999999997543221 111111111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHH-HHHHHHHHHHh
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKE-VADEIEYIISI 616 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e-v~~~L~~i~~~ 616 (624)
.. .+... ......++.+++.+||+.||++||+..+ +...|.++...
T Consensus 236 ~~----~~~~~------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 236 PI----PPSAR------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp CC----CHHHH------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CC----Ccccc------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 10 00000 0123456788999999999999996554 55666665543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=345.97 Aligned_cols=264 Identities=28% Similarity=0.411 Sum_probs=207.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCE--EEEEEcccC-CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTV--TAIKRAKLG-NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 404 (624)
++|++.+.||+|+||.||+++.. ++.. +|+|+++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57889999999999999999954 5654 488987643 233456789999999999 899999999999999999999
Q ss_pred EeeccCCCccccccccc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 405 YEYIPNGTLFDHLHCDF-----------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
|||+++++|.+++.... ......+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997431 012357999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 552 (624)
||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 182 kL~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~ 250 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------L 250 (327)
T ss_dssp EECCTTCEESSCEE-----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H
T ss_pred EEcccCcCcccccc-----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------H
Confidence 99999998753321 11123456889999999988889999999999999999998 999986543211 1
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
... ...+.. . .........+.+|+.+||+.+|++|||+.|+++.|+++.......
T Consensus 251 ~~~-~~~~~~-----~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 251 YEK-LPQGYR-----L-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp HHH-GGGTCC-----C-------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred HHH-hhcCCC-----C-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 111 111100 0 011123356788999999999999999999999999998865443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=349.62 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=194.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|.+.+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999965 78999999987543 3346788999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC--eEEeecCCccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN--AKVSDFGLSRLVE 485 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~--~kl~DfGla~~~~ 485 (624)
+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999863 246999999999999999999999999 999999999999987765 9999999997533
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCc-cchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDK-SDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.. .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....... .....+........ .
T Consensus 170 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~--~ 240 (361)
T 3uc3_A 170 LH-----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKY--S 240 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCC--C
T ss_pred cc-----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCC--C
Confidence 21 11234569999999999988777655 899999999999999999997543322 12222222211110 0
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
. . ........+.+|+.+||+.+|++|||+.|+++.
T Consensus 241 ~-~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 I-P---------DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp C-C---------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C-C---------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 0 001123467889999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.61 Aligned_cols=248 Identities=27% Similarity=0.341 Sum_probs=194.0
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|++.+.||+|+||.||+++. .+++.||||+++.. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46789999999999999999995 46899999998643 233456688999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.
T Consensus 227 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999863 2469999999999999999999998 88 99999999999999999999999999986
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 299 ~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~-~- 366 (446)
T 4ejn_A 299 GIK----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEE-I- 366 (446)
T ss_dssp TCC---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-C-
T ss_pred ccC----CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC-C-
Confidence 432 1222345679999999999999899999999999999999999999997543221 111111111 0
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
..+......+.+|+.+||+.||.+|| +++|+++
T Consensus 367 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00112234578899999999999999 9999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=345.83 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=195.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCC--CceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNH--RSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 404 (624)
.++|++.+.||+|+||.||++...+++.||||++..... ...+.+.+|+.++++++| |||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 456899999999999999999988899999999875432 335678999999999986 9999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|| +.+++|.+++.. ...+++.++..|+.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EC-CCSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred Ee-CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99 458899999973 356999999999999999999999999 99999999999997 578999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccc-----------cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRN-----------FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 553 (624)
.... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ....+
T Consensus 158 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~ 230 (343)
T 3dbq_A 158 QPDT--TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKL 230 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHH
T ss_pred Cccc--ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHH
Confidence 4321 1112345679999999999864 5688999999999999999999999963221 11112
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.......... ..+ ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 231 ~~~~~~~~~~---------~~~---~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 HAIIDPNHEI---------EFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHCTTSCC---------CCC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcCCccc---------CCc---ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 2222111100 001 1112457789999999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=335.81 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=204.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456889999999999999999965 4778999998766566678899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE---CCCCCeEEeecCCcccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill---~~~~~~kl~DfGla~~~ 484 (624)
+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 88 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 88 CTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999998863 245999999999999999999999999 9999999999999 78899999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+ ...... .....
T Consensus 160 ~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~- 225 (277)
T 3f3z_A 160 KPGK-----MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIR-EGTFT- 225 (277)
T ss_dssp CTTS-----CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCCC-
T ss_pred cCcc-----chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hCCCC-
Confidence 4321 2234568999999999876 48999999999999999999999997543221 111111 11000
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 226 ~-~~~~~-------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 F-PEKDW-------LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp C-CHHHH-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C-Cchhh-------hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 012456788999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.49 Aligned_cols=264 Identities=20% Similarity=0.249 Sum_probs=200.2
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
..++|.+.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999999999999964 688999999865422 224678999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
|+||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 112 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999732 46999999999999999999999999 99999999999999999999999999976
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... .........++..|+|||.+.+..++.++||||||+++|||++|+.||...... .+........
T Consensus 184 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-- 251 (309)
T 2h34_A 184 TTDE---KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-- 251 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC--
T ss_pred cccc---ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC--
Confidence 5432 112233456899999999999888999999999999999999999999743221 1111111110
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHHHHhccc
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-SMKEVADEIEYIISIAKG 619 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~~~~~ 619 (624)
..+. ......+..+.+++.+||+.||++|| +++++++.|+++...++.
T Consensus 252 --~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 252 --PRPS------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp --CCGG------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred --CCcc------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0000 00112334678899999999999999 999999999988765543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=341.91 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=198.5
Q ss_pred hCCCCc-cceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSK-DNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.+.|.+ .++||+|+||+||+++. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 356776 47899999999999994 57899999998766556677899999999985 7999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC---eEEeecCCcc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN---AKVSDFGLSR 482 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~---~kl~DfGla~ 482 (624)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999742 46899999999999999999999999 999999999999998776 9999999997
Q ss_pred cccccCCC---CcceeecccccccccCcccccc-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccH-----
Q 039681 483 LVERTETN---DSHIFTTAQGTMGYLDPEYYRN-----FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNL----- 549 (624)
Q Consensus 483 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~----- 549 (624)
........ .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 65421110 1112234569999999999865 4688999999999999999999999976543221100
Q ss_pred ---HHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 550 ---VVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 550 ---~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...+...+..... ...+... ......+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~i~~~~~-~~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQEGKY-EFPDKDW--------AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHHCCC-CCCHHHH--------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHhccCc-ccCchhc--------ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0001111111100 0000000 013356788999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.99 Aligned_cols=267 Identities=21% Similarity=0.316 Sum_probs=196.6
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcch-hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|.+.+.||+|+||+||+|+.. +++.||+|++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999965 78999999987543322 23466899999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
++ |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 96 688888863 2346999999999999999999999999 999999999999999999999999999765421
Q ss_pred CCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.....................
T Consensus 154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 154 ----TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ----ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 122344568999999999876 568999999999999999999999997654433222111111111111111111
Q ss_pred chh-hhhc-c--------CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPV-LKER-A--------THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~-l~~~-~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... .... . ..........+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 100 0000 0 0000123356788999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=359.92 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=203.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57889999999999999999965 78999999986432 223467899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 96 E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999962 356999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.. .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......+ ....... +..
T Consensus 168 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~-~~~-- 233 (476)
T 2y94_A 168 DG-----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKICD-GIF-- 233 (476)
T ss_dssp TT-----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHHHT-TCC--
T ss_pred cc-----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhc-CCc--
Confidence 32 12345679999999999988765 689999999999999999999997543221 1111111 110
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+......+.+|+.+||+.||++|||++|+++
T Consensus 234 -----------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -----------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 001112345778999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=336.06 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=204.6
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEe---------
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE--------- 397 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 397 (624)
..++|+..+.||+|+||.||++... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456889999999999999999975 78999999987543 457899999999999999999999865
Q ss_pred -------CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC
Q 039681 398 -------LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK 470 (624)
Q Consensus 398 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~ 470 (624)
....++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 34579999999999999999643 2346999999999999999999999999 9999999999999999
Q ss_pred CCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHH
Q 039681 471 LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550 (624)
Q Consensus 471 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 550 (624)
+.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 159 ~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------- 225 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------- 225 (284)
T ss_dssp TEEEECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------
T ss_pred CCEEECcchhheeccccc-----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------
Confidence 999999999998764321 1234568999999999998889999999999999999999998864210
Q ss_pred HHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 551 VYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 551 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
. .........+.. .....+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus 226 ~-~~~~~~~~~~~~---------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 226 K-FFTDLRDGIISD---------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp H-HHHHHHTTCCCT---------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred H-HHHHhhcccccc---------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 0 111111111111 12234678999999999999999999999999887644
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.27 Aligned_cols=273 Identities=26% Similarity=0.387 Sum_probs=215.6
Q ss_pred ccCHHHHHHHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeE
Q 039681 319 IFTGKEIRRATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRL 391 (624)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 391 (624)
.+..++++...++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3555566677788999999999999999999854 367899999875432 345578999999999999999999
Q ss_pred eeEEEeCCceeEEEeeccCCCccccccccc-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 392 LGCCVELDQTLMIYEYIPNGTLFDHLHCDF-----TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 392 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
++++.+.+..++||||+++|+|.+++.... ......+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 999999999999999999999999986421 112246899999999999999999999999 999999999999
Q ss_pred ECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccc
Q 039681 467 LDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEE 545 (624)
Q Consensus 467 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~ 545 (624)
++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred EcCCCeEEECcCccccccccccc--cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 99999999999999986543211 111123346889999999988889999999999999999999 788886432211
Q ss_pred cccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
....... ..... ........+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 249 ------~~~~~~~-~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 ------VLRFVME-GGLLD------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------HHHHHHT-TCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHHHHc-CCcCC------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111111 11100 011234567889999999999999999999999987643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.48 Aligned_cols=251 Identities=25% Similarity=0.317 Sum_probs=204.5
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc------hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK------GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
.++|++.+.||+|+||.||+++.. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456889999999999999999965 6899999988654322 356799999999999999999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC----CeEEee
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL----NAKVSD 477 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~----~~kl~D 477 (624)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++ .+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 999999999999999963 356999999999999999999999999 99999999999999888 799999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ......
T Consensus 163 fg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~ 231 (321)
T 2a2a_A 163 FGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANIT 231 (321)
T ss_dssp CTTCEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHH
T ss_pred CccceecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH
Confidence 99998764321 1234568999999999998899999999999999999999999997543221 111111
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... ...++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~---~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 232 SVS---YDFDEEFFS-------HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTC---CCCCHHHHT-------TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hcc---cccChhhhc-------ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 110 011111111 12345788999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=349.85 Aligned_cols=270 Identities=13% Similarity=0.179 Sum_probs=209.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC---------CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceee---------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD---------GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVR--------- 390 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 390 (624)
.++|.+.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4679999999999999999999653 789999998643 46889999999999999988
Q ss_pred ------EeeEEEe-CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 039681 391 ------LLGCCVE-LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSS 463 (624)
Q Consensus 391 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~ 463 (624)
+++++.. ....++||||+ +++|.+++... ....+++.+++.|+.||+.||+|||+.+ |+||||||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 6777776 67889999999 99999999743 1356999999999999999999999999 999999999
Q ss_pred CeEECCCC--CeEEeecCCcccccccCCCC---cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCC
Q 039681 464 NILLDEKL--NAKVSDFGLSRLVERTETND---SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538 (624)
Q Consensus 464 Nill~~~~--~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~ 538 (624)
|||++.++ .+||+|||+++.+....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 89999999998765322111 11123457999999999999889999999999999999999999999
Q ss_pred CCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 539 DFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
....... ............ ......+.... .......+.+++.+||+.||++|||++||++.|+++.....
T Consensus 269 ~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 269 TNCLPNT-EDIMKQKQKFVD--KPGPFVGPCGH------WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGGTTCH-HHHHHHHHHHHH--SCCCEECTTSC------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCcCH-HHHHHHHHhccC--Chhhhhhhccc------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 7543211 111111111111 11111111100 00123567889999999999999999999999999988654
Q ss_pred c
Q 039681 619 G 619 (624)
Q Consensus 619 ~ 619 (624)
.
T Consensus 340 ~ 340 (352)
T 2jii_A 340 V 340 (352)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=347.40 Aligned_cols=271 Identities=22% Similarity=0.302 Sum_probs=204.2
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeC--------
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-------- 398 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 398 (624)
++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5789999999999999999996 5789999998865433 2345788999999999999999999999874
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
+..++||||++ ++|.+.+.. ....+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccC-CCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 46899999997 477777753 2346999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
|+++.+...............||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998765433333334456678999999999876 458999999999999999999999998654433222211111111
Q ss_pred cccccccccchhhhh-------ccCcCcH-----HHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DEERLMEVVDPVLKE-------RATHLDL-----ETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~-------~~~~~~~-----~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+.....-+..... ....... .....+.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111111110000000 0000000 01345788999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=365.25 Aligned_cols=253 Identities=27% Similarity=0.383 Sum_probs=205.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|...++||+|+||.||+++.. +|+.||+|++... .....+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888999999999999999964 6899999998643 223356688999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999998642 2345999999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... . +........
T Consensus 337 ~~~-----~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~-i~~~i~~~~--- 405 (576)
T 2acx_A 337 PEG-----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--E-VERLVKEVP--- 405 (576)
T ss_dssp CTT-----CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--H-HHHHHHHCC---
T ss_pred ccC-----ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--H-HHHHhhccc---
Confidence 422 12345689999999999998889999999999999999999999997644322111 1 111111110
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
...+......+.+|+.+||+.||.+|| +++||++
T Consensus 406 ----------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ----------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 000112335678899999999999999 7788864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=349.32 Aligned_cols=268 Identities=16% Similarity=0.191 Sum_probs=200.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEc----CCCEEEEEEcccCCcc-----------hhHHHHHHHHHHHhcCCCceeeEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAKLGNTK-----------GTDLVLNEVRILCQVNHRSLVRLLG 393 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 393 (624)
.++|.+.+.||+|+||.||+|... ++..+|||+....... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5788999988754322 1234678889999999999999999
Q ss_pred EEEe----CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC
Q 039681 394 CCVE----LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE 469 (624)
Q Consensus 394 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~ 469 (624)
++.+ ....++||||+ +++|.+++... ..+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEcc
Confidence 9988 67899999999 99999999742 37999999999999999999999999 999999999999998
Q ss_pred CC--CeEEeecCCcccccccCCCC---cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 039681 470 KL--NAKVSDFGLSRLVERTETND---SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544 (624)
Q Consensus 470 ~~--~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~ 544 (624)
++ .+||+|||+++.+....... ........||..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 77 99999999998765322111 11123457999999999999888999999999999999999999999642211
Q ss_pred ccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
.. ........... .+.+.+..... ....+.++.+++.+||+.+|++|||+++|++.|+++.
T Consensus 267 ~~--~~~~~~~~~~~-----~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 267 PV--AVQTAKTNLLD-----ELPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HH--HHHHHHHHHHH-----TTTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cH--HHHHHHHhhcc-----cccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11 11111111111 11111111000 0123456888999999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=347.69 Aligned_cols=243 Identities=24% Similarity=0.366 Sum_probs=201.0
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc--------chhHHHHHHHHHHHhcCCCceeeEeeEEEeC
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT--------KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL 398 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 398 (624)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456799999999999999999995 5688999999875432 1334678899999999999999999999999
Q ss_pred CceeEEEeeccCC-CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 399 DQTLMIYEYIPNG-TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 399 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
+..++||||+.+| +|.+++. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID-----RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH-----TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999777 9999886 3356999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
||++....... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 174 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------ 236 (335)
T 3dls_A 174 FGSAAYLERGK-----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------ 236 (335)
T ss_dssp CTTCEECCTTC-----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------
T ss_pred cccceECCCCC-----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------
Confidence 99998764321 1234568999999999988776 78999999999999999999998632110
Q ss_pred hcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 557 MDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
...... .+......+.+|+.+||+.||++|||++|+++.
T Consensus 237 -----~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAAIH---------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----HhhccC---------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 001123457889999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.98 Aligned_cols=247 Identities=28% Similarity=0.348 Sum_probs=192.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHH-HHhcCCCceeeEeeEEEeCCceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRI-LCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.++|++.+.||+|+||.||+++.. +++.||||+++... ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999965 58899999986543 2234556777776 577899999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 9999999999999963 246899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 189 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~-~- 256 (373)
T 2r5t_A 189 NIEH----NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKP-L- 256 (373)
T ss_dssp GBCC----CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHHHHHSC-C-
T ss_pred cccC----CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhcc-c-
Confidence 4321 112345679999999999999899999999999999999999999997543221 111111111 0
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
.........+.+|+.+||+.||.+||++.+.+
T Consensus 257 ------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 ------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 00112234577899999999999999986433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=335.86 Aligned_cols=249 Identities=28% Similarity=0.399 Sum_probs=183.0
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35688999999999999999996 578999999986432 12246789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999999863 2356999999999999999999999999 999999999999999999999999999865
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..... .
T Consensus 163 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~----~- 227 (278)
T 3cok_A 163 KMPH----EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVVL----A- 227 (278)
T ss_dssp C--------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS----S-
T ss_pred cCCC----CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHhh----c-
Confidence 4221 1123456899999999998888999999999999999999999999754332111 00000 0
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+..+ +......+.+++.+||+.||++|||++++++
T Consensus 228 --~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 --DYEM-------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCC-------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --ccCC-------ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0000 1123346788999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=338.55 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=200.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-CceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-DQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 407 (624)
.++|++.+.||+|+||+||++... ++.||||+++.. ...+.+.+|++++++++||||+++++++.+. ...++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467889999999999999999874 889999998743 3457799999999999999999999997654 478999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 9999999999642 1224899999999999999999999999 999999999999999999999999999765421
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. . ....+.
T Consensus 171 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~-~~~~~~----- 231 (278)
T 1byg_A 171 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---P-RVEKGY----- 231 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH---H-HHTTTC-----
T ss_pred -------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---H-HHhcCC-----
Confidence 123357889999999988889999999999999999998 999987543221 11 1 111110
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
.+ .........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 232 ~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 232 KM-------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CC-------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00 011123456788999999999999999999999999997653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=373.27 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=199.3
Q ss_pred ceeccCCcEEEEEEEEc---CCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILD---DGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|+++|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 467899999875432 33578999999999999999999999986 4568899999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~- 524 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN- 524 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc-
Confidence 999999963 346999999999999999999999999 99999999999999999999999999987653221
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
.........+|..|+|||++.+..++.++||||||++||||++ |+.||......+ +...+..+...
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~------ 591 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM------ 591 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC------
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence 1112233456789999999998899999999999999999998 999997543321 11111111111
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
..+...+.++.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 592 ------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 592 ------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01122345688899999999999999999999999998753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=345.42 Aligned_cols=271 Identities=21% Similarity=0.303 Sum_probs=209.2
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEe----CCce
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE----LDQT 401 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 401 (624)
...++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3456799999999999999999996 5789999999876666667889999999999999999999999973 3478
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++|+||+++|+|.+++.... .....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 89999999999999986432 13467999999999999999999999999 999999999999999999999999998
Q ss_pred ccccccCCCCc-----ceeecccccccccCcccccccC---CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 039681 482 RLVERTETNDS-----HIFTTAQGTMGYLDPEYYRNFQ---LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553 (624)
Q Consensus 482 ~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 553 (624)
........... .......||+.|+|||.+.... ++.++||||||+++|||++|+.||........ ......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~ 260 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAV 260 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHh
Confidence 76532111100 0112345799999999986543 78999999999999999999999853211111 111100
Q ss_pred HHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 554 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
. .. . . . .........+.+++.+||+.||.+|||++|+++.|+.+.....
T Consensus 261 ~----~~-~-~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 261 Q----NQ-L-S-----I-----PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp H----CC---------C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred h----cc-C-C-----C-----CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0 00 0 0 0 0011233568889999999999999999999999998765443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=337.57 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=199.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457889999999999999999864 57799999875432 12245688999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999998632 46999999999999999999999999 999999999999999999999999998654
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 160 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~-- 224 (279)
T 3fdn_A 160 PSS------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVE-F-- 224 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-C--
T ss_pred Ccc------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHHhCC-C--
Confidence 321 1234568999999999998889999999999999999999999997443221 111111100 0
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+......+.+|+.+||+.+|++|||++|+++.
T Consensus 225 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 -----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -----------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -----------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011223457789999999999999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=346.96 Aligned_cols=271 Identities=23% Similarity=0.353 Sum_probs=213.3
Q ss_pred HHHHHhCCCCccceeccCCcEEEEEEEEcC-C-----CEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEE
Q 039681 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDD-G-----TVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCC 395 (624)
Q Consensus 324 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 395 (624)
+++...++|.+.+.||+|+||.||+|.... + ..||+|++..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344456789999999999999999999642 2 4799999875433 3456799999999999 899999999999
Q ss_pred EeCCceeEEEeeccCCCcccccccccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeE
Q 039681 396 VELDQTLMIYEYIPNGTLFDHLHCDFT---------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNIL 466 (624)
Q Consensus 396 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nil 466 (624)
.+.+..++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 999999999999999999999864210 01346899999999999999999999999 999999999999
Q ss_pred ECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccc
Q 039681 467 LDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEE 545 (624)
Q Consensus 467 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~ 545 (624)
+++++.+||+|||+++...... .........+|..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS--NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT--TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred ECCCCeEEECcccccccccccc--ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 9999999999999998764321 1112234557889999999988889999999999999999998 888886543221
Q ss_pred cccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
. +.......... .. +......+.+++.+||+.+|.+|||+.||++.|+++....
T Consensus 275 ~------~~~~~~~~~~~--~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 275 K------FYKLVKDGYQM--AQ----------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp H------HHHHHHHTCCC--CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H------HHHHHhcCCCC--CC----------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1 11111111000 00 1112346788999999999999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.31 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=191.8
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--------cchhHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--------TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 397 (624)
...++|.+.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 3457899999999999999999996 468999999876432 122345889999999999999999999975
Q ss_pred CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC---CCeE
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK---LNAK 474 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~---~~~k 474 (624)
.+..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ ..+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred cCceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence 4568999999999999998863 356999999999999999999999999 9999999999999754 4599
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCcccccc---cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN---FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV 551 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 551 (624)
|+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+..
T Consensus 283 l~DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~ 355 (419)
T 3i6u_A 283 ITDFGHSKILGET-----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD 355 (419)
T ss_dssp ECCSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH
T ss_pred EeecccceecCCC-----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH
Confidence 9999999876422 22345679999999999853 568889999999999999999999997543221 1111
Q ss_pred HHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 552 YMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 552 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. ....... ..+... ......+.+|+.+||+.||++|||++|+++
T Consensus 356 ~----i~~~~~~--~~~~~~-------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 Q----ITSGKYN--FIPEVW-------AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp H----HHTTCCC--CCHHHH-------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H----HhcCCCC--CCchhh-------cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1 1111110 001110 113456788999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.52 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=196.0
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcC--CCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVN--HRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4589999999999999999998889999999986543 334577999999999996 599999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
| +.+++|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 136 E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 568899999973 246899999999999999999999999 99999999999996 5789999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccc-----------cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRN-----------FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 554 (624)
... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ....+.
T Consensus 206 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~ 278 (390)
T 2zmd_A 206 PDT--TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH 278 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHH
T ss_pred CCC--ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHH
Confidence 321 1112345679999999999865 3688999999999999999999999964321 111122
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...... .....+. .....+.+|+.+||+.||++|||+.|+++
T Consensus 279 ~~~~~~---------~~~~~~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 279 AIIDPN---------HEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHCTT---------SCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCcc---------ccCCCCc---cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 222111 1000010 11345788999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.10 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=203.2
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999964 58999999986443 234567889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC---eEEeecCCcc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN---AKVSDFGLSR 482 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~---~kl~DfGla~ 482 (624)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 85 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999888632 46999999999999999999999999 999999999999986655 9999999997
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .... ......
T Consensus 157 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~-~~~~~~ 224 (284)
T 3kk8_A 157 EVNDS-----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQ-IKAGAY 224 (284)
T ss_dssp ECCSS-----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHTCC
T ss_pred EcccC-----ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHH-HHhccc
Confidence 65432 12234678999999999999899999999999999999999999996543221 1111 111110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 225 -~~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 -DYPSPEW--------DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -CCCTTTT--------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cCCchhh--------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 122345788999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=345.30 Aligned_cols=251 Identities=18% Similarity=0.279 Sum_probs=198.8
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||.||++... +++.||||++..... ...+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456899999999999999999965 688999999865432 346788888888 79999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC----CCeEEeecCCcc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK----LNAKVSDFGLSR 482 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~----~~~kl~DfGla~ 482 (624)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++
T Consensus 97 ~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 97 LMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999863 356999999999999999999999999 9999999999998543 349999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..........+ ... +..+..
T Consensus 169 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~-i~~~~~ 240 (342)
T 2qr7_A 169 QLRAE----NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LAR-IGSGKF 240 (342)
T ss_dssp ECBCT----TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHH-HHHCCC
T ss_pred cCcCC----CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHH-HccCCc
Confidence 76432 1123456789999999999887899999999999999999999999975332221111 111 111111
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. . ... ........+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~-~-~~~-------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 S-L-SGG-------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp C-C-CST-------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c-c-Ccc-------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0 000 00123456788999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=359.82 Aligned_cols=197 Identities=28% Similarity=0.416 Sum_probs=155.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----Cc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-----DQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 400 (624)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999999999999954 6899999988643 233456789999999999999999999999543 56
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||||+ +++|.+++.. ...+++..+..|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccccc
Confidence 89999998 5789988863 356999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCC-----------------------cceeecccccccccCcccc-cccCCCCccchhhHHHHHHHHHhC
Q 039681 481 SRLVERTETND-----------------------SHIFTTAQGTMGYLDPEYY-RNFQLTDKSDVYSFGVVLLELLTS 534 (624)
Q Consensus 481 a~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~s~G~vl~elltg 534 (624)
++......... ....+...||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 98764321110 1124556789999999986 556799999999999999999993
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.81 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=190.7
Q ss_pred CCCCcc-ceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHh-cCCCceeeEeeEEEe----CCcee
Q 039681 330 NNFSKD-NLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQ-VNHRSLVRLLGCCVE----LDQTL 402 (624)
Q Consensus 330 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~ 402 (624)
++|... ++||+|+||+||++... +++.||||+++. ...+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455554 68999999999999964 689999999863 2457788988744 589999999999876 56789
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEEeecC
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKVSDFG 479 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl~DfG 479 (624)
+||||+++|+|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 136 lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999742 2346999999999999999999999999 999999999999997 7899999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccc-cHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENV-NLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~ 558 (624)
+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .....+.
T Consensus 210 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---- 280 (400)
T 1nxk_A 210 FAKETTSH-----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---- 280 (400)
T ss_dssp TCEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----
T ss_pred cccccCCC-----CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----
Confidence 99865421 1234567899999999999889999999999999999999999999755432211 1111111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+.. ....+. ......++.+|+.+||+.||++|||+.|+++.
T Consensus 281 ~~~~-~~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 281 MGQY-EFPNPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HTCC-CCCTTT--------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCcc-cCCCcc--------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1110 000000 01234567889999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=347.98 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=193.8
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
....++|++.+.||+|+||+||+++. .+++.||||+++..... ..+.+.+|++++++++||||+++++++.+....+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34557899999999999999999995 47899999998754332 2456789999999999999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE-----CCCCCeEEee
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL-----DEKLNAKVSD 477 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill-----~~~~~~kl~D 477 (624)
+||||++ |+|.+++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|
T Consensus 110 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999997 599999863 246999999999999999999999999 9999999999999 4556699999
Q ss_pred cCCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
||+++..... ........+|..|+|||++.+. .++.++||||||+++|||++|+.||......+.. ..+...
T Consensus 181 fg~a~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~ 253 (329)
T 3gbz_A 181 FGLARAFGIP----IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL---FKIFEV 253 (329)
T ss_dssp TTHHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHH
T ss_pred CCCccccCCc----ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH---HHHHHH
Confidence 9999876422 1223455689999999999764 4899999999999999999999999755432211 111111
Q ss_pred hcc---cccccc-------------cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 557 MDE---ERLMEV-------------VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 557 ~~~---~~~~~~-------------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... ...... ....+... .......++.+|+.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV---LGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHH---HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCchhhhhhhhhhhhhhhhhhhhccccHhhh---cccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 110 000000 00000000 00013356789999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=329.06 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=203.4
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356889999999999999999965 68999999986443 3345778999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 86 ~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999862 356999999999999999999999999 99999999999999999999999999986543
Q ss_pred cCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .........|+..|+|||.+.+..+ +.++||||||+++|||++|+.||........ . ......... .
T Consensus 158 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~~~~~~---~ 227 (276)
T 2yex_A 158 NN--RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E----YSDWKEKKT---Y 227 (276)
T ss_dssp TT--EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-H----HHHHHTTCT---T
T ss_pred Cc--chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-H----HHHhhhccc---c
Confidence 21 1112345678999999999987665 7899999999999999999999975432211 0 111111100 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+ .......+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 LNP---------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp STT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCc---------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000 0122345778999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.67 Aligned_cols=268 Identities=21% Similarity=0.280 Sum_probs=197.4
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc-----hhHHHHHHHHHHHhcCCCceeeEeeEEEeCC
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK-----GTDLVLNEVRILCQVNHRSLVRLLGCCVELD 399 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 399 (624)
....++|.+.+.||+|+||.||+++.. +++.||||++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999964 6899999998753221 1346889999999999999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+++ +|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred ceEEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 99999999975 88888753 3346899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+++..... ........+|+.|+|||++.+. .++.++||||||+++|||++|..||......+. ...+.....
T Consensus 158 ~a~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~ 230 (346)
T 1ua2_A 158 LAKSFGSP----NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLG 230 (346)
T ss_dssp GGSTTTSC----CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHC
T ss_pred cceeccCC----cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcC
Confidence 99876422 1223456789999999998654 488999999999999999999999875443221 111111111
Q ss_pred c---cccccc---cchhhhhccCcCc-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 E---ERLMEV---VDPVLKERATHLD-----LETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ~---~~~~~~---~d~~l~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. +..... .+.......+... ......+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1 111000 0000000000000 123357889999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=352.09 Aligned_cols=267 Identities=19% Similarity=0.252 Sum_probs=209.9
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC-CceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH-RSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|.+.++||+|+||.||+|+. .+++.||||++.... ..+.+..|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46799999999999999999995 578999999876433 23468899999999986 566666677778888999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE---CCCCCeEEeecCCccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRL 483 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill---~~~~~~kl~DfGla~~ 483 (624)
|+ +++|.+++.. ....+++.+++.|+.||+.||+|||+++ |+||||||+|||| ++++.+||+|||+++.
T Consensus 84 ~~-g~sL~~ll~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 84 LL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp CC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CC-CCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99 9999999963 2346999999999999999999999999 9999999999999 6889999999999987
Q ss_pred ccccCCCCc---ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 484 VERTETNDS---HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 484 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
......... .......||..|+|||++.+..++.++||||||++||||++|+.||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 654322111 11235679999999999999999999999999999999999999997644332222222111111100
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
.++ .+. .....++.+|+.+||+.+|++||++.+|++.|+++....
T Consensus 236 ----~~~-~l~-------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 236 ----SIE-ALC-------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp ----CHH-HHH-------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----cHH-HHh-------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 000 010 122356888999999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.65 Aligned_cols=245 Identities=29% Similarity=0.414 Sum_probs=198.4
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
+.|+..+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3478889999999999999995 5789999999875432 23457899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||++ |+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9996 6888877532 346999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.. ....||+.|+|||++. ...++.++||||||+++|||++|+.||......+ .+........
T Consensus 206 ~~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~~- 270 (348)
T 1u5q_A 206 PA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES- 270 (348)
T ss_dssp SB--------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC-
T ss_pred CC--------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCC-
Confidence 21 2346899999999984 4578999999999999999999999986433211 1111111110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+. .......+.+++.+||+.+|++|||++++++
T Consensus 271 -----~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 -----PALQ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp -----CCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCC------CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000 0122345778999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=348.40 Aligned_cols=254 Identities=27% Similarity=0.359 Sum_probs=201.9
Q ss_pred hCCCCccceeccCCcEEEEEEEE----cCCCEEEEEEcccCC----cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCC
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKRAKLGN----TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELD 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 399 (624)
.++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36789999999999999999996 368999999986432 23346678899999999 6999999999999999
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999999632 46999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccc--cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
+++...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .........
T Consensus 205 ~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~ 279 (355)
T 1vzo_A 205 LSKEFVADE---TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRIL 279 (355)
T ss_dssp EEEECCGGG---GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHH
T ss_pred CCeecccCC---CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHh
Confidence 998654221 122234579999999999975 3578999999999999999999999975433221 111111111
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVADE 609 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~ 609 (624)
... ...+......+.+|+.+||+.||.+|| +++|+++.
T Consensus 280 ~~~--------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 280 KSE--------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccC--------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 110 011112335577899999999999999 99999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=343.50 Aligned_cols=266 Identities=24% Similarity=0.341 Sum_probs=206.9
Q ss_pred HhCCCCccceeccCCcEEEEEEEE------cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
..++|.+.+.||+|+||.||+|+. .++..||||++.... ......+.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346799999999999999999983 346789999986442 3445678999999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEE
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFT--GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKV 475 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl 475 (624)
.++||||+++++|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999975321 12246999999999999999999999999 999999999999984 456999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 554 (624)
+|||++........ ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...
T Consensus 185 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLE 256 (327)
T ss_dssp CCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHH
T ss_pred Cccccccccccccc--cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HHH
Confidence 99999976542211 111234567889999999988889999999999999999998 888886433211 111
Q ss_pred HHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 555 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
....... . .........+.+++.+||+.+|.+|||+.|+++.|+.+....
T Consensus 257 ~~~~~~~-~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 257 FVTSGGR-M------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHTTCC-C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHhcCCC-C------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1111110 0 001123346788999999999999999999999999987644
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.25 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=204.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|...+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457888999999999999999965 57899999876432 23456789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 94 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 999999999998863 246999999999999999999999999 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 166 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~-- 232 (294)
T 2rku_A 166 EYDG----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE-Y-- 232 (294)
T ss_dssp CSTT----CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-C--
T ss_pred ccCc----cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhhcc-C--
Confidence 4221 11234568999999999998889999999999999999999999997543221 111111110 0
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+......+.+++.+||+.||++|||++|+++.
T Consensus 233 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -----------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0011223457789999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=348.33 Aligned_cols=265 Identities=24% Similarity=0.336 Sum_probs=203.4
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56889999999999999999965 68999999987553 33456789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999632 4689999999999999999999996 7 99999999999999999999999999976532
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH-------------
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM------------- 553 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~------------- 553 (624)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+........
T Consensus 185 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 185 S------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp H------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred c------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 1 123456899999999999989999999999999999999999999754332210000000
Q ss_pred ----------HHHhcccccccccchhhhhccCcC-cHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 554 ----------KKIMDEERLMEVVDPVLKERATHL-DLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 554 ----------~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..........+..+.......... ......++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000011111111100000 1123456889999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=332.04 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=197.1
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|.+.+.||+|+||.||++.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5688999999999999999996 468899999886543 33457899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE---CCCCCeEEeecCCcccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill---~~~~~~kl~DfGla~~~ 484 (624)
+++|+|.+++..... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 102 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 102 CEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999998863211 2357999999999999999999999999 9999999999999 45688999999999865
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
.... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+. .........
T Consensus 178 ~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~~--- 242 (285)
T 3is5_A 178 KSDE-----HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQKATYKEP--- 242 (285)
T ss_dssp --------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC---
T ss_pred CCcc-----cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH------HhhhccCCc---
Confidence 4321 1235568999999999864 689999999999999999999999975432211 111110000
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...... ......+.+|+.+||+.||++|||+.|+++
T Consensus 243 ----~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 ----NYAVEC----RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----cccccc----CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 012345778999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=333.21 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=198.2
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
+|....+||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355566999999999999995 5688999999887666667789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEeecCCcccccccC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~DfGla~~~~~~~ 488 (624)
+++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 103 GGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999743 12345789999999999999999999999 999999999999987 8999999999998654221
Q ss_pred CCCcceeecccccccccCccccccc--CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNF--QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
.......|+..|+|||++.+. .++.++||||||+++|||++|+.||........ . ........ .
T Consensus 178 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~-~~~~~~~~-----~ 243 (295)
T 2clq_A 178 ----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----A-MFKVGMFK-----V 243 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----H-HHHHHHHC-----C
T ss_pred ----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----H-HHhhcccc-----c
Confidence 112345689999999998764 388999999999999999999999864322110 0 00000000 0
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+ +......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEI-------PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCC-------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc-------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111 1123456788999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=333.11 Aligned_cols=257 Identities=25% Similarity=0.297 Sum_probs=204.3
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc------chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT------KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
++|++.+.||+|+||.||+++.. +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999975 689999998765422 13567999999999999999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC----CeEEeec
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL----NAKVSDF 478 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~----~~kl~Df 478 (624)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++ .+||+||
T Consensus 85 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999963 246999999999999999999999999 99999999999998877 8999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
|++....... ......+++.|+|||++.+..++.++||||||+++|||++|+.||......+ .......
T Consensus 157 g~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~ 225 (283)
T 3bhy_A 157 GIAHKIEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNISA 225 (283)
T ss_dssp TTCEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHT
T ss_pred ccceeccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHhHh
Confidence 9998754321 1234568999999999998889999999999999999999999997543221 1111111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH--HHHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD--EIEYIIS 615 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~i~~ 615 (624)
.. ...++... ......+.+++.+||+.||++|||+.|+++ .++.+..
T Consensus 226 ~~---~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 226 VN---YDFDEEYF-------SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp TC---CCCCHHHH-------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred cc---cCCcchhc-------ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 00 00111111 112346788999999999999999999997 4555544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=335.58 Aligned_cols=249 Identities=29% Similarity=0.441 Sum_probs=204.6
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.+.|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688899999999999999985 468999999987543 3446789999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 101 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999852 46999999999999999999999999 99999999999999999999999999987643
Q ss_pred cCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+ . ... ......
T Consensus 172 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~-~~~~~~---- 236 (303)
T 3a7i_A 172 TQ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---V---LFL-IPKNNP---- 236 (303)
T ss_dssp TB----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHH-HHHSCC----
T ss_pred cc----cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---H---HHH-hhcCCC----
Confidence 21 11234568999999999998889999999999999999999999986433211 1 111 111110
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
+.+ .......+.+|+.+||+.+|++|||+.|+++.
T Consensus 237 -~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 -PTL-------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -CCC-------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -CCC-------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 011 11223457889999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.94 Aligned_cols=263 Identities=21% Similarity=0.278 Sum_probs=195.4
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD------ 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 399 (624)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 56799999999999999999996 568999999985432 233567899999999999999999999998753
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 8899998863 35899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+++..... .....+|+.|+|||++.+ ..++.++||||+|++++||++|+.||......+....+........
T Consensus 174 ~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 174 LARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp TCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99865421 234578999999999876 6799999999999999999999999976543322111111000000
Q ss_pred ccccccccchhh-----------hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 EERLMEVVDPVL-----------KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ~~~~~~~~d~~l-----------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+..+..... ..............+.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000000000 00000001123456788999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=358.81 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=201.9
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|...++||+|+||.||+++.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999974 68999999986432 233467899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+.
T Consensus 265 E~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999986431 12457999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ............. .
T Consensus 341 ~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~-~--- 410 (543)
T 3c4z_A 341 AGQ----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQA-V--- 410 (543)
T ss_dssp TTC----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCC-C---
T ss_pred CCC----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcc-c---
Confidence 321 11234579999999999999899999999999999999999999997543221 1111111111110 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
..+......+.+|+.+||+.||++||++
T Consensus 411 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ----------TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ----------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0111234567789999999999999976
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.00 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=201.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|.+.+.||+|+||.||+++.. +++.||+|+++.......+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456888999999999999999964 7899999998865555556789999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE---CCCCCeEEeecCCcccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill---~~~~~~kl~DfGla~~~ 484 (624)
+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++...
T Consensus 88 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 88 VSGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCCccHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999998863 246899999999999999999999999 9999999999999 78899999999999754
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ...... .+.. .
T Consensus 160 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~-~~~~-~ 225 (304)
T 2jam_A 160 QNG------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEKIK-EGYY-E 225 (304)
T ss_dssp CCB------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HCCC-C
T ss_pred CCC------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCCC-C
Confidence 321 1234568999999999998889999999999999999999999997543211 111111 1110 0
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. .... .......+.+++.+||+.||++|||+.|+++
T Consensus 226 ~-~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 F-ESPF-------WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp C-CTTT-------TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred C-Cccc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0000 0123356788999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=344.29 Aligned_cols=268 Identities=23% Similarity=0.375 Sum_probs=199.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc--hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK--GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.++|+..+.||+|+||.||+++.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888999999999999999965 5899999987654332 3456889999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLEL-----FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHH-----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 9999999888765 2346999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHH
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM--------KKI 556 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~ 556 (624)
.. ........+|..|+|||++.+. .++.++||||||+++|||++|+.||......+........ ...
T Consensus 176 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 AP----GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CC----ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 22 1223455789999999999765 6899999999999999999999999765433221111100 000
Q ss_pred hc-ccccccccchhhhhccC--cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 557 MD-EERLMEVVDPVLKERAT--HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 557 ~~-~~~~~~~~d~~l~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. .........+.+..... .........+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000011111100000 000123467889999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.28 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=204.4
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
..++|.+.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3467889999999999999999965 5789999987643 22345678999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 119 v~e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 119 VLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EECCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 9999999999998863 246999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
..... .......||..|+|||++.+..++.++||||||+++|||++|+.||......+ ......... .
T Consensus 191 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-~- 258 (335)
T 2owb_A 191 VEYDG----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE-Y- 258 (335)
T ss_dssp CCSTT----CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-C-
T ss_pred cccCc----ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhcCC-C-
Confidence 64221 11234568999999999998889999999999999999999999997543221 111111110 0
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+ +......+.+|+.+||+.||++|||++|+++.
T Consensus 259 -----~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 -----SI-------PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -----CC-------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----CC-------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01123457789999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.57 Aligned_cols=253 Identities=13% Similarity=0.174 Sum_probs=195.0
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHH---HHHHhcCCCceeeEe-------e
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEV---RILCQVNHRSLVRLL-------G 393 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~ 393 (624)
..++|.+.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+ +++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346788899999999999999995 57999999998733 334567789999 555566899999998 6
Q ss_pred EEEeCC-----------------ceeEEEeeccCCCccccccccc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 039681 394 CCVELD-----------------QTLMIYEYIPNGTLFDHLHCDF--TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPP 454 (624)
Q Consensus 394 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ 454 (624)
++.+.+ ..++||||+ +|+|.+++.... ......+++..++.|+.||+.||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 666553 278999999 689999997421 111234567899999999999999999999
Q ss_pred eEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCccccccc-----------CCCCccchhh
Q 039681 455 IYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-----------QLTDKSDVYS 523 (624)
Q Consensus 455 iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDv~s 523 (624)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999999999999999999985321 2345567 999999999877 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 524 FGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 524 ~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
||+++|||++|+.||......+.. ..+.. ... .....+.+|+.+||+.||++|||+
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~---------------~~~~~-----~~~----~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGS---------------EWIFR-----SCK----NIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCS---------------GGGGS-----SCC----CCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HHHHHHHHHHCCCCCcccccccch---------------hhhhh-----hcc----CCCHHHHHHHHHHcCCCchhCCCH
Confidence 999999999999998643322111 01100 001 123467889999999999999999
Q ss_pred HHHHH--HHHHHHHh
Q 039681 604 KEVAD--EIEYIISI 616 (624)
Q Consensus 604 ~ev~~--~L~~i~~~ 616 (624)
.|+++ .++++...
T Consensus 355 ~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 355 LQAMETPEYEQLRTE 369 (377)
T ss_dssp HHHHTSHHHHHHHHH
T ss_pred HHHhhChHHHHHHHH
Confidence 99985 45555443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=352.92 Aligned_cols=202 Identities=25% Similarity=0.356 Sum_probs=167.1
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----C
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-----D 399 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 399 (624)
..++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+|++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 357899999999999999999996 46889999998653 233456789999999999999999999999876 5
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCC
Confidence 7899999985 699999863 356999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCC------------------cceeecccccccccCcccc-cccCCCCccchhhHHHHHHHHHhCCCCC
Q 039681 480 LSRLVERTETND------------------SHIFTTAQGTMGYLDPEYY-RNFQLTDKSDVYSFGVVLLELLTSKKAI 538 (624)
Q Consensus 480 la~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDv~s~G~vl~elltg~~p~ 538 (624)
+++......... ....+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 998765321110 0224567899999999986 5557999999999999999999865444
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=344.98 Aligned_cols=268 Identities=22% Similarity=0.308 Sum_probs=203.0
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----C
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-----D 399 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 399 (624)
...++|++.+.||+|+||.||++... +++.||||++..... ...+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34568999999999999999999964 688899999875332 3346789999999999999999999999765 3
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++|+||+. |+|.+++.. ..+++.+++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCc
Confidence 6899999996 689988853 35999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+++....... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... +.....
T Consensus 174 ~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~ 249 (364)
T 3qyz_A 174 LARVADPDHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILG 249 (364)
T ss_dssp TCEECCGGGC-BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHC
T ss_pred ceEecCCCCC-ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhC
Confidence 9987653211 1111244579999999998754 4589999999999999999999999976554332221 111111
Q ss_pred c---cccccccchhhhh---c---cCcC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 E---ERLMEVVDPVLKE---R---ATHL-----DLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ~---~~~~~~~d~~l~~---~---~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. +.+....+..... . .... .......+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 1111111000000 0 0000 0112356788999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.57 Aligned_cols=271 Identities=22% Similarity=0.264 Sum_probs=199.0
Q ss_pred HHHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc-----------hhHHHHHHHHHHHhcCCCceee
Q 039681 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK-----------GTDLVLNEVRILCQVNHRSLVR 390 (624)
Q Consensus 322 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~ 390 (624)
..++....++|.+.+.||+|+||.||+|...+++.||||++...... ..+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 35667778999999999999999999999888999999987543221 1367899999999999999999
Q ss_pred EeeEEEeCC-----ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 039681 391 LLGCCVELD-----QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNI 465 (624)
Q Consensus 391 l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Ni 465 (624)
+++++.... ..++||||++ |+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 999996533 5799999997 688888863 3357999999999999999999999999 99999999999
Q ss_pred EECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 039681 466 LLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544 (624)
Q Consensus 466 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~ 544 (624)
|++.++.+||+|||+++..... .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD-----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp EECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEcCCCCEEEEecCcccccccc-----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999754322 11234568999999999876 57899999999999999999999999765432
Q ss_pred ccccHHHHHHHHhcccccc-----------cccchhhhhcc----CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 545 ENVNLVVYMKKIMDEERLM-----------EVVDPVLKERA----THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~-----------~~~d~~l~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+... .+.......... +.+...+.... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 NQLN---KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHH---HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH---HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 2211 111111111000 00000000000 0000122356788999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=333.18 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=201.6
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999965 57889999885432 223467899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999998642 36899999999999999999999999 9999999999999999999999999987653
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 166 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~----- 228 (284)
T 2vgo_A 166 SL------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVNVD----- 228 (284)
T ss_dssp SS------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-----
T ss_pred cc------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhccc-----
Confidence 21 1234568999999999998889999999999999999999999997543221 111111110
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+ +......+.+++.+||+.+|++|||++|+++
T Consensus 229 --~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 --LKF-------PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCC-------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCC-------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 000 1122345778999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=336.28 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=202.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEe--CCceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE--LDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 403 (624)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457889999999999999999964 68999999987543 3345678999999999999999999998865 567899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA--VPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||+++++.+||+|||++
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999999964321 2356999999999999999999999987 234899999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
+..... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||......+ . . ..+..+.
T Consensus 164 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~-~~i~~~~ 232 (279)
T 2w5a_A 164 RILNHD----TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---L---A-GKIREGK 232 (279)
T ss_dssp HHC-------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H-HHHHHTC
T ss_pred eeeccc----cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---H---H-HHHhhcc
Confidence 765421 111234568999999999988889999999999999999999999987543211 1 1 1111111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
... .+......+.+++.+||+.+|++|||+.||++.+.
T Consensus 233 ~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 FRR------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ccc------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 111 11123456788999999999999999999997653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=330.18 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=194.8
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367899999999999999999975 78999999986432 23345789999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999632 45899999999999999999999999 999999999999999999999999999875
Q ss_pred cccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
... .......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||......+ .... ......
T Consensus 162 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~~- 228 (276)
T 2h6d_A 162 SDG-----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LFKK-IRGGVF- 228 (276)
T ss_dssp CC------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHCCC-
T ss_pred CCC-----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHH-hhcCcc-
Confidence 432 11234568999999999987665 689999999999999999999986432211 1111 111100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
..+......+.+++.+||+.||++|||+.|+++.
T Consensus 229 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011123457789999999999999999999873
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=350.03 Aligned_cols=201 Identities=26% Similarity=0.328 Sum_probs=173.5
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhc------CCCceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQV------NHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 401 (624)
..+|++.+.||+|+||+||+|... +++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456899999999999999999864 5889999998743 33456778899888887 577999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC--eEEeecC
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN--AKVSDFG 479 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~--~kl~DfG 479 (624)
++||||+. ++|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999995 6999988743 3345999999999999999999999999 999999999999999887 9999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~ 544 (624)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 248 ~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 248 SSCYEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TCEETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99754321 23457899999999999989999999999999999999999999765443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=336.91 Aligned_cols=258 Identities=19% Similarity=0.293 Sum_probs=199.8
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEe--CCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVE--LDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 405 (624)
++|++.+.||+|+||+||+|+. .+++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688999999999999999985 57899999998633 3467899999999997 9999999999998 66789999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGla~~~ 484 (624)
||+++++|.+++. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 113 e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp ECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999998884 3899999999999999999999999 99999999999999776 8999999999876
Q ss_pred cccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .....+..........
T Consensus 182 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 182 HPGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLY 254 (330)
T ss_dssp CTTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHH
T ss_pred CCCC-----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhh
Confidence 4321 1234568999999999876 568999999999999999999999996433221 1111111111111111
Q ss_pred cc-------cchhhhh-------------ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EV-------VDPVLKE-------------RATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~-------~d~~l~~-------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+. .++.... ............+.+|+.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 10 0110000 000001113567889999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.19 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=202.3
Q ss_pred HHHHHhCCCCcc-ceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcC-CCceeeEeeEEEeC
Q 039681 324 EIRRATNNFSKD-NLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVN-HRSLVRLLGCCVEL 398 (624)
Q Consensus 324 ~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 398 (624)
..+...++|.+. +.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++++. ||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344555667776 88999999999999965 68999999886432 233567899999999995 69999999999999
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEE
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKV 475 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl 475 (624)
...++||||+++|+|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred CeEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 9999999999999999998632 3357999999999999999999999999 999999999999998 789999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 555 (624)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..
T Consensus 176 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~ 247 (327)
T 3lm5_A 176 VDFGMSRKIGHAC-----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNISQ 247 (327)
T ss_dssp CCGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred eeCccccccCCcc-----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHh
Confidence 9999998764321 12345799999999999988999999999999999999999999975433211 111111
Q ss_pred HhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 556 IMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 556 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. .. .. .... .......+.+++.+||+.||++|||++|+++
T Consensus 248 ---~-~~-~~-~~~~-------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 ---V-NV-DY-SEET-------FSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---T-CC-CC-CTTT-------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---c-cc-cc-Cchh-------hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 00 00 0000 0123456788999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=341.49 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=203.9
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc--------hhHHHHHHHHHHHhc-CCCceeeEeeE
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK--------GTDLVLNEVRILCQV-NHRSLVRLLGC 394 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~ 394 (624)
.....++|.+.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455677999999999999999999975 7999999998654321 135678999999999 79999999999
Q ss_pred EEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 395 CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 395 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
+......++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999863 246999999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCcccccc------cCCCCccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN------FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~ 548 (624)
|+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 241 l~DfG~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--- 312 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--- 312 (365)
T ss_dssp ECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred EEecCcccccCCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---
Confidence 99999998764321 2345679999999999863 358889999999999999999999996432211
Q ss_pred HHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 549 LVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...... ..... ...+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 313 ---~~~~i~-~~~~~-~~~~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 ---MLRMIM-EGQYQ-FSSPEW--------DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHH-HTCCC-CCHHHH--------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHH-hCCCC-CCCccc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 11100 000000 012345788999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=370.74 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=201.1
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCce
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 401 (624)
...++|++.++||+|+||.||+++.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999964 6889999998643 233456788999999988 699999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++||||+++|+|.++++.. ..+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++++||+|||++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence 9999999999999999742 46999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
+..... ........||+.|+|||++.+..++.++||||||++||||++|+.||......+ .........
T Consensus 490 ~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~- 558 (674)
T 3pfq_A 490 KENIWD----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHN- 558 (674)
T ss_dssp EECCCT----TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHSSC-
T ss_pred eccccC----CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH------HHHHHHhCC-
Confidence 854321 122345679999999999999899999999999999999999999997543221 122222111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~ 603 (624)
. ..+.....++.+|+.+||+.||++||++
T Consensus 559 ~-------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 V-------------AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp C-------------CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred C-------------CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 0 0111234567889999999999999997
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.40 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=197.4
Q ss_pred hCCCCccceeccCCcEEEEEEEEc--CCC--EEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD--DGT--VTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
.++|++.+.||+|+||+||+|++. +++ .||||+++.. .....+.+.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357899999999999999999853 333 6899988654 2344678999999999999999999999998754 8
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++|+||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence 8999999999999999642 245899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
........ .........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .........
T Consensus 169 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~ 241 (291)
T 1u46_A 169 RALPQNDD-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEG 241 (291)
T ss_dssp EECCC-CC-EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSC
T ss_pred cccccccc-chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccC
Confidence 87643211 1111234457888999999988889999999999999999999 999986543221 111111111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
... .........+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 242 ~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 ERL------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCC------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 000 00112345688899999999999999999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.62 Aligned_cols=261 Identities=21% Similarity=0.344 Sum_probs=185.4
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC------
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL------ 398 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 398 (624)
..++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999995 568999999986532 23456788999999999999999999999754
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
...++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-
T ss_pred CeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeec
Confidence 5679999999 7899988852 46999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
|+++..... .....||..|+|||++.+ ..++.++||||||+++|||++|+.||......+... .+....
T Consensus 177 G~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~ 246 (367)
T 2fst_X 177 GLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLV 246 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHH
T ss_pred ccccccccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHh
Confidence 999865321 234578999999999876 578999999999999999999999997654332221 111111
Q ss_pred cc---cccccccchhhh---h---ccCcCc-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DE---ERLMEVVDPVLK---E---RATHLD-----LETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~---~~~~~~~d~~l~---~---~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. +.+..+...... . ...... ......+.+|+.+||+.||++|||+.|+++
T Consensus 247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11 111111110000 0 000000 012356788999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=344.05 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=192.3
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD------ 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 399 (624)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999985 46889999998653 2334567899999999999999999999998765
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||++ ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence 6799999996 57888774 24899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc-
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD- 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 558 (624)
+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+.....
T Consensus 173 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~ 244 (371)
T 2xrw_A 173 LARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGT 244 (371)
T ss_dssp C---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHC-CCC
T ss_pred cccccccc-----cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCC
Confidence 99865421 1233457899999999999888999999999999999999999999765432211 10100000
Q ss_pred ------------------c-cc-----cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 ------------------E-ER-----LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ------------------~-~~-----~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. .. .......................+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 00 00000000000000001223567899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=337.55 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=193.3
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEe-----
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVE----- 397 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~----- 397 (624)
+.....+|++.++||+|+||.||+++. .+++.||||++........+.+.+|+.+++++. ||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 334456789999999999999999996 478999999987666666778999999999996 9999999999953
Q ss_pred ---CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 398 ---LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 398 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
....++|+||+. |+|.+++.... ....+++.+++.|+.||+.||+|||+.+ ++|+||||||+|||++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEE
Confidence 334789999995 79999886421 2346999999999999999999999986 3489999999999999999999
Q ss_pred EeecCCcccccccCCCCc--------ceeecccccccccCcccc---cccCCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 039681 475 VSDFGLSRLVERTETNDS--------HIFTTAQGTMGYLDPEYY---RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNRE 543 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~ 543 (624)
|+|||+++.......... .......+|+.|+|||++ .+..++.++||||||+++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999999987653211100 011134589999999998 566789999999999999999999999864322
Q ss_pred cccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 544 EENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.. ........ . .. ......+.+|+.+||+.+|++|||+.|+++.|+.+.....
T Consensus 259 ~~------~~~~~~~~-------~--~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 259 LR------IVNGKYSI-------P--PH-------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------CCC-------C--TT-------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HH------hhcCcccC-------C--cc-------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 11 00000000 0 00 0112236779999999999999999999999999987544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=331.71 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=197.8
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC--CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|++.+.||+|+||+||+++.. +++.||+|++... .......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457889999999999999999975 7899999998753 234456789999999999 899999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---------------
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE--------------- 469 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~--------------- 469 (624)
|||+++++|.+++..... ....+++..++.|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999964311 1256999999999999999999999999 999999999999984
Q ss_pred ----CCCeEEeecCCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCcc
Q 039681 470 ----KLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544 (624)
Q Consensus 470 ----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~ 544 (624)
...+||+|||++...... ....||..|+|||.+.+. .++.++||||||+++|||++|..++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS--------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred ccCCceEEEEcccccccccCCc--------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 447999999999876432 123489999999999765 567899999999999999999877542210
Q ss_pred ccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. . ......... + +......+.+++.+||+.||++|||+.|+++
T Consensus 237 -----~---~-~~~~~~~~~-----~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -----W---H-EIRQGRLPR-----I-------PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----H---H-HHHTTCCCC-----C-------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----H---H-HHHcCCCCC-----C-------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 1 111111111 1 1123356788999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.39 Aligned_cols=249 Identities=23% Similarity=0.391 Sum_probs=197.2
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEe----CCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE----LDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 402 (624)
+.|.+.+.||+|+||+||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3477788999999999999996 46788999987643 23445678999999999999999999999876 34589
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-CCCCeEEeecCCc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLS 481 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-~~~~~kl~DfGla 481 (624)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ ++|+||||||+|||++ +++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999963 246899999999999999999999986 3489999999999998 7899999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
...... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ..... .....
T Consensus 180 ~~~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~ 246 (290)
T 1t4h_A 180 TLKRAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRR-VTSGV 246 (290)
T ss_dssp GGCCTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHH-HTTTC
T ss_pred cccccc------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHHH-HhccC
Confidence 754321 1234568999999998875 58999999999999999999999996433211 11111 11111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... ... ......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~----~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KPA----SFD-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCG----GGG-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccc----ccC-------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 110 111 112245788999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=346.94 Aligned_cols=263 Identities=22% Similarity=0.283 Sum_probs=196.4
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC------
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL------ 398 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 398 (624)
+...++|++.+.||+|+||+||+|+. .+++.||||++.... ....+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999995 578999999886432 2234799999999999999999998543
Q ss_pred --------------------------------CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 039681 399 --------------------------------DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446 (624)
Q Consensus 399 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~y 446 (624)
...++||||++ |+|.+.+.... .....+++..+..++.||++||+|
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHH
Confidence 33789999997 58877775321 134579999999999999999999
Q ss_pred HHhcCCCCeEeecCCCCCeEEC-CCCCeEEeecCCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhH
Q 039681 447 LHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSF 524 (624)
Q Consensus 447 LH~~~~~~iiH~Dik~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~ 524 (624)
||+.+ |+||||||+|||++ +++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++|||||
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 99999 99999999999998 68899999999998764322 12345689999999998765 48999999999
Q ss_pred HHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc---cc------------cccchhhhhccCcCcHHHHHHHHHHH
Q 039681 525 GVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER---LM------------EVVDPVLKERATHLDLETMKALGLLA 589 (624)
Q Consensus 525 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~------------~~~d~~l~~~~~~~~~~~~~~l~~l~ 589 (624)
|+++|||++|+.||......+.. ..+........ +. .......... .+......+.+|+
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 302 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQL---VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI---LPEGTPSLAIDLL 302 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH---SCTTCCHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhh---CCCCCCHHHHHHH
Confidence 99999999999999765433221 11111111100 00 0000000000 0112345688999
Q ss_pred HHchhcCCCCCCCHHHHHH
Q 039681 590 ASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 590 ~~cl~~~p~~RPs~~ev~~ 608 (624)
.+||+.||++|||+.|+++
T Consensus 303 ~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHT
T ss_pred HHHccCChhhCCCHHHHhc
Confidence 9999999999999999984
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=341.63 Aligned_cols=261 Identities=20% Similarity=0.321 Sum_probs=203.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcch-----------------hHHHHHHHHHHHhcCCCceeeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKG-----------------TDLVLNEVRILCQVNHRSLVRL 391 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 391 (624)
.++|.+.+.||+|+||.||++.. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 89999999876432111 1789999999999999999999
Q ss_pred eeEEEeCCceeEEEeeccCCCcccc------cccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCC
Q 039681 392 LGCCVELDQTLMIYEYIPNGTLFDH------LHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSN 464 (624)
Q Consensus 392 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~N 464 (624)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||+|||+ .+ |+||||||+|
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK---NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh---ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 9999999999999999999999999 432 124679999999999999999999999 88 9999999999
Q ss_pred eEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCccccccc-CCCC-ccchhhHHHHHHHHHhCCCCCCCCC
Q 039681 465 ILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTD-KSDVYSFGVVLLELLTSKKAIDFNR 542 (624)
Q Consensus 465 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDv~s~G~vl~elltg~~p~~~~~ 542 (624)
||++.++.+||+|||++...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865422 23456789999999999876 5666 9999999999999999999997543
Q ss_pred ccccccHHHHHHHHhcccccccc------cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 543 EEENVNLVVYMKKIMDEERLMEV------VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~------~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... ..... +........ ..+................+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~-----~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 257 SLV-----ELFNN-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSH-----HHHHH-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHH-----HHHHH-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 311 11111 111111000 0000000000000223456888999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=332.50 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=198.8
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467899999999999999999975 589999999877666667889999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999988632 246999999999999999999999999 99999999999999999999999998764321
Q ss_pred cCCCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
. ........||..|+|||++. +..++.++||||||+++|||++|+.||......+ ..........
T Consensus 170 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~ 239 (302)
T 2j7t_A 170 T----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDP 239 (302)
T ss_dssp H----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC
T ss_pred c----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCC
Confidence 1 11123456899999999983 5578999999999999999999999987443211 1111111110
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..... +......+.+++.+||+.||++|||+.++++
T Consensus 240 -~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 -PTLLT----------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CCCSS----------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -cccCC----------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 1123356788999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.04 Aligned_cols=252 Identities=24% Similarity=0.294 Sum_probs=195.8
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc--------chhHHHHHHHHHHHhcCCCceeeEeeEEEeC
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT--------KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL 398 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 398 (624)
..++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3457899999999999999999964 578999998864321 2234588999999999999999999998765
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC---eEE
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN---AKV 475 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~---~kl 475 (624)
. .++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence 4 8999999999999998862 357999999999999999999999999 999999999999987654 999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
+|||+++..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+...
T Consensus 159 ~Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~ 231 (322)
T 2ycf_A 159 TDFGHSKILGET-----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ 231 (322)
T ss_dssp CCCTTCEECCCC-----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH
T ss_pred ccCccceecccc-----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH
Confidence 999999875421 1123456899999999974 4568999999999999999999999997543321 11111
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+. .+... ..+... ......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~----~~~~~--~~~~~~-------~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 IT----SGKYN--FIPEVW-------AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HH----HTCCC--CCHHHH-------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH----hCccc--cCchhh-------hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11 11100 011111 112356788999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=338.21 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=195.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEE-----------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCV----------- 396 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 396 (624)
.++|...+.||+|+||.||+|... +++.||+|++...+....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467899999999999999999975 48999999988766666788999999999999999999999874
Q ss_pred ---eCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-CCCC
Q 039681 397 ---ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLN 472 (624)
Q Consensus 397 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-~~~~ 472 (624)
+....++||||++ |+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence 3467899999997 699998852 46899999999999999999999999 99999999999997 5779
Q ss_pred eEEeecCCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 039681 473 AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV 551 (624)
Q Consensus 473 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 551 (624)
+||+|||+++....... .........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. .
T Consensus 160 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~ 235 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYS-HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---Q 235 (320)
T ss_dssp EEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H
T ss_pred EEEccCccccccCCCcc-cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 99999999987643211 1112234567899999998865 67899999999999999999999999755432211 1
Q ss_pred HHHHHhcc---cc---cccccchhhhhcc--CcC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 552 YMKKIMDE---ER---LMEVVDPVLKERA--THL-----DLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 552 ~~~~~~~~---~~---~~~~~d~~l~~~~--~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+...... +. +...+...+.... ... .......+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11111000 00 0000000000000 000 0123467889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.59 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=203.5
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC--------CCceeeEeeEEE---
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN--------HRSLVRLLGCCV--- 396 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 396 (624)
.++|.+.+.||+|+||+||+|+. .+++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46799999999999999999985 46889999998743 344567899999999985 788999999998
Q ss_pred -eCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCC---
Q 039681 397 -ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKL--- 471 (624)
Q Consensus 397 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~--- 471 (624)
+....++||||+ +++|.+++... ....+++..++.|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 456789999999 66777766532 235699999999999999999999998 8 99999999999999775
Q ss_pred ----------------------------------------------CeEEeecCCcccccccCCCCcceeeccccccccc
Q 039681 472 ----------------------------------------------NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505 (624)
Q Consensus 472 ----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~ 505 (624)
.+||+|||++...... .....||..|+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~ 260 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGC
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCccc
Confidence 7999999999865421 23456899999
Q ss_pred CcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHH---HHHHHhccc--------c-cccccch-----
Q 039681 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV---YMKKIMDEE--------R-LMEVVDP----- 568 (624)
Q Consensus 506 aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~--------~-~~~~~d~----- 568 (624)
|||++.+..++.++||||||++||||++|+.||......+...... .+....... . ..+....
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9999998889999999999999999999999997654433221111 111111100 0 0000000
Q ss_pred -----------hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 -----------VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 -----------~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
................+.+|+.+||+.||++|||+.|+++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000111224566778999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=355.05 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=197.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.++|.+.+.||+|+||+||+++.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456899999999999999999965 68899999986543 234567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEEeecCCcc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKVSDFGLSR 482 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl~DfGla~ 482 (624)
||+++|+|.+++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++.
T Consensus 116 e~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 116 ECYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999998863 246999999999999999999999999 999999999999976 4559999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
...... ......||+.|+|||++.+ .++.++||||||+++|||++|..||......+ ...... .+..
T Consensus 188 ~~~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~~~~ 254 (494)
T 3lij_A 188 VFENQK-----KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVE-KGKY 254 (494)
T ss_dssp ECBTTB-----CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCC
T ss_pred ECCCCc-----cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCC
Confidence 765321 2345679999999999864 69999999999999999999999997543321 111111 1111
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. ...+.. ......+.+|+.+||+.+|.+|||+.|+++
T Consensus 255 ~-~~~~~~--------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 T-FDSPEW--------KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp C-CCSGGG--------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-CCchhc--------ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0 001111 122346788999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=329.60 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=197.6
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC----cchhHHHHHHHHHHHhcCCCceeeEeeEEE--eCCc
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN----TKGTDLVLNEVRILCQVNHRSLVRLLGCCV--ELDQ 400 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 400 (624)
..++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 346899999999999999999996 468899999986432 234567999999999999999999999985 4557
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||||++++ |.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 76776532 2356999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccC--CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ--LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+....... .........||..|+|||++.+.. .+.++||||||+++|||++|+.||...... ..... +.
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-i~ 226 (305)
T 2wtk_C 156 AEALHPFA--ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFEN-IG 226 (305)
T ss_dssp CEECCTTC--SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH-HH
T ss_pred ccccCccc--cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHH-Hh
Confidence 98764321 122234567899999999987643 478999999999999999999999753321 11111 11
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.... .........+.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 KGSY-------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HCCC-------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCCC-------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1110 0011233457789999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=364.95 Aligned_cols=261 Identities=26% Similarity=0.385 Sum_probs=205.7
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
...++|.+.+.||+|+||.||+|.... +..||||+.+.... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 344668888999999999999998642 45799998875433 33567999999999999999999999985 4678
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHH----TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 999999999999999963 2346999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+...... ........+++.|+|||++.+..++.++||||||+++|||++ |..||......+ . ........
T Consensus 539 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~---~~~i~~~~ 609 (656)
T 2j0j_A 539 RYMEDST---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V---IGRIENGE 609 (656)
T ss_dssp CSCCC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHHHHTC
T ss_pred eecCCCc---ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHHHcCC
Confidence 8764321 111233456789999999988899999999999999999997 888987543221 1 11111111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
.. ..+...+..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 610 ~~-------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 610 RL-------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC-------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 00 011123456788999999999999999999999999998654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=328.18 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=199.1
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
...++|++.+.||+|+||.||+|... +++.||+|++... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34567999999999999999999965 5899999998753 34567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 104 EYCGAGSVSDIIRL----RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp ECCTTEEHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred ecCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 99999999999863 2346999999999999999999999999 9999999999999999999999999997664
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ........ .....
T Consensus 177 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~~ 245 (314)
T 3com_A 177 DTM----AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTN-PPPTF 245 (314)
T ss_dssp TTB----SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-CCCCC
T ss_pred hhc----cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcC-CCccc
Confidence 321 11234568999999999998889999999999999999999999986433211 11111111 00000
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. .......+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~----------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RK----------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SS----------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC----------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 1122356788999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.85 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=200.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.++|.+.+.||+|+||+||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456999999999999999999964 7899999997532 2334567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC---CCCCeEEeecCCcc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD---EKLNAKVSDFGLSR 482 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~---~~~~~kl~DfGla~ 482 (624)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 101 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999988632 46999999999999999999999999 99999999999995 46679999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... .......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+ ...... .+..
T Consensus 173 ~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~~~~ 239 (486)
T 3mwu_A 173 CFQQN-----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVE-TGKY 239 (486)
T ss_dssp TBCCC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCC
T ss_pred ECCCC-----CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCC
Confidence 66432 12345679999999999876 58999999999999999999999997543321 111111 1111
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. ..+.. ......+.+|+.+||+.+|.+|||+.|+++
T Consensus 240 ~~-~~~~~--------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 240 AF-DLPQW--------RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CS-CSGGG--------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC-CCccc--------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00000 123356788999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=356.01 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=203.4
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356889999999999999999965 78999999986432 33467799999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE---CCCCCeEEeecCCc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL---DEKLNAKVSDFGLS 481 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill---~~~~~~kl~DfGla 481 (624)
+||+++|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 105 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp ECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999998863 356999999999999999999999999 9999999999999 56789999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
+...... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+ ..... ..+.
T Consensus 177 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i-~~~~ 243 (484)
T 3nyv_A 177 THFEASK-----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKV-EKGK 243 (484)
T ss_dssp HHBCCCC-----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCC
T ss_pred EEccccc-----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcCC
Confidence 8764321 2345579999999999876 69999999999999999999999997543321 11111 1111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..- ..+.. ......+.+|+.+||+.+|.+|||+.|+++
T Consensus 244 ~~~-~~~~~--------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 244 YTF-ELPQW--------KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCC-CSGGG--------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-CCccc--------ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 100 00000 123356788999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=332.93 Aligned_cols=261 Identities=21% Similarity=0.321 Sum_probs=203.6
Q ss_pred hCCCCccceeccCCcEEEEEEEE--cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCC------ceeeEeeEEEeCCc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL--DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR------SLVRLLGCCVELDQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 400 (624)
.++|++.+.||+|+||+||++.. .+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46799999999999999999986 36889999998643 34456789999999998765 49999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-----------
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE----------- 469 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~----------- 469 (624)
.++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred EEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999 89999998743 2346899999999999999999999999 999999999999987
Q ss_pred --------CCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 039681 470 --------KLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541 (624)
Q Consensus 470 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~ 541 (624)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999764321 23456899999999999889999999999999999999999999765
Q ss_pred CccccccHHHHHHHHhcc---cccc-----cccc--------------------hhhhhccCcCcHHHHHHHHHHHHHch
Q 039681 542 REEENVNLVVYMKKIMDE---ERLM-----EVVD--------------------PVLKERATHLDLETMKALGLLAASCL 593 (624)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~---~~~~-----~~~d--------------------~~l~~~~~~~~~~~~~~l~~l~~~cl 593 (624)
...+.... +...... .... .... ..+. ............+.+|+.+||
T Consensus 238 ~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 238 DSKEHLAM---MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK-EFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CHHHHHHH---HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG-GGCSCCSHHHHHHHHHHHHHT
T ss_pred ChHHHHHH---HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchh-hhcccchhhHHHHHHHHHHHh
Confidence 43322211 1111110 0000 0000 0000 001112345677899999999
Q ss_pred hcCCCCCCCHHHHHH
Q 039681 594 DERRQNRPSMKEVAD 608 (624)
Q Consensus 594 ~~~p~~RPs~~ev~~ 608 (624)
+.||++|||+.|+++
T Consensus 314 ~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 314 EYDPAKRITLREALK 328 (339)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CcCcccccCHHHHhc
Confidence 999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.48 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=200.2
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-------------chhHHHHHHHHHHHhcCCCceeeEee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-------------KGTDLVLNEVRILCQVNHRSLVRLLG 393 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 393 (624)
..++|.+.+.||+|+||+||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999964 578999999864321 23567899999999999999999999
Q ss_pred EEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC--
Q 039681 394 CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-- 471 (624)
Q Consensus 394 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-- 471 (624)
++.+....++||||+++|+|.+++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence 99999999999999999999998863 246999999999999999999999999 99999999999998775
Q ss_pred -CeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHH
Q 039681 472 -NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550 (624)
Q Consensus 472 -~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 550 (624)
.+||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|||++|..||......+
T Consensus 186 ~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----- 254 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKD-----YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----- 254 (504)
T ss_dssp SSEEECCCTTCEECCTT-----SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred ccEEEEECCCCEEcCCC-----CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 6999999999876432 12345679999999999874 68999999999999999999999997543321
Q ss_pred HHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 551 VYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 551 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.... .+... .+.... .....++.+|+.+||+.||.+|||++|+++
T Consensus 255 -~~~~i~-~~~~~--~~~~~~-------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 -IIKKVE-KGKYY--FDFNDW-------KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -HHHHHH-HCCCC--CCHHHH-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHH-cCCCC--CCcccc-------CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111 11110 000000 012356788999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=332.92 Aligned_cols=267 Identities=24% Similarity=0.359 Sum_probs=187.1
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
....++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34467899999999999999999984 478999999886543 2345678899999999999999999999999999999
Q ss_pred EEeeccCCCccccccccc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 404 IYEYIPNGTLFDHLHCDF---TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~---~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
||||+++++|.+++.... ......+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999986311 112456999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCC-CcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 481 SRLVERTETN-DSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 481 a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+......... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .. ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LM---LTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HH---HHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HH---HHhc
Confidence 8765432111 1111234568999999999865 4689999999999999999999999975433221 11 1111
Q ss_pred cc--ccc-cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 EE--RLM-EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ~~--~~~-~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. ... ...++.+. ......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDPPSLETGVQDKEML-------KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCCCTTC-----CCC-------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCCccccccccchhh-------hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 000 00011110 122346788999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=333.64 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=202.0
Q ss_pred HHhCCCCccceeccCCcEEEEEEEE--cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhc---CCCceeeEeeEEE---
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGIL--DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQV---NHRSLVRLLGCCV--- 396 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 396 (624)
...++|++.+.||+|+||.||++.. .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999997 4688999998864322 2234577888887776 8999999999987
Q ss_pred --eCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 397 --ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 397 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
.....++||||++ |+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEE
Confidence 4567899999997 6999998643 2345999999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 554 (624)
|+|||+++...... ......+|..|+|||++.+..++.++||||||+++|||++|+.||......+. ...+.
T Consensus 161 l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~ 232 (326)
T 1blx_A 161 LADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKIL 232 (326)
T ss_dssp ECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH
T ss_pred EecCcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHH
Confidence 99999998654221 22345689999999999988899999999999999999999999975543221 11111
Q ss_pred HHhc---ccccccccc-h--hhh----hccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 555 KIMD---EERLMEVVD-P--VLK----ERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 555 ~~~~---~~~~~~~~d-~--~l~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... ......... + .+. .............+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111 011000000 0 000 0000011123456788999999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.47 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=198.9
Q ss_pred HHHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEe--
Q 039681 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVE-- 397 (624)
Q Consensus 322 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 397 (624)
..++....++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334445677899999999999999999996 47899999998754 33457789999999999 79999999999987
Q ss_pred ----CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 398 ----LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 398 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
....++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46789999999999999999743 2346999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~ 548 (624)
||+|||++....... .......|+..|+|||++. +..++.++||||||+++|||++|+.||......+
T Consensus 169 kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--- 241 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--- 241 (326)
T ss_dssp EECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred EEeeCcCceecCcCc----cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---
Confidence 999999998654221 1123456899999999986 4568999999999999999999999986433211
Q ss_pred HHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 549 LVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
........ ...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 242 ---~~~~~~~~-~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 ---ALFLIPRN-PAPRLK-----------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ---HHHHHHHS-CCCCCS-----------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHhhcC-ccccCC-----------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111111 000000 0112346788999999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.09 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=186.7
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc-h-hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK-G-TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.++|++.+.||+|+||+||++.. .+++.||+|+++..... . .+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788999999999999999996 57899999998754322 2 233455555688889999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
||++ |+|.+++.... .....+++..++.|+.|++.||+|||++ + |+||||||+|||++.++.+||+|||++...
T Consensus 86 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9996 58888775321 1345799999999999999999999998 8 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccc----cccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYY----RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||...... ...........
T Consensus 161 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~ 230 (290)
T 3fme_A 161 VDDV-----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEP 230 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSC
T ss_pred cccc-----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccC
Confidence 4321 12334689999999996 4557899999999999999999999999642221 11111111111
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. ... .......+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~-~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 SP-QLP-----------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC-CCC-----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-Ccc-----------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 10 000 0123356788999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=328.62 Aligned_cols=253 Identities=25% Similarity=0.319 Sum_probs=202.6
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc---------chhHHHHHHHHHHHhcC-CCceeeEeeEE
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---------KGTDLVLNEVRILCQVN-HRSLVRLLGCC 395 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 395 (624)
...++|.+.+.||+|+||.||++... +++.||||++..... ...+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999974 688999999865431 22456889999999996 99999999999
Q ss_pred EeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEE
Q 039681 396 VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475 (624)
Q Consensus 396 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl 475 (624)
.+....++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence 999999999999999999999963 246999999999999999999999999 999999999999999999999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCccccc------ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYR------NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNL 549 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~ 549 (624)
+|||++....... ......++..|+|||++. ...++.++||||||+++|||++|+.||......+
T Consensus 166 ~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 236 (298)
T 1phk_A 166 TDFGFSCQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---- 236 (298)
T ss_dssp CCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----
T ss_pred ecccchhhcCCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH----
Confidence 9999998764321 123456899999999985 3468899999999999999999999986433211
Q ss_pred HHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 550 VVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 550 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....... .... ...+. .......+.+++.+||+.||++|||+.|+++
T Consensus 237 --~~~~~~~-~~~~-~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 237 --MLRMIMS-GNYQ-FGSPE--------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHHHHHH-TCCC-CCTTT--------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHHHHhc-CCcc-cCccc--------ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111111 1100 00010 0123456888999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=347.33 Aligned_cols=262 Identities=25% Similarity=0.342 Sum_probs=192.9
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC------cee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD------QTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 402 (624)
.+|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35888999999999999999975 68999999886432 23357999999999999999999986522 367
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC-CCeEEeecCCc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDFGLS 481 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~-~~~kl~DfGla 481 (624)
+||||+++ +|.+.+... ......+++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 130 lv~e~~~~-~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 89999975 666655421 113457999999999999999999999999 9999999999999955 66899999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc-
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE- 559 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 559 (624)
+.+..... .....+|+.|+|||++.+. .++.++|||||||+||||++|+.||......+.. ..+......
T Consensus 205 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l---~~i~~~lg~p 276 (420)
T 1j1b_A 205 KQLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL---VEIIKVLGTP 276 (420)
T ss_dssp EECCTTCC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCSC
T ss_pred hhcccCCC-----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCC
Confidence 87643211 2345689999999998764 7899999999999999999999999765432221 111111110
Q ss_pred --cccc-------cccchhhhhccC--cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 --ERLM-------EVVDPVLKERAT--HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 --~~~~-------~~~d~~l~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+. +..-+.+..... ........++.+|+.+||+.||++|||+.|+++
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0010 000010000000 001123456889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.07 Aligned_cols=274 Identities=21% Similarity=0.286 Sum_probs=194.0
Q ss_pred CHHHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC
Q 039681 321 TGKEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD 399 (624)
Q Consensus 321 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 399 (624)
...+.....++|.+.+.||+|+||.||+|+. .+++.||||++... ......+.+|++.++.++||||+++++++....
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 3455667788999999999999999999996 46899999988643 333456788899999999999999999997644
Q ss_pred c-------eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeecCCCCCeEECC-
Q 039681 400 Q-------TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH--SAAVPPIYHRDVKSSNILLDE- 469 (624)
Q Consensus 400 ~-------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH--~~~~~~iiH~Dik~~Nill~~- 469 (624)
. .++||||+++ +|.+.+... ......+++..+..++.|++.||.||| +.+ |+||||||+|||++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNY-YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEA 167 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCC
Confidence 3 7899999975 555444321 123467899999999999999999999 888 999999999999996
Q ss_pred CCCeEEeecCCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 039681 470 KLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548 (624)
Q Consensus 470 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~ 548 (624)
++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+...
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSE-----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp TTEEEECCCTTCBCCCTTS-----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCcEEEeeCCCceecCCCC-----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 8999999999998765322 12345689999999998655 48999999999999999999999997654332211
Q ss_pred HHHHHHHHhccc--ccccccch-----h--------hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 549 LVVYMKKIMDEE--RLMEVVDP-----V--------LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 549 ~~~~~~~~~~~~--~~~~~~d~-----~--------l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+....... ......++ . ...............+.+|+.+||+.||.+|||+.|+++
T Consensus 243 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 243 ---EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp ---HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111111100 00000000 0 000001111224567899999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.31 Aligned_cols=268 Identities=22% Similarity=0.352 Sum_probs=202.6
Q ss_pred HHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc
Q 039681 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 323 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 400 (624)
.+.....++|++.+.||+|+||.||+|...+ .+|+|+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444556789999999999999999998754 48999886542 2334668899999999999999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++|+||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+
T Consensus 104 ~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred eEEEeecccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999963 2346999999999999999999999999 99999999999998 67999999999
Q ss_pred cccccccCCC-CcceeecccccccccCcccccc---------cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHH
Q 039681 481 SRLVERTETN-DSHIFTTAQGTMGYLDPEYYRN---------FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550 (624)
Q Consensus 481 a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 550 (624)
+......... .........|+..|+|||.+.. ..++.++||||||+++|||++|+.||......+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----- 250 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----- 250 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 8765321111 1122234568999999999864 347889999999999999999999997543221
Q ss_pred HHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 551 VYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 551 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
..... .......... ......+.+++.+||+.+|++|||+.+++++|+++.....
T Consensus 251 -~~~~~-~~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 251 -IIWQM-GTGMKPNLSQ-----------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp -HHHHH-HTTCCCCCCC-----------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred -HHHHh-ccCCCCCCCc-----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111 1111111100 0122347789999999999999999999999999877543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.21 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=193.4
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc------ee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ------TL 402 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 402 (624)
..+|+..++||+|+||+||+|+..++..+|+|++..... ...+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346899999999999999999987777789998754321 23479999999999999999999976443 78
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-CCCCeEEeecCCc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLS 481 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-~~~~~kl~DfGla 481 (624)
+||||++++.+....... .....+++..++.++.||++||+|||+.+ |+||||||+|||++ +++.+||+|||++
T Consensus 115 lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEECCSEEHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeeccCccHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 999999765433322211 12357999999999999999999999999 99999999999999 7999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+....... .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+.. ..+.......
T Consensus 190 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p 261 (394)
T 4e7w_A 190 KILIAGEP-----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL---VEIIKVLGTP 261 (394)
T ss_dssp EECCTTCC-----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCC
T ss_pred ccccCCCC-----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCC
Confidence 87643221 2345689999999998665 5899999999999999999999999865433221 1111111100
Q ss_pred ---cccc----ccchhhhhccC-----cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 ---RLME----VVDPVLKERAT-----HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ---~~~~----~~d~~l~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.. ..+..+..... ........++.+|+.+||+.||.+|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000 00000000000 001123457889999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.32 Aligned_cols=260 Identities=20% Similarity=0.293 Sum_probs=196.6
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce---
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT--- 401 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 401 (624)
..++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 346899999999999999999995 4689999999875432 3356789999999999999999999999877655
Q ss_pred ---eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 402 ---LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 402 ---~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEec
Confidence 99999996 68887774 24999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
|+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ..+....
T Consensus 189 g~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~ 258 (371)
T 4exu_A 189 GLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVT 258 (371)
T ss_dssp TCC---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH
T ss_pred CcccccccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHh
Confidence 999865321 234568999999999877 67899999999999999999999999754432221 1111111
Q ss_pred cc---cccccccchhh-------hhccC----cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DE---ERLMEVVDPVL-------KERAT----HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~---~~~~~~~d~~l-------~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. +....+.+... ..... .........+.+|+.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 00000000000 00000 000122457889999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.72 Aligned_cols=267 Identities=21% Similarity=0.280 Sum_probs=199.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----Cce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-----DQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 401 (624)
.++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999965 689999999864433 3356788999999999999999999998764 678
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++||||+. ++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 99999996 689988863 36999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCc------ceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 039681 482 RLVERTETNDS------HIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554 (624)
Q Consensus 482 ~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 554 (624)
+.......... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~ 236 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIF 236 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHH
Confidence 87653211111 11233568999999998754 67899999999999999999999999765432211 1111
Q ss_pred HHhcccc----cccccchhhhh---c---cCcC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 555 KIMDEER----LMEVVDPVLKE---R---ATHL-----DLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 555 ~~~~~~~----~~~~~d~~l~~---~---~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....... ......+.... . .... .......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111100 00000000000 0 0000 0123456788999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=333.75 Aligned_cols=259 Identities=21% Similarity=0.298 Sum_probs=196.5
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc-----
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ----- 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 400 (624)
.++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46789999999999999999996 4689999999865422 335678999999999999999999999987654
Q ss_pred -eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 401 -TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 401 -~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
.++||||+. ++|.+++. ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecc
Confidence 499999996 68888774 24999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 172 ~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~ 241 (353)
T 3coi_A 172 LARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTG 241 (353)
T ss_dssp CTTC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHC
T ss_pred cccCCCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence 99765321 234568999999999876 5789999999999999999999999975443221 111111111
Q ss_pred c---cccccccchhh-----------hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 E---ERLMEVVDPVL-----------KERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ~---~~~~~~~d~~l-----------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. +....+.+... ..............+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000000000 00000111233567889999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=335.07 Aligned_cols=265 Identities=18% Similarity=0.276 Sum_probs=200.5
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-----------CCceeeEeeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-----------HRSLVRLLGCCV 396 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 396 (624)
.++|.+.+.||+|+||+||+|+. .+++.||||++.. .....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46799999999999999999996 5789999999864 3344567889999999886 899999999998
Q ss_pred eCC----ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEEC---
Q 039681 397 ELD----QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLD--- 468 (624)
Q Consensus 397 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~--- 468 (624)
... ..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence 754 789999999 89999998743 234599999999999999999999998 8 99999999999994
Q ss_pred ---CCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 039681 469 ---EKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545 (624)
Q Consensus 469 ---~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~ 545 (624)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CCcCcceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999865421 234568999999999999889999999999999999999999997544321
Q ss_pred cccHHH---HHHHHhccc------------------c-cccccc------hhhhhccCcCcHHHHHHHHHHHHHchhcCC
Q 039681 546 NVNLVV---YMKKIMDEE------------------R-LMEVVD------PVLKERATHLDLETMKALGLLAASCLDERR 597 (624)
Q Consensus 546 ~~~~~~---~~~~~~~~~------------------~-~~~~~d------~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p 597 (624)
...... .+....... . ...+.. ..........+......+.+|+.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 111111 111111100 0 000000 001111122345677889999999999999
Q ss_pred CCCCCHHHHHH
Q 039681 598 QNRPSMKEVAD 608 (624)
Q Consensus 598 ~~RPs~~ev~~ 608 (624)
++|||++|+++
T Consensus 323 ~~Rpt~~ell~ 333 (373)
T 1q8y_A 323 RKRADAGGLVN 333 (373)
T ss_dssp TTCBCHHHHHT
T ss_pred cccCCHHHHhh
Confidence 99999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=332.61 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=179.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHH-HHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVR-ILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.++|...+.||+|+||.||++... +++.||||++..... .....+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999974 689999999875432 33445666666 677789999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
||++ ++|.+++..........+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9997 4887777532222345799999999999999999999998 8 999999999999999999999999999876
Q ss_pred cccCCCCcceeecccccccccCcccc----cccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYY----RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
.... ......||..|+|||++ .+..++.++||||||+++|||++|+.||....... ..+..
T Consensus 177 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~----- 241 (327)
T 3aln_A 177 VDSI-----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQ----- 241 (327)
T ss_dssp ----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-----
T ss_pred cccc-----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHH-----
Confidence 4321 12334689999999998 45568999999999999999999999996432110 00000
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
......+.+.. .........+.+|+.+||+.||++|||+.|+++
T Consensus 242 -~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 242 -VVKGDPPQLSN---SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCSCCCCCCC---CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HhcCCCCCCCC---cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000011100 001123456888999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=341.63 Aligned_cols=270 Identities=20% Similarity=0.297 Sum_probs=182.3
Q ss_pred CCc-cceeccCCcEEEEEEEEc---CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEe--CCceeEEE
Q 039681 332 FSK-DNLIGTGGFGEVFKGILD---DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE--LDQTLMIY 405 (624)
Q Consensus 332 ~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 405 (624)
|.+ .++||+|+||+||+|+.. +++.||||++... ...+.+.+|+.+|++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 568999999999999965 5788999998643 233568899999999999999999999965 66889999
Q ss_pred eeccCCCccccccccc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE----CCCCCeEEee
Q 039681 406 EYIPNGTLFDHLHCDF----TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL----DEKLNAKVSD 477 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill----~~~~~~kl~D 477 (624)
||+. ++|.+++.... ......+++..++.|+.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 58888775221 112335999999999999999999999999 9999999999999 7789999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccc------cccHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEE------NVNLV 550 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~------~~~~~ 550 (624)
||+++...... ..........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..+..
T Consensus 176 fg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 176 MGFARLFNSPL-KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp TTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred CCCceecCCCC-cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99998765321 111223456789999999999774 58999999999999999999999997544321 01111
Q ss_pred HHHHHHhccc---ccccc---cch-----hhhh-ccCcCc---------HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 551 VYMKKIMDEE---RLMEV---VDP-----VLKE-RATHLD---------LETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 551 ~~~~~~~~~~---~~~~~---~d~-----~l~~-~~~~~~---------~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+...+... .+..+ .+. .+.. ...... ......+.+|+.+||+.||.+|||++|+++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111110 00000 000 0000 000000 001346788999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=338.86 Aligned_cols=254 Identities=11% Similarity=0.001 Sum_probs=181.5
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc---chhHHHHHHHHHHHhc--CCCceeeEe-------eEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---KGTDLVLNEVRILCQV--NHRSLVRLL-------GCC 395 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 395 (624)
..+|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888999999999999999964 789999999886543 3345677885544444 699988755 455
Q ss_pred EeC-----------------CceeEEEeeccCCCcccccccccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCC
Q 039681 396 VEL-----------------DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLR------LVIAHQIAEGLTYLHSAAV 452 (624)
Q Consensus 396 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~L~yLH~~~~ 452 (624)
... ...++||||++ |+|.+++... ...+++..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQSKG- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence 433 23799999998 8999999743 123455566 788899999999999999
Q ss_pred CCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccc--cCCCCccchhhHHHHHHH
Q 039681 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLE 530 (624)
Q Consensus 453 ~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~e 530 (624)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||++|||
T Consensus 215 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 215 --LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp --EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred --CccCcCCHHHEEECCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 999999999999999999999999999865321 124557799999999987 679999999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 531 LLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 531 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
|++|+.||.......... ................ .........+.+|+.+||+.||++|||+.|+++
T Consensus 286 lltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAF---GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCC---TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHhCCCCCCCcCcccccc--------hhhhhhhhccccccch---hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999997553321100 0000000000000000 000123456888999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.09 Aligned_cols=256 Identities=23% Similarity=0.309 Sum_probs=197.1
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcC--CCceeeEeeEEEeCCc
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVN--HRSLVRLLGCCVELDQ 400 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 400 (624)
+....++|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++++++ |+||+++++++.+...
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 344556799999999999999999998889999999986543 334577899999999997 5999999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||| +.+++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||+++ +.+||+|||+
T Consensus 103 ~~lv~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred EEEEEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 999999 568899999973 246899999999999999999999999 999999999999965 7999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccc-----------cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccH
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-----------FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNL 549 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~ 549 (624)
+........ ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .
T Consensus 173 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~ 245 (313)
T 3cek_A 173 ANQMQPDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----Q 245 (313)
T ss_dssp SCC----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----H
T ss_pred cccccCccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----H
Confidence 987643211 111234568999999999865 4688899999999999999999999864321 1
Q ss_pred HHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 550 VVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 550 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
............... .+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~---------~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 ISKLHAIIDPNHEIE---------FP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHCTTSCCC---------CC---CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhcccccC---------Cc---ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111222221111000 00 1113467889999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.67 Aligned_cols=203 Identities=26% Similarity=0.350 Sum_probs=172.3
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CC-----ceeeEeeEEEeC
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HR-----SLVRLLGCCVEL 398 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 398 (624)
....++|++.+.||+|+||+||+|+.. +++.||||+++.. ....+.+..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344678999999999999999999964 6889999998743 334567788999988885 44 499999999999
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCCeEeecCCCCCeEEC--CCCCeE
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS--AAVPPIYHRDVKSSNILLD--EKLNAK 474 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~--~~~~~iiH~Dik~~Nill~--~~~~~k 474 (624)
+..++||||++ ++|.+++... ....+++..++.++.||+.||+|||+ .+ |+||||||+|||++ .++.+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred CceEEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 99999999995 6999998743 23469999999999999999999995 45 99999999999994 578899
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNRE 543 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~ 543 (624)
|+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 202 L~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 202 IVDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ECCCTTCEETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEeccCceecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999876421 2345789999999999998999999999999999999999999986543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=341.67 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=186.9
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345567889999999998776778999999988642 345678999999887 8999999999999999999999999
Q ss_pred cCCCcccccccccCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC-------------CCe
Q 039681 409 PNGTLFDHLHCDFTGKW--PPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK-------------LNA 473 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~-------------~~~ 473 (624)
. |+|.+++........ ...++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 699999974321110 11234456789999999999999999 9999999999999654 489
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccc-------cCCCCccchhhHHHHHHHHHh-CCCCCCCCCccc
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN-------FQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEE 545 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~ 545 (624)
||+|||+++.................||+.|+|||++.+ ..++.++||||||+++|||++ |+.||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999998765432211112345679999999999865 568999999999999999999 899986432211
Q ss_pred cccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
............. ..........++.+|+.+||+.||.+|||+.||++
T Consensus 248 ----~~i~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SNIIRGIFSLDEM-----------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHHHTCCCCCCC-----------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHhcCCCCcccc-----------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111110000000 00112356678899999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=329.71 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=200.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CC-CEEEEEEcccCCcchhHHHHHHHHHHHhcCCCc------eeeEeeEEEeCCc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DG-TVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS------LVRLLGCCVELDQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 400 (624)
.++|++.+.||+|+||+||++... ++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999964 34 68999998643 344567889999999997766 9999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE-------------
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL------------- 467 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill------------- 467 (624)
.++||||+ +++|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred EEEEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 99999999 67777777532 2346999999999999999999999999 9999999999999
Q ss_pred ------CCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 039681 468 ------DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFN 541 (624)
Q Consensus 468 ------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~ 541 (624)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56889999999999764321 23456899999999999889999999999999999999999999755
Q ss_pred CccccccHHHHHHHHhcc---ccccccc------------chh------hh------hccCcCcHHHHHHHHHHHHHchh
Q 039681 542 REEENVNLVVYMKKIMDE---ERLMEVV------------DPV------LK------ERATHLDLETMKALGLLAASCLD 594 (624)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~---~~~~~~~------------d~~------l~------~~~~~~~~~~~~~l~~l~~~cl~ 594 (624)
...+.. ..+...... ....... +.. .. .............+.+|+.+||+
T Consensus 243 ~~~~~~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 243 ENREHL---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp SHHHHH---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CHHHHH---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 433221 111111110 0000000 000 00 00001122345678899999999
Q ss_pred cCCCCCCCHHHHHH
Q 039681 595 ERRQNRPSMKEVAD 608 (624)
Q Consensus 595 ~~p~~RPs~~ev~~ 608 (624)
.||++|||+.|+++
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.02 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=200.8
Q ss_pred HhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999965 68999999986432 33467799999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC---CCeEEeecCCc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK---LNAKVSDFGLS 481 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~---~~~kl~DfGla 481 (624)
+||+++++|.+++... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.+ +.+||+|||++
T Consensus 100 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999988632 36899999999999999999999999 9999999999999754 46999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
....... ......++..|+|||.+.+ .++.++||||||+++|||++|+.||......+ .... +..+.
T Consensus 172 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~ 238 (287)
T 2wei_A 172 TCFQQNT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKR-VETGK 238 (287)
T ss_dssp GTBCCCS-----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHCC
T ss_pred eeecCCC-----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHcCC
Confidence 8654321 1223458899999999876 58999999999999999999999997543221 1111 11111
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... .+.. ......+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~~-~~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 YAFD-LPQW--------RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCC-SGGG--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-chhh--------hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1000 0000 122356788999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=324.91 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=191.3
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEe----------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE---------- 397 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 397 (624)
.++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45788999999999999999996 47899999998642 3445778999999999999999999999875
Q ss_pred ---CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 398 ---LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 398 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 35678999999999999999642 246888999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccccccCC----------CCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCc
Q 039681 475 VSDFGLSRLVERTET----------NDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNRE 543 (624)
Q Consensus 475 l~DfGla~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~ 543 (624)
|+|||++........ ..........|+..|+|||.+.+. .++.++||||||+++|||++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 999999986542210 001223455689999999999764 68999999999999999998 443211
Q ss_pred cccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 544 EENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+. ........ ... ....+. ........+.+++.+||+.||++|||+.|+++
T Consensus 233 -~~---~~~~~~~~-~~~--~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -ER---VNILKKLR-SVS--IEFPPD-------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HH---HHHHHHHH-STT--CCCCTT-------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hH---HHHHHhcc-ccc--cccCcc-------ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 11111111 100 001111 11233456788999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=327.64 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=190.0
Q ss_pred HHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc------chhHHHHHHHHHHHhc----CCCceeeEe
Q 039681 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT------KGTDLVLNEVRILCQV----NHRSLVRLL 392 (624)
Q Consensus 324 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~ 392 (624)
+.....++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455667899999999999999999985 5689999999865432 1234567899999999 899999999
Q ss_pred eEEEeCCceeEEEee-ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-CC
Q 039681 393 GCCVELDQTLMIYEY-IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EK 470 (624)
Q Consensus 393 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-~~ 470 (624)
+++.+.+..++|+|| +.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 999999999999999 789999999974 246999999999999999999999999 99999999999999 88
Q ss_pred CCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccH
Q 039681 471 LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNL 549 (624)
Q Consensus 471 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~ 549 (624)
+.+||+|||++...... ......|+..|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 177 ~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------ 244 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDE------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ 244 (312)
T ss_dssp TEEEECCCSSCEECCSS------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------
T ss_pred CeEEEEEcchhhhcccC------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------
Confidence 99999999999876432 1234568999999999877665 4589999999999999999999863210
Q ss_pred HHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 550 VVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 550 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... .. .........+.+++.+||+.+|++|||++|+++
T Consensus 245 ------~~~~-~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ------ILEA-EL-------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ------HHHT-CC-------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------Hhhh-cc-------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 001122345778999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.70 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=198.3
Q ss_pred HHHHHHhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc------hhHHHHHHHHHHHhcC--CCceeeEee
Q 039681 323 KEIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK------GTDLVLNEVRILCQVN--HRSLVRLLG 393 (624)
Q Consensus 323 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~ 393 (624)
.+.....++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 33444567899999999999999999985 56899999998654321 2345788999999996 599999999
Q ss_pred EEEeCCceeEEEeeccC-CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-CCC
Q 039681 394 CCVELDQTLMIYEYIPN-GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKL 471 (624)
Q Consensus 394 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-~~~ 471 (624)
++.+.+..++|+|++.+ ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 99999999999999976 899999863 246999999999999999999999999 99999999999999 789
Q ss_pred CeEEeecCCcccccccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHH
Q 039681 472 NAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLV 550 (624)
Q Consensus 472 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 550 (624)
.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 188 ~~kL~Dfg~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------- 254 (320)
T 3a99_A 188 ELKLIDFGSGALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------- 254 (320)
T ss_dssp EEEECCCTTCEECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CEEEeeCccccccccc------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------
Confidence 9999999999876422 1234568999999999977665 6889999999999999999999863210
Q ss_pred HHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 551 VYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 551 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..... . .. .......+.+|+.+||+.||++|||++|+++
T Consensus 255 -----~~~~~-~--~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -----IIRGQ-V--FF-----------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -----HHHCC-C--CC-----------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----hhccc-c--cc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0 00 0112345778999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.66 Aligned_cols=252 Identities=21% Similarity=0.259 Sum_probs=172.1
Q ss_pred HhCCCCcc-ceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHH-HHHHhcCCCceeeEeeEEEe----CCc
Q 039681 328 ATNNFSKD-NLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEV-RILCQVNHRSLVRLLGCCVE----LDQ 400 (624)
Q Consensus 328 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~----~~~ 400 (624)
..++|.+. ++||+|+||+||+++.. +++.||||++... ....+|+ ..++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 34678874 57999999999999965 6899999998642 1223333 34667799999999999986 445
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEEee
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKVSD 477 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl~D 477 (624)
.++||||+++|+|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEec
Confidence 89999999999999999742 2346999999999999999999999999 999999999999976 45599999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
||+++..... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||.......... ......
T Consensus 175 fg~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~ 245 (336)
T 3fhr_A 175 FGFAKETTQN------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRI 245 (336)
T ss_dssp CTTCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred cccceecccc------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhh
Confidence 9999865421 1234568999999999988889999999999999999999999996543221100 000000
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..... ....+ ........+.+|+.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~-~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 246 RLGQY-GFPNP--------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------CCCTT--------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcccc-ccCch--------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 00000 00123456788999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=334.68 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=186.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
..+|...++||+|+||+||.....+++.||||++.... .+.+.+|+++++++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34688889999999999766556689999999986432 23467899999999 799999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-----CCCeEEeecCCcc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-----KLNAKVSDFGLSR 482 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-----~~~~kl~DfGla~ 482 (624)
++ |+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++
T Consensus 100 ~~-g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 100 CA-ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CS-EEHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CC-CCHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 95 6999998643 223455567899999999999999999 999999999999943 3468899999998
Q ss_pred cccccCCCCcceeecccccccccCccccc---ccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYR---NFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
........ ........||+.|+|||++. ...++.++||||||+++|||++ |..||....... ......
T Consensus 172 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~ 243 (432)
T 3p23_A 172 KLAVGRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLG 243 (432)
T ss_dssp CC-------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTT
T ss_pred eccCCCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhc
Confidence 76532111 11234567999999999997 4567889999999999999999 888885322111 111111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
.... .... ........+.+|+.+||+.||.+|||+.||+
T Consensus 244 ~~~~-~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 244 ACSL-DCLH---------PEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp CCCC-TTSC---------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCc-cccC---------ccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 1110 1000 1123345577899999999999999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=316.00 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=178.3
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcc-h-hHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTK-G-TDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.++|+..+.||+|+||.||++... +++.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999974 6899999998754332 2 233445556788889999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
||+ ++.+..+... ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||++...
T Consensus 104 e~~-~~~~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999 4444444432 234699999999999999999999995 8 999999999999999999999999999765
Q ss_pred cccCCCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
.... ......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ..........
T Consensus 176 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~ 245 (318)
T 2dyl_A 176 VDDK-----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQE 245 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHS
T ss_pred cCCc-----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhcc
Confidence 4321 123456899999999984 456889999999999999999999998743221 1111111111
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. . .+.. .......+.+++.+||+.||.+|||++|+++
T Consensus 246 ~~-~-----~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 246 EP-P-----LLPG-----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC-C-----CCCS-----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC-C-----CCCc-----cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 10 0 0000 0112345788999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=343.76 Aligned_cols=273 Identities=25% Similarity=0.325 Sum_probs=203.8
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEe------CCc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE------LDQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 400 (624)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36799999999999999999996 46899999998654 33445679999999999999999999998765 667
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCC---eEEee
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLN---AKVSD 477 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~---~kl~D 477 (624)
.++||||+++|+|.+++... .....+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcc
Confidence 89999999999999999742 22346899999999999999999999999 999999999999997665 99999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
||++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... .|.....
T Consensus 168 FG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~ 237 (676)
T 3qa8_A 168 LGYAKELDQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVR 237 (676)
T ss_dssp CCCCCBTTSCC-----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC
T ss_pred ccccccccccc-----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhh
Confidence 99998764321 2234678999999999998899999999999999999999999997542211 0000000
Q ss_pred cccc----cccccchhh-----hhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHH-----HHHHHHHHHHh
Q 039681 558 DEER----LMEVVDPVL-----KERATHLDLETMKALGLLAASCLDERRQNRPSMKE-----VADEIEYIISI 616 (624)
Q Consensus 558 ~~~~----~~~~~d~~l-----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e-----v~~~L~~i~~~ 616 (624)
.... ..+...... ..............+.+++.+||+.||++|||+.| ..+.++.+...
T Consensus 238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0000 000000000 00011123346678899999999999999999988 45666666653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=345.27 Aligned_cols=240 Identities=22% Similarity=0.341 Sum_probs=194.6
Q ss_pred CCCCccceeccCCcEEEEEEEEc--CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc-----e
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD--DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ-----T 401 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 401 (624)
++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67999999999999999999975 68999999886443 3445678999999999999999999999998766 6
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCc
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLS 481 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla 481 (624)
++||||+++++|.+++. ..+++.+++.|+.||+.||+|||+++ |+||||||+|||++++ .+||+|||++
T Consensus 160 ~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 99999999999988774 26999999999999999999999999 9999999999999986 8999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 482 RLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
+..... ....||+.|+|||++.+. .+.++||||||+++|||++|..|+.......
T Consensus 229 ~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------- 283 (681)
T 2pzi_A 229 SRINSF--------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------- 283 (681)
T ss_dssp EETTCC--------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------
T ss_pred hhcccC--------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------------
Confidence 875421 345689999999998764 4889999999999999999988875321110
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-SMKEVADEIEYIIS 615 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~ 615 (624)
+. .. .........+.+++.+||+.||++|| +++++...|..++.
T Consensus 284 ~~---~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 LP---ED-------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CC---TT-------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred cc---cc-------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00 00 00112335678899999999999998 57777777777653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.69 Aligned_cols=235 Identities=11% Similarity=0.068 Sum_probs=184.6
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999975 489999999875433 2346799999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++++|.+++.. . ....++.+|+.||+.||+|||+++ |+||||||+|||+++++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999852 1 355678899999999999999999 9999999999999999999998543
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
|++ .++.++||||||+++|||++|+.||......+..... ......
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~ 220 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAG 220 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTS
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhcc
Confidence 223 3688999999999999999999999865432211000 000000
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
...+ .... .......+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 221 ~~~~-~~~~----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 221 QPIE-PADI----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CBCC-HHHH----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCCC-hhhc----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0000 0000 11234568889999999999999 99999999999876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=303.44 Aligned_cols=230 Identities=20% Similarity=0.245 Sum_probs=177.3
Q ss_pred CCCCcc-ceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHH-HhcCCCceeeEeeEEEe----CCcee
Q 039681 330 NNFSKD-NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRIL-CQVNHRSLVRLLGCCVE----LDQTL 402 (624)
Q Consensus 330 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 402 (624)
++|.+. ++||+|+||.||++.. .+++.||+|+++. ...+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 7899999999999996 5689999999863 24577899888 55689999999999987 67789
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEEeecC
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKVSDFG 479 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl~DfG 479 (624)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999743 2346999999999999999999999999 999999999999998 7889999999
Q ss_pred CcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
++.... +..++.++||||||+++|||++|+.||......+.. .
T Consensus 166 ~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~ 208 (299)
T 3m2w_A 166 FAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------P 208 (299)
T ss_dssp TCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------C
T ss_pred cccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------H
Confidence 986432 134678999999999999999999999643321100 0
Q ss_pred cccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.....+....... ...........+.+++.+||+.||++|||+.|+++
T Consensus 209 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 209 GMKTRIRMGQYEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSCCSSCTTCCSS-CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhccccC-CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000000000 00000123456888999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=323.47 Aligned_cols=245 Identities=12% Similarity=0.172 Sum_probs=180.9
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCC-Cce---------e----
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNH-RSL---------V---- 389 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------v---- 389 (624)
....|...++||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.+++.++| +|. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 334577788999999999999994 5789999999874333 235779999999999987 221 1
Q ss_pred --e------EeeEEEe-----CCceeEEEeeccCCCcccccccc--cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 039681 390 --R------LLGCCVE-----LDQTLMIYEYIPNGTLFDHLHCD--FTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPP 454 (624)
Q Consensus 390 --~------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~ 454 (624)
. +..+... ....+++|+++ +++|.+++..- .......+++..++.|+.||++||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1 1111111 12345666655 78999888411 0113456889999999999999999999999
Q ss_pred eEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccc----------cccCCCCccchhhH
Q 039681 455 IYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYY----------RNFQLTDKSDVYSF 524 (624)
Q Consensus 455 iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDv~s~ 524 (624)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 999999999999999999999999998765321 345567 999999999 55568889999999
Q ss_pred HHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHH
Q 039681 525 GVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604 (624)
Q Consensus 525 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ 604 (624)
|+++|||++|+.||......+.. +..+.. .. ..+..+.+|+.+||+.||++||++.
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~-------------------~~~~~~-~~----~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGS-------------------EWIFRS-CK----NIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCS-------------------GGGGSS-CC----CCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHCCCCCCCcchhhhH-------------------HHHHhh-cc----cCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999999754322211 111110 01 1235688899999999999999988
Q ss_pred HHHH
Q 039681 605 EVAD 608 (624)
Q Consensus 605 ev~~ 608 (624)
|+++
T Consensus 360 ~~l~ 363 (413)
T 3dzo_A 360 QAME 363 (413)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.98 Aligned_cols=242 Identities=20% Similarity=0.216 Sum_probs=184.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc--------chhHHHHHHHHHHHhcC---------CCceeeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT--------KGTDLVLNEVRILCQVN---------HRSLVRL 391 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~l 391 (624)
.++|++.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999987 689999999875432 23477899999999886 7788777
Q ss_pred eeEEE------------------------------eCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHH
Q 039681 392 LGCCV------------------------------ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441 (624)
Q Consensus 392 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~ 441 (624)
.+++. +....++||||+++|++.+.+.. ..+++..++.|+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 77653 26789999999999988777742 4689999999999999
Q ss_pred HHHHHHH-hcCCCCeEeecCCCCCeEECCCC--------------------CeEEeecCCcccccccCCCCcceeecccc
Q 039681 442 EGLTYLH-SAAVPPIYHRDVKSSNILLDEKL--------------------NAKVSDFGLSRLVERTETNDSHIFTTAQG 500 (624)
Q Consensus 442 ~~L~yLH-~~~~~~iiH~Dik~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~g 500 (624)
.||+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...|
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~g 239 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVF 239 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEEC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEE
Confidence 9999999 899 99999999999999887 8999999999876421 2368
Q ss_pred cccccCcccccccCCCCccchhhHHHH-HHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcH
Q 039681 501 TMGYLDPEYYRNFQLTDKSDVYSFGVV-LLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDL 579 (624)
Q Consensus 501 t~~y~aPE~~~~~~~~~ksDv~s~G~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 579 (624)
|+.|+|||++.+.. +.++||||++.+ .+++++|..||.... .................... .....
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~-------~~~~~ 306 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQMTFKTKCN-------TPAMK 306 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTCCCSSCCC-------SHHHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhhccCcccc-------hhhhh
Confidence 99999999998766 889999998777 778889998874210 00000111111100000000 01123
Q ss_pred HHHHHHHHHHHHchhcCCCCCCCHHHHH
Q 039681 580 ETMKALGLLAASCLDERRQNRPSMKEVA 607 (624)
Q Consensus 580 ~~~~~l~~l~~~cl~~~p~~RPs~~ev~ 607 (624)
....++.+|+.+||+.| |++|++
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHH
Confidence 56778999999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=284.82 Aligned_cols=184 Identities=16% Similarity=0.088 Sum_probs=129.8
Q ss_pred eccCCcEEEEEEE-EcCCCEEEEEEcccCC----------cchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEEE
Q 039681 338 IGTGGFGEVFKGI-LDDGTVTAIKRAKLGN----------TKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 338 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 405 (624)
.+.|+.|.+..++ ..-|+.+++|++.... ....++|.+|+++|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555544 3457889999886431 12345699999999999 6999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||++|++|.++|.. ..+++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999973 3456654 58899999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCC
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKA 537 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p 537 (624)
.. ........||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~----~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QD----CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC----CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 122345679999999999976 567789999999998887666544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-27 Score=255.86 Aligned_cols=186 Identities=20% Similarity=0.221 Sum_probs=145.1
Q ss_pred ccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc--------hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 334 KDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK--------GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 334 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
..++||+|+||+||++.. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 5677888875432211 1345899999999999999997777777888889999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++++|.+++.. ++.|+.|+++||+|||+++ |+||||||+|||+++ ++||+|||+++...
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 99999999999962 5689999999999999999 999999999999999 99999999998765
Q ss_pred ccCCCCcc---eeecccccccccCcccccc--cCCCCccchhhHHHHHHHHHhCCCCC
Q 039681 486 RTETNDSH---IFTTAQGTMGYLDPEYYRN--FQLTDKSDVYSFGVVLLELLTSKKAI 538 (624)
Q Consensus 486 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~ksDv~s~G~vl~elltg~~p~ 538 (624)
........ ......||+.|||||++.. ..|+.+.|+||..+-.++-+.++.++
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32111000 1235679999999999976 56888999999999999888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=210.05 Aligned_cols=161 Identities=19% Similarity=0.165 Sum_probs=126.4
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc------------------chhHHHHHHHHHHHhcCCCc
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT------------------KGTDLVLNEVRILCQVNHRS 387 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~n 387 (624)
......|.+.+.||+|+||.||+|...+|+.||||+++.... .....+.+|++++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 344556777799999999999999997799999999864321 13456899999999999 4
Q ss_pred eeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE
Q 039681 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 388 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill 467 (624)
+++.+++.. +..++||||+++++|.+ +.. .....++.|++.||+|||+.+ |+||||||+|||+
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 666665443 56799999999999988 531 124579999999999999999 9999999999999
Q ss_pred CCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccc----------cCCCCccchhh
Q 039681 468 DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN----------FQLTDKSDVYS 523 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~ksDv~s 523 (624)
+ ++.+||+|||+++.. ..++|||++.. ..+..++|+|.
T Consensus 227 ~-~~~vkl~DFG~a~~~-----------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEV-----------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp E-TTEEEECCCTTCEET-----------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred E-CCcEEEEECCCCeEC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9 999999999999643 34688998753 23455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=178.41 Aligned_cols=136 Identities=20% Similarity=0.173 Sum_probs=105.8
Q ss_pred CCccceeccCCcEEEEEEEE-cCCCE--EEEEEcccCCcc------------------------hhHHHHHHHHHHHhcC
Q 039681 332 FSKDNLIGTGGFGEVFKGIL-DDGTV--TAIKRAKLGNTK------------------------GTDLVLNEVRILCQVN 384 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 384 (624)
|.+.+.||+|+||.||+|.. .+|+. ||||+.+..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999997 78888 999986543111 0135789999999998
Q ss_pred CCce--eeEeeEEEeCCceeEEEeeccC-C----CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 039681 385 HRSL--VRLLGCCVELDQTLMIYEYIPN-G----TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH-SAAVPPIY 456 (624)
Q Consensus 385 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH-~~~~~~ii 456 (624)
|+++ +.+++. ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 8754 344432 367899999942 5 45444321 234567889999999999999 888 99
Q ss_pred eecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 457 HRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 457 H~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
||||||+|||+++ .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=4.4e-17 Score=167.04 Aligned_cols=138 Identities=13% Similarity=0.169 Sum_probs=101.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc--------------hhH--------HHHHHHHHHHhcCCC
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK--------------GTD--------LVLNEVRILCQVNHR 386 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~E~~~l~~l~h~ 386 (624)
..-|++.+.||+|++|.||+|...+|+.||||+++..... ... ....|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 3348899999999999999999889999999987532110 000 123466677777544
Q ss_pred cee--eEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCC
Q 039681 387 SLV--RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSN 464 (624)
Q Consensus 387 niv--~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~N 464 (624)
++. ..++. ...+|||||+++++|.++... .....++.||+.+|.|||+.+ ||||||||.|
T Consensus 174 gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~N 235 (397)
T 4gyi_A 174 GFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG---LIHGDFNEFN 235 (397)
T ss_dssp TCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred CCCCCeeeec----cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 432 22222 234799999999888765431 123567899999999999999 9999999999
Q ss_pred eEECCCC----------CeEEeecCCcccc
Q 039681 465 ILLDEKL----------NAKVSDFGLSRLV 484 (624)
Q Consensus 465 ill~~~~----------~~kl~DfGla~~~ 484 (624)
||+++++ .+.|+||+-+...
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9998776 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.6e-12 Score=126.73 Aligned_cols=147 Identities=14% Similarity=0.045 Sum_probs=114.8
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeE
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 403 (624)
+......|+....++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |.++.+++++..+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3444567887888888899999998754 6889999876432233456899999999985 6788899999999889999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA-------------------------------- 451 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-------------------------------- 451 (624)
||||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 9999999998765421 1123478889999999999821
Q ss_pred ------------------------CCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 452 ------------------------VPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 452 ------------------------~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0338999999999999876667799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=1.8e-11 Score=120.37 Aligned_cols=138 Identities=15% Similarity=0.138 Sum_probs=102.8
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCc--eeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS--LVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 407 (624)
..+....+.+.|..+.||+....+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345544333456669999998777888999987543 3356789999999986544 45688888887889999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA------------------------------------ 451 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------------------ 451 (624)
++|.+|. .. ..+ ...++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 97 VPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred cCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9998884 21 011 2367788888899988753
Q ss_pred -------------------CCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 452 -------------------VPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 452 -------------------~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
...++|+|++|.|||++++..+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=3.2e-10 Score=117.23 Aligned_cols=141 Identities=16% Similarity=0.283 Sum_probs=106.9
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcc--cCC-cchhHHHHHHHHHHHhcC--CCceeeEeeEEEeC---CceeEEEe
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAK--LGN-TKGTDLVLNEVRILCQVN--HRSLVRLLGCCVEL---DQTLMIYE 406 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 406 (624)
.+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999988654 577888765 322 123457889999999997 45688899888776 34899999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA----------------------------------- 451 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~----------------------------------- 451 (624)
|+++.++.+.. ...++..++..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 122 FVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred ecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99988875422 134788899999999999999999831
Q ss_pred --------------------CCCeEeecCCCCCeEECCCCC--eEEeecCCccc
Q 039681 452 --------------------VPPIYHRDVKSSNILLDEKLN--AKVSDFGLSRL 483 (624)
Q Consensus 452 --------------------~~~iiH~Dik~~Nill~~~~~--~kl~DfGla~~ 483 (624)
...++|+|+++.|||+++++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.3e-09 Score=109.88 Aligned_cols=188 Identities=19% Similarity=0.201 Sum_probs=122.6
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCc--eeeEeeEEEeCC---ceeEEEeec
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRS--LVRLLGCCVELD---QTLMIYEYI 408 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 408 (624)
.+.++.|....||+.. ..+++|+... ......+.+|.++++.+. +.. +.+.+....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 4578887542 234567899999998883 332 344544433332 358899999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA------------------------------------- 451 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~------------------------------------- 451 (624)
+|.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 99 KGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred CCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9988865332 24778888899999999999999621
Q ss_pred ------------------CCCeEeecCCCCCeEECC--CCCeEEeecCCcccccccCCCCcceeec-----------ccc
Q 039681 452 ------------------VPPIYHRDVKSSNILLDE--KLNAKVSDFGLSRLVERTETNDSHIFTT-----------AQG 500 (624)
Q Consensus 452 ------------------~~~iiH~Dik~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~-----------~~g 500 (624)
.+.++|+|++|.||++++ ...+.|+||+.+...... .+....... ...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHH
Confidence 134899999999999998 556889999988653211 000000000 000
Q ss_pred cccccC-cccccccCCCCccchhhHHHHHHHHHhCCCCC
Q 039681 501 TMGYLD-PEYYRNFQLTDKSDVYSFGVVLLELLTSKKAI 538 (624)
Q Consensus 501 t~~y~a-PE~~~~~~~~~ksDv~s~G~vl~elltg~~p~ 538 (624)
..+... |+.... .....+.|+++.++|++.+|..++
T Consensus 251 ~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001111 222111 112358999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=4.3e-07 Score=89.50 Aligned_cols=135 Identities=21% Similarity=0.157 Sum_probs=99.1
Q ss_pred eeccCCcE-EEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 337 LIGTGGFG-EVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 337 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
.+..|..+ .||+.... ++..+++|+... .....+.+|...|+.+. +-.+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 35556555 68987744 566788998653 23456888999998885 44577889999999999999999999887
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV----------------------------------------- 452 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----------------------------------------- 452 (624)
.+.... .......+..++++.|+-||+...
T Consensus 108 ~~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 765431 112334567778888888885321
Q ss_pred --------------CCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 453 --------------PPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 453 --------------~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.2e-06 Score=87.92 Aligned_cols=136 Identities=17% Similarity=0.161 Sum_probs=97.7
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCC---ceeeEeeEEE-eCCceeEEEeeccC
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR---SLVRLLGCCV-ELDQTLMIYEYIPN 410 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 410 (624)
.+.++.|....||+. +..+++|+.. .......+.+|.++|+.+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888998999987 4667788743 223456789999999999742 3566666664 34567899999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA--------------------------------------- 451 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--------------------------------------- 451 (624)
.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 98 ~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 98 QILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp EECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 88865321 13456666777777777777777532
Q ss_pred ------------------CCCeEeecCCCCCeEECC---CCC-eEEeecCCccc
Q 039681 452 ------------------VPPIYHRDVKSSNILLDE---KLN-AKVSDFGLSRL 483 (624)
Q Consensus 452 ------------------~~~iiH~Dik~~Nill~~---~~~-~kl~DfGla~~ 483 (624)
.+.++|+|+++.|||+++ ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123699999999999987 455 48999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=9.9e-07 Score=90.70 Aligned_cols=82 Identities=11% Similarity=-0.009 Sum_probs=57.8
Q ss_pred ccee-ccCCcEEEEEEEEc-------CCCEEEEEEcccCC---cchhHHHHHHHHHHHhcC-C--CceeeEeeEEEeC--
Q 039681 335 DNLI-GTGGFGEVFKGILD-------DGTVTAIKRAKLGN---TKGTDLVLNEVRILCQVN-H--RSLVRLLGCCVEL-- 398 (624)
Q Consensus 335 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 398 (624)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+. + ..+.+++++..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999988754 26678888765322 112356788999998884 3 3577788877655
Q ss_pred -CceeEEEeeccCCCcccc
Q 039681 399 -DQTLMIYEYIPNGTLFDH 416 (624)
Q Consensus 399 -~~~~lv~e~~~~g~L~~~ 416 (624)
...++||||++|.++.+.
T Consensus 105 ~g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp TSSCEEEEECCCCBCCCBT
T ss_pred cCCceEEEEecCCCChhhc
Confidence 356899999998877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.3e-05 Score=78.55 Aligned_cols=142 Identities=17% Similarity=0.145 Sum_probs=80.0
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC--CceeeEee------EEEeCCceeEEEee
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH--RSLVRLLG------CCVELDQTLMIYEY 407 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 407 (624)
+.|+.|..+.||+....+| .+++|+.... .+.+..|..+++.+.. -.+.+++. +....+..++|+||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999887655 4888987642 2333445555555531 12333332 12345678999999
Q ss_pred ccCCCccc--------------ccccccCC---C------CCCCCHHHH-------------------------------
Q 039681 408 IPNGTLFD--------------HLHCDFTG---K------WPPLPWHLR------------------------------- 433 (624)
Q Consensus 408 ~~~g~L~~--------------~l~~~~~~---~------~~~l~~~~~------------------------------- 433 (624)
++|.++.. .+|..... . ...-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99866531 11211000 0 011233221
Q ss_pred HHHHHHHHHHHHHHHh--------c--CCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 434 LVIAHQIAEGLTYLHS--------A--AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 434 ~~i~~~i~~~L~yLH~--------~--~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
..+..++..++++|+. . ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111234456677763 1 23449999999999999888899999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2e-05 Score=82.13 Aligned_cols=75 Identities=17% Similarity=0.123 Sum_probs=49.9
Q ss_pred cceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-------chhHHHHHHHHHHHhcCC--Cc-eeeEeeEEEeCCceeE
Q 039681 335 DNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-------KGTDLVLNEVRILCQVNH--RS-LVRLLGCCVELDQTLM 403 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 403 (624)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999753 567899997543211 123557889999988742 33 3445543 4556789
Q ss_pred EEeeccCC
Q 039681 404 IYEYIPNG 411 (624)
Q Consensus 404 v~e~~~~g 411 (624)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.90 E-value=6.1e-05 Score=74.68 Aligned_cols=78 Identities=15% Similarity=0.096 Sum_probs=57.9
Q ss_pred CCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-C--CceeeEeeEEEeCCceeEEEeec
Q 039681 332 FSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-H--RSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 332 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
....+.+|.|..+.||+.+..+|+.+++|+...........|..|+..|+.+. . -.+.+.+++ +..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 44456799999999999999999999999876544444556889999999884 2 234555553 2357899999
Q ss_pred cCCCc
Q 039681 409 PNGTL 413 (624)
Q Consensus 409 ~~g~L 413 (624)
+.+..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00013 Score=72.86 Aligned_cols=140 Identities=14% Similarity=0.085 Sum_probs=92.2
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC---CCceeeEeeEEEeCCceeEEEeeccCC
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN---HRSLVRLLGCCVELDQTLMIYEYIPNG 411 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 411 (624)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+++.+++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999875 4677888986532 3567889999998884 367888998888888899999999987
Q ss_pred Cccc-----------ccccccC-CC----------------CCCCCHHHHH---HHHH----------------HHHHH-
Q 039681 412 TLFD-----------HLHCDFT-GK----------------WPPLPWHLRL---VIAH----------------QIAEG- 443 (624)
Q Consensus 412 ~L~~-----------~l~~~~~-~~----------------~~~l~~~~~~---~i~~----------------~i~~~- 443 (624)
.+.. .||.... .. .-.-+|.... ++.. ++...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6532 1221110 00 0012454322 1111 11111
Q ss_pred HHHHHh-cCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 444 LTYLHS-AAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 444 L~yLH~-~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123432 2245699999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00032 Score=73.58 Aligned_cols=79 Identities=9% Similarity=0.062 Sum_probs=47.2
Q ss_pred CCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCccccccc---CCCCccchhhHHHHHH
Q 039681 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF---QLTDKSDVYSFGVVLL 529 (624)
Q Consensus 453 ~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~vl~ 529 (624)
+.++|+|+++.|||+++++ ++|+||+.+..-... .+-..... .-...|.+|+..... ......++.+....+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLG--NLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHH--HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHH--HHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3499999999999998876 999999988753211 00000000 012346666655321 1122345567788888
Q ss_pred HHHhCC
Q 039681 530 ELLTSK 535 (624)
Q Consensus 530 elltg~ 535 (624)
+..++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00076 Score=67.12 Aligned_cols=71 Identities=15% Similarity=0.084 Sum_probs=44.7
Q ss_pred cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCce-eeEeeEEEeCCceeEEEeec-cCCC
Q 039681 335 DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL-VRLLGCCVELDQTLMIYEYI-PNGT 412 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~ 412 (624)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++++ +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 577888999999998 45788876543211 1223568888877743223 355543 344567899999 5544
Q ss_pred c
Q 039681 413 L 413 (624)
Q Consensus 413 L 413 (624)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0013 Score=66.11 Aligned_cols=160 Identities=13% Similarity=0.079 Sum_probs=88.3
Q ss_pred cCHHHHHHHhCCCCc-----cceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCc--eeeEe
Q 039681 320 FTGKEIRRATNNFSK-----DNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS--LVRLL 392 (624)
Q Consensus 320 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 392 (624)
++.+++...-..|.. .+.|+.|....+|+....+| .+++|+.... ...+.+..|+.++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 445555555555654 23466788889999887666 5778877642 12345567777777764212 23333
Q ss_pred eE------EEeCCceeEEEeeccCCCcccc--------------cccc---cCCCC-CC---CCHHHHHH----------
Q 039681 393 GC------CVELDQTLMIYEYIPNGTLFDH--------------LHCD---FTGKW-PP---LPWHLRLV---------- 435 (624)
Q Consensus 393 ~~------~~~~~~~~lv~e~~~~g~L~~~--------------l~~~---~~~~~-~~---l~~~~~~~---------- 435 (624)
.. ....+..+++++|++|..+... +|.. ..... .. ..|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1234567899999988665321 1111 00000 00 12322111
Q ss_pred --HHHHHHHHHHHHHhcC----CCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 436 --IAHQIAEGLTYLHSAA----VPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 436 --i~~~i~~~L~yLH~~~----~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+...+.+.++.++... ...++|+|+++.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 1112445566665421 2348999999999999987666899999774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00061 Score=71.49 Aligned_cols=73 Identities=21% Similarity=0.193 Sum_probs=49.7
Q ss_pred ceeccCCcEEEEEEEEcC--------CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCce-eeEeeEEEeCCceeEEEe
Q 039681 336 NLIGTGGFGEVFKGILDD--------GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL-VRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 406 (624)
+.|+.|....+|+....+ +..+++|+..... ..+.+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 567888889999998653 4788899874311 12456689999988853333 556665532 38999
Q ss_pred eccCCCcc
Q 039681 407 YIPNGTLF 414 (624)
Q Consensus 407 ~~~~g~L~ 414 (624)
|+++.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99865543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0026 Score=63.91 Aligned_cols=144 Identities=12% Similarity=0.056 Sum_probs=82.0
Q ss_pred ceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCC--ceeeEeeE-----EEeCCceeEEEeec
Q 039681 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHR--SLVRLLGC-----CVELDQTLMIYEYI 408 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~ 408 (624)
+.|+ |....||+....+|+.+++|+..... ...+.+..|..+++.+... .+++++.. ....+..++|+||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77889998877677788999876331 2345667788888777421 23444442 22245567899999
Q ss_pred cCCCccc----c----------cccccC----CCCCCCCHHHH----HH---------------HHHHHHHHHHHHHhc-
Q 039681 409 PNGTLFD----H----------LHCDFT----GKWPPLPWHLR----LV---------------IAHQIAEGLTYLHSA- 450 (624)
Q Consensus 409 ~~g~L~~----~----------l~~~~~----~~~~~l~~~~~----~~---------------i~~~i~~~L~yLH~~- 450 (624)
+|.++.. . +|.... .....+++... .. +...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8765431 0 111000 01112232211 00 111112223333321
Q ss_pred ---CCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 451 ---AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 451 ---~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223489999999999999 4 899999987753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0018 Score=65.33 Aligned_cols=143 Identities=13% Similarity=0.048 Sum_probs=72.6
Q ss_pred ceeccCCcEE-EEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC--CceeeEeeEEEeCCceeEEEeeccCCC
Q 039681 336 NLIGTGGFGE-VFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH--RSLVRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 336 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
+.|+.|.... +|+....++..+++|...... .+.+..|+.+++.+.. -.+.+++.+.. ..-+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 3465555444 567655446777777654321 1334567777766642 23555666532 23378999997666
Q ss_pred cccccccc---------------------cCCCCCCCCHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 039681 413 LFDHLHCD---------------------FTGKWPPLPWHLRL-------V-------------IAHQIAEGLTYLHS-- 449 (624)
Q Consensus 413 L~~~l~~~---------------------~~~~~~~l~~~~~~-------~-------------i~~~i~~~L~yLH~-- 449 (624)
+.+++... .......++..... . ....+...++.|..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54433210 00001112221110 0 00112222333321
Q ss_pred -cCCCCeEeecCCCCCeEECCC----CCeEEeecCCccc
Q 039681 450 -AAVPPIYHRDVKSSNILLDEK----LNAKVSDFGLSRL 483 (624)
Q Consensus 450 -~~~~~iiH~Dik~~Nill~~~----~~~kl~DfGla~~ 483 (624)
.....++|||+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 122349999999999999874 6799999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0033 Score=66.29 Aligned_cols=75 Identities=13% Similarity=0.020 Sum_probs=48.3
Q ss_pred cceeccCCcEEEEEEEEcC-CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCce-eeEeeEEEeCCceeEEEeeccCCC
Q 039681 335 DNLIGTGGFGEVFKGILDD-GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL-VRLLGCCVELDQTLMIYEYIPNGT 412 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 412 (624)
.+.|+.|-...+|+....+ +..+++|+..... ...-.-.+|..+++.+...++ .++++.+. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888889999998765 4778888764322 111122689999999875445 45666652 2 35999998765
Q ss_pred cc
Q 039681 413 LF 414 (624)
Q Consensus 413 L~ 414 (624)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0019 Score=66.33 Aligned_cols=143 Identities=20% Similarity=0.181 Sum_probs=83.6
Q ss_pred ceeccCCcEEEEEEEEc--------CCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCceeEEEe
Q 039681 336 NLIGTGGFGEVFKGILD--------DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 406 (624)
+.|..|-...+|+.... +++.+++|+.... ........+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45767888889998864 2478899986322 234556678999998885 2223556666543 29999
Q ss_pred eccCCCcccc-----------------cccc-cCCCCCCC-CHHHHHHHHHHHHH-------------------HHHHH-
Q 039681 407 YIPNGTLFDH-----------------LHCD-FTGKWPPL-PWHLRLVIAHQIAE-------------------GLTYL- 447 (624)
Q Consensus 407 ~~~~g~L~~~-----------------l~~~-~~~~~~~l-~~~~~~~i~~~i~~-------------------~L~yL- 447 (624)
|++|.+|..- ||.. ......+. -|.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 1110 00011111 24555555544422 23333
Q ss_pred ---HhcC-CCCeEeecCCCCCeEECCC----CCeEEeecCCccc
Q 039681 448 ---HSAA-VPPIYHRDVKSSNILLDEK----LNAKVSDFGLSRL 483 (624)
Q Consensus 448 ---H~~~-~~~iiH~Dik~~Nill~~~----~~~kl~DfGla~~ 483 (624)
.... ...++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 2348999999999999876 7899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0026 Score=65.28 Aligned_cols=73 Identities=15% Similarity=0.079 Sum_probs=44.3
Q ss_pred ceeccCCcEEEEEEEEcC---------CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCc-eeeEeeEEEeCCceeEEE
Q 039681 336 NLIGTGGFGEVFKGILDD---------GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS-LVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 405 (624)
+.|+.|..-.+|+....+ +..+++|+..... ........|..+++.+...+ ..++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 457778888999988654 2678888865432 22223467888888875333 34566543 236899
Q ss_pred eeccCCCc
Q 039681 406 EYIPNGTL 413 (624)
Q Consensus 406 e~~~~g~L 413 (624)
||+++.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.018 Score=58.18 Aligned_cols=31 Identities=19% Similarity=0.354 Sum_probs=27.3
Q ss_pred CCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 453 PPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 453 ~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0082 Score=55.50 Aligned_cols=102 Identities=14% Similarity=0.081 Sum_probs=66.6
Q ss_pred CcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCCC
Q 039681 412 TLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491 (624)
Q Consensus 412 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 491 (624)
+|.+.|.. ...+|+++++|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~----~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEILRL----YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHH----cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 67777763 346899999999999999998776322111 1233456899999999988764 2110
Q ss_pred cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCC
Q 039681 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKA 537 (624)
Q Consensus 492 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p 537 (624)
.....+.+||... ...+.+.=|||+|++||..+--..|
T Consensus 98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888764 3557788999999999999875554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.023 Score=59.07 Aligned_cols=142 Identities=14% Similarity=0.100 Sum_probs=84.8
Q ss_pred ceeccCCcEEEEEEEEcC--------CCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCc-eeeEeeEEEeCCceeEEEe
Q 039681 336 NLIGTGGFGEVFKGILDD--------GTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS-LVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 406 (624)
+.|..|-...+|+....+ +..+++|+..... ...-+-.+|..+++.+.-.+ ..++++.+ . -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 457778888899988653 5788899865432 22223467888888885222 34555533 2 378999
Q ss_pred eccCCCcccc-c----------------ccc-c-----CC--CCCCCCHHHHHHHHHHHH-------------------H
Q 039681 407 YIPNGTLFDH-L----------------HCD-F-----TG--KWPPLPWHLRLVIAHQIA-------------------E 442 (624)
Q Consensus 407 ~~~~g~L~~~-l----------------~~~-~-----~~--~~~~l~~~~~~~i~~~i~-------------------~ 442 (624)
|+++.+|..- + |.. . .. ...+.-|.++.++..++- .
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998665321 1 110 0 11 112223555555443322 2
Q ss_pred HHHHHHhc---------------------CCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 443 GLTYLHSA---------------------AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 443 ~L~yLH~~---------------------~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
.+..|.+. ....++|+|+.+.||+ ++++.+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 23333211 1233899999999999 8888999999998854
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.56 E-value=0.025 Score=37.42 Aligned_cols=23 Identities=39% Similarity=0.520 Sum_probs=9.1
Q ss_pred eehhHHHHHHHHHHHHHHHHHHHH
Q 039681 264 IAGMVAALGGSLLVVLIGILVYNK 287 (624)
Q Consensus 264 i~~iv~~~~~~~l~i~i~~~~~~k 287 (624)
.++++.|+.++++++ +++++|+|
T Consensus 14 A~gVVgGv~~~~ii~-~~~~~~~R 36 (44)
T 2ks1_B 14 ATGMVGALLLLLVVA-LGIGLFMR 36 (44)
T ss_dssp THHHHHHHHHHHHHH-HHHHHHHH
T ss_pred EeehhHHHHHHHHHH-HHHHHHhh
Confidence 334444343333333 33444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.04 E-value=0.043 Score=36.10 Aligned_cols=25 Identities=16% Similarity=0.077 Sum_probs=9.8
Q ss_pred eehhHHHHHHHHHHHHHHHHHHHHHh
Q 039681 264 IAGMVAALGGSLLVVLIGILVYNKLN 289 (624)
Q Consensus 264 i~~iv~~~~~~~l~i~i~~~~~~k~~ 289 (624)
+++.++|+. +++++.+.+++|.|+|
T Consensus 14 Ia~~vVGvl-l~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 14 IISAVVGIL-LVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHH-HHHHHHHHHHhheehh
Confidence 444444422 2223333344554433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.46 E-value=0.32 Score=50.07 Aligned_cols=29 Identities=38% Similarity=0.532 Sum_probs=24.9
Q ss_pred eEeecCCCCCeEE------CCCCCeEEeecCCccc
Q 039681 455 IYHRDVKSSNILL------DEKLNAKVSDFGLSRL 483 (624)
Q Consensus 455 iiH~Dik~~Nill------~~~~~~kl~DfGla~~ 483 (624)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998854
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.16 E-value=0.056 Score=35.62 Aligned_cols=7 Identities=29% Similarity=0.496 Sum_probs=3.0
Q ss_pred HHHHHHH
Q 039681 281 GILVYNK 287 (624)
Q Consensus 281 ~~~~~~k 287 (624)
.+++|+|
T Consensus 29 ~~~~~~R 35 (44)
T 2l2t_A 29 TFAVYVR 35 (44)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 3344443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.37 E-value=0.88 Score=41.88 Aligned_cols=117 Identities=13% Similarity=0.158 Sum_probs=77.5
Q ss_pred cCCCceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 039681 383 VNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKS 462 (624)
Q Consensus 383 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~ 462 (624)
..||++++. .+-.+.+...+.|+.-+++.=...+ ..++...+++++.+|+..-.+++.. +|--|.|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P 107 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAP 107 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEec
Confidence 358888876 4555566555555544322222223 2478899999999999877555433 7899999
Q ss_pred CCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCC
Q 039681 463 SNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAID 539 (624)
Q Consensus 463 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~ 539 (624)
+|+++|.++.+++.-.|+...+. |. ..++..=.-.+=+++..+++++..|.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l~---------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVVD---------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTBS---------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccCCC---------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999998877654332 11 11111223356678888999887764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.54 E-value=1.5 Score=40.47 Aligned_cols=85 Identities=11% Similarity=0.048 Sum_probs=59.6
Q ss_pred CCCceeeEeeEEEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEeecCCC
Q 039681 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT-YLHSAAVPPIYHRDVKS 462 (624)
Q Consensus 384 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~-yLH~~~~~~iiH~Dik~ 462 (624)
.||++ -..+-.+.+...+.|+--+++.=...++ .++...+++++.+|+.... +++. -+|--|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 57887 3344456666666666554433333332 4788899999988877665 4433 47889999
Q ss_pred CCeEECCCCCeEEeecCCccc
Q 039681 463 SNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 463 ~Nill~~~~~~kl~DfGla~~ 483 (624)
+||++|.++.++|.-.|+-..
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp GGEEECTTCCEEESCCEETTT
T ss_pred ceEEEeCCCcEEEEEcCCccc
Confidence 999999999999988886543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 624 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 8e-68
Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 29/293 (9%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
EI + IG+G FG V+KG + + NEV +L +
Sbjct: 4 EIPD--GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
H +++ +G Q ++ ++ +L+ HLH + IA Q A+G
Sbjct: 62 RHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQG 116
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
+ YLH I HRD+KS+NI L E L K+ DFGL+ + R SH F G++
Sbjct: 117 MDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS--GSHQFEQLSGSIL 171
Query: 504 YLDPEYYRNFQ---LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
++ PE R + +SDVY+FG+VL EL+T + + + +V
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY----- 226
Query: 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
+ P L + ++ KA+ L A CL ++R RP ++ IE +
Sbjct: 227 -----LSPDLSKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 8e-63
Identities = 80/294 (27%), Positives = 134/294 (45%), Gaps = 35/294 (11%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
E+ R +G G FGEV+ G + T A+K K G+ D L E ++ Q+
Sbjct: 9 EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQL 65
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
H+ LVRL + + +I EY+ NG+L D L T L + L +A QIAEG
Sbjct: 66 QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQIAEG 121
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
+ ++ HRD++++NIL+ + L+ K++DFGL+RL+E N+ A+ +
Sbjct: 122 MAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIK 175
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563
+ PE T KSDV+SFG++L E++T + V ++ + R++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYRMV 230
Query: 564 --EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615
+ L + L C ER ++RP+ + +E +
Sbjct: 231 RPDNCPEELYQ---------------LMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (528), Expect = 8e-63
Identities = 76/310 (24%), Positives = 135/310 (43%), Gaps = 40/310 (12%)
Query: 320 FTGKEIRRATNNFSK---------DNLIGTGGFGEVFKGIL----DDGTVTAIKRAKLGN 366
FT ++ A F+K + +IG G FGEV G L AIK K G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 367 T-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKW 425
T K L+E I+ Q +H +++ L G + ++I E++ NG+L L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ----ND 122
Query: 426 PPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485
+ + IA G+ YL HRD+ + NIL++ L KVSDFGLSR +E
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 486 RTETNDSHIFTTAQ-GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREE 544
++ ++ + + PE + + T SDV+S+G+V+ E+++
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS----------- 228
Query: 545 ENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK 604
Y ++ + +V++ + ++ ++ AL L C + R +RP
Sbjct: 229 -------YGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 605 EVADEIEYII 614
++ + ++ +I
Sbjct: 282 QIVNTLDKMI 291
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 7e-61
Identities = 67/305 (21%), Positives = 118/305 (38%), Gaps = 39/305 (12%)
Query: 328 ATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGT-DLVLNEVRILCQVNH 385
++F K + +G G G VFK G V A K L + ++ E+++L + N
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+V G + + E++ G+L L K +P + ++ + +GLT
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLT 118
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
YL I HRDVK SNIL++ + K+ DFG+S + + + GT Y+
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA------NSFVGTRSYM 170
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE-------------------- 545
PE + + +SD++S G+ L+E+ + I +E
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 546 ---NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGL-LAASCLDERRQNRP 601
L Y + E++D ++ E L CL + R
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 602 SMKEV 606
+K++
Sbjct: 291 DLKQL 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 9e-61
Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 41/295 (13%)
Query: 322 GKEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILC 381
G + IG G FG+V G V A+K K N L E ++
Sbjct: 1 GWALNM--KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIK--NDATAQAFLAEASVMT 55
Query: 382 QVNHRSLVRLLGCCVELDQTL-MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQI 440
Q+ H +LV+LLG VE L ++ EY+ G+L D+L + L L + +
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDV 112
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
E + YL HRD+ + N+L+ E AKVSDFGL++ T+ T +
Sbjct: 113 CEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGKL 162
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
+ + PE R + + KSDV+SFG++L E+ + + ++V + ++
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGY 217
Query: 561 RL--MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
++ + P + E + +C RPS ++ +++E+I
Sbjct: 218 KMDAPDGCPPAVYE---------------VMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-59
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 33/287 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV 389
+ + IG+G FG V G + AIK + G D + E ++ +++H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDF-IEEAEVMMKLSHPKLV 63
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
+L G C+E +++E++ +G L D+L + L + + EG+ YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
+ HRD+ + N L+ E KVSDFG++R V + S + + + PE
Sbjct: 120 ---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST---GTKFPVKWASPEV 173
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM--EVVD 567
+ + + KSDV+SFGV++ E+ + K NR V ++ I RL +
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLAS 228
Query: 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614
+ + + C ER ++RP+ + ++ I
Sbjct: 229 THVYQ---------------IMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-59
Identities = 70/296 (23%), Positives = 130/296 (43%), Gaps = 32/296 (10%)
Query: 323 KEIRRATNNFSKDNL-IGTGGFGEVFKGIL---DDGTVTAIKRAKLGNTKG-TDLVLNEV 377
K++ +N ++ +G G FG V +G+ AIK K G K T+ ++ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 378 RILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIA 437
+I+ Q+++ +VRL+G C + + +++ E G L L GK +P +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELL 115
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
HQ++ G+ YL HRD+ + N+LL + AK+SDFGLS+ + ++ +
Sbjct: 116 HQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSA 171
Query: 498 AQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557
+ + + PE + + +SDV+S+GV + E L+ Y +K
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS------------------YGQKPY 213
Query: 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
+ + EV+ + + + E L L + C + ++RP V +
Sbjct: 214 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 4e-59
Identities = 57/295 (19%), Positives = 116/295 (39%), Gaps = 29/295 (9%)
Query: 338 IGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE 397
IG G FGEV++G G A+K + + E+ + H +++ + +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 398 LDQTL----MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV- 452
+ T ++ +Y +G+LFD+L+ + + +A A GL +LH V
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 453 ----PPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
P I HRD+KS NIL+ + ++D GL+ + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 509 YY------RNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE----NVNLVVYMKKIMD 558
++F+ ++D+Y+ G+V E+ + + + ++ + M
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
+ + + P + R E ++ + + C R + + + +
Sbjct: 243 KVVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-58
Identities = 65/284 (22%), Positives = 113/284 (39%), Gaps = 33/284 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV 389
+ + +GTG FG V G AIK K G+ + + E +++ ++H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEF-IEEAKVMMNLSHEKLV 62
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
+L G C + +I EY+ NG L ++L L + + E + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLE- 117
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
HRD+ + N L++++ KVSDFGLSR V ++ ++ + + PE
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEV 172
Query: 510 YRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM--EVVD 567
+ + KSD+++FGV++ E+ + K + I RL +
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AEHIAQGLRLYRPHLAS 227
Query: 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
+ + SC E+ RP+ K + I
Sbjct: 228 EKVYT---------------IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 4e-58
Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 35/289 (12%)
Query: 335 DNLIGTGGFGEVFKGILDDGTVT----AIKRAKLGNTKG-TDLVLNEVRILCQVNHRSLV 389
+ +IG G FG V+ G L D A+K G L E I+ +H +++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 390 RLLGCCVELD-QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
LLG C+ + L++ Y+ +G L + + + + Q+A+G+ +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
HRD+ + N +LDEK KV+DFGL+R + E + H T A+ + ++ E
Sbjct: 148 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM--EVV 566
+ + T KSDV+SFGV+L EL+T +VN ++ RL+ E
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLLQPEYC 259
Query: 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615
L E + C + + RPS E+ I I S
Sbjct: 260 PDPLYE---------------VMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-58
Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 31/288 (10%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV 383
EI R + + +G G FGEV+ G + T AIK K T + L E +++ ++
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 69
Query: 384 NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
H LV+L + ++ EY+ G+L D L + L + +A QIA G
Sbjct: 70 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASG 125
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
+ Y+ HRD++++NIL+ E L KV+DFGL+RL+ E N+ A+ +
Sbjct: 126 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIK 179
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563
+ PE + T KSDV+SFG++L EL T + V + ++ R+
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGYRM- 233
Query: 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
E ++L L C + + RP+ + + +E
Sbjct: 234 ------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-58
Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 34/297 (11%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVT-----AIKRAKLGNTKGTDL-VLNEV 377
EI + ++ +IG G FGEV+KG+L + AIK K G T+ + L E
Sbjct: 3 EIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 378 RILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIA 437
I+ Q +H +++RL G + ++I EY+ NG L L K + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR----EKDGEFSVLQLVGML 116
Query: 438 HQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTT 497
IA G+ YL + HRD+ + NIL++ L KVSDFGLSR++E ++ +
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-TYTTSG 172
Query: 498 AQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557
+ + + PE + T SDV+SFG+V+ E++T + + V MK I
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAIN 227
Query: 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614
D RL ++ A+ L C + R RP ++ ++ +I
Sbjct: 228 DGFRL-------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 5e-57
Identities = 72/316 (22%), Positives = 122/316 (38%), Gaps = 51/316 (16%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNTKGT-DLVLNE 376
E R NN IG G FG VF+ + T+ A+K K + E
Sbjct: 9 EYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLH------------------ 418
++ + ++ ++V+LLG C +++EY+ G L + L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 419 -CDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477
+ PPL +L IA Q+A G+ YL HRD+ + N L+ E + K++D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIAD 183
Query: 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKA 537
FGLSR + + + ++ PE + T +SDV+++GVVL E+ +
Sbjct: 184 FGLSRNIY--SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 538 IDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERR 597
+ E V + + D L + LE L C +
Sbjct: 242 PYYGMAHEEV-----IYYVRDGNIL---------ACPENCPLELYN----LMRLCWSKLP 283
Query: 598 QNRPSMKEVADEIEYI 613
+RPS + ++ +
Sbjct: 284 ADRPSFCSIHRILQRM 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 9e-57
Identities = 70/293 (23%), Positives = 125/293 (42%), Gaps = 31/293 (10%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQ 382
E+ R + + + +G G +GEV++G+ A+K K + + L E ++ +
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-LKEAAVMKE 69
Query: 383 VNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
+ H +LV+LLG C +I E++ G L D+L + + L +A QI+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISS 126
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
+ YL HRD+ + N L+ E KV+DFGLSRL+ + A+ +
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPI 180
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562
+ PE + + KSDV++FGV+L E+ T + +D ++
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG---------------IDLSQV 225
Query: 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615
E+++ + E + L +C +RPS E+ E +
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-56
Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 31/283 (10%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRS 387
++ IGTG +G K DG + K G+ + +++EV +L ++ H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 388 LVRLLGCCVELDQTL--MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+VR ++ T ++ EY G L + T + L L + Q+ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 446 YLH--SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMG 503
H S + HRD+K +N+ LD K N K+ DFGL+R++ +D+ GT
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTSFAKAFVGTPY 179
Query: 504 YLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563
Y+ PE +KSD++S G +L EL +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCA-------------------LMPPFTAFSQK 220
Query: 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
E+ + + + + L + L+ + +RPS++E+
Sbjct: 221 ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-56
Identities = 68/281 (24%), Positives = 108/281 (38%), Gaps = 38/281 (13%)
Query: 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNH 385
+F +G G FG V+ + A+K +A+L + EV I + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+++RL G + + +I EY P GT++ L K ++A L+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALS 120
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
Y HS + HRD+K N+LL K++DFG S + T GT+ YL
Sbjct: 121 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------TLCGTLDYL 171
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565
PE +K D++S GV+ E L K + N +E Y + E +
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISRVEFTFPDF 226
Query: 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
V ++ L + L RP ++EV
Sbjct: 227 VTEGARD---------------LISRLLKHNPSQRPMLREV 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-55
Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 38/280 (13%)
Query: 335 DNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHRSLVRL 391
D IG G F V+KG+ + A + ++ E +L + H ++VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 392 LGCCVELDQT----LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+ +++ E + +GTL +L ++ + + QI +GL +L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFL 128
Query: 448 HSAAVPPIYHRDVKSSNILL-DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
H+ PPI HRD+K NI + + K+ D GL+ L + GT ++
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA------KAVIGTPEFMA 181
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566
PE Y + + DVY+FG+ +LE+ TS+ ++ + + + + +V
Sbjct: 182 PEMYEE-KYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
P +KE + C+ + + R S+K++
Sbjct: 239 IPEVKE---------------IIEGCIRQNKDERYSIKDL 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-55
Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 33/283 (11%)
Query: 334 KDNLIGTGGFGEVFKGILDD---GTVTAIKRAKLGNTKGT--DLVLNEVRILCQVNHRSL 388
+D +G+G FG V KG A+K K D +L E ++ Q+++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
VR++G C E + +++ E G L +L + + + + HQ++ G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLE 124
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPE 508
HRD+ + N+LL + AK+SDFGLS+ + + N T + + + PE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR-ADENYYKAQTHGKWPVKWYAPE 180
Query: 509 YYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568
++ + KSDV+SFGV++ E + + + V + ER+
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----TAMLEKGERM------ 229
Query: 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
+ + L C +NRP V +
Sbjct: 230 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 7e-55
Identities = 73/311 (23%), Positives = 122/311 (39%), Gaps = 42/311 (13%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVT---AIKRAKLGNTK-GTDLVLNEVRILCQV-N 384
N+ ++IG G FG+V K + + AIKR K +K E+ +LC++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPP-----------LPWHLR 433
H +++ LLG C + EY P+G L D L + P L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 434 LVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSH 493
L A +A G+ YL HRD+ + NIL+ E AK++DFGLSR E
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 494 IFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553
T + + ++ E T SDV+S+GV+L E+++
Sbjct: 184 --TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------- 225
Query: 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613
E+ + + + L + L C E+ RPS ++ + +
Sbjct: 226 --PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
Query: 614 ISIAKGRISES 624
+ K ++ +
Sbjct: 284 LEERKTYVNTT 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 9e-55
Identities = 63/280 (22%), Positives = 111/280 (39%), Gaps = 30/280 (10%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRS 387
++ +G G +GEV + A+K + + + E+ I +NH +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V+ G E + + EY G LFD + +P HQ+ G+ YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
H I HRD+K N+LLDE+ N K+SDFGL+ + N + GT+ Y+ P
Sbjct: 120 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR--YNNRERLLNKMCGTLPYVAP 174
Query: 508 EYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566
E + + + DV+S G+VL +L + +++ ++ K+ + +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGEL--PWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
D L L E R ++ ++
Sbjct: 233 DSAPLA---------------LLHKILVENPSARITIPDI 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-54
Identities = 76/313 (24%), Positives = 127/313 (40%), Gaps = 45/313 (14%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLG-NTKGTDLVLNE 376
E R N S +G G FG+V + D A+K K + + +++E
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 377 VRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLH-------------CDFT 422
+++L + NH ++V LLG C TL+I EY G L + L
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 423 GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
L L ++Q+A+G+ +L S HRD+ + NILL K+ DFGL+R
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNR 542
++ + A+ + ++ PE N T +SDV+S+G+ L EL + +
Sbjct: 194 DIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 543 EEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS 602
++ K++ E M + E + + +C D RP+
Sbjct: 252 PVDSK-----FYKMIKEGFRMLSPEHAPAE------------MYDIMKTCWDADPLKRPT 294
Query: 603 MKEVADEIEYIIS 615
K++ IE IS
Sbjct: 295 FKQIVQLIEKQIS 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-54
Identities = 59/279 (21%), Positives = 116/279 (41%), Gaps = 31/279 (11%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS 387
+++ IG G G V+ + + G AI++ L +L++NE+ ++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V L + D+ ++ EY+ G+L D + + + + + L +L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFL 132
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
HS + HRD+KS NILL + K++DFG + T + +T GT ++ P
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAP 185
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567
E K D++S G++ +E++ + + E L + E + E +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ ++ CLD + R S KE+
Sbjct: 244 AIFRD---------------FLNRCLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-54
Identities = 72/299 (24%), Positives = 117/299 (39%), Gaps = 40/299 (13%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKRAKLGNTKGT-DLVLNEVR 378
EI+R IG G FG+V +GI + AIK K + + L E
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH 438
+ Q +H +V+L+G E + +I E G L L + L ++ A+
Sbjct: 61 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV----RKYSLDLASLILYAY 115
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q++ L YL S HRD+ + N+L+ K+ DFGLSR +E + + +
Sbjct: 116 QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKG 169
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558
+ + ++ PE + T SDV+ FGV + E+L + +V + +I +
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIEN 224
Query: 559 EERLM--EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615
ERL P L L C RP E+ ++ I+
Sbjct: 225 GERLPMPPNCPPTLYS---------------LMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 9e-54
Identities = 64/314 (20%), Positives = 124/314 (39%), Gaps = 50/314 (15%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVT------AIKRAKLGNTKGT-DLVLNE 376
E R N ++G+G FG+V + T A+K K + +++E
Sbjct: 33 EFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 90
Query: 377 VRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLH----------------- 418
++++ Q+ +H ++V LLG C +I+EY G L ++L
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 419 -CDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477
+ L + L A+Q+A+G+ +L HRD+ + N+L+ K+ D
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICD 207
Query: 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKA 537
FGL+R + ++ + A+ + ++ PE T KSDV+S+G++L E+ +
Sbjct: 208 FGLARDI--MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 538 IDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERR 597
+ K++ M+ +E + ++ SC
Sbjct: 266 PYPGIPVDAN-----FYKLIQNGFKMDQPFYATEE------------IYIIMQSCWAFDS 308
Query: 598 QNRPSMKEVADEIE 611
+ RPS + +
Sbjct: 309 RKRPSFPNLTSFLG 322
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 4e-53
Identities = 67/285 (23%), Positives = 107/285 (37%), Gaps = 47/285 (16%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL---VLNEVRILCQVNHRS 387
FS IG G FG V+ + + V AIK+ + + ++ EVR L ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
++ GC + ++ EY PL + H +GL YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
HS + HRDVK+ NILL E K+ DFG + ++ + GT ++ P
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--------NSFVGTPYWMAP 180
Query: 508 EYYRNF---QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM- 563
E Q K DV+S G+ +EL K + N+N + + I E
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQNESPAL 234
Query: 564 --EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ SCL + Q+RP+ + +
Sbjct: 235 QSGHWSEYFRN---------------FVDSCLQKIPQDRPTSEVL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 60/293 (20%), Positives = 106/293 (36%), Gaps = 37/293 (12%)
Query: 323 KEIRRATN---NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVR 378
+ + R N + +G G FG+V+K + + A K + + + + E+
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 61
Query: 379 ILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAH 438
IL +H ++V+LL + ++ E+ G + + PL V+
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCK 117
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q + L YLH I HRD+K+ NIL + K++DFG+S RT +
Sbjct: 118 QTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR----RDSF 170
Query: 499 QGTMGYLDPEYYRNFQLTD-----KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553
GT ++ PE D K+DV+S G+ L+E+ + +
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VL 224
Query: 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
KI E CL++ R + ++
Sbjct: 225 LKIAKSEPPTLAQPSRWSSNFKD-----------FLKKCLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-52
Identities = 64/291 (21%), Positives = 120/291 (41%), Gaps = 38/291 (13%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRA-----KLGNTKGTDLVLNEVRILCQVNH 385
F K ++G+G FG V+KG+ + +G I A + + K +L+E ++ V++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
+ RLLG C+ +I + +P G L D++ + L QIA+G+
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMN 125
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
YL + HRD+ + N+L+ + K++DFGL++L+ E + + + ++
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWM 180
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM-- 563
E + T +SDV+S+GV + EL+T + + ERL
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKGERLPQP 235
Query: 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614
+ + + C +RP +E+ E +
Sbjct: 236 PICTIDVYM---------------IMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 7e-51
Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 33/289 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILD----DGTVTAIKRAK---LGNTKGTDLVLNEVRILCQ 382
+ +G G FG V +G D A+K K L + D + EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 383 VNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
++HR+L+RL G + M+ E P G+L D L A Q+AE
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLR----KHQGHFLLGTLSRYAVQVAE 122
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
G+ YL S HRD+ + N+LL + K+ DFGL R + + + + + +
Sbjct: 123 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-YVMQEHRKVPF 178
Query: 503 GYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562
+ PE + + SD + FGV L E+ T + + + KI E
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGER 233
Query: 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
+ + ++ + + C + ++RP+ + D +
Sbjct: 234 LPRPEDCPQD------------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (446), Expect = 3e-50
Identities = 54/280 (19%), Positives = 104/280 (37%), Gaps = 31/280 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL 388
+++ +GTG FG V + G A K + + V E++ + + H +L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
V L + ++ +MIYE++ G LF+ + + + + Q+ +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 449 SAAVPPIYHRDVKSSNILLDEKLN--AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
H D+K NI+ K + K+ DFGL+ + + GT +
Sbjct: 142 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-----DPKQSVKVTTGTAEFAA 193
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566
PE + +D++S GV+ LL+ ++E + V MD+ +
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-I 252
Query: 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
K+ L R ++ +
Sbjct: 253 SEDGKD---------------FIRKLLLADPNTRMTIHQA 277
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-50
Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 37/303 (12%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL------DDGTVTAIKRAKLGNT-KGTDLVLNE 376
E+ R + +G G FG V++G+ + T AIK + + LNE
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 377 VRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC-----DFTGKWPPLPWH 431
++ + N +VRLLG + TL+I E + G L +L P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 432 LRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETND 491
+ +A +IA+G+ YL++ HRD+ + N ++ E K+ DFG++R + ET+
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDY 188
Query: 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV 551
+ ++ PE ++ T SDV+SFGVVL E+ T + E V
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---- 244
Query: 552 YMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
++ +M+ L + D L L C + RPS E+ I+
Sbjct: 245 -LRFVMEGGLL-DKPDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIK 290
Query: 612 YII 614
+
Sbjct: 291 EEM 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-49
Identities = 57/291 (19%), Positives = 103/291 (35%), Gaps = 36/291 (12%)
Query: 326 RRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILC 381
++ +F ++G G F V L AIK + + V E ++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 382 QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441
+++H V+L + ++ Y NG L ++ K +I
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIV 118
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGT 501
L YLH I HRD+K NILL+E ++ +++DFG ++++ + GT
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ--ARANSFVGT 173
Query: 502 MGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE- 560
Y+ PE SD+++ G ++ +L+ F N + +KI+ E
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAG----NEYLIFQKIIKLEY 227
Query: 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
E P ++ L L R +E+
Sbjct: 228 DFPEKFFPKARD---------------LVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (427), Expect = 1e-47
Identities = 57/280 (20%), Positives = 105/280 (37%), Gaps = 31/280 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL 388
+ + +G+G FG V + + G V K V NE+ I+ Q++H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
+ L + + ++I E++ G LFD + + + + Q EGL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 449 SAAVPPIYHRDVKSSNILLDEKLNA--KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
I H D+K NI+ + K + K+ DFGL+ + E T +
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-----ATAEFAA 196
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566
PE + +D+++ GV+ LL+ + E + V DE+ V
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS-V 255
Query: 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
P K+ + L + + R ++ +
Sbjct: 256 SPEAKD---------------FIKNLLQKEPRKRLTVHDA 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 67/314 (21%), Positives = 127/314 (40%), Gaps = 46/314 (14%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGIL--------DDGTVTAIKRAKLGNT-KGTDLVL 374
E+ R + +G G FG+V + T A+K K T K ++
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 375 NEVRILCQV-NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHC-----------DFT 422
+E+ ++ + H++++ LLG C + +I EY G L ++L
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 423 GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
L + A+Q+A G+ YL S HRD+ + N+L+ E K++DFGL+R
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNR 542
+ + + + ++ PE + T +SDV+SFGV+L E+ T +
Sbjct: 184 DIHHIDYYKKTT--NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 543 EEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS 602
E + K + + R+ L ++ C RP+
Sbjct: 242 PVEEL-----FKLLKEGHRM-------------DKPSNCTNELYMMMRDCWHAVPSQRPT 283
Query: 603 MKEVADEIEYIISI 616
K++ ++++ I+++
Sbjct: 284 FKQLVEDLDRIVAL 297
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-47
Identities = 57/287 (19%), Positives = 115/287 (40%), Gaps = 35/287 (12%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILC 381
KE+ + +G G FG V + + K K+ T LV E+ IL
Sbjct: 1 KELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILN 56
Query: 382 QVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIA 441
HR+++ L +++ +MI+E+I +F+ ++ L + HQ+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVC 112
Query: 442 EGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA--KVSDFGLSRLVERTETNDSHIFTTAQ 499
E L +LHS I H D++ NI+ + ++ K+ +FG +R ++ + F
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-----FRLLF 164
Query: 500 GTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559
Y PE +++ ++ +D++S G ++ LL+ ++ + ++ + DE
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 560 ERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
E E + + L + R++R + E
Sbjct: 225 EAFKE-ISIEAMD---------------FVDRLLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 71/311 (22%), Positives = 120/311 (38%), Gaps = 44/311 (14%)
Query: 324 EIRRATNNFSKDNLIGTGGFGEVFKGI------LDDGTVTAIKRAKLGNTKGTDL-VLNE 376
E R + +G G FG+V + A+K K G T +++E
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 377 VRILCQVNHRS-LVRLLGCCVELDQTLMI-YEYIPNGTLFDHLHCDFTGKWP-------- 426
++IL + H +V LLG C + LM+ E+ G L +L P
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 427 ---PLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483
L + + Q+A+G+ +L S HRD+ + NILL EK K+ DFGL+R
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNRE 543
+ + A+ + ++ PE + T +SDV+SFGV+L E+ + +
Sbjct: 184 IYKDPDYVRK--GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 237
Query: 544 EENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSM 603
V + + + E M D E + C RP+
Sbjct: 238 -PGVKIDEEFCRRLKEGTRMRAPDYTTPE------------MYQTMLDCWHGEPSQRPTF 284
Query: 604 KEVADEIEYII 614
E+ + + ++
Sbjct: 285 SELVEHLGNLL 295
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (410), Expect = 4e-46
Identities = 62/292 (21%), Positives = 106/292 (36%), Gaps = 34/292 (11%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVN 384
++ + ++G GG EV L A+K + + E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 385 HRSLVRLLGCCVELDQTL----MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQI 440
H ++V + ++ EY+ TL D +H P+ + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 120
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
+ L + H I HRDVK +NI++ KV DFG++R + + + + G
Sbjct: 121 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIG 176
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
T YL PE R + +SDVYS G VL E+LT + + V I
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236
Query: 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-SMKEVADEIE 611
R E + L + L + +NR + E+ ++
Sbjct: 237 RH-EGLSADLDA---------------VVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 160 bits (405), Expect = 2e-45
Identities = 59/293 (20%), Positives = 105/293 (35%), Gaps = 46/293 (15%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL---------VLNEVRIL 380
N+ ++G G V + I A+K + L EV IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 381 CQVN-HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQ 439
+V+ H ++++L ++++ + G LFD+L + L I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRA 118
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
+ E + LH I HRD+K NILLD+ +N K++DFG S + +
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DPGEKLREVC 170
Query: 500 GTMGYLDPEYYRNFQL------TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM 553
GT YL PE + D++S GV++ LL ++ + +++
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
Query: 554 KKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ +K+ L + L + Q R + +E
Sbjct: 231 NYQFGSPEWDD-YSDTVKD---------------LVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (412), Expect = 2e-45
Identities = 70/290 (24%), Positives = 116/290 (40%), Gaps = 40/290 (13%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQV-- 383
N+FS +IG GGFGEV+ D G + A+K + ++ +G L LNE +L V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 384 -NHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
+ +V + D+ I + + G L HL + A +I
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIIL 118
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
GL ++H+ + +RD+K +NILLDE + ++SD GL+ + + + S GT
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTH 169
Query: 503 GYLDPEYYRNFQLTD-KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561
GY+ PE + D +D +S G +L +LL F + + + +
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVE 227
Query: 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-MKEVADEI 610
L + P L+ L L R + A E+
Sbjct: 228 LPDSFSPELRS---------------LLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 3e-45
Identities = 52/286 (18%), Positives = 103/286 (36%), Gaps = 28/286 (9%)
Query: 323 KEIRRATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGT-DLVLNEVRIL 380
K+ + + +++GTG F EV + AIK +G + NE+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 381 CQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQI 440
++ H ++V L +I + + G LFD + + + Q+
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQV 116
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
+ + YLH + + LDE +SDFGLS++ + + +TA G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-----DPGSVLSTACG 171
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
T GY+ PE + D +S GV+ LL + + ++ + D
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
Query: 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ + K+ +++ + R + ++
Sbjct: 232 -YWDDISDSAKD---------------FIRHLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 7e-43
Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 42/287 (14%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNH 385
+F +GTG FG V +G A+K + + K + +E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
++R+ G + Q MI +YI G LF L P + A ++ L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALE 118
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
YLHS I +RD+K NILLD+ + K++DFG ++ V T GT Y+
Sbjct: 119 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-------TYTLCGTPDYI 168
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE-RLME 564
PE D +SFG+++ E+L F N + +KI++ E R
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDS----NTMKTYEKILNAELRFPP 222
Query: 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-SMKEVADEI 610
+ +K+ L + + R +++ +++
Sbjct: 223 FFNEDVKD---------------LLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 62/281 (22%), Positives = 101/281 (35%), Gaps = 37/281 (13%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK---RAKLGNTKGTDLVLNEVRIL-CQVN 384
+F ++G G FG+VF AIK + + + + E R+L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 385 HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
H L + + + EY+ G L H+ A +I GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGL 116
Query: 445 TYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
+LHS I +RD+K NILLD+ + K++DFG+ + + T GT Y
Sbjct: 117 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK----TNTFCGTPDY 169
Query: 505 LDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564
+ PE + D +SFGV+L E+L + EEE ++ MD
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIRMDNPFYPR 224
Query: 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKE 605
++ K+ L + R ++
Sbjct: 225 WLEKEAKD---------------LLVKLFVREPEKRLGVRG 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-41
Identities = 62/295 (21%), Positives = 106/295 (35%), Gaps = 23/295 (7%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKG--ILDDGTVTAIKRAKLGNTKGTDL--VLNEVRI--- 379
RA + IG G +G+VFK + + G A+KR ++ + + EV +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 380 LCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLF-DHLHCDFTGKWPPLPWHLRLVIAH 438
L H ++VRL C + + D P +P +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 439 QIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
Q+ GL +LHS + HRD+K NIL+ K++DFGL+R+ + T+
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI-----YSFQMALTSV 175
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558
T+ Y PE D++S G + E+ K + + + + ++ + +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 559 EERLMEVVDPVLKERATHLDLETMKALGL-------LAASCLDERRQNRPSMKEV 606
EE V + + K + L CL R S
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 64/294 (21%), Positives = 119/294 (40%), Gaps = 32/294 (10%)
Query: 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV 389
+++ +IG G FG V++ L D G + AIK+ + E++I+ +++H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 390 RLLGCCVELDQT------LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEG 443
RL + ++ +Y+P H ++ LP + +Q+
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRS 134
Query: 444 LTYLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
L Y+HS I HRD+K N+LLD K+ DFG ++ + R E N S+I +
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----- 186
Query: 503 GYLDP-EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561
Y P + T DV+S G VL ELL + + + + ++ + E+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 562 LMEVVDPVLKERATHLDLETMKALGL---------LAASCLDERRQNRPSMKEV 606
+ E+ + + + + L + L+ R + E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 7e-40
Identities = 50/293 (17%), Positives = 90/293 (30%), Gaps = 30/293 (10%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH 385
R N + IG+G FG+++ G + G AIK + + E +I +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQG 61
Query: 386 RSLVRLLG-CCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGL 444
+ + C E D +M+ E + C L++A Q+ +
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-----RKFSLKTVLLLADQMISRI 116
Query: 445 TYLHSAAVPPIYHRDVKSSNIL---LDEKLNAKVSDFGLSRLVERTETNDSHIF---TTA 498
Y+HS HRDVK N L + + DFGL++ T+ +
Sbjct: 117 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558
GT Y + + + + D+ S G VL+ + + +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
Query: 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611
+ + E C R ++P +
Sbjct: 234 STPIEVLCKGYPSE------------FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-39
Identities = 61/304 (20%), Positives = 112/304 (36%), Gaps = 32/304 (10%)
Query: 327 RATNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQV 383
+ + K IG G FGEVFK G A+K+ + N K L E++IL +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 384 NHRSLVRLLGCCVELDQT--------LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV 435
H ++V L+ C +++++ + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKR 121
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIF 495
+ + GL Y+H I HRD+K++N+L+ K++DFGL+R + + + +
Sbjct: 122 VMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 496 TTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMK 554
T T+ Y PE + D++ G ++ E+ T + N E+ + L+ +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 555 KIMDEERLMEVVDPVLKERATHLDLETMKALGLLAA------------SCLDERRQNRPS 602
+ E V + L E+ + + K L A L R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 603 MKEV 606
+
Sbjct: 299 SDDA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 61/296 (20%), Positives = 117/296 (39%), Gaps = 28/296 (9%)
Query: 329 TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKG-TDLVLNEVRILCQVNHR 386
++ + IG G +G V + AIK+ + L E++IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 387 SLVRLLGCC----VELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAE 442
+++ + +E + + + ++ L+ L L +QI
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILR 120
Query: 443 GLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTM 502
GL Y+HSA + HRD+K SN+LL+ + K+ DFGL+R+ + + T T
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF-LTEYVATR 176
Query: 503 GYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561
Y PE N + KS D++S G +L E+L+++ + +N ++ + +E
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 562 LMEVVD----------PVLKERATHLDLETMKALGL-LAASCLDERRQNRPSMKEV 606
L +++ P + + + L L L R +++
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 50/288 (17%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKR------AKLGNTKGTDLVLNEVRILCQ 382
+ + L+G+GGFG V+ GI + D AIK + G V EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 383 VN--HRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQI 440
V+ ++RLL D ++I E + L L Q+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQV 119
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRLVERTETNDSHIFTTAQ 499
E + + H+ + HRD+K NIL+D + K+ DFG L++ T ++T
Sbjct: 120 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFD 170
Query: 500 GTMGYLDPEYYRNFQLTDKS-DVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558
GT Y PE+ R + +S V+S G++L +++ F +EE + V+ ++ +
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--FEHDEEIIRGQVFFRQRVS 228
Query: 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
E + L CL R +RP+ +E+
Sbjct: 229 SE---------CQH---------------LIRWCLALRPSDRPTFEEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 53/286 (18%), Positives = 105/286 (36%), Gaps = 27/286 (9%)
Query: 336 NLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTD-----LVLNEVRILCQVNHRSLV 389
+ +G G F V+K + + AIK+ KLG+ L E+++L +++H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 390 RLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS 449
LL ++++++ L +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 450 AAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEY 509
I HRD+K +N+LLDE K++DFGL++ + + +T T Y PE
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG----SPNRAYTHQVVTRWYRAPEL 171
Query: 510 YRNFQLTD-KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568
++ D+++ G +L ELL + + + + + + EE+ ++
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 569 VLKERATHLDLETMKALGL--------LAASCLDERRQNRPSMKEV 606
+ + L R + +
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (361), Expect = 3e-39
Identities = 49/288 (17%), Positives = 101/288 (35%), Gaps = 22/288 (7%)
Query: 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRS 387
+ IG G +G V+K + G A+K+ +L + + E+ IL ++ H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V+L + ++++E++ C+ L Q+ G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYC 116
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
H + HRD+K N+L++ + K++DFGL+R
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---VRKYTHEIVTLWYRAPD 170
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV- 566
+ + + D++S G + E++ E + + + + + + V
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 567 ----DPVLKERATHLDLETMKALGL----LAASCLDERRQNRPSMKEV 606
DP +K L L + L R + K+
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 65/295 (22%), Positives = 112/295 (37%), Gaps = 49/295 (16%)
Query: 332 FSKDNL---------IGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTD------LVLN 375
F ++N+ +G+G F V K G A K K TK + +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 376 EVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLV 435
EV IL ++ H +++ L ++I E + G LFD L + L
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-----EKESLTEEEATE 117
Query: 436 IAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE----KLNAKVSDFGLSRLVERTETND 491
QI G+ YLHS I H D+K NI+L + K K+ DFGL+ ++
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172
Query: 492 SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV 551
F GT ++ PE L ++D++S GV+ LL+ + ++E + V
Sbjct: 173 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229
Query: 552 YMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
+ ++E + K+ L + + R ++++
Sbjct: 230 AVNYEFEDEYFSN-TSALAKD---------------FIRRLLVKDPKKRMTIQDS 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 67/286 (23%), Positives = 102/286 (35%), Gaps = 37/286 (12%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLV---LNEVRILCQVNH 385
N+F L+G G FG+V G A+K + D V + E R+L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
L L D+ + EY G LF HL + +I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALE 119
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYL 505
YLHS + +RD+K N++LD+ + K++DFGL + GT YL
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC----GTPEYL 172
Query: 506 DPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565
PE + D + GVV+ E++ + E ++ +M+E R
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILMEEIRFPRT 227
Query: 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV-ADEI 610
+ P K L A L + + R A E+
Sbjct: 228 LSPEAKS---------------LLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (349), Expect = 2e-37
Identities = 41/294 (13%), Positives = 85/294 (28%), Gaps = 30/294 (10%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL 388
++ IG G FG +F+G L + AIK + +E R + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 389 VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLH 448
+ + + ++ + +L D L + A Q+ + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 449 SAAVPPIYHRDVKSSNILLDEKLN-----AKVSDFGLSRLVERTETND---SHIFTTAQG 500
+ +RD+K N L+ + V DFG+ + T G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
T Y+ + + + + D+ + G V + L + N + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614
L E+ +E + P + ++
Sbjct: 236 PLRELCAGFPEE------------FYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-37
Identities = 59/288 (20%), Positives = 106/288 (36%), Gaps = 22/288 (7%)
Query: 331 NFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRS 387
NF K IG G +G V+K G V A+K+ +L + E+ +L ++NH +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 388 LVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYL 447
+V+LL ++ +++E++ D +P L Q+ +GL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 448 HSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
HS + HRD+K N+L++ + K++DFGL+R
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPE 172
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL----- 562
+ D++S G + E++T + + E + + + DE
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 563 MEVVDPVLKERATHLDLETMKALGLLAAS----CLDERRQNRPSMKEV 606
M P + A + + L S L R S K
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 7e-37
Identities = 63/247 (25%), Positives = 101/247 (40%), Gaps = 27/247 (10%)
Query: 293 KKETKKLLIKQREEMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGI-L 351
++ K+ L K +E+ L + T + + F + +GTG FG V
Sbjct: 12 QESVKEFLAKAKEDFLK--------KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 352 DDGTVTAIK---RAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408
+ G A+K + K+ K + LNE RIL VN LV+L + M+ EY+
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD 468
G +F HL + A QI YLHS + +RD+K N+L+D
Sbjct: 124 AGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLID 175
Query: 469 EKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVL 528
++ +V+DFG ++ T GT L PE + D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAK-------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 529 LELLTSK 535
E+
Sbjct: 229 YEMAAGY 235
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 58/279 (20%), Positives = 95/279 (34%), Gaps = 37/279 (13%)
Query: 337 LIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGC 394
++G G G+V + A+K + EV + + +VR++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 395 CVELDQT----LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA 450
L L++ E + G LF + I I E + YLHS
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 451 AVPPIYHRDVKSSNILLDEKLN---AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP 507
I HRDVK N+L K K++DFG ++ ET + TT T Y+ P
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTTPCYTPYYVAP 182
Query: 508 EYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567
E + D++S GV++ LL N + ++ E
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEV 606
V +E + +L + L R ++ E
Sbjct: 243 EVSEE------------VKMLIRNLLKTEPTQRMTITEF 269
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-34
Identities = 80/318 (25%), Positives = 129/318 (40%), Gaps = 42/318 (13%)
Query: 306 EMLNAKAAGKSARIFTGKEIRRATNNFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKR 361
++L K ++A + TG + NF ++GTG +G+VF D G + A+K
Sbjct: 1 QLLTVKHELRTANL-TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV 59
Query: 362 AK----LGNTKGTDLVLNEVRILCQVNHRS-LVRLLGCCVELDQTLMIYEYIPNGTLFDH 416
K + K T+ E ++L + LV L + +I +YI G LF H
Sbjct: 60 LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH 119
Query: 417 LHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVS 476
L + H + +I L +LH I +RD+K NILLD + ++
Sbjct: 120 LS-----QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLT 171
Query: 477 DFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQ--LTDKSDVYSFGVVLLELLTS 534
DFGLS+ ET ++ F GT+ Y+ P+ R D +S GV++ ELLT
Sbjct: 172 DFGLSKEFVADETERAYDF---CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 535 KKAIDFNREEENVNLVVYMKKIMDEE-RLMEVVDPVLKERATHLDLETMKALGLLAASCL 593
F + E + ++I+ E + + + K+ L L
Sbjct: 229 ASP--FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD---------------LIQRLL 271
Query: 594 DERRQNRPSM-KEVADEI 610
+ + R ADEI
Sbjct: 272 MKDPKKRLGCGPRDADEI 289
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 7e-34
Identities = 53/290 (18%), Positives = 104/290 (35%), Gaps = 24/290 (8%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL--VLNEVRILCQVNHR 386
+ K IG G +G VFK + + A+KR +L + L E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 387 SLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTY 446
++VRL + +++E+ C L + Q+ +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGF 116
Query: 447 LHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLD 506
H + HRD+K N+L++ K+++FGL+R S T
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT---LWYRPP 170
Query: 507 PEYYRNFQLTDKSDVYSFGVVLLELLTSKKAI-DFNREEENVNLVVYMKKIMDEERLMEV 565
+ + D++S G + EL + + + N ++ + + + EE+ +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 566 VDPVLKERATHLDLETMKALGL---------LAASCLDERRQNRPSMKEV 606
+ T + L + L R S +E
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 8e-34
Identities = 60/310 (19%), Positives = 107/310 (34%), Gaps = 38/310 (12%)
Query: 320 FTGKEIRRAT----NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK--RAKLGNTKGTDL 372
F +E+ + + +G+G +G V + G AIK +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 373 VLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHL 432
E+R+L + H +++ LL + ++ K L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-KHEKLGEDR 122
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492
+ +Q+ +GL Y+H+ I HRD+K N+ ++E K+ DFGL+R +
Sbjct: 123 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----- 174
Query: 493 HIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSK---------------K 536
T T Y PE N+ T D++S G ++ E++T K
Sbjct: 175 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 537 AIDFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDER 596
+ E V + + + L E+ T+ A+ LL L
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL---AVNLL-EKMLVLD 288
Query: 597 RQNRPSMKEV 606
+ R + E
Sbjct: 289 AEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (312), Expect = 5e-32
Identities = 48/244 (19%), Positives = 104/244 (42%), Gaps = 27/244 (11%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRS 387
+++ +G G + EVF+ I + + +K K K + E++IL + +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 388 LVRLLGCCVELDQTL--MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
++ L + +++E++ N L + ++I + L
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALD 143
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEK-LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGY 504
Y HS I HRDVK N+++D + ++ D+GL+ + + + + +
Sbjct: 144 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-----ASRYF 195
Query: 505 LDPEYYRNFQLTD-KSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563
PE ++Q+ D D++S G +L ++ K+ F +N + +V + K++ E L
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 564 EVVD 567
+ +D
Sbjct: 254 DYID 257
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 5e-30
Identities = 56/306 (18%), Positives = 100/306 (32%), Gaps = 30/306 (9%)
Query: 320 FTGKEIRRA----TNNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDL-- 372
F +E+ + + + +G+G +G V G A+K+
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 373 VLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHL 432
E+R+L + H +++ LL + L + K L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDH 122
Query: 433 RLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDS 492
+ +QI GL Y+HS I HRD+K SN+ ++E K+ DFGL+R D
Sbjct: 123 VQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDD 173
Query: 493 HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552
+ D++S G ++ ELLT + + + L++
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 553 MKKIMDEERLMEVVDPVLKER------------ATHLDLETMKALGLLAASCLDERRQNR 600
+ E L ++ + A A+ LL L R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL-EKMLVLDSDKR 292
Query: 601 PSMKEV 606
+ +
Sbjct: 293 ITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 59/309 (19%), Positives = 101/309 (32%), Gaps = 49/309 (15%)
Query: 330 NNFSKDNLIGTGGFGEVFKGI-LDDGTVTAIK--RAKLGNTKGTDLVLNEVRILCQVNHR 386
+ IG+G G V AIK N E+ ++ VNH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 387 SLVRLLGCCV------ELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQI 440
+++ LL E ++ E + + +Q+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQM 128
Query: 441 AEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQG 500
G+ +LHS I HRD+K SNI++ K+ DFGL+R S + T
Sbjct: 129 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPYVV 180
Query: 501 TMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560
T Y PE + D++S G ++ E++ K + N V+ E
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 561 RLMEVV-----------------------DPVLKERATHLDLETMKALGLLAASCLDERR 597
+ ++ D + + H L+ +A LL + L
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL-SKMLVIDP 299
Query: 598 QNRPSMKEV 606
R S+ +
Sbjct: 300 AKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (257), Expect = 1e-24
Identities = 40/240 (16%), Positives = 88/240 (36%), Gaps = 18/240 (7%)
Query: 332 FSKDNLIGTGGFGEVFKGI-LDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL-- 388
+ +G G F V+ + + T A+K + G+ T+ +E+++L +VN
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 389 ---------VRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQ 439
++LL + + + L + +P I+ Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 440 IAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRLVERTETNDSHIFTTA 498
+ GL Y+H I H D+K N+L++ + ++ L ++ + +
Sbjct: 134 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS-- 189
Query: 499 QGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558
T Y PE +D++S ++ EL+T + + ++ +I++
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 28/157 (17%), Positives = 49/157 (31%), Gaps = 22/157 (14%)
Query: 336 NLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLV----------LNEVRILCQVNH 385
L+G G VF + +K K+G+T + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 386 RSLVRLLGCCVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLT 445
R+L +L G V +Y + N + L + + I E +
Sbjct: 66 RALQKLQGLAVP-----KVYAWEGNA-VLMELIDAKELYRVRVENPDE--VLDMILEEVA 117
Query: 446 YLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482
+ I H D+ N+L+ E+ + DF S
Sbjct: 118 KFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 624 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.63 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.24 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 88.06 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 85.34 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.64 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 81.17 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 80.59 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=418.68 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=202.8
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|++.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578889999999999999999988899999998754 3445789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+|+|.+++.. ....+++..+++|+.|||+||+|||+.+ |+||||||+|||+|+++.+||+|||+++......
T Consensus 84 ~g~L~~~l~~----~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 84 HGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp TCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 9999999863 3456999999999999999999999999 9999999999999999999999999998765321
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
........||+.|+|||++.+..++.++||||||+++|||+|++.|+...... ..+...+. ... ....|
T Consensus 156 --~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~---~~~---~~~~p- 224 (263)
T d1sm2a_ 156 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDIS---TGF---RLYKP- 224 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHH---HTC---CCCCC-
T ss_pred --ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHH---hcC---CCCCc-
Confidence 12223457899999999999989999999999999999999976655432211 11111111 111 01111
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
.....++.+|+.+||+.||++||||+||++.|++|++.
T Consensus 225 ---------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 ---------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 12234678899999999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=414.29 Aligned_cols=261 Identities=30% Similarity=0.496 Sum_probs=204.7
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||+||+|+++ ..||||+++.. +....+.|.+|+++|++++|||||++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467999999999999999999864 35999998654 34456789999999999999999999998754 57899999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|.++++. ....+++..+++|+.||++||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHT----SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 9999999999963 2346999999999999999999999999 99999999999999999999999999987653
Q ss_pred cCCCCcceeecccccccccCccccccc---CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNF---QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.. .........||+.|||||++.+. .++.++|||||||+||||+||+.||......+. +......+.
T Consensus 157 ~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~-- 226 (276)
T d1uwha_ 157 WS--GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGY-- 226 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTS--
T ss_pred cC--CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCC--
Confidence 21 22234566799999999998643 589999999999999999999999974332211 111111111
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
..+.+.. .....++.+.+|+.+||+.||++||||+||++.|+.|.+
T Consensus 227 --~~p~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 227 --LSPDLSK----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp --CCCCGGG----SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCcchh----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111111 112334568889999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=415.54 Aligned_cols=260 Identities=29% Similarity=0.436 Sum_probs=210.4
Q ss_pred HhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
..++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 34678889999999999999999988899999998754 3445789999999999999999999998754 567999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++|+|.+++... ....+++..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 89 ~~~g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 89 MENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999988643 2235999999999999999999999999 999999999999999999999999999877532
Q ss_pred CCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
.........||+.|+|||++.+..++.++|||||||++|||+||+.|+...... ...........+
T Consensus 163 ---~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~~~~~i~~~~~------ 228 (272)
T d1qpca_ 163 ---EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNLERGYR------ 228 (272)
T ss_dssp ---CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCC------
T ss_pred ---ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcCC------
Confidence 222234567899999999999889999999999999999999977766433221 111111111110
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
+ ..+...+.++.+|+.+||+.||++||||+||++.|+.+...
T Consensus 229 ~-------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 M-------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0 01112345678899999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-52 Score=418.56 Aligned_cols=263 Identities=27% Similarity=0.440 Sum_probs=200.8
Q ss_pred CCCCccceeccCCcEEEEEEEEcC-C---CEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD-G---TVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++|++.++||+|+||+||+|+... + ..||||++.... ....+.|.+|+++|++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 346677899999999999999642 2 368899876543 34456799999999999999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.+++.. ....++|.++++|+.||++||+|||+++ |+||||||+||||++++++||+|||+|+.+
T Consensus 106 ~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999998863 3456999999999999999999999999 999999999999999999999999999877
Q ss_pred cccCCCCc-ceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 485 ERTETNDS-HIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 485 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
........ .......||+.|+|||.+.+..++.++|||||||+||||+| |+.||......+ + ........+.
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~---~~~i~~~~~~ 252 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---V---INAIEQDYRL 252 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHHHTTCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---H---HHHHHcCCCC
Confidence 54322111 11223457899999999999899999999999999999998 888986433221 1 1111111110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
..+...+..+.+|+.+||+.||++||||.||++.|+++++.++
T Consensus 253 -------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 253 -------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 1112345668889999999999999999999999999987554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-52 Score=419.52 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=214.9
Q ss_pred HHHHhCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 325 IRRATNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 325 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++...++|++.+.||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+.+..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3344567888999999999999999975 5889999998754 3456789999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++... ....+++..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.
T Consensus 91 v~E~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 91 ITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EeecccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999998643 3457999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... .........|++.|+|||++.+..++.++||||||+++|||++|+.|+....... . +...+..+...
T Consensus 165 ~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-----~-~~~~i~~~~~~ 235 (287)
T d1opja_ 165 MTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----Q-VYELLEKDYRM 235 (287)
T ss_dssp CCSS---SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----H-HHHHHHTTCCC
T ss_pred cCCC---CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-----H-HHHHHhcCCCC
Confidence 6532 2223345568899999999999999999999999999999999887765332211 1 11111111100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
..+...+.++.+|+.+||+.||++|||++||++.|+.+.+
T Consensus 236 ------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111234568889999999999999999999999988754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=408.17 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=202.6
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5789999999999999999996 4689999999865432 3356799999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+++|+|.+++. +...+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ~~gg~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 85 CSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999996 3357999999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
. ........+||+.|||||++.+..+ +.++|||||||++|||++|+.||........ . ...........
T Consensus 157 ~--~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~---~~~~~~~~~~~--- 226 (271)
T d1nvra_ 157 N--RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E---YSDWKEKKTYL--- 226 (271)
T ss_dssp T--EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--H---HHHHHTTCTTS---
T ss_pred C--ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--H---HHHHhcCCCCC---
Confidence 1 1222456789999999999988776 5789999999999999999999975432211 1 11111111000
Q ss_pred chhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 DPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
. .......++.+|+.+||+.||++|||++|+++
T Consensus 227 ~---------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 N---------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp T---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00122345678999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=410.91 Aligned_cols=265 Identities=29% Similarity=0.443 Sum_probs=206.1
Q ss_pred CCCCccceeccCCcEEEEEEEEcCC-----CEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDG-----TVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
+.|+..++||+|+||+||+|.+++. ..||||+++.... ...++|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999996542 3799999865433 345679999999999999999999999999999999
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+.+++|.+++.. ....++|.++++++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHH----TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEecccCcchhhhhc----ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999988753 3357999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
+.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.|+....... ... ..+..+..
T Consensus 160 ~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-----~~~-~~i~~~~~- 231 (283)
T d1mqba_ 160 LEDDP-EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVM-KAINDGFR- 231 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH-HHHHTTCC-
T ss_pred ccCCC-ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-----HHH-HHHhccCC-
Confidence 65321 11122234568999999999999999999999999999999999877765332211 111 11111110
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
...+...+..+.+|+.+||+.+|++||||.||++.|+++++.++..
T Consensus 232 -----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l 277 (283)
T d1mqba_ 232 -----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277 (283)
T ss_dssp -----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred -----------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcccc
Confidence 0111234456888999999999999999999999999999876543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=404.47 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=207.7
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
++|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999995 579999999987666666778999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.+++.. ..+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+...
T Consensus 100 ~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~- 169 (293)
T d1yhwa1 100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (293)
T ss_dssp TTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred CCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc-
Confidence 99999988752 35999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+......... ...
T Consensus 170 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~-~~~-- 237 (293)
T d1yhwa1 170 ---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-ELQ-- 237 (293)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-CCS--
T ss_pred ---cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC-CCC--
Confidence 122345679999999999999899999999999999999999999996443221 11111111110 000
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+......+.+|+.+||+.||++|||++|+++
T Consensus 238 --------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 --------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01123456788999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=401.91 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=210.6
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeecc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIP 409 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 409 (624)
++|++.+.||+|+||+||+|++++++.||||+++... ...++|++|+.++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888899999987543 345789999999999999999999999999999999999999
Q ss_pred CCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCC
Q 039681 410 NGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTET 489 (624)
Q Consensus 410 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 489 (624)
+|+|.+++.. ....+++..+++|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~g~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 154 (258)
T d1k2pa_ 83 NGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 154 (258)
T ss_dssp TEEHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred CCcHHHhhhc----cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC-
Confidence 9999999763 2356899999999999999999999999 9999999999999999999999999998765322
Q ss_pred CCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 490 NDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 490 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
........+|..|+|||.+.+..++.++||||||+++|||+| |+.||......+ . ... +..+. ....|
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~---~~~-i~~~~--~~~~p 223 (258)
T d1k2pa_ 155 --YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---T---AEH-IAQGL--RLYRP 223 (258)
T ss_dssp --CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---H---HHH-HHTTC--CCCCC
T ss_pred --ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---H---HHH-HHhCC--CCCCc
Confidence 122334668999999999999899999999999999999998 788886543221 1 111 11111 11111
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHH
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEY 612 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~ 612 (624)
...+..+.+|+.+||+.||++|||++||++.|.+
T Consensus 224 ----------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 ----------HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1233568889999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=404.60 Aligned_cols=245 Identities=27% Similarity=0.403 Sum_probs=204.5
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999974 6899999987632 2233567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..+..|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999999963 246999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. ......||+.|+|||++.+..++.++|||||||+||||++|+.||......+ ......... .
T Consensus 158 ~~------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-~--- 221 (263)
T d2j4za1 158 SS------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVE-F--- 221 (263)
T ss_dssp CC------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-C---
T ss_pred CC------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-C---
Confidence 22 1345679999999999999899999999999999999999999997543221 111111111 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 222 ----------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 011123356788999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-51 Score=405.53 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=207.6
Q ss_pred CCCCccce-eccCCcEEEEEEEEc---CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNL-IGTGGFGEVFKGILD---DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++|.+.+. ||+|+||+||+|++. ++..||||+++.... ...+.|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34556664 999999999999853 355799999875433 446789999999999999999999999864 568999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.+++.. ....+++.++++|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 87 mE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999998753 3357999999999999999999999999 999999999999999999999999999877
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
..... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +. ..+..+...
T Consensus 160 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~----~~i~~~~~~ 231 (285)
T d1u59a_ 160 GADDS-YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKRM 231 (285)
T ss_dssp TTCSC-EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTCCC
T ss_pred ccccc-ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCC
Confidence 53221 1111234568999999999998899999999999999999998 899987433221 11 111111111
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
..+...+.++.+|+.+||+.+|++||||.+|++.|+.+....
T Consensus 232 ------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 232 ------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 111233456788999999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=407.33 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=194.6
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEe--CCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE--LDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 404 (624)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5789999999999999999996 468999999986543 2345678999999999999999999999975 4568999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA--VPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~--~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
|||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ ..+|+||||||+||||++++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999864211 2457999999999999999999999875 2349999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ... +..+..
T Consensus 163 ~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~---~~~-i~~~~~ 231 (269)
T d2java1 163 ILNHD----TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---L---AGK-IREGKF 231 (269)
T ss_dssp HC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHH-HHHTCC
T ss_pred ecccC----CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---H---HHH-HHcCCC
Confidence 76532 122345679999999999999899999999999999999999999997543221 1 111 111111
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.. .+...+.++.+|+.+||+.||++|||++|+++
T Consensus 232 ~~------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 RR------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 11123456888999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=402.07 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=199.0
Q ss_pred ceeccCCcEEEEEEEEcC---CCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeeccC
Q 039681 336 NLIGTGGFGEVFKGILDD---GTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYIPN 410 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 410 (624)
+.||+|+||+||+|.+.+ ++.||||+++.. +....+.|.+|+++|++++|||||+++|++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 468999998643 23345679999999999999999999999864 567899999999
Q ss_pred CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccCCC
Q 039681 411 GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTETN 490 (624)
Q Consensus 411 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 490 (624)
|+|.++++. ...+++.++++|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~- 162 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN- 162 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS-
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc-
Confidence 999999863 356999999999999999999999999 99999999999999999999999999987653211
Q ss_pred CcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccchh
Q 039681 491 DSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDPV 569 (624)
Q Consensus 491 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 569 (624)
.........||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ + ...+..+...
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~----~~~i~~~~~~------ 229 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKGERM------ 229 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTCCC------
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---H----HHHHHcCCCC------
Confidence 1112234568999999999998899999999999999999998 899987433211 1 1111111110
Q ss_pred hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 570 LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 570 l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
..+...+.++.+|+.+||+.||++|||+++|++.|+...
T Consensus 230 ------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 ------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 111223456888999999999999999999999998864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=402.33 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=206.5
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
+.|++.+.||+|+||+||+|+. .+++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688899999999999999996 468999999998777777888999999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.+++.. ....+++.++..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~----~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~- 163 (288)
T d2jfla1 92 AGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 163 (288)
T ss_dssp TTEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC-
Confidence 99999998753 2346999999999999999999999999 999999999999999999999999999765421
Q ss_pred CCCcceeecccccccccCccccc-----ccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYR-----NFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
........||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .. ....... ..
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~~i~~~~-~~ 233 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---LKIAKSE-PP 233 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHHSC-CC
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---HHHHcCC-CC
Confidence 11223567999999999984 4458899999999999999999999997543322 11 1111111 00
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... .+...+.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLA----------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCS----------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC----------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 01123456788999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=404.68 Aligned_cols=259 Identities=29% Similarity=0.410 Sum_probs=205.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++|++.+.||+|+||+||+|+.++++.||||+++.. ....+.|.+|+.++++++|||||+++|++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 4678999999999999999999988889999998754 344578999999999999999999999985 46689999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|..++... ....++|.+++.|+.||+.||+|||+++ |+||||||+|||||+++++||+|||+++......
T Consensus 94 ~~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999988743 2246999999999999999999999999 9999999999999999999999999998765321
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
........||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ...+.......+
T Consensus 168 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~~~i~~~~~------- 232 (285)
T d1fmka3 168 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVERGYR------- 232 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCC-------
T ss_pred ---ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcCC-------
Confidence 12234567899999999999999999999999999999999987776543221 111111111110
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
...+...+.++.+++.+||+.||++||||++|+++|+.....
T Consensus 233 ------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 233 ------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 011123345688899999999999999999999999986654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=411.20 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=204.7
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46799999999999999999996 468999999987543 3345678999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSA-AVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~-~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+||||++++++||+|||+|+...
T Consensus 85 y~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999973 24699999999999999999999975 7 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHH-HHHHHhcc-----
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVV-YMKKIMDE----- 559 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~----- 559 (624)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+...... ........
T Consensus 157 ~~~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 157 DSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHT------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred CCc------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 321 235679999999999999999999999999999999999999997644321100000 00000000
Q ss_pred -----------------cccccccchhhhhccCcC-cHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 -----------------ERLMEVVDPVLKERATHL-DLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 -----------------~~~~~~~d~~l~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....+..+.......+.. ......++.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000000000000000 0112356788999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-50 Score=406.81 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=205.1
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC-C-----CEEEEEEcccC-CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD-G-----TVTAIKRAKLG-NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 400 (624)
.++|++.++||+|+||+||+|+... + ..||||++... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678889999999999999999643 2 36899987643 334456799999999998 89999999999999999
Q ss_pred eeEEEeeccCCCcccccccccC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFT------------------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKS 462 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~------------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~ 462 (624)
.++||||+++|+|.++|+.... .....+++..++.|+.||++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999974321 11246899999999999999999999999 99999999
Q ss_pred CCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 039681 463 SNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFN 541 (624)
Q Consensus 463 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~ 541 (624)
+|||++.++.+||+|||+|+...... .........||+.|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDS--NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hccccccCCeEEEeeccccccccCCC--ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998765321 2222345668999999999999999999999999999999998 89998754
Q ss_pred CccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHH
Q 039681 542 REEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIE 611 (624)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~ 611 (624)
...+. +......+... ..+...+.++.+|+.+||+.||++|||++||++.|.
T Consensus 271 ~~~~~------~~~~~~~~~~~------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDAN------FYKLIQNGFKM------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHH------HHHHHHTTCCC------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHH------HHHHHhcCCCC------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 32211 11112111100 111223456888999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=393.18 Aligned_cols=246 Identities=23% Similarity=0.389 Sum_probs=195.9
Q ss_pred CccceeccCCcEEEEEEEEc-CCCEEEEEEcccC--CcchhHHHHHHHHHHHhcCCCceeeEeeEEEe----CCceeEEE
Q 039681 333 SKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG--NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVE----LDQTLMIY 405 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 405 (624)
+..+.||+|+||+||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999964 6889999987643 23345679999999999999999999999875 34578999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC-CCCCeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD-EKLNAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~-~~~~~kl~DfGla~~~ 484 (624)
||+++|+|.+++.. ...+++..++.|+.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999963 246999999999999999999999986 4599999999999996 5789999999999864
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... .... .+..+..
T Consensus 166 ~~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~-~i~~~~~-- 230 (270)
T d1t4ha_ 166 RAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYR-RVTSGVK-- 230 (270)
T ss_dssp CTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHH-HHTTTCC--
T ss_pred cCC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHH-HHHcCCC--
Confidence 321 2345679999999999876 69999999999999999999999996432211 1111 1111111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+.+. .....++.+|+.+||+.||++|||++|+++
T Consensus 231 --~~~~~-------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 --PASFD-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CGGGG-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CcccC-------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111 112335778999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=402.97 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=203.0
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999996 46899999998643 2234567999999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 88 Ey~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999998863 346999999999999999999999999 9999999999999999999999999998765
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
... .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......... .
T Consensus 160 ~~~--~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-~--- 227 (288)
T d1uu3a_ 160 PES--KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLE-Y--- 227 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTC-C---
T ss_pred cCC--cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHcCC-C---
Confidence 321 1222345679999999999999899999999999999999999999997543221 111111111 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+ +.....++.+|+.+||+.||++|||++|+++
T Consensus 228 ---~~-------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ---DF-------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CC-------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CC-------CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 01 1123345788999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-50 Score=402.85 Aligned_cols=265 Identities=25% Similarity=0.363 Sum_probs=210.7
Q ss_pred HHHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCcc-hhHHHHHHHHHHHhcCCCceeeEeeEEEeC
Q 039681 326 RRATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNTK-GTDLVLNEVRILCQVNHRSLVRLLGCCVEL 398 (624)
Q Consensus 326 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 398 (624)
+...++|++.+.||+|+||+||+|+.. +++.||||+++..... ..++|.+|+++|++++||||+++++++.+.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 334567999999999999999999864 3578999998755433 356799999999999999999999999999
Q ss_pred CceeEEEeeccCCCccccccccc-------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeec
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDF-------------------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRD 459 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~D 459 (624)
+..++||||+++|+|.++++... ......+++..++.|+.||+.||+|||+.+ |||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrD 165 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 165 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeE
Confidence 99999999999999999986321 112345899999999999999999999999 99999
Q ss_pred CCCCCeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCC-CC
Q 039681 460 VKSSNILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK-AI 538 (624)
Q Consensus 460 ik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~-p~ 538 (624)
|||+|||+|.++.+||+|||+|+...... .....+...+++.|+|||.+.+..++.++|||||||++|||++|.. ||
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSAD--YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGG--CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCc--cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999998764321 2222345678999999999999999999999999999999999975 55
Q ss_pred CCCCccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHH
Q 039681 539 DFNREEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYII 614 (624)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~ 614 (624)
......+ .... +..+.... .+...+.++.+|+.+||+.+|++||||.||+++|++|.
T Consensus 244 ~~~~~~e------~~~~-v~~~~~~~------------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEE------VIYY-VRDGNILA------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHH------HHHH-HHTTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHH------HHHH-HHcCCCCC------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 4332221 1111 22221111 11123456788999999999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=393.90 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=199.5
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC----CCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD----GTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
.++|++.+.||+|+||+||+|++.. +..||||+++.... ...+.|.+|++++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578889999999999999998642 35688998865433 33567999999999999999999999985 467899
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~----~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHH----TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhc----cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999998753 3357999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
.... .........||+.|+|||++.+..++.++|||||||++|||++ |..||......+ +...+ ......
T Consensus 158 ~~~~---~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i---~~~~~~ 228 (273)
T d1mp8a_ 158 MEDS---TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI---ENGERL 228 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH---HTTCCC
T ss_pred ccCC---cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH---HcCCCC
Confidence 6532 1222345568999999999999899999999999999999998 788886543322 11111 111110
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
..+...+..+.+|+.+||+.||++|||++||++.|+++++..+
T Consensus 229 -------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 229 -------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1112334568889999999999999999999999999987543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.5e-49 Score=403.32 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=208.5
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
-++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999996 46899999999876666677899999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC--CCCCeEEeecCCccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD--EKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~--~~~~~kl~DfGla~~~~ 485 (624)
+++|+|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 105 ~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999853 3356999999999999999999999999 99999999999996 46789999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .......||+.|||||++.+..++.++|||||||++|||++|+.||......+ .+........ .
T Consensus 178 ~~-----~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~--~- 243 (350)
T d1koaa2 178 PK-----QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDW--N- 243 (350)
T ss_dssp TT-----SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC--C-
T ss_pred cc-----cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC--C-
Confidence 32 22345679999999999999899999999999999999999999997543221 1111111110 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.++... ......+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 244 MDDSAF-------SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp SCCGGG-------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcccc-------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011110 122346788999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=395.27 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=205.9
Q ss_pred cceeccCCcEEEEEEEEcCC----CEEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-CceeEEEeec
Q 039681 335 DNLIGTGGFGEVFKGILDDG----TVTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-DQTLMIYEYI 408 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 408 (624)
.++||+|+||+||+|++.++ ..||||+++.. +....+.|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999996432 35899998643 444567899999999999999999999998764 5789999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.++++. ....+++..+++++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999863 3456889999999999999999999999 9999999999999999999999999998876443
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccccch
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVVDP 568 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 568 (624)
...........||..|+|||.+.+..++.++||||||+++|||+||+.||....... +... .... +. ....|
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~---~i~~-g~--~~~~p 256 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV---YLLQ-GR--RLLQP 256 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHT-TC--CCCCC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH---HHHc-CC--CCCCc
Confidence 333333345678999999999999999999999999999999999988876432211 1111 1111 11 01111
Q ss_pred hhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 569 VLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 569 ~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
......+.+|+.+||+.||++||||.||++.|+++++.
T Consensus 257 ----------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 ----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12335678899999999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=390.74 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=198.6
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC-CceeEEEeec
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-DQTLMIYEYI 408 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 408 (624)
++|++.+.||+|+||.||+|+++ |+.||||+++. ....+.|.+|++++++++||||++++|++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46788899999999999999984 77899999864 34557899999999999999999999999654 5689999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
++|+|.+++... ....++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp TTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence 999999999643 2235899999999999999999999998 999999999999999999999999999865422
Q ss_pred CCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccccccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERLMEVVD 567 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 567 (624)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+...... ++...+ ..+...
T Consensus 157 ------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~~~~---- 219 (262)
T d1byga_ 157 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYKM---- 219 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTCCC----
T ss_pred ------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCCC----
Confidence 223457899999999998899999999999999999998 56666543222 222221 111111
Q ss_pred hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 568 PVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 568 ~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
..+.....++.+|+.+||+.||++||||.||+++|++|+..
T Consensus 220 --------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 220 --------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 11112335678899999999999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-48 Score=394.51 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=190.0
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.+.|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466999999999999999999964 689999999865432 234568899999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC---CCCCeEEeecCCccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD---EKLNAKVSDFGLSRL 483 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~---~~~~~kl~DfGla~~ 483 (624)
|+++|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+.
T Consensus 88 ~~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 88 LVSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCSCBHHHHHH-----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ccCCCcHHHhhh-----cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999996 3357999999999999999999999999 99999999999994 578999999999986
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...........
T Consensus 160 ~~~~-----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~- 227 (307)
T d1a06a_ 160 EDPG-----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYE- 227 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTCCC-
T ss_pred ccCC-----CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccCCC-
Confidence 5422 22345679999999999999899999999999999999999999997543221 11111111100
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.+... ....+.++.+|+.+||+.||++|||++|+++
T Consensus 228 --~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 --FDSPY-------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --CCTTT-------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCcc-------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00000 1123456788999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=393.58 Aligned_cols=275 Identities=21% Similarity=0.321 Sum_probs=205.4
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHH--HHHHHHhcCCCceeeEeeEEEeCC----ceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLN--EVRILCQVNHRSLVRLLGCCVELD----QTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l 403 (624)
++|.+.+.||+|+||+||+|++ +|+.||||+++.. ....+.. |+..+.+++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567788999999999999987 5889999998643 2233444 455556789999999999998754 5789
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAA-----VPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~-----~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
||||+++|+|.++++. ..++|.++++++.|+|.||+|||+.. ..+|+||||||+||||++++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999973 35999999999999999999999741 123999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCccccccc------CCCCccchhhHHHHHHHHHhCCCCCCCCCcccc------
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF------QLTDKSDVYSFGVVLLELLTSKKAIDFNREEEN------ 546 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~------ 546 (624)
|+++.................||+.|+|||++.+. .++.|+|||||||+||||+||..|+........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 99987754322222233457799999999998654 367799999999999999999988754322111
Q ss_pred --ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccC
Q 039681 547 --VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGR 620 (624)
Q Consensus 547 --~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~ 620 (624)
.............+. .+|.+..... +.+....+.+|+.+||+.||++|||+.||++.|++|.+....+
T Consensus 233 ~~~~~~~~~~~~~~~~~----~~p~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQK----LRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp CSSCCHHHHHHHHTTSC----CCCCCCGGGG--GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred cccchHHHHHHHHhccc----cCCCCCcccC--ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 011111222222211 1222211111 2346677899999999999999999999999999998766543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=394.23 Aligned_cols=244 Identities=27% Similarity=0.352 Sum_probs=199.5
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
.|+..+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999995 5688999999875433 234568999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+++|+|..++. ....+++.+++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~-----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHH-----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999876664 2357999999999999999999999999 99999999999999999999999999986542
Q ss_pred cCCCCcceeecccccccccCcccccc---cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRN---FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLM 563 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (624)
. ....||+.|||||++.+ ..++.++|||||||++|||++|+.||......+ .+....... ..
T Consensus 168 ~--------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~~~~-~~ 232 (309)
T d1u5ra_ 168 A--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-SP 232 (309)
T ss_dssp B--------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-CC
T ss_pred C--------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCC-CC
Confidence 1 24569999999999864 358999999999999999999999996433211 111111111 00
Q ss_pred cccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 564 EVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 564 ~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... +...+..+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~-----------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ALQ-----------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCS-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC-----------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 000 1123356788999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=397.13 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=201.9
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCC----EEEEEEcccC-CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGT----VTAIKRAKLG-NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLM 403 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 403 (624)
++|++.++||+|+||+||+|.+. +|+ .||+|+++.. +.+..++|.+|++++++++|||||+++|++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46899999999999999999864 443 5889987643 33456789999999999999999999999986 45678
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
++||+.+|+|.+++.. ....+++..+++|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence 8999999999998864 3457999999999999999999999999 99999999999999999999999999987
Q ss_pred ccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhccccc
Q 039681 484 VERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEERL 562 (624)
Q Consensus 484 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (624)
..... .........||+.|+|||++.+..++.++||||||++||||+| |..||......+ +...+.. ..+.
T Consensus 161 ~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~---~~~~ 232 (317)
T d1xkka_ 161 LGAEE--KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEK---GERL 232 (317)
T ss_dssp TTTTC--C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHH---TCCC
T ss_pred ccccc--ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc---CCCC
Confidence 65322 1222234568999999999999899999999999999999998 677776443222 2111111 1100
Q ss_pred ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 563 MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 563 ~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
..+...+..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 233 -------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 -------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11112345678899999999999999999999999988653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=395.89 Aligned_cols=265 Identities=28% Similarity=0.405 Sum_probs=207.7
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCC--EEEEEEcccC-CcchhHHHHHHHHHHHhc-CCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGT--VTAIKRAKLG-NTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 404 (624)
++|++.++||+|+||+||+|++. ++. .||||+++.. .....+.|.+|+++|+++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888999999999999999965 444 4778876533 334567899999999999 799999999999999999999
Q ss_pred EeeccCCCccccccccc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCe
Q 039681 405 YEYIPNGTLFDHLHCDF-----------TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNA 473 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~ 473 (624)
|||+++|+|.++|+... ......+++.++++++.||++||+|||+.+ |+||||||+|||+++++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999996431 123467999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCC-CCCCCccccccHHHH
Q 039681 474 KVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKA-IDFNREEENVNLVVY 552 (624)
Q Consensus 474 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p-~~~~~~~~~~~~~~~ 552 (624)
||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|..| |.... ....
T Consensus 167 kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAEL 235 (309)
T ss_dssp EECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHH
T ss_pred EEccccccccccccc-----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHH
Confidence 999999998654221 11244689999999999998999999999999999999998764 53221 1111
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcccCC
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAKGRI 621 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~ 621 (624)
... +..+.. ...+...+.++.+|+.+||+.||++||||+||++.|+++++.....+
T Consensus 236 ~~~-i~~~~~------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~ 291 (309)
T d1fvra_ 236 YEK-LPQGYR------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291 (309)
T ss_dssp HHH-GGGTCC------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred HHH-HHhcCC------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCC
Confidence 111 111110 11112234568889999999999999999999999999987654433
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-48 Score=399.86 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=208.2
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999996 57999999998766656667889999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC--CCCCeEEeecCCccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD--EKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~--~~~~~kl~DfGla~~~~ 485 (624)
+++|+|.+++.. ....+++.+++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+.
T Consensus 108 ~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 108 LSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecC
Confidence 999999987752 3346999999999999999999999999 99999999999998 67899999999998765
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+....... ..
T Consensus 181 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~-~~-- 246 (352)
T d1koba_ 181 PD-----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCD-WE-- 246 (352)
T ss_dssp TT-----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCC-CC--
T ss_pred CC-----CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CC--
Confidence 32 22445679999999999999999999999999999999999999997543321 111111111 00
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
..... ......++.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~-------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDA-------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSST-------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCccc-------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0123456788999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=390.46 Aligned_cols=251 Identities=24% Similarity=0.299 Sum_probs=204.7
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc------chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCce
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT------KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQT 401 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 401 (624)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999996 5789999998864322 2356799999999999999999999999999999
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC----CeEEee
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL----NAKVSD 477 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~----~~kl~D 477 (624)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence 999999999999999963 246999999999999999999999999 99999999999998776 499999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHh
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIM 557 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 557 (624)
||+|+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......
T Consensus 161 fG~a~~~~~~-----~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~ 229 (293)
T d1jksa_ 161 FGLAHKIDFG-----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVS 229 (293)
T ss_dssp CTTCEECTTS-----CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred hhhhhhcCCC-----ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHH
Confidence 9999876432 12345678999999999999899999999999999999999999997543221 111111
Q ss_pred cccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 558 DEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 558 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... . ...+... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~-~--~~~~~~~-------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 230 AVN-Y--EFEDEYF-------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TTC-C--CCCHHHH-------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcC-C--CCCchhc-------CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110 0 0001110 122356778999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=391.52 Aligned_cols=271 Identities=25% Similarity=0.347 Sum_probs=202.2
Q ss_pred HHHHHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEE
Q 039681 324 EIRRATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCC 395 (624)
Q Consensus 324 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 395 (624)
+++...++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|..++.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33334467999999999999999999853 246899999875433 3456788888888887 689999999998
Q ss_pred EeCC-ceeEEEeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCC
Q 039681 396 VELD-QTLMIYEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSS 463 (624)
Q Consensus 396 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~ 463 (624)
.+.+ ..++||||+++|+|.++++.... .....+++.+++.++.||++||+|||+++ |+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 7654 68999999999999999964321 12346899999999999999999999999 999999999
Q ss_pred CeEECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCC-CCCCCC
Q 039681 464 NILLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKK-AIDFNR 542 (624)
Q Consensus 464 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~-p~~~~~ 542 (624)
||||++++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||+||.. ||....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDP--DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GEEECGGGCEEECC------CCSCT--TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeECCCCcEEEccCcchhhccccc--cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999998764321 1122345679999999999999999999999999999999999765 554332
Q ss_pred ccccccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 543 EEENVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
..+ .+......+..... +...+.++.+|+.+||+.||++|||++||++.|++|++..
T Consensus 242 ~~~------~~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 242 IDE------EFCRRLKEGTRMRA------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp CSH------HHHHHHHHTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH------HHHHHHhcCCCCCC------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 211 11112222211111 1123346788999999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=394.14 Aligned_cols=247 Identities=26% Similarity=0.337 Sum_probs=205.0
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||.||+++. .+|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5789999999999999999996 57999999998643 2334577899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999873 356899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....... +..
T Consensus 157 ~~----~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~-~~~--- 222 (337)
T d1o6la_ 157 SD----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILM-EEI--- 222 (337)
T ss_dssp CT----TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCC---
T ss_pred cC----CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhc-CCC---
Confidence 22 122345679999999999999999999999999999999999999997544321 1111111 111
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
..+.....++.+|+.+||+.||.+||+ ++|+++
T Consensus 223 ----------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 001123345778999999999999995 788775
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=385.63 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=196.7
Q ss_pred CCCCccceeccCCcEEEEEEEEcC--C--CEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDD--G--TVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
++|++.+.||+|+||+||+|++.. + ..||||+++.. .....+.|.+|+.+|++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568889999999999999998542 2 36899987643 23445689999999999999999999999965 5678
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+++|+|.+++..+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999888642 346999999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
...... ..........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... ..+......+.
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~ 232 (273)
T d1u46a_ 160 ALPQND-DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE 232 (273)
T ss_dssp ECCC-C-CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCC
T ss_pred hcccCC-CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCC
Confidence 775332 11122234567889999999999899999999999999999998 89998643322 12222222221
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYI 613 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i 613 (624)
... .....+..+.+|+.+||+.||++||||.||.+.|++.
T Consensus 233 ~~~------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLP------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 110 0112335688899999999999999999999998875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.6e-48 Score=383.51 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=203.3
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc---chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCc----
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT---KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQ---- 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 400 (624)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|++++++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999995 5789999999865432 334578999999999999999999999987543
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||||+++++|.+++.. ...+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++..+|+|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhh
Confidence 7899999999999998863 346999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+....... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||......+ .........
T Consensus 158 ~~~~~~~~-~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~ 230 (277)
T d1o6ya_ 158 ARAIADSG-NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVRED 230 (277)
T ss_dssp CEECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCC
T ss_pred hhhhcccc-ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcC
Confidence 87654321 22223456679999999999999899999999999999999999999997543221 122222222
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-CHHHHHHHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-SMKEVADEIEYII 614 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~ 614 (624)
... +.. .....+.++.+++.+||+.||++|| |+++++..|.+++
T Consensus 231 ~~~----~~~------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 PIP----PSA------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCC----GGG------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCC----Cch------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 110 000 0012345678899999999999999 8999999998875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=388.44 Aligned_cols=265 Identities=26% Similarity=0.404 Sum_probs=207.6
Q ss_pred hCCCCccceeccCCcEEEEEEEEcC--------CCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEEEeC
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILDD--------GTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL 398 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 398 (624)
.++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +|||||++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578889999999999999998532 24799999875443 3457789999999888 799999999999999
Q ss_pred CceeEEEeeccCCCcccccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEE
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFT-----------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILL 467 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill 467 (624)
...++||||+++|+|.++|..... .....+++.++++++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999964321 12356999999999999999999999999 9999999999999
Q ss_pred CCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHh-CCCCCCCCCcccc
Q 039681 468 DEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLT-SKKAIDFNREEEN 546 (624)
Q Consensus 468 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~ellt-g~~p~~~~~~~~~ 546 (624)
+.++.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCT--TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred cCCCCeEeccchhhcccccccc--ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence 9999999999999987764322 222345678999999999999999999999999999999998 566765332211
Q ss_pred ccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhc
Q 039681 547 VNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIA 617 (624)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~ 617 (624)
+...+..+.... .+...+..+.+|+.+||+.||++|||+.||++.|++|.+.-
T Consensus 246 ------~~~~i~~~~~~~------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 246 ------LFKLLKEGHRMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp ------HHHHHHTTCCCC------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------HHHHHHcCCCCC------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 112222211111 11123356888999999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-47 Score=388.48 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=203.5
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688999999999999999996 56899999998643 2334577999999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999998863 356899999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......... .
T Consensus 156 ~~-------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~-~--- 218 (316)
T d1fota_ 156 DV-------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAE-L--- 218 (316)
T ss_dssp SC-------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCC-C---
T ss_pred cc-------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHHHHcCC-C---
Confidence 22 235679999999999999899999999999999999999999997543221 112211111 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
..+.....++.+++.+||+.||.+|| |++|+++
T Consensus 219 ----------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ----------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 00112234577899999999999996 8999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=387.71 Aligned_cols=268 Identities=27% Similarity=0.369 Sum_probs=212.2
Q ss_pred HHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCCc-chhHHHHHHHHHHHhc-CCCceeeEeeEEEeC
Q 039681 327 RATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGNT-KGTDLVLNEVRILCQV-NHRSLVRLLGCCVEL 398 (624)
Q Consensus 327 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 398 (624)
...++|++.++||+|+||.||+|++. +++.||||+++.... .....|.+|+.+++++ +|||||+++|++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 33467888999999999999999852 457899999875433 3456799999999999 699999999999999
Q ss_pred CceeEEEeeccCCCcccccccccC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCe
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFT-------------GKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNI 465 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Ni 465 (624)
...++||||+++|+|.++++.... .....+++..+++|+.||++||+|||+++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 999999999999999999874321 12346999999999999999999999999 99999999999
Q ss_pred EECCCCCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccc
Q 039681 466 LLDEKLNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEE 545 (624)
Q Consensus 466 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~ 545 (624)
|++.++.+||+|||+++...... .........||+.|+|||.+.+..++.++||||||+++|||+|++.|+.......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCT--TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccCcccccccchheeccCCC--cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998765321 2223345678999999999999899999999999999999999665544322211
Q ss_pred cccHHHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHh
Q 039681 546 NVNLVVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISI 616 (624)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~ 616 (624)
.. +......+... ..+...+..+.+|+.+||+.||++||||+||+++|+++++.
T Consensus 255 --~~---~~~~i~~~~~~------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 --SK---FYKMIKEGFRM------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp --HH---HHHHHHHTCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HH---HHHHHhcCCCC------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11 11112111100 00112335688899999999999999999999999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=390.69 Aligned_cols=269 Identities=26% Similarity=0.365 Sum_probs=212.7
Q ss_pred HHHHHHhCCCCccceeccCCcEEEEEEEEc------CCCEEEEEEcccCC-cchhHHHHHHHHHHHhcCCCceeeEeeEE
Q 039681 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILD------DGTVTAIKRAKLGN-TKGTDLVLNEVRILCQVNHRSLVRLLGCC 395 (624)
Q Consensus 323 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 395 (624)
++++...++|++.+.||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++|||||+++|++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 344445578889999999999999999863 35789999987543 33445789999999999999999999999
Q ss_pred EeCCceeEEEeeccCCCccccccccc-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCC
Q 039681 396 VELDQTLMIYEYIPNGTLFDHLHCDF-----TGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEK 470 (624)
Q Consensus 396 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~ 470 (624)
......++||||+++|+|.++++... ......+++..+.+++.|+|+||+|||+++ |+||||||+|||+|++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCC
Confidence 99999999999999999999986321 123356899999999999999999999998 9999999999999999
Q ss_pred CCeEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCC-CCCCCCCccccccH
Q 039681 471 LNAKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSK-KAIDFNREEENVNL 549 (624)
Q Consensus 471 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~-~p~~~~~~~~~~~~ 549 (624)
+++||+|||+|+....... ........+|+.|+|||.+.+..++.++||||||+++|||+||+ .||.....
T Consensus 170 ~~~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------ 241 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------ 241 (308)
T ss_dssp CCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------
T ss_pred ceEEEeecccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------
Confidence 9999999999987653211 11123346899999999999999999999999999999999996 55543221
Q ss_pred HHHHHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 550 VVYMKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 550 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
........+.. ... .+...+..+.+|+.+||+.+|++||||+||+++|++.++
T Consensus 242 ~~~~~~i~~~~-~~~------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 242 EQVLRFVMEGG-LLD------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHHHTTC-CCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHHhCC-CCC------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11222222211 111 111233568889999999999999999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-47 Score=377.46 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=202.8
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc---------hhHHHHHHHHHHHhcC-CCceeeEeeEEEeC
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK---------GTDLVLNEVRILCQVN-HRSLVRLLGCCVEL 398 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 398 (624)
++|++.+.||+|+||+||+|+. .+++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999996 57899999998654321 1345889999999997 99999999999999
Q ss_pred CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeec
Q 039681 399 DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDF 478 (624)
Q Consensus 399 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~Df 478 (624)
+..+|||||+++|+|.++++. ...+++.+++.++.||++||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 999999999999999999963 246999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccc------cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRN------FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVY 552 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 552 (624)
|+++.+... ...+...||..|+|||++.+ ..++.++||||+||++|||++|+.||......+ .
T Consensus 155 G~a~~~~~~-----~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~ 223 (277)
T d1phka_ 155 GFSCQLDPG-----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------M 223 (277)
T ss_dssp TTCEECCTT-----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred hheeEccCC-----CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------H
Confidence 999876532 12345679999999999863 246889999999999999999999997543221 1
Q ss_pred HHHHhcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 553 MKKIMDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 553 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
........ .. ...+. ....+.++.+|+.+||+.||++|||++||++
T Consensus 224 ~~~i~~~~-~~-~~~~~--------~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 224 LRMIMSGN-YQ-FGSPE--------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHTC-CC-CCTTT--------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHhCC-CC-CCCcc--------cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111111 10 00000 1123456788999999999999999999865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=381.70 Aligned_cols=259 Identities=21% Similarity=0.264 Sum_probs=195.4
Q ss_pred cceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcc-----hhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEeec
Q 039681 335 DNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTK-----GTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEYI 408 (624)
Q Consensus 335 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 408 (624)
.++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999995 56899999998654322 1346899999999999999999999999999999999999
Q ss_pred cCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccccC
Q 039681 409 PNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERTE 488 (624)
Q Consensus 409 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 488 (624)
.++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 83 ~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~- 153 (299)
T d1ua2a_ 83 ETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 153 (299)
T ss_dssp SEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred cchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC-
Confidence 8887766654 3456899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc---ccccc
Q 039681 489 TNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE---ERLME 564 (624)
Q Consensus 489 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 564 (624)
........||+.|+|||++... .++.++|||||||++|||++|..||......+. ...+...... +....
T Consensus 154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 154 ---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp ---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSS
T ss_pred ---cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccc
Confidence 1122345799999999998654 579999999999999999999999976543322 1222221111 10000
Q ss_pred ccc---hhhhhccCcCc-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 565 VVD---PVLKERATHLD-----LETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 565 ~~d---~~l~~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
... .......+..+ .....++.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 00000000000 112356888999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=381.97 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=204.9
Q ss_pred hCCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
.++|++.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467899999999999999999964 68899999987543 3445688999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC--CCCeEEeecCCccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE--KLNAKVSDFGLSRLVE 485 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~--~~~~kl~DfGla~~~~ 485 (624)
+++|+|.+++.. ....+++.+++.|+.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++...
T Consensus 83 ~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 83 ISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999963 2346999999999999999999999999 999999999999985 4589999999998754
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
. ........+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+ .+........ .
T Consensus 156 ~-----~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~~---~ 221 (321)
T d1tkia_ 156 P-----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEY---T 221 (321)
T ss_dssp T-----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC---C
T ss_pred c-----CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC---C
Confidence 2 122345678999999999999899999999999999999999999997543321 1122111110 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
++.... .....++.+|+.+||+.||++|||++|+++
T Consensus 222 ~~~~~~-------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDEEAF-------KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHH-------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhc-------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 012345788999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=386.28 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=201.1
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccC---CcchhHHHHHHHHHHH-hcCCCceeeEeeEEEeCCceeEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLG---NTKGTDLVLNEVRILC-QVNHRSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 404 (624)
++|.+.+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|..++. .++|||||++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999964 6899999998642 2234456777777765 68999999999999999999999
Q ss_pred EeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccc
Q 039681 405 YEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLV 484 (624)
Q Consensus 405 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~ 484 (624)
|||+++|+|.++++. ...+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhc
Confidence 999999999999973 246899999999999999999999999 999999999999999999999999999865
Q ss_pred cccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccc
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLME 564 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (624)
... ....+...||+.|+|||++.+..++.++|||||||++|||++|+.||......+ + ... +..+.
T Consensus 154 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~---~~~-i~~~~--- 219 (320)
T d1xjda_ 154 MLG----DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L---FHS-IRMDN--- 219 (320)
T ss_dssp CCT----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHH-HHHCC---
T ss_pred ccc----cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---H---HHH-HHcCC---
Confidence 422 122345679999999999999999999999999999999999999997543321 1 111 11111
Q ss_pred ccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHH-HHH
Q 039681 565 VVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMK-EVA 607 (624)
Q Consensus 565 ~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~ 607 (624)
+ ..+.....++.+|+.+||+.||++|||+. |++
T Consensus 220 ---~-------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 220 ---P-------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ---C-------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---C-------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 0 01112335578899999999999999995 675
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-47 Score=388.18 Aligned_cols=244 Identities=26% Similarity=0.332 Sum_probs=203.4
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccC---CcchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLG---NTKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 405 (624)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|+.++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999996 47999999987532 2234567899999999999999999999999999999999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVE 485 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~ 485 (624)
||+.+|+|.+++.. ...+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+.
T Consensus 121 e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 99999999999863 246999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccccccc
Q 039681 486 RTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEV 565 (624)
Q Consensus 486 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 565 (624)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 193 ~~-------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~-~--- 255 (350)
T d1rdqe_ 193 GR-------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGK-V--- 255 (350)
T ss_dssp SC-------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C---
T ss_pred cc-------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHhcCC-C---
Confidence 21 23457999999999999999999999999999999999999999754321 1111111111 0
Q ss_pred cchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCC-----CHHHHHH
Q 039681 566 VDPVLKERATHLDLETMKALGLLAASCLDERRQNRP-----SMKEVAD 608 (624)
Q Consensus 566 ~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~ 608 (624)
..+.....++.+|+.+||+.||.+|+ |++|+++
T Consensus 256 ----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 00112334678899999999999994 8999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-46 Score=388.11 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=197.0
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC---cchhHHHHH---HHHHHHhcCCCceeeEeeEEEeCCcee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN---TKGTDLVLN---EVRILCQVNHRSLVRLLGCCVELDQTL 402 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 402 (624)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999964 69999999875321 112223444 466777788999999999999999999
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999963 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
.+.... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||......+. ...... .....
T Consensus 156 ~~~~~~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~-~~~~~ 225 (364)
T d1omwa3 156 DFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRM-TLTMA 225 (364)
T ss_dssp ECSSSC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHH-SSSCC
T ss_pred ecCCCc------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh-cccCC
Confidence 764321 234579999999999864 5689999999999999999999999975443221 111111 11100
Q ss_pred cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 562 LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 562 ~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
+ ..+.....++.+|+.+||+.||++||| ++|+++
T Consensus 226 ------~-------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 ------V-------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ------C-------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ------C-------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 001123345788999999999999999 577764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=380.93 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=197.3
Q ss_pred hCCCCcc-ceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhc-CCCceeeEeeEEEe----CCce
Q 039681 329 TNNFSKD-NLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQV-NHRSLVRLLGCCVE----LDQT 401 (624)
Q Consensus 329 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 401 (624)
.++|.+. ++||+|+||+||+|+. .+++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3578765 5699999999999996 5789999999863 34678899987655 89999999999876 4568
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC---CCCeEEeec
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE---KLNAKVSDF 478 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~---~~~~kl~Df 478 (624)
++||||+++|+|.+++... ....+++.+++.|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccc
Confidence 9999999999999999632 2346999999999999999999999999 999999999999985 567999999
Q ss_pred CCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 479 GLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 479 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
|+|+...... ......||+.|+|||++.+..++.++|||||||+||||+||+.||......+... .+.....
T Consensus 159 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~ 230 (335)
T d2ozaa1 159 GFAKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIR 230 (335)
T ss_dssp TTCEECCCCC-----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC
T ss_pred ceeeeccCCC-----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHh
Confidence 9998764321 2345679999999999999899999999999999999999999997543322111 1111111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... .... ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~-~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 MGQY-EFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCSS-SCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCC-CCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000 0000 001234567889999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=376.32 Aligned_cols=267 Identities=23% Similarity=0.350 Sum_probs=199.9
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999996 5789999999865432 235679999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
|+.++ +.+++... ....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~-~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSEE-HHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCCc-hhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC
Confidence 99654 44444322 3456999999999999999999999999 99999999999999999999999999987642
Q ss_pred cCCCCcceeecccccccccCcccccccC-CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc-cc-cc
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE-ER-LM 563 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~ 563 (624)
. ........||+.|+|||.+.... ++.++|||||||++|||++|+.||......+... ......... +. ..
T Consensus 155 ~----~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 155 P----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWP 228 (298)
T ss_dssp C----SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTST
T ss_pred C----cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--HHHHhcCCCchhhcc
Confidence 2 12234557999999999886655 5889999999999999999999997554322111 111111110 00 00
Q ss_pred ccc-chhhhhcc---CcC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 564 EVV-DPVLKERA---THL-----DLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 564 ~~~-d~~l~~~~---~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
... .+...... ... ......++.+|+.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 00000000 000 01223567889999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.9e-46 Score=371.26 Aligned_cols=264 Identities=19% Similarity=0.256 Sum_probs=200.9
Q ss_pred CCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEee
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYEY 407 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 407 (624)
++|++.+.||+|+||+||+|+.++|+.||||+++.... ...+.+.+|+.+|++++||||+++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57889999999999999999998999999999865432 3356799999999999999999999999999999999999
Q ss_pred ccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCccccccc
Q 039681 408 IPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVERT 487 (624)
Q Consensus 408 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 487 (624)
+.++.+..+.. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHT-----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHh-----hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 98776666654 3467999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccccccccc
Q 039681 488 ETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEERLMEVV 566 (624)
Q Consensus 488 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 566 (624)
. .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+. ...+.............
T Consensus 154 ~----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 154 V----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWP 226 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTST
T ss_pred c----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhcc
Confidence 1 122344689999999998654 578999999999999999999999975443221 11111111111000000
Q ss_pred --------chhhhhc----cCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 567 --------DPVLKER----ATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 567 --------d~~l~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+...... ...........+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00001123356788999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=372.95 Aligned_cols=240 Identities=28% Similarity=0.451 Sum_probs=194.9
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc------chhHHHHHHHHHHHhcC--CCceeeEeeEEEeCC
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT------KGTDLVLNEVRILCQVN--HRSLVRLLGCCVELD 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 399 (624)
.++|++.++||+|+||+||+|+. .+|+.||||+++.... .....+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999996 5789999998864321 12234778999999997 899999999999999
Q ss_pred ceeEEEeeccC-CCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-CCCeEEee
Q 039681 400 QTLMIYEYIPN-GTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-KLNAKVSD 477 (624)
Q Consensus 400 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-~~~~kl~D 477 (624)
..++||||+.+ +++.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence 99999999976 577777753 346999999999999999999999999 999999999999985 57999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCcccccccCC-CCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQL-TDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
||+|+..... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 155 FG~a~~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i 216 (273)
T d1xwsa_ 155 FGSGALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------I 216 (273)
T ss_dssp CTTCEECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H
T ss_pred cccceecccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------H
Confidence 9999865421 2345679999999999987765 5678999999999999999999964210 0
Q ss_pred hcccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 557 MDEERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
.... . ... ...+.++.+|+.+||+.||++|||++|+++
T Consensus 217 ~~~~-~--~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 IRGQ-V--FFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHCC-C--CCS-----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhcc-c--CCC-----------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0000 0 000 112346788999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=372.92 Aligned_cols=269 Identities=22% Similarity=0.314 Sum_probs=198.7
Q ss_pred HhCCCCccceeccCCcEEEEEEEE-cC-CCEEEEEEcccCC--cchhHHHHHHHHHHHhc---CCCceeeEeeEEEe---
Q 039681 328 ATNNFSKDNLIGTGGFGEVFKGIL-DD-GTVTAIKRAKLGN--TKGTDLVLNEVRILCQV---NHRSLVRLLGCCVE--- 397 (624)
Q Consensus 328 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 397 (624)
..++|++.+.||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 346899999999999999999996 34 6679999986432 22344577888887766 79999999999864
Q ss_pred --CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEE
Q 039681 398 --LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKV 475 (624)
Q Consensus 398 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl 475 (624)
....++++||+.++++...... ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred ccCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeee
Confidence 2467899999988776544432 3457999999999999999999999999 999999999999999999999
Q ss_pred eecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 039681 476 SDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKK 555 (624)
Q Consensus 476 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 555 (624)
+|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.....
T Consensus 158 ~dfg~~~~~~~~-----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 232 (305)
T d1blxa_ 158 ADFGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232 (305)
T ss_dssp CSCCSCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhhhhhhccc-----ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence 999999865422 223466799999999999999999999999999999999999999976543332211111110
Q ss_pred Hhccccccccc---chhhhh----ccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 556 IMDEERLMEVV---DPVLKE----RATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 556 ~~~~~~~~~~~---d~~l~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
........... ...... ............+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00111000000 000000 000011123356778999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=368.39 Aligned_cols=272 Identities=21% Similarity=0.288 Sum_probs=198.5
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEe--------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVE-------- 397 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 397 (624)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36799999999999999999996 579999999976442 2345678999999999999999999999865
Q ss_pred CCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEee
Q 039681 398 LDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSD 477 (624)
Q Consensus 398 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~D 477 (624)
....++||||+.++++..+.. ....+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~-----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhhh-----cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeee
Confidence 345789999998777665443 3457899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 039681 478 FGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKI 556 (624)
Q Consensus 478 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 556 (624)
||+++.................||+.|+|||++.+. .++.++|||||||++|||++|+.||......+...........
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999987654322222223445799999999998765 6899999999999999999999999755433322222111111
Q ss_pred hcccccccccchhhhh-------ccCcCc-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 557 MDEERLMEVVDPVLKE-------RATHLD-----LETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 557 ~~~~~~~~~~d~~l~~-------~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
...+............ ...... ......+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1111111111000000 000000 111245678999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-43 Score=355.65 Aligned_cols=268 Identities=15% Similarity=0.143 Sum_probs=211.1
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCC-CceeeEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNH-RSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||+||+|+. .+|+.||||++... ...+.+.+|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46799999999999999999995 46899999987543 234567889999999975 899999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECC-----CCCeEEeecCCc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDE-----KLNAKVSDFGLS 481 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~-----~~~~kl~DfGla 481 (624)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~-~~~l~~~~~~----~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 82 LL-GPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp CC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHh----hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccccee
Confidence 99 7899988863 2346999999999999999999999999 999999999999974 578999999999
Q ss_pred ccccccCCCC---cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 482 RLVERTETND---SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 482 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+......... ........||+.|||||++.+..++.++||||||+++|||++|+.||..............+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 8765432211 1123456799999999999998999999999999999999999999976544332222111111111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHHhcc
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIISIAK 618 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~ 618 (624)
.... +.+. ...+.++.+++..|++.+|++||+++.+.+.|+++.....
T Consensus 234 ~~~~-----~~l~-------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 234 STPL-----RELC-------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HSCH-----HHHT-------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCCh-----HHhc-------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1000 0111 1123567889999999999999999999999999876443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-43 Score=358.18 Aligned_cols=265 Identities=19% Similarity=0.234 Sum_probs=201.2
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCcee-eEeeEEEeCCceeEEEe
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLV-RLLGCCVELDQTLMIYE 406 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e 406 (624)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ..+++..|+++++.++|+|++ .+.++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 35799999999999999999996 568999999876542 335688999999999877655 55566677888899999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEEC---CCCCeEEeecCCccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLD---EKLNAKVSDFGLSRL 483 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~---~~~~~kl~DfGla~~ 483 (624)
|+ +++|.+.+.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.
T Consensus 84 ~~-~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 84 LL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp CC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred Ec-CCchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99 5666666542 2356999999999999999999999999 99999999999985 456799999999998
Q ss_pred ccccCCCC---cceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc
Q 039681 484 VERTETND---SHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE 560 (624)
Q Consensus 484 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 560 (624)
+....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 75432221 112345679999999999999999999999999999999999999997654433222211111100000
Q ss_pred ccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHHHHHHHH
Q 039681 561 RLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADEIEYIIS 615 (624)
Q Consensus 561 ~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~ 615 (624)
. .+.+. ...+.++.+++.+||+.+|++||++.++.+.|+++..
T Consensus 236 ~-----~~~~~-------~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 P-----IEVLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp C-----HHHHT-------TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred C-----hhHhc-------cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0 00110 1233567889999999999999999999999998865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=369.56 Aligned_cols=271 Identities=21% Similarity=0.285 Sum_probs=198.6
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc-chhHHHHHHHHHHHhcCCCceeeEeeEEEeCC----cee
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT-KGTDLVLNEVRILCQVNHRSLVRLLGCCVELD----QTL 402 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 402 (624)
+++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+++|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999985 5799999999875433 34567899999999999999999999997653 335
Q ss_pred EEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 403 MIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 403 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+++
T Consensus 87 ~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence 56677779999999963 35999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER 561 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 561 (624)
........ ........||+.|+|||++.. ..++.++||||+|+++|||++|+.||......+................
T Consensus 158 ~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 158 VADPDHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp ECCGGGCB-CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eccCCCcc-ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 76533221 122345679999999999854 4578999999999999999999999976544322211111110000000
Q ss_pred cccccchhhhh------ccCcC-----cHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 562 LMEVVDPVLKE------RATHL-----DLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 562 ~~~~~d~~l~~------~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
........... ..... ......++.+|+.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000 00000 00122467889999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-44 Score=366.81 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=192.1
Q ss_pred CCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCceeeEeeEEEeC------CceeE
Q 039681 331 NFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL------DQTLM 403 (624)
Q Consensus 331 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 403 (624)
+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|+++|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 578889999999999999996 4689999999865432 235799999999999999999998653 24689
Q ss_pred EEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeecCCcc
Q 039681 404 IYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSR 482 (624)
Q Consensus 404 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGla~ 482 (624)
||||++++.+..+.+. ......+++.++..|+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 97 v~Ey~~~~~~~~l~~~--~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEEHHHHHHHH--HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEeccCCccHHHHHhh--hhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence 9999976644333321 113457999999999999999999999999 99999999999999775 89999999998
Q ss_pred cccccCCCCcceeecccccccccCcccccc-cCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc--
Q 039681 483 LVERTETNDSHIFTTAQGTMGYLDPEYYRN-FQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE-- 559 (624)
Q Consensus 483 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 559 (624)
...... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... +.+....
T Consensus 172 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~---i~~~~g~~~ 243 (350)
T d1q5ka_ 172 QLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE---IIKVLGTPT 243 (350)
T ss_dssp ECCTTS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH---HHHHHCCCC
T ss_pred hccCCc-----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHH---HHHHhCCCh
Confidence 764322 2334579999999998765 4689999999999999999999999975543322111 1111000
Q ss_pred -cccccc----cchhhhhcc-----CcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 -ERLMEV----VDPVLKERA-----THLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 -~~~~~~----~d~~l~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+.+... .+..+.... .........++.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000000000 0001123456788999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=365.81 Aligned_cols=260 Identities=21% Similarity=0.285 Sum_probs=193.4
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCC------
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELD------ 399 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 399 (624)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999996 469999999987532 234567899999999999999999999998654
Q ss_pred ceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecC
Q 039681 400 QTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFG 479 (624)
Q Consensus 400 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfG 479 (624)
..++||||+ +.+|..+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence 469999999 5667666642 46999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 480 LSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 480 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
+|+..... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||......+.............
T Consensus 167 ~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 167 LARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp TCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ceeccCCc-------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 99865421 2456799999999998764 578999999999999999999999976543222111111100000
Q ss_pred cccc---------------ccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHHH
Q 039681 559 EERL---------------MEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVADE 609 (624)
Q Consensus 559 ~~~~---------------~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~ 609 (624)
.+.. .+.....+.. ........+.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFAS----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGG----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHH----hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000000000 011223457789999999999999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=353.73 Aligned_cols=265 Identities=19% Similarity=0.278 Sum_probs=203.7
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeCCceeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 406 (624)
++|++.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999996 578999999986543 3346789999999999999999999999999999999999
Q ss_pred eccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCCcccccc
Q 039681 407 YIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVER 486 (624)
Q Consensus 407 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 486 (624)
++.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++....
T Consensus 82 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDS-----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHH-----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccc-----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccC
Confidence 999998888775 3457899999999999999999999999 99999999999999999999999999987643
Q ss_pred cCCCCcceeecccccccccCcccccccC-CCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcccc---c
Q 039681 487 TETNDSHIFTTAQGTMGYLDPEYYRNFQ-LTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEER---L 562 (624)
Q Consensus 487 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 562 (624)
.. .......++..|+|||.+.... ++.++|||||||++|||++|+.||....... +....+........ .
T Consensus 154 ~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 154 PV----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CC----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTC
T ss_pred CC----ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhh
Confidence 21 1223455788999999987654 6899999999999999999999975433221 11111221111100 0
Q ss_pred ---ccccch----h--hhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 563 ---MEVVDP----V--LKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 563 ---~~~~d~----~--l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....+. . ...............+.+|+.+||+.||.+|||++||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0 000001111223456788999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=357.47 Aligned_cols=252 Identities=27% Similarity=0.364 Sum_probs=200.9
Q ss_pred CCCCccceeccCCcEEEEEEEE----cCCCEEEEEEcccCC----cchhHHHHHHHHHHHhcCC-CceeeEeeEEEeCCc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL----DDGTVTAIKRAKLGN----TKGTDLVLNEVRILCQVNH-RSLVRLLGCCVELDQ 400 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 400 (624)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999985 247899999876432 2345678899999999976 899999999999999
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999743 45788999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCccccccc--CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF--QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMD 558 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 558 (624)
++.+.... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+..... ......
T Consensus 176 a~~~~~~~---~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~ 250 (322)
T d1vzoa_ 176 SKEFVADE---TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILK 250 (322)
T ss_dssp EEECCGGG---GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHH
T ss_pred hhhhcccc---cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhccc
Confidence 98764322 2223456799999999998654 4788999999999999999999999765443322111 111111
Q ss_pred ccccccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCC-----HHHHHH
Q 039681 559 EERLMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPS-----MKEVAD 608 (624)
Q Consensus 559 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~ 608 (624)
.. ...+.....++.+|+.+||+.||++||| ++|+++
T Consensus 251 ~~--------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 SE--------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC--------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 10 0111134456788999999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-42 Score=354.64 Aligned_cols=258 Identities=18% Similarity=0.282 Sum_probs=196.3
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeC--CceeEEE
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVEL--DQTLMIY 405 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 405 (624)
++|++.+.||+|+||+||+|+. .+++.||||+++.. ..+.+.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 57899999998643 3467899999999995 99999999999854 5689999
Q ss_pred eeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCC-CeEEeecCCcccc
Q 039681 406 EYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKL-NAKVSDFGLSRLV 484 (624)
Q Consensus 406 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~-~~kl~DfGla~~~ 484 (624)
||+++++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+..
T Consensus 112 e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred eecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 999999997764 25999999999999999999999999 99999999999998654 6999999999876
Q ss_pred cccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhccc---
Q 039681 485 ERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDEE--- 560 (624)
Q Consensus 485 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 560 (624)
.... ......+|+.|+|||.+.+. .++.++||||+|++++||++|+.||........ ....+.......
T Consensus 181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 181 HPGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLY 253 (328)
T ss_dssp CTTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHH
T ss_pred cCCC-----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhh
Confidence 4321 23456789999999998765 479999999999999999999999975443221 111111111100
Q ss_pred ------------ccccccch----hhhhccC-cCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 561 ------------RLMEVVDP----VLKERAT-HLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 561 ------------~~~~~~d~----~l~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
........ ....... ........++.+|+.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 0000000 001123456788999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=357.71 Aligned_cols=263 Identities=20% Similarity=0.247 Sum_probs=190.3
Q ss_pred CCCCccceeccCCcEEEEEEEEc-CCCEEEEEEcccCC--cchhHHHHHHHHHHHhcCCCceeeEeeEEEeC------Cc
Q 039681 330 NNFSKDNLIGTGGFGEVFKGILD-DGTVTAIKRAKLGN--TKGTDLVLNEVRILCQVNHRSLVRLLGCCVEL------DQ 400 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 400 (624)
++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999964 69999999987442 33456789999999999999999999999643 57
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.++||||+.++.+ +.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 8999999965544 4443 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHH-------
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYM------- 553 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~------- 553 (624)
++..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...............
T Consensus 166 ~~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 166 ARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhccccc-----cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 8865432 2234567899999999999989999999999999999999999999754432211111000
Q ss_pred ---------HHHhccc-c-----cccccchhhhhccCcCcHHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 554 ---------KKIMDEE-R-----LMEVVDPVLKERATHLDLETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 554 ---------~~~~~~~-~-----~~~~~d~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
....... . .......................+.+|+.+||+.||++|||++||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 0 00000001101111112345667899999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=356.70 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=196.0
Q ss_pred hCCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCc--chhHHHHHHHHHHHhcCCCceeeEeeEEEeC-----Cc
Q 039681 329 TNNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNT--KGTDLVLNEVRILCQVNHRSLVRLLGCCVEL-----DQ 400 (624)
Q Consensus 329 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 400 (624)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999995 5799999999875432 3456789999999999999999999998743 34
Q ss_pred eeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeEEeecCC
Q 039681 401 TLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAKVSDFGL 480 (624)
Q Consensus 401 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~kl~DfGl 480 (624)
.+++++|+.+|+|.++++. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence 5777888889999999852 35999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCccccccc-CCCCccchhhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHhcc
Q 039681 481 SRLVERTETNDSHIFTTAQGTMGYLDPEYYRNF-QLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVNLVVYMKKIMDE 559 (624)
Q Consensus 481 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 559 (624)
+...... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.........
T Consensus 168 a~~~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 168 ARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp --CCTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred hcccCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9765321 2345689999999987665 4688999999999999999999999765433222111111000000
Q ss_pred cccccccchhhh------hccCcCc-----HHHHHHHHHHHHHchhcCCCCCCCHHHHHH
Q 039681 560 ERLMEVVDPVLK------ERATHLD-----LETMKALGLLAASCLDERRQNRPSMKEVAD 608 (624)
Q Consensus 560 ~~~~~~~d~~l~------~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~ 608 (624)
+........... ....... .....++.+|+.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000000 0000000 112356788999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-37 Score=319.82 Aligned_cols=266 Identities=18% Similarity=0.221 Sum_probs=190.7
Q ss_pred CCCCccceeccCCcEEEEEEEE-cCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-----------CCceeeEeeEEEe
Q 039681 330 NNFSKDNLIGTGGFGEVFKGIL-DDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-----------HRSLVRLLGCCVE 397 (624)
Q Consensus 330 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 397 (624)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999996 57999999998743 233467788999988875 5789999998865
Q ss_pred C--CceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeecCCCCCeEECCCCC--
Q 039681 398 L--DQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHS-AAVPPIYHRDVKSSNILLDEKLN-- 472 (624)
Q Consensus 398 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~-~~~~~iiH~Dik~~Nill~~~~~-- 472 (624)
. ...++++++...+........ ......+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence 3 456677777755543333221 2244678999999999999999999998 77 999999999999986553
Q ss_pred ----eEEeecCCcccccccCCCCcceeecccccccccCcccccccCCCCccchhhHHHHHHHHHhCCCCCCCCCcccccc
Q 039681 473 ----AKVSDFGLSRLVERTETNDSHIFTTAQGTMGYLDPEYYRNFQLTDKSDVYSFGVVLLELLTSKKAIDFNREEENVN 548 (624)
Q Consensus 473 ----~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv~s~G~vl~elltg~~p~~~~~~~~~~~ 548 (624)
+|++|||.+...... .....||+.|+|||++....++.++||||+|++++||++|+.||..........
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ccceeeEeecccccccccc-------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 999999999754321 234569999999999998899999999999999999999999987543322211
Q ss_pred HHHHHHHH---hcc---cc------cccccc----------------hhhhhccCcCcHHHHHHHHHHHHHchhcCCCCC
Q 039681 549 LVVYMKKI---MDE---ER------LMEVVD----------------PVLKERATHLDLETMKALGLLAASCLDERRQNR 600 (624)
Q Consensus 549 ~~~~~~~~---~~~---~~------~~~~~d----------------~~l~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 600 (624)
........ ... .. .....+ ................++.+|+.+||+.||++|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 11111111 000 00 000000 000011112235567789999999999999999
Q ss_pred CCHHHHHH
Q 039681 601 PSMKEVAD 608 (624)
Q Consensus 601 Ps~~ev~~ 608 (624)
||++|+++
T Consensus 320 pta~e~L~ 327 (362)
T d1q8ya_ 320 ADAGGLVN 327 (362)
T ss_dssp BCHHHHHT
T ss_pred cCHHHHhc
Confidence 99999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=9.9e-24 Score=196.35 Aligned_cols=163 Identities=20% Similarity=0.213 Sum_probs=120.0
Q ss_pred CccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcc------------------hhHHHHHHHHHHHhcCCCceeeEeeE
Q 039681 333 SKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTK------------------GTDLVLNEVRILCQVNHRSLVRLLGC 394 (624)
Q Consensus 333 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~~~ 394 (624)
.+.+.||+|+||+||+|+..+|+.||||+++..... ....+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999888999999986532110 11234578899999999999988765
Q ss_pred EEeCCceeEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeecCCCCCeEECCCCCeE
Q 039681 395 CVELDQTLMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAVPPIYHRDVKSSNILLDEKLNAK 474 (624)
Q Consensus 395 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~~~iiH~Dik~~Nill~~~~~~k 474 (624)
. ..+++|||+++..+.+ +++....+++.|++++|+|||+.+ |+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 3 3479999998765433 233345689999999999999999 9999999999999965 589
Q ss_pred EeecCCcccccccCCCCcceeecccccccccCc------ccccccCCCCccchhhHHHHH
Q 039681 475 VSDFGLSRLVERTETNDSHIFTTAQGTMGYLDP------EYYRNFQLTDKSDVYSFGVVL 528 (624)
Q Consensus 475 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~ksDv~s~G~vl 528 (624)
|+|||+|........ ..|... |.+ ...|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGW------------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTH------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCc------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999976542110 011111 111 34688899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=9.5e-08 Score=91.37 Aligned_cols=150 Identities=14% Similarity=0.072 Sum_probs=105.6
Q ss_pred HHHHHHhCCCCccceeccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC-CCceeeEeeEEEeCCce
Q 039681 323 KEIRRATNNFSKDNLIGTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN-HRSLVRLLGCCVELDQT 401 (624)
Q Consensus 323 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 401 (624)
.+++...+.|+..+..+.++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35566666777665544455578998764 45566788766544445556788999988774 44467788888888899
Q ss_pred eEEEeeccCCCcccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----------------------------
Q 039681 402 LMIYEYIPNGTLFDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV----------------------------- 452 (624)
Q Consensus 402 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----------------------------- 452 (624)
++||+++++.++.+..... .....++.++++.|+.||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred EEEEEeccccccccccccc----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999998876544211 1233456677777777875321
Q ss_pred ---------------------------CCeEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 453 ---------------------------PPIYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 453 ---------------------------~~iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
..++|+|+.|.|||++++...-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999876677999997753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=5e-06 Score=78.50 Aligned_cols=130 Identities=17% Similarity=0.156 Sum_probs=89.3
Q ss_pred eeccCCc-EEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcC--CCceeeEeeEEEeCCceeEEEeeccCCCc
Q 039681 337 LIGTGGF-GEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVN--HRSLVRLLGCCVELDQTLMIYEYIPNGTL 413 (624)
Q Consensus 337 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L 413 (624)
.+..|.. ..||+...+++..+++|...... ...+..|...++.+. .-.+.+++++..+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455553 67899988888888999865432 345677888887774 33467788888888899999999988766
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 039681 414 FDHLHCDFTGKWPPLPWHLRLVIAHQIAEGLTYLHSAAV----------------------------------------- 452 (624)
Q Consensus 414 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~yLH~~~~----------------------------------------- 452 (624)
.+.. +.. ..++.++++.|+-||+...
T Consensus 94 ~~~~----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 94 LSSH----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTSC----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccc----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 4421 111 1223344555555553210
Q ss_pred --------------CCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 453 --------------PPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 453 --------------~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 127999999999999988777899999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.63 E-value=7.4e-05 Score=75.07 Aligned_cols=76 Identities=18% Similarity=0.151 Sum_probs=49.0
Q ss_pred ceeccCCcEEEEEEEEc-CCCEEEEEEcccC-------CcchhHHHHHHHHHHHhcC-C--CceeeEeeEEEeCCceeEE
Q 039681 336 NLIGTGGFGEVFKGILD-DGTVTAIKRAKLG-------NTKGTDLVLNEVRILCQVN-H--RSLVRLLGCCVELDQTLMI 404 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 404 (624)
+.||.|..-.||+.... +++.++||..... .....+....|.+.|+.+. + ..+.+++. .+.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 45899999999999854 4678899964321 1123345567888887663 3 34555554 356677899
Q ss_pred EeeccCCCc
Q 039681 405 YEYIPNGTL 413 (624)
Q Consensus 405 ~e~~~~g~L 413 (624)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.0026 Score=61.59 Aligned_cols=138 Identities=13% Similarity=0.104 Sum_probs=78.9
Q ss_pred cEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCce--eeEe-----eEEEeCCceeEEEeeccCCCccc
Q 039681 343 FGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL--VRLL-----GCCVELDQTLMIYEYIPNGTLFD 415 (624)
Q Consensus 343 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L~~ 415 (624)
--.||+....+|+.+++|+.+.. ....+++..|...+..|....+ +..+ ..+......+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 34799999999999999987643 3345667889888887742221 1111 12234567788999997644321
Q ss_pred c--------------ccc----ccCCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHhc----CCCC
Q 039681 416 H--------------LHC----DFTGKWPPLPWH-------------------LRLVIAHQIAEGLTYLHSA----AVPP 454 (624)
Q Consensus 416 ~--------------l~~----~~~~~~~~l~~~-------------------~~~~i~~~i~~~L~yLH~~----~~~~ 454 (624)
. +|. .....+..+++. .+..+...+.+.++.+... ....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 010 000011122221 1112222233333343332 1234
Q ss_pred eEeecCCCCCeEECCCCCeEEeecCCccc
Q 039681 455 IYHRDVKSSNILLDEKLNAKVSDFGLSRL 483 (624)
Q Consensus 455 iiH~Dik~~Nill~~~~~~kl~DfGla~~ 483 (624)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899997753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.27 E-value=0.0091 Score=59.26 Aligned_cols=73 Identities=21% Similarity=0.210 Sum_probs=48.6
Q ss_pred ceeccCCcEEEEEEEEcCC--------CEEEEEEcccCCcchhHHHHHHHHHHHhcCCCce-eeEeeEEEeCCceeEEEe
Q 039681 336 NLIGTGGFGEVFKGILDDG--------TVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRSL-VRLLGCCVELDQTLMIYE 406 (624)
Q Consensus 336 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 406 (624)
+.|+.|-.=.+|+....++ +.|++++.. . ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4677788889999886543 456666654 2 2233455789999988853344 466776642 68999
Q ss_pred eccCCCcc
Q 039681 407 YIPNGTLF 414 (624)
Q Consensus 407 ~~~~g~L~ 414 (624)
|+++.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99875543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.24 E-value=0.0067 Score=58.15 Aligned_cols=160 Identities=9% Similarity=-0.041 Sum_probs=82.7
Q ss_pred cCHHHHHHHhCCCCcccee-----ccCCcEEEEEEEEcCCCEEEEEEcccCCcchhHHHHHHHHHHHhcCCCc--eeeEe
Q 039681 320 FTGKEIRRATNNFSKDNLI-----GTGGFGEVFKGILDDGTVTAIKRAKLGNTKGTDLVLNEVRILCQVNHRS--LVRLL 392 (624)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 392 (624)
.+.++++...++|.+.++. ..|---+.|+.+.++|+ +++|+.... ...+++..|++++..+...+ +...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 4667788888888775543 35555778998877665 788887542 22344555667776663221 11111
Q ss_pred e------EEEeCCceeEEEeeccCCCccccccc-----------------ccC-C-CCCCCCH-----------------
Q 039681 393 G------CCVELDQTLMIYEYIPNGTLFDHLHC-----------------DFT-G-KWPPLPW----------------- 430 (624)
Q Consensus 393 ~------~~~~~~~~~lv~e~~~~g~L~~~l~~-----------------~~~-~-~~~~l~~----------------- 430 (624)
- +.........++.++.+......-.. ... . ......+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 11223455667777765433221100 000 0 0000000
Q ss_pred HHHHHHHHHHHHHHHHHHhcC-CCCeEeecCCCCCeEECCCCCeEEeecCCcc
Q 039681 431 HLRLVIAHQIAEGLTYLHSAA-VPPIYHRDVKSSNILLDEKLNAKVSDFGLSR 482 (624)
Q Consensus 431 ~~~~~i~~~i~~~L~yLH~~~-~~~iiH~Dik~~Nill~~~~~~kl~DfGla~ 482 (624)
......+..+...+.-.+... ...+||+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222222222211 1238999999999999998777899999774
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.06 E-value=0.13 Score=32.10 Aligned_cols=23 Identities=35% Similarity=0.836 Sum_probs=18.3
Q ss_pred CCcceeecCCCCccCCCCCCCcc
Q 039681 223 PGLKRCLCNPGFIWDPVNGLCQS 245 (624)
Q Consensus 223 ~~~~~C~c~~~~~~~p~~~~C~~ 245 (624)
.++|+|.|++||..++....|++
T Consensus 18 ~Gsy~C~C~~Gy~L~~d~~~C~a 40 (41)
T d1i0ua2 18 EGGYKCQCEEGFQLDPHTKACKA 40 (41)
T ss_dssp SSCCEECCCTTEEECTTTCCEEE
T ss_pred CCCEEeECCCCCeECCCCCcccc
Confidence 36799999999998886656653
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.34 E-value=0.14 Score=32.26 Aligned_cols=29 Identities=34% Similarity=0.763 Sum_probs=21.5
Q ss_pred CCccccCCCCCCcceeecCCCCccCCCCCCCc
Q 039681 213 HSNCLADPMYPGLKRCLCNPGFIWDPVNGLCQ 244 (624)
Q Consensus 213 ~~~C~~~~~~~~~~~C~c~~~~~~~p~~~~C~ 244 (624)
++.|.+.. ++|.|.|+.||..++....|.
T Consensus 14 ~~~C~Nt~---G~y~C~C~~Gy~l~~d~~~C~ 42 (43)
T d1uzka1 14 SGNCVNTP---GSYICDCPPDFELNPTRVGCV 42 (43)
T ss_dssp TSEEEEET---TEEEEECCTTCEECTTSSBEE
T ss_pred CCEeECCC---CCEEEecCCCCEECCCCCccc
Confidence 35565443 679999999999888665664
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.64 E-value=0.36 Score=30.28 Aligned_cols=28 Identities=21% Similarity=0.650 Sum_probs=20.6
Q ss_pred CCccccCCCCCCcceeecCCCCccCCCCCCC
Q 039681 213 HSNCLADPMYPGLKRCLCNPGFIWDPVNGLC 243 (624)
Q Consensus 213 ~~~C~~~~~~~~~~~C~c~~~~~~~p~~~~C 243 (624)
++.|.+.. ++|+|.|+.||..++....|
T Consensus 15 ~~~C~Nt~---Gsy~C~C~~Gy~l~~~~~~C 42 (43)
T d1uzka2 15 GGKCINTF---GSFQCRCPTGYYLNEDTRVC 42 (43)
T ss_dssp TSEEEECS---SCEEEECCTTCCBCTTTCBB
T ss_pred CCEEECCC---CCeEeECCCCCeECcCCCcc
Confidence 45676553 67999999999987755444
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.17 E-value=0.26 Score=30.38 Aligned_cols=28 Identities=18% Similarity=0.376 Sum_probs=21.6
Q ss_pred ccCCCCCCccccCCCCCCcceeecCCCCccCCC
Q 039681 207 DCKDLLHSNCLADPMYPGLKRCLCNPGFIWDPV 239 (624)
Q Consensus 207 ~C~~~~~~~C~~~~~~~~~~~C~c~~~~~~~p~ 239 (624)
.|.. +..|.+.. ++|.|.|++||.||..
T Consensus 8 ~C~~--~A~C~Nt~---Gsy~C~C~~Gy~GdG~ 35 (40)
T d1gl4a2 8 QCSV--HAECRDYA---TGFCCRCVANYTGNGR 35 (40)
T ss_dssp GSCT--TEEEEECS---SCEEEEECTTEEECSS
T ss_pred CCCC--CCEeecCC---CCeEeECCCCCcCCCC
Confidence 5654 78887543 6799999999999874
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.59 E-value=0.38 Score=29.79 Aligned_cols=25 Identities=20% Similarity=0.432 Sum_probs=19.1
Q ss_pred CCccccCCCCCCcceeecCCCCccCC
Q 039681 213 HSNCLADPMYPGLKRCLCNPGFIWDP 238 (624)
Q Consensus 213 ~~~C~~~~~~~~~~~C~c~~~~~~~p 238 (624)
+|.|...... .+|.|.|+.||.|.-
T Consensus 9 gG~C~~~~~~-~~y~C~C~~g~~G~~ 33 (41)
T d1tpga1 9 GGTCQQALYF-SDFVCQCPEGFAGKS 33 (41)
T ss_dssp TCEEEEESSS-SCEEEECCTTCBSSS
T ss_pred CCEEecCCCC-CCeEECCCCCCCCCC
Confidence 7888765444 579999999998754
|